data_2iij_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2iij _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.648 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.2 mptp? -96.6 -18.53 19.68 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.26 -176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.83 125.36 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.752 0.787 . . . . 0.0 110.71 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.536 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.36 100.05 7.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.786 176.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.586 ' HB ' ' HH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -77.96 131.84 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.403 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -111.73 -66.77 1.05 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.071 -166.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.525 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.4 t-20 -102.76 154.05 19.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.82 -176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' H ' ' ND2' ' A' ' 8' ' ' ASN . 6.1 p -144.83 99.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 CA-C-O 122.104 0.955 . . . . 0.0 109.214 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -92.26 95.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.322 1.058 . . . . 0.0 108.572 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.85 127.72 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.763 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.928 HD13 ' HB3' ' A' ' 23' ' ' GLN . 1.2 mt -97.48 -39.05 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.318 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.597 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 9.8 t0 -70.91 65.13 0.34 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.316 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.658 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -84.84 173.44 7.15 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 162.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.827 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.0 Cg_endo -50.32 101.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 121.508 1.574 . . . . 0.0 113.101 -158.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.631 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 13.9 m -136.21 169.44 13.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.861 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 70.5 Cg_exo -38.31 137.47 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.18 2.587 . . . . 0.0 113.496 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.742 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 19.2 t80 -63.09 -20.76 65.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 21.4 m-85 -94.38 5.62 51.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 111.235 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.77 140.92 47.44 Favored Pre-proline 0 C--O 1.213 -0.831 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 14.3 Cg_exo -74.56 141.92 28.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.691 2.261 . . . . 0.0 112.185 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.795 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 94.8 m-85 -60.24 117.07 4.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 122.964 0.506 . . . . 0.0 110.015 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.928 ' HB3' HD13 ' A' ' 12' ' ' LEU . 39.3 mt-30 -115.5 111.27 20.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.32 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.604 ' CD2' HD12 ' A' ' 97' ' ' ILE . 70.0 m-85 -121.58 107.51 12.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.497 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.579 ' HB2' HD21 ' A' ' 12' ' ' LEU . 22.0 tt0 -90.14 85.05 6.17 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.476 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 14.4 mt -86.83 132.4 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.694 0.759 . . . . 0.0 112.114 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.7 m -108.47 106.85 17.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.294 174.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.3 p90 -118.79 150.92 38.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.529 0.681 . . . . 0.0 109.717 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.801 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 47.2 tt0 -107.46 111.04 23.14 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.49 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 29.1 t -72.96 108.1 5.69 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -74.55 -27.21 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.031 -173.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 8.2 mt-10 -143.8 179.62 7.05 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.88 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -73.57 146.63 44.59 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.054 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -106.73 157.03 18.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -174.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -113.97 -41.85 3.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.889 0.852 . . . . 0.0 110.545 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.792 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 33.2 tt0 -113.33 -165.84 1.03 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.042 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.792 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -98.51 143.59 28.76 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.819 0.819 . . . . 0.0 110.599 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.845 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.68 124.13 29.92 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.38 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.576 ' HB3' ' O ' ' A' ' 100' ' ' THR . 42.3 tt0 -107.55 90.15 3.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.929 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.609 ' O ' ' HA ' ' A' ' 59' ' ' SER . 24.5 m95 -81.67 122.74 28.01 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.6 ttmt -126.4 141.59 51.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.549 ' CG2' HG23 ' A' ' 95' ' ' VAL . 13.8 mt -102.9 120.13 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.684 ' HB ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -114.38 106.33 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.287 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.693 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.5 t80 -88.87 116.69 27.34 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.73 105.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.151 0.5 . . . . 0.0 109.899 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.44 -35.77 92.49 Favored Glycine 0 CA--C 1.501 -0.808 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.172 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.55 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 46.6 t -139.14 116.56 11.25 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -70.35 -1.2 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 167.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -96.3 -27.02 15.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 47' ' ' SER . 14.5 m -144.67 109.45 4.99 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.828 0.823 . . . . 0.0 111.091 171.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.812 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -70.08 -23.76 63.12 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.399 -166.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -67.4 -2.33 6.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 4.2 m-30 -85.71 -4.02 59.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.041 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.2 p-10 -42.53 112.32 0.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.316 1.055 . . . . 0.0 112.206 -175.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 3.1 mt-30 -91.36 168.49 11.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.923 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.42 114.25 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -173.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 77' ' ' ASP . 3.1 mm? -82.73 -49.29 9.92 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.059 -174.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -163.92 164.04 23.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 27.8 p -141.43 117.46 10.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.2 p -100.29 132.76 45.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.624 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.36 105.93 15.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.638 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.23 113.81 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.65 -166.38 12.39 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.098 -168.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.054 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.8 Cg_endo -65.23 115.27 3.22 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.407 1.404 . . . . 0.0 110.365 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 31.1 m -131.99 141.36 41.19 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.614 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.55 79.11 3.31 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.082 1.854 . . . . 0.0 113.482 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.431 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.29 -171.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.015 -1.902 . . . . 0.0 112.343 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.94 122.79 2.62 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.947 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.801 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.9 ttt180 -87.69 118.24 27.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -161.06 166.0 28.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.41 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.608 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -108.64 139.46 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.174 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 9.8 p90 -126.69 160.91 29.39 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 73' ' ' VAL . 8.2 p -124.14 106.42 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-O 123.06 1.41 . . . . 0.0 111.898 -169.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.582 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 140.97 37.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.443 -2.162 . . . . 0.0 110.572 -176.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.795 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.0 mt-30 -150.68 149.84 30.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 165.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -158.65 132.14 7.48 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.457 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.712 ' O ' HD13 ' A' ' 57' ' ' LEU . 12.9 m-20 -67.18 143.19 56.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.163 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.509 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -52.2 157.22 2.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 124.704 1.201 . . . . 0.0 114.028 -173.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.663 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.03 -179.92 3.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.97 3.113 . . . . 0.0 113.267 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 96.1 m-20 -82.18 119.17 74.4 Favored Pre-proline 0 CA--C 1.515 -0.388 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.263 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 16.1 Cg_endo -60.32 -25.18 79.64 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.538 2.826 . . . . 0.0 112.576 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.0 -15.86 81.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.417 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.3 mt -79.57 -25.94 41.47 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.242 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.69 129.29 49.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -80.06 164.02 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.746 2.964 . . . . 0.0 112.794 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 m-20 -45.12 -55.0 6.11 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.823 0.849 . . . . 0.0 113.071 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.0 -18.56 61.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.218 0.533 . . . . 0.0 110.596 -168.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.559 ' HA ' ' NZ ' ' B' ' 122' ' ' LYS . 40.2 t0 -92.36 -35.82 13.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -70.17 -45.38 66.84 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.381 0.61 . . . . 0.0 111.332 -171.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.19 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.77 0.795 . . . . 0.0 111.559 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.45 -160.14 10.09 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.433 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.643 HG13 ' ND2' ' A' ' 114' ' ' ASN . 4.7 m -94.87 144.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.887 ' HB ' HG12 ' A' ' 113' ' ' VAL . 2.8 m -151.15 170.24 19.92 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.9 t -132.7 144.6 36.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 118.939 0.79 . . . . 0.0 110.954 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' CG2' ' A' ' 42' ' ' ILE . 10.5 p -129.04 105.48 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.909 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -104.13 135.51 45.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.792 -169.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 45.1 mt -103.29 99.82 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-O 121.919 0.866 . . . . 0.0 109.08 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 58.0 p -93.61 112.33 24.19 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.639 ' SG ' HD13 ' A' ' 38' ' ' LEU . 1.4 t -79.52 122.3 26.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.576 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 18.8 m -121.83 103.71 9.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.021 -167.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.669 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 61.4 t80 -109.14 120.28 42.05 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.413 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.669 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 15.5 mtp180 69.67 22.42 6.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.778 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.81 85.0 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -110.05 117.79 34.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.847 -0.676 . . . . 0.0 109.386 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 60.0 mt-10 -82.54 132.47 35.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.845 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.9 p90 -123.19 1.77 9.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.84 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.6 tt -159.24 157.86 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.615 ' HD2' ' O ' ' B' ' 130' ' ' ILE . 22.3 ttm180 -150.99 101.37 2.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.463 0.477 . . . . 0.0 109.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.909 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -84.52 98.66 6.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.228 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.17 77.25 2.12 Favored Glycine 0 CA--C 1.488 -1.606 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.586 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.96 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -74.06 115.9 14.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.137 -1.032 . . . . 0.0 109.121 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 140' ' ' LEU . 1.7 m-85 -66.31 120.58 13.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.887 HG12 ' HB ' ' A' ' 93' ' ' THR . 2.6 p -103.18 110.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.643 ' ND2' HG13 ' A' ' 92' ' ' VAL . 6.0 t-20 -92.43 110.76 22.17 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.184 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 39.1 m-80 -97.78 107.84 20.42 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.96 141.22 36.44 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.184 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.732 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 46.4 m-85 -47.97 151.93 0.86 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -174.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -86.81 -37.72 17.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.534 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.3 mt-10 -82.94 132.0 35.17 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.766 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 m -55.73 -36.17 66.95 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.55 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.85 -40.42 84.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.897 0.856 . . . . 0.0 109.991 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 46.0 mt -77.73 -23.09 49.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.799 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -80.15 -37.04 34.28 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.2 mm-40 -56.19 -43.1 78.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.769 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.466 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -152.72 89.11 3.82 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.447 0.641 . . . . 0.0 109.854 177.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.5 Cg_endo -50.46 116.01 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.769 2.979 . . . . 0.0 112.865 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.732 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 77.7 Cg_exo -52.75 136.79 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.007 2.471 . . . . 0.0 111.249 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 HG13 ' HE2' ' A' ' 129' ' ' LYS . 22.5 t -51.68 -40.68 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.555 -173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 1.8 mmpt? -94.83 137.96 22.25 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-O 121.153 0.501 . . . . 0.0 110.798 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.576 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 11.8 Cg_exo -69.89 123.77 10.38 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.7 2.933 . . . . 0.0 112.332 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.57 97.09 7.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.681 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.67 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 33.4 m-85 -68.0 -16.33 64.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.994 0.902 . . . . 0.0 110.549 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.463 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 2.9 p -83.3 -21.72 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -104.58 5.12 33.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.439 HD13 ' HB3' ' A' ' 115' ' ' ASN . 17.6 tp -87.82 137.83 31.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.556 -168.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 4.5 tt0 -120.41 127.5 52.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.827 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 21.2 mtm-85 -90.46 104.93 17.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 15.3 t30 -89.75 98.75 11.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.628 HG23 HG13 ' A' ' 11' ' ' VAL . 1.6 mp -78.73 100.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 112' ' ' TYR . 95.8 mt -62.2 92.57 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.706 0.765 . . . . 0.0 111.14 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.96 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -78.93 -8.82 59.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.419 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 p -80.66 -10.55 59.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.03 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.4 t-20 -142.27 62.97 14.41 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.513 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 4.7 Cg_exo -81.0 109.11 2.14 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.3 2.0 . . . . 0.0 111.098 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.635 ' HB3' HD13 ' B' ' 130' ' ' ILE . 15.0 tpt180 -82.23 82.61 7.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.98 106.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.2 m -116.46 105.65 12.72 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.601 0.715 . . . . 0.0 109.308 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.5 ptt180 -112.53 148.32 34.74 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.805 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -129.42 167.45 17.79 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.145 -173.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -106.1 123.14 47.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.931 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 101' ' ' TYR . 38.9 pt -121.45 158.73 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.461 HD21 ' H ' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -87.25 103.22 15.23 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.495 1.14 . . . . 0.0 110.365 172.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 7.9 m95 -75.54 -3.56 34.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.64 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 . . . . . 0 N--CA 1.438 -1.048 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.212 -176.059 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 9.5 mmmm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -40.59 -54.89 2.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.044 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.9 tp -69.06 -32.07 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.851 0.357 . . . . 0.0 111.247 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 8.4 mm100 -58.07 -46.91 84.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 173.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.542 ' O ' HG13 ' B' ' 130' ' ' ILE . 30.8 mt -68.35 -43.62 77.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.319 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.29 68.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.712 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 95.9 mtt180 -54.14 -57.65 10.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.812 ' HD3' ' HB2' ' A' ' 51' ' ' GLU . 6.1 tpt180 -61.4 -35.45 77.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.269 -171.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.635 HD13 ' HB3' ' A' ' 145' ' ' ARG . 23.8 mt -76.83 -49.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.65 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' B' ' 131' ' ' ARG . 7.3 mmm180 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 111.534 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.609 ' HB2' HD11 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.927 0.394 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.909 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.58 -21.57 18.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.457 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 3.4 t -137.53 129.22 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.772 0.796 . . . . 0.0 111.08 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.4 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp-100 -115.04 100.55 8.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.233 -1.349 . . . . 0.0 107.421 169.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.502 HG21 ' CH2' ' A' ' 40' ' ' TRP . 29.9 t -74.28 124.73 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -107.39 -65.65 1.09 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.09 0.947 . . . . 0.0 109.146 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.643 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.9 t-20 -106.41 151.8 24.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.849 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.661 HG21 HG13 ' A' ' 26' ' ' ILE . 3.2 p -146.77 99.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.367 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.914 HG21 ' HB3' ' A' ' 25' ' ' GLU . 2.4 m -93.67 107.11 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 109.979 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.867 HG11 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -78.72 136.6 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.568 -176.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 23' ' ' GLN . 7.6 mt -111.05 -42.14 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.32 -172.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 23' ' ' GLN . 4.2 p-10 -69.69 43.66 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.41 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -79.0 169.91 18.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.7 Cg_endo -53.02 100.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.048 1.165 . . . . 0.0 114.206 -138.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.645 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.6 m -136.76 171.22 9.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 112.008 -2.36 . . . . 0.0 107.482 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 62.4 Cg_exo -39.83 141.46 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.695 2.263 . . . . 0.0 112.912 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 1.004 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.0 t80 -60.31 -30.6 69.59 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.378 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -79.38 -6.17 56.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.089 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.487 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -77.59 119.94 79.46 Favored Pre-proline 0 CA--C 1.507 -0.682 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.532 ' C ' HH22 ' A' ' 137' ' ' ARG . 47.2 Cg_exo -60.57 154.43 54.28 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 123.844 3.03 . . . . 0.0 113.391 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.745 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 80.2 m-85 -62.93 133.36 54.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.71 ' HB3' HD13 ' A' ' 12' ' ' LEU . 39.9 mt-30 -132.27 89.86 2.72 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.307 0.575 . . . . 0.0 109.552 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.54 ' CG ' HD11 ' A' ' 97' ' ' ILE . 79.9 m-85 -100.44 109.14 21.27 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.56 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.914 ' HB3' HG21 ' A' ' 10' ' ' VAL . 31.8 tt0 -91.66 85.87 5.81 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.661 HG13 HG21 ' A' ' 9' ' ' VAL . 2.6 mp -81.85 140.06 17.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.764 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 11.3 m -115.25 107.16 14.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.327 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.466 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 17.6 p90 -121.27 153.41 37.7 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.85 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 21.9 tt0 -109.4 118.3 36.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 24.4 m -74.07 109.25 7.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -72.81 -31.4 36.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.962 -174.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.909 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 47.8 mt-10 -142.89 166.74 23.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.772 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.2 m-20 -61.71 131.2 49.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.751 HD11 ' CE1' ' A' ' 101' ' ' TYR . 2.1 mm? -85.51 152.29 23.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -113.54 -36.82 4.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.68 0.752 . . . . 0.0 110.126 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 13.7 tt0 -117.13 -167.37 1.29 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.449 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.5 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 5.3 m-20 -96.19 138.43 33.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.516 0.674 . . . . 0.0 111.316 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.706 HD13 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.47 120.02 29.45 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.922 178.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.8 tt0 -106.92 89.32 2.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.638 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.676 ' O ' ' HA ' ' A' ' 59' ' ' SER . 27.6 m95 -76.35 129.08 36.08 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 30.0 ttmt -133.38 142.48 48.4 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.903 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.559 HG21 HG21 ' A' ' 95' ' ' VAL . 10.7 mt -103.22 121.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -114.29 105.71 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.119 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.848 ' CE2' HG11 ' A' ' 113' ' ' VAL . 28.3 t80 -89.72 124.55 34.72 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.898 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.01 111.54 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.376 0.608 . . . . 0.0 110.343 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.76 -35.71 66.45 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.715 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 39.6 t -134.53 118.85 17.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.771 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -66.05 0.23 2.04 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.999 0.428 . . . . 0.0 110.01 167.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 47' ' ' SER . 4.6 mt-10 -102.12 -17.12 16.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.286 172.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.715 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 50.4 m -124.64 -171.69 2.4 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.775 0.798 . . . . 0.0 111.086 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.65 -3.31 1.15 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.516 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -94.25 -13.16 26.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.675 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.672 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 3.5 m-30 -84.92 -15.82 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.335 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 8.7 p-10 -42.44 115.48 0.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.134 0.968 . . . . 0.0 111.979 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -91.17 166.85 12.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.943 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.81 107.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.0 mm? -74.92 -40.06 61.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.671 -171.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.34 176.26 2.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.887 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 58.1 p -151.49 115.28 4.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.84 132.42 45.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.918 -175.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 6.4 mt -102.73 106.26 16.85 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -92.98 120.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -84.16 -156.68 24.44 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.925 -165.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 38.6 Cg_endo -64.6 118.79 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.952 1.768 . . . . 0.0 110.53 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.543 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 28.5 m -134.8 141.87 40.22 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.514 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -86.17 75.33 2.98 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.421 2.08 . . . . 0.0 114.599 -173.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 48.19 -179.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.954 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 114.45 129.22 4.73 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.138 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.85 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.1 ptt-85 -75.87 126.21 30.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 4.9 p80 -153.68 141.6 20.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.936 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -95.55 137.75 34.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -177.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.7 p90 -135.68 146.37 47.71 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 13.8 p -104.26 125.65 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 122.318 1.056 . . . . 0.0 110.438 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.512 ' CE1' HG12 ' A' ' 60' ' ' VAL . 12.0 t80 -119.53 113.04 20.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.764 -163.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 38.3 mt-30 -138.46 149.99 46.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.476 -167.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' C ' ' HB3' ' A' ' 21' ' ' PRO . . . -169.34 146.07 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.351 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.609 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.1 p-10 -61.24 170.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.05 0.452 . . . . 0.0 111.413 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.669 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . . . -71.12 164.22 58.82 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.688 -170.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.745 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 34.7 Cg_endo -60.92 168.21 7.59 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.355 2.703 . . . . 0.0 111.69 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -69.75 115.54 34.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.0 -175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.89 -26.68 79.31 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.225 2.617 . . . . 0.0 112.045 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.61 14.55 55.26 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.292 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 mt -116.74 -33.75 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.391 0.139 . . . . 0.0 110.816 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.435 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 36.5 mt -73.71 129.89 84.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.127 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HG3' ' HG ' ' A' ' 47' ' ' SER . 95.0 Cg_endo -79.92 162.26 23.72 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.221 2.614 . . . . 0.0 112.699 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.664 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 12.1 m-20 -45.85 -52.54 11.19 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.673 0.789 . . . . 0.0 112.202 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.71 -28.61 65.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.825 ' HA ' ' NZ ' ' B' ' 122' ' ' LYS . 49.1 t0 -80.87 -38.97 27.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -65.45 -38.7 90.62 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -165.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.39 46.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 -138.85 3.0 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.118 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.569 HG21 ' ND2' ' A' ' 114' ' ' ASN . 1.1 t -97.13 135.87 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.059 0.933 . . . . 0.0 113.256 -172.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.691 ' HB ' HG12 ' A' ' 113' ' ' VAL . 1.7 m -140.51 168.82 18.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -125.54 143.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 118.318 0.508 . . . . 0.0 111.127 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 42' ' ' ILE . 7.3 p -131.06 108.23 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.835 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.65 154.91 18.46 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.983 -171.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.4 mt -117.39 105.07 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.0 p -100.62 114.8 28.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.227 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.574 ' HB2' HG21 ' A' ' 107' ' ' ILE . 62.6 m -79.68 115.76 19.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.452 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -108.54 101.91 11.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.991 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.751 ' CE1' HD11 ' A' ' 34' ' ' LEU . 87.1 t80 -104.31 127.83 52.02 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.593 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 37.0 mtp180 67.02 14.19 9.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.3 65.24 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.731 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.747 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -119.74 129.37 54.47 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.8 mp0 -83.6 133.68 34.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.418 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.706 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 50.5 p90 -121.47 -5.1 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.817 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.9 tt -156.17 158.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 174.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.937 HH22 ' HG3' ' A' ' 145' ' ' ARG . 4.3 tmm_? -150.87 107.68 3.54 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -174.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.2 p -102.64 101.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.188 0.994 . . . . 0.0 109.321 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.23 86.66 1.38 Allowed Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 119.762 -1.209 . . . . 0.0 111.499 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.759 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 17.1 m-85 -82.17 122.29 27.69 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.192 -1.004 . . . . 0.0 108.805 172.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB2' ' HB2' ' A' ' 140' ' ' LEU . 31.6 m-85 -68.48 131.91 46.08 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.332 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.848 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.6 p -104.89 111.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.569 ' ND2' HG21 ' A' ' 92' ' ' VAL . 3.0 t-20 -90.58 110.51 21.65 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.349 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 28.5 m-80 -102.68 107.34 18.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -131.91 130.03 41.06 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.612 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.588 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.7 m-85 -40.86 148.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.8 p -89.65 -29.27 18.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.771 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 30.2 mm-40 -91.31 140.0 30.2 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.556 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.0 m -52.05 -47.95 64.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 117.928 0.331 . . . . 0.0 111.206 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.27 -39.76 67.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.988 0.899 . . . . 0.0 110.045 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.5 mt -77.6 -30.34 52.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.376 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 52.1 mtp180 -76.83 -39.06 52.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.501 0.667 . . . . 0.0 109.516 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.71 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 1.5 pt-20 -80.85 -20.6 41.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.597 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.71 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -149.82 77.38 8.58 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.841 170.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.03 118.42 5.28 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.634 2.889 . . . . 0.0 112.94 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 14.9 Cg_exo -71.63 147.81 51.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.065 2.51 . . . . 0.0 110.197 172.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.1 -27.75 43.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.866 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -89.12 122.21 68.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 0.0 111.271 175.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.664 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 36.5 Cg_exo -63.54 131.78 33.0 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 124.253 3.302 . . . . 0.0 112.588 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.0 t0 -114.05 105.28 13.03 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.719 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 42.6 m-85 -77.87 -19.86 54.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.846 0.832 . . . . 0.0 110.344 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.3 t -79.94 -29.91 39.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.804 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 71.6 mmtt -98.82 14.41 28.97 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 28.8 tp -99.68 143.91 29.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.213 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.91 129.95 51.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 1.004 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 10.0 mtm180 -95.5 106.01 18.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.758 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 4.4 t30 -96.35 99.71 11.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.867 HG23 HG11 ' A' ' 11' ' ' VAL . 10.0 mm -68.05 117.86 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.633 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . 62.4 mt -74.35 75.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.719 0.771 . . . . 0.0 110.334 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.759 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -68.85 -13.14 62.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.974 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -75.46 -12.77 60.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.457 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.405 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.5 t-20 -133.9 60.46 45.69 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 24.1 Cg_exo -68.84 105.24 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.549 1.499 . . . . 0.0 111.497 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.937 ' HG3' HH22 ' A' ' 108' ' ' ARG . 18.2 tpt85 -87.69 88.67 7.73 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.74 HG11 HG21 ' A' ' 109' ' ' VAL . 22.6 m -92.54 124.58 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.591 HG22 ' CE2' ' A' ' 149' ' ' PHE . 98.8 m -132.8 107.78 8.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.379 0.609 . . . . 0.0 109.708 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -106.64 140.33 39.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.418 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.591 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -126.18 118.7 25.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.458 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.85 143.49 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 110.812 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.747 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 46.6 pt -131.9 177.29 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.595 ' C ' ' H ' ' A' ' 154' ' ' GLU . 3.1 p30 -97.97 94.2 6.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.313 1.054 . . . . 0.0 109.425 176.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.0 m95 -71.73 4.55 3.13 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.178 -1.373 . . . . 0.0 108.897 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 152' ' ' ASN . 16.9 mt-10 . . . . . 0 N--CA 1.436 -1.13 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.622 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.825 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 75.7 mmtt . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 p30 13.18 -93.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 13.7 tt -62.03 -27.36 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.5 tm0? -63.84 -58.56 6.42 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 121.745 0.783 . . . . 0.0 110.196 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' A' ' 94' ' ' VAL . 1.2 mm? -64.23 -28.89 70.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.611 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . . . -62.33 -40.53 96.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.813 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -51.35 -53.88 31.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' B' ' 129' ' ' ARG . 16.6 mmm180 -70.47 -25.85 63.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.87 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.516 HG12 HH12 ' A' ' 108' ' ' ARG . 5.6 mt -65.47 -39.48 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.395 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.426 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.703 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 22.0 mmtt -101.02 -9.02 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.055 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.502 HG21 ' CE2' ' A' ' 28' ' ' PHE . 2.7 t -142.95 126.96 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.417 0.627 . . . . 0.0 110.687 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.623 ' HB2' HD13 ' A' ' 31' ' ' ILE . 6.0 tp-100 -124.09 100.8 6.9 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.099 174.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.561 HG13 ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -82.48 131.43 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.127 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -115.81 -63.53 1.44 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.531 -162.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.679 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -100.07 148.88 24.07 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.852 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG13 ' OH ' ' A' ' 111' ' ' TYR . 4.3 p -146.08 102.23 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-O 121.797 0.808 . . . . 0.0 109.934 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.919 HG21 ' HB3' ' A' ' 25' ' ' GLU . 3.3 m -98.39 96.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.779 0.799 . . . . 0.0 109.804 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.813 HG13 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -74.96 129.43 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 122.017 0.913 . . . . 0.0 110.427 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 23' ' ' GLN . 1.1 mt -98.82 -36.36 9.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.455 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.699 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 16.9 t70 -68.88 39.55 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.683 170.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.655 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -79.22 172.47 9.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.3 Cg_endo -50.38 101.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 120.841 1.336 . . . . 0.0 113.006 -152.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.628 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 21.2 m -141.95 171.62 7.07 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 112.193 -2.276 . . . . 0.0 107.676 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 67.2 Cg_exo -38.22 132.65 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.484 2.123 . . . . 0.0 112.301 175.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.704 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 33.3 t80 -54.22 -28.13 39.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.868 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -86.84 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.74 0.305 . . . . 0.0 111.039 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.62 120.22 79.48 Favored Pre-proline 0 CA--C 1.513 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.4 Cg_exo -63.85 146.04 91.2 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 123.821 3.014 . . . . 0.0 113.161 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 37.8 m-85 -60.35 115.11 3.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.904 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.874 ' HB3' HD13 ' A' ' 12' ' ' LEU . 37.0 mt-30 -118.99 102.03 8.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.95 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.631 ' CD1' HD11 ' A' ' 97' ' ' ILE . 87.5 m-85 -109.65 111.4 22.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.462 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.919 ' HB3' HG21 ' A' ' 10' ' ' VAL . 30.6 tt0 -93.38 85.23 4.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.95 132.95 32.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 122.049 0.928 . . . . 0.0 112.609 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 25.5 m -104.15 107.17 17.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.173 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 27.5 p90 -117.53 148.2 42.09 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.925 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.841 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.9 tm-20 -101.94 111.33 23.55 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.4 t -72.4 108.63 5.6 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.623 HD13 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -75.03 -23.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.086 -171.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.702 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 50.3 mt-10 -155.37 148.31 24.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.62 131.47 50.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.947 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 4.7 tp -86.67 154.24 21.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.768 -168.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -113.18 -30.49 6.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.584 0.707 . . . . 0.0 110.372 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.815 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.8 tt0 -117.01 -167.51 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.815 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 4.6 p-10 -100.67 137.68 38.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.843 0.83 . . . . 0.0 111.523 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.26 122.25 27.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.112 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.9 tt0 -106.84 89.82 3.13 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.28 -176.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.614 ' O ' ' HA ' ' A' ' 59' ' ' SER . 15.1 m95 -78.0 135.8 37.85 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.7 ttmt -137.37 137.5 38.93 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.288 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.826 HG21 HG22 ' A' ' 95' ' ' VAL . 8.9 mt -102.46 110.16 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.586 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 49.9 mt -108.43 106.11 20.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.74 -172.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.85 ' CE2' HG12 ' A' ' 113' ' ' VAL . 25.3 t80 -89.49 108.53 19.7 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.867 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t -53.44 104.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.748 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.08 99.84 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.152 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.407 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 29.4 t -131.78 128.81 39.6 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.93 -5.94 48.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.978 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -100.03 -35.52 9.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 8.9 m -122.35 97.41 5.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.056 0.931 . . . . 0.0 110.059 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' B' ' 128' ' ' ARG . 0.0 OUTLIER -67.65 -11.08 57.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.03 -172.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.73 -12.08 60.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.651 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 16.9 m-30 -87.65 10.25 18.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.273 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 4.9 p-10 -54.93 110.3 0.64 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.092 0.949 . . . . 0.0 111.162 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' TYR . 4.8 mt-30 -92.7 169.95 10.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.507 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.64 112.64 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -169.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.7 mm? -76.34 -42.66 44.19 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.484 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 5.4 p-10 -170.6 173.95 5.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.489 171.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 50.8 p -145.36 117.56 8.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.63 128.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.459 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.609 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.9 mt -103.18 104.02 14.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.049 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.49 119.43 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -82.27 -151.67 9.74 Favored Glycine 0 CA--C 1.482 -1.979 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.158 -165.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.947 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 2.1 Cg_endo -46.35 117.14 1.83 Allowed 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.454 1.436 . . . . 0.0 109.144 167.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.66 120.98 15.86 Favored Pre-proline 0 C--N 1.288 -2.106 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.7 -170.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.71 130.75 41.58 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.154 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -44.61 147.21 0.63 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.832 0.708 . . . . 0.0 111.255 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.435 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 144.84 130.29 2.25 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.09 -174.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.841 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -74.43 116.97 15.71 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.789 0.804 . . . . 0.0 110.889 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.435 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 8.2 p80 -150.72 152.13 33.44 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.36 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.6 ttp -98.92 126.94 44.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.324 0.583 . . . . 0.0 111.116 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -117.95 133.18 56.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.3 p -101.95 127.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.433 1.111 . . . . 0.0 110.392 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.542 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 1.2 t80 -117.34 133.89 55.46 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.655 -1.612 . . . . 0.0 109.465 -164.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.759 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 66.8 mt-30 -151.69 150.36 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.047 0.451 . . . . 0.0 110.398 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -160.37 168.48 25.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.38 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.07 -175.32 0.07 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.844 0.831 . . . . 0.0 112.162 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -89.52 158.28 45.9 Favored Pre-proline 0 N--CA 1.438 -1.046 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.726 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.734 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 46.6 Cg_endo -65.41 168.57 14.21 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.042 2.495 . . . . 0.0 111.602 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 5.1 m-20 -79.56 115.3 52.42 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.3 Cg_endo -62.85 -19.91 69.93 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.634 2.889 . . . . 0.0 112.707 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.56 -5.06 79.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.349 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.444 HD13 ' HG2' ' A' ' 55' ' ' GLN . 9.3 mt -95.5 -27.82 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.965 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.545 HD12 ' CE1' ' A' ' 44' ' ' TYR . 11.4 mt -82.66 130.86 56.79 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 0.0 112.339 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 84' ' ' ILE . 5.4 Cg_endo -81.13 156.6 19.94 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.22 2.614 . . . . 0.0 111.903 170.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.721 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.9 m-20 -47.25 -49.12 24.07 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.67 76.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.521 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.5 -17.27 23.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.085 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -71.59 -45.87 60.96 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.3 0.572 . . . . 0.0 111.258 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.74 45.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.95 -173.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.74 -135.5 2.03 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.838 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.833 HG22 HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -98.94 135.27 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-O 122.164 0.983 . . . . 0.0 112.552 -170.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.16 167.62 24.57 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -112.83 141.96 26.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.586 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 42' ' ' ILE . 3.8 p -125.61 101.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 158.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.586 ' CD1' ' HB ' ' A' ' 43' ' ' ILE . 1.1 pp -94.62 149.34 21.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.448 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.683 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 3.2 mt -114.74 101.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.352 0.596 . . . . 0.0 109.829 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 70.7 p -98.37 116.48 30.69 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.047 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.635 ' HB2' HG21 ' A' ' 107' ' ' ILE . 58.4 m -82.31 118.23 23.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 20.8 m -106.85 128.22 54.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.761 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 65.3 t80 -132.7 121.18 22.71 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.826 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 67.65 26.17 8.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.292 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.02 6.01 82.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.414 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -116.44 115.28 25.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.083 -0.558 . . . . 0.0 109.836 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 44.0 mp0 -77.27 124.89 28.47 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.761 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 29.0 p90 -113.88 -4.2 13.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 98' ' ' THR . 7.7 tt -158.08 158.83 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.489 ' HB2' HG23 ' A' ' 98' ' ' THR . 24.4 ttp180 -150.71 106.81 3.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.336 0.397 . . . . 0.0 110.043 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.769 HG21 HG22 ' A' ' 146' ' ' VAL . 2.2 p -91.27 99.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.544 1.164 . . . . 0.0 108.455 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.471 ' HA3' HG12 ' B' ' 130' ' ' ILE . . . -80.49 95.8 1.6 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.231 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.993 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 4.4 m-85 -93.6 109.57 21.19 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.957 0.884 . . . . 0.0 109.245 174.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.473 ' N ' ' HD1' ' A' ' 112' ' ' TYR . 2.3 m-85 -76.15 114.88 15.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.286 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.85 HG12 ' CE2' ' A' ' 44' ' ' TYR . 3.1 p -88.09 108.67 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.833 HD21 HG22 ' A' ' 92' ' ' VAL . 16.4 t-20 -95.56 103.61 15.48 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.477 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -91.97 121.41 33.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.288 0.566 . . . . 0.0 110.064 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.84 138.91 30.64 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.565 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 47.5 m-85 -48.8 156.65 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -92.12 -30.18 16.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.982 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.482 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 4.6 mm-40 -82.22 129.57 34.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.097 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.709 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.4 m -53.86 -40.83 66.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.991 0.182 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.01 -35.58 66.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.11 0.957 . . . . 0.0 110.179 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.542 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 82.4 mt -85.07 -22.0 29.13 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.785 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 47.3 mtp180 -83.17 -39.67 20.71 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.741 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 11.5 pt-20 -70.35 -31.7 69.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.725 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.741 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 1.2 p30 -147.61 82.08 8.23 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.14 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 29.5 Cg_endo -61.75 117.86 4.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.551 2.834 . . . . 0.0 112.248 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -69.04 161.05 47.44 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.915 2.41 . . . . 0.0 110.943 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.69 -25.36 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.525 ' HD3' ' HD3' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -89.7 128.38 50.73 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 121.397 0.618 . . . . 0.0 110.788 172.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.721 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 1.1 Cg_endo -82.66 141.64 11.09 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.054 3.169 . . . . 0.0 112.15 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.1 t70 -124.85 112.18 16.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.231 0.538 . . . . 0.0 109.592 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.682 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.1 m-85 -79.4 -19.77 49.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.488 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.1 p -83.31 -24.06 32.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.482 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 73.3 mmtt -98.87 11.76 37.82 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 19.9 tp -95.91 133.45 40.08 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.806 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.16 120.47 39.12 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.727 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.35 109.05 21.23 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.644 -172.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.678 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -86.2 98.5 10.95 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.094 173.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.813 HG23 HG13 ' A' ' 11' ' ' VAL . 1.4 mp -72.65 108.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.165 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.4 mt -64.51 91.81 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.222 0.534 . . . . 0.0 111.834 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.993 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -80.66 -12.19 59.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -80.14 -11.92 59.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.997 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -138.51 70.12 45.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.818 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 63.9 Cg_endo -81.83 104.97 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.207 1.272 . . . . 0.0 109.666 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -83.66 81.76 8.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.255 0.55 . . . . 0.0 110.532 -175.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.769 HG22 HG21 ' A' ' 109' ' ' VAL . 3.9 t -86.4 104.43 13.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.961 -174.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 149' ' ' PHE . 48.8 m -112.77 106.93 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.726 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -108.37 138.24 44.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.8 0.81 . . . . 0.0 110.891 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.411 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -122.3 136.1 54.84 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.88 -178.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.479 ' O ' ' HD2' ' A' ' 150' ' ' HIS . 0.8 OUTLIER -73.79 141.61 46.22 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.707 175.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.03 172.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -90.94 106.33 18.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.17 0.986 . . . . 0.0 110.451 171.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.703 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 8.0 m95 -81.28 5.77 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.956 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 152' ' ' ASN . 34.2 mt-10 . . . . . 0 N--CA 1.428 -1.563 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.805 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' B' ' 122' ' ' LYS . 11.5 mptt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.246 0.07 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -44.41 -45.16 8.85 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.321 0.388 . . . . 0.0 111.845 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 -43.07 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.257 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.5 mm100 -53.41 -54.16 40.77 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.618 0.723 . . . . 0.0 111.278 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.38 -37.4 85.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.481 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.96 75.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 51' ' ' GLU . 10.4 mtm180 -59.02 -47.07 86.53 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -60.17 -41.6 93.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.471 HG12 ' HA3' ' A' ' 110' ' ' GLY . 3.8 mp -90.45 -5.79 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.481 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.844 ' HB3' HD21 ' A' ' 34' ' ' LEU . 10.2 mptt -100.11 -22.05 15.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.414 HG23 HD22 ' A' ' 34' ' ' LEU . 3.6 t -139.28 131.94 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.871 0.843 . . . . 0.0 110.964 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.731 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -125.67 100.14 6.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.851 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.413 HG22 ' CH2' ' A' ' 40' ' ' TRP . 11.6 t -70.79 146.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -131.16 -65.88 0.76 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.65 0.738 . . . . 0.0 109.594 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.653 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.8 t-20 -104.82 148.21 26.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.105 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -146.73 105.23 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.107 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 1.075 HG21 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -98.02 97.81 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.554 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.91 116.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.892 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.625 HD21 ' HB2' ' A' ' 25' ' ' GLU . 1.4 mm? -80.71 -31.49 36.1 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.62 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' HB3' ' CG ' ' A' ' 23' ' ' GLN . 7.3 p-10 -82.62 44.47 0.9 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.681 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HB3' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -73.59 168.61 23.91 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 159.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HG3' ' CG ' ' A' ' 138' ' ' ASN . 31.6 Cg_exo -51.47 101.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.569 0 CA-C-O 122.729 1.054 . . . . 0.0 113.3 -135.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.841 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 70.1 m -129.99 166.87 23.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.731 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 50.1 Cg_exo -46.38 133.48 15.92 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.685 174.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 1.077 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 20.2 t80 -55.4 -23.98 27.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.056 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -92.91 5.56 50.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.841 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -96.3 120.15 63.01 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 169.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 70.3 Cg_exo -55.29 144.43 71.52 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.747 2.298 . . . . 0.0 112.91 -167.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.827 ' HE1' ' HD3' ' A' ' 79' ' ' PRO . 84.3 m-85 -52.58 143.02 16.69 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.745 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.678 ' CG ' ' HB3' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -143.25 110.64 5.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.747 0.784 . . . . 0.0 109.599 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.612 ' CD1' HD13 ' A' ' 97' ' ' ILE . 81.7 m-85 -114.0 103.52 11.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.461 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.075 ' HB3' HG21 ' A' ' 10' ' ' VAL . 33.6 tt0 -84.23 85.13 7.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.721 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 4.5 mt -82.47 141.94 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.001 0.905 . . . . 0.0 113.042 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.653 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.5 m -119.51 108.8 14.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.294 171.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 17.3 p90 -117.96 146.38 44.04 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.245 0.545 . . . . 0.0 109.655 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.846 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.6 tt0 -101.89 109.36 21.09 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.696 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.9 m -72.79 119.76 17.48 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.614 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -90.2 -28.01 5.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.253 -169.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -146.69 169.06 19.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.979 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.06 127.9 34.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.965 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -81.7 155.21 25.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.158 0.504 . . . . 0.0 109.658 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.6 p -113.42 -14.36 12.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.208 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 102' ' ' ARG . 7.7 tt0 -138.64 -167.52 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.65 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.786 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 22.2 m-20 -97.74 136.38 38.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 110.872 -175.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.468 HD23 ' CZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -81.67 120.09 24.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.202 175.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 100' ' ' THR . 44.1 tt0 -105.65 90.12 3.3 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.093 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.721 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 31.0 m95 -74.12 109.41 7.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 0.4 OUTLIER -116.31 129.61 56.36 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -173.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.641 HG21 HG22 ' A' ' 95' ' ' VAL . 7.7 mt -102.1 115.96 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.84 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.611 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.795 ' CE2' HG13 ' A' ' 113' ' ' VAL . 26.4 t80 -84.02 119.78 25.35 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.489 HG12 HD13 ' B' ' 126' ' ' LEU . 17.6 t -70.57 97.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -85.75 -4.54 85.02 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.633 ' HB2' ' C ' ' A' ' 50' ' ' SER . 3.7 p -115.19 68.04 0.7 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.056 0.455 . . . . 0.0 111.439 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.15 -8.82 57.87 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.81 0.814 . . . . 0.0 108.834 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -99.17 -49.62 4.43 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.48 -1.237 . . . . 0.0 109.863 172.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.633 ' C ' ' HB2' ' A' ' 47' ' ' SER . 3.5 m -103.01 -138.88 0.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.877 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.61 3.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.502 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -97.7 -7.26 31.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 111.814 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.539 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 37.4 m-85 -94.81 -0.98 53.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -170.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 18.5 p-10 -51.51 110.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.989 0.899 . . . . 0.0 110.592 172.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 80' ' ' ASN . 18.5 mp0 -91.71 168.26 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.247 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.655 HG13 ' CE ' ' A' ' 41' ' ' LYS . 2.5 t -126.09 110.86 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.193 -173.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -82.11 -57.58 3.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -172.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 7.7 t70 -170.35 162.35 8.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.686 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 12.1 p -130.19 119.4 22.9 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.0 p -101.59 129.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.3 mt -104.85 103.32 12.89 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.455 0.645 . . . . 0.0 110.967 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.02 119.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -87.96 -136.87 5.38 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.754 -1.212 . . . . 0.0 111.922 -162.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.965 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 5.7 Cg_endo -50.32 117.02 2.84 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.231 1.954 . . . . 0.0 111.324 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.457 HG21 ' SG ' ' A' ' 30' ' ' CYS . 13.0 m -121.41 111.67 33.25 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.187 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.8 61.49 5.51 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 123.353 2.702 . . . . 0.0 114.284 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.696 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.52 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 112.797 -2.001 . . . . 0.0 112.605 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.466 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 111.14 122.96 4.34 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 175.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.846 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 5.6 ptp85 -66.65 130.93 44.81 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.858 0.837 . . . . 0.0 110.005 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.466 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -151.58 158.2 43.21 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.099 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.2 138.11 51.91 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.296 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 11.2 p90 -137.49 148.82 46.33 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.3 p -106.67 119.27 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 122.316 1.055 . . . . 0.0 110.555 -174.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.509 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -111.11 154.27 24.53 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.468 -1.696 . . . . 0.0 109.217 -168.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.686 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.0 mt-30 -151.89 160.67 43.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -168.98 145.34 3.48 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.436 ' O ' HD11 ' A' ' 57' ' ' LEU . 6.5 m-20 -59.26 -177.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 112.24 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -84.4 155.12 63.02 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.827 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -66.83 157.52 60.9 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.684 2.256 . . . . 0.0 110.856 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 94.9 m-20 -63.12 117.84 37.16 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 -170.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.87 -13.42 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.41 2.74 . . . . 0.0 112.004 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.37 -1.1 69.44 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.569 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 83' ' ' LEU . 20.7 mt -103.87 -34.09 8.64 Favored 'General case' 0 CA--C 1.514 -0.421 0 O-C-N 122.928 -0.16 . . . . 0.0 111.286 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 89' ' ' ALA . 36.4 mt -72.35 125.43 91.38 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.801 -175.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.449 ' O ' HG21 ' A' ' 84' ' ' ILE . 95.8 Cg_endo -79.26 163.14 25.19 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.788 2.992 . . . . 0.0 111.932 170.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.8 m-20 -45.43 -54.08 7.84 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.176 0.99 . . . . 0.0 113.498 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.46 -8.64 58.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.512 0.196 . . . . 0.0 111.442 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.41 -38.77 11.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.997 0.427 . . . . 0.0 110.37 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.25 -46.16 35.51 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.915 -169.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.23 46.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.34 -134.53 2.03 Favored Glycine 0 CA--C 1.497 -1.057 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.782 HG12 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -104.49 130.77 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 CA-C-O 122.261 1.029 . . . . 0.0 113.574 -170.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.614 HG23 HG11 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -143.71 173.17 11.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.051 -1.886 . . . . 0.0 105.921 173.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.624 HG12 HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.0 143.52 39.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.704 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.641 HG22 HG21 ' A' ' 42' ' ' ILE . 9.9 p -121.78 104.43 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.919 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.75 126.81 48.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.711 -169.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 39.1 mt -95.18 102.0 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.099 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 67.8 p -91.14 109.81 21.07 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.844 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.606 ' HB2' HG23 ' A' ' 107' ' ' ILE . 61.5 m -73.44 109.1 6.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.894 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 16.1 m -103.68 101.87 11.72 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.529 -174.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.502 ' CE1' HD13 ' A' ' 34' ' ' LEU . 71.4 t80 -107.6 118.51 36.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 41.0 mtp180 72.97 19.63 3.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.96 0.504 . . . . 0.0 111.667 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.81 5.29 74.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.198 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.639 HE22 ' ND2' ' A' ' 152' ' ' ASN . 2.5 pt20 -120.65 127.96 52.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.0 mp0 -84.18 135.55 34.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.46 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.468 ' CZ ' HD23 ' A' ' 38' ' ' LEU . 54.5 p90 -122.04 -1.5 9.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.1 tt -157.69 162.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.743 ' HG3' HG22 ' A' ' 98' ' ' THR . 9.0 ttm180 -149.2 99.39 2.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.919 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.25 100.55 8.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.823 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.61 79.58 1.74 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 119.413 -1.375 . . . . 0.0 111.116 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.89 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.7 m-85 -71.22 114.43 9.27 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CE2' HD23 ' B' ' 126' ' ' LEU . 2.7 m-85 -66.59 110.84 3.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.795 HG13 ' CE2' ' A' ' 44' ' ' TYR . 2.8 p -92.53 109.99 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.782 ' ND2' HG12 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -95.82 108.13 20.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.499 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.67 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.3 m-80 -97.77 121.44 39.68 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.347 0.594 . . . . 0.0 110.086 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.86 140.36 32.88 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.855 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 46.5 m-85 -46.52 151.91 0.51 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.9 p -93.29 -29.92 15.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.345 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 70.5 mm-40 -76.37 125.56 29.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.603 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 16.7 m -55.72 -32.08 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.401 -172.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.45 -39.15 77.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.506 0.67 . . . . 0.0 110.013 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 81.8 mt -73.32 -23.69 60.28 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.626 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 22.0 mtt180 -74.45 -36.67 63.38 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 120' ' ' THR . 11.4 mm-40 -67.85 -44.23 77.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.776 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.6 p30 -138.13 82.05 25.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.729 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.4 Cg_endo -57.56 113.64 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.09 2.527 . . . . 0.0 111.579 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.79 154.15 74.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.666 2.244 . . . . 0.0 111.593 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.1 p -46.76 -50.23 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 123.725 0.641 . . . . 0.0 112.428 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.7 mmtt -84.39 129.13 59.0 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 121.37 0.605 . . . . 0.0 111.055 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.651 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -72.06 125.18 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.653 2.902 . . . . 0.0 111.786 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -104.3 108.82 20.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.596 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 27.2 m-85 -77.91 -17.4 57.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.154 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 72.6 p -88.31 -15.07 36.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.911 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.1 mmtt -107.05 13.0 27.97 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.3 tp -95.93 143.41 27.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.0 -172.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -124.29 124.05 41.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 1.077 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 25.7 mtm-85 -87.92 104.15 16.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.784 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.598 ' CG ' ' HG3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -90.34 89.38 7.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 113' ' ' VAL . 1.3 mp -66.44 109.08 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 112' ' ' TYR . 89.6 mt -69.2 88.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.721 0.772 . . . . 0.0 110.433 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.89 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.63 -12.99 60.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.579 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.1 p -78.84 -12.01 60.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.72 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.47 64.21 57.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.661 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 98.6 Cg_endo -85.76 103.96 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.357 1.371 . . . . 0.0 109.902 172.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.607 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -84.47 80.35 9.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.306 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 109' ' ' VAL . 26.7 m -76.88 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.739 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.52 HG22 ' CE1' ' A' ' 149' ' ' PHE . 97.7 m -138.82 107.56 5.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.467 0.651 . . . . 0.0 109.286 173.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 4.2 ptt180 -108.95 142.82 39.04 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.958 0.885 . . . . 0.0 111.321 -175.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.52 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -125.04 169.32 12.25 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.199 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.475 ' HD2' ' O ' ' A' ' 150' ' ' HIS . 1.1 p-80 -93.59 149.69 21.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.291 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.542 ' HB ' ' OE1' ' A' ' 104' ' ' GLN . 45.3 pt -142.29 168.33 14.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.639 ' ND2' HE22 ' A' ' 104' ' ' GLN . 3.2 p30 -96.55 89.84 5.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.313 1.054 . . . . 0.0 109.979 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.828 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 8.1 m95 -64.43 -1.57 1.81 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.681 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.581 ' H ' ' C ' ' A' ' 152' ' ' ASN . 41.9 mt-10 . . . . . 0 N--CA 1.427 -1.625 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.26 -167.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.627 ' HG3' HG23 ' A' ' 92' ' ' VAL . 9.8 mmtp . . . . . 0 C--O 1.224 -0.243 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.527 ' HA ' ' HH ' ' A' ' 112' ' ' TYR . 1.6 m-20 -43.06 -58.13 2.58 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.928 0.768 . . . . 0.0 112.05 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 8.1 tp -65.98 -37.75 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -60.46 -52.7 64.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.262 0.554 . . . . 0.0 110.509 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.615 HD21 ' O ' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -65.42 -44.12 88.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.032 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -40.49 82.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.29 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -59.31 -46.19 89.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 110.833 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -63.5 -39.15 93.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.607 HD13 ' HB3' ' A' ' 145' ' ' ARG . 31.0 mt -76.44 -43.61 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.544 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -176.057 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.664 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.45 -18.01 27.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 -177.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 34' ' ' LEU . 2.7 t -139.97 139.4 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.482 0.658 . . . . 0.0 111.101 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.635 ' HB2' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -140.39 102.82 4.43 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.894 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 2.9 m -72.66 149.66 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.789 175.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.14 -63.02 1.02 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.447 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.603 HD21 ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.31 112.41 25.51 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.244 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.603 ' N ' HD21 ' A' ' 8' ' ' ASN . 8.2 p -96.83 109.49 23.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -106.48 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 122.368 1.08 . . . . 0.0 108.965 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG12 ' CD2' ' A' ' 24' ' ' PHE . 18.4 m -77.29 123.15 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.333 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.5 mt -89.63 -47.35 8.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.672 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.634 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 8.2 t0 -66.2 83.0 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.367 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.776 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -100.7 174.4 2.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.31 -1.768 . . . . 0.0 107.021 164.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.872 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 3.2 Cg_endo -49.44 102.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.274 1.491 . . . . 0.0 113.123 -151.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.645 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 20.1 m -129.9 170.54 10.73 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 112.587 -2.097 . . . . 0.0 108.886 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.0 Cg_exo -40.77 139.49 1.29 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.888 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.722 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 44.7 t80 -68.36 -10.29 53.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -96.32 8.26 44.4 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.561 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -95.88 126.11 46.15 Favored Pre-proline 0 CA--C 1.508 -0.672 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 169.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 77' ' ' ASP . 27.5 Cg_exo -64.97 154.09 75.03 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.254 2.636 . . . . 0.0 112.519 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HE2' HH21 ' A' ' 137' ' ' ARG . 25.4 m-85 -65.28 128.41 35.74 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.256 174.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.675 ' HA ' ' HG2' ' A' ' 75' ' ' GLN . 33.1 mt-30 -125.76 102.74 7.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.798 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 11' ' ' VAL . 50.6 m-85 -105.77 144.92 31.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.726 ' HG3' ' HE2' ' A' ' 71' ' ' MET . 26.7 tt0 -118.78 88.29 2.9 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 168.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 HD13 ' A' ' 97' ' ' ILE . 43.2 mt -84.51 119.52 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.939 0.876 . . . . 0.0 111.67 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 20.0 m -100.16 105.15 16.72 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.415 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.8 p90 -118.32 150.75 38.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.853 0.835 . . . . 0.0 110.343 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.86 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.8 tt0 -108.65 116.22 31.57 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.636 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.668 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 47.7 t -73.16 117.02 14.39 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -83.16 -28.85 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.832 -171.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.664 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 4.6 mt-10 -150.07 147.63 28.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.55 134.54 46.53 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.665 0.269 . . . . 0.0 111.238 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.781 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -94.31 157.79 15.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.288 -170.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.6 m -112.59 -39.58 4.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.037 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.828 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.6 tt0 -119.44 -168.28 1.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.297 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.828 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 3.2 m-20 -93.69 136.88 33.53 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.391 0.615 . . . . 0.0 110.205 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mm? -83.73 127.09 33.53 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.787 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 57.8 tt0 -116.68 90.23 3.29 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.628 -173.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.688 ' HZ3' HG22 ' A' ' 107' ' ' ILE . 35.7 m95 -84.21 133.65 34.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.754 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.5 ttmt -129.84 144.76 51.47 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.935 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.913 HG21 HD21 ' A' ' 57' ' ' LEU . 44.2 mm -102.02 107.45 21.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -102.13 113.6 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.831 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.441 ' HA ' HG11 ' A' ' 95' ' ' VAL . 34.4 t80 -95.16 122.24 37.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.111 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.786 HG11 ' CE2' ' A' ' 53' ' ' TYR . 4.8 t -72.51 98.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.698 0.761 . . . . 0.0 109.489 171.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.669 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -72.38 -55.13 7.07 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.383 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.579 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 44.4 m -119.8 73.17 0.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.7 0.4 . . . . 0.0 110.55 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -49.69 -19.06 0.55 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.337 0.589 . . . . 0.0 111.927 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' OE2' ' HE2' ' B' ' 122' ' ' LYS . 1.5 tp10 -71.46 -19.29 62.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.043 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.614 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 39.9 m -117.04 -151.2 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 8.5 pt-20 -154.25 19.01 0.49 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.669 0.747 . . . . 0.0 111.267 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' OE1' ' HB3' ' A' ' 50' ' ' SER . 2.0 mp0 -98.18 -36.97 9.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.827 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.786 ' CE2' HG11 ' A' ' 45' ' ' VAL . 10.7 p90 -54.65 -41.79 70.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.593 -169.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 9.8 p-10 -30.71 105.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.212 0 O-C-N 125.134 1.521 . . . . 0.0 112.546 -165.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.697 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 24.0 mt-30 -95.12 165.86 12.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.905 -168.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -120.15 108.96 24.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.148 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.913 HD21 HG21 ' A' ' 42' ' ' ILE . 6.6 mp -73.31 -40.7 64.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.602 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -176.53 165.83 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.073 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.9 p -144.63 123.85 12.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.9 p -100.42 136.26 32.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.788 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.5 mt -110.71 105.72 14.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.023 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 89.3 t -96.4 118.15 42.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.35 -160.39 10.11 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.56 -165.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.781 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.7 Cg_endo -67.9 115.28 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.397 1.398 . . . . 0.0 110.231 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.473 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 34.1 m -124.99 141.18 37.69 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.185 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -83.26 77.31 3.58 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 122.48 2.12 . . . . 0.0 113.575 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.668 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 44.98 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.012 -1.903 . . . . 0.0 112.357 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.39 139.43 9.77 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.496 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.86 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttt180 -77.69 116.88 18.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.797 0.808 . . . . 0.0 110.091 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -128.68 122.07 29.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.18 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.726 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -83.59 121.27 27.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.641 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.7 p90 -120.66 160.08 24.01 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.1 133.83 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 121.911 0.863 . . . . 0.0 110.093 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.641 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 2.7 t80 -135.44 107.57 7.19 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.951 -161.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.675 ' HG2' ' HA ' ' A' ' 23' ' ' GLN . 77.3 mt-30 -124.19 155.13 39.05 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.94 134.58 10.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.183 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 2.6 t0 -65.48 171.84 3.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.481 ' HB1' HH12 ' A' ' 137' ' ' ARG . . . -69.87 159.77 82.79 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.658 . . . . 0.0 111.304 -171.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HD2' HH22 ' A' ' 137' ' ' ARG . 56.6 Cg_endo -66.75 172.87 8.86 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.343 2.696 . . . . 0.0 111.449 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 10.0 m-80 -70.97 121.37 83.87 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.014 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.5 Cg_endo -63.57 -12.84 33.06 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.154 2.569 . . . . 0.0 110.944 175.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.48 -19.18 46.04 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.714 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 12.4 mt -94.61 -1.56 53.02 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.577 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 24.8 mt -100.7 125.92 37.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.913 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 86.0 Cg_endo -79.28 158.76 26.29 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.017 2.478 . . . . 0.0 111.145 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.634 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 9.1 m-20 -47.53 -47.02 28.08 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.99 -37.21 47.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.798 175.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -68.68 -47.43 66.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.064 -167.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.93 46.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-O 122.208 1.004 . . . . 0.0 110.396 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.88 -139.44 2.66 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.654 -163.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.717 HG11 ' HB2' ' B' ' 122' ' ' LYS . 12.4 p -122.44 145.73 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 121.875 0.845 . . . . 0.0 110.366 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.765 HG22 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -160.66 174.36 14.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' B' ' 126' ' ' LEU . 1.9 t -132.16 144.38 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.882 0.372 . . . . 0.0 111.686 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 29.3 m -124.74 105.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.4 pp -103.5 145.06 30.57 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.163 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 46.1 mt -102.83 100.77 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.615 0.722 . . . . 0.0 109.235 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.85 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 80.8 p -99.8 114.37 27.48 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.702 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.637 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 4.6 t -80.83 158.79 25.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.867 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -148.44 109.17 4.22 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -165.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.642 ' CE1' ' HA ' ' A' ' 153' ' ' TRP . 56.1 t80 -124.0 120.83 33.58 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.512 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 43.1 mtp180 66.76 25.85 9.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.275 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.62 11.74 73.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.455 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.37 131.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.137 0.494 . . . . 0.0 110.078 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.2 mp0 -86.7 125.5 33.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.501 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.557 ' CD1' HD11 ' A' ' 151' ' ' ILE . 54.8 p90 -119.82 2.58 11.08 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -168.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.85 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.0 tt -156.35 154.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.832 HH21 HG22 ' A' ' 147' ' ' THR . 0.3 OUTLIER -153.6 108.17 3.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -177.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 4.2 p -97.39 100.64 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 122.16 0.981 . . . . 0.0 109.26 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -83.43 84.11 1.58 Allowed Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.616 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.9 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 6.3 m-85 -80.52 116.17 20.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.126 . . . . 0.0 109.109 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -68.4 135.99 52.61 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 93' ' ' THR . 4.1 p -121.25 111.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 108.826 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -96.34 120.45 36.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.968 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 49.2 m-80 -100.42 118.82 37.44 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.535 0.683 . . . . 0.0 109.413 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.62 131.04 42.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.694 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.676 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 20.2 m-85 -43.88 151.48 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -92.56 -29.47 16.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.003 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 14.3 mm-40 -84.18 128.57 34.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.952 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.707 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.2 m -48.41 -45.96 36.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.048 0.218 . . . . 0.0 111.344 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.61 -31.38 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.766 0.793 . . . . 0.0 110.423 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.676 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 83.4 mt -84.6 -25.52 28.56 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.326 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 63.4 mtp180 -81.1 -36.63 30.14 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 120' ' ' THR . 9.6 pt-20 -74.01 -36.49 64.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.117 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.643 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.6 OUTLIER -142.88 80.58 13.73 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.096 176.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 19.0 Cg_endo -57.36 119.49 6.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.408 2.739 . . . . 0.0 112.045 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 16.8 Cg_exo -69.57 163.12 39.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.966 2.444 . . . . 0.0 111.737 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.29 -45.6 89.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 2.1 mmtt -89.5 129.87 45.61 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 121.385 0.612 . . . . 0.0 110.989 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.634 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_endo -79.21 147.72 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.966 3.111 . . . . 0.0 112.248 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.8 t0 -116.64 111.63 20.12 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.722 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 13.0 m-85 -77.92 -13.46 59.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.049 0.928 . . . . 0.0 109.659 -173.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -87.35 -24.05 24.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.186 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . 74.8 mmtt -98.92 9.6 43.15 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 115' ' ' ASN . 19.7 tp -94.36 144.86 25.18 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.535 -172.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.519 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 1.1 tt0 -128.82 126.13 39.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.584 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -90.49 105.79 18.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.74 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.652 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.2 t30 -95.15 108.39 20.5 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.639 0.733 . . . . 0.0 109.434 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 139' ' ' ILE . 1.3 mp -85.19 109.71 18.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.058 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.58 85.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.673 . . . . 0.0 110.178 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.9 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.454 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.4 p -72.77 -16.36 61.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.11 68.67 76.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 46.1 Cg_endo -92.03 104.95 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.954 1.769 . . . . 0.0 110.327 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 18.4 tpt180 -85.98 92.5 8.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.16 0.505 . . . . 0.0 110.482 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.599 HG12 HG23 ' A' ' 109' ' ' VAL . 29.7 m -86.33 129.79 37.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.516 0.674 . . . . 0.0 111.446 -175.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.832 HG22 HH21 ' A' ' 108' ' ' ARG . 21.1 m -140.86 107.46 5.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.706 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -110.78 130.05 55.68 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.607 0.717 . . . . 0.0 110.701 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.05 142.55 46.83 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.922 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 137.18 42.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 110.892 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 101' ' ' TYR . 46.4 pt -131.74 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 92.56 7.8 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.038 0.923 . . . . 0.0 111.479 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.642 ' HA ' ' CE1' ' A' ' 101' ' ' TYR . 19.2 m95 -77.3 0.92 20.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.445 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.426 -1.673 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.778 178.218 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.717 ' HB2' HG11 ' A' ' 92' ' ' VAL . 22.1 mmtp . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -11.85 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 166.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.33 -36.2 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 17.4 mm100 -58.21 -52.37 65.86 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.92 0.867 . . . . 0.0 110.663 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.53 ' O ' HG13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -62.74 -40.88 98.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.042 177.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' B' ' 131' ' ' ARG . . . -63.24 -26.05 68.61 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.339 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 63.9 mtp85 -64.01 -52.05 61.36 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.819 0.343 . . . . 0.0 110.196 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.604 ' HD2' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -62.35 -36.86 83.53 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.759 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 49.4 mt -85.12 -3.01 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.863 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . 0.54 ' CZ ' ' HA ' ' B' ' 131' ' ' ARG . 1.4 tpm_? . . . . . 0 C--N 1.315 -0.934 0 O-C-N 121.18 -0.95 . . . . 0.0 109.995 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.679 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.07 -8.48 39.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.809 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.752 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 1.5 t -147.28 140.78 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.389 0.614 . . . . 0.0 110.999 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.657 ' HB2' HD12 ' A' ' 31' ' ' ILE . 22.9 tp60 -136.85 99.95 4.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.653 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.741 ' CG1' ' HB3' ' A' ' 28' ' ' PHE . 5.1 m -72.05 145.25 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.262 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -125.93 -62.05 1.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.931 -165.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.6 t-20 -102.9 152.51 21.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.832 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.413 ' H ' ' ND2' ' A' ' 8' ' ' ASN . 2.8 p -145.45 99.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 1.075 HG21 ' HB2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -88.71 99.5 9.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.825 -174.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.734 HG12 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.43 118.42 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.897 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.71 HD21 ' HG3' ' A' ' 25' ' ' GLU . 2.8 mt -88.79 -45.28 9.89 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.154 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.666 ' OD2' ' HD3' ' A' ' 137' ' ' ARG . 2.9 t70 -74.31 72.3 1.78 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.12 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.886 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.7 m120 -84.07 174.84 5.32 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.719 -2.037 . . . . 0.0 107.801 162.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.886 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.0 Cg_endo -49.12 102.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 CA-C-N 120.912 1.362 . . . . 0.0 113.176 -149.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.836 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 67.7 m -129.93 168.43 16.65 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.535 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.8 Cg_exo -43.17 132.69 6.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.417 2.078 . . . . 0.0 112.622 174.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.689 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 65.2 t80 -61.51 -9.14 5.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -95.76 -1.66 49.34 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.725 -0.61 . . . . 0.0 112.226 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.836 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.2 OUTLIER -97.04 134.85 22.38 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.2 Cg_exo -65.11 151.74 84.61 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.271 2.647 . . . . 0.0 113.007 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 27.5 m-85 -62.97 118.8 8.31 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.204 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.621 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 7.8 mt-30 -115.79 111.89 21.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.459 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 97' ' ' ILE . 93.9 m-85 -116.0 155.34 28.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.142 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.075 ' HB2' HG21 ' A' ' 10' ' ' VAL . 43.4 mt-10 -126.78 91.07 3.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 162.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.571 HD11 HD11 ' A' ' 97' ' ' ILE . 10.6 mt -77.2 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.8 m -111.19 107.18 16.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.303 176.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.741 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -113.54 150.35 33.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 CA-C-O 122.153 0.977 . . . . 0.0 111.131 176.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.86 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.9 tt0 -103.51 105.63 15.93 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 172.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.6 m -70.57 126.44 29.63 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -87.04 -25.71 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -165.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.679 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 44.6 mt-10 -147.47 167.9 23.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.908 174.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -74.72 142.42 44.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.941 HD12 ' HE1' ' A' ' 101' ' ' TYR . 0.4 OUTLIER -107.21 156.38 18.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.879 -168.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.549 ' N ' HD13 ' A' ' 34' ' ' LEU . 15.2 m -115.38 -35.99 4.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.694 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 23.1 tt0 -104.3 -166.32 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -172.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.694 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.3 p-10 -101.19 138.67 37.91 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 121.641 -0.662 . . . . 0.0 111.416 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.74 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.45 128.99 35.22 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.19 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 32.7 tt0 -104.03 90.4 3.59 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.616 ' CZ3' HG11 ' A' ' 6' ' ' VAL . 14.8 m95 -86.84 109.5 19.33 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 1.056 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.4 OUTLIER -118.51 160.26 22.06 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.992 173.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.865 HD11 ' HB3' ' A' ' 76' ' ' ALA . 48.8 mt -101.68 108.71 24.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.713 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 2.2 mp -98.2 105.62 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.801 ' CE1' HG11 ' A' ' 113' ' ' VAL . 40.4 t80 -90.67 109.07 20.25 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG12 HD22 ' B' ' 126' ' ' LEU . 40.5 t -65.19 98.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.497 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.34 42.75 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 171.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.765 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 16.8 p -85.63 87.5 7.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.982 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.1 -13.89 51.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -100.49 -36.6 9.14 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.439 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.663 ' C ' ' HB2' ' A' ' 47' ' ' SER . 50.6 m -103.64 -154.45 0.5 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.39 5.07 0.45 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -94.92 -8.25 37.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.765 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 19.5 m-85 -98.18 11.07 39.0 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -170.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -64.32 99.08 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.082 0.944 . . . . 0.0 110.314 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -95.76 169.64 9.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.511 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 41' ' ' LYS . 23.5 t -127.94 112.42 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -172.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.538 HD11 ' O ' ' A' ' 77' ' ' ASP . 3.3 mm? -77.51 -52.04 9.74 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.863 -175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 35.0 t70 -168.46 153.8 6.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.061 173.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 1.056 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 21.3 p -124.79 120.46 31.8 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG11 ' HD1' ' A' ' 40' ' ' TRP . 4.4 p -101.87 139.06 23.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.736 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.74 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.61 105.35 14.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.293 0.568 . . . . 0.0 111.601 -173.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 21.9 t -116.24 110.84 32.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.567 ' O ' HG11 ' A' ' 65' ' ' VAL . . . -97.48 -112.63 3.03 Favored Glycine 0 CA--C 1.487 -1.711 0 C-N-CA 118.665 -1.731 . . . . 0.0 113.417 -159.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.871 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 17.5 Cg_endo -58.71 115.9 2.87 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 121.071 1.181 . . . . 0.0 109.961 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 63' ' ' GLY . 27.5 m -130.31 122.38 19.99 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.987 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.88 126.84 18.15 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.999 1.799 . . . . 0.0 111.021 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -41.02 134.14 2.05 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.05 0.844 . . . . 0.0 112.004 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 136.41 135.16 3.38 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.86 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.3 ptt180 -66.28 139.1 58.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.604 0.716 . . . . 0.0 110.46 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 11.0 p80 -166.39 151.23 7.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.392 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 2.1 ttp -107.9 137.81 45.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.341 0.591 . . . . 0.0 111.627 -174.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.3 p90 -125.69 150.67 47.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.727 HG21 ' HG2' ' A' ' 25' ' ' GLU . 7.5 p -105.37 135.12 44.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.8 0.81 . . . . 0.0 110.754 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.66 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.7 t80 -135.47 118.95 16.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.449 -166.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -130.35 154.29 47.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.51 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.865 ' HB3' HD11 ' A' ' 42' ' ' ILE . . . -155.33 153.33 30.34 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.538 ' O ' HD11 ' A' ' 57' ' ' LEU . 10.0 p-10 -64.35 -171.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.933 0.873 . . . . 0.0 113.137 -170.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -86.09 142.96 36.55 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.299 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.689 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.7 Cg_exo -57.76 149.36 69.25 Favored 'Trans proline' 0 CA--C 1.502 -1.123 0 C-N-CA 124.116 3.21 . . . . 0.0 112.824 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 9.8 t-20 -59.56 119.01 36.24 Favored Pre-proline 0 N--CA 1.428 -1.538 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.367 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.19 -10.99 22.97 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.996 2.464 . . . . 0.0 111.498 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.09 -8.81 58.7 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 33.7 mt -96.82 -17.38 20.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.549 0.214 . . . . 0.0 111.555 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 25.3 mt -88.48 129.29 49.78 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.293 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 2.5 Cg_endo -77.5 146.68 24.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.652 2.902 . . . . 0.0 111.625 170.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.66 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 3.1 m-20 -47.75 -40.3 20.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.278 1.431 . . . . 0.0 113.621 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.85 -29.95 58.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.605 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.503 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 29.8 m-20 -89.16 -21.58 23.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.807 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.34 -49.36 19.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 121.086 0.47 . . . . 0.0 111.86 -174.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.41 47.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.598 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.73 -128.89 1.13 Allowed Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.194 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.668 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.04 138.28 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.476 ' OG1' HG12 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -147.64 166.26 27.94 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.72 HG12 HD23 ' A' ' 96' ' ' LEU . 5.5 t -126.77 131.85 70.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.049 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.626 HG23 HG23 ' A' ' 42' ' ' ILE . 2.1 p -106.23 106.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.272 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.837 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -104.2 132.74 50.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 -174.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.635 ' HB ' HG11 ' A' ' 109' ' ' VAL . 50.8 mt -94.48 102.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.77 HG21 ' HG3' ' A' ' 108' ' ' ARG . 17.8 p -95.73 109.47 21.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.927 ' SG ' HG21 ' A' ' 107' ' ' ILE . 3.2 m -81.02 111.98 17.99 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.65 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 19.3 m -108.7 111.88 23.89 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.421 -170.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.941 ' HE1' HD12 ' A' ' 34' ' ' LEU . 60.8 t80 -117.49 120.67 38.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.698 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 54.7 mtp180 67.87 25.12 7.9 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.204 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.46 8.45 87.04 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -113.06 115.05 27.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.844 -0.678 . . . . 0.0 109.373 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 28.2 mp0 -78.99 118.64 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.679 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 36.3 p90 -105.63 -5.85 19.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.927 HG21 ' SG ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -160.57 161.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 121.433 -0.792 . . . . 0.0 109.584 173.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.77 ' HG3' HG21 ' A' ' 98' ' ' THR . 12.2 ttm180 -149.48 97.6 2.66 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.837 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -86.48 100.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.696 175.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 83.83 1.59 Allowed Glycine 0 CA--C 1.488 -1.633 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.227 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.895 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -76.13 118.13 18.56 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.78 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 140' ' ' LEU . 4.2 m-85 -68.28 115.54 7.84 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.53 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.801 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.0 p -101.99 112.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.668 ' ND2' HG13 ' A' ' 92' ' ' VAL . 1.7 t-20 -95.39 126.13 40.48 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.274 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 55.5 m-80 -113.33 108.47 17.28 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.929 0.871 . . . . 0.0 109.107 -169.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -125.18 137.94 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.042 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 39.7 m-85 -51.59 149.38 4.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 42.7 p -100.4 -24.24 14.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.495 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.826 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 18.7 mm-40 -81.28 120.49 24.98 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.743 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.498 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 29.1 m -45.94 -40.65 10.56 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.83 0.706 . . . . 0.0 112.058 -169.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.32 -37.49 77.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.351 0.596 . . . . 0.0 110.372 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -71.2 -28.68 64.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.094 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 51.5 mtt180 -70.02 -42.04 73.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.2 mm-40 -58.02 -42.84 86.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.039 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 4.1 p30 -152.17 87.66 4.23 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.68 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.6 Cg_endo -56.24 115.71 2.66 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.435 2.757 . . . . 0.0 112.509 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.19 151.25 85.76 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.76 2.307 . . . . 0.0 111.282 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.9 -27.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.679 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -91.63 127.58 49.79 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.626 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.66 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.0 Cg_exo -77.29 127.79 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.764 2.976 . . . . 0.0 111.556 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' A' ' 134' ' ' LYS . 10.2 t70 -111.8 108.68 18.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.653 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 22.5 m-85 -77.19 -16.42 59.1 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.086 -171.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.5 t -82.62 -19.93 37.35 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.334 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.826 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.0 mmtt -107.33 15.08 25.36 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.484 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 16.3 tp -98.1 149.99 21.91 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.115 -171.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 1.6 tt0 -127.88 121.5 30.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.852 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -84.02 104.0 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 14.6 t30 -92.91 103.48 15.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.734 HG23 HG12 ' A' ' 11' ' ' VAL . 1.4 mp -81.79 104.15 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 112' ' ' TYR . 85.1 mt -64.74 86.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.686 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.895 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -71.83 -11.56 60.86 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.06 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -22.83 60.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.988 173.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -129.69 71.15 82.17 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.312 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.68 104.78 1.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.473 1.449 . . . . 0.0 109.933 167.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.579 ' HB3' HD12 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -81.15 81.68 7.28 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.638 HG12 HG21 ' A' ' 109' ' ' VAL . 16.1 m -81.94 117.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.299 0.571 . . . . 0.0 110.864 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.461 HG22 ' CE2' ' A' ' 149' ' ' PHE . 21.7 m -126.02 106.32 9.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.721 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -114.74 146.16 41.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.258 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.461 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.41 170.4 14.23 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.885 -173.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -103.74 115.04 29.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.246 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.9 pt -119.39 166.66 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.539 ' H ' HD21 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -95.51 100.26 12.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.548 1.166 . . . . 0.0 111.013 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.752 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 19.4 m95 -73.01 -6.65 46.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.896 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 154' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.43 -1.458 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.068 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.5 mmtt . . . . . 0 CA--C 1.52 -0.184 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.11 -52.28 21.11 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.63 0.581 . . . . 0.0 111.806 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.49 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 9.7 tt -63.95 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.699 0.285 . . . . 0.0 111.186 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' B' ' 125' ' ' GLN . 9.0 mm100 -63.88 -47.86 78.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.263 0.554 . . . . 0.0 111.029 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.576 HD22 HG12 ' A' ' 45' ' ' VAL . 43.3 mt -65.24 -46.17 81.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.825 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.18 -40.72 77.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.971 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 57.1 mtp180 -52.41 -52.59 53.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 111.457 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.68 -37.48 86.6 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.596 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 145' ' ' ARG . 13.0 mt -74.11 -51.6 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.073 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.505 -177.01 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.454 ' HB3' HD11 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.896 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.86 -17.33 28.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.28 -178.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.563 HG23 HD21 ' A' ' 34' ' ' LEU . 3.2 t -140.62 129.75 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.733 . . . . 0.0 111.289 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.43 ' HB2' HD12 ' A' ' 31' ' ' ILE . 23.0 tp60 -121.99 99.05 6.23 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 171.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.724 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -77.4 143.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.518 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -123.77 -65.98 1.03 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.173 -164.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.663 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -104.4 152.3 22.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.471 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.77 99.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 1.045 HG21 ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.3 101.38 12.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.826 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -76.96 115.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.042 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.571 HD11 HG23 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -88.51 -38.72 14.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.524 -175.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.624 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.97 79.44 0.91 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.559 168.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.615 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -106.14 176.02 1.85 Allowed Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 111.371 -2.649 . . . . 0.0 106.38 170.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.846 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.1 Cg_endo -48.65 102.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.892 1.711 . . . . 0.0 113.291 -154.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.9 m -137.04 171.87 7.88 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 111.926 -2.397 . . . . 0.0 108.593 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 56.1 Cg_exo -39.94 139.09 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.828 2.352 . . . . 0.0 112.25 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.794 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 35.7 t80 -60.16 -27.57 67.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.705 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -83.58 -13.7 53.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.286 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -62.28 128.05 90.58 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.655 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.3 Cg_exo -68.0 153.82 74.22 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 123.772 2.981 . . . . 0.0 113.266 -172.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 19.6 m-85 -65.26 122.68 17.68 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.061 0.458 . . . . 0.0 109.961 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.748 ' HA ' ' HG3' ' A' ' 75' ' ' GLN . 19.7 mt-30 -127.07 92.91 3.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.48 -172.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.565 ' CD1' HD13 ' A' ' 97' ' ' ILE . 92.2 m-85 -103.39 126.07 50.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.045 ' HB3' HG21 ' A' ' 10' ' ' VAL . 32.7 tt0 -105.44 87.25 2.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.735 HG22 ' CZ3' ' A' ' 40' ' ' TRP . 3.3 mt -80.04 133.02 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.85 0.833 . . . . 0.0 112.192 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.1 m -109.73 104.74 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.193 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.724 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 17.8 p90 -118.3 146.44 44.32 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.899 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.6 tt0 -105.56 116.81 32.57 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -73.26 110.83 7.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.454 HD11 ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -76.78 -29.49 17.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.05 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.896 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 5.8 mt-10 -149.54 147.51 28.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -52.82 133.31 37.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.77 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -87.66 157.23 19.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.578 -172.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -112.89 -34.41 5.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.946 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.699 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.1 tt0 -124.07 -167.88 1.71 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.699 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.93 145.01 24.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.499 0.666 . . . . 0.0 110.758 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.686 HD13 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -92.7 121.96 34.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.312 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 25.6 tt0 -102.58 93.51 5.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.626 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.735 ' CZ3' HG22 ' A' ' 26' ' ' ILE . 23.0 m95 -84.33 111.44 19.42 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 31.2 ttmt -115.81 143.06 45.94 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.958 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.589 HG21 HD23 ' A' ' 57' ' ' LEU . 10.9 mt -102.95 106.8 20.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.469 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.547 HD13 ' HG2' ' A' ' 41' ' ' LYS . 3.0 mp -105.73 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.29 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.761 ' CE2' HG13 ' A' ' 113' ' ' VAL . 37.2 t80 -91.69 120.02 32.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.561 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.491 HG13 ' CD2' ' B' ' 126' ' ' LEU . 24.0 t -58.37 101.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 110.095 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.18 -37.24 94.27 Favored Glycine 0 CA--C 1.506 -0.512 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.109 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.742 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 66.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.03 54.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.198 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.09 -23.97 21.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 51.9 m -117.2 -154.91 0.57 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.85 164.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.553 ' OE1' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -134.0 -33.89 1.02 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.659 0.266 . . . . 0.0 110.913 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.553 ' HG3' ' OE1' ' A' ' 51' ' ' GLU . 29.3 mt-10 -71.43 -3.93 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.742 ' CD1' ' HB2' ' A' ' 47' ' ' SER . 96.8 m-85 -85.98 -1.86 57.73 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.446 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.22 111.85 0.54 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.133 0.968 . . . . 0.0 110.481 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 1.5 mt-30 -93.4 168.6 10.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.716 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 HG21 ' HD3' ' A' ' 41' ' ' LYS . 42.5 t -124.03 113.28 36.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.459 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 42' ' ' ILE . 10.9 mp -74.54 -50.32 18.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.499 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.642 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -170.83 -177.93 2.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.663 -177.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.569 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 36.1 p -152.69 124.32 7.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -100.54 135.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.0 mt -110.69 105.41 14.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.01 0.433 . . . . 0.0 110.573 -176.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.42 119.11 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.67 -164.21 11.41 Favored Glycine 0 CA--C 1.499 -0.911 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.385 -167.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.77 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 53.4 Cg_endo -66.14 115.42 3.46 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.298 1.332 . . . . 0.0 110.194 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.493 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.4 m -123.04 138.4 29.71 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.849 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.41 78.18 2.55 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.363 2.042 . . . . 0.0 113.83 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 52.26 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.641 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.554 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 106.07 137.96 8.99 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.658 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.899 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 6.2 ptt180 -76.14 127.1 32.24 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.997 0.903 . . . . 0.0 109.474 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.554 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 22.5 m-70 -123.65 135.25 53.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.683 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.1 ttp -109.22 99.56 8.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 5.8 p90 -108.67 142.31 39.35 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 3.4 p -104.96 130.55 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.492 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 5.1 t80 -132.86 132.04 41.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.817 -159.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.748 ' HG3' ' HA ' ' A' ' 23' ' ' GLN . 22.1 mp0 -145.28 156.05 43.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.106 0.479 . . . . 0.0 110.57 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.46 32.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.047 -0.978 . . . . 0.0 108.375 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.7 178.4 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.652 0.739 . . . . 0.0 112.28 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . . . -68.76 159.94 79.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.199 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 78' ' ' ALA . 57.4 Cg_endo -74.62 166.54 29.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.778 2.319 . . . . 0.0 110.503 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.569 ' HB2' HD13 ' A' ' 83' ' ' LEU . 3.7 m-20 -75.88 114.19 34.57 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.207 0.527 . . . . 0.0 111.161 -171.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.33 -21.64 66.73 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.578 2.852 . . . . 0.0 112.131 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.38 -0.54 84.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.251 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 80' ' ' ASN . 35.0 mt -103.68 -20.57 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.571 0.224 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.48 ' CG2' ' HB3' ' A' ' 89' ' ' ALA . 27.9 mt -89.8 129.39 46.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.232 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.528 ' HG2' ' CG ' ' A' ' 88' ' ' ASP . 88.1 Cg_endo -79.99 163.58 22.97 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.527 2.818 . . . . 0.0 111.732 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.658 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -45.64 -56.68 4.91 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.068 0.947 . . . . 0.0 113.268 -174.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -24.39 61.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 111.197 -167.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' CG ' ' HG2' ' A' ' 85' ' ' PRO . 1.4 m-20 -86.65 -24.97 25.09 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.476 -175.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.643 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -82.91 -46.87 12.44 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.016 -173.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -94.23 46.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-O 122.043 0.925 . . . . 0.0 111.275 -174.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.87 -124.71 0.8 Allowed Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.103 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.498 HG21 ' ND2' ' A' ' 114' ' ' ASN . 1.1 t -114.57 134.68 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 -168.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 169.93 17.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.461 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.5 t -127.17 152.31 35.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 118.37 0.532 . . . . 0.0 111.603 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.6 p -130.83 108.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.21 133.25 47.38 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.025 -172.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.751 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 33.9 mt -102.23 97.65 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.038 0.923 . . . . 0.0 108.797 174.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.81 HG22 ' HG3' ' A' ' 108' ' ' ARG . 49.4 p -91.72 114.11 26.56 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.258 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 61.4 m -81.99 105.69 13.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.919 0.866 . . . . 0.0 110.706 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.5 m -93.3 106.51 18.47 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.668 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.615 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 65.7 t80 -116.64 119.63 36.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.038 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.615 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.3 mtp180 64.88 23.71 12.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.2 -0.58 64.07 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.62 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.31 121.11 39.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 46.8 mt-10 -72.63 131.36 42.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.783 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.686 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 50.6 p90 -115.66 -1.85 12.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.1 tt -157.77 161.54 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 109.602 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.81 ' HG3' HG22 ' A' ' 98' ' ' THR . 17.7 ttm180 -150.71 95.78 2.27 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.927 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -83.15 100.36 6.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 118.776 -1.169 . . . . 0.0 108.558 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.536 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -87.78 78.65 1.79 Allowed Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.869 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.925 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -72.88 117.99 15.27 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.585 ' HB3' HD11 ' A' ' 140' ' ' LEU . 22.6 m-85 -67.55 130.34 42.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.761 HG13 ' CE2' ' A' ' 44' ' ' TYR . 4.9 p -112.02 111.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.643 ' HB3' ' ND2' ' A' ' 138' ' ' ASN . 3.9 t-20 -94.46 116.78 29.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.386 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.643 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -108.39 108.53 19.53 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -171.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -131.5 129.07 40.63 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.392 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.513 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.8 m-85 -39.55 150.09 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 136' ' ' GLN . 68.7 p -92.46 -28.66 16.7 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.167 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.947 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.4 mm-40 -84.4 117.31 23.54 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.216 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.7 m -53.07 -34.36 56.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.039 -172.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -32.03 72.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.687 0.756 . . . . 0.0 110.283 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.503 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 70.4 mt -76.96 -24.38 52.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.123 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.2 mtp-105 -78.57 -31.79 47.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.722 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.2 mm-40 -61.57 -39.02 89.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.328 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 6.0 p30 -157.96 95.28 1.99 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.113 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 10.8 Cg_endo -53.8 118.37 4.86 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.528 2.152 . . . . 0.0 110.965 175.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.484 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 73.7 Cg_exo -53.02 144.39 46.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.101 1.867 . . . . 0.0 109.424 172.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.52 -27.34 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.101 -166.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HE2' ' HB2' ' A' ' 129' ' ' LYS . 10.0 tppt? -116.35 107.1 47.78 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.655 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.658 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 75.9 Cg_exo -40.27 139.84 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 125.242 3.962 . . . . 0.0 113.881 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -110.59 106.15 15.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.764 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.5 m-85 -74.47 -12.58 60.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.581 -171.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -89.36 -21.1 23.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.271 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.947 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 70.9 mmtt -100.01 10.84 40.64 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 115' ' ' ASN . 21.3 tp -95.38 133.12 39.68 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.522 -171.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.466 ' HB2' HG23 ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.31 123.56 49.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.794 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -103.26 108.32 19.49 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.874 -174.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.846 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p-10 -92.77 104.66 16.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.862 0.839 . . . . 0.0 109.475 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.662 HG23 HG13 ' A' ' 11' ' ' VAL . 1.3 mp -70.96 108.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 112' ' ' TYR . 88.8 mt -67.04 86.57 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.685 0.755 . . . . 0.0 110.7 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.925 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.9 -15.31 60.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.318 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 p -81.97 -1.45 48.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -141.56 64.64 19.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.7 Cg_endo -93.18 106.18 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.059 1.839 . . . . 0.0 111.362 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.507 ' HB3' HD13 ' B' ' 130' ' ' ILE . 16.4 tpt180 -77.61 81.93 4.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.451 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.424 HG12 HG21 ' A' ' 109' ' ' VAL . 3.0 m -76.92 103.46 4.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.3 0.571 . . . . 0.0 110.501 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.447 HG22 ' CE2' ' A' ' 149' ' ' PHE . 35.2 m -116.49 106.09 13.21 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.615 0.722 . . . . 0.0 109.362 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.2 ptt-85 -118.96 154.44 33.02 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.782 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -138.07 168.49 19.61 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.931 -172.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.17 144.65 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.94 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.597 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 22.1 pt -133.99 -172.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.47 0.653 . . . . 0.0 109.936 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -98.31 92.7 5.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.38 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.586 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 15.2 m95 -78.46 -16.57 57.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.398 176.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.49 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 3.0 mp0 . . . . . 0 N--CA 1.433 -1.312 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.233 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 46.8 mmtm . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.88 -57.62 4.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.259 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.69 -35.62 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.292 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.8 mm100 -54.82 -51.74 64.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.826 0.822 . . . . 0.0 110.497 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.564 ' HB3' HG22 ' A' ' 94' ' ' VAL . 44.5 mt -66.22 -43.65 86.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.611 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.88 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.68 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' B' ' 128' ' ' ARG . 18.6 mtp180 -60.09 -49.02 79.29 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.894 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -60.62 -41.78 95.53 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.935 0.398 . . . . 0.0 111.133 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.536 HD13 ' HA3' ' A' ' 110' ' ' GLY . 7.0 mt -75.25 -43.88 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.213 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 . . . . . 0 C--N 1.33 -0.243 0 O-C-N 123.607 0.567 . . . . 0.0 111.05 -176.263 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.421 ' HB2' HD11 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.782 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.55 -19.89 24.45 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.482 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 4.0 t -140.96 130.49 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.755 0.788 . . . . 0.0 111.526 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 20.8 tp60 -125.06 100.55 6.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.57 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -74.4 144.59 12.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.76 177.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -123.29 -66.52 1.0 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.469 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.5 t-20 -103.28 151.65 22.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.536 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.739 HG21 HG13 ' A' ' 26' ' ' ILE . 2.6 p -147.43 99.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.578 174.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.91 HG21 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -92.87 109.67 21.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.564 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -82.32 132.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -110.91 -68.8 0.91 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.733 0.777 . . . . 0.0 112.328 -162.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.0 34.7 1.51 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.161 -162.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.697 ' HB3' ' NH2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -138.78 99.64 8.35 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 171.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 60.7 Cg_endo -124.99 92.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.27 1 C-N-CA 125.696 4.264 . . . . 0.0 106.139 108.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.651 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 7.5 m -153.83 168.98 10.65 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.188 -167.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 87.9 Cg_exo -38.3 132.26 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.814 2.343 . . . . 0.0 111.679 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.905 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 10.1 t80 -60.85 -22.19 63.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.401 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -84.87 -10.56 57.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.988 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.611 HD21 ' NH1' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -77.35 128.57 80.07 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 122.49 1.138 . . . . 0.0 108.728 167.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.65 152.83 32.44 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 124.76 3.64 . . . . 0.0 112.995 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.587 ' HA ' HH21 ' A' ' 137' ' ' ARG . 27.1 m-85 -81.21 124.4 29.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.486 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 1.036 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.2 mp0 -113.32 114.07 26.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.682 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CG ' HD13 ' A' ' 97' ' ' ILE . 73.4 m-85 -120.97 114.41 21.48 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.91 ' HB3' HG21 ' A' ' 10' ' ' VAL . 33.1 tt0 -97.88 87.12 3.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.739 HG13 HG21 ' A' ' 9' ' ' VAL . 4.5 mp -82.63 140.51 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.929 0.871 . . . . 0.0 112.363 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 14.9 m -113.33 107.13 15.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.286 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.4 p90 -116.39 150.01 38.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.377 0.608 . . . . 0.0 109.565 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.848 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -105.42 112.21 25.22 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.481 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 4.2 t -72.97 108.16 5.72 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -73.76 -25.15 20.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.384 -174.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.782 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -152.8 158.0 41.61 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.409 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.6 129.16 40.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.508 . . . . 0.0 110.339 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.122 HD11 ' HE2' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -84.5 148.64 26.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.671 -170.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.54 ' N ' HD12 ' A' ' 34' ' ' LEU . 17.7 m -115.37 -25.99 7.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.909 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 35.8 tt0 -118.44 -163.41 0.95 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.909 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 8.8 m-20 -93.84 131.32 39.35 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.707 -0.621 . . . . 0.0 109.337 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.701 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.62 118.58 23.41 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.655 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 40.8 tt0 -102.31 127.61 49.22 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.585 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.588 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.9 m95 -115.72 127.52 55.2 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.762 ' HD2' HD13 ' A' ' 43' ' ' ILE . 2.7 ttmp? -123.71 146.54 48.19 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.053 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.59 HD12 HG12 ' A' ' 97' ' ' ILE . 44.1 mm -102.83 105.8 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.685 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.762 HD13 ' HD2' ' A' ' 41' ' ' LYS . 2.9 mp -103.1 110.8 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.592 ' CE2' HG11 ' A' ' 113' ' ' VAL . 32.2 t80 -95.86 110.78 22.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.256 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG13 HD23 ' B' ' 126' ' ' LEU . 22.9 t -61.53 101.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.404 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -74.34 -42.94 33.07 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.75 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 27.8 p -95.44 99.65 11.52 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' B' ' 122' ' ' LYS . . . -90.98 -5.07 55.91 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 161.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -99.83 -48.75 4.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.607 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.596 ' C ' ' HB2' ' A' ' 47' ' ' SER . 38.7 m -98.56 -157.43 0.6 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 170.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HB3' HE22 ' B' ' 125' ' ' GLN . 12.9 pt-20 -143.42 -25.91 0.58 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.319 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -79.42 2.81 20.44 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 9.6 m-30 -88.51 -1.63 58.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.554 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -47.6 109.59 0.23 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.617 0.722 . . . . 0.0 110.536 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.695 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 55.2 mt-30 -91.58 166.04 13.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.812 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.51 112.1 28.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.286 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.6 HD21 ' HD3' ' A' ' 79' ' ' PRO . 8.3 mp -82.18 -56.87 3.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.901 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.12 161.37 42.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.355 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.0 p -146.46 114.98 6.76 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.27 138.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 10.7 mt -110.88 103.2 11.68 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.107 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -97.2 122.79 49.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -77.3 -158.56 9.7 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.331 -162.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.04 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.6 Cg_endo -65.35 116.75 4.06 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.444 1.429 . . . . 0.0 110.097 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 63' ' ' GLY . 24.5 m -126.22 150.49 70.0 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.35 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.04 138.78 44.89 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.746 2.297 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.644 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -43.86 144.58 0.84 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.324 0.583 . . . . 0.0 112.138 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 134.03 126.97 2.7 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -174.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.4 ptt180 -70.93 130.79 42.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.375 1.083 . . . . 0.0 110.794 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.518 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 9.0 p80 -150.82 151.1 31.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.151 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -107.36 138.45 43.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.455 -172.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 6.2 p90 -139.51 152.27 46.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.2 p -111.51 107.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 122.647 1.213 . . . . 0.0 111.339 -169.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.2 t80 -108.91 121.45 45.14 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.637 -170.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 1.036 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 33.4 mt-30 -119.81 166.43 13.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.245 -172.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.73 132.6 6.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.848 0.295 . . . . 0.0 111.644 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.92 156.69 35.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.55 152.13 36.2 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HD3' HD21 ' A' ' 57' ' ' LEU . 55.5 Cg_endo -72.38 177.4 7.39 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.853 3.035 . . . . 0.0 112.236 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -73.69 116.88 56.08 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.436 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.24 1.08 3.79 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 123.67 2.913 . . . . 0.0 112.654 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.51 -15.18 28.01 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.695 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 61.4 mt -97.86 -8.87 27.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.525 -0.837 . . . . 0.0 110.926 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 85' ' ' PRO . 22.6 mt -96.07 129.6 33.5 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.051 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 3.4 Cg_exo -77.43 155.35 32.18 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.357 2.705 . . . . 0.0 111.673 169.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.765 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.1 p30 -47.52 -47.25 27.86 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.06 -28.13 68.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.423 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 10.7 m-20 -98.58 -21.78 16.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.429 -173.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -81.33 -46.5 14.61 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.242 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.836 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -95.25 46.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.468 0.652 . . . . 0.0 112.247 -174.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.7 -129.62 1.38 Allowed Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.075 -172.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.642 HG12 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -98.27 135.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -168.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.48 167.86 28.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.368 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.603 HG12 HD23 ' A' ' 96' ' ' LEU . 69.4 t -118.66 128.7 75.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.354 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.19 106.51 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -105.75 148.43 27.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.056 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.733 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 45.6 mt -106.98 108.29 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 121.313 0.577 . . . . 0.0 109.528 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.841 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 41.8 p -101.92 114.25 28.18 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.189 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 64.1 m -79.32 158.0 27.58 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.282 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -151.14 119.68 6.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -167.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 1.122 ' HE2' HD11 ' A' ' 34' ' ' LEU . 34.6 t80 -138.29 124.14 19.97 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.612 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 61.1 mtp180 65.31 32.87 9.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.386 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.97 83.44 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.574 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -114.28 132.23 56.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.15 0.5 . . . . 0.0 110.068 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 31.7 mt-10 -93.89 130.12 40.07 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.146 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.701 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.7 p90 -118.44 -1.17 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -164.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' A' ' 98' ' ' THR . 5.4 tt -156.47 160.29 2.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 120.883 -1.136 . . . . 0.0 109.388 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.654 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 13.5 ttp180 -148.08 102.22 3.36 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 123.93 0.769 . . . . 0.0 109.433 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.6 p -89.95 101.26 12.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.723 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.18 92.05 1.78 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 119.613 -1.279 . . . . 0.0 112.136 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.74 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 8.7 m-85 -83.95 126.09 32.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.895 -0.652 . . . . 0.0 109.943 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -68.24 112.12 4.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.962 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.9 p -93.89 111.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.642 HD22 HG12 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -101.63 104.42 15.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.013 -176.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.663 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.6 m-80 -94.3 110.27 22.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.255 -172.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.14 128.03 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.642 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 31.6 m-85 -39.29 154.12 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.5 p -98.19 -26.15 14.65 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.253 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.409 ' HB2' HD11 ' A' ' 122' ' ' LEU . 26.6 mm-40 -78.64 120.99 24.11 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.633 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.8 m -54.33 -32.02 55.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.543 -169.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -70.61 -36.17 73.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.682 0.753 . . . . 0.0 109.572 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.547 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 65.9 mt -74.88 -25.85 59.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.213 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 32.7 mtt180 -70.96 -36.7 72.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.995 0.903 . . . . 0.0 108.787 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 120' ' ' THR . 44.0 mm-40 -69.39 -40.92 77.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.972 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.0 p30 -146.51 91.06 5.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 0.0 111.218 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.419 ' HA ' ' CE2' ' A' ' 117' ' ' TYR . 14.6 Cg_endo -56.41 114.97 2.15 Favored 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 122.831 2.354 . . . . 0.0 111.244 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 50.9 Cg_exo -56.32 160.08 11.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.432 2.088 . . . . 0.0 111.072 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.512 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 11.7 p -51.25 -36.58 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -166.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.517 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 4.8 mmtt -116.19 116.0 40.09 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-O 121.896 0.855 . . . . 0.0 111.745 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.836 ' HB3' HG13 ' A' ' 90' ' ' VAL . 3.0 Cg_exo -47.4 141.74 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 125.018 3.812 . . . . 0.0 113.952 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -111.64 109.94 20.08 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 170.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.734 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 18.4 m-85 -70.93 -15.49 62.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.649 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -87.39 -17.81 31.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.641 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 47.7 mmtm -101.91 1.56 37.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.485 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 20.7 tp -86.63 139.79 30.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.125 -171.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -121.34 116.61 25.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.905 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 4.2 mtp-105 -80.39 101.33 8.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.649 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -97.48 106.83 19.21 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.618 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 12.3 mt -95.6 114.11 31.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.945 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.0 mt -73.54 90.05 1.73 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.329 -172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.74 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -75.45 -9.72 58.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.494 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 p -85.06 -3.37 58.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.679 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -137.12 70.44 55.94 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.584 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.4 Cg_endo -91.28 109.66 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.883 2.389 . . . . 0.0 112.07 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.36 81.38 7.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 109' ' ' VAL . 16.1 m -71.71 129.29 35.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.152 0.501 . . . . 0.0 111.301 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.5 m -141.09 105.4 4.83 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 172.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.761 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -118.52 143.95 46.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.883 0.849 . . . . 0.0 110.836 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.36 168.42 13.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.715 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.89 151.03 22.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.005 0.431 . . . . 0.0 111.107 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.757 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 27.9 pt -135.75 172.34 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -94.69 86.56 4.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.545 1.164 . . . . 0.0 111.059 -178.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.625 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 35.2 m95 -64.52 -16.61 62.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.556 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -48.33 -48.47 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.073 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tt -67.69 -39.83 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.196 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.459 HE22 ' HB3' ' A' ' 51' ' ' GLU . 3.5 mm100 -63.41 -37.4 87.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 89.4 mt -67.23 -43.57 81.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.276 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.72 72.77 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.959 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.36 -47.05 86.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.14 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.9 -43.44 83.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.382 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.654 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 69.7 mt -68.04 -16.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.397 0.618 . . . . 0.0 110.645 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 20.8 tpt85 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.875 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.565 ' HB2' HD11 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.589 ' HG2' ' CD2' ' A' ' 153' ' ' TRP . 33.3 mmtt -99.9 -7.56 25.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.436 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.7 t -146.1 128.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.113 0.482 . . . . 0.0 110.575 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.583 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 24.0 tp60 -125.09 103.98 8.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.532 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.763 HG23 ' CH2' ' A' ' 40' ' ' TRP . 2.3 t -65.78 128.85 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.884 0.849 . . . . 0.0 109.092 171.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -118.33 -54.33 2.29 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.852 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.756 HD22 HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -104.96 128.9 53.43 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.116 -174.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.725 ' N ' HD21 ' A' ' 8' ' ' ASN . 2.2 t -129.11 99.53 4.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.403 169.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 25' ' ' GLU . 1.5 m -95.4 101.37 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.444 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.835 HG11 HG23 ' A' ' 139' ' ' ILE . 2.5 t -83.99 117.88 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.325 1.06 . . . . 0.0 108.851 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -86.33 -36.09 19.47 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.341 -175.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.624 ' OD2' ' HA ' ' A' ' 22' ' ' PHE . 36.7 t0 -74.14 58.28 0.69 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.982 168.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -82.44 174.48 6.01 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 113.139 -1.846 . . . . 0.0 106.376 160.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.0 Cg_endo -49.91 103.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.82 1.686 . . . . 0.0 113.065 -153.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.631 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 15.7 m -139.33 171.16 8.47 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.428 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.2 Cg_exo -40.64 132.49 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.458 2.105 . . . . 0.0 111.941 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.767 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 36.6 t80 -57.96 -27.1 63.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.266 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 18.9 m-85 -87.06 -3.3 59.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.139 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -76.24 125.56 87.64 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 164.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.557 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 38.5 Cg_exo -62.89 150.58 87.98 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 123.264 2.643 . . . . 0.0 112.855 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.6 m-85 -62.65 103.55 0.43 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.804 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.614 ' HB3' HD12 ' A' ' 12' ' ' LEU . 33.6 mt-30 -106.91 103.02 12.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.237 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CD1' HD13 ' A' ' 97' ' ' ILE . 82.9 m-85 -104.57 155.6 18.69 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.895 ' HB3' HG21 ' A' ' 10' ' ' VAL . 12.7 tt0 -130.51 87.34 2.49 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.502 ' CG2' HG21 ' A' ' 6' ' ' VAL . 23.3 mt -78.06 138.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.782 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 5.5 m -119.29 109.78 16.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.254 171.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.662 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 19.2 p90 -112.27 140.74 46.73 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.561 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.0 tt0 -101.75 114.82 29.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.5 m -72.2 113.4 9.19 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -73.83 -24.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.109 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.516 -173.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 40.0 mt-10 -150.78 164.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.81 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.46 133.72 50.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.2 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.055 HD11 ' HE2' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -95.5 152.57 18.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.112 -172.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.521 ' N ' HD12 ' A' ' 34' ' ' LEU . 11.8 p -115.58 -33.11 5.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.702 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.9 tt0 -108.17 -163.13 0.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -173.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.702 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 12.4 m-20 -89.73 163.12 15.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.592 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -114.58 119.78 37.94 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.1 mp0 -91.19 126.73 36.36 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.017 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.763 ' CH2' HG23 ' A' ' 6' ' ' VAL . 53.5 m95 -120.36 125.81 48.94 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.844 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.1 ttmt -128.72 143.67 50.98 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.649 -173.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 95' ' ' VAL . 12.8 mt -103.69 106.98 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.844 HD11 ' HD2' ' A' ' 41' ' ' LYS . 74.0 mt -107.12 106.8 21.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.739 0.781 . . . . 0.0 109.987 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.838 ' CE2' HG13 ' A' ' 113' ' ' VAL . 58.3 t80 -90.62 131.67 36.19 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.743 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.94 101.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.578 0.704 . . . . 0.0 110.639 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.08 -40.22 97.93 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.548 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.897 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 89.8 p -132.57 118.66 19.49 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.663 0.268 . . . . 0.0 110.854 172.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -78.21 -3.62 43.6 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 163.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' CD ' ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -99.44 -17.09 18.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.769 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.533 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 53.2 m -131.41 -148.33 0.35 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.87 -32.7 0.27 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 118.854 0.752 . . . . 0.0 112.507 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.84 1.35 20.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.897 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 3.2 m-30 -82.35 -17.7 44.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.311 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.411 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p-10 -42.38 115.62 0.72 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 111.895 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.484 ' CG ' HD13 ' A' ' 83' ' ' LEU . 12.4 mp0 -92.7 165.62 12.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.04 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.599 HG23 HG12 ' A' ' 43' ' ' ILE . 37.5 t -130.24 110.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.4 mm? -79.52 -40.33 29.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.618 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -174.43 157.8 2.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 21.0 p -140.12 117.44 11.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.3 p -98.65 141.2 16.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.764 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.482 ' CD1' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -110.63 104.96 13.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.882 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -83.37 154.16 3.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' HG11 ' A' ' 65' ' ' VAL . . . -96.48 -162.41 32.73 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 118.633 -1.746 . . . . 0.0 112.456 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.025 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 45.0 Cg_endo -66.3 118.92 5.91 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.928 1.752 . . . . 0.0 109.91 173.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 30' ' ' CYS . 35.8 m -121.15 131.94 24.34 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.398 -173.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.07 138.26 51.46 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.486 2.124 . . . . 0.0 110.789 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -40.58 141.5 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.063 0.852 . . . . 0.0 112.433 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.05 149.24 7.51 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.898 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 9.4 ptt180 -75.72 143.63 41.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.028 0.918 . . . . 0.0 111.157 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.582 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 91.6 m-70 -137.85 136.09 36.82 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.607 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.31 123.8 48.6 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.608 0.718 . . . . 0.0 110.763 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.6 p90 -127.97 144.12 51.1 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.365 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 p -105.42 125.9 60.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.109 0.956 . . . . 0.0 110.213 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.666 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 7.3 t80 -126.6 113.1 16.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.025 -162.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.2 mt-30 -130.55 154.25 48.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -158.13 154.32 27.26 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.31 -174.93 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.839 0.828 . . . . 0.0 113.056 -171.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -81.94 150.49 65.44 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.476 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.767 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 46.7 Cg_exo -62.77 173.75 3.48 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 123.389 2.726 . . . . 0.0 112.495 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -81.8 115.6 58.14 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.525 -174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.08 -9.69 26.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.267 2.645 . . . . 0.0 112.236 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 6.46 64.98 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.698 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.484 HD13 ' CG ' ' A' ' 55' ' ' GLN . 10.3 mt -108.9 -37.68 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.548 0.213 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.572 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 49.3 mt -69.57 130.08 90.87 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.45 ' O ' HG23 ' A' ' 84' ' ' ILE . 73.2 Cg_endo -79.69 161.62 24.61 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 0.0 112.468 171.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.601 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.0 OUTLIER -46.31 -52.74 12.12 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.787 0.835 . . . . 0.0 112.974 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . . . -75.0 -23.03 58.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.983 -170.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.742 ' HA ' ' HZ3' ' B' ' 122' ' ' LYS . 12.9 t0 -82.68 -27.3 31.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 0.0 110.591 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 130' ' ' PRO . . . -73.94 -40.4 63.1 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.759 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.38 44.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 114' ' ' ASN . . . -174.77 -129.56 1.2 Allowed Glycine 0 CA--C 1.496 -1.113 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.992 -173.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.729 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -103.04 120.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.187 0.994 . . . . 0.0 113.433 -165.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.845 ' HB ' HG11 ' A' ' 113' ' ' VAL . 5.2 m -135.35 169.12 17.97 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.488 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' B' ' 126' ' ' LEU . 8.3 t -130.89 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 118.049 0.386 . . . . 0.0 110.638 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 42' ' ' ILE . 7.6 p -131.78 107.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.875 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -97.26 130.21 44.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.664 -168.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.76 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 49.1 mt -95.36 93.75 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.792 HG21 ' HG3' ' A' ' 108' ' ' ARG . 32.4 p -92.35 112.94 25.07 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.677 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.013 ' SG ' HG22 ' A' ' 107' ' ' ILE . 23.5 p -75.52 159.14 31.61 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 28.2 m -150.95 103.65 3.08 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -171.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 1.055 ' HE2' HD11 ' A' ' 34' ' ' LEU . 51.0 t80 -118.9 125.52 49.68 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 16.4 mmt180 67.18 14.46 9.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.898 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.26 4.55 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.595 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.45 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.73 138.22 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 6.8 mt-10 -87.45 127.62 35.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.539 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.592 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.9 p90 -116.95 1.73 12.66 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 1.013 HG22 ' SG ' ' A' ' 99' ' ' CYS . 4.8 tt -154.44 153.98 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.381 -0.825 . . . . 0.0 109.2 167.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.909 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 4.1 ttm-85 -143.63 91.2 2.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.582 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.875 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -83.39 100.95 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.266 1.031 . . . . 0.0 108.294 175.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.72 81.73 1.43 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.791 -1.195 . . . . 0.0 111.158 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.526 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 27.4 m-85 -69.73 115.1 8.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.619 ' HB3' HD11 ' A' ' 140' ' ' LEU . 2.4 m-85 -66.93 111.37 3.75 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.845 HG11 ' HB ' ' A' ' 93' ' ' THR . 1.5 p -91.47 109.33 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.729 ' ND2' HG13 ' A' ' 92' ' ' VAL . 1.7 t-20 -96.7 113.66 25.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.431 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.49 ' HB3' HD13 ' A' ' 135' ' ' LEU . 57.6 m-80 -101.82 108.84 20.46 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.861 0.839 . . . . 0.0 109.151 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.16 132.46 39.85 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.814 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 50.6 m-85 -49.01 155.5 0.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -172.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 18.3 p -92.27 -28.89 16.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.257 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.583 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 21.7 mm-40 -80.81 122.96 27.84 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.298 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.566 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 21.2 m -51.75 -34.09 37.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.336 -170.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.23 -37.33 80.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.652 0.739 . . . . 0.0 109.438 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 55.8 mt -78.77 -19.28 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.551 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 45.9 mtt180 -77.58 -35.11 53.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.7 mm-40 -74.45 -38.08 63.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.438 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.2 p30 -142.3 83.23 12.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 110.441 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 16.3 Cg_endo -57.39 114.97 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.141 2.561 . . . . 0.0 111.918 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.641 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 34.7 Cg_exo -62.72 142.77 90.54 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.0 110.347 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 t -55.94 -32.84 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.511 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.3 mmtt -79.4 133.09 60.56 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 121.132 0.491 . . . . 0.0 110.875 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.601 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 6.4 Cg_endo -77.45 129.32 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.588 2.859 . . . . 0.0 112.433 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.2 t70 -125.63 108.03 11.16 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.885 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.702 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.5 m-85 -78.5 -16.83 57.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.273 1.035 . . . . 0.0 110.579 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.42 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 31.0 t -83.11 -27.95 29.81 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.301 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.583 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 71.9 mmtt -100.8 11.62 39.19 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.3 tp -94.55 129.08 41.5 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.885 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.562 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 3.2 tt0 -112.72 120.06 40.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.739 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.06 107.12 19.44 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.639 -174.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 16.5 t30 -78.74 102.88 8.32 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.828 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.835 HG23 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -76.89 105.83 6.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.911 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 112' ' ' TYR . 83.9 mt -67.11 90.99 0.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.757 0.789 . . . . 0.0 111.336 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.526 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.21 -19.51 43.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.454 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 p -80.14 -17.32 52.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.949 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -131.31 61.5 59.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.709 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.72 116.5 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.81 1.673 . . . . 0.0 111.058 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.656 ' HG3' HG12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.84 81.11 7.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.387 0.613 . . . . 0.0 109.942 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.866 HG12 HG21 ' A' ' 109' ' ' VAL . 19.4 m -89.36 137.39 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.771 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.5 m -149.18 108.76 4.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.487 0.661 . . . . 0.0 110.008 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.683 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -101.64 140.75 35.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.0 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -118.11 168.51 10.49 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.798 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -104.83 114.54 28.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.413 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 101' ' ' TYR . 42.3 pt -118.69 -173.47 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.518 0.675 . . . . 0.0 110.971 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -96.07 92.74 6.59 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.726 -177.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.589 ' CD2' ' HG2' ' A' ' 3' ' ' LYS . 37.8 m95 -77.28 -12.5 59.96 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 109.838 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.434 -1.271 0 CA-C-O 121.832 0.825 . . . . 0.0 110.595 -172.202 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.742 ' HZ3' ' HA ' ' A' ' 88' ' ' ASP . 75.5 mmtt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -24.79 -66.72 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.778 1.299 . . . . 0.0 114.001 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.74 -35.61 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 128' ' ' ARG . 7.4 mm100 -66.5 -50.11 64.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.954 0.407 . . . . 0.0 111.899 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 94' ' ' VAL . 1.5 mm? -68.3 -33.96 75.28 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.18 90.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.549 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 49.9 mtp180 -51.77 -56.41 14.0 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.28 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.791 ' HD2' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -56.93 -42.69 80.45 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 -176.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.909 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 1.7 mp -70.13 -50.2 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 123.747 0.654 . . . . 0.0 112.543 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -174.221 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.904 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -90.68 -20.58 22.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 -176.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.469 ' HB ' ' CZ3' ' A' ' 153' ' ' TRP . 3.0 t -136.64 129.51 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.482 0.658 . . . . 0.0 110.275 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.725 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -115.54 99.59 7.46 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -73.12 134.03 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -120.24 -64.88 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.89 0.852 . . . . 0.0 109.465 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.673 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.2 t-20 -105.09 150.0 25.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.587 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 HG13 ' OH ' ' A' ' 111' ' ' TYR . 5.9 p -145.57 102.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.957 0.885 . . . . 0.0 109.322 173.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -95.75 100.22 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.513 1.149 . . . . 0.0 109.667 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 139' ' ' ILE . 2.1 m -79.18 126.87 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.184 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.864 HD13 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -102.76 -34.75 8.9 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.745 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.701 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 26.0 t70 -59.34 28.79 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.874 -1.966 . . . . 0.0 112.566 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.655 ' H ' ' C ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -82.22 172.48 9.47 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.871 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 24.2 Cg_exo -54.37 101.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.323 1.349 . . . . 0.0 113.658 -136.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.57 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.8 m -138.44 168.51 15.64 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.252 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 82.6 Cg_exo -36.49 132.86 0.36 Allowed 'Trans proline' 0 CA--C 1.504 -1.011 0 C-N-CA 123.31 2.673 . . . . 0.0 112.07 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.726 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 16.5 t80 -51.27 -24.25 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.786 0.679 . . . . 0.0 112.535 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -86.32 0.85 53.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.934 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.505 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 31.2 p-10 -63.56 138.73 97.45 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 165.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.693 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 16.6 Cg_exo -78.89 145.71 20.06 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 122.843 2.362 . . . . 0.0 111.715 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.817 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 53.5 m-85 -60.65 126.22 26.61 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.864 ' HB3' HD13 ' A' ' 12' ' ' LEU . 34.5 mt-30 -125.72 99.36 5.94 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.733 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 67.9 m-85 -107.92 102.37 11.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.88 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 10' ' ' VAL . 29.5 tt0 -85.94 83.7 7.73 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.657 HG22 ' CZ3' ' A' ' 40' ' ' TRP . 7.3 mt -84.91 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.57 0.7 . . . . 0.0 112.441 -176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.4 m -111.68 107.45 16.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.323 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.456 ' HB3' HG13 ' A' ' 6' ' ' VAL . 27.7 p90 -121.21 148.14 44.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.821 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 37.0 tt0 -106.01 112.66 25.8 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.739 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 41.5 t -73.49 109.41 6.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.522 ' C ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -78.63 -29.0 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.641 -173.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.904 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 1.8 mt-10 -149.66 148.15 28.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.4 p-10 -56.27 135.04 53.7 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 111.691 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.077 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 93.3 mt -82.74 160.47 22.31 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.356 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.6 t -113.17 -21.62 10.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.803 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.902 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.5 tt0 -137.89 -168.52 2.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.902 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 17.6 m-20 -95.12 137.4 34.23 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.418 0.628 . . . . 0.0 109.69 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.725 HD12 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.31 118.95 23.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.602 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.8 tt0 -108.63 89.76 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.878 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' CZ3' HG22 ' A' ' 26' ' ' ILE . 15.0 m95 -78.22 126.54 30.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.793 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.9 ttmp? -126.15 141.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.048 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -102.88 107.9 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.781 ' HB ' HD11 ' A' ' 96' ' ' LEU . 40.1 mt -111.74 104.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.839 0.828 . . . . 0.0 109.034 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.863 ' CE2' HG13 ' A' ' 113' ' ' VAL . 17.0 t80 -86.81 115.42 24.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.195 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 HG11 HD12 ' B' ' 126' ' ' LEU . 6.8 t -62.27 101.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.237 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.49 56.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.831 ' HB3' ' CG ' ' A' ' 53' ' ' TYR . 14.8 p -96.94 88.36 4.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.857 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -80.41 -17.72 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -100.3 -23.47 14.78 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.028 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.709 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 48.7 m -110.32 -147.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -155.96 -5.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.76 1.44 53.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.831 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 4.2 m-30 -91.33 -14.42 30.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.369 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -40.81 113.99 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.449 1.119 . . . . 0.0 112.605 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.431 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 14.8 mt-30 -92.71 163.09 13.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.219 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.559 HG21 HG12 ' A' ' 43' ' ' ILE . 39.4 t -132.6 115.67 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.3 mm? -84.2 -45.26 13.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.655 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -170.5 165.75 8.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 61.9 p -141.8 117.53 10.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -100.0 136.6 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.639 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.2 mt -107.9 104.84 14.4 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.99 110.76 23.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' O ' HG11 ' A' ' 65' ' ' VAL . . . -71.7 -170.19 12.28 Favored Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.889 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.077 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 35.2 Cg_endo -62.12 115.11 2.63 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 121.259 1.306 . . . . 0.0 109.994 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 34.0 m -123.94 140.25 34.22 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.342 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.55 76.81 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.987 1.791 . . . . 0.0 113.463 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.64 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.039 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.21 124.89 3.56 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.992 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.821 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 31.9 ttt180 -79.53 118.19 21.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.446 0.641 . . . . 0.0 109.501 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -150.74 143.92 24.81 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.394 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -96.86 134.23 40.44 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.361 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -127.0 150.02 49.62 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.15 101.67 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-O 123.189 1.471 . . . . 0.0 111.448 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.733 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -76.13 137.26 39.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 112.494 -2.139 . . . . 0.0 109.841 -176.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.817 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 24.1 mt-30 -151.84 152.28 32.42 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.034 0.445 . . . . 0.0 109.941 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.44 155.89 6.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 10.0 p-10 -62.34 179.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.53 0.605 . . . . 0.0 111.983 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.455 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . . . -77.06 158.65 79.75 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.663 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 38.8 Cg_endo -63.73 164.73 20.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.5 2.134 . . . . 0.0 110.817 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.21 115.97 37.48 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.599 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -66.74 -12.76 37.24 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.098 2.532 . . . . 0.0 112.519 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.86 -5.54 61.08 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.105 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.431 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 20.7 mt -96.45 -37.11 10.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 122.613 -0.345 . . . . 0.0 110.592 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.435 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 19.2 mt -72.35 127.7 89.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.05 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 84' ' ' ILE . 72.0 Cg_endo -79.62 162.55 24.46 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.902 2.401 . . . . 0.0 112.423 172.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.831 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 t70 -43.72 -54.53 5.04 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.055 0.942 . . . . 0.0 113.487 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.851 ' HB3' ' HZ2' ' B' ' 122' ' ' LYS . . . -64.45 -28.51 69.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.071 0.462 . . . . 0.0 111.369 -168.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -97.19 -21.33 17.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.578 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.77 -48.22 12.8 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -92.87 47.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 112.68 -175.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.48 -127.23 1.11 Allowed Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.067 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.675 HG13 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -100.41 136.04 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.447 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -151.84 166.77 30.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' B' ' 126' ' ' LEU . 15.2 t -121.98 138.86 50.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.555 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 95' ' ' VAL . 9.9 p -120.95 106.99 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.928 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -104.65 139.83 38.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.236 -170.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.793 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 34.5 mt -109.67 96.63 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.911 0.862 . . . . 0.0 109.097 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 72.7 p -96.07 116.26 28.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.884 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.609 ' HB2' HG23 ' A' ' 107' ' ' ILE . 75.0 m -80.59 104.49 11.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.493 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.624 ' HG1' ' HG2' ' A' ' 105' ' ' GLU . 23.7 m -85.6 102.19 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.175 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.617 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 32.7 t80 -117.98 126.11 51.68 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.929 -0.482 . . . . 0.0 110.26 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 53.8 mtp85 60.39 28.82 18.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.848 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.35 -20.22 51.33 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.752 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.694 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 4.0 pt20 -111.57 142.99 43.15 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.637 0.732 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.624 ' HG2' ' HG1' ' A' ' 100' ' ' THR . 25.9 mt-10 -93.79 119.72 33.12 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.212 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.725 ' HZ ' HD12 ' A' ' 38' ' ' LEU . 43.9 p90 -104.53 -0.52 27.7 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.806 ' O ' ' HA ' ' A' ' 98' ' ' THR . 6.1 tt -157.58 160.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.686 HH21 HG22 ' A' ' 147' ' ' THR . 10.5 ttp180 -151.48 119.24 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 123.674 0.609 . . . . 0.0 109.776 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.928 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.6 p -96.01 100.05 10.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.515 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.62 73.42 2.49 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 119.252 -1.452 . . . . 0.0 110.961 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.872 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.8 m-85 -67.67 115.62 7.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.996 -1.102 . . . . 0.0 109.087 175.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.508 ' HB3' HD13 ' A' ' 140' ' ' LEU . 1.8 m-85 -67.68 113.26 5.32 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.863 HG13 ' CE2' ' A' ' 44' ' ' TYR . 5.3 p -93.8 110.56 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.675 HD22 HG13 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -95.25 108.61 20.77 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.611 -178.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.664 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 37.8 m-80 -101.79 107.49 18.71 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -129.14 124.01 33.59 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.276 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.581 ' CE2' HG12 ' A' ' 90' ' ' VAL . 29.0 m-85 -42.13 153.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.66 HG22 ' HB2' ' A' ' 136' ' ' GLN . 17.9 p -96.49 -27.75 14.73 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.607 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.533 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -79.48 120.86 24.46 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.497 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 5.8 m -55.49 -30.8 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.986 -170.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.25 -39.73 93.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.878 0.847 . . . . 0.0 109.866 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 66.1 mt -76.68 -24.98 53.2 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.268 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 39.4 mtt180 -72.49 -32.8 66.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.1 mm-40 -71.9 -41.13 68.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.922 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.9 p30 -148.98 102.84 3.37 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 122.051 0.929 . . . . 0.0 111.452 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 33.6 Cg_endo -66.47 113.94 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.425 2.75 . . . . 0.0 110.98 172.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.8 157.79 31.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.592 2.195 . . . . 0.0 111.094 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.07 -21.9 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.683 -169.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 1.9 mmpt? -128.36 103.86 20.02 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 122.012 0.91 . . . . 0.0 112.133 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.831 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 12.6 Cg_exo -44.28 140.27 5.83 Favored 'Trans proline' 0 N--CA 1.455 -0.737 1 C-N-CA 125.553 4.169 . . . . 0.0 113.82 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.0 t70 -111.6 114.67 27.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.368 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.6 m-85 -78.63 -7.13 57.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.21 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.6 p -96.69 -34.56 11.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.533 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 72.2 mmtt -81.78 -17.22 48.38 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 32.6 tp -66.67 139.65 57.86 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.744 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.66 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.9 tt0 -129.02 121.95 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.752 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.78 108.98 20.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.743 0.782 . . . . 0.0 112.236 -175.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.453 ' CB ' ' HG3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -91.33 101.54 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.603 170.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.602 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 6.3 mm -68.96 106.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 112' ' ' TYR . 66.4 mt -66.72 87.38 0.13 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.922 0.868 . . . . 0.0 111.2 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.872 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.51 -4.85 57.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.162 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.2 p -83.23 -11.65 57.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.576 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 63.3 t30 -143.9 59.86 7.58 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.408 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 13.9 Cg_exo -71.8 105.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.698 1.599 . . . . 0.0 110.658 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.677 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -79.91 81.35 6.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.156 0.503 . . . . 0.0 110.143 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.9 m -80.38 141.67 14.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.205 0.526 . . . . 0.0 111.084 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.686 HG22 HH21 ' A' ' 108' ' ' ARG . 54.2 m -148.83 105.87 3.6 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.778 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -115.46 140.28 49.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 110.381 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -119.43 169.94 9.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.788 -175.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -103.98 111.57 24.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.694 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 22.3 pt -115.06 -173.91 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 121.377 0.608 . . . . 0.0 110.596 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 152' ' ' ASN . 0.0 OUTLIER -88.57 114.45 25.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.793 1.282 . . . . 0.0 109.733 175.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.556 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 59.8 m95 -96.06 -8.46 33.43 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.529 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.218 -174.742 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.851 ' HZ2' ' HB3' ' A' ' 87' ' ' ALA . 13.6 mptt . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -37.04 -59.22 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.518 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 12.8 tt -68.92 -32.68 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' B' ' 125' ' ' GLN . 8.7 mm100 -62.93 -56.04 20.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.605 ' HB3' HG22 ' A' ' 94' ' ' VAL . 2.1 mm? -69.48 -29.59 67.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.869 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.3 77.42 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 90.7 mtt180 -53.34 -46.5 69.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.306 0.574 . . . . 0.0 110.312 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.687 ' HG3' HD22 ' A' ' 96' ' ' LEU . 21.4 tpt180 -65.93 -35.66 81.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.518 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.677 HD13 ' HB3' ' A' ' 145' ' ' ARG . 18.1 mt -94.72 -22.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 . . . . . 0 C--N 1.324 -0.527 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.432 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.818 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.88 -8.81 51.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.623 -175.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.618 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 38.8 t -148.15 138.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.041 ' HG2' HD12 ' A' ' 31' ' ' ILE . 14.4 mm-40 -124.03 101.29 7.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.73 167.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 81.6 t -72.67 102.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -88.5 -60.7 1.89 Allowed 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.722 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.711 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -107.51 150.59 26.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.217 -1.81 . . . . 0.0 110.386 -171.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.663 HG13 ' HE2' ' A' ' 111' ' ' TYR . 2.6 p -145.81 99.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.791 169.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.622 HG21 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -92.21 107.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.653 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -77.55 119.82 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.677 -178.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.765 HD12 ' HB3' ' A' ' 23' ' ' GLN . 2.4 mt -89.31 -47.79 7.8 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.093 -171.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 9.5 t70 -78.58 73.65 5.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.046 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.642 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -81.72 176.7 3.57 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 111.726 -2.488 . . . . 0.0 106.614 169.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.989 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 3.0 Cg_endo -46.74 104.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.68 1.636 . . . . 0.0 113.374 -147.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.775 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 75.1 m -126.5 168.82 13.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.493 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -40.69 132.56 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.298 1.998 . . . . 0.0 111.031 173.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.705 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 7.9 t80 -58.11 -25.36 61.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.753 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.444 ' CD2' ' HA ' ' A' ' 133' ' ' SER . 5.2 m-85 -89.83 3.95 51.34 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.86 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.775 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -97.25 142.72 24.96 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.618 170.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.618 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 6.3 Cg_endo -42.29 151.17 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.16 1 C-N-CA 126.551 4.834 . . . . 0.0 115.877 -178.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.836 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 45.8 m-85 -84.5 120.22 26.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.655 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.913 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.5 mp0 -110.4 121.7 45.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 82.6 m-85 -125.59 104.34 8.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.219 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.883 ' HG3' ' HE1' ' A' ' 71' ' ' MET . 35.5 tt0 -88.14 86.27 7.07 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.636 HG13 HG21 ' A' ' 9' ' ' VAL . 4.6 mt -83.51 134.01 27.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.192 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.711 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.5 m -109.1 109.01 19.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.553 172.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.607 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 13.7 p90 -123.37 148.56 45.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.892 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.853 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.3 tt0 -108.39 112.49 24.94 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 110.44 7.4 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 1.041 HD12 ' HG2' ' A' ' 5' ' ' GLN . 1.2 mt -72.04 -35.94 55.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.695 -171.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.818 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 23.9 mt-10 -143.35 172.02 13.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 p-10 -71.62 144.24 49.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.36 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.981 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 62.5 mt -95.88 161.08 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -112.47 -25.02 9.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.122 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.51 -168.14 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.122 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.12 140.84 29.08 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.751 HD13 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -81.73 119.18 23.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.935 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.688 ' HG2' HD23 ' A' ' 61' ' ' LEU . 24.3 mt-10 -101.96 89.29 3.59 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.442 -173.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.572 ' CH2' HG23 ' A' ' 6' ' ' VAL . 19.1 m95 -77.65 151.59 34.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.661 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 0.6 OUTLIER -153.23 134.05 13.88 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.554 -0.459 . . . . 0.0 109.85 -179.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 33.0 mt -103.18 120.54 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.648 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -119.04 106.24 19.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.839 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.776 ' CE2' HG11 ' A' ' 113' ' ' VAL . 56.0 t80 -89.15 126.0 35.28 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.856 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.932 HG23 ' HE2' ' A' ' 53' ' ' TYR . 31.4 t -73.52 117.94 18.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.195 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -92.98 -59.24 1.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 119.846 -1.169 . . . . 0.0 112.092 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.654 ' H ' ' CB ' ' A' ' 53' ' ' TYR . 7.4 m -105.26 72.39 0.98 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.433 ' HB1' ' OD1' ' A' ' 88' ' ' ASP . . . -48.19 -21.27 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.552 0.532 . . . . 0.0 111.62 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.674 ' HG3' ' HE2' ' B' ' 122' ' ' LYS . 5.2 tt0 -85.71 -31.99 22.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.388 0.675 . . . . 0.0 112.23 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.7 m -95.62 -27.59 15.24 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 1.002 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER 64.25 11.63 6.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.865 1.266 . . . . 0.0 112.489 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -99.11 -13.06 19.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.452 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 1.002 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 29.3 p90 -73.17 -46.51 50.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.563 -1.653 . . . . 0.0 114.416 -161.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.616 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 7.6 p-10 -30.8 113.76 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 125.011 1.445 . . . . 0.0 114.388 -154.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 14.1 mt-30 -95.84 170.78 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.607 -169.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.56 HG11 ' HE2' ' A' ' 41' ' ' LYS . 2.3 t -130.49 116.03 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.863 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 ' O ' ' A' ' 77' ' ' ASP . 3.3 mm? -92.56 -56.66 2.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.289 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.53 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 15.2 t70 -162.5 156.63 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.998 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.661 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 36.6 p -132.96 121.82 23.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.507 HG13 ' CE1' ' A' ' 72' ' ' PHE . 3.6 p -111.2 137.32 44.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.688 HD23 ' HG2' ' A' ' 39' ' ' GLU . 7.8 mt -108.99 105.06 14.42 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.458 -176.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.01 114.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.59 -176.08 11.23 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.011 -167.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.981 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 43.6 Cg_endo -65.15 114.71 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.146 1.231 . . . . 0.0 110.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.84 140.35 34.31 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.034 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 60.5 Cg_endo -80.55 79.5 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.292 1.994 . . . . 0.0 113.589 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 53.25 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.633 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.03 128.06 3.89 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.703 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.853 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 51.0 ttt180 -87.23 115.92 24.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.698 0.761 . . . . 0.0 109.345 175.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.534 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.1 p80 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.484 -172.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.883 ' HE1' ' HG3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -94.16 136.51 34.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.795 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.547 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -121.29 153.03 38.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.33 121.0 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.622 1.201 . . . . 0.0 111.989 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -95.23 141.01 29.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.329 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.913 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 26.6 mt-30 -152.08 152.54 32.5 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 167.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -169.39 126.98 0.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.709 ' O ' HD11 ' A' ' 57' ' ' LEU . 29.4 t70 -64.53 147.99 51.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.685 0.279 . . . . 0.0 111.445 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -37.17 152.37 0.12 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -170.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.836 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 32.9 Cg_endo -64.04 -179.78 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 125.087 3.858 . . . . 0.0 113.344 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -92.84 119.19 67.99 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.206 0.527 . . . . 0.0 110.99 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -66.97 -23.24 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.273 2.649 . . . . 0.0 112.501 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.58 -2.85 90.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.953 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.57 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 53.2 mt -108.05 1.99 22.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.573 0.225 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.606 HD12 ' HE1' ' A' ' 44' ' ' TYR . 10.1 mt -109.5 123.52 36.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.503 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 91.5 Cg_endo -80.02 163.85 22.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.687 2.925 . . . . 0.0 112.22 168.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.575 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 10.3 t70 -44.46 -55.03 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.112 0.965 . . . . 0.0 113.195 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.49 70.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.164 0.507 . . . . 0.0 111.607 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 35.5 m-20 -94.45 -8.6 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.638 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -88.35 -47.77 8.14 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 121.123 0.487 . . . . 0.0 111.955 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.94 44.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.523 0.678 . . . . 0.0 111.906 -174.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.88 -124.13 0.71 Allowed Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.597 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.88 130.12 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-O 122.236 1.017 . . . . 0.0 111.91 -169.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -146.77 170.67 16.52 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.416 -1.72 . . . . 0.0 107.719 179.11 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.0 t -128.58 151.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.56 0.219 . . . . 0.0 111.481 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 95' ' ' VAL . 7.8 p -131.29 107.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.935 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.9 pp -102.52 140.56 36.64 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.433 -170.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 58.7 mt -112.44 106.47 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.47 0.652 . . . . 0.0 109.393 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 62.9 p -93.86 119.47 32.84 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.46 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.65 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.1 m -85.39 128.78 34.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 169.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.7 m -122.65 119.9 32.11 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.386 -171.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.631 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 75.2 t80 -124.89 122.85 38.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.537 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.631 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 48.4 mtp180 69.53 28.09 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.062 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.13 -0.7 82.0 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.265 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -121.69 128.64 52.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.203 0.525 . . . . 0.0 110.519 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.3 mp0 -79.84 139.75 37.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.946 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.751 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 42.6 p90 -124.1 -0.63 8.34 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.788 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.4 tt -159.12 158.86 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.617 -0.677 . . . . 0.0 109.185 174.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.587 ' HG3' HG22 ' A' ' 98' ' ' THR . 16.3 ttm180 -151.37 102.56 2.92 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -176.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.935 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.62 99.17 7.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.292 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.673 ' HA3' HD11 ' B' ' 130' ' ' ILE . . . -83.72 78.04 2.05 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.889 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.87 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -73.56 113.27 10.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.424 ' CB ' HD13 ' A' ' 140' ' ' LEU . 18.3 m-85 -67.3 127.57 33.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.222 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.776 HG11 ' CE2' ' A' ' 44' ' ' TYR . 7.7 p -109.53 111.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.37 1.081 . . . . 0.0 108.088 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.47 111.06 21.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.271 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 51.8 m-80 -99.29 107.71 20.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -173.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.54 131.63 34.12 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.836 -175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 55.7 m-85 -39.7 151.74 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.3 p -88.97 -33.88 17.06 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.328 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.66 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 6.5 mm-40 -82.46 122.42 28.0 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.875 177.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -55.75 -33.38 64.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.673 -171.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.92 -37.92 87.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.705 0.764 . . . . 0.0 109.549 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.0 mt -74.11 -23.35 59.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.557 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -76.29 -31.24 58.11 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 120' ' ' THR . 30.9 mm-40 -77.97 -33.95 51.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.46 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 1.9 p30 -144.67 87.57 7.44 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.106 0.479 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 11.6 Cg_endo -53.62 117.93 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.764 2.309 . . . . 0.0 110.727 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.499 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 77.3 Cg_exo -53.39 160.12 5.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.624 2.216 . . . . 0.0 110.798 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.49 -38.87 9.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 O-C-N 123.658 0.599 . . . . 0.0 111.494 -168.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.677 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 4.6 mmtt -124.44 127.6 25.21 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.677 ' HD2' ' HD3' ' A' ' 129' ' ' LYS . 7.5 Cg_exo -41.31 134.22 3.07 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.613 3.542 . . . . 0.0 113.257 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 25.0 t70 -114.52 114.46 25.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.705 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.2 m-85 -78.57 -16.93 56.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.08 -168.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.444 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -83.32 -28.65 28.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.241 177.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.66 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 66.0 mmtt -98.56 11.46 38.28 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 26.2 tp -91.05 147.11 23.3 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.894 -177.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.596 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 20.8 tt0 -124.88 123.06 39.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.828 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.0 mtp-105 -82.73 103.6 12.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.989 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 2.1 t30 -99.47 105.0 16.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.944 0.878 . . . . 0.0 108.808 171.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.684 HG23 HG13 ' A' ' 11' ' ' VAL . 1.6 mp -78.41 111.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.731 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.424 HD13 ' CB ' ' A' ' 112' ' ' TYR . 69.3 mt -68.16 86.91 0.27 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.87 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.62 -11.41 59.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 p -78.96 -10.66 59.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.069 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.495 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 17.1 m120 -133.06 58.4 34.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.065 -174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 6.0 Cg_exo -80.43 105.28 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.814 1.676 . . . . 0.0 111.053 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.662 ' HB3' HD11 ' B' ' 130' ' ' ILE . 12.6 tpp180 -82.45 81.16 8.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.519 HG12 HG23 ' A' ' 109' ' ' VAL . 6.1 m -83.26 104.77 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.609 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.475 HG22 ' CE1' ' A' ' 149' ' ' PHE . 21.4 m -111.48 106.8 15.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.687 0.756 . . . . 0.0 109.595 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.788 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.0 ptt180 -113.82 146.04 40.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.386 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.1 169.37 15.4 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.241 -173.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -105.0 130.31 53.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.687 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 101' ' ' TYR . 43.4 pt -129.08 -177.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -103.38 87.54 2.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.673 0.749 . . . . 0.0 111.37 -174.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.618 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 37.3 m95 -73.15 -1.18 16.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.401 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -173.163 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.674 ' HE2' ' HG3' ' A' ' 49' ' ' GLU . 23.2 mmtp . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.856 -0.053 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -37.26 -53.06 1.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.489 0.493 . . . . 0.0 111.804 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.76 -30.22 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.573 0.225 . . . . 0.0 111.408 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.627 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 9.1 mm100 -60.95 -52.33 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.291 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.672 ' HB3' HG22 ' A' ' 94' ' ' VAL . 2.4 mm? -67.07 -39.99 86.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.05 88.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.29 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 9.3 ptm180 -66.42 -35.89 81.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.78 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -64.7 -38.92 92.62 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.673 HD11 ' HA3' ' A' ' 110' ' ' GLY . 14.8 mt -76.05 -50.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.95 -174.321 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 1.095 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.82 -20.42 23.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.98 -175.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.828 HG22 HD22 ' A' ' 38' ' ' LEU . 4.0 t -141.72 130.07 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.642 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -121.66 100.2 6.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.064 173.184 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.783 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -79.61 146.4 7.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.366 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -129.14 -65.57 0.86 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.202 -165.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.664 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.61 150.45 23.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.779 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.641 HG23 HG13 ' A' ' 26' ' ' ILE . 3.5 p -146.18 100.05 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 169.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -87.6 103.73 13.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.687 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.692 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -77.86 109.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.713 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.965 HD11 ' HG2' ' A' ' 23' ' ' GLN . 1.7 mt -89.72 -44.64 9.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.989 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.855 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.6 OUTLIER -69.32 75.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.622 1.677 . . . . 0.0 109.597 167.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -85.37 177.9 2.65 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.138 163.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.849 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.8 Cg_endo -48.83 103.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 121.916 1.72 . . . . 0.0 113.603 -154.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.668 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.4 m -129.78 171.24 9.2 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.425 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 83.7 Cg_exo -42.84 138.82 3.64 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.685 2.257 . . . . 0.0 112.106 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CE1' ' HG2' ' A' ' 79' ' ' PRO . 43.9 t80 -58.11 -29.62 65.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.659 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -89.12 1.3 55.82 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -78.66 144.52 65.12 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 12.1 Cg_exo -79.54 137.48 13.03 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 123.221 2.614 . . . . 0.0 112.831 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.666 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 25.3 m-85 -55.24 146.24 19.52 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.931 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.965 ' HG2' HD11 ' A' ' 12' ' ' LEU . 6.6 tt0 -136.46 92.44 2.77 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.206 -167.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 97' ' ' ILE . 52.9 m-85 -113.27 108.38 17.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.329 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.026 ' HB3' HG22 ' A' ' 10' ' ' VAL . 38.4 tt0 -96.27 88.1 4.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.641 HG13 HG23 ' A' ' 9' ' ' VAL . 3.2 mt -81.43 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.185 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.7 m -108.4 106.48 16.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.935 170.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.783 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 39.1 p90 -121.22 146.14 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.4 tt0 -102.36 110.52 22.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.506 ' HB2' ' C ' ' A' ' 67' ' ' ALA . 20.7 m -72.8 115.36 12.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -80.68 -31.38 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.856 -171.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.095 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 34.8 mt-10 -145.28 168.24 20.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.4 p-10 -73.45 131.57 41.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 111.798 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD12 HD21 ' A' ' 38' ' ' LEU . 75.6 mt -83.15 159.21 22.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.497 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 p -112.25 -19.65 12.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.643 0.735 . . . . 0.0 109.215 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -136.97 -172.45 3.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.516 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.94 151.48 33.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.481 0.658 . . . . 0.0 110.761 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.828 HD22 HG22 ' A' ' 4' ' ' VAL . 4.6 tp -107.46 123.16 47.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 23.3 tt0 -106.03 135.58 47.23 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.868 -174.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.609 ' CE3' ' SG ' ' A' ' 99' ' ' CYS . 19.1 m95 -132.14 124.52 29.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.832 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.0 ttmp? -125.49 146.62 49.56 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.812 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.553 HD12 HG12 ' A' ' 97' ' ' ILE . 18.9 mm -102.75 106.87 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 87.6 mt -103.02 106.94 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.801 0.81 . . . . 0.0 109.886 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.667 ' CE2' ' HG3' ' A' ' 79' ' ' PRO . 18.8 t80 -87.46 115.61 25.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.756 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 t -66.38 99.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 121.378 0.608 . . . . 0.0 109.712 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -57.91 -43.45 94.86 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.231 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.661 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 46.7 t -123.69 109.38 13.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.97 -5.66 32.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.419 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -100.89 -22.09 14.92 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.163 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.491 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.9 m -116.07 -150.32 0.46 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.989 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.51 ' HB2' ' HD2' ' B' ' 129' ' ' ARG . 8.9 pt-20 -150.69 -33.28 0.17 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.767 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.78 2.57 5.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.389 0.614 . . . . 0.0 111.401 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.661 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 95.8 m-85 -94.58 4.28 54.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.53 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.53 110.17 0.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.012 0.91 . . . . 0.0 109.938 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 4.4 mt-30 -96.02 166.69 11.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.306 -176.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.696 HG21 ' HD3' ' A' ' 41' ' ' LYS . 42.3 t -127.31 106.26 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.971 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.605 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 4.0 mt -75.16 -48.23 24.6 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.741 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -170.48 165.3 8.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.843 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 p -141.9 128.92 20.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.553 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.4 p -99.5 133.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.946 -173.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.36 105.13 14.67 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.733 0.777 . . . . 0.0 110.099 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 98.3 t -83.56 155.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.47 -163.19 37.08 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.826 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.633 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 61.1 Cg_endo -89.83 118.21 0.75 Allowed 'Trans proline' 0 N--CA 1.424 -2.565 0 C-N-CA 122.057 1.838 . . . . 0.0 110.284 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.481 ' H ' HD11 ' A' ' 34' ' ' LEU . 33.8 m -119.51 134.0 23.81 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.489 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.8 Cg_endo -79.13 83.51 2.25 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 113.453 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.506 ' C ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.04 -171.35 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.653 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.613 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 105.01 132.32 7.36 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.824 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 14.8 ttp180 -75.08 113.69 12.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.458 0.647 . . . . 0.0 110.286 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.613 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 21.8 m-70 -111.39 129.1 56.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 ttp -106.66 111.84 24.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 168.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CD1' ' HE1' ' A' ' 28' ' ' PHE . 4.8 p90 -126.13 141.09 52.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.739 0.781 . . . . 0.0 109.326 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.793 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 2.2 p -101.41 116.71 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.536 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.45 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -119.28 132.28 55.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.281 -168.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 44.6 mt-30 -125.15 160.45 29.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.699 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . . . -153.48 137.63 16.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.035 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 20.6 t70 -57.4 162.1 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . . . -62.61 158.42 50.65 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 121.509 0.671 . . . . 0.0 111.526 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.687 ' HG2' ' CE1' ' A' ' 18' ' ' PHE . 28.9 Cg_endo -62.28 171.41 5.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.813 2.342 . . . . 0.0 111.702 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.87 115.28 62.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.603 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.56 -16.2 53.23 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.631 2.888 . . . . 0.0 112.816 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.84 -18.3 56.54 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.127 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.544 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 46.5 mt -91.9 -15.22 28.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.683 0.278 . . . . 0.0 111.385 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.51 HD12 ' CE1' ' A' ' 44' ' ' TYR . 17.1 mt -91.42 127.61 50.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.447 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.418 ' O ' HG21 ' A' ' 84' ' ' ILE . 98.5 Cg_endo -80.68 160.01 21.86 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.726 2.284 . . . . 0.0 111.81 171.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.726 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 6.5 m-20 -46.45 -50.02 17.45 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.419 0.687 . . . . 0.0 112.615 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB1' ' HZ3' ' B' ' 122' ' ' LYS . . . -63.17 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.538 -169.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.02 -19.63 21.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.929 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.9 -46.36 30.51 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.147 0.499 . . . . 0.0 111.635 -175.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -98.17 48.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.289 1.042 . . . . 0.0 110.492 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.58 -137.75 2.27 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.391 -161.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' B' ' 122' ' ' LYS . 9.8 p -130.46 145.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.714 0.769 . . . . 0.0 110.835 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.616 HG23 HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -157.33 174.59 15.19 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 96' ' ' LEU . 2.2 t -124.17 145.01 31.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.511 -0.475 . . . . 0.0 112.152 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.505 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 27.7 m -116.78 105.17 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.793 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.57 136.27 41.7 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.922 -173.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.832 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 25.7 mt -95.79 103.14 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.885 HG23 ' HG3' ' A' ' 108' ' ' ARG . 58.1 p -97.04 110.8 23.27 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.75 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 107' ' ' ILE . 4.7 m -85.6 143.88 28.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.891 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -135.16 129.35 33.67 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -172.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 153' ' ' TRP . 84.3 t80 -135.84 118.1 15.59 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.78 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 29.2 mtp180 67.66 27.12 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.779 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.08 70.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.363 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.16 120.66 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.012 0.434 . . . . 0.0 110.354 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.2 mp0 -76.85 124.89 28.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 151' ' ' ILE . 34.3 p90 -110.37 -8.66 14.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -168.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 98' ' ' THR . 1.7 tt -158.89 162.4 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 119.443 1.02 . . . . 0.0 110.332 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.885 ' HG3' HG23 ' A' ' 98' ' ' THR . 14.1 ttm180 -146.53 105.59 3.88 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.2 p -95.22 100.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.235 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.76 80.99 1.78 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.878 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.866 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 9.6 m-85 -77.34 116.63 18.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.636 ' HE2' ' HA ' ' B' ' 123' ' ' ASP . 20.5 m-85 -68.0 133.11 48.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.446 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.653 HG11 ' CE2' ' A' ' 44' ' ' TYR . 7.2 p -113.95 110.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.14 130.0 40.51 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.603 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 40.3 m-80 -111.14 113.45 25.98 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -171.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -123.96 124.87 43.54 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.519 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 17.0 m-85 -44.73 151.88 0.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.851 0.834 . . . . 0.0 112.658 173.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -92.43 -34.08 14.28 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.602 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.654 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 2.0 tm-20 -78.76 122.95 26.67 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.977 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 6.1 m -52.57 -34.94 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.465 -171.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.11 -35.65 66.6 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 43.2 mt -71.72 -27.76 63.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.483 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 17.9 mtt180 -73.07 -32.46 65.04 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.3 mm-40 -67.58 -38.68 84.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.917 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.547 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -157.47 96.07 2.05 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 121.306 0.574 . . . . 0.0 110.57 178.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.5 Cg_endo -56.14 117.61 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.954 2.436 . . . . 0.0 111.368 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.79 153.51 43.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.128 1.885 . . . . 0.0 110.353 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.1 p -42.14 -41.01 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.851 0.72 . . . . 0.0 112.104 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.512 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -110.4 109.75 58.25 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 122.293 1.044 . . . . 0.0 113.334 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.726 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.6 Cg_exo -45.54 140.33 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.778 1 C-N-CA 125.54 4.16 . . . . 0.0 113.892 175.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.62 112.84 22.73 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.686 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 3.6 m-85 -77.98 -18.38 56.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.812 0.815 . . . . 0.0 110.847 -168.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -13.25 50.3 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.3 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.9 mmtt -104.09 12.67 33.73 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.7 tp -99.83 133.38 44.27 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.392 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.94 122.09 41.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.971 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.849 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.69 110.93 23.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.484 0.659 . . . . 0.0 111.501 -175.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.841 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 3.4 t30 -95.03 109.32 21.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.64 176.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.692 HG23 HG13 ' A' ' 11' ' ' VAL . 1.6 mp -81.54 114.67 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.227 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.413 HD13 ' CB ' ' A' ' 112' ' ' TYR . 80.8 mt -69.78 85.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 110.772 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.866 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -72.13 -20.11 61.67 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.528 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.7 p -78.83 -8.55 58.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.767 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -135.07 69.34 70.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.016 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 77.2 Cg_endo -89.84 114.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.36 2.04 . . . . 0.0 111.608 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.513 ' CB ' HD11 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -82.21 81.76 7.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.202 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.541 HG12 HG21 ' A' ' 109' ' ' VAL . 26.8 m -78.24 130.04 36.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.406 HG22 ' CE2' ' A' ' 149' ' ' PHE . 51.6 m -148.82 106.88 3.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.254 176.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -112.73 147.13 37.47 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.983 0.897 . . . . 0.0 110.705 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -126.06 170.41 11.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.45 -173.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -94.91 119.94 34.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.994 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 18.0 pt -120.26 -173.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.0 109.766 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.483 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -108.2 91.6 3.71 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.437 -176.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.602 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 17.9 m95 -78.78 -13.51 59.77 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.303 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.441 -0.901 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.772 -173.248 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.595 ' C ' HD23 ' B' ' 126' ' ' LEU . 4.0 mptp? . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.636 ' HA ' ' HE2' ' A' ' 112' ' ' TYR . 1.2 p30 -37.73 -49.93 1.18 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 7.1 tp -65.2 -40.73 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 111.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.615 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 0.7 OUTLIER -65.2 -35.78 82.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 110.648 177.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.595 HD23 ' C ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -64.03 -42.58 97.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.48 -33.03 73.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.96 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.615 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 10.4 mmm180 -54.59 -49.33 70.66 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.22 0.533 . . . . 0.0 110.006 173.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.51 ' HD2' ' HB2' ' A' ' 51' ' ' GLU . 6.2 mmp_? -69.18 -30.63 68.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.135 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.622 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 56.7 mt -75.08 -15.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.049 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.577 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.731 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 2.7 mmtt -100.15 -7.1 25.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.506 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.3 t -139.57 123.24 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.329 0.585 . . . . 0.0 110.553 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp60 -117.0 100.5 7.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.3 m -79.64 135.73 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -117.16 -63.61 1.42 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.003 -164.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.582 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.0 t-20 -103.96 152.7 21.68 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.644 -174.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.453 HG13 ' CE2' ' A' ' 111' ' ' TYR . 3.1 p -146.89 100.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 1.007 HG21 ' HB2' ' A' ' 25' ' ' GLU . 1.0 OUTLIER -94.18 97.58 7.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.012 -177.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.572 HG12 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -73.62 132.91 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.158 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 1.068 HD13 ' HG2' ' A' ' 23' ' ' GLN . 7.0 mt -103.85 -65.04 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.384 -169.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.576 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -88.15 55.04 3.28 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.382 1.087 . . . . 0.0 111.748 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 1.043 ' HA ' HD11 ' A' ' 139' ' ' ILE . 27.0 p-10 -81.42 -176.21 0.74 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 161.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.3 Cg_endo -41.67 104.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 122.428 2.085 . . . . 0.0 114.95 -125.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.652 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.2 m -139.61 172.72 5.98 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 110.305 -3.134 . . . . 0.0 107.054 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 85.3 Cg_exo -41.26 136.56 2.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.139 1.893 . . . . 0.0 111.964 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.699 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 28.6 t80 -60.18 -27.27 66.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.158 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -78.71 -14.32 59.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.706 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -72.95 134.21 81.3 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 22.9 Cg_exo -71.81 146.18 47.51 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.738 2.959 . . . . 0.0 113.599 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 62.4 m-85 -55.71 124.86 18.86 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.587 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 1.068 ' HG2' HD13 ' A' ' 12' ' ' LEU . 8.7 tt0 -125.56 100.28 6.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.455 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.639 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.9 m-85 -111.39 155.53 22.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.442 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.007 ' HB2' HG21 ' A' ' 10' ' ' VAL . 59.2 mt-10 -126.27 91.28 3.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 163.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.549 HG23 ' CZ3' ' A' ' 40' ' ' TRP . 6.7 mt -83.72 127.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 122.065 0.936 . . . . 0.0 112.432 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.3 m -101.21 106.42 17.64 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.526 173.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.814 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 25.1 p90 -110.86 141.62 44.0 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.526 0.679 . . . . 0.0 109.913 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.848 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.6 tt0 -102.83 113.46 26.9 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.7 m -71.87 122.32 20.55 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -87.41 -23.94 6.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.639 -169.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.23 178.13 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.74 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.865 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 21.9 t70 -78.49 123.47 27.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.414 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.95 HD13 HD23 ' A' ' 38' ' ' LEU . 1.9 mt -81.34 154.96 26.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.033 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -111.81 -35.07 5.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.297 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.685 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 30.5 tt0 -116.47 -169.06 1.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.085 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.685 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -88.38 151.76 22.37 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.669 0.747 . . . . 0.0 109.666 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.95 HD23 HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.74 123.32 42.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.651 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 18.5 tt0 -97.05 132.75 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.336 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.754 ' CH2' HG13 ' A' ' 6' ' ' VAL . 69.3 m95 -130.48 109.42 10.68 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.305 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.879 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 4.6 ptpp? -126.0 154.81 42.4 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.217 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.0 mt -103.37 118.71 50.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.266 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.515 HD12 ' CD ' ' A' ' 41' ' ' LYS . 2.5 mp -102.46 105.97 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.55 ' HD1' ' CG1' ' A' ' 95' ' ' VAL . 76.7 t80 -83.6 114.33 21.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG11 HD13 ' B' ' 126' ' ' LEU . 4.1 t -62.11 98.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -35.37 40.58 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.749 ' HB3' ' CG ' ' A' ' 53' ' ' TYR . 6.7 p -99.21 88.49 3.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.708 -0.746 . . . . 0.0 112.321 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.624 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -90.5 -16.89 28.06 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 163.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -89.43 -42.69 11.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.238 -1.347 . . . . 0.0 109.566 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.736 ' C ' ' HB2' ' A' ' 47' ' ' SER . 57.7 m -106.64 -146.76 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -150.62 -4.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -95.62 3.05 54.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.749 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 6.7 m-30 -90.12 -15.46 31.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 119.169 -0.443 . . . . 0.0 111.419 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -41.64 111.59 0.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.295 1.045 . . . . 0.0 111.564 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 53' ' ' TYR . 14.4 mt-30 -93.45 166.56 12.21 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.173 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.431 HG21 HG13 ' A' ' 43' ' ' ILE . 54.6 t -130.94 103.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 3.6 mm? -70.57 -37.22 73.94 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -171.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 24.8 t0 -177.5 154.11 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.01 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.879 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 97.6 p -130.07 110.32 11.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 40' ' ' TRP . 11.7 p -99.2 139.84 20.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.895 -166.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 mt -108.22 103.68 12.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.547 0.689 . . . . 0.0 111.353 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.6 t -85.34 155.05 3.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.76 -164.57 40.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.654 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.72 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.6 Cg_endo -69.97 114.57 3.78 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.238 1.292 . . . . 0.0 109.967 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.3 m -108.85 119.33 49.33 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.036 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.865 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 70.7 Cg_endo -84.26 77.48 3.18 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.725 2.283 . . . . 0.0 113.654 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.69 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 51.39 169.15 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.796 -2.002 . . . . 0.0 112.554 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.32 123.0 3.22 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.072 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 11.2 ttt180 -74.76 122.33 23.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.499 0.666 . . . . 0.0 110.852 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.517 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.0 p80 -154.35 146.13 23.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.163 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.679 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 5.5 ttp -97.78 130.2 44.74 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.213 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.3 p90 -112.26 153.44 27.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.625 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.7 p -111.16 132.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.845 0.831 . . . . 0.0 110.224 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.639 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -117.13 130.94 56.95 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.933 -165.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.731 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 25.7 mt-30 -141.6 153.78 45.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -164.51 157.85 17.61 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.526 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.71 -177.22 0.22 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.683 0.754 . . . . 0.0 112.56 -172.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -89.7 147.77 38.46 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.868 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.66 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.8 Cg_exo -55.43 154.99 22.08 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 123.521 2.814 . . . . 0.0 113.106 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -77.91 118.42 72.04 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.403 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.43 -13.73 41.31 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.523 2.816 . . . . 0.0 112.778 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.62 -4.93 57.94 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.898 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.79 -25.5 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.55 0.214 . . . . 0.0 110.769 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 85' ' ' PRO . 41.1 mt -84.66 130.3 53.73 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.919 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.499 ' O ' HG23 ' A' ' 84' ' ' ILE . 62.6 Cg_endo -80.11 164.62 22.11 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.36 2.706 . . . . 0.0 112.359 170.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.671 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 7.5 t70 -43.94 -58.04 3.0 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.669 1.187 . . . . 0.0 113.768 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HZ3' ' B' ' 122' ' ' LYS . . . -83.0 -8.11 59.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.133 -165.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.523 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 56.5 m-20 -94.44 -22.37 18.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.681 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -85.64 -47.16 10.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.629 -176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 130' ' ' PRO . 1.6 m -101.34 46.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.814 0.816 . . . . 0.0 111.049 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.89 -157.68 8.57 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.48 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.614 ' CG1' ' HB2' ' B' ' 122' ' ' LYS . 10.0 p -97.36 144.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.67 0.748 . . . . 0.0 109.533 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.62 171.6 19.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -171.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.0 t -133.68 146.68 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.787 0.722 . . . . 0.0 111.944 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.55 ' CG1' ' HD1' ' A' ' 44' ' ' TYR . 27.2 m -121.8 106.31 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.924 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -102.17 125.01 48.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.127 -173.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 50.4 mt -96.0 101.94 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.8 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 45.2 p -98.67 117.0 32.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.38 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 62.4 m -80.66 152.46 28.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.612 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 11.7 m -145.56 119.02 9.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.652 ' CE1' ' HA ' ' A' ' 153' ' ' TRP . 35.1 t80 -135.43 128.75 32.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 4.5 mmp_? 67.0 12.84 9.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.416 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.48 1.14 57.88 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.825 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -116.6 150.3 38.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -99.72 134.41 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.847 -172.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.752 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 52.4 p90 -120.01 -2.94 10.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -170.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.8 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.5 tt -156.75 159.92 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.848 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 17.7 ttp180 -151.6 99.94 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.845 0.716 . . . . 0.0 109.306 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.924 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.4 p -85.44 101.49 9.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.258 175.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.79 78.08 2.04 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.722 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.951 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -73.7 114.2 11.7 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.455 -0.872 . . . . 0.0 109.015 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.424 ' CB ' HD13 ' A' ' 140' ' ' LEU . 23.5 m-85 -67.72 126.39 29.24 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.532 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.531 HG11 ' HE1' ' A' ' 44' ' ' TYR . 7.5 p -111.49 111.23 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 26.3 t-20 -92.87 117.74 30.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.472 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.448 ' HB3' HD12 ' A' ' 135' ' ' LEU . 48.2 m-80 -109.5 108.65 19.21 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.81 0.814 . . . . 0.0 109.883 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -137.48 139.24 40.45 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.33 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.681 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 62.0 m-85 -46.76 152.42 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -174.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.408 HG22 ' HG3' ' A' ' 136' ' ' GLN . 30.3 p -91.27 -38.29 12.76 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.063 -1.426 . . . . 0.0 108.846 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.908 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -78.25 125.49 29.43 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.062 -174.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 4.9 m -47.76 -43.11 27.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.824 0.702 . . . . 0.0 111.697 -168.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.19 -35.88 82.46 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.627 0.727 . . . . 0.0 110.266 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 56.3 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.44 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -74.54 -37.33 63.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.8 mm-40 -63.6 -43.43 96.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.705 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.442 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.3 p30 -144.35 82.03 10.91 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.11 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.2 Cg_endo -50.19 116.87 2.71 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.491 2.794 . . . . 0.0 112.326 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.681 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 69.0 Cg_exo -54.54 137.64 73.33 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.713 2.276 . . . . 0.0 111.088 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.589 HG12 ' HE2' ' A' ' 129' ' ' LYS . 36.7 t -50.04 -40.36 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.987 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HE2' HG12 ' A' ' 128' ' ' VAL . 2.0 mmpt? -103.35 136.51 19.21 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 111.121 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.671 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -64.39 131.27 29.39 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.749 2.966 . . . . 0.0 113.022 -175.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 23.7 t70 -114.21 114.34 25.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 171.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.699 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 20.6 m-85 -79.22 -15.45 58.01 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.847 -169.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 -28.18 26.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.521 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.908 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 69.7 mmtt -101.68 10.93 39.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 27.0 tp -89.23 138.54 31.34 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.516 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.408 ' HG3' HG22 ' A' ' 118' ' ' THR . 3.4 tt0 -113.45 123.03 49.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.841 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -93.02 106.74 18.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.249 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.5 t30 -92.23 105.88 18.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.946 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 1.043 HD11 ' HA ' ' A' ' 14' ' ' ASN . 1.1 mp -80.66 107.18 12.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.424 HD13 ' CB ' ' A' ' 112' ' ' TYR . 85.9 mt -67.81 84.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.968 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.951 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -73.05 -12.81 61.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.673 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 -9.51 59.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.906 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.49 70.47 76.5 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.783 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 72.1 Cg_endo -89.28 105.02 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.543 1.496 . . . . 0.0 110.404 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.67 81.06 8.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.7 m -77.06 104.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 0.0 111.261 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.448 HG22 ' CE2' ' A' ' 149' ' ' PHE . 26.5 m -109.4 105.05 14.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.76 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -116.78 133.3 56.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.531 0.681 . . . . 0.0 110.533 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -119.34 167.79 11.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.913 -175.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -104.58 123.14 47.01 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.571 HD11 ' HB3' ' A' ' 101' ' ' TYR . 45.1 pt -119.26 -174.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.505 0.669 . . . . 0.0 109.873 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 1.0 OUTLIER -90.73 105.71 18.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.032 176.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.731 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 11.8 m95 -86.47 2.41 47.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.435 -1.203 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.78 176.751 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.689 ' O ' HD23 ' B' ' 126' ' ' LEU . 27.4 mmtp . . . . . 0 CA--C 1.518 -0.262 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -36.66 -51.76 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.7 0.625 . . . . 0.0 112.292 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.7 -40.62 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 5.5 mm100 -54.6 -51.08 66.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 174.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.689 HD23 ' O ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -65.28 -43.99 89.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.989 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.64 -37.47 81.61 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.304 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -61.39 -39.12 89.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.5 mmt180 -73.09 -28.39 62.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.084 0.468 . . . . 0.0 110.003 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.848 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 31.1 mt -82.76 -8.5 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.723 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.445 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.763 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.62 -20.92 21.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.597 HG23 HD21 ' A' ' 34' ' ' LEU . 4.3 t -140.71 130.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 111.396 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.617 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 13.7 tp60 -123.72 99.71 6.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.656 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -75.87 142.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.073 177.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -127.21 -71.84 0.66 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.263 -163.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.42 100.75 10.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.519 -171.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.636 HG13 ' OH ' ' A' ' 111' ' ' TYR . 2.4 p -100.45 105.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.627 HG21 ' HB3' ' A' ' 25' ' ' GLU . 2.5 m -99.33 98.27 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.917 0.865 . . . . 0.0 109.435 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.522 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 132.58 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.111 -176.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 1.0 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -101.65 -40.07 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.048 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.561 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 37.1 t0 -67.05 64.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.73 165.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.888 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m120 -83.06 172.95 8.29 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.121 -1.854 . . . . 0.0 108.148 160.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.888 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.4 Cg_endo -50.88 102.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.374 1.383 . . . . 0.0 113.181 -153.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.572 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 17.9 m -132.02 170.96 9.98 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.815 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 68.7 Cg_exo -42.44 140.86 2.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.416 2.077 . . . . 0.0 111.768 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.708 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 6.3 t80 -59.6 -32.12 70.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.043 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -81.68 -9.75 59.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.0 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -63.0 126.23 88.5 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 26.0 Cg_exo -68.25 146.1 68.44 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 123.347 2.698 . . . . 0.0 112.845 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.801 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 87.1 m-85 -52.04 135.72 30.56 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.178 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 1.0 ' HG2' HD12 ' A' ' 12' ' ' LEU . 6.6 tt0 -140.42 84.93 1.98 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.451 -171.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.722 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 96.6 m-85 -100.08 149.76 23.16 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.68 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.926 ' HG3' ' HE2' ' A' ' 71' ' ' MET . 32.9 tt0 -124.62 87.43 2.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.591 HG23 ' CZ3' ' A' ' 40' ' ' TRP . 26.8 mt -88.75 125.49 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.697 0.76 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 21.5 m -103.39 110.68 22.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.467 172.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HE2' HG21 ' A' ' 65' ' ' VAL . 31.8 p90 -112.75 145.29 40.8 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.836 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.5 tt0 -101.68 114.05 27.75 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 53.2 t -72.35 114.85 10.92 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -81.32 -25.14 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.411 -173.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.763 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.3 mt-10 -153.84 143.56 21.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -55.98 129.97 41.94 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.592 0.558 . . . . 0.0 110.866 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.916 ' HG ' HD22 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -85.1 163.75 18.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.586 0.708 . . . . 0.0 112.365 -169.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 t -113.17 -40.71 3.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.206 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.46 -167.74 1.66 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.311 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -89.84 135.57 33.56 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.236 1.017 . . . . 0.0 109.295 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.916 HD22 ' HG ' ' A' ' 34' ' ' LEU . 3.9 mm? -79.07 143.56 35.46 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.892 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 33.3 tt0 -116.12 135.61 53.77 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.673 173.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.626 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.7 m95 -123.39 125.76 45.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.763 ' HD2' HD12 ' A' ' 43' ' ' ILE . 23.6 ttmt -123.35 143.05 50.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.374 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.7 mt -103.49 108.34 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.358 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.763 HD12 ' HD2' ' A' ' 41' ' ' LYS . 3.8 mp -107.06 109.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.5 0.667 . . . . 0.0 109.427 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.765 ' CD2' ' HG3' ' A' ' 79' ' ' PRO . 22.9 t80 -89.9 109.59 20.6 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.214 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.766 ' O ' HG22 ' A' ' 93' ' ' THR . 25.3 t -69.71 96.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -72.63 -32.54 61.57 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.202 -1.475 . . . . 0.0 109.965 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.773 ' HB2' ' C ' ' A' ' 50' ' ' SER . 4.1 p -88.55 75.93 8.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.4 59.0 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 161.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -100.27 -45.69 5.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.331 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.773 ' C ' ' HB2' ' A' ' 47' ' ' SER . 49.4 m -103.42 -147.32 0.38 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.79 9.07 0.45 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.111 0.481 . . . . 0.0 110.476 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.19 -8.8 26.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.528 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.613 ' HB2' ' N ' ' A' ' 47' ' ' SER . 29.8 m-85 -95.8 1.9 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -168.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.32 104.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.026 0.917 . . . . 0.0 110.875 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 46.7 mt-30 -95.6 164.12 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.485 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 43' ' ' ILE . 49.5 t -131.07 112.21 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.62 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 mm? -82.29 -55.32 4.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.052 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.65 153.42 30.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.72 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 26.2 p -133.44 109.86 9.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -97.99 135.4 32.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.922 -169.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.8 mt -105.25 103.23 12.73 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.201 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.71 131.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.588 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.45 -159.51 11.26 Favored Glycine 0 CA--C 1.494 -1.248 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.998 -164.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.708 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 37.1 Cg_endo -63.71 114.78 2.71 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.71 HG21 ' HE2' ' A' ' 28' ' ' PHE . 35.1 m -110.71 145.36 32.17 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.85 -174.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 136.86 26.69 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.701 2.267 . . . . 0.0 111.448 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -46.76 139.28 5.46 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 111.28 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.505 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 128.84 135.1 3.91 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.836 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.2 ptt180 -76.65 130.4 37.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.432 1.111 . . . . 0.0 111.062 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.505 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 12.5 p80 -149.98 143.61 25.31 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.038 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.926 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -93.02 146.44 23.62 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.566 0.698 . . . . 0.0 112.537 -174.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' N ' ' HG2' ' A' ' 71' ' ' MET . 3.0 p90 -133.6 160.74 36.6 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 1.7 p -118.75 139.32 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 121.734 0.778 . . . . 0.0 111.091 -172.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.722 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -121.96 125.87 47.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.95 -166.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.801 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.2 mt-30 -144.19 148.23 34.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.989 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.02 128.62 0.73 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.569 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 57' ' ' LEU . 6.0 p-10 -62.12 165.11 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.646 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.582 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . . . -59.01 160.73 10.51 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -170.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.765 ' HG3' ' CD2' ' A' ' 44' ' ' TYR . 60.5 Cg_endo -67.67 178.67 3.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.75 2.967 . . . . 0.0 111.673 175.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 91.6 m-20 -72.13 119.45 74.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.249 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -64.07 -19.58 66.45 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.347 2.698 . . . . 0.0 111.756 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.19 -9.1 77.24 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.361 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.5 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 5.7 mt -94.1 -25.36 17.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.993 0.396 . . . . 0.0 110.91 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 89' ' ' ALA . 21.2 mt -78.7 127.84 79.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.797 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 96.3 Cg_endo -78.21 163.23 27.93 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.396 2.73 . . . . 0.0 112.231 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.66 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 15.2 t70 -44.53 -57.06 3.83 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.32 1.048 . . . . 0.0 113.614 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB2' ' HE2' ' B' ' 122' ' ' LYS . . . -74.22 -20.88 60.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.776 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.87 -33.82 22.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.356 0.598 . . . . 0.0 109.658 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -77.2 -42.51 37.24 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.752 -171.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.688 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.4 m -103.08 47.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.634 0.73 . . . . 0.0 112.075 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -119.98 0.55 Allowed Glycine 0 CA--C 1.504 -0.601 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.15 -169.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.485 HG12 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -112.88 141.15 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.981 ' HB ' HG11 ' A' ' 113' ' ' VAL . 24.2 m -143.08 167.96 20.86 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.2 t -134.42 139.08 48.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 170.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 111' ' ' TYR . 1.8 p -119.82 104.97 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.92 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.2 pp -101.27 131.51 47.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.385 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.2 mt -99.42 92.68 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.79 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.83 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 73.1 p -91.09 112.99 25.13 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 89.7 m -76.69 156.29 32.66 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.008 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.0 m -150.96 108.66 3.67 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -170.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.66 ' CZ ' HD11 ' A' ' 34' ' ' LEU . 79.5 t80 -126.76 132.77 50.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.424 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.3 mmm180 67.22 12.56 9.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.493 0.496 . . . . 0.0 111.998 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.6 56.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.118 174.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.816 ' CG ' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.2 149.17 43.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 23.8 mp0 -95.66 134.59 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.069 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 99' ' ' CYS . 53.4 p90 -120.52 -3.76 9.86 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -170.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.83 ' O ' ' HA ' ' A' ' 98' ' ' THR . 10.6 tt -155.48 161.21 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 O-C-N 121.209 -0.932 . . . . 0.0 109.058 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.795 ' HE ' ' HB ' ' A' ' 147' ' ' THR . 0.4 OUTLIER -153.91 99.47 2.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.92 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.3 p -87.16 101.79 11.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.088 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.8 86.52 1.55 Allowed Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 118.943 -1.598 . . . . 0.0 111.129 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.87 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.6 m-85 -73.91 115.2 13.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.276 -0.962 . . . . 0.0 109.538 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' A' ' 140' ' ' LEU . 3.3 m-85 -67.06 112.94 4.66 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.479 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.981 HG11 ' HB ' ' A' ' 93' ' ' THR . 2.4 p -104.31 111.31 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.485 HD22 HG12 ' A' ' 92' ' ' VAL . 1.6 t-20 -96.5 113.65 25.24 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.852 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.8 m-20 -94.65 109.15 21.11 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.48 0.657 . . . . 0.0 109.415 -170.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.47 124.41 40.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.828 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.581 ' CZ ' ' HD2' ' A' ' 127' ' ' PRO . 42.9 m-85 -39.39 149.43 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 29.8 p -87.58 -32.82 19.14 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.544 -174.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.511 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.2 mt-10 -87.78 126.39 34.98 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.262 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.575 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 22.0 m -56.27 -31.22 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.164 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.64 -37.89 76.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.595 0.712 . . . . 0.0 110.008 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 45.2 mt -71.29 -25.41 62.43 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.329 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -73.81 -36.94 65.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.598 0.713 . . . . 0.0 109.136 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.6 mm-40 -66.82 -36.78 83.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.982 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -143.42 87.99 8.19 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.679 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 115.04 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.664 2.243 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.581 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 89.2 Cg_exo -51.06 163.77 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.847 2.364 . . . . 0.0 111.783 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.476 HG13 ' HE2' ' A' ' 129' ' ' LYS . 40.5 t -51.87 -52.17 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.166 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.514 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 1.7 mmtt -116.96 121.24 32.89 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 121.435 0.636 . . . . 0.0 110.928 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.688 ' HB3' HG13 ' A' ' 90' ' ' VAL . 16.3 Cg_exo -35.32 131.73 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 1 C-N-CA 125.778 4.319 . . . . 0.0 114.34 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -105.42 109.27 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.127 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 40.2 m-85 -75.32 -17.26 60.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.94 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -84.2 -25.43 29.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.262 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 72.8 mmtt -95.51 6.16 49.69 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 115' ' ' ASN . 31.1 tp -92.36 127.84 37.99 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.578 -173.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.543 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 1.3 tt0 -111.6 114.46 27.53 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.771 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.9 ptt180 -90.46 111.44 22.71 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.413 0.625 . . . . 0.0 111.05 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 19.7 t30 -87.89 98.06 11.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.105 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.522 HG23 HG13 ' A' ' 11' ' ' VAL . 2.2 mp -73.43 101.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 112' ' ' TYR . 76.7 mt -63.0 89.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.325 0.583 . . . . 0.0 110.792 -176.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.87 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -77.83 -9.71 59.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.96 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.41 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 5.7 p -79.55 -15.6 57.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 172.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.421 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 47.3 t-20 -128.29 66.69 73.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.94 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 4.5 Cg_exo -83.05 105.01 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.03 1.82 . . . . 0.0 110.616 170.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.7 81.32 8.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.941 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.456 ' CG1' HG23 ' A' ' 109' ' ' VAL . 7.2 m -79.28 106.68 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.543 . . . . 0.0 111.722 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.795 ' HB ' ' HE ' ' A' ' 108' ' ' ARG . 42.0 m -110.45 105.34 14.29 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.714 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -113.13 123.82 51.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.597 0.713 . . . . 0.0 110.396 -175.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.02 168.24 9.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.728 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -104.11 111.92 24.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.816 ' HB ' ' CG ' ' A' ' 104' ' ' GLN . 18.3 pt -118.13 172.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.893 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 154' ' ' GLU . 3.4 p30 -101.98 97.67 7.98 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.595 1.188 . . . . 0.0 109.903 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.467 ' HA ' ' CD2' ' A' ' 101' ' ' TYR . 13.1 m95 -67.98 0.82 3.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.732 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' A' ' 152' ' ' ASN . 34.6 mt-10 . . . . . 0 N--CA 1.437 -1.102 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.584 -173.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.504 ' HE2' ' HB2' ' A' ' 87' ' ' ALA . 12.9 mptt . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -37.11 -53.07 1.02 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 tp -70.9 -29.08 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' B' ' 129' ' ' ARG . 10.8 mm100 -65.69 -50.99 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.469 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.659 ' HB3' HG22 ' A' ' 94' ' ' VAL . 2.5 mm? -63.82 -40.59 96.97 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.3 ptm180 -67.94 -25.87 65.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 15.7 mmm180 -80.08 -28.04 39.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.621 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 65.2 mt -76.77 1.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.088 0.947 . . . . 0.0 109.263 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 6.6 tpt180 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.212 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.769 ' HB2' ' CD1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.838 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.5 mptp? -101.17 -21.34 14.97 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -168.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.988 HG22 HD12 ' A' ' 38' ' ' LEU . 6.5 t -148.81 145.54 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.052 ' HG2' HD12 ' A' ' 31' ' ' ILE . 20.2 mm-40 -143.58 121.16 11.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.18 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 1.031 HG23 HD11 ' A' ' 107' ' ' ILE . 35.7 m -79.62 117.34 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 117.583 -1.647 . . . . 0.0 109.274 171.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -86.54 -73.38 0.46 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.522 -172.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.21 109.94 21.87 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.942 -178.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.633 HG13 ' HE2' ' A' ' 111' ' ' TYR . 3.1 p -96.13 99.92 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.415 0.626 . . . . 0.0 109.352 169.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.974 HG21 ' HB3' ' A' ' 25' ' ' GLU . 4.1 m -91.19 98.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.829 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.675 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -76.43 129.67 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.471 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -99.59 -36.89 9.37 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.979 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.927 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 11.3 t70 -63.33 39.88 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.656 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.796 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -79.73 171.54 12.17 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.847 171.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.822 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.8 Cg_endo -52.65 103.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.5 1.466 . . . . 0.0 114.003 -146.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.557 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 14.9 m -133.37 169.77 13.09 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 112.863 -1.972 . . . . 0.0 109.183 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.1 Cg_exo -39.54 131.61 1.71 Allowed 'Trans proline' 0 C--O 1.21 -0.875 0 C-N-CA 122.943 2.429 . . . . 0.0 111.744 171.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.883 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 17.2 t80 -58.38 -17.86 23.46 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 133' ' ' SER . 7.1 m-30 -83.43 -3.99 58.08 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.781 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 33.0 p-10 -61.13 143.96 91.69 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 165.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.64 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 11.9 Cg_exo -83.37 135.99 7.44 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.643 2.229 . . . . 0.0 111.443 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.779 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 40.8 m-85 -50.49 113.38 0.87 Allowed 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 122.965 0.506 . . . . 0.0 111.351 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.927 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 24.4 mt-30 -112.65 103.82 11.87 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.315 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.593 ' CD1' HD13 ' A' ' 97' ' ' ILE . 91.2 m-85 -108.51 149.79 28.34 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.974 ' HB3' HG21 ' A' ' 10' ' ' VAL . 40.7 tt0 -123.54 87.35 2.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 168.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.546 ' CG2' HG13 ' A' ' 6' ' ' VAL . 15.9 mt -79.97 137.06 22.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.499 -173.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 58.6 m -115.52 104.7 11.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.619 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 28.2 p90 -106.47 146.78 30.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.659 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.894 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.5 tt0 -100.2 114.57 28.09 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.78 ' HG ' HG23 ' A' ' 65' ' ' VAL . 10.0 m -71.85 101.48 2.64 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 1.052 HD12 ' HG2' ' A' ' 5' ' ' GLN . 1.3 mt -64.71 -34.09 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.263 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 35.1 mt-10 -142.92 179.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.338 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.79 128.58 35.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.959 0.409 . . . . 0.0 110.204 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.823 HD13 ' CE2' ' A' ' 101' ' ' TYR . 4.0 mm? -88.54 149.03 23.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.985 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.1 p -114.92 -37.22 4.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.978 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.748 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.3 tt0 -105.97 -171.34 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.748 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 30.7 m-20 -100.52 142.61 31.76 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.507 0.67 . . . . 0.0 110.62 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.988 HD12 HG22 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -81.47 119.61 23.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.059 173.041 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.745 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.2 tt0 -102.57 88.04 3.14 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.802 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.823 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 61.7 m95 -80.76 119.75 23.75 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.789 ' HD2' HD11 ' A' ' 43' ' ' ILE . 11.6 ttmt -126.47 139.58 53.13 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.303 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.582 HG21 HG21 ' A' ' 95' ' ' VAL . 13.2 mt -103.22 109.21 26.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.789 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.2 mp -107.43 106.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.953 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 113' ' ' VAL . 61.8 t80 -86.36 119.25 26.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.438 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.61 101.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.298 0.571 . . . . 0.0 109.625 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.23 88.79 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.549 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 41.2 t -128.79 128.16 43.41 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.766 0.793 . . . . 0.0 110.129 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -85.13 -2.59 58.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.232 170.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.76 -38.32 11.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.847 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 49.6 m -134.85 121.1 20.15 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.476 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.658 ' HB3' ' OE1' ' B' ' 125' ' ' GLN . 10.3 pt-20 -64.7 -14.11 57.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.269 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.69 1.77 11.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.61 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.557 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 89.9 m-85 -105.16 -0.81 26.19 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 31.6 p-10 -53.08 110.61 0.55 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.244 1.021 . . . . 0.0 111.488 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 4.4 mt-30 -92.58 170.01 10.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.426 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.411 HG21 HG13 ' A' ' 43' ' ' ILE . 54.8 t -130.84 107.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.888 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.08 -41.2 51.2 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.362 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -176.46 170.93 2.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 45.5 p -145.63 118.05 8.49 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.522 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -100.03 134.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.715 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.6 mt -108.91 104.04 13.2 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 9.0 t -119.7 107.44 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.699 ' CA ' ' HA ' ' A' ' 37' ' ' ASP . . . -102.3 -104.08 2.78 Favored Glycine 0 CA--C 1.475 -2.469 0 C-N-CA 118.831 -1.652 . . . . 0.0 112.926 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.48 113.45 0.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.127 1.884 . . . . 0.0 111.625 176.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.78 HG23 ' HG ' ' A' ' 30' ' ' CYS . 30.3 m -141.9 122.68 8.55 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.871 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.07 130.48 22.95 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.184 1.923 . . . . 0.0 110.495 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.94 133.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.936 0.773 . . . . 0.0 112.117 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.478 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 151.64 117.12 0.74 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -173.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.894 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 24.2 ttt180 -66.21 111.87 3.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.772 0.796 . . . . 0.0 110.816 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.478 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.7 p80 -145.67 160.81 41.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.87 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.673 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.97 141.64 46.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.515 0.674 . . . . 0.0 112.615 -174.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.2 p90 -131.69 160.21 36.11 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.24 138.22 50.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.695 0.76 . . . . 0.0 110.278 -173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.624 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -139.93 121.15 14.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.365 -160.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.779 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -137.81 157.55 46.2 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.97 159.28 26.34 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.82 179.14 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.887 0.851 . . . . 0.0 112.824 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -82.05 151.45 66.85 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.448 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.661 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 65.8 Cg_exo -53.79 153.6 19.06 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 123.995 3.13 . . . . 0.0 113.515 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HB2' HD11 ' A' ' 83' ' ' LEU . 17.3 m120 -71.63 113.58 20.99 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.24 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -65.71 -21.28 58.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.891 2.394 . . . . 0.0 111.623 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 5.0 83.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.219 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.443 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 35.1 mt -113.38 -20.34 11.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.561 0.22 . . . . 0.0 111.213 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.515 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 30.2 mt -84.62 129.51 56.9 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.557 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 1.2 Cg_endo -80.06 159.36 23.83 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.914 2.409 . . . . 0.0 112.128 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.75 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 4.7 m-20 -47.31 -50.19 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.444 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.27 69.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -169.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.557 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 44.0 m-20 -93.94 -17.99 22.39 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -172.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.29 -47.49 23.53 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-O 121.173 0.511 . . . . 0.0 111.824 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.543 HG12 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -92.39 47.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.67 -122.58 0.68 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.789 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.432 HG13 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -110.51 141.23 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 121.746 0.784 . . . . 0.0 112.456 -173.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.93 168.38 24.7 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.132 173.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.4 t -124.81 147.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.832 174.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 42' ' ' ILE . 9.6 p -129.7 107.3 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.889 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -103.01 135.43 44.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.272 -169.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.772 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 59.9 mt -102.18 93.07 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.803 0.811 . . . . 0.0 109.149 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 108' ' ' ARG . 51.9 p -93.96 114.93 27.23 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.592 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.889 ' SG ' HG23 ' A' ' 107' ' ' ILE . 7.0 p -84.82 137.32 33.24 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.947 175.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 51.9 m -118.8 114.94 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.255 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.823 ' CE2' HD13 ' A' ' 34' ' ' LEU . 45.3 t80 -127.32 126.3 42.34 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 1.8 mmp_? 69.14 14.53 8.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.464 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.15 4.1 69.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -125.73 132.25 52.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.559 -0.82 . . . . 0.0 109.543 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.2 mp0 -76.26 142.06 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.009 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.711 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 2.8 p90 -115.68 -18.59 10.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 1.031 HD11 HG23 ' A' ' 6' ' ' VAL . 10.3 tt -159.7 156.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.656 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 10.6 ttp180 -145.38 124.85 13.13 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.889 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -101.4 102.2 13.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 122.158 0.98 . . . . 0.0 109.758 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.55 79.98 1.84 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.239 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.839 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 7.3 m-85 -79.72 123.13 27.39 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.552 ' CE2' HD21 ' B' ' 126' ' ' LEU . 5.8 m-85 -67.38 129.98 41.6 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 44' ' ' TYR . 2.2 p -108.93 110.9 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.432 HD22 HG13 ' A' ' 92' ' ' VAL . 1.4 t-20 -96.72 121.17 38.28 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.21 -177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.679 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.4 m-80 -110.57 110.81 21.67 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.993 0.901 . . . . 0.0 109.017 -171.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -125.81 125.08 42.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.617 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.613 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 18.9 m-85 -39.97 146.61 0.11 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -85.49 -33.77 21.76 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.202 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -88.76 125.93 35.1 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.487 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -59.78 -28.21 67.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.789 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.14 -39.78 94.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.8 0.81 . . . . 0.0 109.614 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 77.6 mt -72.72 -27.87 62.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.713 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 43.3 mtp180 -76.4 -29.34 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.404 0.621 . . . . 0.0 109.412 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.31 -41.68 84.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.136 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -145.62 80.39 10.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.66 113.07 1.07 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.313 2.676 . . . . 0.0 112.455 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.613 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 52.7 Cg_exo -57.19 134.94 67.43 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.758 2.305 . . . . 0.0 110.702 174.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.51 HG11 ' HE2' ' A' ' 129' ' ' LYS . 3.4 p -56.02 -38.27 52.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.184 -171.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.51 ' HE2' HG11 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -91.09 107.72 23.15 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-O 121.088 0.471 . . . . 0.0 110.444 169.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.75 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 35.6 Cg_exo -45.93 140.18 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.593 3.529 . . . . 0.0 113.366 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.5 t0 -110.44 107.27 16.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.637 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 38.2 m-85 -77.48 -20.0 55.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.996 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.43 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 64.7 p -85.88 -21.55 27.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.483 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.3 mmtt -102.79 17.12 24.66 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 19.0 tp -99.62 132.32 45.03 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.015 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.36 118.11 31.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.883 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -93.37 105.38 17.45 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.28 0.562 . . . . 0.0 111.257 -177.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 12.6 t30 -85.55 98.18 10.48 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.461 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.675 HG23 HG13 ' A' ' 11' ' ' VAL . 1.5 mp -70.66 107.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.08 86.29 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.578 0.704 . . . . 0.0 110.446 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.839 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -76.49 -11.29 59.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.729 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.7 t -88.24 6.18 38.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.928 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.44 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 33.6 t-20 -139.16 64.92 34.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 1.8 Cg_endo -84.37 105.61 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.33 2.02 . . . . 0.0 111.264 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB3' HD11 ' B' ' 130' ' ' ILE . 5.5 tpt180 -84.24 85.4 7.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 3.3 p -87.63 110.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.894 -174.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.52 ' HB ' ' HE ' ' A' ' 108' ' ' ARG . 90.2 m -112.05 107.69 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.814 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.0 ptt180 -105.39 135.82 46.07 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.421 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -110.26 170.59 7.98 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.843 -174.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -104.96 120.17 40.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.683 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 40.5 pt -132.38 155.84 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.056 0.455 . . . . 0.0 110.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.416 HD21 ' N ' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -82.17 94.51 7.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.136 0.97 . . . . 0.0 110.686 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.838 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 9.8 m95 -69.34 -4.33 17.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.956 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.431 -1.402 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.465 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.496 ' C ' HD22 ' B' ' 126' ' ' LEU . 3.3 mptp? . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -50.56 -32.95 20.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.139 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.538 HG21 ' N ' ' B' ' 125' ' ' GLN . 7.9 tp -69.37 -40.77 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 122.062 0.934 . . . . 0.0 109.576 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.658 ' OE1' ' HB3' ' A' ' 51' ' ' GLU . 6.6 tp-100 -71.69 -47.0 57.04 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.791 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.563 ' O ' HG13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -59.94 -44.96 94.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.186 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.15 -44.93 94.59 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.054 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -53.98 -45.7 71.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.471 ' HB3' HD22 ' A' ' 96' ' ' LEU . 2.0 mmp_? -69.01 -45.84 69.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.374 -176.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.656 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 14.9 mt -75.11 -30.08 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.441 . . . . 0.0 111.546 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 . . . . . 0 C--N 1.315 -0.909 0 CA-C-O 121.611 0.72 . . . . 0.0 109.388 176.674 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.533 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 11.9 mmtt -100.64 -11.64 19.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.282 -175.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.71 122.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 0.0 110.772 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.524 ' HB2' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -121.3 100.18 6.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 171.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.974 HG11 ' CH2' ' A' ' 40' ' ' TRP . 1.1 m -79.45 140.17 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.306 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -120.13 -61.5 1.59 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.592 -164.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.659 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.2 t-20 -104.61 152.3 22.61 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.735 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 2.6 p -147.08 99.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.644 HG21 ' HB3' ' A' ' 25' ' ' GLU . 2.0 m -93.18 97.71 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.332 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.581 HG11 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 128.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.049 -178.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.93 HD13 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -98.59 -41.1 7.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.766 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' HB2' ' CB ' ' A' ' 23' ' ' GLN . 23.9 t0 -63.82 76.78 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.981 167.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.467 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -96.6 174.28 3.47 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.825 169.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.8 Cg_endo -51.71 104.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.797 1.665 . . . . 0.0 113.834 -157.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 37.3 m -135.01 171.03 9.69 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.46 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 89.8 Cg_exo -42.16 138.56 2.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.559 2.172 . . . . 0.0 112.148 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.794 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 28.2 t80 -55.83 -29.32 59.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.156 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.23 -19.69 53.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -62.02 132.47 93.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.2 Cg_exo -72.65 154.16 54.53 Favored 'Trans proline' 0 C--N 1.329 -0.467 0 C-N-CA 123.71 2.94 . . . . 0.0 113.577 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 78.2 m-85 -62.97 133.94 55.4 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.93 ' HG2' HD13 ' A' ' 12' ' ' LEU . 7.3 tt0 -136.68 83.05 1.98 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.633 -170.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.714 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 97.3 m-85 -97.05 153.98 17.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.125 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.644 ' HB3' HG21 ' A' ' 10' ' ' VAL . 36.7 tt0 -132.34 87.66 2.45 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 14.6 mt -88.11 122.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.706 0.765 . . . . 0.0 112.738 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.773 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 13.2 m -91.73 107.34 19.14 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.467 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.728 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 23.2 p90 -119.19 148.11 43.47 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.93 0.871 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.832 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 48.6 tt0 -103.45 114.93 29.59 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.39 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.666 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 5.0 t -73.36 107.08 5.46 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 171.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -74.98 -22.46 17.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.773 -173.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.625 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 1.5 mt-10 -154.87 167.1 31.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.985 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.32 143.68 55.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.79 0.329 . . . . 0.0 110.549 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.75 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 15.1 mt -95.21 152.67 18.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.091 0.472 . . . . 0.0 111.504 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.3 t -113.13 -35.56 5.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.666 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.808 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.0 tt0 -110.36 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.808 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 39.6 m-20 -98.29 141.6 30.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.573 0.701 . . . . 0.0 110.02 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.39 118.35 23.13 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.28 176.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.5 tt0 -105.72 90.13 3.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.86 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.974 ' CH2' HG11 ' A' ' 6' ' ' VAL . 16.5 m95 -78.58 153.28 31.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.835 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.9 ttmp? -153.31 140.59 19.55 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.213 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.13 115.32 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.82 HG12 HG13 ' A' ' 56' ' ' VAL . 88.0 mt -112.29 108.19 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.768 0.794 . . . . 0.0 109.855 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.634 ' CZ ' HG23 ' A' ' 93' ' ' THR . 76.7 t80 -88.18 130.91 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.084 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.753 HG13 ' CE2' ' A' ' 53' ' ' TYR . 7.1 t -77.52 97.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 122.071 0.939 . . . . 0.0 110.01 173.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.753 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -81.85 -2.94 90.7 Favored Glycine 0 C--O 1.214 -1.133 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.086 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 49' ' ' GLU . 22.8 m -162.57 80.17 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.453 0.627 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.83 -0.73 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.141 0.576 . . . . 0.0 112.491 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' A' ' 47' ' ' SER . 1.7 mm-40 -95.49 -25.61 16.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.341 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.61 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 15.7 m -118.96 -153.36 0.53 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.783 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.2 pt-20 -149.27 20.89 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.807 0.813 . . . . 0.0 110.835 171.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.48 -34.58 10.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.988 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p90 -57.7 -49.17 77.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.738 -167.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.7 p-10 -34.95 105.3 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.235 1.585 . . . . 0.0 113.284 -158.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.542 ' CG ' HD11 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -93.04 167.44 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.975 -175.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.82 HG13 HG12 ' A' ' 43' ' ' ILE . 19.9 m -128.0 124.97 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 4.1 mm? -89.54 -31.0 17.82 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.167 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -175.39 159.27 2.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.064 170.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 35.2 p -136.71 112.42 9.45 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.49 132.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.823 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.638 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.1 mt -108.7 103.65 12.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.627 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.0 t -96.08 121.13 46.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -86.17 -152.61 20.66 Favored Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.569 -164.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.75 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.7 Cg_endo -47.2 117.91 2.52 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.778 1.652 . . . . 0.0 109.468 168.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 34' ' ' LEU . 2.4 p -140.12 129.13 13.36 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.654 -171.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.02 128.33 26.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.117 1.878 . . . . 0.0 111.092 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.666 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -40.52 145.83 0.16 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.077 0.86 . . . . 0.0 111.977 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.488 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 150.05 122.46 1.12 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.832 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.5 ttt180 -68.87 113.99 6.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.776 0.798 . . . . 0.0 109.789 175.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.1 p80 -150.89 150.95 31.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.164 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.773 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -91.73 134.31 34.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.92 -178.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.404 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -121.54 150.41 41.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.465 ' HB ' ' HE1' ' A' ' 71' ' ' MET . 4.5 p -112.94 139.81 36.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.662 0.744 . . . . 0.0 110.666 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.714 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -127.47 119.19 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 -164.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 16.4 mt-30 -134.14 153.75 51.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -166.69 158.84 13.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.7 -175.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.686 0.755 . . . . 0.0 112.448 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -88.51 151.89 48.81 Favored Pre-proline 0 N--CA 1.438 -1.055 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.784 175.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.715 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.3 Cg_exo -61.25 173.37 2.57 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.653 2.902 . . . . 0.0 113.071 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.9 m-20 -87.14 115.73 63.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.185 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.48 -23.16 74.38 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.407 2.738 . . . . 0.0 112.294 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.46 -13.97 77.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.61 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.542 HD11 ' CG ' ' A' ' 55' ' ' GLN . 3.1 mt -90.06 -28.79 18.8 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.734 -0.274 . . . . 0.0 110.789 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 31.9 mt -75.33 125.96 88.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.469 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.8 Cg_endo -80.94 165.31 19.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.03 3.153 . . . . 0.0 113.462 171.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 8.7 t0 -42.74 -48.18 5.55 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.989 171.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.99 -20.93 51.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -168.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.424 ' OD2' HG11 ' A' ' 45' ' ' VAL . 12.8 t70 -89.96 -38.36 13.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.142 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -72.27 -41.27 66.91 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -163.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.77 47.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.59 -126.92 1.0 Allowed Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.222 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.558 HG11 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -104.66 132.65 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 122.162 0.982 . . . . 0.0 113.03 -172.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.808 ' HB ' HG13 ' A' ' 113' ' ' VAL . 15.8 m -133.07 167.44 20.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 113.0 -1.909 . . . . 0.0 106.976 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.634 HG12 HD23 ' A' ' 96' ' ' LEU . 37.0 t -133.6 141.47 44.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 120.877 0.37 . . . . 0.0 111.175 177.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.555 ' CG1' ' HD1' ' A' ' 44' ' ' TYR . 27.1 m -124.13 106.6 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -95.27 137.11 34.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.353 -174.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.835 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 9.1 mt -109.45 91.31 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.463 1.125 . . . . 0.0 108.89 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -90.51 125.69 35.68 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.624 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.653 ' HB2' HG21 ' A' ' 107' ' ' ILE . 72.0 m -90.03 153.53 20.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.248 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 18.5 m -150.1 113.5 4.94 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -168.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.579 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 55.4 t80 -128.05 124.04 36.1 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 31.4 mtp180 64.28 35.77 9.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.461 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.82 -1.96 87.28 Favored Glycine 0 C--N 1.317 -0.482 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.554 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -118.62 131.25 56.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.085 0.469 . . . . 0.0 109.932 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 24.0 mt-10 -89.3 136.1 33.21 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.292 -173.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.572 ' HZ ' HD12 ' A' ' 38' ' ' LEU . 51.7 p90 -122.91 0.99 9.27 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.0 tt -156.62 159.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 O-C-N 121.37 -0.831 . . . . 0.0 109.255 171.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.541 ' CZ ' ' HZ ' ' A' ' 149' ' ' PHE . 9.9 ttm180 -153.21 89.13 1.34 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.588 0.555 . . . . 0.0 109.683 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -86.93 100.86 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.352 1.073 . . . . 0.0 108.332 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 96' ' ' LEU . . . -91.02 87.48 1.36 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.437 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.971 ' HE2' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -74.57 116.67 15.52 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.477 ' CB ' HD13 ' A' ' 140' ' ' LEU . 7.1 m-85 -67.26 117.98 10.01 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.627 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.808 HG13 ' HB ' ' A' ' 93' ' ' THR . 9.0 p -99.7 110.24 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.558 ' ND2' HG11 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -91.61 114.27 26.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.867 -176.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 86.3 m-20 -99.48 106.38 18.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 124.72 39.38 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.35 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 28.1 m-85 -40.21 149.55 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.0 p -87.31 -33.64 19.15 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.783 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 17.1 mt-10 -86.63 134.16 33.64 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.716 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.578 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 90.6 m -57.17 -38.83 74.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -51.81 -39.51 58.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.053 0.93 . . . . 0.0 109.642 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 67.4 mt -84.13 -30.01 26.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.927 -173.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 23.4 mtp180 -77.63 -41.7 37.52 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.361 0.6 . . . . 0.0 110.025 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.742 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 2.8 pt-20 -79.09 -20.74 48.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.017 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.742 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.3 OUTLIER -150.11 82.45 6.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-O 121.719 0.771 . . . . 0.0 109.987 169.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 15.7 Cg_endo -56.18 121.46 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.788 2.992 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.542 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 17.5 Cg_exo -68.68 147.24 69.29 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.843 2.362 . . . . 0.0 110.583 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -28.99 45.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.616 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 2.1 mmtt -103.84 131.78 21.66 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.232 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 3.0 Cg_exo -70.06 140.94 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.527 2.818 . . . . 0.0 113.133 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.586 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 8.7 t0 -119.6 111.41 18.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CE1' ' HB ' ' A' ' 84' ' ' ILE . 18.5 m-85 -78.51 -22.81 46.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.005 0.907 . . . . 0.0 110.293 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -80.25 -17.7 51.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.212 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . 75.8 mmtt -106.94 16.38 24.34 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 115' ' ' ASN . 15.2 tp -102.4 126.5 49.45 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.191 -170.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -112.13 118.0 34.15 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.794 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -95.57 107.06 19.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.5 0.667 . . . . 0.0 111.081 -172.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 6.3 t30 -91.03 104.91 17.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.94 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.581 HG23 HG11 ' A' ' 11' ' ' VAL . 3.6 mp -81.15 108.98 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.427 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.477 HD13 ' CB ' ' A' ' 112' ' ' TYR . 91.4 mt -64.58 89.95 0.07 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.155 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.971 ' HA ' ' HE2' ' A' ' 111' ' ' TYR . . . -79.6 -7.13 58.33 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.259 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 p -93.24 -1.88 55.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.741 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -141.67 75.64 21.55 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.402 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 57.2 Cg_endo -88.15 106.41 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.37 2.047 . . . . 0.0 111.533 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -80.69 80.1 7.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.983 0.421 . . . . 0.0 110.586 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.512 ' HB ' HG21 ' A' ' 109' ' ' VAL . 4.9 p -94.6 111.18 24.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 111.927 -173.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -108.65 106.36 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.467 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 3.6 ptt180 -113.45 131.42 56.03 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.541 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -118.44 168.63 10.47 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.673 -174.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.51 152.81 21.24 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.057 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 23.4 pt -143.07 174.71 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.12 96.32 10.26 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.388 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.581 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 18.4 m95 -74.2 -6.52 48.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.514 0.673 . . . . 0.0 109.949 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 . . . . . 0 N--CA 1.441 -0.899 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.158 175.631 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 2.5 mppt? . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -44.38 -52.91 7.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 tt -61.92 -36.05 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 111.623 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.812 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 9.2 mm100 -74.96 -39.04 61.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.591 0.71 . . . . 0.0 110.936 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.533 HD22 HG12 ' A' ' 45' ' ' VAL . 29.0 mt -63.22 -36.77 84.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.953 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -68.76 -33.74 74.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.998 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.812 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 8.5 mmm180 -48.74 -47.38 41.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.344 0.592 . . . . 0.0 109.437 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -73.91 -48.79 28.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.689 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.953 HG13 ' HA ' ' B' ' 127' ' ' ALA . 2.6 pp -66.87 -17.68 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . 0.532 ' HG2' HD13 ' B' ' 130' ' ' ILE . 34.7 mmt180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.607 0.241 . . . . 0.0 110.951 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.822 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.85 -21.16 20.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -177.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.99 134.21 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.667 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.594 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -137.09 105.39 5.73 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.316 176.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.739 HG12 ' CD1' ' A' ' 28' ' ' PHE . 27.5 m -70.29 149.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.301 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 29' ' ' GLU . 53.5 m-80 -127.93 -59.34 1.19 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.073 -168.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.664 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.8 t-20 -104.01 150.84 23.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.139 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG13 ' OH ' ' A' ' 111' ' ' TYR . 3.3 p -145.64 98.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -91.88 97.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 122.403 1.096 . . . . 0.0 108.858 -177.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.54 133.45 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.193 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 1.051 HD12 ' HG2' ' A' ' 23' ' ' GLN . 8.7 mt -110.53 -42.62 4.04 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.626 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.767 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 2.9 p-10 -68.17 44.94 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.662 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.697 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.34 175.74 4.21 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.706 177.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.814 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.6 Cg_endo -49.78 103.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.562 1.593 . . . . 0.0 113.187 -150.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.675 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -148.89 172.0 5.67 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 111.648 -2.524 . . . . 0.0 107.627 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 59.6 Cg_exo -37.16 130.21 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.774 2.316 . . . . 0.0 112.969 174.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.746 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 8.9 t80 -55.43 -27.9 50.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.422 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -78.5 -14.22 59.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -69.93 138.43 87.69 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -73.34 133.07 18.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 112.76 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 88.8 m-85 -56.62 121.17 9.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.149 -176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 1.051 ' HG2' HD12 ' A' ' 12' ' ' LEU . 9.6 tt0 -128.92 92.35 3.38 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.949 -157.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 97' ' ' ILE . 83.9 m-85 -106.1 115.05 29.56 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.666 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.564 ' HB2' HD13 ' A' ' 12' ' ' LEU . 22.1 tt0 -90.35 83.71 5.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.436 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 36.6 mt -82.12 141.4 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.671 0.748 . . . . 0.0 111.931 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 20.9 m -125.24 107.31 10.6 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.266 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.739 ' CD1' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.6 166.79 10.15 Favored 'General case' 0 CA--C 1.472 -2.027 0 C-N-CA 118.713 -1.195 . . . . 0.0 110.916 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 29.9 tt0 -117.65 107.54 14.34 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.816 -1.993 . . . . 0.0 106.023 168.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.3 m -72.46 108.04 5.33 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -72.48 -33.62 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.307 -169.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.822 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 6.0 mt-10 -143.74 171.68 13.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 p-10 -76.53 131.72 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.099 0.476 . . . . 0.0 110.964 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.686 HD12 HG21 ' A' ' 65' ' ' VAL . 7.9 mt -87.1 153.47 21.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.26 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -112.6 -31.3 6.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.694 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 20.2 tt0 -122.33 -168.99 1.82 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.694 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.2 p-10 -92.94 147.59 22.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 110.36 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -95.59 122.87 38.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.219 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.636 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 22.9 tt0 -103.92 89.93 3.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.065 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.806 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 50.0 m95 -82.66 115.46 21.61 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.8 ttmt -118.02 138.98 51.84 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.052 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG21 HG22 ' A' ' 95' ' ' VAL . 4.8 mt -104.78 123.29 58.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -114.15 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.796 -175.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.623 ' CE2' HG12 ' A' ' 113' ' ' VAL . 46.4 t80 -89.0 117.22 27.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.321 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.845 HG11 ' CE2' ' A' ' 53' ' ' TYR . 3.8 t -66.6 111.54 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.803 173.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.694 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -81.32 -63.1 1.89 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.437 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.597 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 15.1 m -102.15 70.77 1.22 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . . . -47.98 -28.4 2.73 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.61 0.569 . . . . 0.0 111.733 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' B' ' 122' ' ' LYS . 4.8 tt0 -67.64 -18.46 64.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.068 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.69 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 24.2 m -115.25 -152.45 0.5 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.7 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.1 pt-20 -154.89 22.48 0.44 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.742 0.782 . . . . 0.0 111.05 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -100.18 -31.61 11.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.368 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.845 ' CE2' HG11 ' A' ' 45' ' ' VAL . 12.1 p90 -63.38 -42.53 98.85 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 125.752 1.621 . . . . 0.0 113.242 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.6 p-10 -23.55 113.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.033 1.458 . . . . 0.0 114.256 -161.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.403 HE22 ' HA3' ' A' ' 46' ' ' GLY . 1.4 mp0 -96.64 166.76 11.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.256 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.91 118.53 50.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.568 ' HB3' ' CB ' ' A' ' 76' ' ' ALA . 3.9 mm? -87.72 -48.84 7.55 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.934 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -166.0 161.82 17.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.1 p -139.1 113.23 8.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 3.3 p -98.86 130.64 47.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.7 mt -101.16 104.05 15.12 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.961 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.12 116.84 36.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -67.74 -168.34 4.12 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.304 -168.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -67.56 112.26 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 N-CA-C 109.573 -0.972 . . . . 0.0 109.573 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.686 HG21 HD12 ' A' ' 34' ' ' LEU . 27.4 m -110.68 117.37 50.84 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.525 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 59.6 Cg_endo -76.01 79.92 2.78 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 122.513 2.142 . . . . 0.0 113.09 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.601 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 52.43 174.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.629 -2.078 . . . . 0.0 112.494 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.74 117.53 3.35 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.107 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.811 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 ttt-85 -64.66 128.5 36.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.069 0.461 . . . . 0.0 110.312 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -164.84 158.23 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.103 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.488 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -113.37 144.46 42.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.411 0.624 . . . . 0.0 111.885 -175.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CE2' HG13 ' A' ' 60' ' ' VAL . 2.1 p90 -132.37 160.33 36.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.1 127.44 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.46 1.124 . . . . 0.0 111.065 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.64 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -108.33 145.4 34.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.148 -168.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.742 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 22.2 mt-30 -150.08 152.04 34.16 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -159.68 118.64 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.599 0.237 . . . . 0.0 111.633 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.62 123.36 19.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.246 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . . . -23.96 147.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 127.273 2.229 . . . . 0.0 116.962 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.594 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 38.7 Cg_endo -65.93 179.2 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.653 3.569 . . . . 0.0 112.722 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.41 122.12 85.47 Favored Pre-proline 0 CA--C 1.508 -0.654 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.393 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.45 -5.93 17.77 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.933 2.422 . . . . 0.0 111.471 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.17 -8.22 50.84 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.739 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.401 HD11 ' HG2' ' A' ' 55' ' ' GLN . 27.0 mt -97.46 -8.73 28.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.046 0.45 . . . . 0.0 110.404 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.578 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 21.8 mt -95.33 125.39 50.14 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.158 171.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.597 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.4 Cg_endo -79.84 162.92 23.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.696 2.931 . . . . 0.0 111.472 171.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.69 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 4.0 m-20 -46.5 -53.67 10.78 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.77 82.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.666 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 48' ' ' ALA . 61.1 m-20 -87.79 -16.89 32.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.682 -173.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.24 -46.13 29.57 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.643 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.43 HG12 ' CE2' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -99.98 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.502 0.668 . . . . 0.0 112.053 -174.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.94 -132.47 1.55 Allowed Glycine 0 CA--C 1.498 -1.026 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.571 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.606 HG12 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.99 136.08 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.674 0.75 . . . . 0.0 112.785 -168.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.689 HG22 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.18 167.77 28.18 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.46 135.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.112 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 42' ' ' ILE . 14.3 p -115.86 105.55 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 171.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.811 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.3 pp -103.41 147.68 26.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.728 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 24' ' ' PHE . 41.4 mt -112.26 102.87 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.667 0.746 . . . . 0.0 109.67 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.846 HG21 ' HB2' ' A' ' 108' ' ' ARG . 78.0 p -101.32 110.05 22.0 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.668 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.006 ' SG ' HG21 ' A' ' 107' ' ' ILE . 11.9 p -75.62 152.2 37.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.81 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 31.3 m -142.01 103.26 4.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.6 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 89.9 t80 -113.18 122.11 46.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 37.5 mtp180 68.58 23.17 7.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.107 0.479 . . . . 0.0 111.628 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.56 76.03 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.253 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -128.96 123.68 33.12 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 16.2 mp0 -82.25 136.19 35.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 -173.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 38' ' ' LEU . 52.3 p90 -128.62 -0.32 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 1.006 HG21 ' SG ' ' A' ' 99' ' ' CYS . 5.2 tt -157.63 160.34 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 O-C-N 121.178 -0.951 . . . . 0.0 108.799 169.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.846 ' HB2' HG21 ' A' ' 98' ' ' THR . 15.9 ttp180 -150.16 104.39 3.26 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.811 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.7 p -88.9 99.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.624 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.23 82.01 1.56 Allowed Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.251 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 1.03 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.7 m-85 -72.8 120.81 18.94 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.408 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.544 ' HB3' HD22 ' A' ' 140' ' ' LEU . 2.9 m-85 -66.84 123.7 20.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.623 HG12 ' CE2' ' A' ' 44' ' ' TYR . 2.5 p -107.96 111.26 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.678 ' HB2' HD21 ' A' ' 140' ' ' LEU . 0.5 OUTLIER -98.43 113.54 25.57 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.767 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 38.7 m-80 -97.31 132.14 43.33 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.353 0.597 . . . . 0.0 110.032 -174.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.32 134.46 22.76 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.786 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 31.7 m-85 -49.56 151.32 1.67 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.1 p -90.32 -34.42 15.72 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.013 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.32 121.98 23.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.769 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.9 m -50.3 -36.77 33.19 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.762 -172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -64.91 -40.16 94.65 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.615 0.722 . . . . 0.0 110.321 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.8 mt -73.36 -22.24 60.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.654 -176.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 10.4 mtt180 -78.73 -36.75 42.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.769 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.7 mm-40 -61.32 -44.13 97.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.012 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -145.73 85.95 7.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.059 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.16 115.67 2.73 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.047 2.498 . . . . 0.0 112.092 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.43 164.12 33.93 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.142 2.561 . . . . 0.0 111.498 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.01 -62.46 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.076 0.235 . . . . 0.0 110.708 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -67.77 125.79 91.77 Favored Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-O 121.731 0.777 . . . . 0.0 111.785 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.69 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 22.0 Cg_exo -70.27 139.2 37.92 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 124.215 3.277 . . . . 0.0 111.827 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.558 ' CG ' ' HG2' ' A' ' 134' ' ' LYS . 30.1 t0 -117.07 104.04 10.84 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.746 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 37.0 m-85 -74.01 -16.11 61.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.039 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.7 t -85.43 -21.51 28.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.283 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.558 ' HG2' ' CG ' ' A' ' 131' ' ' ASP . 47.0 mmtm -101.12 -0.5 36.04 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.6 tp -85.95 123.51 31.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.308 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.5 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 2.2 tt0 -108.39 116.93 32.89 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.814 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.56 119.63 38.37 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.74 -174.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.3 t30 -96.03 120.04 35.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.653 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.59 HG22 HG13 ' A' ' 11' ' ' VAL . 3.5 mm -88.34 102.13 12.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 114' ' ' ASN . 3.1 mm? -60.21 84.6 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 1.03 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -63.47 -15.49 57.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.347 168.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.47 -18.14 55.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.107 171.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.99 60.21 33.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.176 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 84.6 Cg_endo -91.36 105.97 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.815 1.677 . . . . 0.0 110.741 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.461 ' HB3' HD11 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -82.13 81.54 8.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 109' ' ' VAL . 17.0 m -78.55 114.54 19.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 111.56 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.829 HG22 HH21 ' A' ' 108' ' ' ARG . 53.7 m -120.4 105.31 10.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.398 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.792 ' HB3' HG13 ' A' ' 107' ' ' ILE . 1.7 ptt180 -106.01 133.87 50.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.51 0.671 . . . . 0.0 110.65 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' HD2' ' CA ' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -109.18 168.56 9.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.781 -176.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.533 ' HD2' ' O ' ' A' ' 150' ' ' HIS . 0.9 OUTLIER -103.51 139.7 38.51 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 173.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.1 pt -139.68 -177.9 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -102.41 82.64 2.2 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.428 0.633 . . . . 0.0 111.34 -172.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.688 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.1 m95 -69.05 -11.98 61.27 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.932 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.413 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.525 ' HB3' ' CD2' ' B' ' 126' ' ' LEU . 12.0 mptt . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -35.23 -61.33 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.292 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 7.2 tt -69.39 -33.47 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.515 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 9.2 mm100 -63.23 -52.33 62.6 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.385 0.612 . . . . 0.0 110.822 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' B' ' 122' ' ' LYS . 1.9 mm? -64.69 -36.37 84.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.129 177.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.97 -37.32 73.97 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 99.7 mtt180 -59.23 -47.83 83.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 111.156 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.449 ' HA ' ' HD2' ' B' ' 129' ' ' ARG . 18.1 mmm180 -74.44 -21.67 59.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.286 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.477 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 23.3 mt -93.19 -7.76 10.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.613 0.721 . . . . 0.0 109.885 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.469 174.334 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.872 0.367 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.73 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -91.42 -17.16 26.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.215 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.434 HG13 ' HD2' ' A' ' 28' ' ' PHE . 2.4 t -137.71 130.05 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.594 0.711 . . . . 0.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.44 HE22 ' HD3' ' A' ' 148' ' ' ARG . 26.1 tp60 -122.88 101.71 7.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.679 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -78.08 132.23 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -116.5 -69.58 0.84 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.207 -163.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.651 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.9 t-20 -93.04 152.68 19.15 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.8 -177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' H ' ' ND2' ' A' ' 8' ' ' ASN . 7.4 p -146.4 107.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-O 122.244 1.021 . . . . 0.0 109.766 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.826 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.1 t -92.59 92.62 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.023 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG13 ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -76.45 120.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.309 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.999 HD13 ' HB3' ' A' ' 23' ' ' GLN . 4.6 mt -105.45 -40.11 5.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.647 -168.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.961 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 17.4 p-10 -67.01 38.25 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.454 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.599 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -78.46 174.53 5.88 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.601 178.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.816 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 4.3 Cg_endo -50.05 103.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.802 1.668 . . . . 0.0 113.639 -153.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.631 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.5 m -146.34 171.43 6.44 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 111.236 -2.711 . . . . 0.0 106.715 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.635 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 45.5 Cg_exo -38.13 143.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.804 2.336 . . . . 0.0 112.407 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.891 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.3 t80 -60.42 -31.25 70.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.705 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -75.23 -11.27 60.03 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.608 0.242 . . . . 0.0 110.571 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.635 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -67.86 117.32 47.17 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 121.882 0.849 . . . . 0.0 109.271 168.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.614 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 46.4 Cg_exo -60.04 169.08 5.15 Favored 'Trans proline' 0 C--N 1.327 -0.571 1 C-N-CA 125.434 4.09 . . . . 0.0 114.291 -173.055 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.839 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 99.1 m-85 -78.27 103.25 8.09 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.552 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.999 ' HB3' HD13 ' A' ' 12' ' ' LEU . 2.6 mp0 -104.81 109.8 21.9 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.508 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.708 ' CD2' HD12 ' A' ' 97' ' ' ILE . 83.2 m-85 -123.48 101.4 7.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 1.065 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.9 tt0 -86.16 82.65 7.98 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.344 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.1 mt -87.88 129.27 39.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.081 -176.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.3 m -103.01 104.73 14.94 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 20.7 p90 -112.6 141.87 45.85 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.64 0.733 . . . . 0.0 110.025 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.861 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.6 tt0 -101.7 117.87 35.76 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t -73.85 104.88 4.89 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.463 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -71.48 -30.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.573 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 40.3 mt-10 -149.63 146.4 27.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.069 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.24 138.88 57.85 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.739 0.649 . . . . 0.0 111.288 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.733 HD13 HD21 ' A' ' 38' ' ' LEU . 6.8 mt -95.35 151.08 19.58 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.876 -171.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.3 t -114.1 -25.75 8.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.307 0.575 . . . . 0.0 110.152 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.716 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 19.9 tt0 -121.39 -168.33 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.716 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.8 p-10 -94.41 135.4 35.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.506 0.669 . . . . 0.0 110.482 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -83.05 119.29 24.29 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.584 176.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 1.2 tm-20 -104.98 89.74 3.24 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.211 -171.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.625 ' O ' ' HA ' ' A' ' 59' ' ' SER . 9.6 m95 -82.25 139.93 33.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.0 ttmp? -138.92 145.69 40.16 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.831 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' A' ' 74' ' ' PHE . 49.3 mt -103.26 116.48 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.716 ' HB ' HD13 ' A' ' 96' ' ' LEU . 4.0 mp -113.92 107.25 22.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.864 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.0 t80 -92.78 115.45 28.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.667 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 t -59.29 107.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.65 12.77 61.24 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -134.13 62.1 1.66 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.754 -0.723 . . . . 0.0 112.443 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 -10.91 59.87 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.672 0.749 . . . . 0.0 108.982 165.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -100.12 -46.83 5.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.239 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.471 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 49.3 m -105.61 -134.38 0.33 Allowed 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 9.0 pt-20 -154.45 -19.72 0.13 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -90.46 2.86 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.495 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 23.3 m-85 -93.61 0.36 56.52 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -54.07 95.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.89 0.852 . . . . 0.0 110.57 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -94.83 169.35 10.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.064 -173.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.0 t -126.11 117.65 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.996 -167.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 mm? -85.88 -58.22 2.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.183 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -153.35 152.6 31.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.134 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.2 p -134.75 110.87 9.51 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.466 HG13 ' CE1' ' A' ' 72' ' ' PHE . 3.1 p -99.59 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.837 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 10.6 mt -105.89 104.65 14.41 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.303 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.25 113.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -164.9 4.21 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.497 -167.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 64.5 Cg_endo -68.29 113.88 3.24 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 120.812 1.008 . . . . 0.0 109.685 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.598 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 27.4 m -120.94 134.34 24.32 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.812 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.57 78.68 3.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.106 1.871 . . . . 0.0 113.168 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.532 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 51.0 -171.83 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.63 -2.077 . . . . 0.0 111.943 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.47 135.73 8.11 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.861 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.4 ttp180 -73.1 115.21 12.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.043 0.925 . . . . 0.0 111.195 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -114.38 118.03 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.231 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.66 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 20.5 ttp -87.82 103.3 15.51 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 173.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.496 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -110.02 128.39 55.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.04 -178.405 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.065 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -102.05 111.83 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 122.682 1.23 . . . . 0.0 111.376 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -72.61 143.42 48.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.652 -2.067 . . . . 0.0 109.614 179.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.932 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 25.3 mt-30 -152.55 145.2 24.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.23 134.5 2.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.631 ' O ' HD13 ' A' ' 57' ' ' LEU . 10.4 p-10 -55.84 159.62 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.731 0.3 . . . . 0.0 110.756 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -76.03 164.65 58.89 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 123.061 0.544 . . . . 0.0 111.642 -167.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 36.0 Cg_endo -59.57 163.38 13.11 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.116 2.544 . . . . 0.0 112.127 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.5 m-20 -69.52 117.17 50.25 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.989 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.4 Cg_endo -61.23 -22.18 73.89 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.678 2.919 . . . . 0.0 112.33 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.37 -10.97 69.95 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.086 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 24.0 mt -91.14 -31.28 16.28 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 122.685 -0.303 . . . . 0.0 110.491 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.558 HG21 ' OD1' ' A' ' 88' ' ' ASP . 17.0 mt -74.76 124.73 89.82 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.459 ' O ' HG22 ' A' ' 84' ' ' ILE . 94.1 Cg_endo -79.15 163.51 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.776 2.984 . . . . 0.0 112.075 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 12.7 t70 -44.92 -55.42 5.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.02 62.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.25 0.548 . . . . 0.0 111.108 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.558 ' OD1' HG21 ' A' ' 84' ' ' ILE . 10.9 t70 -97.25 -24.43 15.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.634 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -88.84 -46.26 9.09 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.34 49.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -170.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.79 -128.98 1.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.352 -168.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.756 HG22 ' ND2' ' A' ' 114' ' ' ASN . 21.5 t -109.89 133.61 54.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.598 -172.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.692 ' HB ' HG12 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -144.16 170.42 16.0 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.3 t -129.89 145.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 118.719 0.69 . . . . 0.0 111.737 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.549 HG22 ' CE1' ' A' ' 22' ' ' PHE . 7.7 p -132.08 108.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.876 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.6 pp -107.37 147.3 30.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.255 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 36.8 mt -114.91 105.6 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 109.303 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.765 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 56.6 p -100.49 116.57 32.74 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.977 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.68 ' HB2' HG23 ' A' ' 107' ' ' ILE . 76.4 m -81.83 123.22 28.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.11 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 28.3 m -113.32 120.29 40.62 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.567 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 61.3 t80 -123.22 117.35 25.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.255 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.567 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.1 mtp180 66.08 23.81 11.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.445 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.05 54.94 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.892 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -111.26 132.52 54.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.931 175.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 33.4 mt-10 -83.38 130.06 35.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.598 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 50.0 p90 -118.29 1.5 11.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.817 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.4 tt -157.97 155.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.698 HH22 ' HG3' ' A' ' 145' ' ' ARG . 2.8 tmm_? -151.14 113.38 4.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.876 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -104.6 100.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.308 1.052 . . . . 0.0 109.689 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.479 ' HA3' HH11 ' A' ' 108' ' ' ARG . . . -93.03 87.14 1.2 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.98 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 88.7 m-85 -76.13 146.58 39.15 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.558 ' HB2' HD13 ' A' ' 140' ' ' LEU . 6.6 m-85 -83.2 132.47 35.06 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.864 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.5 p -108.84 109.31 27.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.756 ' ND2' HG22 ' A' ' 92' ' ' VAL . 4.0 t-20 -97.51 108.47 21.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.187 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.659 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 42.7 m-80 -97.03 110.58 23.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.04 133.74 49.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.591 ' CG ' ' HB3' ' A' ' 122' ' ' LEU . 39.3 m-85 -42.69 157.49 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -95.74 -30.84 13.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.438 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.669 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 4.3 mm-40 -86.33 128.73 34.97 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.571 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.7 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.3 m -48.48 -46.45 38.2 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.08 0.4 . . . . 0.0 111.841 -172.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -53.59 -37.33 62.87 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.234 1.016 . . . . 0.0 110.115 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 48.2 mt -84.53 -24.74 29.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.919 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 60.9 mtp180 -78.48 -40.43 35.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.936 0.874 . . . . 0.0 108.689 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.725 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 12.6 pt-20 -73.38 -29.78 62.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.977 -177.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.725 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 1.8 p30 -153.73 90.79 3.31 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.006 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.8 Cg_endo -55.81 117.99 4.69 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 122.889 2.393 . . . . 0.0 111.45 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 32.5 Cg_exo -59.5 151.38 69.45 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.375 2.05 . . . . 0.0 110.224 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.9 p -48.74 -29.02 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.286 -170.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.502 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -118.28 110.96 38.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-O 122.264 1.03 . . . . 0.0 113.451 173.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.548 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.0 Cg_exo -44.29 139.93 6.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 125.386 4.057 . . . . 0.0 113.659 174.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.9 t70 -120.23 116.61 25.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.896 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.622 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.7 m-85 -79.18 -16.33 56.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.878 0.846 . . . . 0.0 111.026 -170.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.1 m -83.09 -24.78 32.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.344 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.669 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.3 mmtt -101.23 13.98 33.42 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 115' ' ' ASN . 24.4 tp -98.08 144.7 27.29 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.855 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -125.22 125.76 44.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.891 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 16.7 mtm105 -91.17 104.38 16.95 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.163 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.558 ' C ' HD21 ' A' ' 138' ' ' ASN . 0.1 OUTLIER -89.7 90.99 8.47 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 170.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.821 HD12 HH12 ' A' ' 137' ' ' ARG . 1.3 mm -71.57 115.41 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.898 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 112' ' ' TYR . 35.8 mt -78.73 75.22 5.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.851 0.834 . . . . 0.0 110.797 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.7 -19.99 61.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.472 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 p -73.65 -11.96 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.741 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.02 66.96 33.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.627 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.608 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 66.1 Cg_endo -87.64 105.92 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.822 1.682 . . . . 0.0 111.787 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.698 ' HG3' HH22 ' A' ' 108' ' ' ARG . 8.7 tpt180 -76.01 88.57 2.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.501 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.3 p -95.24 137.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.431 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.7 m -145.76 107.9 4.38 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.761 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.817 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 1.0 OUTLIER -96.86 149.98 21.25 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.423 0.63 . . . . 0.0 110.244 175.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -122.16 169.51 10.81 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.404 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -104.83 125.31 50.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.26 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 101' ' ' TYR . 13.7 pt -135.96 173.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 154' ' ' GLU . 4.8 p30 -95.38 109.5 21.65 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.171 0.986 . . . . 0.0 109.675 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.73 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.3 m95 -82.41 15.58 2.43 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.067 171.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 152' ' ' ASN . 63.2 mm-40 . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.559 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.679 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 3.2 mppt? . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 121.185 0.516 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.72 -55.01 15.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.012 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.414 ' HA ' ' HB2' ' B' ' 127' ' ' ALA . 14.4 tt -73.9 -26.02 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.14 -45.34 85.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 122.068 0.937 . . . . 0.0 110.161 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 24.6 mt -65.17 -43.52 91.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.648 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' B' ' 124' ' ' ILE . . . -59.28 -39.1 81.86 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.568 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -66.92 -47.02 73.01 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -39.98 95.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.639 HG12 ' NH1' ' A' ' 108' ' ' ARG . 5.1 mt -56.31 -60.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 113.099 -1.864 . . . . 0.0 112.533 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . 0.48 ' N ' HG23 ' B' ' 130' ' ' ILE . 12.4 mmm180 . . . . . 0 CA--C 1.515 -0.377 0 O-C-N 123.424 0.453 . . . . 0.0 110.991 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.481 0.658 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.677 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -95.14 -18.17 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.505 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.452 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.6 t -136.49 126.38 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.515 0.674 . . . . 0.0 110.241 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.571 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 18.7 tp60 -116.27 100.08 7.66 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.89 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -76.73 134.79 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.364 176.518 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.05 -62.72 1.56 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 -165.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.66 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.51 151.06 23.3 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.865 -176.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 3.6 p -144.63 99.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.5 170.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.626 HG21 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.15 95.39 4.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.165 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.705 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -67.31 125.3 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.699 177.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.975 HD13 ' HG2' ' A' ' 23' ' ' GLN . 7.3 mt -97.31 -52.31 3.86 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.184 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 7.7 t70 -74.49 78.64 1.93 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.733 1.254 . . . . 0.0 110.456 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.737 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -82.38 178.09 2.63 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.437 165.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.887 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.9 Cg_endo -48.0 104.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.839 1.693 . . . . 0.0 114.619 -149.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.533 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 8.2 m -131.76 170.45 11.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 112.767 -2.015 . . . . 0.0 108.495 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 51.6 Cg_exo -46.85 144.58 7.91 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 111.636 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.7 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 11.3 t80 -61.36 -37.14 82.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.85 -0.85 32.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.897 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.556 HD22 ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -89.2 131.35 41.03 Favored Pre-proline 0 N--CA 1.431 -1.388 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 171.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 31.8 Cg_exo -63.72 150.12 89.2 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 123.792 2.995 . . . . 0.0 114.364 -168.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 95.0 m-85 -66.12 139.15 58.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.103 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.975 ' HG2' HD13 ' A' ' 12' ' ' LEU . 7.8 tt0 -133.83 99.43 4.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.139 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.708 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.5 m-85 -103.37 155.72 18.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.294 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.702 ' HB2' HD11 ' A' ' 12' ' ' LEU . 39.5 tt0 -134.71 88.13 2.41 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.536 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 14.0 mt -86.85 131.52 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.941 0.877 . . . . 0.0 112.366 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 24.6 m -108.53 108.1 18.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.345 173.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.682 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 32.5 p90 -120.0 148.05 44.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.778 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 72.0 tt0 -106.76 115.01 29.45 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.64 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -72.68 111.64 8.02 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.571 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -77.67 -29.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.44 -174.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.599 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 42.2 mm-40 -151.81 154.77 36.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.437 0.46 . . . . 0.0 110.054 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.72 128.31 20.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.87 0.731 . . . . 0.0 111.256 -175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.09 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -83.46 146.63 28.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.563 -170.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.417 ' HB3' ' HH ' ' A' ' 101' ' ' TYR . 23.1 t -113.2 -23.17 10.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.384 -172.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.83 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 29.3 tt0 -129.51 -164.85 1.45 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.83 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.3 m-20 -95.27 137.17 34.7 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.611 HD12 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 47.8 tt0 -105.66 89.7 3.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.571 -171.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.633 ' O ' ' HA ' ' A' ' 59' ' ' SER . 23.4 m95 -80.34 124.67 29.06 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.7 ttmt -130.93 142.5 50.36 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.72 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 95' ' ' VAL . 12.5 mt -103.62 112.97 39.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.3 mp -104.43 105.74 19.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.669 ' CE2' HG11 ' A' ' 113' ' ' VAL . 33.5 t80 -90.42 111.87 23.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.795 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -53.43 109.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.253 0.549 . . . . 0.0 109.846 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.61 -45.56 52.5 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.452 -0.88 . . . . 0.0 110.97 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.834 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 91.4 p -128.1 125.02 38.41 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.358 0.599 . . . . 0.0 111.515 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -89.21 -0.1 57.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 161.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.558 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 4.8 mt-10 -88.5 -29.58 20.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.655 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.43 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 64.1 m -121.92 -107.88 0.35 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.593 173.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 7.0 pt-20 -179.98 -47.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.173 0.189 . . . . 0.0 111.327 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 38.0 mt-10 -72.83 1.15 9.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.088 0.47 . . . . 0.0 111.777 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 2.0 m-30 -80.73 -7.93 59.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -44.01 108.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.207 1.003 . . . . 0.0 111.057 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.611 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 40.8 mt-30 -92.71 169.44 10.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.512 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.67 110.35 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -172.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 77' ' ' ASP . 3.6 mm? -75.54 -54.61 6.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.614 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 19.3 p-10 -160.38 170.43 21.05 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 67.5 p -146.92 115.39 6.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.1 p -99.63 134.65 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.382 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.94 103.92 13.51 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.048 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.59 118.74 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.72 -162.33 24.69 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.219 -165.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.09 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 31.4 Cg_endo -63.5 117.36 4.32 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.784 1.656 . . . . 0.0 110.806 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 23.1 m -128.0 137.56 31.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.857 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -82.02 77.23 3.91 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.23 1.953 . . . . 0.0 114.082 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . 51.85 177.37 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.116 -1.856 . . . . 0.0 112.618 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 110.68 129.62 5.61 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 172.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.824 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.3 ptt180 -79.87 128.06 33.0 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.321 1.058 . . . . 0.0 109.787 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -154.12 143.77 21.66 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.395 -177.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -92.85 136.23 33.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.533 -176.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 6.4 p90 -121.36 160.09 24.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 168.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.46 134.13 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-O 121.882 0.849 . . . . 0.0 110.808 -171.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.708 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -115.95 129.75 56.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.345 -164.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 19.3 mt-30 -151.67 143.7 23.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.941 0.4 . . . . 0.0 110.542 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.11 138.43 2.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.835 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.614 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.2 p-10 -72.96 156.19 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -174.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.63 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -44.1 156.93 0.3 Allowed Pre-proline 0 N--CA 1.443 -0.789 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.523 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 57.3 Cg_endo -66.97 170.57 12.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.841 3.027 . . . . 0.0 111.418 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.8 m-20 -66.55 117.83 48.07 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.0 Cg_endo -61.36 -25.74 80.6 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.544 2.829 . . . . 0.0 111.948 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.0 -11.29 82.77 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.311 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 25.2 mt -91.85 -21.91 20.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.644 0.259 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 10.1 mt -84.49 130.07 55.05 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.38 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 1.5 Cg_endo -79.96 161.19 23.95 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.123 2.549 . . . . 0.0 112.076 170.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.733 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -46.54 -53.32 11.56 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.07 69.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.178 0.513 . . . . 0.0 111.114 -167.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 9.8 m-20 -95.74 -19.88 19.32 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.754 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.04 -47.28 15.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.52 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.407 HG12 ' CE2' ' A' ' 117' ' ' TYR . 0.7 OUTLIER -96.5 48.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.702 0.763 . . . . 0.0 111.542 -176.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.83 -129.73 1.15 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.089 -166.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.725 HG12 HD21 ' A' ' 114' ' ' ASN . 0.6 OUTLIER -119.91 125.3 74.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.344 0.593 . . . . 0.0 111.524 -173.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.14 169.65 15.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.524 HG12 HD23 ' A' ' 96' ' ' LEU . 2.4 t -126.45 142.53 42.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.266 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 42' ' ' ILE . 9.8 p -127.35 107.47 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 122.14 0.972 . . . . 0.0 108.613 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.837 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -104.02 138.93 39.84 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.345 -171.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 mt -102.81 95.57 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.811 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.6 p -96.7 116.04 28.45 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.599 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 40' ' ' TRP . 76.3 m -82.32 118.16 22.94 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.553 176.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 56.6 m -99.31 113.48 25.81 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.771 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.653 ' HE2' ' CD1' ' A' ' 34' ' ' LEU . 38.2 t80 -123.63 121.72 36.28 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.624 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 34.8 mtp180 63.02 27.37 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.063 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.35 66.51 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.653 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.12 135.44 55.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.165 0.507 . . . . 0.0 110.477 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.569 ' HG3' ' HG1' ' A' ' 100' ' ' THR . 2.4 mp0 -82.18 128.96 34.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.611 ' HZ ' HD12 ' A' ' 38' ' ' LEU . 51.4 p90 -111.65 2.41 17.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.811 ' O ' ' HA ' ' A' ' 98' ' ' THR . 9.3 tt -156.93 158.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.729 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 31.3 ttp180 -151.1 107.51 3.48 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.837 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -96.86 99.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 118.699 -1.201 . . . . 0.0 108.339 171.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.705 ' HA3' HG22 ' B' ' 130' ' ' ILE . . . -87.42 79.51 1.77 Allowed Glycine 0 CA--C 1.483 -1.962 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.123 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.863 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.9 m-85 -71.58 116.05 11.48 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.122 -1.039 . . . . 0.0 109.082 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.622 ' HB3' HD11 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.96 114.58 5.88 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.689 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.669 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.4 p -101.97 110.45 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.725 HD21 HG12 ' A' ' 92' ' ' VAL . 2.0 t-20 -96.87 120.91 38.08 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 47.9 m-80 -108.12 108.95 20.24 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -169.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -127.45 125.01 39.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.18 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.579 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 29.6 m-85 -41.24 153.14 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -91.07 -32.81 15.74 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.749 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.542 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.39 130.04 35.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.788 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.611 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.7 m -56.31 -36.4 68.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.474 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.04 -37.82 78.78 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.564 0.697 . . . . 0.0 110.301 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.565 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 81.8 mt -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.647 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 mtp85 -75.63 -37.88 59.37 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.2 mm-40 -57.65 -37.43 73.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.821 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -160.23 98.53 1.44 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.973 177.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 13.2 Cg_endo -56.5 114.6 1.99 Allowed 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.061 2.508 . . . . 0.0 111.341 173.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HD2' ' HH ' ' A' ' 117' ' ' TYR . 52.6 Cg_exo -55.4 152.26 33.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.494 2.129 . . . . 0.0 110.794 176.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -51.12 -24.49 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.979 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 26.0 mttt -123.95 108.21 30.45 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 121.703 0.763 . . . . 0.0 111.676 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.733 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 8.9 Cg_exo -45.02 141.83 5.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 125.091 3.861 . . . . 0.0 113.456 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -114.41 114.79 26.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.644 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 14.5 m-85 -78.11 -16.89 57.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.67 0.748 . . . . 0.0 111.303 -168.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -85.47 -20.45 29.71 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.355 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.7 mmtt -101.96 5.38 40.74 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 115' ' ' ASN . 26.3 tp -86.82 143.68 27.37 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.362 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 2.3 tt0 -126.43 125.1 41.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.887 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.3 mtp-105 -83.68 104.34 13.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.889 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.596 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -98.32 103.5 15.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.705 HG23 HG13 ' A' ' 11' ' ' VAL . 1.5 mp -82.03 104.96 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.576 -173.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 112' ' ' TYR . 83.5 mt -65.84 91.4 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.852 0.834 . . . . 0.0 111.029 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.863 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.88 -15.26 59.74 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.562 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -77.87 -16.01 58.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.411 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -134.35 67.27 72.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.19 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.569 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 90.5 Cg_endo -91.92 108.29 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.551 2.168 . . . . 0.0 110.951 175.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.588 ' HG3' ' HB ' ' B' ' 130' ' ' ILE . 0.0 OUTLIER -75.53 80.29 2.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.504 -176.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.491 HG12 HG21 ' A' ' 109' ' ' VAL . 5.2 m -79.18 111.16 15.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.597 HG23 HH21 ' A' ' 108' ' ' ARG . 31.3 m -132.15 106.61 8.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.142 0.496 . . . . 0.0 110.333 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.682 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -108.36 133.23 52.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.243 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.66 169.99 8.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.993 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -102.47 116.97 33.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.162 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.7 pt -119.55 179.59 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.194 0.521 . . . . 0.0 109.844 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.416 ' H ' HD21 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -96.45 84.24 3.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 122.191 0.996 . . . . 0.0 112.242 -172.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.677 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 21.8 m95 -69.49 -9.27 53.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.321 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.498 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 4.5 mp0 . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.539 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.6 mmtt . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.013 0.435 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.16 -49.53 77.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.645 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . 0.497 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.7 tp -75.78 -27.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.052 0.453 . . . . 0.0 110.571 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.6 tm0? -56.48 -63.72 1.1 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.792 0.806 . . . . 0.0 109.905 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.587 ' O ' HG12 ' B' ' 130' ' ' ILE . 62.0 mt -58.99 -44.08 91.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.486 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.87 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -57.25 -32.55 66.68 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 123.566 0.541 . . . . 0.0 111.74 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 96.1 mtt180 -53.11 -53.48 49.71 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -62.94 -38.57 91.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.641 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.87 HG13 ' HA ' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -92.88 6.93 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 120.981 0.419 . . . . 0.0 110.253 171.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.74 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 64.0 mmtt -100.3 -14.7 18.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.498 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.52 HG12 HD21 ' A' ' 38' ' ' LEU . 2.1 t -150.98 137.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.353 0.597 . . . . 0.0 112.503 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.877 ' HG2' HD12 ' A' ' 31' ' ' ILE . 23.8 mm-40 -128.53 115.4 18.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.951 172.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 107' ' ' ILE . 5.0 m -78.13 134.71 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.234 -1.786 . . . . 0.0 108.107 167.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.72 -62.09 1.49 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.434 -166.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.463 ' C ' HD21 ' A' ' 8' ' ' ASN . 0.3 OUTLIER -103.64 99.87 9.69 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.168 177.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.529 HG13 ' OH ' ' A' ' 111' ' ' TYR . 3.0 p -95.84 97.86 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -93.54 97.06 6.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 122.236 1.017 . . . . 0.0 108.687 -174.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.483 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.15 135.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.659 -176.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.932 HD12 ' HG2' ' A' ' 23' ' ' GLN . 5.7 mt -106.48 -48.21 3.6 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -172.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.69 78.52 0.83 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.653 1.692 . . . . 0.0 109.659 167.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.712 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -85.91 178.32 2.38 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 112.22 -2.264 . . . . 0.0 107.023 162.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.847 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.2 Cg_endo -49.43 103.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 121.73 1.653 . . . . 0.0 113.242 -157.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.682 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.6 m -132.49 171.11 9.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.668 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.1 Cg_exo -43.18 135.79 5.66 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.313 2.009 . . . . 0.0 111.253 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.672 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 12.6 t80 -60.46 -26.66 66.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.325 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.17 -7.68 59.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.999 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.22 142.94 76.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 170.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.4 Cg_exo -77.55 136.7 15.77 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 123.407 2.738 . . . . 0.0 113.139 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.744 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 32.5 m-85 -57.43 116.43 3.33 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.532 0.682 . . . . 0.0 110.729 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.932 ' HG2' HD12 ' A' ' 12' ' ' LEU . 9.6 tt0 -116.39 106.47 13.66 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.941 -165.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.657 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 92.7 m-85 -110.32 154.01 24.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.564 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.639 ' HG3' ' HE1' ' A' ' 71' ' ' MET . 24.5 tt0 -121.69 87.06 2.68 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 167.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.487 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 74.8 mt -82.99 125.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.624 0.726 . . . . 0.0 112.281 -174.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 37.8 m -107.71 106.38 16.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.037 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.579 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 29.1 p90 -113.94 146.25 40.35 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.677 1.227 . . . . 0.0 110.924 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.921 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.1 tt0 -101.28 113.42 26.46 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.579 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.631 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -72.14 109.79 6.16 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.877 HD12 ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -70.53 -32.07 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.8 -2.0 . . . . 0.0 108.56 178.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.62 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 8.7 mm-40 -144.79 154.05 42.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.182 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.28 132.26 48.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.062 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 44.9 mt -83.06 158.63 22.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.682 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -113.1 -21.08 11.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.454 0.645 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.756 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.7 tt0 -126.44 -168.96 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.756 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.5 m-20 -90.63 149.91 21.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.697 HD23 HD13 ' A' ' 34' ' ' LEU . 4.7 tp -96.38 123.65 40.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.435 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 82.4 tt0 -107.9 92.11 3.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.699 -169.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.69 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 46.2 m95 -88.64 127.78 35.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 22.7 ttmt -124.11 140.59 52.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.032 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.511 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.2 mt -104.13 107.26 21.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.111 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.6 mp -103.01 112.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.443 -174.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 13.4 t80 -96.9 114.2 25.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.492 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.11 103.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.58 -44.91 96.41 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.607 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 43.9 t -134.36 135.32 42.61 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.532 0.682 . . . . 0.0 109.634 176.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -83.61 -11.21 57.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -32.2 25.24 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.938 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.66 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 74.9 m -144.5 117.02 8.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.021 0.915 . . . . 0.0 111.342 166.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.532 ' OE2' ' HD3' ' B' ' 128' ' ' ARG . 9.0 pt-20 -66.89 -14.82 63.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.276 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.2 -9.46 32.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.439 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.66 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 95.4 m-85 -90.89 6.43 44.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.463 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -53.63 103.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.909 0.862 . . . . 0.0 111.13 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -101.24 167.48 10.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.21 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.36 122.5 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.334 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 10.8 mp -81.67 -62.69 1.57 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -147.23 163.35 36.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.211 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 51.4 p -138.49 116.78 11.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -99.4 131.9 45.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.734 -172.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 12.5 mt -102.92 104.19 14.39 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.184 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.38 125.1 47.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' HG11 ' A' ' 65' ' ' VAL . . . -73.11 -166.21 10.2 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.319 -163.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 1.062 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 28.4 Cg_endo -60.57 114.7 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.233 1.289 . . . . 0.0 109.285 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 63' ' ' GLY . 28.2 m -116.9 120.99 33.31 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.661 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.83 131.0 37.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.517 2.145 . . . . 0.0 110.429 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.18 132.15 0.39 Allowed 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 124.26 0.975 . . . . 0.0 112.775 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 156.94 118.96 0.58 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -172.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.921 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.2 ttt180 -65.21 114.63 4.83 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.719 0.771 . . . . 0.0 111.214 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.425 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 5.9 p80 -149.07 156.2 41.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.128 -171.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.639 ' HE1' ' HG3' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -106.05 151.18 25.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' N ' ' HG2' ' A' ' 71' ' ' MET . 1.3 p90 -140.75 160.75 39.36 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 171.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.467 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 2.6 p -117.35 136.98 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 122.168 0.985 . . . . 0.0 111.567 -172.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.657 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -118.07 138.14 52.44 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.49 -169.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.744 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 21.5 mt-30 -148.08 151.46 35.7 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -159.21 121.87 3.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.68 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.83 156.3 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.809 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.541 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.05 151.36 16.8 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.516 -169.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 64.3 Cg_endo -67.36 162.54 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.029 2.486 . . . . 0.0 110.16 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 24.0 m-80 -60.9 119.04 41.22 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 21.0 Cg_endo -66.76 -7.78 19.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.067 2.511 . . . . 0.0 110.796 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.46 1.3 55.8 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.978 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.27 -27.81 10.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.996 0.398 . . . . 0.0 110.638 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 89' ' ' ALA . 15.9 mt -80.82 128.64 70.94 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.991 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' O ' HG22 ' A' ' 84' ' ' ILE . 72.0 Cg_endo -81.88 161.29 18.61 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.066 1.844 . . . . 0.0 111.394 172.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.69 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.5 t70 -46.0 -48.7 16.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.88 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.994 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 7.5 m-20 -106.8 -8.38 16.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.409 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HA ' HG23 ' A' ' 84' ' ' ILE . . . -74.48 -43.8 54.39 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 111.178 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.6 46.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.593 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.31 -138.63 2.75 Favored Glycine 0 CA--C 1.508 -0.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.452 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.732 HG21 HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -100.57 139.08 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -168.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.803 HG21 HG12 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -157.61 169.9 23.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.001 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.655 HG12 HD23 ' A' ' 96' ' ' LEU . 94.9 t -120.95 133.1 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 121.05 0.452 . . . . 0.0 111.63 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.511 ' CG2' HG23 ' A' ' 42' ' ' ILE . 3.0 p -117.15 107.13 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -106.27 151.02 25.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.702 -177.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 61.6 mt -110.51 100.86 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-O 121.709 0.766 . . . . 0.0 109.037 175.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.826 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 76.1 p -97.66 116.26 29.53 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.744 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.69 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 4.3 t -78.9 158.96 27.97 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.322 174.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.1 m -148.05 111.73 5.05 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HB3' HD11 ' A' ' 151' ' ' ILE . 71.3 t80 -123.4 119.82 31.17 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 62.08 33.61 16.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.863 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.84 62.92 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.199 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.425 ' O ' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -132.72 133.32 43.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 0.0 110.98 175.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 3.1 mp0 -81.37 132.84 35.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.307 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.565 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 55.0 p90 -125.73 2.06 7.47 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.826 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.3 tt -156.84 159.49 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.486 ' NH1' ' HA ' ' B' ' 130' ' ' ILE . 5.0 tmm_? -152.79 105.46 2.96 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.708 0.63 . . . . 0.0 109.559 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.3 p -95.0 102.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -89.99 102.65 2.93 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.82 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.943 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 10.3 m-85 -98.96 121.98 41.62 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.573 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.555 ' CB ' HD13 ' A' ' 140' ' ' LEU . 57.2 m-85 -68.97 115.86 8.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.295 176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.803 HG12 HG21 ' A' ' 93' ' ' THR . 1.8 p -101.27 109.71 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 122.32 1.057 . . . . 0.0 108.28 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.732 HD21 HG21 ' A' ' 92' ' ' VAL . 14.4 t-20 -97.14 104.4 16.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.727 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 31.8 m-80 -89.55 110.16 21.04 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.02 130.16 49.45 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.64 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 25.9 m-85 -38.55 150.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -84.44 -34.32 23.49 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.223 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 10.6 tt0 -86.51 119.43 26.76 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.249 -1.796 . . . . 0.0 108.504 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.842 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 99.2 m -54.89 -31.3 59.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.084 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.18 -32.29 70.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 92.0 mt -73.42 -27.05 61.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.253 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.842 ' HE ' ' HA ' ' A' ' 120' ' ' THR . 19.3 mtm180 -74.46 -38.18 63.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.616 0.722 . . . . 0.0 109.257 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.713 ' HG3' ' O ' ' A' ' 120' ' ' THR . 45.9 mt-10 -58.66 -39.64 81.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.339 -1.301 . . . . 0.0 111.126 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.4 p30 -146.8 86.13 6.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 18.7 Cg_endo -57.43 114.36 1.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.789 2.326 . . . . 0.0 111.318 176.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.505 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 54.0 Cg_exo -55.17 141.74 79.56 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.265 1.977 . . . . 0.0 109.899 175.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.75 -13.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.972 0.795 . . . . 0.0 112.454 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.496 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -124.63 100.22 34.89 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.162 0.982 . . . . 0.0 111.824 167.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.69 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.7 Cg_exo -44.77 144.83 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.827 1 C-N-CA 125.453 4.102 . . . . 0.0 113.378 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.2 t70 -113.65 111.67 22.22 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.672 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 9.9 m-85 -75.93 -11.39 59.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.546 1.165 . . . . 0.0 110.596 -170.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -90.3 -34.5 15.71 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.056 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 61.2 mmtt -92.79 17.67 10.09 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 33.1 tp -100.6 128.67 46.57 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.334 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.498 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -120.72 110.93 16.97 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.847 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.94 113.85 25.56 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.096 0.474 . . . . 0.0 111.681 -174.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.707 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 11.5 t30 -89.89 112.55 23.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 172.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.483 HG23 HG13 ' A' ' 11' ' ' VAL . 1.7 mp -83.71 103.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.313 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.555 HD13 ' CB ' ' A' ' 112' ' ' TYR . 86.3 mt -63.57 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.296 0.569 . . . . 0.0 110.938 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.943 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.08 -11.82 60.01 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.738 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -79.23 -3.33 45.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.574 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -143.79 71.08 17.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.94 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.3 Cg_endo -89.72 106.54 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.292 1.995 . . . . 0.0 111.234 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 81.22 8.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.038 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.714 HG13 HG21 ' A' ' 109' ' ' VAL . 32.4 m -77.36 131.52 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.423 HG22 ' CE1' ' A' ' 149' ' ' PHE . 86.2 m -151.09 110.71 4.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.516 0.674 . . . . 0.0 110.566 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.725 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 5.6 ptt-85 -108.46 138.51 44.64 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.798 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.3 OUTLIER -116.11 169.37 9.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.312 -176.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.466 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.3 pt -129.91 -177.2 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.631 0.729 . . . . 0.0 111.469 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.52 ' H ' HD21 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -98.15 84.22 3.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.972 -171.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TRP . . . . . 0.74 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 63.7 m95 -69.45 -7.44 37.93 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.483 -0.76 . . . . 0.0 111.345 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.822 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' LYS . . . . . 0.655 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 39.5 mmtt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.075 0.464 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -31.11 -46.06 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.3 tt -73.82 -38.3 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.4 0.619 . . . . 0.0 110.489 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.612 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 1.6 tp-100 -66.36 -37.39 85.21 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.449 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.788 ' O ' ' HB ' ' B' ' 130' ' ' ILE . 20.0 mt -59.52 -50.32 74.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.299 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' B' ' 131' ' ' ARG . . . -62.65 -42.51 99.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.818 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.532 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 81.3 mtt180 -56.74 -65.1 0.67 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.349 0.595 . . . . 0.0 111.973 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ARG . . . . . 0.451 ' HD3' ' HB2' ' A' ' 51' ' ' GLU . 20.0 mmm180 -60.37 -30.5 69.61 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.118 -175.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.788 ' HB ' ' O ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -87.82 -7.48 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.215 -175.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' B' ' 127' ' ' ALA . 30.3 mmt180 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.513 0.673 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -102.31 155.93 17.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.648 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.2 mptp? -96.6 -18.53 19.68 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.26 -176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.83 125.36 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.752 0.787 . . . . 0.0 110.71 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.536 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.36 100.05 7.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.786 176.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.586 ' HB ' ' HH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -77.96 131.84 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.403 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -111.73 -66.77 1.05 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.071 -166.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.525 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.4 t-20 -102.76 154.05 19.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.82 -176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' H ' ' ND2' ' A' ' 8' ' ' ASN . 6.1 p -144.83 99.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 CA-C-O 122.104 0.955 . . . . 0.0 109.214 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -92.26 95.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.322 1.058 . . . . 0.0 108.572 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.85 127.72 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.763 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.928 HD13 ' HB3' ' A' ' 23' ' ' GLN . 1.2 mt -97.48 -39.05 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.318 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.597 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 9.8 t0 -70.91 65.13 0.34 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.316 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.658 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -84.84 173.44 7.15 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 162.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.827 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.0 Cg_endo -50.32 101.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 121.508 1.574 . . . . 0.0 113.101 -158.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.631 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 13.9 m -136.21 169.44 13.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.861 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 70.5 Cg_exo -38.31 137.47 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.18 2.587 . . . . 0.0 113.496 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.742 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 19.2 t80 -63.09 -20.76 65.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 21.4 m-85 -94.38 5.62 51.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 111.235 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.77 140.92 47.44 Favored Pre-proline 0 C--O 1.213 -0.831 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 14.3 Cg_exo -74.56 141.92 28.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.691 2.261 . . . . 0.0 112.185 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.795 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 94.8 m-85 -60.24 117.07 4.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 122.964 0.506 . . . . 0.0 110.015 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.928 ' HB3' HD13 ' A' ' 12' ' ' LEU . 39.3 mt-30 -115.5 111.27 20.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.32 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.604 ' CD2' HD12 ' A' ' 97' ' ' ILE . 70.0 m-85 -121.58 107.51 12.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.497 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.579 ' HB2' HD21 ' A' ' 12' ' ' LEU . 22.0 tt0 -90.14 85.05 6.17 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.476 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 14.4 mt -86.83 132.4 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.694 0.759 . . . . 0.0 112.114 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.7 m -108.47 106.85 17.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.294 174.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.3 p90 -118.79 150.92 38.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.529 0.681 . . . . 0.0 109.717 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.801 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 47.2 tt0 -107.46 111.04 23.14 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.49 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.431 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 29.1 t -72.96 108.1 5.69 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -74.55 -27.21 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.031 -173.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 8.2 mt-10 -143.8 179.62 7.05 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.88 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -73.57 146.63 44.59 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.054 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -106.73 157.03 18.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -174.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -113.97 -41.85 3.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.889 0.852 . . . . 0.0 110.545 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.792 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 33.2 tt0 -113.33 -165.84 1.03 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.042 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.792 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -98.51 143.59 28.76 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.819 0.819 . . . . 0.0 110.599 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.845 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.68 124.13 29.92 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.38 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.576 ' HB3' ' O ' ' A' ' 100' ' ' THR . 42.3 tt0 -107.55 90.15 3.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.929 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.609 ' O ' ' HA ' ' A' ' 59' ' ' SER . 24.5 m95 -81.67 122.74 28.01 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.6 ttmt -126.4 141.59 51.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.549 ' CG2' HG23 ' A' ' 95' ' ' VAL . 13.8 mt -102.9 120.13 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.684 ' HB ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -114.38 106.33 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.287 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.693 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.5 t80 -88.87 116.69 27.34 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.73 105.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.151 0.5 . . . . 0.0 109.899 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.44 -35.77 92.49 Favored Glycine 0 CA--C 1.501 -0.808 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.172 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.55 ' OG ' ' HG3' ' A' ' 85' ' ' PRO . 46.6 t -139.14 116.56 11.25 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -70.35 -1.2 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 167.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -96.3 -27.02 15.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 47' ' ' SER . 14.5 m -144.67 109.45 4.99 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.828 0.823 . . . . 0.0 111.091 171.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.812 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -70.08 -23.76 63.12 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.399 -166.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -67.4 -2.33 6.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 4.2 m-30 -85.71 -4.02 59.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.041 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.2 p-10 -42.53 112.32 0.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.316 1.055 . . . . 0.0 112.206 -175.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 3.1 mt-30 -91.36 168.49 11.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.923 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.42 114.25 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -173.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 77' ' ' ASP . 3.1 mm? -82.73 -49.29 9.92 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.059 -174.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -163.92 164.04 23.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 27.8 p -141.43 117.46 10.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.2 p -100.29 132.76 45.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.624 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.36 105.93 15.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.638 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.23 113.81 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.65 -166.38 12.39 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.098 -168.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.054 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.8 Cg_endo -65.23 115.27 3.22 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.407 1.404 . . . . 0.0 110.365 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 31.1 m -131.99 141.36 41.19 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.614 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.55 79.11 3.31 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.082 1.854 . . . . 0.0 113.482 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.431 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.29 -171.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.015 -1.902 . . . . 0.0 112.343 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.94 122.79 2.62 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.947 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.801 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.9 ttt180 -87.69 118.24 27.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -161.06 166.0 28.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.41 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.608 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -108.64 139.46 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.174 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 9.8 p90 -126.69 160.91 29.39 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 73' ' ' VAL . 8.2 p -124.14 106.42 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-O 123.06 1.41 . . . . 0.0 111.898 -169.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.582 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 140.97 37.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.443 -2.162 . . . . 0.0 110.572 -176.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.795 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.0 mt-30 -150.68 149.84 30.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 165.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -158.65 132.14 7.48 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.457 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.712 ' O ' HD13 ' A' ' 57' ' ' LEU . 12.9 m-20 -67.18 143.19 56.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.163 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.509 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -52.2 157.22 2.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 124.704 1.201 . . . . 0.0 114.028 -173.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.663 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.03 -179.92 3.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.97 3.113 . . . . 0.0 113.267 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 96.1 m-20 -82.18 119.17 74.4 Favored Pre-proline 0 CA--C 1.515 -0.388 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.263 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 16.1 Cg_endo -60.32 -25.18 79.64 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.538 2.826 . . . . 0.0 112.576 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.0 -15.86 81.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.417 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.3 mt -79.57 -25.94 41.47 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.242 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.69 129.29 49.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.55 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -80.06 164.02 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.746 2.964 . . . . 0.0 112.794 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 m-20 -45.12 -55.0 6.11 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.823 0.849 . . . . 0.0 113.071 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.0 -18.56 61.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.218 0.533 . . . . 0.0 110.596 -168.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.559 ' HA ' ' NZ ' ' B' ' 122' ' ' LYS . 40.2 t0 -92.36 -35.82 13.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -70.17 -45.38 66.84 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.381 0.61 . . . . 0.0 111.332 -171.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.19 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.77 0.795 . . . . 0.0 111.559 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.45 -160.14 10.09 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.433 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.643 HG13 ' ND2' ' A' ' 114' ' ' ASN . 4.7 m -94.87 144.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.887 ' HB ' HG12 ' A' ' 113' ' ' VAL . 2.8 m -151.15 170.24 19.92 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.9 t -132.7 144.6 36.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 118.939 0.79 . . . . 0.0 110.954 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG23 ' CG2' ' A' ' 42' ' ' ILE . 10.5 p -129.04 105.48 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.909 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -104.13 135.51 45.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.792 -169.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 45.1 mt -103.29 99.82 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-O 121.919 0.866 . . . . 0.0 109.08 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.772 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 58.0 p -93.61 112.33 24.19 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.639 ' SG ' HD13 ' A' ' 38' ' ' LEU . 1.4 t -79.52 122.3 26.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.576 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 18.8 m -121.83 103.71 9.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.021 -167.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.669 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 61.4 t80 -109.14 120.28 42.05 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.413 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.669 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 15.5 mtp180 69.67 22.42 6.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.778 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.81 85.0 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -110.05 117.79 34.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.847 -0.676 . . . . 0.0 109.386 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 60.0 mt-10 -82.54 132.47 35.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.845 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.9 p90 -123.19 1.77 9.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.84 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.6 tt -159.24 157.86 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.723 HH12 ' HA2' ' B' ' 132' ' ' GLY . 22.3 ttm180 -150.99 101.37 2.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.463 0.477 . . . . 0.0 109.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.909 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -84.52 98.66 6.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.228 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.17 77.25 2.12 Favored Glycine 0 CA--C 1.488 -1.606 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.586 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.96 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -74.06 115.9 14.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.137 -1.032 . . . . 0.0 109.121 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' A' ' 140' ' ' LEU . 1.7 m-85 -66.31 120.58 13.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.887 HG12 ' HB ' ' A' ' 93' ' ' THR . 2.6 p -103.18 110.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.643 ' ND2' HG13 ' A' ' 92' ' ' VAL . 6.0 t-20 -92.43 110.76 22.17 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.184 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 39.1 m-80 -97.78 107.84 20.42 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.96 141.22 36.44 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.184 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.732 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 46.4 m-85 -47.97 151.93 0.86 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -174.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -86.81 -37.72 17.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.534 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.3 mt-10 -82.94 132.0 35.17 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.766 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 m -55.73 -36.17 66.95 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.55 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.85 -40.42 84.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.897 0.856 . . . . 0.0 109.991 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 46.0 mt -77.73 -23.09 49.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.799 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -80.15 -37.04 34.28 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.2 mm-40 -56.19 -43.1 78.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.769 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.466 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -152.72 89.11 3.82 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.447 0.641 . . . . 0.0 109.854 177.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.5 Cg_endo -50.46 116.01 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.769 2.979 . . . . 0.0 112.865 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.732 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 77.7 Cg_exo -52.75 136.79 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.007 2.471 . . . . 0.0 111.249 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 HG13 ' HE2' ' A' ' 129' ' ' LYS . 22.5 t -51.68 -40.68 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.555 -173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 1.8 mmpt? -94.83 137.96 22.25 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-O 121.153 0.501 . . . . 0.0 110.798 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.576 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 11.8 Cg_exo -69.89 123.77 10.38 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.7 2.933 . . . . 0.0 112.332 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.57 97.09 7.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.681 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.67 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 33.4 m-85 -68.0 -16.33 64.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.994 0.902 . . . . 0.0 110.549 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.463 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 2.9 p -83.3 -21.72 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -104.58 5.12 33.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.439 HD13 ' HB3' ' A' ' 115' ' ' ASN . 17.6 tp -87.82 137.83 31.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.556 -168.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 4.5 tt0 -120.41 127.5 52.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.827 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 21.2 mtm-85 -90.46 104.93 17.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 15.3 t30 -89.75 98.75 11.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.628 HG23 HG13 ' A' ' 11' ' ' VAL . 1.6 mp -78.73 100.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 112' ' ' TYR . 95.8 mt -62.2 92.57 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.706 0.765 . . . . 0.0 111.14 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.96 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -78.93 -8.82 59.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.419 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 p -80.66 -10.55 59.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.03 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.466 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.4 t-20 -142.27 62.97 14.41 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.513 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 4.7 Cg_exo -81.0 109.11 2.14 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.3 2.0 . . . . 0.0 111.098 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.635 ' HB3' HD13 ' B' ' 130' ' ' ILE . 15.0 tpt180 -82.23 82.61 7.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.98 106.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.2 m -116.46 105.65 12.72 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.601 0.715 . . . . 0.0 109.308 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.5 ptt180 -112.53 148.32 34.74 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.805 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -129.42 167.45 17.79 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.145 -173.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -106.1 123.14 47.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.931 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 101' ' ' TYR . 38.9 pt -121.45 158.73 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.461 HD21 ' H ' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -87.25 103.22 15.23 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.495 1.14 . . . . 0.0 110.365 172.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.648 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 7.9 m95 -75.54 -3.56 34.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.64 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -114.41 -173.55 2.31 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.212 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -114.32 71.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.327 178.573 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.47 80.23 7.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 110.101 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.409 ' HE1' ' HB3' ' B' ' 120' ' ' MET . 45.6 ttp -87.76 -32.93 18.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.128 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 85.07 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.304 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 9.5 mmmm -69.24 -50.67 45.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 109.993 -175.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -40.59 -54.89 2.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.044 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.483 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.9 tp -69.06 -32.07 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.851 0.357 . . . . 0.0 111.247 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 8.4 mm100 -58.07 -46.91 84.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 173.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.542 ' O ' HG13 ' B' ' 130' ' ' ILE . 30.8 mt -68.35 -43.62 77.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.319 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.29 68.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.712 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 95.9 mtt180 -54.14 -57.65 10.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 1.076 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 6.1 tpt180 -61.4 -35.45 77.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.269 -171.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.635 HD13 ' HB3' ' A' ' 145' ' ' ARG . 23.8 mt -76.83 -49.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.65 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' B' ' 131' ' ' ARG . 7.3 mmm180 -53.22 -44.92 68.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 111.534 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.723 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 171.9 59.88 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.182 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 1.076 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 6.3 tp10 -128.59 -31.45 2.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.909 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.579 ' HG2' HG22 ' A' ' 98' ' ' THR . 17.6 tpt180 -57.84 -48.69 79.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.478 172.285 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.578 0.228 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.609 ' HB2' HD11 ' A' ' 31' ' ' ILE . . . -82.84 131.2 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 0.0 110.706 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.909 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.58 -21.57 18.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.457 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 3.4 t -137.53 129.22 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.772 0.796 . . . . 0.0 111.08 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.4 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp-100 -115.04 100.55 8.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.233 -1.349 . . . . 0.0 107.421 169.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.502 HG21 ' CH2' ' A' ' 40' ' ' TRP . 29.9 t -74.28 124.73 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -107.39 -65.65 1.09 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.09 0.947 . . . . 0.0 109.146 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.643 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.9 t-20 -106.41 151.8 24.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.849 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.661 HG21 HG13 ' A' ' 26' ' ' ILE . 3.2 p -146.77 99.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.367 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.914 HG21 ' HB3' ' A' ' 25' ' ' GLU . 2.4 m -93.67 107.11 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 109.979 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.867 HG11 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -78.72 136.6 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.568 -176.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 23' ' ' GLN . 7.6 mt -111.05 -42.14 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.32 -172.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 23' ' ' GLN . 4.2 p-10 -69.69 43.66 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.41 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -79.0 169.91 18.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.7 Cg_endo -53.02 100.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.048 1.165 . . . . 0.0 114.206 -138.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.645 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.6 m -136.76 171.22 9.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 112.008 -2.36 . . . . 0.0 107.482 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 62.4 Cg_exo -39.83 141.46 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.695 2.263 . . . . 0.0 112.912 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 1.004 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.0 t80 -60.31 -30.6 69.59 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.378 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -79.38 -6.17 56.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.089 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.487 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -77.59 119.94 79.46 Favored Pre-proline 0 CA--C 1.507 -0.682 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.532 ' C ' HH22 ' A' ' 137' ' ' ARG . 47.2 Cg_exo -60.57 154.43 54.28 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 123.844 3.03 . . . . 0.0 113.391 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.745 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 80.2 m-85 -62.93 133.36 54.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.71 ' HB3' HD13 ' A' ' 12' ' ' LEU . 39.9 mt-30 -132.27 89.86 2.72 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.307 0.575 . . . . 0.0 109.552 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.54 ' CG ' HD11 ' A' ' 97' ' ' ILE . 79.9 m-85 -100.44 109.14 21.27 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.56 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.914 ' HB3' HG21 ' A' ' 10' ' ' VAL . 31.8 tt0 -91.66 85.87 5.81 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.661 HG13 HG21 ' A' ' 9' ' ' VAL . 2.6 mp -81.85 140.06 17.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.764 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.643 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 11.3 m -115.25 107.16 14.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.327 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.466 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 17.6 p90 -121.27 153.41 37.7 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.85 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 21.9 tt0 -109.4 118.3 36.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.573 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 24.4 m -74.07 109.25 7.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -72.81 -31.4 36.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.962 -174.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.909 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 47.8 mt-10 -142.89 166.74 23.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.772 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.2 m-20 -61.71 131.2 49.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.751 HD11 ' CE1' ' A' ' 101' ' ' TYR . 2.1 mm? -85.51 152.29 23.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -113.54 -36.82 4.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.68 0.752 . . . . 0.0 110.126 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 13.7 tt0 -117.13 -167.37 1.29 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.449 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.5 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 5.3 m-20 -96.19 138.43 33.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.516 0.674 . . . . 0.0 111.316 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.706 HD13 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.47 120.02 29.45 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.922 178.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.8 tt0 -106.92 89.32 2.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.638 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.676 ' O ' ' HA ' ' A' ' 59' ' ' SER . 27.6 m95 -76.35 129.08 36.08 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 30.0 ttmt -133.38 142.48 48.4 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.903 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.559 HG21 HG21 ' A' ' 95' ' ' VAL . 10.7 mt -103.22 121.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -114.29 105.71 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.119 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.848 ' CE2' HG11 ' A' ' 113' ' ' VAL . 28.3 t80 -89.72 124.55 34.72 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.898 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.01 111.54 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.376 0.608 . . . . 0.0 110.343 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.76 -35.71 66.45 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.715 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 39.6 t -134.53 118.85 17.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.771 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -66.05 0.23 2.04 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.999 0.428 . . . . 0.0 110.01 167.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 47' ' ' SER . 4.6 mt-10 -102.12 -17.12 16.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.286 172.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.715 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 50.4 m -124.64 -171.69 2.4 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.775 0.798 . . . . 0.0 111.086 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.65 -3.31 1.15 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.516 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -94.25 -13.16 26.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.675 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.672 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 3.5 m-30 -84.92 -15.82 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.335 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 8.7 p-10 -42.44 115.48 0.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.134 0.968 . . . . 0.0 111.979 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -91.17 166.85 12.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.943 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.81 107.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.0 mm? -74.92 -40.06 61.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.671 -171.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.34 176.26 2.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.887 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 58.1 p -151.49 115.28 4.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.84 132.42 45.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.918 -175.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 6.4 mt -102.73 106.26 16.85 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -92.98 120.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -84.16 -156.68 24.44 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.925 -165.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 38.6 Cg_endo -64.6 118.79 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.952 1.768 . . . . 0.0 110.53 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.543 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 28.5 m -134.8 141.87 40.22 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.514 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -86.17 75.33 2.98 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.421 2.08 . . . . 0.0 114.599 -173.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 48.19 -179.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.954 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 114.45 129.22 4.73 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.138 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.85 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.1 ptt-85 -75.87 126.21 30.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 4.9 p80 -153.68 141.6 20.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.936 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -95.55 137.75 34.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -177.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.7 p90 -135.68 146.37 47.71 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 13.8 p -104.26 125.65 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 122.318 1.056 . . . . 0.0 110.438 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.512 ' CE1' HG12 ' A' ' 60' ' ' VAL . 12.0 t80 -119.53 113.04 20.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.764 -163.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 38.3 mt-30 -138.46 149.99 46.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.476 -167.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' C ' ' HB3' ' A' ' 21' ' ' PRO . . . -169.34 146.07 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.351 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.609 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.1 p-10 -61.24 170.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.05 0.452 . . . . 0.0 111.413 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.669 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . . . -71.12 164.22 58.82 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.688 -170.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.745 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 34.7 Cg_endo -60.92 168.21 7.59 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.355 2.703 . . . . 0.0 111.69 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -69.75 115.54 34.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.0 -175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -61.89 -26.68 79.31 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.225 2.617 . . . . 0.0 112.045 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.61 14.55 55.26 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.292 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.6 mt -116.74 -33.75 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.391 0.139 . . . . 0.0 110.816 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.435 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 36.5 mt -73.71 129.89 84.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.127 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HG3' ' HG ' ' A' ' 47' ' ' SER . 95.0 Cg_endo -79.92 162.26 23.72 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.221 2.614 . . . . 0.0 112.699 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.664 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 12.1 m-20 -45.85 -52.54 11.19 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.673 0.789 . . . . 0.0 112.202 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.71 -28.61 65.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.825 ' HA ' ' NZ ' ' B' ' 122' ' ' LYS . 49.1 t0 -80.87 -38.97 27.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -65.45 -38.7 90.62 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -165.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.39 46.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 -138.85 3.0 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.118 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.569 HG21 ' ND2' ' A' ' 114' ' ' ASN . 1.1 t -97.13 135.87 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.059 0.933 . . . . 0.0 113.256 -172.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.691 ' HB ' HG12 ' A' ' 113' ' ' VAL . 1.7 m -140.51 168.82 18.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -125.54 143.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 118.318 0.508 . . . . 0.0 111.127 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 42' ' ' ILE . 7.3 p -131.06 108.23 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.835 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.65 154.91 18.46 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.983 -171.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.4 mt -117.39 105.07 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.0 p -100.62 114.8 28.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.227 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.574 ' HB2' HG21 ' A' ' 107' ' ' ILE . 62.6 m -79.68 115.76 19.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.452 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -108.54 101.91 11.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.991 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.751 ' CE1' HD11 ' A' ' 34' ' ' LEU . 87.1 t80 -104.31 127.83 52.02 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.593 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 37.0 mtp180 67.02 14.19 9.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.3 65.24 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.731 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.747 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -119.74 129.37 54.47 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.8 mp0 -83.6 133.68 34.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.418 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.706 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 50.5 p90 -121.47 -5.1 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.817 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.9 tt -156.17 158.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 174.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.937 HH22 ' HG3' ' A' ' 145' ' ' ARG . 4.3 tmm_? -150.87 107.68 3.54 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -174.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.2 p -102.64 101.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.188 0.994 . . . . 0.0 109.321 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.23 86.66 1.38 Allowed Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 119.762 -1.209 . . . . 0.0 111.499 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.759 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 17.1 m-85 -82.17 122.29 27.69 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.192 -1.004 . . . . 0.0 108.805 172.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB2' ' HB2' ' A' ' 140' ' ' LEU . 31.6 m-85 -68.48 131.91 46.08 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.332 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.848 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.6 p -104.89 111.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.569 ' ND2' HG21 ' A' ' 92' ' ' VAL . 3.0 t-20 -90.58 110.51 21.65 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.349 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 28.5 m-80 -102.68 107.34 18.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -131.91 130.03 41.06 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.612 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.588 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.7 m-85 -40.86 148.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.8 p -89.65 -29.27 18.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.771 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 30.2 mm-40 -91.31 140.0 30.2 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.556 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.0 m -52.05 -47.95 64.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 117.928 0.331 . . . . 0.0 111.206 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.27 -39.76 67.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.988 0.899 . . . . 0.0 110.045 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.5 mt -77.6 -30.34 52.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.376 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 52.1 mtp180 -76.83 -39.06 52.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.501 0.667 . . . . 0.0 109.516 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.71 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 1.5 pt-20 -80.85 -20.6 41.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.597 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.71 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -149.82 77.38 8.58 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.841 170.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.03 118.42 5.28 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.634 2.889 . . . . 0.0 112.94 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 14.9 Cg_exo -71.63 147.81 51.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.065 2.51 . . . . 0.0 110.197 172.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.1 -27.75 43.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.866 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -89.12 122.21 68.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 0.0 111.271 175.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.664 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 36.5 Cg_exo -63.54 131.78 33.0 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 124.253 3.302 . . . . 0.0 112.588 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.0 t0 -114.05 105.28 13.03 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.719 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 42.6 m-85 -77.87 -19.86 54.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.846 0.832 . . . . 0.0 110.344 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.3 t -79.94 -29.91 39.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.804 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 71.6 mmtt -98.82 14.41 28.97 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 28.8 tp -99.68 143.91 29.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.213 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.91 129.95 51.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 1.004 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 10.0 mtm180 -95.5 106.01 18.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.758 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 4.4 t30 -96.35 99.71 11.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.867 HG23 HG11 ' A' ' 11' ' ' VAL . 10.0 mm -68.05 117.86 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.633 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . 62.4 mt -74.35 75.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.719 0.771 . . . . 0.0 110.334 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.759 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -68.85 -13.14 62.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.974 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -75.46 -12.77 60.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.457 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.405 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.5 t-20 -133.9 60.46 45.69 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 24.1 Cg_exo -68.84 105.24 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.549 1.499 . . . . 0.0 111.497 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.937 ' HG3' HH22 ' A' ' 108' ' ' ARG . 18.2 tpt85 -87.69 88.67 7.73 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.74 HG11 HG21 ' A' ' 109' ' ' VAL . 22.6 m -92.54 124.58 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.591 HG22 ' CE2' ' A' ' 149' ' ' PHE . 98.8 m -132.8 107.78 8.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.379 0.609 . . . . 0.0 109.708 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -106.64 140.33 39.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.418 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.591 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -126.18 118.7 25.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.458 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.85 143.49 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 110.812 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.747 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 46.6 pt -131.9 177.29 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.595 ' C ' ' H ' ' A' ' 154' ' ' GLU . 3.1 p30 -97.97 94.2 6.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.313 1.054 . . . . 0.0 109.425 176.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.0 m95 -71.73 4.55 3.13 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.178 -1.373 . . . . 0.0 108.897 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 152' ' ' ASN . 16.9 mt-10 -133.29 151.93 51.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.622 -173.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.06 70.12 9.98 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.0 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.842 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.673 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.715 -0.154 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -161.43 -174.07 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 73.5 mtm -72.54 -65.35 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.6 -64.74 0.11 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.825 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 75.7 mmtt -148.44 -61.85 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 p30 13.18 -93.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 13.7 tt -62.03 -27.36 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.5 tm0? -63.84 -58.56 6.42 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 121.745 0.783 . . . . 0.0 110.196 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' A' ' 94' ' ' VAL . 1.2 mm? -64.23 -28.89 70.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.611 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . . . -62.33 -40.53 96.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.813 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -51.35 -53.88 31.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.552 ' O ' ' HB3' ' B' ' 133' ' ' GLU . 16.6 mmm180 -70.47 -25.85 63.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.87 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.516 HG12 HH12 ' A' ' 108' ' ' ARG . 5.6 mt -65.47 -39.48 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.395 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.62 31.6 5.49 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.426 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 178.67 37.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.173 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -59.5 -62.55 1.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.903 175.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.435 ' H ' ' CG ' ' B' ' 133' ' ' GLU . 0.7 OUTLIER -135.07 -31.2 1.01 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.175 -174.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.305 179.338 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' ' HE2' ' A' ' 3' ' ' LYS . 24.0 ptm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.789 0.328 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -93.22 141.58 28.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.703 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 22.0 mmtt -101.02 -9.02 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.055 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.502 HG21 ' CE2' ' A' ' 28' ' ' PHE . 2.7 t -142.95 126.96 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.417 0.627 . . . . 0.0 110.687 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.623 ' HB2' HD13 ' A' ' 31' ' ' ILE . 6.0 tp-100 -124.09 100.8 6.9 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.099 174.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.561 HG13 ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -82.48 131.43 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.127 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -115.81 -63.53 1.44 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.531 -162.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.679 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -100.07 148.88 24.07 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.852 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG13 ' OH ' ' A' ' 111' ' ' TYR . 4.3 p -146.08 102.23 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-O 121.797 0.808 . . . . 0.0 109.934 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.919 HG21 ' HB3' ' A' ' 25' ' ' GLU . 3.3 m -98.39 96.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.779 0.799 . . . . 0.0 109.804 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.813 HG13 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -74.96 129.43 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 122.017 0.913 . . . . 0.0 110.427 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 23' ' ' GLN . 1.1 mt -98.82 -36.36 9.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.455 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.699 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 16.9 t70 -68.88 39.55 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.683 170.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.655 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -79.22 172.47 9.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.3 Cg_endo -50.38 101.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 120.841 1.336 . . . . 0.0 113.006 -152.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.628 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 21.2 m -141.95 171.62 7.07 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 112.193 -2.276 . . . . 0.0 107.676 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 67.2 Cg_exo -38.22 132.65 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.484 2.123 . . . . 0.0 112.301 175.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.704 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 33.3 t80 -54.22 -28.13 39.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.868 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -86.84 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.74 0.305 . . . . 0.0 111.039 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.62 120.22 79.48 Favored Pre-proline 0 CA--C 1.513 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.691 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.4 Cg_exo -63.85 146.04 91.2 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 123.821 3.014 . . . . 0.0 113.161 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 37.8 m-85 -60.35 115.11 3.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.904 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.874 ' HB3' HD13 ' A' ' 12' ' ' LEU . 37.0 mt-30 -118.99 102.03 8.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.95 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.631 ' CD1' HD11 ' A' ' 97' ' ' ILE . 87.5 m-85 -109.65 111.4 22.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.462 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.919 ' HB3' HG21 ' A' ' 10' ' ' VAL . 30.6 tt0 -93.38 85.23 4.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.95 132.95 32.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 122.049 0.928 . . . . 0.0 112.609 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 25.5 m -104.15 107.17 17.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.173 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 27.5 p90 -117.53 148.2 42.09 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.925 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.841 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.9 tm-20 -101.94 111.33 23.55 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.4 t -72.4 108.63 5.6 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.623 HD13 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -75.03 -23.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.086 -171.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.702 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 50.3 mt-10 -155.37 148.31 24.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.62 131.47 50.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.947 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 4.7 tp -86.67 154.24 21.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.768 -168.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -113.18 -30.49 6.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.584 0.707 . . . . 0.0 110.372 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.815 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.8 tt0 -117.01 -167.51 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.815 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 4.6 p-10 -100.67 137.68 38.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.843 0.83 . . . . 0.0 111.523 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.26 122.25 27.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.112 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.9 tt0 -106.84 89.82 3.13 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.28 -176.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.614 ' O ' ' HA ' ' A' ' 59' ' ' SER . 15.1 m95 -78.0 135.8 37.85 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.7 ttmt -137.37 137.5 38.93 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.288 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.826 HG21 HG22 ' A' ' 95' ' ' VAL . 8.9 mt -102.46 110.16 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.586 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 49.9 mt -108.43 106.11 20.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.74 -172.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.85 ' CE2' HG12 ' A' ' 113' ' ' VAL . 25.3 t80 -89.49 108.53 19.7 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.867 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t -53.44 104.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.748 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.08 99.84 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.152 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.407 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 29.4 t -131.78 128.81 39.6 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.93 -5.94 48.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.978 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -100.03 -35.52 9.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 8.9 m -122.35 97.41 5.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.056 0.931 . . . . 0.0 110.059 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' CD ' HH21 ' B' ' 128' ' ' ARG . 0.0 OUTLIER -67.65 -11.08 57.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.03 -172.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.73 -12.08 60.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.651 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 16.9 m-30 -87.65 10.25 18.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.273 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 4.9 p-10 -54.93 110.3 0.64 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.092 0.949 . . . . 0.0 111.162 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 53' ' ' TYR . 4.8 mt-30 -92.7 169.95 10.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.507 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.64 112.64 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -169.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.7 mm? -76.34 -42.66 44.19 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.484 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 5.4 p-10 -170.6 173.95 5.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.489 171.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 50.8 p -145.36 117.56 8.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.63 128.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.459 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.609 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.9 mt -103.18 104.02 14.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.049 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.49 119.43 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -82.27 -151.67 9.74 Favored Glycine 0 CA--C 1.482 -1.979 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.158 -165.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.947 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 2.1 Cg_endo -46.35 117.14 1.83 Allowed 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.454 1.436 . . . . 0.0 109.144 167.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.66 120.98 15.86 Favored Pre-proline 0 C--N 1.288 -2.106 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.7 -170.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.71 130.75 41.58 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.154 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -44.61 147.21 0.63 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.832 0.708 . . . . 0.0 111.255 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.435 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 144.84 130.29 2.25 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.09 -174.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.841 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -74.43 116.97 15.71 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.789 0.804 . . . . 0.0 110.889 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.435 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 8.2 p80 -150.72 152.13 33.44 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.36 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.698 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.6 ttp -98.92 126.94 44.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.324 0.583 . . . . 0.0 111.116 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -117.95 133.18 56.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.3 p -101.95 127.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.433 1.111 . . . . 0.0 110.392 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.542 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 1.2 t80 -117.34 133.89 55.46 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.655 -1.612 . . . . 0.0 109.465 -164.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.759 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 66.8 mt-30 -151.69 150.36 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.047 0.451 . . . . 0.0 110.398 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -160.37 168.48 25.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.38 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.07 -175.32 0.07 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.844 0.831 . . . . 0.0 112.162 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -89.52 158.28 45.9 Favored Pre-proline 0 N--CA 1.438 -1.046 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.726 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.734 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 46.6 Cg_endo -65.41 168.57 14.21 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.042 2.495 . . . . 0.0 111.602 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 5.1 m-20 -79.56 115.3 52.42 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.3 Cg_endo -62.85 -19.91 69.93 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.634 2.889 . . . . 0.0 112.707 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.56 -5.06 79.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.349 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.444 HD13 ' HG2' ' A' ' 55' ' ' GLN . 9.3 mt -95.5 -27.82 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.965 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.545 HD12 ' CE1' ' A' ' 44' ' ' TYR . 11.4 mt -82.66 130.86 56.79 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 0.0 112.339 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.429 ' O ' HG23 ' A' ' 84' ' ' ILE . 5.4 Cg_endo -81.13 156.6 19.94 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.22 2.614 . . . . 0.0 111.903 170.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.721 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.9 m-20 -47.25 -49.12 24.07 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.67 76.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.521 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.5 -17.27 23.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.085 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -71.59 -45.87 60.96 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.3 0.572 . . . . 0.0 111.258 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.74 45.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.95 -173.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.74 -135.5 2.03 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.838 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.833 HG22 HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -98.94 135.27 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-O 122.164 0.983 . . . . 0.0 112.552 -170.8 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.16 167.62 24.57 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -112.83 141.96 26.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.586 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 42' ' ' ILE . 3.8 p -125.61 101.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 158.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.586 ' CD1' ' HB ' ' A' ' 43' ' ' ILE . 1.1 pp -94.62 149.34 21.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.448 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.683 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 3.2 mt -114.74 101.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.352 0.596 . . . . 0.0 109.829 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 70.7 p -98.37 116.48 30.69 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.047 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.635 ' HB2' HG21 ' A' ' 107' ' ' ILE . 58.4 m -82.31 118.23 23.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 20.8 m -106.85 128.22 54.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.761 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 65.3 t80 -132.7 121.18 22.71 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.826 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 67.65 26.17 8.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.292 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.02 6.01 82.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.414 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -116.44 115.28 25.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.083 -0.558 . . . . 0.0 109.836 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 44.0 mp0 -77.27 124.89 28.47 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.761 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 29.0 p90 -113.88 -4.2 13.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 98' ' ' THR . 7.7 tt -158.08 158.83 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.541 HH22 ' HA2' ' B' ' 132' ' ' GLY . 24.4 ttp180 -150.71 106.81 3.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.336 0.397 . . . . 0.0 110.043 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.769 HG21 HG22 ' A' ' 146' ' ' VAL . 2.2 p -91.27 99.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.544 1.164 . . . . 0.0 108.455 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.471 ' HA3' HG12 ' B' ' 130' ' ' ILE . . . -80.49 95.8 1.6 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.231 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.993 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 4.4 m-85 -93.6 109.57 21.19 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.957 0.884 . . . . 0.0 109.245 174.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.473 ' N ' ' HD1' ' A' ' 112' ' ' TYR . 2.3 m-85 -76.15 114.88 15.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.286 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.85 HG12 ' CE2' ' A' ' 44' ' ' TYR . 3.1 p -88.09 108.67 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.833 HD21 HG22 ' A' ' 92' ' ' VAL . 16.4 t-20 -95.56 103.61 15.48 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.477 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -91.97 121.41 33.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.288 0.566 . . . . 0.0 110.064 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.84 138.91 30.64 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.565 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 47.5 m-85 -48.8 156.65 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -92.12 -30.18 16.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.982 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.482 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 4.6 mm-40 -82.22 129.57 34.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.097 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.709 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.4 m -53.86 -40.83 66.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.991 0.182 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.01 -35.58 66.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.11 0.957 . . . . 0.0 110.179 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.542 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 82.4 mt -85.07 -22.0 29.13 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.785 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 47.3 mtp180 -83.17 -39.67 20.71 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.741 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 11.5 pt-20 -70.35 -31.7 69.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.725 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.741 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 1.2 p30 -147.61 82.08 8.23 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.14 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 29.5 Cg_endo -61.75 117.86 4.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.551 2.834 . . . . 0.0 112.248 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -69.04 161.05 47.44 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.915 2.41 . . . . 0.0 110.943 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.69 -25.36 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.525 ' HD3' ' HD3' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -89.7 128.38 50.73 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 121.397 0.618 . . . . 0.0 110.788 172.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.721 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 1.1 Cg_endo -82.66 141.64 11.09 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.054 3.169 . . . . 0.0 112.15 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.1 t70 -124.85 112.18 16.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.231 0.538 . . . . 0.0 109.592 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.682 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.1 m-85 -79.4 -19.77 49.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.488 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.1 p -83.31 -24.06 32.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.482 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 73.3 mmtt -98.87 11.76 37.82 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 19.9 tp -95.91 133.45 40.08 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.806 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.16 120.47 39.12 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.727 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.35 109.05 21.23 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.644 -172.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.678 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -86.2 98.5 10.95 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.094 173.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.813 HG23 HG13 ' A' ' 11' ' ' VAL . 1.4 mp -72.65 108.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.165 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.4 mt -64.51 91.81 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.222 0.534 . . . . 0.0 111.834 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.993 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -80.66 -12.19 59.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -80.14 -11.92 59.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.997 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -138.51 70.12 45.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.818 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 63.9 Cg_endo -81.83 104.97 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.207 1.272 . . . . 0.0 109.666 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 145' ' ' ARG . 0.2 OUTLIER -83.66 81.76 8.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.255 0.55 . . . . 0.0 110.532 -175.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.769 HG22 HG21 ' A' ' 109' ' ' VAL . 3.9 t -86.4 104.43 13.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.961 -174.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 149' ' ' PHE . 48.8 m -112.77 106.93 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.726 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -108.37 138.24 44.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.8 0.81 . . . . 0.0 110.891 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.411 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -122.3 136.1 54.84 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.88 -178.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.479 ' O ' ' HD2' ' A' ' 150' ' ' HIS . 0.8 OUTLIER -73.79 141.61 46.22 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.707 175.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.03 172.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.5 HD21 ' H ' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -90.94 106.33 18.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.17 0.986 . . . . 0.0 110.451 171.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.703 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 8.0 m95 -81.28 5.77 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.956 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 152' ' ' ASN . 34.2 mt-10 -130.25 -172.52 2.81 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.805 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.49 70.33 3.09 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.44 0.638 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 -178.034 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.44 48.86 1.01 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.224 0.535 . . . . 0.0 110.745 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 43.4 mtp -105.09 -64.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.149 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.63 136.61 15.16 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.284 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' B' ' 122' ' ' LYS . 11.5 mptt -91.95 -31.84 15.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.246 0.07 . . . . 0.0 110.906 -177.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -44.41 -45.16 8.85 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.321 0.388 . . . . 0.0 111.845 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 -43.07 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.257 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.5 mm100 -53.41 -54.16 40.77 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.618 0.723 . . . . 0.0 111.278 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -62.38 -37.4 85.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.481 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.96 75.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 51' ' ' GLU . 10.4 mtm180 -59.02 -47.07 86.53 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.717 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 10.8 mmm180 -60.17 -41.6 93.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.471 HG12 ' HA3' ' A' ' 110' ' ' GLY . 3.8 mp -90.45 -5.79 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -68.48 -44.83 73.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.541 ' HA2' HH22 ' A' ' 108' ' ' ARG . . . -175.46 25.65 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.36 -0.924 . . . . 0.0 113.638 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.717 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 0.4 OUTLIER -113.84 75.49 0.93 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.766 0.793 . . . . 0.0 108.873 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 19.1 mtm180 -53.46 -75.74 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.208 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.383 -177.253 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 31' ' ' ILE . 39.2 ttp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.393 0.145 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . -91.04 -62.12 1.52 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.844 ' HB3' HD21 ' A' ' 34' ' ' LEU . 10.2 mptt -100.11 -22.05 15.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.414 HG23 HD22 ' A' ' 34' ' ' LEU . 3.6 t -139.28 131.94 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.871 0.843 . . . . 0.0 110.964 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.731 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -125.67 100.14 6.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.851 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.413 HG22 ' CH2' ' A' ' 40' ' ' TRP . 11.6 t -70.79 146.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -131.16 -65.88 0.76 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.65 0.738 . . . . 0.0 109.594 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.653 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.8 t-20 -104.82 148.21 26.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.105 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -146.73 105.23 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.107 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 1.075 HG21 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -98.02 97.81 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.554 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.91 116.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.892 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.625 HD21 ' HB2' ' A' ' 25' ' ' GLU . 1.4 mm? -80.71 -31.49 36.1 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.62 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' HB3' ' CG ' ' A' ' 23' ' ' GLN . 7.3 p-10 -82.62 44.47 0.9 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.681 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HB3' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -73.59 168.61 23.91 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 159.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HG3' ' CG ' ' A' ' 138' ' ' ASN . 31.6 Cg_exo -51.47 101.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.569 0 CA-C-O 122.729 1.054 . . . . 0.0 113.3 -135.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.841 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 70.1 m -129.99 166.87 23.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.731 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 50.1 Cg_exo -46.38 133.48 15.92 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.685 174.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 1.077 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 20.2 t80 -55.4 -23.98 27.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.056 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -92.91 5.56 50.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.841 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -96.3 120.15 63.01 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 169.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 70.3 Cg_exo -55.29 144.43 71.52 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.747 2.298 . . . . 0.0 112.91 -167.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.827 ' HE1' ' HD3' ' A' ' 79' ' ' PRO . 84.3 m-85 -52.58 143.02 16.69 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.745 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.678 ' CG ' ' HB3' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -143.25 110.64 5.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.747 0.784 . . . . 0.0 109.599 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.612 ' CD1' HD13 ' A' ' 97' ' ' ILE . 81.7 m-85 -114.0 103.52 11.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.461 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.075 ' HB3' HG21 ' A' ' 10' ' ' VAL . 33.6 tt0 -84.23 85.13 7.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.721 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 4.5 mt -82.47 141.94 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.001 0.905 . . . . 0.0 113.042 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.653 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.5 m -119.51 108.8 14.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.294 171.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 17.3 p90 -117.96 146.38 44.04 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.245 0.545 . . . . 0.0 109.655 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.846 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.6 tt0 -101.89 109.36 21.09 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.696 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.9 m -72.79 119.76 17.48 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.614 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -90.2 -28.01 5.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.253 -169.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -146.69 169.06 19.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.979 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.06 127.9 34.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.965 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -81.7 155.21 25.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.158 0.504 . . . . 0.0 109.658 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.6 p -113.42 -14.36 12.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.208 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 102' ' ' ARG . 7.7 tt0 -138.64 -167.52 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.65 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.786 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 22.2 m-20 -97.74 136.38 38.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 110.872 -175.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.468 HD23 ' CZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -81.67 120.09 24.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.202 175.35 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 100' ' ' THR . 44.1 tt0 -105.65 90.12 3.3 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.093 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.721 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 31.0 m95 -74.12 109.41 7.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 0.4 OUTLIER -116.31 129.61 56.36 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -173.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.641 HG21 HG22 ' A' ' 95' ' ' VAL . 7.7 mt -102.1 115.96 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.84 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.611 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.795 ' CE2' HG13 ' A' ' 113' ' ' VAL . 26.4 t80 -84.02 119.78 25.35 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.489 HG12 HD13 ' B' ' 126' ' ' LEU . 17.6 t -70.57 97.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -85.75 -4.54 85.02 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.633 ' HB2' ' C ' ' A' ' 50' ' ' SER . 3.7 p -115.19 68.04 0.7 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.056 0.455 . . . . 0.0 111.439 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.15 -8.82 57.87 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.81 0.814 . . . . 0.0 108.834 166.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -99.17 -49.62 4.43 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.48 -1.237 . . . . 0.0 109.863 172.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.633 ' C ' ' HB2' ' A' ' 47' ' ' SER . 3.5 m -103.01 -138.88 0.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.877 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.61 3.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.502 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -97.7 -7.26 31.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 111.814 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.539 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 37.4 m-85 -94.81 -0.98 53.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -170.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 18.5 p-10 -51.51 110.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.989 0.899 . . . . 0.0 110.592 172.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 80' ' ' ASN . 18.5 mp0 -91.71 168.26 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.247 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.655 HG13 ' CE ' ' A' ' 41' ' ' LYS . 2.5 t -126.09 110.86 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.193 -173.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.565 HD22 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -82.11 -57.58 3.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -172.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 7.7 t70 -170.35 162.35 8.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.686 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 12.1 p -130.19 119.4 22.9 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.0 p -101.59 129.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.3 mt -104.85 103.32 12.89 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.455 0.645 . . . . 0.0 110.967 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.02 119.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -87.96 -136.87 5.38 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.754 -1.212 . . . . 0.0 111.922 -162.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.965 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 5.7 Cg_endo -50.32 117.02 2.84 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.231 1.954 . . . . 0.0 111.324 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.457 HG21 ' SG ' ' A' ' 30' ' ' CYS . 13.0 m -121.41 111.67 33.25 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.187 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.8 61.49 5.51 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 123.353 2.702 . . . . 0.0 114.284 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.696 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.52 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 112.797 -2.001 . . . . 0.0 112.605 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.466 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 111.14 122.96 4.34 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 175.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.846 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 5.6 ptp85 -66.65 130.93 44.81 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.858 0.837 . . . . 0.0 110.005 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.466 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -151.58 158.2 43.21 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.099 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.2 138.11 51.91 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.296 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 11.2 p90 -137.49 148.82 46.33 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.3 p -106.67 119.27 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 122.316 1.055 . . . . 0.0 110.555 -174.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.509 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -111.11 154.27 24.53 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.468 -1.696 . . . . 0.0 109.217 -168.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.686 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.0 mt-30 -151.89 160.67 43.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -168.98 145.34 3.48 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.436 ' O ' HD11 ' A' ' 57' ' ' LEU . 6.5 m-20 -59.26 -177.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 112.24 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -84.4 155.12 63.02 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.827 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -66.83 157.52 60.9 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.684 2.256 . . . . 0.0 110.856 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 94.9 m-20 -63.12 117.84 37.16 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 -170.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.87 -13.42 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.41 2.74 . . . . 0.0 112.004 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.37 -1.1 69.44 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.569 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 83' ' ' LEU . 20.7 mt -103.87 -34.09 8.64 Favored 'General case' 0 CA--C 1.514 -0.421 0 O-C-N 122.928 -0.16 . . . . 0.0 111.286 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 89' ' ' ALA . 36.4 mt -72.35 125.43 91.38 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.801 -175.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' O ' HG21 ' A' ' 84' ' ' ILE . 95.8 Cg_endo -79.26 163.14 25.19 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.788 2.992 . . . . 0.0 111.932 170.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.8 m-20 -45.43 -54.08 7.84 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.176 0.99 . . . . 0.0 113.498 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.46 -8.64 58.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.512 0.196 . . . . 0.0 111.442 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.41 -38.77 11.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.997 0.427 . . . . 0.0 110.37 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.25 -46.16 35.51 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.915 -169.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.23 46.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.34 -134.53 2.03 Favored Glycine 0 CA--C 1.497 -1.057 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.782 HG12 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -104.49 130.77 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 CA-C-O 122.261 1.029 . . . . 0.0 113.574 -170.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.614 HG23 HG11 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -143.71 173.17 11.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.051 -1.886 . . . . 0.0 105.921 173.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.624 HG12 HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.0 143.52 39.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.704 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.641 HG22 HG21 ' A' ' 42' ' ' ILE . 9.9 p -121.78 104.43 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.919 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.75 126.81 48.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.711 -169.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 39.1 mt -95.18 102.0 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.099 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 67.8 p -91.14 109.81 21.07 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.844 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.606 ' HB2' HG23 ' A' ' 107' ' ' ILE . 61.5 m -73.44 109.1 6.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.894 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 16.1 m -103.68 101.87 11.72 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.529 -174.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.502 ' CE1' HD13 ' A' ' 34' ' ' LEU . 71.4 t80 -107.6 118.51 36.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 41.0 mtp180 72.97 19.63 3.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.96 0.504 . . . . 0.0 111.667 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.81 5.29 74.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.198 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.639 HE22 ' ND2' ' A' ' 152' ' ' ASN . 2.5 pt20 -120.65 127.96 52.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.54 ' OE2' ' HB1' ' B' ' 135' ' ' ALA . 4.0 mp0 -84.18 135.55 34.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.46 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.468 ' CZ ' HD23 ' A' ' 38' ' ' LEU . 54.5 p90 -122.04 -1.5 9.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.77 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.1 tt -157.69 162.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.743 ' HG3' HG22 ' A' ' 98' ' ' THR . 9.0 ttm180 -149.2 99.39 2.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.919 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.25 100.55 8.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.823 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.61 79.58 1.74 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 119.413 -1.375 . . . . 0.0 111.116 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.89 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.7 m-85 -71.22 114.43 9.27 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.584 ' CE2' HD23 ' B' ' 126' ' ' LEU . 2.7 m-85 -66.59 110.84 3.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.795 HG13 ' CE2' ' A' ' 44' ' ' TYR . 2.8 p -92.53 109.99 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.782 ' ND2' HG12 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -95.82 108.13 20.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.499 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.67 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.3 m-80 -97.77 121.44 39.68 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.347 0.594 . . . . 0.0 110.086 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.86 140.36 32.88 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.855 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 46.5 m-85 -46.52 151.91 0.51 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.9 p -93.29 -29.92 15.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.345 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 70.5 mm-40 -76.37 125.56 29.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.603 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 16.7 m -55.72 -32.08 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.401 -172.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.45 -39.15 77.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.506 0.67 . . . . 0.0 110.013 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 81.8 mt -73.32 -23.69 60.28 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.626 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 22.0 mtt180 -74.45 -36.67 63.38 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 120' ' ' THR . 11.4 mm-40 -67.85 -44.23 77.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.776 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.6 p30 -138.13 82.05 25.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.729 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.4 Cg_endo -57.56 113.64 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.09 2.527 . . . . 0.0 111.579 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.79 154.15 74.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.666 2.244 . . . . 0.0 111.593 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.1 p -46.76 -50.23 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 123.725 0.641 . . . . 0.0 112.428 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.7 mmtt -84.39 129.13 59.0 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 121.37 0.605 . . . . 0.0 111.055 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.651 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -72.06 125.18 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.653 2.902 . . . . 0.0 111.786 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -104.3 108.82 20.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.596 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 27.2 m-85 -77.91 -17.4 57.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.154 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 72.6 p -88.31 -15.07 36.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.911 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.1 mmtt -107.05 13.0 27.97 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 18.3 tp -95.93 143.41 27.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.0 -172.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -124.29 124.05 41.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 1.077 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 25.7 mtm-85 -87.92 104.15 16.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.784 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.598 ' CG ' ' HG3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -90.34 89.38 7.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 113' ' ' VAL . 1.3 mp -66.44 109.08 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 112' ' ' TYR . 89.6 mt -69.2 88.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.721 0.772 . . . . 0.0 110.433 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.89 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.63 -12.99 60.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.579 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.1 p -78.84 -12.01 60.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.72 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.47 64.21 57.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.661 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 98.6 Cg_endo -85.76 103.96 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.357 1.371 . . . . 0.0 109.902 172.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.607 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -84.47 80.35 9.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.306 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.649 HG12 HG23 ' A' ' 109' ' ' VAL . 26.7 m -76.88 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.739 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.52 HG22 ' CE1' ' A' ' 149' ' ' PHE . 97.7 m -138.82 107.56 5.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.467 0.651 . . . . 0.0 109.286 173.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 4.2 ptt180 -108.95 142.82 39.04 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.958 0.885 . . . . 0.0 111.321 -175.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.52 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -125.04 169.32 12.25 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.199 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.475 ' HD2' ' O ' ' A' ' 150' ' ' HIS . 1.1 p-80 -93.59 149.69 21.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.291 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.542 ' HB ' ' OE1' ' A' ' 104' ' ' GLN . 45.3 pt -142.29 168.33 14.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.639 ' ND2' HE22 ' A' ' 104' ' ' GLN . 3.2 p30 -96.55 89.84 5.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.313 1.054 . . . . 0.0 109.979 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.828 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 8.1 m95 -64.43 -1.57 1.81 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.681 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.581 ' H ' ' C ' ' A' ' 152' ' ' ASN . 41.9 mt-10 -135.02 161.58 34.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.26 -167.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -83.68 70.18 10.28 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.152 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.638 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.23 91.4 1.67 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 111.934 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 68.6 mtm -133.93 -66.34 0.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -116.78 136.79 13.02 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.876 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.627 ' HG3' HG23 ' A' ' 92' ' ' VAL . 9.8 mmtp -66.31 -34.48 78.09 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.527 ' HA ' ' HH ' ' A' ' 112' ' ' TYR . 1.6 m-20 -43.06 -58.13 2.58 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.928 0.768 . . . . 0.0 112.05 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 8.1 tp -65.98 -37.75 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -60.46 -52.7 64.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.262 0.554 . . . . 0.0 110.509 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.615 HD21 ' O ' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -65.42 -44.12 88.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.032 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -40.49 82.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.29 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -59.31 -46.19 89.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 110.833 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.814 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 11.6 tpt180 -63.5 -39.15 93.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.607 HD13 ' HB3' ' A' ' 145' ' ' ARG . 31.0 mt -76.44 -43.61 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.544 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -61.29 -30.13 70.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.52 72.86 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.795 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.814 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 36.1 tt0 -131.24 -28.48 1.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.191 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.417 ' HD3' ' C ' ' B' ' 134' ' ' ARG . 3.3 tmt_? -56.53 -52.97 62.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.54 ' HB1' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . 0 C--O 1.248 0.986 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.733 0.301 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -83.87 137.95 33.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.664 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.45 -18.01 27.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 -177.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 34' ' ' LEU . 2.7 t -139.97 139.4 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.482 0.658 . . . . 0.0 111.101 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.635 ' HB2' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -140.39 102.82 4.43 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.894 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 2.9 m -72.66 149.66 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.789 175.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.14 -63.02 1.02 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.447 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.603 HD21 ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.31 112.41 25.51 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.244 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.603 ' N ' HD21 ' A' ' 8' ' ' ASN . 8.2 p -96.83 109.49 23.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -106.48 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 122.368 1.08 . . . . 0.0 108.965 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG12 ' CD2' ' A' ' 24' ' ' PHE . 18.4 m -77.29 123.15 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.333 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.5 mt -89.63 -47.35 8.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.672 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.634 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 8.2 t0 -66.2 83.0 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.367 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.776 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -100.7 174.4 2.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.31 -1.768 . . . . 0.0 107.021 164.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.872 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 3.2 Cg_endo -49.44 102.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.274 1.491 . . . . 0.0 113.123 -151.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.645 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 20.1 m -129.9 170.54 10.73 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 112.587 -2.097 . . . . 0.0 108.886 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.0 Cg_exo -40.77 139.49 1.29 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.888 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.722 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 44.7 t80 -68.36 -10.29 53.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -96.32 8.26 44.4 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.561 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -95.88 126.11 46.15 Favored Pre-proline 0 CA--C 1.508 -0.672 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 169.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 77' ' ' ASP . 27.5 Cg_exo -64.97 154.09 75.03 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.254 2.636 . . . . 0.0 112.519 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HE2' HH21 ' A' ' 137' ' ' ARG . 25.4 m-85 -65.28 128.41 35.74 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.256 174.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.675 ' HA ' ' HG2' ' A' ' 75' ' ' GLN . 33.1 mt-30 -125.76 102.74 7.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.798 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.577 ' CD2' HG12 ' A' ' 11' ' ' VAL . 50.6 m-85 -105.77 144.92 31.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.726 ' HG3' ' HE2' ' A' ' 71' ' ' MET . 26.7 tt0 -118.78 88.29 2.9 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 168.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD13 HD13 ' A' ' 97' ' ' ILE . 43.2 mt -84.51 119.52 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.939 0.876 . . . . 0.0 111.67 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 20.0 m -100.16 105.15 16.72 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.415 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 32.8 p90 -118.32 150.75 38.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.853 0.835 . . . . 0.0 110.343 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.86 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.8 tt0 -108.65 116.22 31.57 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.636 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.668 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 47.7 t -73.16 117.02 14.39 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -83.16 -28.85 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.832 -171.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.664 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 4.6 mt-10 -150.07 147.63 28.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.55 134.54 46.53 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.665 0.269 . . . . 0.0 111.238 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.781 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -94.31 157.79 15.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.288 -170.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.6 m -112.59 -39.58 4.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.037 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.828 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.6 tt0 -119.44 -168.28 1.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.297 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.828 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 3.2 m-20 -93.69 136.88 33.53 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.391 0.615 . . . . 0.0 110.205 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mm? -83.73 127.09 33.53 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.787 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 57.8 tt0 -116.68 90.23 3.29 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.628 -173.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.688 ' HZ3' HG22 ' A' ' 107' ' ' ILE . 35.7 m95 -84.21 133.65 34.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.754 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.5 ttmt -129.84 144.76 51.47 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.935 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.913 HG21 HD21 ' A' ' 57' ' ' LEU . 44.2 mm -102.02 107.45 21.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -102.13 113.6 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.831 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.441 ' HA ' HG11 ' A' ' 95' ' ' VAL . 34.4 t80 -95.16 122.24 37.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.111 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.786 HG11 ' CE2' ' A' ' 53' ' ' TYR . 4.8 t -72.51 98.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.698 0.761 . . . . 0.0 109.489 171.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.669 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -72.38 -55.13 7.07 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.383 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.579 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 44.4 m -119.8 73.17 0.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.7 0.4 . . . . 0.0 110.55 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -49.69 -19.06 0.55 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.337 0.589 . . . . 0.0 111.927 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' OE2' ' HE2' ' B' ' 122' ' ' LYS . 1.5 tp10 -71.46 -19.29 62.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.043 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.614 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 39.9 m -117.04 -151.2 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.785 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 8.5 pt-20 -154.25 19.01 0.49 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.669 0.747 . . . . 0.0 111.267 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' OE1' ' HB3' ' A' ' 50' ' ' SER . 2.0 mp0 -98.18 -36.97 9.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.827 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.786 ' CE2' HG11 ' A' ' 45' ' ' VAL . 10.7 p90 -54.65 -41.79 70.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.593 -169.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 9.8 p-10 -30.71 105.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.212 0 O-C-N 125.134 1.521 . . . . 0.0 112.546 -165.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.697 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 24.0 mt-30 -95.12 165.86 12.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.905 -168.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -120.15 108.96 24.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.148 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.913 HD21 HG21 ' A' ' 42' ' ' ILE . 6.6 mp -73.31 -40.7 64.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.602 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -176.53 165.83 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.073 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.9 p -144.63 123.85 12.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.9 p -100.42 136.26 32.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.788 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.695 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.5 mt -110.71 105.72 14.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.023 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 89.3 t -96.4 118.15 42.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.35 -160.39 10.11 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.56 -165.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.781 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.7 Cg_endo -67.9 115.28 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.397 1.398 . . . . 0.0 110.231 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.473 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 34.1 m -124.99 141.18 37.69 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.185 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -83.26 77.31 3.58 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 122.48 2.12 . . . . 0.0 113.575 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.668 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 44.98 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.012 -1.903 . . . . 0.0 112.357 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.39 139.43 9.77 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.496 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.86 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttt180 -77.69 116.88 18.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.797 0.808 . . . . 0.0 110.091 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -128.68 122.07 29.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.18 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.726 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -83.59 121.27 27.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.641 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.7 p90 -120.66 160.08 24.01 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.1 133.83 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 121.911 0.863 . . . . 0.0 110.093 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.641 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 2.7 t80 -135.44 107.57 7.19 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.951 -161.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.675 ' HG2' ' HA ' ' A' ' 23' ' ' GLN . 77.3 mt-30 -124.19 155.13 39.05 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.94 134.58 10.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.183 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 2.6 t0 -65.48 171.84 3.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.481 ' HB1' HH12 ' A' ' 137' ' ' ARG . . . -69.87 159.77 82.79 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.658 . . . . 0.0 111.304 -171.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HD2' HH22 ' A' ' 137' ' ' ARG . 56.6 Cg_endo -66.75 172.87 8.86 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.343 2.696 . . . . 0.0 111.449 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 10.0 m-80 -70.97 121.37 83.87 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.014 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.5 Cg_endo -63.57 -12.84 33.06 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.154 2.569 . . . . 0.0 110.944 175.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.48 -19.18 46.04 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.714 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 12.4 mt -94.61 -1.56 53.02 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.577 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 24.8 mt -100.7 125.92 37.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.913 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 86.0 Cg_endo -79.28 158.76 26.29 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.017 2.478 . . . . 0.0 111.145 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.634 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 9.1 m-20 -47.53 -47.02 28.08 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.99 -37.21 47.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.798 175.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -68.68 -47.43 66.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.064 -167.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.93 46.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-O 122.208 1.004 . . . . 0.0 110.396 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.88 -139.44 2.66 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.654 -163.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.717 HG11 ' HB2' ' B' ' 122' ' ' LYS . 12.4 p -122.44 145.73 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 121.875 0.845 . . . . 0.0 110.366 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.765 HG22 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -160.66 174.36 14.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' B' ' 126' ' ' LEU . 1.9 t -132.16 144.38 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.882 0.372 . . . . 0.0 111.686 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 29.3 m -124.74 105.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.4 pp -103.5 145.06 30.57 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.163 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 46.1 mt -102.83 100.77 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.615 0.722 . . . . 0.0 109.235 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.85 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 80.8 p -99.8 114.37 27.48 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.702 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.637 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 4.6 t -80.83 158.79 25.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.867 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -148.44 109.17 4.22 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -165.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.642 ' CE1' ' HA ' ' A' ' 153' ' ' TRP . 56.1 t80 -124.0 120.83 33.58 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.512 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 43.1 mtp180 66.76 25.85 9.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.275 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.62 11.74 73.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.455 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.37 131.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.137 0.494 . . . . 0.0 110.078 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.654 ' HB2' ' HB2' ' B' ' 134' ' ' ARG . 37.2 mp0 -86.7 125.5 33.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.501 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.557 ' CD1' HD11 ' A' ' 151' ' ' ILE . 54.8 p90 -119.82 2.58 11.08 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -168.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.85 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.0 tt -156.35 154.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.832 HH21 HG22 ' A' ' 147' ' ' THR . 0.3 OUTLIER -153.6 108.17 3.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -177.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 4.2 p -97.39 100.64 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 122.16 0.981 . . . . 0.0 109.26 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -83.43 84.11 1.58 Allowed Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.616 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.9 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 6.3 m-85 -80.52 116.17 20.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.126 . . . . 0.0 109.109 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -68.4 135.99 52.61 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 93' ' ' THR . 4.1 p -121.25 111.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 108.826 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -96.34 120.45 36.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.968 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 49.2 m-80 -100.42 118.82 37.44 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.535 0.683 . . . . 0.0 109.413 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.62 131.04 42.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.694 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.676 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 20.2 m-85 -43.88 151.48 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -92.56 -29.47 16.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.003 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 14.3 mm-40 -84.18 128.57 34.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.952 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.707 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.2 m -48.41 -45.96 36.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.048 0.218 . . . . 0.0 111.344 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.61 -31.38 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.766 0.793 . . . . 0.0 110.423 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.676 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 83.4 mt -84.6 -25.52 28.56 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.326 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 63.4 mtp180 -81.1 -36.63 30.14 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 120' ' ' THR . 9.6 pt-20 -74.01 -36.49 64.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.117 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.643 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.6 OUTLIER -142.88 80.58 13.73 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.096 176.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 19.0 Cg_endo -57.36 119.49 6.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.408 2.739 . . . . 0.0 112.045 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 16.8 Cg_exo -69.57 163.12 39.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.966 2.444 . . . . 0.0 111.737 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.29 -45.6 89.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 2.1 mmtt -89.5 129.87 45.61 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 121.385 0.612 . . . . 0.0 110.989 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.634 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_endo -79.21 147.72 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.966 3.111 . . . . 0.0 112.248 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.8 t0 -116.64 111.63 20.12 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.722 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 13.0 m-85 -77.92 -13.46 59.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.049 0.928 . . . . 0.0 109.659 -173.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -87.35 -24.05 24.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.186 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . 74.8 mmtt -98.92 9.6 43.15 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.483 HD12 ' HB3' ' A' ' 115' ' ' ASN . 19.7 tp -94.36 144.86 25.18 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.535 -172.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.519 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 1.1 tt0 -128.82 126.13 39.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.584 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.872 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -90.49 105.79 18.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.74 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.652 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.2 t30 -95.15 108.39 20.5 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.639 0.733 . . . . 0.0 109.434 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 139' ' ' ILE . 1.3 mp -85.19 109.71 18.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.058 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.58 85.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.673 . . . . 0.0 110.178 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.9 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.454 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.4 p -72.77 -16.36 61.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.11 68.67 76.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 46.1 Cg_endo -92.03 104.95 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.954 1.769 . . . . 0.0 110.327 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 18.4 tpt180 -85.98 92.5 8.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.16 0.505 . . . . 0.0 110.482 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.599 HG12 HG23 ' A' ' 109' ' ' VAL . 29.7 m -86.33 129.79 37.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.516 0.674 . . . . 0.0 111.446 -175.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.832 HG22 HH21 ' A' ' 108' ' ' ARG . 21.1 m -140.86 107.46 5.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.706 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -110.78 130.05 55.68 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.607 0.717 . . . . 0.0 110.701 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.05 142.55 46.83 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.922 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 137.18 42.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 110.892 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 101' ' ' TYR . 46.4 pt -131.74 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 92.56 7.8 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.038 0.923 . . . . 0.0 111.479 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.642 ' HA ' ' CE1' ' A' ' 101' ' ' TYR . 19.2 m95 -77.3 0.92 20.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.445 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.454 ' CG ' HD21 ' A' ' 156' ' ' ASN . 6.7 pt-20 -104.0 168.71 8.94 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.778 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -96.76 67.95 2.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.094 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.454 HD21 ' CG ' ' A' ' 154' ' ' GLU . 5.3 p30 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.51 163.48 16.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 58.9 ttp -61.04 -75.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 110.325 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.673 ' O ' HG13 ' A' ' 92' ' ' VAL . . . -128.39 37.41 2.27 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.717 ' HB2' HG11 ' A' ' 92' ' ' VAL . 22.1 mmtp 65.12 -25.84 0.09 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.729 1.212 . . . . 0.0 112.518 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' B' ' 121' ' ' GLY . 0.9 OUTLIER -11.85 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 166.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.33 -36.2 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 17.4 mm100 -58.21 -52.37 65.86 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.92 0.867 . . . . 0.0 110.663 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.53 ' O ' HG13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -62.74 -40.88 98.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.042 177.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' B' ' 131' ' ' ARG . . . -63.24 -26.05 68.61 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.339 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 63.9 mtp85 -64.01 -52.05 61.36 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.819 0.343 . . . . 0.0 110.196 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.641 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 0.2 OUTLIER -62.35 -36.86 83.53 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.759 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 49.4 mt -85.12 -3.01 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.863 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . 0.54 ' CZ ' ' HA ' ' B' ' 131' ' ' ARG . 1.4 tpm_? -90.97 -40.63 11.57 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.18 -0.95 . . . . 0.0 109.995 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 170.0 54.43 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.291 -1.433 . . . . 0.0 113.18 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.641 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 2.8 tp10 -88.5 -52.07 5.37 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.471 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 38.5 ptt180 44.18 115.83 0.0 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-O 123.382 1.563 . . . . 0.0 115.162 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.283 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.567 -176.378 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 150' ' ' HIS . 13.7 ptp . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' A' ' 31' ' ' ILE . . . -86.29 126.79 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.857 0.361 . . . . 0.0 110.74 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.679 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.07 -8.48 39.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.809 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.752 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 1.5 t -147.28 140.78 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.389 0.614 . . . . 0.0 110.999 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.657 ' HB2' HD12 ' A' ' 31' ' ' ILE . 22.9 tp60 -136.85 99.95 4.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.653 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.741 ' CG1' ' HB3' ' A' ' 28' ' ' PHE . 5.1 m -72.05 145.25 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.262 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -125.93 -62.05 1.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.931 -165.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.6 t-20 -102.9 152.51 21.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.832 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' H ' ' ND2' ' A' ' 8' ' ' ASN . 2.8 p -145.45 99.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 1.075 HG21 ' HB2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -88.71 99.5 9.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.825 -174.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.734 HG12 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.43 118.42 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.897 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.71 HD21 ' HG3' ' A' ' 25' ' ' GLU . 2.8 mt -88.79 -45.28 9.89 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.154 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.666 ' OD2' ' HD3' ' A' ' 137' ' ' ARG . 2.9 t70 -74.31 72.3 1.78 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.12 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.886 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.7 m120 -84.07 174.84 5.32 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.719 -2.037 . . . . 0.0 107.801 162.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.886 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.0 Cg_endo -49.12 102.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 CA-C-N 120.912 1.362 . . . . 0.0 113.176 -149.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.836 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 67.7 m -129.93 168.43 16.65 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.535 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.8 Cg_exo -43.17 132.69 6.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.417 2.078 . . . . 0.0 112.622 174.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.689 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 65.2 t80 -61.51 -9.14 5.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -95.76 -1.66 49.34 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.725 -0.61 . . . . 0.0 112.226 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.836 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.2 OUTLIER -97.04 134.85 22.38 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.2 Cg_exo -65.11 151.74 84.61 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.271 2.647 . . . . 0.0 113.007 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 27.5 m-85 -62.97 118.8 8.31 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.204 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.621 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 7.8 mt-30 -115.79 111.89 21.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.459 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CD1' HD13 ' A' ' 97' ' ' ILE . 93.9 m-85 -116.0 155.34 28.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.142 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.075 ' HB2' HG21 ' A' ' 10' ' ' VAL . 43.4 mt-10 -126.78 91.07 3.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 162.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.571 HD11 HD11 ' A' ' 97' ' ' ILE . 10.6 mt -77.2 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.8 m -111.19 107.18 16.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.303 176.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.741 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -113.54 150.35 33.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 CA-C-O 122.153 0.977 . . . . 0.0 111.131 176.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.86 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.9 tt0 -103.51 105.63 15.93 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 172.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.6 m -70.57 126.44 29.63 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -87.04 -25.71 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -165.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.679 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 44.6 mt-10 -147.47 167.9 23.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.908 174.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -74.72 142.42 44.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.941 HD12 ' HE1' ' A' ' 101' ' ' TYR . 0.4 OUTLIER -107.21 156.38 18.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.879 -168.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.549 ' N ' HD13 ' A' ' 34' ' ' LEU . 15.2 m -115.38 -35.99 4.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.694 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 23.1 tt0 -104.3 -166.32 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -172.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.694 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.3 p-10 -101.19 138.67 37.91 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 121.641 -0.662 . . . . 0.0 111.416 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.74 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.45 128.99 35.22 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.19 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 32.7 tt0 -104.03 90.4 3.59 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.616 ' CZ3' HG11 ' A' ' 6' ' ' VAL . 14.8 m95 -86.84 109.5 19.33 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 1.056 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.4 OUTLIER -118.51 160.26 22.06 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.992 173.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.865 HD11 ' HB3' ' A' ' 76' ' ' ALA . 48.8 mt -101.68 108.71 24.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.713 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 2.2 mp -98.2 105.62 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.801 ' CE1' HG11 ' A' ' 113' ' ' VAL . 40.4 t80 -90.67 109.07 20.25 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG12 HD22 ' B' ' 126' ' ' LEU . 40.5 t -65.19 98.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.497 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.34 42.75 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 171.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.765 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 16.8 p -85.63 87.5 7.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.982 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.1 -13.89 51.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -100.49 -36.6 9.14 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.439 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.663 ' C ' ' HB2' ' A' ' 47' ' ' SER . 50.6 m -103.64 -154.45 0.5 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.39 5.07 0.45 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -94.92 -8.25 37.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.765 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 19.5 m-85 -98.18 11.07 39.0 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -170.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -64.32 99.08 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.082 0.944 . . . . 0.0 110.314 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -95.76 169.64 9.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.511 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 41' ' ' LYS . 23.5 t -127.94 112.42 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -172.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.538 HD11 ' O ' ' A' ' 77' ' ' ASP . 3.3 mm? -77.51 -52.04 9.74 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.863 -175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 35.0 t70 -168.46 153.8 6.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.061 173.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 1.056 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 21.3 p -124.79 120.46 31.8 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG11 ' HD1' ' A' ' 40' ' ' TRP . 4.4 p -101.87 139.06 23.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.736 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.74 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.61 105.35 14.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.293 0.568 . . . . 0.0 111.601 -173.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 21.9 t -116.24 110.84 32.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.567 ' O ' HG11 ' A' ' 65' ' ' VAL . . . -97.48 -112.63 3.03 Favored Glycine 0 CA--C 1.487 -1.711 0 C-N-CA 118.665 -1.731 . . . . 0.0 113.417 -159.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.871 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 17.5 Cg_endo -58.71 115.9 2.87 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 121.071 1.181 . . . . 0.0 109.961 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 63' ' ' GLY . 27.5 m -130.31 122.38 19.99 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.987 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.88 126.84 18.15 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.999 1.799 . . . . 0.0 111.021 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -41.02 134.14 2.05 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.05 0.844 . . . . 0.0 112.004 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 136.41 135.16 3.38 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.86 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.3 ptt180 -66.28 139.1 58.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.604 0.716 . . . . 0.0 110.46 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 11.0 p80 -166.39 151.23 7.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.392 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.644 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 2.1 ttp -107.9 137.81 45.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.341 0.591 . . . . 0.0 111.627 -174.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.3 p90 -125.69 150.67 47.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.727 HG21 ' HG2' ' A' ' 25' ' ' GLU . 7.5 p -105.37 135.12 44.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.8 0.81 . . . . 0.0 110.754 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.66 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.7 t80 -135.47 118.95 16.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.449 -166.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -130.35 154.29 47.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.51 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.865 ' HB3' HD11 ' A' ' 42' ' ' ILE . . . -155.33 153.33 30.34 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.538 ' O ' HD11 ' A' ' 57' ' ' LEU . 10.0 p-10 -64.35 -171.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.933 0.873 . . . . 0.0 113.137 -170.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -86.09 142.96 36.55 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.299 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.689 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.7 Cg_exo -57.76 149.36 69.25 Favored 'Trans proline' 0 CA--C 1.502 -1.123 0 C-N-CA 124.116 3.21 . . . . 0.0 112.824 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 9.8 t-20 -59.56 119.01 36.24 Favored Pre-proline 0 N--CA 1.428 -1.538 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.367 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.19 -10.99 22.97 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.996 2.464 . . . . 0.0 111.498 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.09 -8.81 58.7 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 33.7 mt -96.82 -17.38 20.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.549 0.214 . . . . 0.0 111.555 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 25.3 mt -88.48 129.29 49.78 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.293 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 2.5 Cg_endo -77.5 146.68 24.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.652 2.902 . . . . 0.0 111.625 170.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.66 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 3.1 m-20 -47.75 -40.3 20.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.278 1.431 . . . . 0.0 113.621 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.85 -29.95 58.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.605 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 29.8 m-20 -89.16 -21.58 23.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.807 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.34 -49.36 19.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 121.086 0.47 . . . . 0.0 111.86 -174.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.41 47.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.598 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.73 -128.89 1.13 Allowed Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.194 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.668 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.04 138.28 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.476 ' OG1' HG12 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -147.64 166.26 27.94 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.72 HG12 HD23 ' A' ' 96' ' ' LEU . 5.5 t -126.77 131.85 70.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.049 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.626 HG23 HG23 ' A' ' 42' ' ' ILE . 2.1 p -106.23 106.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.272 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.837 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -104.2 132.74 50.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 -174.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.635 ' HB ' HG11 ' A' ' 109' ' ' VAL . 50.8 mt -94.48 102.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.77 HG21 ' HG3' ' A' ' 108' ' ' ARG . 17.8 p -95.73 109.47 21.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.927 ' SG ' HG21 ' A' ' 107' ' ' ILE . 3.2 m -81.02 111.98 17.99 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.65 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 19.3 m -108.7 111.88 23.89 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.421 -170.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.941 ' HE1' HD12 ' A' ' 34' ' ' LEU . 60.8 t80 -117.49 120.67 38.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.698 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 54.7 mtp180 67.87 25.12 7.9 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.204 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.46 8.45 87.04 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -113.06 115.05 27.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.844 -0.678 . . . . 0.0 109.373 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 28.2 mp0 -78.99 118.64 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.679 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 36.3 p90 -105.63 -5.85 19.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.927 HG21 ' SG ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -160.57 161.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 121.433 -0.792 . . . . 0.0 109.584 173.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.77 ' HG3' HG21 ' A' ' 98' ' ' THR . 12.2 ttm180 -149.48 97.6 2.66 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.837 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -86.48 100.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.696 175.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 83.83 1.59 Allowed Glycine 0 CA--C 1.488 -1.633 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.227 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.895 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -76.13 118.13 18.56 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.78 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 140' ' ' LEU . 4.2 m-85 -68.28 115.54 7.84 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.53 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.801 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.0 p -101.99 112.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.668 ' ND2' HG13 ' A' ' 92' ' ' VAL . 1.7 t-20 -95.39 126.13 40.48 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.274 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 55.5 m-80 -113.33 108.47 17.28 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.929 0.871 . . . . 0.0 109.107 -169.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -125.18 137.94 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.042 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 39.7 m-85 -51.59 149.38 4.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 42.7 p -100.4 -24.24 14.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.495 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.826 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 18.7 mm-40 -81.28 120.49 24.98 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.743 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.498 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 29.1 m -45.94 -40.65 10.56 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.83 0.706 . . . . 0.0 112.058 -169.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.32 -37.49 77.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.351 0.596 . . . . 0.0 110.372 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -71.2 -28.68 64.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.094 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 51.5 mtt180 -70.02 -42.04 73.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.2 mm-40 -58.02 -42.84 86.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.039 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 4.1 p30 -152.17 87.66 4.23 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.68 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.6 Cg_endo -56.24 115.71 2.66 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.435 2.757 . . . . 0.0 112.509 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.19 151.25 85.76 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.76 2.307 . . . . 0.0 111.282 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.9 -27.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.679 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -91.63 127.58 49.79 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.626 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.66 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.0 Cg_exo -77.29 127.79 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.764 2.976 . . . . 0.0 111.556 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' A' ' 134' ' ' LYS . 10.2 t70 -111.8 108.68 18.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.653 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 22.5 m-85 -77.19 -16.42 59.1 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.086 -171.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.5 t -82.62 -19.93 37.35 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.334 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.826 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.0 mmtt -107.33 15.08 25.36 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.484 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 16.3 tp -98.1 149.99 21.91 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.115 -171.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 1.6 tt0 -127.88 121.5 30.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.852 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -84.02 104.0 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 14.6 t30 -92.91 103.48 15.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.734 HG23 HG12 ' A' ' 11' ' ' VAL . 1.4 mp -81.79 104.15 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 112' ' ' TYR . 85.1 mt -64.74 86.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.686 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.895 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -71.83 -11.56 60.86 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.06 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -22.83 60.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.988 173.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -129.69 71.15 82.17 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.312 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.68 104.78 1.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.473 1.449 . . . . 0.0 109.933 167.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.579 ' HB3' HD12 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -81.15 81.68 7.28 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.638 HG12 HG21 ' A' ' 109' ' ' VAL . 16.1 m -81.94 117.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.299 0.571 . . . . 0.0 110.864 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.461 HG22 ' CE2' ' A' ' 149' ' ' PHE . 21.7 m -126.02 106.32 9.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.721 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -114.74 146.16 41.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.258 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.461 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.41 170.4 14.23 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.885 -173.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.468 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 13.7 m170 -103.74 115.04 29.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.246 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.9 pt -119.39 166.66 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.539 ' H ' HD21 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -95.51 100.26 12.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.548 1.166 . . . . 0.0 111.013 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.752 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 19.4 m95 -73.01 -6.65 46.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.896 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 154' ' ' GLU . 1.0 OUTLIER -131.47 160.33 35.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.068 -174.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -94.17 65.87 3.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.408 178.2 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.52 -98.64 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.706 0.253 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 7.8 tpt 63.6 153.52 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.51 0.671 . . . . 0.0 111.954 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.31 168.94 45.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.541 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.5 mmtt -127.79 -61.1 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.989 0.394 . . . . 0.0 110.363 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.11 -52.28 21.11 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.63 0.581 . . . . 0.0 111.806 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.49 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 9.7 tt -63.95 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.699 0.285 . . . . 0.0 111.186 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' B' ' 125' ' ' GLN . 9.0 mm100 -63.88 -47.86 78.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.263 0.554 . . . . 0.0 111.029 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.576 HD22 HG12 ' A' ' 45' ' ' VAL . 43.3 mt -65.24 -46.17 81.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.825 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.18 -40.72 77.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.971 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 57.1 mtp180 -52.41 -52.59 53.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 111.457 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.668 ' HD2' ' HB3' ' B' ' 133' ' ' GLU . 12.9 tpt180 -62.68 -37.48 86.6 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.596 -173.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 145' ' ' ARG . 13.0 mt -74.11 -51.6 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.073 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -50.27 -37.35 35.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.505 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.555 ' HA2' ' NH1' ' A' ' 108' ' ' ARG . . . 154.09 64.16 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.673 176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.668 ' HB3' ' HD2' ' B' ' 129' ' ' ARG . 4.9 tp10 -100.72 -43.01 6.27 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.319 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -59.4 2.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.557 ' C ' HH22 ' A' ' 108' ' ' ARG . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 117.459 -1.257 . . . . 0.0 108.614 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.741 0.305 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.454 ' HB3' HD11 ' A' ' 31' ' ' ILE . . . -84.45 135.56 34.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.896 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.86 -17.33 28.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.28 -178.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.563 HG23 HD21 ' A' ' 34' ' ' LEU . 3.2 t -140.62 129.75 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.733 . . . . 0.0 111.289 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.43 ' HB2' HD12 ' A' ' 31' ' ' ILE . 23.0 tp60 -121.99 99.05 6.23 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 171.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.724 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -77.4 143.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.518 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -123.77 -65.98 1.03 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.173 -164.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.663 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -104.4 152.3 22.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.471 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.77 99.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 1.045 HG21 ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.3 101.38 12.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.826 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.662 HG13 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -76.96 115.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.042 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.571 HD11 HG23 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -88.51 -38.72 14.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.524 -175.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.624 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.97 79.44 0.91 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.559 168.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.615 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -106.14 176.02 1.85 Allowed Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 111.371 -2.649 . . . . 0.0 106.38 170.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.846 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.1 Cg_endo -48.65 102.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.892 1.711 . . . . 0.0 113.291 -154.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.9 m -137.04 171.87 7.88 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 111.926 -2.397 . . . . 0.0 108.593 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 56.1 Cg_exo -39.94 139.09 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.828 2.352 . . . . 0.0 112.25 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.794 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 35.7 t80 -60.16 -27.57 67.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.705 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -83.58 -13.7 53.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.286 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -62.28 128.05 90.58 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.655 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.3 Cg_exo -68.0 153.82 74.22 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 123.772 2.981 . . . . 0.0 113.266 -172.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 19.6 m-85 -65.26 122.68 17.68 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.061 0.458 . . . . 0.0 109.961 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.748 ' HA ' ' HG3' ' A' ' 75' ' ' GLN . 19.7 mt-30 -127.07 92.91 3.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.48 -172.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.565 ' CD1' HD13 ' A' ' 97' ' ' ILE . 92.2 m-85 -103.39 126.07 50.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.045 ' HB3' HG21 ' A' ' 10' ' ' VAL . 32.7 tt0 -105.44 87.25 2.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.735 HG22 ' CZ3' ' A' ' 40' ' ' TRP . 3.3 mt -80.04 133.02 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.85 0.833 . . . . 0.0 112.192 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.1 m -109.73 104.74 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.193 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.724 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 17.8 p90 -118.3 146.44 44.32 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.899 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.6 tt0 -105.56 116.81 32.57 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -73.26 110.83 7.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.454 HD11 ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -76.78 -29.49 17.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.05 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.896 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 5.8 mt-10 -149.54 147.51 28.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -52.82 133.31 37.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.77 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -87.66 157.23 19.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.578 -172.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -112.89 -34.41 5.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.946 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.699 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.1 tt0 -124.07 -167.88 1.71 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.699 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.93 145.01 24.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.499 0.666 . . . . 0.0 110.758 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.686 HD13 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -92.7 121.96 34.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.312 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 25.6 tt0 -102.58 93.51 5.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.626 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.735 ' CZ3' HG22 ' A' ' 26' ' ' ILE . 23.0 m95 -84.33 111.44 19.42 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 31.2 ttmt -115.81 143.06 45.94 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.958 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.589 HG21 HD23 ' A' ' 57' ' ' LEU . 10.9 mt -102.95 106.8 20.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.469 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.547 HD13 ' HG2' ' A' ' 41' ' ' LYS . 3.0 mp -105.73 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.29 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.761 ' CE2' HG13 ' A' ' 113' ' ' VAL . 37.2 t80 -91.69 120.02 32.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.561 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.491 HG13 ' CD2' ' B' ' 126' ' ' LEU . 24.0 t -58.37 101.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 110.095 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.18 -37.24 94.27 Favored Glycine 0 CA--C 1.506 -0.512 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.109 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.742 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 66.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.03 54.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.198 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.09 -23.97 21.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 51.9 m -117.2 -154.91 0.57 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.85 164.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.553 ' OE1' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -134.0 -33.89 1.02 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.659 0.266 . . . . 0.0 110.913 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' HG3' ' OE1' ' A' ' 51' ' ' GLU . 29.3 mt-10 -71.43 -3.93 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.742 ' CD1' ' HB2' ' A' ' 47' ' ' SER . 96.8 m-85 -85.98 -1.86 57.73 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.446 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.22 111.85 0.54 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.133 0.968 . . . . 0.0 110.481 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 1.5 mt-30 -93.4 168.6 10.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.716 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 HG21 ' HD3' ' A' ' 41' ' ' LYS . 42.5 t -124.03 113.28 36.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.459 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 42' ' ' ILE . 10.9 mp -74.54 -50.32 18.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.499 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.642 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -170.83 -177.93 2.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.663 -177.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.569 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 36.1 p -152.69 124.32 7.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -100.54 135.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.0 mt -110.69 105.41 14.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.01 0.433 . . . . 0.0 110.573 -176.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.42 119.11 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.67 -164.21 11.41 Favored Glycine 0 CA--C 1.499 -0.911 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.385 -167.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.77 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 53.4 Cg_endo -66.14 115.42 3.46 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.298 1.332 . . . . 0.0 110.194 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.493 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.4 m -123.04 138.4 29.71 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.849 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.41 78.18 2.55 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.363 2.042 . . . . 0.0 113.83 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 52.26 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.641 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.554 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 106.07 137.96 8.99 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.658 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.899 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 6.2 ptt180 -76.14 127.1 32.24 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.997 0.903 . . . . 0.0 109.474 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.554 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 22.5 m-70 -123.65 135.25 53.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.683 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.1 ttp -109.22 99.56 8.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 5.8 p90 -108.67 142.31 39.35 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 3.4 p -104.96 130.55 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.492 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.642 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 5.1 t80 -132.86 132.04 41.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.817 -159.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.748 ' HG3' ' HA ' ' A' ' 23' ' ' GLN . 22.1 mp0 -145.28 156.05 43.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.106 0.479 . . . . 0.0 110.57 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.46 32.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.047 -0.978 . . . . 0.0 108.375 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.7 178.4 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.652 0.739 . . . . 0.0 112.28 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.542 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . . . -68.76 159.94 79.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.199 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 78' ' ' ALA . 57.4 Cg_endo -74.62 166.54 29.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.778 2.319 . . . . 0.0 110.503 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.569 ' HB2' HD13 ' A' ' 83' ' ' LEU . 3.7 m-20 -75.88 114.19 34.57 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.207 0.527 . . . . 0.0 111.161 -171.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.33 -21.64 66.73 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.578 2.852 . . . . 0.0 112.131 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.38 -0.54 84.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.251 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 80' ' ' ASN . 35.0 mt -103.68 -20.57 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.571 0.224 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.48 ' CG2' ' HB3' ' A' ' 89' ' ' ALA . 27.9 mt -89.8 129.39 46.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.232 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.528 ' HG2' ' CG ' ' A' ' 88' ' ' ASP . 88.1 Cg_endo -79.99 163.58 22.97 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.527 2.818 . . . . 0.0 111.732 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.658 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -45.64 -56.68 4.91 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.068 0.947 . . . . 0.0 113.268 -174.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -24.39 61.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 111.197 -167.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' CG ' ' HG2' ' A' ' 85' ' ' PRO . 1.4 m-20 -86.65 -24.97 25.09 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.476 -175.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.643 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -82.91 -46.87 12.44 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.016 -173.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -94.23 46.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-O 122.043 0.925 . . . . 0.0 111.275 -174.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.87 -124.71 0.8 Allowed Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.103 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.498 HG21 ' ND2' ' A' ' 114' ' ' ASN . 1.1 t -114.57 134.68 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 -168.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 169.93 17.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.461 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.5 t -127.17 152.31 35.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 118.37 0.532 . . . . 0.0 111.603 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.6 p -130.83 108.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.21 133.25 47.38 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.025 -172.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.751 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 33.9 mt -102.23 97.65 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.038 0.923 . . . . 0.0 108.797 174.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.81 HG22 ' HG3' ' A' ' 108' ' ' ARG . 49.4 p -91.72 114.11 26.56 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.258 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 61.4 m -81.99 105.69 13.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.919 0.866 . . . . 0.0 110.706 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.5 m -93.3 106.51 18.47 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.668 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.615 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 65.7 t80 -116.64 119.63 36.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.038 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.615 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.3 mtp180 64.88 23.71 12.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.2 -0.58 64.07 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.62 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.31 121.11 39.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.551 ' OE1' ' HG3' ' B' ' 134' ' ' ARG . 46.8 mt-10 -72.63 131.36 42.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.783 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.686 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 50.6 p90 -115.66 -1.85 12.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.1 tt -157.77 161.54 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 109.602 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.81 ' HG3' HG22 ' A' ' 98' ' ' THR . 17.7 ttm180 -150.71 95.78 2.27 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.927 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -83.15 100.36 6.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 118.776 -1.169 . . . . 0.0 108.558 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.536 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -87.78 78.65 1.79 Allowed Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.869 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.925 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -72.88 117.99 15.27 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.585 ' HB3' HD11 ' A' ' 140' ' ' LEU . 22.6 m-85 -67.55 130.34 42.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.761 HG13 ' CE2' ' A' ' 44' ' ' TYR . 4.9 p -112.02 111.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.643 ' HB3' ' ND2' ' A' ' 138' ' ' ASN . 3.9 t-20 -94.46 116.78 29.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.386 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.643 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -108.39 108.53 19.53 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -171.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -131.5 129.07 40.63 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.392 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.513 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.8 m-85 -39.55 150.09 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 136' ' ' GLN . 68.7 p -92.46 -28.66 16.7 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.167 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.947 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.4 mm-40 -84.4 117.31 23.54 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.216 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.722 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.7 m -53.07 -34.36 56.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.039 -172.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -32.03 72.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.687 0.756 . . . . 0.0 110.283 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.503 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 70.4 mt -76.96 -24.38 52.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.123 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.2 mtp-105 -78.57 -31.79 47.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.722 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.2 mm-40 -61.57 -39.02 89.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.328 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 6.0 p30 -157.96 95.28 1.99 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.113 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 10.8 Cg_endo -53.8 118.37 4.86 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.528 2.152 . . . . 0.0 110.965 175.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.484 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 73.7 Cg_exo -53.02 144.39 46.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.101 1.867 . . . . 0.0 109.424 172.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.52 -27.34 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.101 -166.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.505 ' HE2' ' HB2' ' A' ' 129' ' ' LYS . 10.0 tppt? -116.35 107.1 47.78 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.655 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.658 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 75.9 Cg_exo -40.27 139.84 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 125.242 3.962 . . . . 0.0 113.881 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -110.59 106.15 15.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.764 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.5 m-85 -74.47 -12.58 60.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.581 -171.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -89.36 -21.1 23.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.271 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.947 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 70.9 mmtt -100.01 10.84 40.64 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 115' ' ' ASN . 21.3 tp -95.38 133.12 39.68 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.522 -171.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.466 ' HB2' HG23 ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.31 123.56 49.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.794 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -103.26 108.32 19.49 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.874 -174.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.846 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p-10 -92.77 104.66 16.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.862 0.839 . . . . 0.0 109.475 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.662 HG23 HG13 ' A' ' 11' ' ' VAL . 1.3 mp -70.96 108.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 112' ' ' TYR . 88.8 mt -67.04 86.57 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.685 0.755 . . . . 0.0 110.7 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.925 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.9 -15.31 60.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.318 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 p -81.97 -1.45 48.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -141.56 64.64 19.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.7 Cg_endo -93.18 106.18 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.059 1.839 . . . . 0.0 111.362 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.507 ' HB3' HD13 ' B' ' 130' ' ' ILE . 16.4 tpt180 -77.61 81.93 4.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.451 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.424 HG12 HG21 ' A' ' 109' ' ' VAL . 3.0 m -76.92 103.46 4.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.3 0.571 . . . . 0.0 110.501 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.447 HG22 ' CE2' ' A' ' 149' ' ' PHE . 35.2 m -116.49 106.09 13.21 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.615 0.722 . . . . 0.0 109.362 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.2 ptt-85 -118.96 154.44 33.02 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.782 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.447 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -138.07 168.49 19.61 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.931 -172.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.17 144.65 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.94 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.597 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 22.1 pt -133.99 -172.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.47 0.653 . . . . 0.0 109.936 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -98.31 92.7 5.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.38 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.586 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 15.2 m95 -78.46 -16.57 57.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.398 176.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.49 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 3.0 mp0 -112.9 153.64 27.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.233 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.81 72.49 9.88 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.916 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.112 174.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.2 -25.57 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 51.7 ttp 73.4 -58.08 0.61 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.624 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.43 120.46 21.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.791 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 46.8 mmtm -73.39 -32.7 64.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.711 0.291 . . . . 0.0 110.876 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.88 -57.62 4.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.259 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.69 -35.62 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.292 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.444 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.8 mm100 -54.82 -51.74 64.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.826 0.822 . . . . 0.0 110.497 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.564 ' HB3' HG22 ' A' ' 94' ' ' VAL . 44.5 mt -66.22 -43.65 86.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.611 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.88 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.68 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' B' ' 128' ' ' ARG . 18.6 mtp180 -60.09 -49.02 79.29 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.894 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.702 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 4.8 mmt180 -60.62 -41.78 95.53 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.935 0.398 . . . . 0.0 111.133 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.536 HD13 ' HA3' ' A' ' 110' ' ' GLY . 7.0 mt -75.25 -43.88 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.213 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -52.14 -53.68 39.86 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.607 0.567 . . . . 0.0 111.05 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.591 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . -176.03 57.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.587 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.702 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 3.2 mm-40 -102.27 -48.18 4.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.643 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.633 ' HG2' ' H ' ' B' ' 135' ' ' ALA . 41.5 ttp180 57.43 -178.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 112.749 172.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.633 ' H ' ' HG2' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--N 1.309 -1.169 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.092 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' HB2' HD11 ' A' ' 31' ' ' ILE . . . -87.35 138.66 31.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.026 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.782 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.55 -19.89 24.45 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.482 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 4.0 t -140.96 130.49 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.755 0.788 . . . . 0.0 111.526 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 20.8 tp60 -125.06 100.55 6.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.57 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -74.4 144.59 12.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.76 177.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -123.29 -66.52 1.0 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.469 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.5 t-20 -103.28 151.65 22.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.536 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.739 HG21 HG13 ' A' ' 26' ' ' ILE . 2.6 p -147.43 99.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.578 174.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.91 HG21 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -92.87 109.67 21.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.564 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 139' ' ' ILE . 0.0 OUTLIER -82.32 132.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -110.91 -68.8 0.91 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.733 0.777 . . . . 0.0 112.328 -162.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.0 34.7 1.51 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.161 -162.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.697 ' HB3' ' NH2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -138.78 99.64 8.35 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 171.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 60.7 Cg_endo -124.99 92.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.27 1 C-N-CA 125.696 4.264 . . . . 0.0 106.139 108.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.651 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 7.5 m -153.83 168.98 10.65 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.188 -167.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 87.9 Cg_exo -38.3 132.26 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.814 2.343 . . . . 0.0 111.679 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.905 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 10.1 t80 -60.85 -22.19 63.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.401 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -84.87 -10.56 57.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.988 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.611 HD21 ' NH1' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -77.35 128.57 80.07 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 122.49 1.138 . . . . 0.0 108.728 167.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.65 152.83 32.44 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 124.76 3.64 . . . . 0.0 112.995 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.587 ' HA ' HH21 ' A' ' 137' ' ' ARG . 27.1 m-85 -81.21 124.4 29.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.486 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.036 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.2 mp0 -113.32 114.07 26.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.682 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' CG ' HD13 ' A' ' 97' ' ' ILE . 73.4 m-85 -120.97 114.41 21.48 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.91 ' HB3' HG21 ' A' ' 10' ' ' VAL . 33.1 tt0 -97.88 87.12 3.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.739 HG13 HG21 ' A' ' 9' ' ' VAL . 4.5 mp -82.63 140.51 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.929 0.871 . . . . 0.0 112.363 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 14.9 m -113.33 107.13 15.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.286 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.4 p90 -116.39 150.01 38.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.377 0.608 . . . . 0.0 109.565 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.848 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -105.42 112.21 25.22 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.481 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 4.2 t -72.97 108.16 5.72 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -73.76 -25.15 20.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.384 -174.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.782 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -152.8 158.0 41.61 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.409 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.6 129.16 40.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.508 . . . . 0.0 110.339 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.122 HD11 ' HE2' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -84.5 148.64 26.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.671 -170.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.54 ' N ' HD12 ' A' ' 34' ' ' LEU . 17.7 m -115.37 -25.99 7.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.909 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 35.8 tt0 -118.44 -163.41 0.95 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.909 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 8.8 m-20 -93.84 131.32 39.35 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.707 -0.621 . . . . 0.0 109.337 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.701 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.62 118.58 23.41 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.655 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 40.8 tt0 -102.31 127.61 49.22 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.585 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.588 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.9 m95 -115.72 127.52 55.2 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.762 ' HD2' HD13 ' A' ' 43' ' ' ILE . 2.7 ttmp? -123.71 146.54 48.19 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.053 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.59 HD12 HG12 ' A' ' 97' ' ' ILE . 44.1 mm -102.83 105.8 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.685 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.762 HD13 ' HD2' ' A' ' 41' ' ' LYS . 2.9 mp -103.1 110.8 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.592 ' CE2' HG11 ' A' ' 113' ' ' VAL . 32.2 t80 -95.86 110.78 22.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.256 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG13 HD23 ' B' ' 126' ' ' LEU . 22.9 t -61.53 101.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -74.34 -42.94 33.07 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.75 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 27.8 p -95.44 99.65 11.52 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' B' ' 122' ' ' LYS . . . -90.98 -5.07 55.91 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 161.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -99.83 -48.75 4.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.607 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.596 ' C ' ' HB2' ' A' ' 47' ' ' SER . 38.7 m -98.56 -157.43 0.6 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 170.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HB3' HE22 ' B' ' 125' ' ' GLN . 12.9 pt-20 -143.42 -25.91 0.58 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.319 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -79.42 2.81 20.44 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 9.6 m-30 -88.51 -1.63 58.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.554 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -47.6 109.59 0.23 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.617 0.722 . . . . 0.0 110.536 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.695 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 55.2 mt-30 -91.58 166.04 13.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.812 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.51 112.1 28.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.286 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.6 HD21 ' HD3' ' A' ' 79' ' ' PRO . 8.3 mp -82.18 -56.87 3.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.901 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.12 161.37 42.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.355 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.0 p -146.46 114.98 6.76 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.27 138.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 10.7 mt -110.88 103.2 11.68 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.107 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -97.2 122.79 49.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -77.3 -158.56 9.7 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.331 -162.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.04 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.6 Cg_endo -65.35 116.75 4.06 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.444 1.429 . . . . 0.0 110.097 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 63' ' ' GLY . 24.5 m -126.22 150.49 70.0 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.35 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.04 138.78 44.89 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.746 2.297 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.644 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -43.86 144.58 0.84 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.324 0.583 . . . . 0.0 112.138 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 134.03 126.97 2.7 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -174.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.4 ptt180 -70.93 130.79 42.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.375 1.083 . . . . 0.0 110.794 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.518 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 9.0 p80 -150.82 151.1 31.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.151 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -107.36 138.45 43.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.455 -172.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 6.2 p90 -139.51 152.27 46.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.2 p -111.51 107.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 122.647 1.213 . . . . 0.0 111.339 -169.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.2 t80 -108.91 121.45 45.14 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.637 -170.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 1.036 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 33.4 mt-30 -119.81 166.43 13.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.245 -172.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.73 132.6 6.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.848 0.295 . . . . 0.0 111.644 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.92 156.69 35.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.55 152.13 36.2 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HD3' HD21 ' A' ' 57' ' ' LEU . 55.5 Cg_endo -72.38 177.4 7.39 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.853 3.035 . . . . 0.0 112.236 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -73.69 116.88 56.08 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.436 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.24 1.08 3.79 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 123.67 2.913 . . . . 0.0 112.654 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.51 -15.18 28.01 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.695 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 61.4 mt -97.86 -8.87 27.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.525 -0.837 . . . . 0.0 110.926 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 85' ' ' PRO . 22.6 mt -96.07 129.6 33.5 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.051 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 3.4 Cg_exo -77.43 155.35 32.18 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.357 2.705 . . . . 0.0 111.673 169.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.765 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.1 p30 -47.52 -47.25 27.86 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.06 -28.13 68.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.423 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 10.7 m-20 -98.58 -21.78 16.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.429 -173.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -81.33 -46.5 14.61 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.242 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.836 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -95.25 46.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.468 0.652 . . . . 0.0 112.247 -174.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.7 -129.62 1.38 Allowed Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.075 -172.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.642 HG12 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -98.27 135.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -168.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.48 167.86 28.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.368 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.603 HG12 HD23 ' A' ' 96' ' ' LEU . 69.4 t -118.66 128.7 75.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.354 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.19 106.51 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.762 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -105.75 148.43 27.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.056 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.733 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 45.6 mt -106.98 108.29 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 121.313 0.577 . . . . 0.0 109.528 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.841 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 41.8 p -101.92 114.25 28.18 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.189 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 64.1 m -79.32 158.0 27.58 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.282 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -151.14 119.68 6.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -167.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 1.122 ' HE2' HD11 ' A' ' 34' ' ' LEU . 34.6 t80 -138.29 124.14 19.97 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.612 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 61.1 mtp180 65.31 32.87 9.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.386 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.97 83.44 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.574 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -114.28 132.23 56.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.15 0.5 . . . . 0.0 110.068 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 31.7 mt-10 -93.89 130.12 40.07 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.146 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.701 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.7 p90 -118.44 -1.17 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -164.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' A' ' 98' ' ' THR . 5.4 tt -156.47 160.29 2.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 120.883 -1.136 . . . . 0.0 109.388 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.654 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 13.5 ttp180 -148.08 102.22 3.36 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 123.93 0.769 . . . . 0.0 109.433 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.6 p -89.95 101.26 12.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.723 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.18 92.05 1.78 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 119.613 -1.279 . . . . 0.0 112.136 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.74 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 8.7 m-85 -83.95 126.09 32.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.895 -0.652 . . . . 0.0 109.943 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -68.24 112.12 4.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.962 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.9 p -93.89 111.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.642 HD22 HG12 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -101.63 104.42 15.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.013 -176.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.663 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.6 m-80 -94.3 110.27 22.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.255 -172.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.14 128.03 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.642 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 31.6 m-85 -39.29 154.12 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.5 p -98.19 -26.15 14.65 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.253 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.409 ' HB2' HD11 ' A' ' 122' ' ' LEU . 26.6 mm-40 -78.64 120.99 24.11 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.633 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.8 m -54.33 -32.02 55.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.543 -169.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -70.61 -36.17 73.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.682 0.753 . . . . 0.0 109.572 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.547 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 65.9 mt -74.88 -25.85 59.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.213 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 32.7 mtt180 -70.96 -36.7 72.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.995 0.903 . . . . 0.0 108.787 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 120' ' ' THR . 44.0 mm-40 -69.39 -40.92 77.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.972 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.0 p30 -146.51 91.06 5.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 0.0 111.218 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.419 ' HA ' ' CE2' ' A' ' 117' ' ' TYR . 14.6 Cg_endo -56.41 114.97 2.15 Favored 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 122.831 2.354 . . . . 0.0 111.244 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.504 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 50.9 Cg_exo -56.32 160.08 11.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.432 2.088 . . . . 0.0 111.072 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.512 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 11.7 p -51.25 -36.58 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -166.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.517 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 4.8 mmtt -116.19 116.0 40.09 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-O 121.896 0.855 . . . . 0.0 111.745 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.836 ' HB3' HG13 ' A' ' 90' ' ' VAL . 3.0 Cg_exo -47.4 141.74 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 125.018 3.812 . . . . 0.0 113.952 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -111.64 109.94 20.08 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 170.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.734 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 18.4 m-85 -70.93 -15.49 62.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.649 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -87.39 -17.81 31.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.641 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 47.7 mmtm -101.91 1.56 37.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.485 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 20.7 tp -86.63 139.79 30.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.125 -171.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -121.34 116.61 25.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.905 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 4.2 mtp-105 -80.39 101.33 8.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.649 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -97.48 106.83 19.21 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.618 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 12.3 mt -95.6 114.11 31.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.945 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.0 mt -73.54 90.05 1.73 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.329 -172.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.74 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -75.45 -9.72 58.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.494 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 p -85.06 -3.37 58.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.679 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -137.12 70.44 55.94 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.584 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.4 Cg_endo -91.28 109.66 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.883 2.389 . . . . 0.0 112.07 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.36 81.38 7.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 109' ' ' VAL . 16.1 m -71.71 129.29 35.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.152 0.501 . . . . 0.0 111.301 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.5 m -141.09 105.4 4.83 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 172.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.761 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -118.52 143.95 46.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.883 0.849 . . . . 0.0 110.836 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.36 168.42 13.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.715 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.89 151.03 22.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.005 0.431 . . . . 0.0 111.107 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.757 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 27.9 pt -135.75 172.34 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -94.69 86.56 4.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.545 1.164 . . . . 0.0 111.059 -178.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.625 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 35.2 m95 -64.52 -16.61 62.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.556 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -132.49 167.99 18.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.6 70.6 6.11 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.614 -166.128 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.48 69.53 4.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 0.0 110.5 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 10.6 tpt -75.71 117.38 17.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 143.05 3.26 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.775 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 0.0 OUTLIER -74.27 -23.39 59.11 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -48.33 -48.47 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.073 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tt -67.69 -39.83 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.196 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.459 HE22 ' HB3' ' A' ' 51' ' ' GLU . 3.5 mm100 -63.41 -37.4 87.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 89.4 mt -67.23 -43.57 81.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.276 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.72 72.77 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.959 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.36 -47.05 86.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.14 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' B' ' 133' ' ' GLU . 4.4 mmp_? -66.9 -43.44 83.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.382 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.654 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 69.7 mt -68.04 -16.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.397 0.618 . . . . 0.0 110.645 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 20.8 tpt85 -81.39 -26.26 35.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.875 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.618 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 156.41 84.74 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.788 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.64 ' OE1' ' HG2' ' B' ' 134' ' ' ARG . 0.0 OUTLIER -93.68 -56.51 2.87 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 165.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.64 ' HG2' ' OE1' ' B' ' 133' ' ' GLU . 19.5 mmm180 -72.2 -68.49 0.46 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 173.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.823 174.904 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HE2' ' HB3' ' A' ' 150' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.565 ' HB2' HD11 ' A' ' 31' ' ' ILE . . . -80.04 150.69 30.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' HG2' ' CD2' ' A' ' 153' ' ' TRP . 33.3 mmtt -99.9 -7.56 25.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.436 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.7 t -146.1 128.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.113 0.482 . . . . 0.0 110.575 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.583 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 24.0 tp60 -125.09 103.98 8.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.532 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.763 HG23 ' CH2' ' A' ' 40' ' ' TRP . 2.3 t -65.78 128.85 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.884 0.849 . . . . 0.0 109.092 171.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -118.33 -54.33 2.29 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.852 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.756 HD22 HG11 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -104.96 128.9 53.43 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.116 -174.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.725 ' N ' HD21 ' A' ' 8' ' ' ASN . 2.2 t -129.11 99.53 4.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.403 169.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 25' ' ' GLU . 1.5 m -95.4 101.37 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.444 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.835 HG11 HG23 ' A' ' 139' ' ' ILE . 2.5 t -83.99 117.88 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.325 1.06 . . . . 0.0 108.851 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -86.33 -36.09 19.47 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.341 -175.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.624 ' OD2' ' HA ' ' A' ' 22' ' ' PHE . 36.7 t0 -74.14 58.28 0.69 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.982 168.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -82.44 174.48 6.01 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 113.139 -1.846 . . . . 0.0 106.376 160.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.0 Cg_endo -49.91 103.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.82 1.686 . . . . 0.0 113.065 -153.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.631 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 15.7 m -139.33 171.16 8.47 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.428 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.2 Cg_exo -40.64 132.49 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.458 2.105 . . . . 0.0 111.941 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.767 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 36.6 t80 -57.96 -27.1 63.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.266 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 18.9 m-85 -87.06 -3.3 59.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.139 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -76.24 125.56 87.64 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 164.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.557 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 38.5 Cg_exo -62.89 150.58 87.98 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 123.264 2.643 . . . . 0.0 112.855 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.6 m-85 -62.65 103.55 0.43 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.804 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.614 ' HB3' HD12 ' A' ' 12' ' ' LEU . 33.6 mt-30 -106.91 103.02 12.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.237 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CD1' HD13 ' A' ' 97' ' ' ILE . 82.9 m-85 -104.57 155.6 18.69 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.895 ' HB3' HG21 ' A' ' 10' ' ' VAL . 12.7 tt0 -130.51 87.34 2.49 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.502 ' CG2' HG21 ' A' ' 6' ' ' VAL . 23.3 mt -78.06 138.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.782 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 5.5 m -119.29 109.78 16.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.254 171.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.662 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 19.2 p90 -112.27 140.74 46.73 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.561 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.0 tt0 -101.75 114.82 29.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.5 m -72.2 113.4 9.19 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.583 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -73.83 -24.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.109 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.516 -173.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 40.0 mt-10 -150.78 164.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.81 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.46 133.72 50.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.2 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.055 HD11 ' HE2' ' A' ' 101' ' ' TYR . 0.3 OUTLIER -95.5 152.57 18.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.112 -172.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.521 ' N ' HD12 ' A' ' 34' ' ' LEU . 11.8 p -115.58 -33.11 5.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.702 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.9 tt0 -108.17 -163.13 0.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -173.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.702 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 12.4 m-20 -89.73 163.12 15.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.592 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -114.58 119.78 37.94 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.701 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.1 mp0 -91.19 126.73 36.36 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.017 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.763 ' CH2' HG23 ' A' ' 6' ' ' VAL . 53.5 m95 -120.36 125.81 48.94 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.844 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.1 ttmt -128.72 143.67 50.98 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.649 -173.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 95' ' ' VAL . 12.8 mt -103.69 106.98 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.844 HD11 ' HD2' ' A' ' 41' ' ' LYS . 74.0 mt -107.12 106.8 21.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.739 0.781 . . . . 0.0 109.987 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.838 ' CE2' HG13 ' A' ' 113' ' ' VAL . 58.3 t80 -90.62 131.67 36.19 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.743 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.94 101.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.578 0.704 . . . . 0.0 110.639 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.08 -40.22 97.93 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.548 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.897 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 89.8 p -132.57 118.66 19.49 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.663 0.268 . . . . 0.0 110.854 172.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -78.21 -3.62 43.6 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 163.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' CD ' ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -99.44 -17.09 18.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.769 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.533 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 53.2 m -131.41 -148.33 0.35 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.87 -32.7 0.27 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 118.854 0.752 . . . . 0.0 112.507 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.84 1.35 20.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.897 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 3.2 m-30 -82.35 -17.7 44.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.311 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.411 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p-10 -42.38 115.62 0.72 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 111.895 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.484 ' CG ' HD13 ' A' ' 83' ' ' LEU . 12.4 mp0 -92.7 165.62 12.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.04 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.599 HG23 HG12 ' A' ' 43' ' ' ILE . 37.5 t -130.24 110.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.4 mm? -79.52 -40.33 29.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.618 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -174.43 157.8 2.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 21.0 p -140.12 117.44 11.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.3 p -98.65 141.2 16.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.764 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.482 ' CD1' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -110.63 104.96 13.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.882 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -83.37 154.16 3.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' HG11 ' A' ' 65' ' ' VAL . . . -96.48 -162.41 32.73 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 118.633 -1.746 . . . . 0.0 112.456 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.025 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 45.0 Cg_endo -66.3 118.92 5.91 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.928 1.752 . . . . 0.0 109.91 173.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.491 HG23 ' HG ' ' A' ' 30' ' ' CYS . 35.8 m -121.15 131.94 24.34 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.398 -173.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.07 138.26 51.46 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.486 2.124 . . . . 0.0 110.789 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -40.58 141.5 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.063 0.852 . . . . 0.0 112.433 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.05 149.24 7.51 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.898 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 9.4 ptt180 -75.72 143.63 41.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.028 0.918 . . . . 0.0 111.157 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.582 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 91.6 m-70 -137.85 136.09 36.82 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.607 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.31 123.8 48.6 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.608 0.718 . . . . 0.0 110.763 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.6 p90 -127.97 144.12 51.1 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.365 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 p -105.42 125.9 60.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.109 0.956 . . . . 0.0 110.213 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.666 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 7.3 t80 -126.6 113.1 16.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.025 -162.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.2 mt-30 -130.55 154.25 48.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -158.13 154.32 27.26 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.31 -174.93 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.839 0.828 . . . . 0.0 113.056 -171.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -81.94 150.49 65.44 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.476 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.767 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 46.7 Cg_exo -62.77 173.75 3.48 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 123.389 2.726 . . . . 0.0 112.495 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -81.8 115.6 58.14 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.525 -174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.08 -9.69 26.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.267 2.645 . . . . 0.0 112.236 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 6.46 64.98 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.698 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.484 HD13 ' CG ' ' A' ' 55' ' ' GLN . 10.3 mt -108.9 -37.68 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.548 0.213 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.572 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 49.3 mt -69.57 130.08 90.87 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.45 ' O ' HG23 ' A' ' 84' ' ' ILE . 73.2 Cg_endo -79.69 161.62 24.61 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 0.0 112.468 171.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.601 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.0 OUTLIER -46.31 -52.74 12.12 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.787 0.835 . . . . 0.0 112.974 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . . . -75.0 -23.03 58.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.983 -170.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.742 ' HA ' ' HZ3' ' B' ' 122' ' ' LYS . 12.9 t0 -82.68 -27.3 31.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 0.0 110.591 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 130' ' ' PRO . . . -73.94 -40.4 63.1 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.759 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.38 44.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 114' ' ' ASN . . . -174.77 -129.56 1.2 Allowed Glycine 0 CA--C 1.496 -1.113 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.992 -173.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.729 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -103.04 120.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.187 0.994 . . . . 0.0 113.433 -165.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.845 ' HB ' HG11 ' A' ' 113' ' ' VAL . 5.2 m -135.35 169.12 17.97 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.488 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' B' ' 126' ' ' LEU . 8.3 t -130.89 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 118.049 0.386 . . . . 0.0 110.638 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 42' ' ' ILE . 7.6 p -131.78 107.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.875 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -97.26 130.21 44.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.664 -168.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.76 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 49.1 mt -95.36 93.75 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.792 HG21 ' HG3' ' A' ' 108' ' ' ARG . 32.4 p -92.35 112.94 25.07 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.677 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 1.013 ' SG ' HG22 ' A' ' 107' ' ' ILE . 23.5 p -75.52 159.14 31.61 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 28.2 m -150.95 103.65 3.08 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -171.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 1.055 ' HE2' HD11 ' A' ' 34' ' ' LEU . 51.0 t80 -118.9 125.52 49.68 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 16.4 mmt180 67.18 14.46 9.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.898 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.26 4.55 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.595 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.45 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.73 138.22 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 6.8 mt-10 -87.45 127.62 35.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.539 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.592 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.9 p90 -116.95 1.73 12.66 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 1.013 HG22 ' SG ' ' A' ' 99' ' ' CYS . 4.8 tt -154.44 153.98 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.381 -0.825 . . . . 0.0 109.2 167.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.909 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 4.1 ttm-85 -143.63 91.2 2.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.582 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.875 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -83.39 100.95 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.266 1.031 . . . . 0.0 108.294 175.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.72 81.73 1.43 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.791 -1.195 . . . . 0.0 111.158 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.526 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 27.4 m-85 -69.73 115.1 8.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.619 ' HB3' HD11 ' A' ' 140' ' ' LEU . 2.4 m-85 -66.93 111.37 3.75 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.845 HG11 ' HB ' ' A' ' 93' ' ' THR . 1.5 p -91.47 109.33 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.729 ' ND2' HG13 ' A' ' 92' ' ' VAL . 1.7 t-20 -96.7 113.66 25.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.431 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.49 ' HB3' HD13 ' A' ' 135' ' ' LEU . 57.6 m-80 -101.82 108.84 20.46 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.861 0.839 . . . . 0.0 109.151 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.16 132.46 39.85 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.814 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.655 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 50.6 m-85 -49.01 155.5 0.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -172.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 18.3 p -92.27 -28.89 16.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.257 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.583 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 21.7 mm-40 -80.81 122.96 27.84 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.298 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.566 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 21.2 m -51.75 -34.09 37.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.336 -170.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.23 -37.33 80.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.652 0.739 . . . . 0.0 109.438 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 55.8 mt -78.77 -19.28 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.551 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 45.9 mtt180 -77.58 -35.11 53.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.7 mm-40 -74.45 -38.08 63.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.438 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.2 p30 -142.3 83.23 12.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 110.441 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 16.3 Cg_endo -57.39 114.97 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.141 2.561 . . . . 0.0 111.918 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.641 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 34.7 Cg_exo -62.72 142.77 90.54 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.0 110.347 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 t -55.94 -32.84 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.511 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.3 mmtt -79.4 133.09 60.56 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 121.132 0.491 . . . . 0.0 110.875 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.601 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 6.4 Cg_endo -77.45 129.32 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.588 2.859 . . . . 0.0 112.433 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.2 t70 -125.63 108.03 11.16 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.885 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.702 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.5 m-85 -78.5 -16.83 57.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.273 1.035 . . . . 0.0 110.579 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.42 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 31.0 t -83.11 -27.95 29.81 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.301 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.583 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 71.9 mmtt -100.8 11.62 39.19 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.3 tp -94.55 129.08 41.5 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.885 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.562 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 3.2 tt0 -112.72 120.06 40.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.739 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.06 107.12 19.44 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.639 -174.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 16.5 t30 -78.74 102.88 8.32 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.828 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.835 HG23 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -76.89 105.83 6.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.911 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 112' ' ' TYR . 83.9 mt -67.11 90.99 0.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.757 0.789 . . . . 0.0 111.336 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.526 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.21 -19.51 43.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.454 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 p -80.14 -17.32 52.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.949 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -131.31 61.5 59.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.709 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.72 116.5 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.81 1.673 . . . . 0.0 111.058 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.656 ' HG3' HG12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.84 81.11 7.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.387 0.613 . . . . 0.0 109.942 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.866 HG12 HG21 ' A' ' 109' ' ' VAL . 19.4 m -89.36 137.39 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.771 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.5 m -149.18 108.76 4.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.487 0.661 . . . . 0.0 110.008 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.683 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -101.64 140.75 35.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.0 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -118.11 168.51 10.49 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.798 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 7.5 m170 -104.83 114.54 28.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.413 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 101' ' ' TYR . 42.3 pt -118.69 -173.47 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.518 0.675 . . . . 0.0 110.971 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -96.07 92.74 6.59 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.726 -177.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.589 ' CD2' ' HG2' ' A' ' 3' ' ' LYS . 37.8 m95 -77.28 -12.5 59.96 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 109.838 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.7 150.49 50.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.832 0.825 . . . . 0.0 110.595 -172.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.49 71.21 9.56 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.286 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.434 HD21 ' N ' ' A' ' 156' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.451 -174.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 CA-C-O 120.285 -0.175 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.623 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . . . -79.94 84.71 5.66 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.065 0.46 . . . . 0.0 111.137 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 5.8 ttp -161.33 126.59 3.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.967 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.55 -153.78 19.29 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.436 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.742 ' HZ3' ' HA ' ' A' ' 88' ' ' ASP . 75.5 mmtt -129.6 -72.52 0.58 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -24.79 -66.72 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.778 1.299 . . . . 0.0 114.001 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.74 -35.61 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.623 ' OE1' ' HA ' ' B' ' 119' ' ' ALA . 7.4 mm100 -66.5 -50.11 64.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.954 0.407 . . . . 0.0 111.899 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 94' ' ' VAL . 1.5 mm? -68.3 -33.96 75.28 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.18 90.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.549 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 49.9 mtp180 -51.77 -56.41 14.0 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.28 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.83 ' HD3' ' HB3' ' B' ' 133' ' ' GLU . 0.1 OUTLIER -56.93 -42.69 80.45 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 -176.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.909 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 1.7 mp -70.13 -50.2 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 123.747 0.654 . . . . 0.0 112.543 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -59.41 -46.57 88.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 175.68 55.29 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.709 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.83 ' HB3' ' HD3' ' B' ' 129' ' ' ARG . 9.1 tp10 -96.97 -2.66 43.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.512 ' HB2' ' OE2' ' A' ' 105' ' ' GLU . 18.6 ptt180 -36.22 147.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 112.592 -2.095 . . . . 0.0 114.024 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.245 176.661 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.925 0.393 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -77.43 138.19 39.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.904 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -90.68 -20.58 22.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 -176.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.469 ' HB ' ' CZ3' ' A' ' 153' ' ' TRP . 3.0 t -136.64 129.51 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.482 0.658 . . . . 0.0 110.275 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.725 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -115.54 99.59 7.46 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -73.12 134.03 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -120.24 -64.88 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.89 0.852 . . . . 0.0 109.465 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.673 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.2 t-20 -105.09 150.0 25.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.587 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 HG13 ' OH ' ' A' ' 111' ' ' TYR . 5.9 p -145.57 102.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.957 0.885 . . . . 0.0 109.322 173.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -95.75 100.22 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.513 1.149 . . . . 0.0 109.667 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 139' ' ' ILE . 2.1 m -79.18 126.87 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.184 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.864 HD13 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -102.76 -34.75 8.9 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.745 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.701 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 26.0 t70 -59.34 28.79 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.874 -1.966 . . . . 0.0 112.566 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.655 ' H ' ' C ' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -82.22 172.48 9.47 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.871 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 24.2 Cg_exo -54.37 101.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.323 1.349 . . . . 0.0 113.658 -136.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.57 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.8 m -138.44 168.51 15.64 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.252 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 82.6 Cg_exo -36.49 132.86 0.36 Allowed 'Trans proline' 0 CA--C 1.504 -1.011 0 C-N-CA 123.31 2.673 . . . . 0.0 112.07 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.726 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 16.5 t80 -51.27 -24.25 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.786 0.679 . . . . 0.0 112.535 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -86.32 0.85 53.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.934 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.505 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 31.2 p-10 -63.56 138.73 97.45 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 165.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.693 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 16.6 Cg_exo -78.89 145.71 20.06 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 122.843 2.362 . . . . 0.0 111.715 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.817 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 53.5 m-85 -60.65 126.22 26.61 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.864 ' HB3' HD13 ' A' ' 12' ' ' LEU . 34.5 mt-30 -125.72 99.36 5.94 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.733 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 67.9 m-85 -107.92 102.37 11.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.88 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.541 ' O ' HG12 ' A' ' 10' ' ' VAL . 29.5 tt0 -85.94 83.7 7.73 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.657 HG22 ' CZ3' ' A' ' 40' ' ' TRP . 7.3 mt -84.91 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.57 0.7 . . . . 0.0 112.441 -176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.673 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.4 m -111.68 107.45 16.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.323 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' HB3' HG13 ' A' ' 6' ' ' VAL . 27.7 p90 -121.21 148.14 44.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.821 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 37.0 tt0 -106.01 112.66 25.8 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.739 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 41.5 t -73.49 109.41 6.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 ' C ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -78.63 -29.0 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.641 -173.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.904 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 1.8 mt-10 -149.66 148.15 28.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.4 p-10 -56.27 135.04 53.7 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 111.691 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.077 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 93.3 mt -82.74 160.47 22.31 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.356 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.6 t -113.17 -21.62 10.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.803 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.902 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.5 tt0 -137.89 -168.52 2.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.902 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 17.6 m-20 -95.12 137.4 34.23 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.418 0.628 . . . . 0.0 109.69 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.725 HD12 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.31 118.95 23.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.602 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.8 tt0 -108.63 89.76 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.878 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' CZ3' HG22 ' A' ' 26' ' ' ILE . 15.0 m95 -78.22 126.54 30.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.793 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.9 ttmp? -126.15 141.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.048 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -102.88 107.9 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.781 ' HB ' HD11 ' A' ' 96' ' ' LEU . 40.1 mt -111.74 104.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.839 0.828 . . . . 0.0 109.034 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.863 ' CE2' HG13 ' A' ' 113' ' ' VAL . 17.0 t80 -86.81 115.42 24.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.195 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 HG11 HD12 ' B' ' 126' ' ' LEU . 6.8 t -62.27 101.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.237 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.49 56.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.831 ' HB3' ' CG ' ' A' ' 53' ' ' TYR . 14.8 p -96.94 88.36 4.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.857 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -80.41 -17.72 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -100.3 -23.47 14.78 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.028 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.709 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 48.7 m -110.32 -147.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -155.96 -5.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.76 1.44 53.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.831 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 4.2 m-30 -91.33 -14.42 30.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.369 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -40.81 113.99 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.449 1.119 . . . . 0.0 112.605 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.431 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 14.8 mt-30 -92.71 163.09 13.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.219 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.559 HG21 HG12 ' A' ' 43' ' ' ILE . 39.4 t -132.6 115.67 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.3 mm? -84.2 -45.26 13.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.655 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -170.5 165.75 8.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 61.9 p -141.8 117.53 10.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -100.0 136.6 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.639 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.2 mt -107.9 104.84 14.4 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.99 110.76 23.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' O ' HG11 ' A' ' 65' ' ' VAL . . . -71.7 -170.19 12.28 Favored Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.889 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.077 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 35.2 Cg_endo -62.12 115.11 2.63 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 121.259 1.306 . . . . 0.0 109.994 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 34.0 m -123.94 140.25 34.22 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.342 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.55 76.81 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.987 1.791 . . . . 0.0 113.463 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.64 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.039 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.21 124.89 3.56 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.992 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.821 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 31.9 ttt180 -79.53 118.19 21.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.446 0.641 . . . . 0.0 109.501 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -150.74 143.92 24.81 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.394 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -96.86 134.23 40.44 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.361 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -127.0 150.02 49.62 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.15 101.67 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-O 123.189 1.471 . . . . 0.0 111.448 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.733 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -76.13 137.26 39.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 112.494 -2.139 . . . . 0.0 109.841 -176.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.817 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 24.1 mt-30 -151.84 152.28 32.42 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.034 0.445 . . . . 0.0 109.941 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.44 155.89 6.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 10.0 p-10 -62.34 179.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.53 0.605 . . . . 0.0 111.983 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.455 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . . . -77.06 158.65 79.75 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.663 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 38.8 Cg_endo -63.73 164.73 20.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.5 2.134 . . . . 0.0 110.817 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.21 115.97 37.48 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.599 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -66.74 -12.76 37.24 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.098 2.532 . . . . 0.0 112.519 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.86 -5.54 61.08 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.105 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 20.7 mt -96.45 -37.11 10.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 122.613 -0.345 . . . . 0.0 110.592 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.435 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 19.2 mt -72.35 127.7 89.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.05 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 84' ' ' ILE . 72.0 Cg_endo -79.62 162.55 24.46 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.902 2.401 . . . . 0.0 112.423 172.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.831 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 t70 -43.72 -54.53 5.04 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.055 0.942 . . . . 0.0 113.487 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.851 ' HB3' ' HZ2' ' B' ' 122' ' ' LYS . . . -64.45 -28.51 69.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.071 0.462 . . . . 0.0 111.369 -168.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -97.19 -21.33 17.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.578 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.77 -48.22 12.8 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -92.87 47.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 112.68 -175.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.48 -127.23 1.11 Allowed Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.067 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.675 HG13 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -100.41 136.04 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.447 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -151.84 166.77 30.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' B' ' 126' ' ' LEU . 15.2 t -121.98 138.86 50.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.555 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 95' ' ' VAL . 9.9 p -120.95 106.99 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.928 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -104.65 139.83 38.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.236 -170.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.793 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 34.5 mt -109.67 96.63 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.911 0.862 . . . . 0.0 109.097 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.806 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 72.7 p -96.07 116.26 28.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.884 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.609 ' HB2' HG23 ' A' ' 107' ' ' ILE . 75.0 m -80.59 104.49 11.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.493 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.624 ' HG1' ' HG2' ' A' ' 105' ' ' GLU . 23.7 m -85.6 102.19 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.175 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.617 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 32.7 t80 -117.98 126.11 51.68 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.929 -0.482 . . . . 0.0 110.26 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 53.8 mtp85 60.39 28.82 18.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.848 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.35 -20.22 51.33 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.752 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.694 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 4.0 pt20 -111.57 142.99 43.15 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.637 0.732 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.624 ' HG2' ' HG1' ' A' ' 100' ' ' THR . 25.9 mt-10 -93.79 119.72 33.12 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.212 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.725 ' HZ ' HD12 ' A' ' 38' ' ' LEU . 43.9 p90 -104.53 -0.52 27.7 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.806 ' O ' ' HA ' ' A' ' 98' ' ' THR . 6.1 tt -157.58 160.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.686 HH21 HG22 ' A' ' 147' ' ' THR . 10.5 ttp180 -151.48 119.24 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 123.674 0.609 . . . . 0.0 109.776 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.928 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.6 p -96.01 100.05 10.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.515 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.62 73.42 2.49 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 119.252 -1.452 . . . . 0.0 110.961 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.872 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.8 m-85 -67.67 115.62 7.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.996 -1.102 . . . . 0.0 109.087 175.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.508 ' HB3' HD13 ' A' ' 140' ' ' LEU . 1.8 m-85 -67.68 113.26 5.32 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.863 HG13 ' CE2' ' A' ' 44' ' ' TYR . 5.3 p -93.8 110.56 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.675 HD22 HG13 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -95.25 108.61 20.77 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.611 -178.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.664 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 37.8 m-80 -101.79 107.49 18.71 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -129.14 124.01 33.59 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.276 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.581 ' CE2' HG12 ' A' ' 90' ' ' VAL . 29.0 m-85 -42.13 153.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.66 HG22 ' HB2' ' A' ' 136' ' ' GLN . 17.9 p -96.49 -27.75 14.73 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.607 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.533 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -79.48 120.86 24.46 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.497 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 5.8 m -55.49 -30.8 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.986 -170.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.25 -39.73 93.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.878 0.847 . . . . 0.0 109.866 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 66.1 mt -76.68 -24.98 53.2 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.268 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 39.4 mtt180 -72.49 -32.8 66.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.1 mm-40 -71.9 -41.13 68.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.922 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.9 p30 -148.98 102.84 3.37 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 122.051 0.929 . . . . 0.0 111.452 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 33.6 Cg_endo -66.47 113.94 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.425 2.75 . . . . 0.0 110.98 172.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.8 157.79 31.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.592 2.195 . . . . 0.0 111.094 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.07 -21.9 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.683 -169.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 1.9 mmpt? -128.36 103.86 20.02 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 122.012 0.91 . . . . 0.0 112.133 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.831 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 12.6 Cg_exo -44.28 140.27 5.83 Favored 'Trans proline' 0 N--CA 1.455 -0.737 1 C-N-CA 125.553 4.169 . . . . 0.0 113.82 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.0 t70 -111.6 114.67 27.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.368 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.622 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.6 m-85 -78.63 -7.13 57.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.21 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.6 p -96.69 -34.56 11.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.533 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 72.2 mmtt -81.78 -17.22 48.38 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 32.6 tp -66.67 139.65 57.86 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.744 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.66 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.9 tt0 -129.02 121.95 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.752 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.78 108.98 20.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.743 0.782 . . . . 0.0 112.236 -175.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.453 ' CB ' ' HG3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -91.33 101.54 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.603 170.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.602 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 6.3 mm -68.96 106.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 112' ' ' TYR . 66.4 mt -66.72 87.38 0.13 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.922 0.868 . . . . 0.0 111.2 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.872 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.51 -4.85 57.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.162 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.2 p -83.23 -11.65 57.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.576 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 63.3 t30 -143.9 59.86 7.58 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.408 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 13.9 Cg_exo -71.8 105.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.698 1.599 . . . . 0.0 110.658 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.677 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -79.91 81.35 6.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.156 0.503 . . . . 0.0 110.143 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.9 m -80.38 141.67 14.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.205 0.526 . . . . 0.0 111.084 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.686 HG22 HH21 ' A' ' 108' ' ' ARG . 54.2 m -148.83 105.87 3.6 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.778 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -115.46 140.28 49.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 110.381 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -119.43 169.94 9.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.788 -175.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -103.98 111.57 24.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.694 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 22.3 pt -115.06 -173.91 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 121.377 0.608 . . . . 0.0 110.596 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 152' ' ' ASN . 0.0 OUTLIER -88.57 114.45 25.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.793 1.282 . . . . 0.0 109.733 175.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.556 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . 59.8 m95 -96.06 -8.46 33.43 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.529 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -131.3 177.76 7.23 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.218 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.95 71.55 4.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.52 0.676 . . . . 0.0 109.181 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.5 m120 . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.954 -178.068 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.17 -173.66 2.33 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.801 -0.235 . . . . 0.0 110.475 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 83.3 mtp 70.94 176.33 0.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 123.697 0.623 . . . . 0.0 111.489 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 122' ' ' LYS . . . 79.43 -20.82 4.76 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.983 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.851 ' HZ2' ' HB3' ' A' ' 87' ' ' ALA . 13.6 mptt 73.43 -47.52 0.66 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.816 0.846 . . . . 0.0 111.679 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -37.04 -59.22 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.518 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 12.8 tt -68.92 -32.68 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' B' ' 125' ' ' GLN . 8.7 mm100 -62.93 -56.04 20.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.605 ' HB3' HG22 ' A' ' 94' ' ' VAL . 2.1 mm? -69.48 -29.59 67.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.869 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.3 77.42 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 90.7 mtt180 -53.34 -46.5 69.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.306 0.574 . . . . 0.0 110.312 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.736 ' HD2' ' HB3' ' B' ' 133' ' ' GLU . 21.4 tpt180 -65.93 -35.66 81.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.518 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.677 HD13 ' HB3' ' A' ' 145' ' ' ARG . 18.1 mt -94.72 -22.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -67.64 -33.16 74.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.46 ' HA2' ' OXT' ' B' ' 135' ' ' ALA . . . 153.04 71.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.829 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.736 ' HB3' ' HD2' ' B' ' 129' ' ' ARG . 16.1 tp10 -110.08 -49.31 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.41 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 19.1 tpt180 -65.83 -51.34 59.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.46 ' OXT' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.245 0.835 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.798 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.651 0.263 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.82 126.17 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.818 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.88 -8.81 51.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.623 -175.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.618 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 38.8 t -148.15 138.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.041 ' HG2' HD12 ' A' ' 31' ' ' ILE . 14.4 mm-40 -124.03 101.29 7.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.73 167.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.607 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 81.6 t -72.67 102.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -88.5 -60.7 1.89 Allowed 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.722 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.711 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -107.51 150.59 26.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.217 -1.81 . . . . 0.0 110.386 -171.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.663 HG13 ' HE2' ' A' ' 111' ' ' TYR . 2.6 p -145.81 99.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.791 169.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.622 HG21 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -92.21 107.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.653 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -77.55 119.82 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.677 -178.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.765 HD12 ' HB3' ' A' ' 23' ' ' GLN . 2.4 mt -89.31 -47.79 7.8 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.093 -171.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 9.5 t70 -78.58 73.65 5.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.046 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.642 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -81.72 176.7 3.57 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 111.726 -2.488 . . . . 0.0 106.614 169.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.989 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 3.0 Cg_endo -46.74 104.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.68 1.636 . . . . 0.0 113.374 -147.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.775 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 75.1 m -126.5 168.82 13.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.493 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -40.69 132.56 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.298 1.998 . . . . 0.0 111.031 173.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.705 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 7.9 t80 -58.11 -25.36 61.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.753 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.444 ' CD2' ' HA ' ' A' ' 133' ' ' SER . 5.2 m-85 -89.83 3.95 51.34 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.86 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.775 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -97.25 142.72 24.96 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.618 170.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.618 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 6.3 Cg_endo -42.29 151.17 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.16 1 C-N-CA 126.551 4.834 . . . . 0.0 115.877 -178.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.836 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 45.8 m-85 -84.5 120.22 26.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.655 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.913 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.5 mp0 -110.4 121.7 45.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 82.6 m-85 -125.59 104.34 8.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.219 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.883 ' HG3' ' HE1' ' A' ' 71' ' ' MET . 35.5 tt0 -88.14 86.27 7.07 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.636 HG13 HG21 ' A' ' 9' ' ' VAL . 4.6 mt -83.51 134.01 27.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.192 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.711 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.5 m -109.1 109.01 19.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.553 172.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.607 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 13.7 p90 -123.37 148.56 45.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.892 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.853 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.3 tt0 -108.39 112.49 24.94 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 110.44 7.4 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 1.041 HD12 ' HG2' ' A' ' 5' ' ' GLN . 1.2 mt -72.04 -35.94 55.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.695 -171.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.818 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 23.9 mt-10 -143.35 172.02 13.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 p-10 -71.62 144.24 49.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.36 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.981 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 62.5 mt -95.88 161.08 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -112.47 -25.02 9.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.122 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.51 -168.14 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.122 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.12 140.84 29.08 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.751 HD13 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -81.73 119.18 23.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.935 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.688 ' HG2' HD23 ' A' ' 61' ' ' LEU . 24.3 mt-10 -101.96 89.29 3.59 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.442 -173.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.572 ' CH2' HG23 ' A' ' 6' ' ' VAL . 19.1 m95 -77.65 151.59 34.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.661 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 0.6 OUTLIER -153.23 134.05 13.88 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.554 -0.459 . . . . 0.0 109.85 -179.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 33.0 mt -103.18 120.54 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.648 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -119.04 106.24 19.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.839 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.776 ' CE2' HG11 ' A' ' 113' ' ' VAL . 56.0 t80 -89.15 126.0 35.28 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.856 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.932 HG23 ' HE2' ' A' ' 53' ' ' TYR . 31.4 t -73.52 117.94 18.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.195 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -92.98 -59.24 1.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 119.846 -1.169 . . . . 0.0 112.092 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.654 ' H ' ' CB ' ' A' ' 53' ' ' TYR . 7.4 m -105.26 72.39 0.98 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.433 ' HB1' ' OD1' ' A' ' 88' ' ' ASP . . . -48.19 -21.27 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.552 0.532 . . . . 0.0 111.62 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.674 ' HG3' ' HE2' ' B' ' 122' ' ' LYS . 5.2 tt0 -85.71 -31.99 22.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.388 0.675 . . . . 0.0 112.23 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.7 m -95.62 -27.59 15.24 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 1.002 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER 64.25 11.63 6.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.865 1.266 . . . . 0.0 112.489 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -99.11 -13.06 19.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.452 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 1.002 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 29.3 p90 -73.17 -46.51 50.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.563 -1.653 . . . . 0.0 114.416 -161.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.616 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 7.6 p-10 -30.8 113.76 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 125.011 1.445 . . . . 0.0 114.388 -154.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 14.1 mt-30 -95.84 170.78 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.607 -169.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.56 HG11 ' HE2' ' A' ' 41' ' ' LYS . 2.3 t -130.49 116.03 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.863 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 ' O ' ' A' ' 77' ' ' ASP . 3.3 mm? -92.56 -56.66 2.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.289 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 15.2 t70 -162.5 156.63 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.998 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.661 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 36.6 p -132.96 121.82 23.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.507 HG13 ' CE1' ' A' ' 72' ' ' PHE . 3.6 p -111.2 137.32 44.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.688 HD23 ' HG2' ' A' ' 39' ' ' GLU . 7.8 mt -108.99 105.06 14.42 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.458 -176.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.01 114.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.59 -176.08 11.23 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.011 -167.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.981 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 43.6 Cg_endo -65.15 114.71 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.146 1.231 . . . . 0.0 110.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.84 140.35 34.31 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.034 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 60.5 Cg_endo -80.55 79.5 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.292 1.994 . . . . 0.0 113.589 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 53.25 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.633 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.03 128.06 3.89 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.703 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.853 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 51.0 ttt180 -87.23 115.92 24.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.698 0.761 . . . . 0.0 109.345 175.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.534 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.1 p80 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.484 -172.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.883 ' HE1' ' HG3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -94.16 136.51 34.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.795 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.547 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -121.29 153.03 38.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.33 121.0 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.622 1.201 . . . . 0.0 111.989 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -95.23 141.01 29.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.329 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.913 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 26.6 mt-30 -152.08 152.54 32.5 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 167.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -169.39 126.98 0.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.709 ' O ' HD11 ' A' ' 57' ' ' LEU . 29.4 t70 -64.53 147.99 51.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.685 0.279 . . . . 0.0 111.445 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -37.17 152.37 0.12 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -170.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.836 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 32.9 Cg_endo -64.04 -179.78 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 125.087 3.858 . . . . 0.0 113.344 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -92.84 119.19 67.99 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.206 0.527 . . . . 0.0 110.99 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -66.97 -23.24 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.273 2.649 . . . . 0.0 112.501 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.58 -2.85 90.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.953 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.57 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 53.2 mt -108.05 1.99 22.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.573 0.225 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.606 HD12 ' HE1' ' A' ' 44' ' ' TYR . 10.1 mt -109.5 123.52 36.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.503 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 91.5 Cg_endo -80.02 163.85 22.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.687 2.925 . . . . 0.0 112.22 168.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.575 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 10.3 t70 -44.46 -55.03 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.112 0.965 . . . . 0.0 113.195 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.49 70.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.164 0.507 . . . . 0.0 111.607 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 35.5 m-20 -94.45 -8.6 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.638 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -88.35 -47.77 8.14 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 121.123 0.487 . . . . 0.0 111.955 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.94 44.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.523 0.678 . . . . 0.0 111.906 -174.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.88 -124.13 0.71 Allowed Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.597 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.88 130.12 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-O 122.236 1.017 . . . . 0.0 111.91 -169.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -146.77 170.67 16.52 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.416 -1.72 . . . . 0.0 107.719 179.11 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.0 t -128.58 151.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.56 0.219 . . . . 0.0 111.481 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 95' ' ' VAL . 7.8 p -131.29 107.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.935 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.9 pp -102.52 140.56 36.64 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.433 -170.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 58.7 mt -112.44 106.47 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.47 0.652 . . . . 0.0 109.393 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.747 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 62.9 p -93.86 119.47 32.84 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.46 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.65 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.1 m -85.39 128.78 34.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 169.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.7 m -122.65 119.9 32.11 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.386 -171.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.631 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 75.2 t80 -124.89 122.85 38.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.537 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.631 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 48.4 mtp180 69.53 28.09 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.062 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.13 -0.7 82.0 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.265 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -121.69 128.64 52.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.203 0.525 . . . . 0.0 110.519 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.3 mp0 -79.84 139.75 37.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.946 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.751 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 42.6 p90 -124.1 -0.63 8.34 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.788 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.4 tt -159.12 158.86 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.617 -0.677 . . . . 0.0 109.185 174.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.587 ' HG3' HG22 ' A' ' 98' ' ' THR . 16.3 ttm180 -151.37 102.56 2.92 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -176.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.935 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.62 99.17 7.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.292 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.673 ' HA3' HD11 ' B' ' 130' ' ' ILE . . . -83.72 78.04 2.05 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.889 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.87 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -73.56 113.27 10.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.424 ' CB ' HD13 ' A' ' 140' ' ' LEU . 18.3 m-85 -67.3 127.57 33.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.222 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.776 HG11 ' CE2' ' A' ' 44' ' ' TYR . 7.7 p -109.53 111.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.37 1.081 . . . . 0.0 108.088 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.47 111.06 21.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.271 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 51.8 m-80 -99.29 107.71 20.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -173.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.54 131.63 34.12 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.836 -175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 55.7 m-85 -39.7 151.74 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.3 p -88.97 -33.88 17.06 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.328 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.66 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 6.5 mm-40 -82.46 122.42 28.0 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.875 177.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -55.75 -33.38 64.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.673 -171.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.92 -37.92 87.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.705 0.764 . . . . 0.0 109.549 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.0 mt -74.11 -23.35 59.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.557 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -76.29 -31.24 58.11 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 120' ' ' THR . 30.9 mm-40 -77.97 -33.95 51.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.46 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 1.9 p30 -144.67 87.57 7.44 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.106 0.479 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 11.6 Cg_endo -53.62 117.93 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.764 2.309 . . . . 0.0 110.727 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.499 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 77.3 Cg_exo -53.39 160.12 5.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.624 2.216 . . . . 0.0 110.798 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.49 -38.87 9.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 O-C-N 123.658 0.599 . . . . 0.0 111.494 -168.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.677 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 4.6 mmtt -124.44 127.6 25.21 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.677 ' HD2' ' HD3' ' A' ' 129' ' ' LYS . 7.5 Cg_exo -41.31 134.22 3.07 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.613 3.542 . . . . 0.0 113.257 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 25.0 t70 -114.52 114.46 25.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.705 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.2 m-85 -78.57 -16.93 56.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.08 -168.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.444 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -83.32 -28.65 28.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.241 177.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.66 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 66.0 mmtt -98.56 11.46 38.28 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 26.2 tp -91.05 147.11 23.3 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.894 -177.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.596 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 20.8 tt0 -124.88 123.06 39.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.828 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.0 mtp-105 -82.73 103.6 12.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.989 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 2.1 t30 -99.47 105.0 16.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.944 0.878 . . . . 0.0 108.808 171.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.684 HG23 HG13 ' A' ' 11' ' ' VAL . 1.6 mp -78.41 111.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.731 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.424 HD13 ' CB ' ' A' ' 112' ' ' TYR . 69.3 mt -68.16 86.91 0.27 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.87 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.62 -11.41 59.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 p -78.96 -10.66 59.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.069 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.495 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 17.1 m120 -133.06 58.4 34.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.065 -174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 6.0 Cg_exo -80.43 105.28 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.814 1.676 . . . . 0.0 111.053 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.662 ' HB3' HD11 ' B' ' 130' ' ' ILE . 12.6 tpp180 -82.45 81.16 8.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.519 HG12 HG23 ' A' ' 109' ' ' VAL . 6.1 m -83.26 104.77 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.609 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.475 HG22 ' CE1' ' A' ' 149' ' ' PHE . 21.4 m -111.48 106.8 15.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.687 0.756 . . . . 0.0 109.595 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.788 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.0 ptt180 -113.82 146.04 40.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.386 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.1 169.37 15.4 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.241 -173.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -105.0 130.31 53.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.687 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.547 HD12 ' HB3' ' A' ' 101' ' ' TYR . 43.4 pt -129.08 -177.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -103.38 87.54 2.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.673 0.749 . . . . 0.0 111.37 -174.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.618 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 37.3 m95 -73.15 -1.18 16.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.401 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -129.79 162.75 27.74 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.79 70.88 3.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.623 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.156 174.306 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.64 151.92 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.259 0.552 . . . . 0.0 111.496 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.507 ' O ' ' HE3' ' B' ' 122' ' ' LYS . 49.3 ttp -74.24 -32.88 63.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.63 105.13 1.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.592 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.674 ' HE2' ' HG3' ' A' ' 49' ' ' GLU . 23.2 mmtp -73.91 -33.7 64.08 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.93 -0.159 . . . . 0.0 110.856 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -37.26 -53.06 1.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.489 0.493 . . . . 0.0 111.804 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.76 -30.22 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.573 0.225 . . . . 0.0 111.408 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.627 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 9.1 mm100 -60.95 -52.33 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.291 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.672 ' HB3' HG22 ' A' ' 94' ' ' VAL . 2.4 mm? -67.07 -39.99 86.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.05 88.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.29 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 9.3 ptm180 -66.42 -35.89 81.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.78 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.781 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 23.0 tpt180 -64.7 -38.92 92.62 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.673 HD11 ' HA3' ' A' ' 110' ' ' GLY . 14.8 mt -76.05 -50.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -51.26 -43.2 61.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.95 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.37 57.66 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.065 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.781 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 26.2 mm-40 -103.83 -50.55 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.61 ' HG2' ' O ' ' B' ' 133' ' ' GLU . 9.7 ptm180 47.31 -179.99 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.294 175.373 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.669 0.271 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 31' ' ' ILE . . . -79.21 127.48 32.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 110.193 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 1.095 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.82 -20.42 23.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.98 -175.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.828 HG22 HD22 ' A' ' 38' ' ' LEU . 4.0 t -141.72 130.07 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.642 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -121.66 100.2 6.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.064 173.184 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.783 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -79.61 146.4 7.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.366 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -129.14 -65.57 0.86 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.202 -165.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.664 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.61 150.45 23.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.779 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.641 HG23 HG13 ' A' ' 26' ' ' ILE . 3.5 p -146.18 100.05 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 169.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -87.6 103.73 13.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.687 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.692 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -77.86 109.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.713 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.965 HD11 ' HG2' ' A' ' 23' ' ' GLN . 1.7 mt -89.72 -44.64 9.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.989 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.855 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.6 OUTLIER -69.32 75.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.622 1.677 . . . . 0.0 109.597 167.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.651 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -85.37 177.9 2.65 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.138 163.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.849 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.8 Cg_endo -48.83 103.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 121.916 1.72 . . . . 0.0 113.603 -154.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.668 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.4 m -129.78 171.24 9.2 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.425 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 83.7 Cg_exo -42.84 138.82 3.64 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.685 2.257 . . . . 0.0 112.106 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CE1' ' HG2' ' A' ' 79' ' ' PRO . 43.9 t80 -58.11 -29.62 65.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.659 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -89.12 1.3 55.82 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -78.66 144.52 65.12 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 12.1 Cg_exo -79.54 137.48 13.03 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 123.221 2.614 . . . . 0.0 112.831 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.666 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 25.3 m-85 -55.24 146.24 19.52 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.931 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.965 ' HG2' HD11 ' A' ' 12' ' ' LEU . 6.6 tt0 -136.46 92.44 2.77 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.206 -167.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 97' ' ' ILE . 52.9 m-85 -113.27 108.38 17.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.329 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.026 ' HB3' HG22 ' A' ' 10' ' ' VAL . 38.4 tt0 -96.27 88.1 4.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.641 HG13 HG23 ' A' ' 9' ' ' VAL . 3.2 mt -81.43 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.185 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.7 m -108.4 106.48 16.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.935 170.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.783 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 39.1 p90 -121.22 146.14 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.4 tt0 -102.36 110.52 22.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.506 ' HB2' ' C ' ' A' ' 67' ' ' ALA . 20.7 m -72.8 115.36 12.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -80.68 -31.38 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.856 -171.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.095 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 34.8 mt-10 -145.28 168.24 20.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.4 p-10 -73.45 131.57 41.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 111.798 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD12 HD21 ' A' ' 38' ' ' LEU . 75.6 mt -83.15 159.21 22.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.497 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 p -112.25 -19.65 12.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.643 0.735 . . . . 0.0 109.215 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -136.97 -172.45 3.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.516 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.94 151.48 33.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.481 0.658 . . . . 0.0 110.761 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.828 HD22 HG22 ' A' ' 4' ' ' VAL . 4.6 tp -107.46 123.16 47.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 23.3 tt0 -106.03 135.58 47.23 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.868 -174.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.609 ' CE3' ' SG ' ' A' ' 99' ' ' CYS . 19.1 m95 -132.14 124.52 29.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.832 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.0 ttmp? -125.49 146.62 49.56 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.812 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.553 HD12 HG12 ' A' ' 97' ' ' ILE . 18.9 mm -102.75 106.87 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 87.6 mt -103.02 106.94 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.801 0.81 . . . . 0.0 109.886 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.667 ' CE2' ' HG3' ' A' ' 79' ' ' PRO . 18.8 t80 -87.46 115.61 25.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.756 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 t -66.38 99.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 121.378 0.608 . . . . 0.0 109.712 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -57.91 -43.45 94.86 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.231 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.661 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 46.7 t -123.69 109.38 13.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.97 -5.66 32.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.419 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -100.89 -22.09 14.92 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.163 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.491 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.9 m -116.07 -150.32 0.46 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.989 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' HB2' ' HD2' ' B' ' 129' ' ' ARG . 8.9 pt-20 -150.69 -33.28 0.17 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.767 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.78 2.57 5.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.389 0.614 . . . . 0.0 111.401 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.661 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 95.8 m-85 -94.58 4.28 54.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.53 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.53 110.17 0.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.012 0.91 . . . . 0.0 109.938 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 4.4 mt-30 -96.02 166.69 11.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.306 -176.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.696 HG21 ' HD3' ' A' ' 41' ' ' LYS . 42.3 t -127.31 106.26 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.971 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.605 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 4.0 mt -75.16 -48.23 24.6 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.741 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -170.48 165.3 8.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.843 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 p -141.9 128.92 20.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.553 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.4 p -99.5 133.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.946 -173.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.36 105.13 14.67 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.733 0.777 . . . . 0.0 110.099 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 98.3 t -83.56 155.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.47 -163.19 37.08 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.826 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.633 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 61.1 Cg_endo -89.83 118.21 0.75 Allowed 'Trans proline' 0 N--CA 1.424 -2.565 0 C-N-CA 122.057 1.838 . . . . 0.0 110.284 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.481 ' H ' HD11 ' A' ' 34' ' ' LEU . 33.8 m -119.51 134.0 23.81 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.489 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.8 Cg_endo -79.13 83.51 2.25 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 113.453 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.506 ' C ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.04 -171.35 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.653 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.613 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 105.01 132.32 7.36 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.824 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 14.8 ttp180 -75.08 113.69 12.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.458 0.647 . . . . 0.0 110.286 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.613 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 21.8 m-70 -111.39 129.1 56.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 ttp -106.66 111.84 24.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 168.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' CD1' ' HE1' ' A' ' 28' ' ' PHE . 4.8 p90 -126.13 141.09 52.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.739 0.781 . . . . 0.0 109.326 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.793 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 2.2 p -101.41 116.71 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.536 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.45 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -119.28 132.28 55.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.281 -168.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 44.6 mt-30 -125.15 160.45 29.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.699 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 57' ' ' LEU . . . -153.48 137.63 16.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.035 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 20.6 t70 -57.4 162.1 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . . . -62.61 158.42 50.65 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 121.509 0.671 . . . . 0.0 111.526 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.687 ' HG2' ' CE1' ' A' ' 18' ' ' PHE . 28.9 Cg_endo -62.28 171.41 5.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.813 2.342 . . . . 0.0 111.702 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.87 115.28 62.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.603 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.56 -16.2 53.23 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.631 2.888 . . . . 0.0 112.816 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.84 -18.3 56.54 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.127 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.544 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 46.5 mt -91.9 -15.22 28.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.683 0.278 . . . . 0.0 111.385 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.51 HD12 ' CE1' ' A' ' 44' ' ' TYR . 17.1 mt -91.42 127.61 50.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.447 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.418 ' O ' HG21 ' A' ' 84' ' ' ILE . 98.5 Cg_endo -80.68 160.01 21.86 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.726 2.284 . . . . 0.0 111.81 171.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.726 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 6.5 m-20 -46.45 -50.02 17.45 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.419 0.687 . . . . 0.0 112.615 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB1' ' HZ3' ' B' ' 122' ' ' LYS . . . -63.17 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.538 -169.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.02 -19.63 21.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.929 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.9 -46.36 30.51 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.147 0.499 . . . . 0.0 111.635 -175.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -98.17 48.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.289 1.042 . . . . 0.0 110.492 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.58 -137.75 2.27 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.391 -161.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' B' ' 122' ' ' LYS . 9.8 p -130.46 145.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.714 0.769 . . . . 0.0 110.835 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.616 HG23 HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -157.33 174.59 15.19 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 96' ' ' LEU . 2.2 t -124.17 145.01 31.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.511 -0.475 . . . . 0.0 112.152 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.505 HG13 ' CZ ' ' A' ' 22' ' ' PHE . 27.7 m -116.78 105.17 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.793 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.57 136.27 41.7 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.922 -173.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.832 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 25.7 mt -95.79 103.14 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.885 HG23 ' HG3' ' A' ' 108' ' ' ARG . 58.1 p -97.04 110.8 23.27 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.75 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.729 ' SG ' HG21 ' A' ' 107' ' ' ILE . 4.7 m -85.6 143.88 28.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.891 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -135.16 129.35 33.67 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -172.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 153' ' ' TRP . 84.3 t80 -135.84 118.1 15.59 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.78 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 29.2 mtp180 67.66 27.12 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.779 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.08 70.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.363 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.16 120.66 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.012 0.434 . . . . 0.0 110.354 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.667 ' OE1' ' HD2' ' B' ' 134' ' ' ARG . 41.2 mp0 -76.85 124.89 28.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 151' ' ' ILE . 34.3 p90 -110.37 -8.66 14.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -168.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 98' ' ' THR . 1.7 tt -158.89 162.4 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 119.443 1.02 . . . . 0.0 110.332 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.885 ' HG3' HG23 ' A' ' 98' ' ' THR . 14.1 ttm180 -146.53 105.59 3.88 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.2 p -95.22 100.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.235 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.76 80.99 1.78 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.878 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.866 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 9.6 m-85 -77.34 116.63 18.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.636 ' HE2' ' HA ' ' B' ' 123' ' ' ASP . 20.5 m-85 -68.0 133.11 48.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.446 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.653 HG11 ' CE2' ' A' ' 44' ' ' TYR . 7.2 p -113.95 110.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.14 130.0 40.51 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.603 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 40.3 m-80 -111.14 113.45 25.98 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -171.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -123.96 124.87 43.54 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.519 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 17.0 m-85 -44.73 151.88 0.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.851 0.834 . . . . 0.0 112.658 173.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -92.43 -34.08 14.28 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.602 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.654 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 2.0 tm-20 -78.76 122.95 26.67 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.977 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 6.1 m -52.57 -34.94 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.465 -171.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.11 -35.65 66.6 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 43.2 mt -71.72 -27.76 63.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.483 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 17.9 mtt180 -73.07 -32.46 65.04 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.3 mm-40 -67.58 -38.68 84.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.917 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.547 ' N ' HD21 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -157.47 96.07 2.05 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 121.306 0.574 . . . . 0.0 110.57 178.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.5 Cg_endo -56.14 117.61 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.954 2.436 . . . . 0.0 111.368 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.79 153.51 43.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.128 1.885 . . . . 0.0 110.353 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.1 p -42.14 -41.01 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.851 0.72 . . . . 0.0 112.104 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.512 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -110.4 109.75 58.25 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 122.293 1.044 . . . . 0.0 113.334 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.726 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.6 Cg_exo -45.54 140.33 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.778 1 C-N-CA 125.54 4.16 . . . . 0.0 113.892 175.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.62 112.84 22.73 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.686 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 3.6 m-85 -77.98 -18.38 56.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.812 0.815 . . . . 0.0 110.847 -168.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -13.25 50.3 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.3 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.9 mmtt -104.09 12.67 33.73 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.7 tp -99.83 133.38 44.27 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.392 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.94 122.09 41.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.971 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.849 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.69 110.93 23.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.484 0.659 . . . . 0.0 111.501 -175.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.841 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 3.4 t30 -95.03 109.32 21.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.64 176.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.692 HG23 HG13 ' A' ' 11' ' ' VAL . 1.6 mp -81.54 114.67 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.227 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.413 HD13 ' CB ' ' A' ' 112' ' ' TYR . 80.8 mt -69.78 85.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 110.772 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.866 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -72.13 -20.11 61.67 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.528 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.7 p -78.83 -8.55 58.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.767 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -135.07 69.34 70.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.016 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 77.2 Cg_endo -89.84 114.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.36 2.04 . . . . 0.0 111.608 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.513 ' CB ' HD11 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -82.21 81.76 7.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.202 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.541 HG12 HG21 ' A' ' 109' ' ' VAL . 26.8 m -78.24 130.04 36.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.406 HG22 ' CE2' ' A' ' 149' ' ' PHE . 51.6 m -148.82 106.88 3.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.254 176.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -112.73 147.13 37.47 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.983 0.897 . . . . 0.0 110.705 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -126.06 170.41 11.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.45 -173.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -94.91 119.94 34.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.994 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 18.0 pt -120.26 -173.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.0 109.766 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.483 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -108.2 91.6 3.71 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.437 -176.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.602 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 17.9 m95 -78.78 -13.51 59.77 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.303 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -128.2 173.89 9.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.772 -173.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -102.08 71.87 1.29 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.182 175.782 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -134.85 27.11 3.62 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.72 -0.283 . . . . 0.0 111.075 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 71.0 mtp 69.5 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.688 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.86 162.15 17.98 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.595 ' C ' HD23 ' B' ' 126' ' ' LEU . 4.0 mptp? -81.67 -50.0 9.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.636 ' HA ' ' HE2' ' A' ' 112' ' ' TYR . 1.2 p30 -37.73 -49.93 1.18 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 7.1 tp -65.2 -40.73 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 111.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.615 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 0.7 OUTLIER -65.2 -35.78 82.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 110.648 177.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.595 HD23 ' C ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -64.03 -42.58 97.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.48 -33.03 73.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.96 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.615 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 10.4 mmm180 -54.59 -49.33 70.66 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.22 0.533 . . . . 0.0 110.006 173.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.714 ' HD3' ' HB2' ' B' ' 133' ' ' GLU . 6.2 mmp_? -69.18 -30.63 68.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.135 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.622 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 56.7 mt -75.08 -15.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -94.32 -20.05 20.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.65 39.6 0.22 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 119.6 -1.286 . . . . 0.0 114.373 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.714 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 5.3 tp10 -138.06 72.34 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.478 0.656 . . . . 0.0 109.552 172.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.667 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 10.8 ptt180 -69.0 -58.28 4.31 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.605 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.543 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.244 0.799 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.288 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.389 0.138 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.577 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -64.15 119.82 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.219 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.731 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 2.7 mmtt -100.15 -7.1 25.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.506 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.3 t -139.57 123.24 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.329 0.585 . . . . 0.0 110.553 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp60 -117.0 100.5 7.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.814 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.3 m -79.64 135.73 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -117.16 -63.61 1.42 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.003 -164.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.582 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.0 t-20 -103.96 152.7 21.68 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.644 -174.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG13 ' CE2' ' A' ' 111' ' ' TYR . 3.1 p -146.89 100.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 1.007 HG21 ' HB2' ' A' ' 25' ' ' GLU . 1.0 OUTLIER -94.18 97.58 7.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.012 -177.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.572 HG12 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -73.62 132.91 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.158 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 1.068 HD13 ' HG2' ' A' ' 23' ' ' GLN . 7.0 mt -103.85 -65.04 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.384 -169.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.576 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -88.15 55.04 3.28 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.382 1.087 . . . . 0.0 111.748 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 1.043 ' HA ' HD11 ' A' ' 139' ' ' ILE . 27.0 p-10 -81.42 -176.21 0.74 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 161.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.841 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.3 Cg_endo -41.67 104.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 122.428 2.085 . . . . 0.0 114.95 -125.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.652 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.2 m -139.61 172.72 5.98 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 110.305 -3.134 . . . . 0.0 107.054 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.652 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 85.3 Cg_exo -41.26 136.56 2.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.139 1.893 . . . . 0.0 111.964 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.699 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 28.6 t80 -60.18 -27.27 66.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.158 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -78.71 -14.32 59.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.706 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -72.95 134.21 81.3 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 22.9 Cg_exo -71.81 146.18 47.51 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.738 2.959 . . . . 0.0 113.599 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 62.4 m-85 -55.71 124.86 18.86 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.587 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.068 ' HG2' HD13 ' A' ' 12' ' ' LEU . 8.7 tt0 -125.56 100.28 6.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.455 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.639 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.9 m-85 -111.39 155.53 22.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.442 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.007 ' HB2' HG21 ' A' ' 10' ' ' VAL . 59.2 mt-10 -126.27 91.28 3.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 163.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.549 HG23 ' CZ3' ' A' ' 40' ' ' TRP . 6.7 mt -83.72 127.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 122.065 0.936 . . . . 0.0 112.432 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.3 m -101.21 106.42 17.64 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.526 173.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.814 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 25.1 p90 -110.86 141.62 44.0 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.526 0.679 . . . . 0.0 109.913 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.848 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.6 tt0 -102.83 113.46 26.9 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.7 m -71.87 122.32 20.55 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -87.41 -23.94 6.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.639 -169.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.23 178.13 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.74 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.865 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 21.9 t70 -78.49 123.47 27.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.414 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.95 HD13 HD23 ' A' ' 38' ' ' LEU . 1.9 mt -81.34 154.96 26.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.033 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -111.81 -35.07 5.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.297 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.685 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 30.5 tt0 -116.47 -169.06 1.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.085 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.685 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -88.38 151.76 22.37 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.669 0.747 . . . . 0.0 109.666 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.95 HD23 HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.74 123.32 42.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.651 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 18.5 tt0 -97.05 132.75 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.336 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.754 ' CH2' HG13 ' A' ' 6' ' ' VAL . 69.3 m95 -130.48 109.42 10.68 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.305 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.879 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 4.6 ptpp? -126.0 154.81 42.4 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.217 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG13 ' CZ ' ' A' ' 74' ' ' PHE . 37.0 mt -103.37 118.71 50.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.266 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.515 HD12 ' CD ' ' A' ' 41' ' ' LYS . 2.5 mp -102.46 105.97 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.55 ' HD1' ' CG1' ' A' ' 95' ' ' VAL . 76.7 t80 -83.6 114.33 21.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG11 HD13 ' B' ' 126' ' ' LEU . 4.1 t -62.11 98.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -35.37 40.58 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.749 ' HB3' ' CG ' ' A' ' 53' ' ' TYR . 6.7 p -99.21 88.49 3.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.708 -0.746 . . . . 0.0 112.321 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.624 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -90.5 -16.89 28.06 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 163.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -89.43 -42.69 11.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.238 -1.347 . . . . 0.0 109.566 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.736 ' C ' ' HB2' ' A' ' 47' ' ' SER . 57.7 m -106.64 -146.76 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -150.62 -4.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -95.62 3.05 54.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.749 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 6.7 m-30 -90.12 -15.46 31.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 119.169 -0.443 . . . . 0.0 111.419 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -41.64 111.59 0.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.295 1.045 . . . . 0.0 111.564 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 53' ' ' TYR . 14.4 mt-30 -93.45 166.56 12.21 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.173 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.431 HG21 HG13 ' A' ' 43' ' ' ILE . 54.6 t -130.94 103.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 3.6 mm? -70.57 -37.22 73.94 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -171.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 24.8 t0 -177.5 154.11 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.01 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.879 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 97.6 p -130.07 110.32 11.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 40' ' ' TRP . 11.7 p -99.2 139.84 20.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.895 -166.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 mt -108.22 103.68 12.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.547 0.689 . . . . 0.0 111.353 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.6 t -85.34 155.05 3.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.76 -164.57 40.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.654 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.72 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.6 Cg_endo -69.97 114.57 3.78 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.238 1.292 . . . . 0.0 109.967 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.3 m -108.85 119.33 49.33 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.036 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.865 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 70.7 Cg_endo -84.26 77.48 3.18 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.725 2.283 . . . . 0.0 113.654 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.69 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 51.39 169.15 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.796 -2.002 . . . . 0.0 112.554 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.32 123.0 3.22 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.072 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 11.2 ttt180 -74.76 122.33 23.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.499 0.666 . . . . 0.0 110.852 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.517 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.0 p80 -154.35 146.13 23.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.163 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.679 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 5.5 ttp -97.78 130.2 44.74 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.213 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.3 p90 -112.26 153.44 27.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.625 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.7 p -111.16 132.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.845 0.831 . . . . 0.0 110.224 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.639 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -117.13 130.94 56.95 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.933 -165.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.731 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 25.7 mt-30 -141.6 153.78 45.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -164.51 157.85 17.61 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.526 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.71 -177.22 0.22 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.683 0.754 . . . . 0.0 112.56 -172.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -89.7 147.77 38.46 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.868 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.66 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.8 Cg_exo -55.43 154.99 22.08 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 123.521 2.814 . . . . 0.0 113.106 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -77.91 118.42 72.04 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.403 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.43 -13.73 41.31 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.523 2.816 . . . . 0.0 112.778 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.62 -4.93 57.94 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.898 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.79 -25.5 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.55 0.214 . . . . 0.0 110.769 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 85' ' ' PRO . 41.1 mt -84.66 130.3 53.73 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.919 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.499 ' O ' HG23 ' A' ' 84' ' ' ILE . 62.6 Cg_endo -80.11 164.62 22.11 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.36 2.706 . . . . 0.0 112.359 170.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.671 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 7.5 t70 -43.94 -58.04 3.0 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.669 1.187 . . . . 0.0 113.768 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HZ3' ' B' ' 122' ' ' LYS . . . -83.0 -8.11 59.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.133 -165.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.523 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 56.5 m-20 -94.44 -22.37 18.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.681 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -85.64 -47.16 10.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.629 -176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 130' ' ' PRO . 1.6 m -101.34 46.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.814 0.816 . . . . 0.0 111.049 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.89 -157.68 8.57 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.48 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.614 ' CG1' ' HB2' ' B' ' 122' ' ' LYS . 10.0 p -97.36 144.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.67 0.748 . . . . 0.0 109.533 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.62 171.6 19.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -171.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.0 t -133.68 146.68 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.787 0.722 . . . . 0.0 111.944 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.55 ' CG1' ' HD1' ' A' ' 44' ' ' TYR . 27.2 m -121.8 106.31 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.924 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -102.17 125.01 48.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.127 -173.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 50.4 mt -96.0 101.94 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.8 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 45.2 p -98.67 117.0 32.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.38 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 62.4 m -80.66 152.46 28.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.612 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 11.7 m -145.56 119.02 9.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.652 ' CE1' ' HA ' ' A' ' 153' ' ' TRP . 35.1 t80 -135.43 128.75 32.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 4.5 mmp_? 67.0 12.84 9.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.416 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.48 1.14 57.88 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.825 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -116.6 150.3 38.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -99.72 134.41 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.847 -172.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.752 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 52.4 p90 -120.01 -2.94 10.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -170.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.8 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.5 tt -156.75 159.92 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.848 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 17.7 ttp180 -151.6 99.94 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.845 0.716 . . . . 0.0 109.306 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.924 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.4 p -85.44 101.49 9.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.258 175.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.79 78.08 2.04 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.722 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.951 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -73.7 114.2 11.7 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.455 -0.872 . . . . 0.0 109.015 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.424 ' CB ' HD13 ' A' ' 140' ' ' LEU . 23.5 m-85 -67.72 126.39 29.24 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.532 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.531 HG11 ' HE1' ' A' ' 44' ' ' TYR . 7.5 p -111.49 111.23 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 26.3 t-20 -92.87 117.74 30.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.472 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.448 ' HB3' HD12 ' A' ' 135' ' ' LEU . 48.2 m-80 -109.5 108.65 19.21 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.81 0.814 . . . . 0.0 109.883 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -137.48 139.24 40.45 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.33 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.681 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 62.0 m-85 -46.76 152.42 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -174.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.408 HG22 ' HG3' ' A' ' 136' ' ' GLN . 30.3 p -91.27 -38.29 12.76 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.063 -1.426 . . . . 0.0 108.846 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.908 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -78.25 125.49 29.43 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.062 -174.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 4.9 m -47.76 -43.11 27.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.824 0.702 . . . . 0.0 111.697 -168.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.19 -35.88 82.46 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.627 0.727 . . . . 0.0 110.266 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 56.3 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.44 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -74.54 -37.33 63.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.8 mm-40 -63.6 -43.43 96.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.705 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.442 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.3 p30 -144.35 82.03 10.91 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.11 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.2 Cg_endo -50.19 116.87 2.71 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.491 2.794 . . . . 0.0 112.326 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.681 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 69.0 Cg_exo -54.54 137.64 73.33 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.713 2.276 . . . . 0.0 111.088 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.589 HG12 ' HE2' ' A' ' 129' ' ' LYS . 36.7 t -50.04 -40.36 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.987 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HE2' HG12 ' A' ' 128' ' ' VAL . 2.0 mmpt? -103.35 136.51 19.21 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 111.121 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.671 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -64.39 131.27 29.39 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.749 2.966 . . . . 0.0 113.022 -175.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 23.7 t70 -114.21 114.34 25.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 171.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.699 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 20.6 m-85 -79.22 -15.45 58.01 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.847 -169.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 -28.18 26.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.521 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.908 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 69.7 mmtt -101.68 10.93 39.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 27.0 tp -89.23 138.54 31.34 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.516 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.408 ' HG3' HG22 ' A' ' 118' ' ' THR . 3.4 tt0 -113.45 123.03 49.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.841 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -93.02 106.74 18.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.249 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.5 t30 -92.23 105.88 18.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.946 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 1.043 HD11 ' HA ' ' A' ' 14' ' ' ASN . 1.1 mp -80.66 107.18 12.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.424 HD13 ' CB ' ' A' ' 112' ' ' TYR . 85.9 mt -67.81 84.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.968 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.951 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -73.05 -12.81 61.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.673 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 -9.51 59.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.906 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.49 70.47 76.5 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.783 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 72.1 Cg_endo -89.28 105.02 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.543 1.496 . . . . 0.0 110.404 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.67 81.06 8.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.7 m -77.06 104.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 0.0 111.261 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.448 HG22 ' CE2' ' A' ' 149' ' ' PHE . 26.5 m -109.4 105.05 14.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.76 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -116.78 133.3 56.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.531 0.681 . . . . 0.0 110.533 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -119.34 167.79 11.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.913 -175.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -104.58 123.14 47.01 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.571 HD11 ' HB3' ' A' ' 101' ' ' TYR . 45.1 pt -119.26 -174.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.505 0.669 . . . . 0.0 109.873 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 1.0 OUTLIER -90.73 105.71 18.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.032 176.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.731 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 11.8 m95 -86.47 2.41 47.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.477 ' HB2' HD21 ' A' ' 156' ' ' ASN . 1.5 mp0 -115.03 -179.45 3.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.78 176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.93 71.9 0.79 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.529 0.68 . . . . 0.0 109.915 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 154' ' ' GLU . 35.4 m-80 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.21 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 60.16 68.64 0.76 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.797 0.439 . . . . 0.0 111.494 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 66.9 mtp -54.93 -73.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.487 0.661 . . . . 0.0 109.592 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.6 154.35 19.68 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.689 ' O ' HD23 ' B' ' 126' ' ' LEU . 27.4 mmtp -64.79 -20.88 66.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.191 0.496 . . . . 0.0 111.395 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -36.66 -51.76 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.7 0.625 . . . . 0.0 112.292 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.7 -40.62 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 5.5 mm100 -54.6 -51.08 66.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 174.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.689 HD23 ' O ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -65.28 -43.99 89.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.989 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.64 -37.47 81.61 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.304 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -61.39 -39.12 89.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.5 mmt180 -73.09 -28.39 62.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.084 0.468 . . . . 0.0 110.003 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.848 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 31.1 mt -82.76 -8.5 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.22 -24.35 18.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.723 177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' B' ' 135' ' ' ALA . . . 164.02 59.02 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.709 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.537 ' OE2' ' HD3' ' B' ' 134' ' ' ARG . 0.2 OUTLIER -76.52 -42.61 42.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.537 ' HD3' ' OE2' ' B' ' 133' ' ' GLU . 3.5 mpt_? -103.28 -75.97 0.6 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.622 169.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.55 ' O ' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.748 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.616 0.246 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.445 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -88.75 130.16 35.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.763 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.62 -20.92 21.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.597 HG23 HD21 ' A' ' 34' ' ' LEU . 4.3 t -140.71 130.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 111.396 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.617 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 13.7 tp60 -123.72 99.71 6.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.656 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -75.87 142.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.073 177.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -127.21 -71.84 0.66 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.263 -163.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.42 100.75 10.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.519 -171.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.636 HG13 ' OH ' ' A' ' 111' ' ' TYR . 2.4 p -100.45 105.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.627 HG21 ' HB3' ' A' ' 25' ' ' GLU . 2.5 m -99.33 98.27 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.917 0.865 . . . . 0.0 109.435 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.522 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 132.58 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.111 -176.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 1.0 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -101.65 -40.07 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.048 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.561 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 37.1 t0 -67.05 64.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.73 165.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.888 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m120 -83.06 172.95 8.29 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.121 -1.854 . . . . 0.0 108.148 160.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.888 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.4 Cg_endo -50.88 102.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.374 1.383 . . . . 0.0 113.181 -153.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.572 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 17.9 m -132.02 170.96 9.98 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.815 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 68.7 Cg_exo -42.44 140.86 2.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.416 2.077 . . . . 0.0 111.768 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.708 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 6.3 t80 -59.6 -32.12 70.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.043 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -81.68 -9.75 59.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.0 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -63.0 126.23 88.5 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 26.0 Cg_exo -68.25 146.1 68.44 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 123.347 2.698 . . . . 0.0 112.845 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.801 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 87.1 m-85 -52.04 135.72 30.56 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.178 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.0 ' HG2' HD12 ' A' ' 12' ' ' LEU . 6.6 tt0 -140.42 84.93 1.98 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.451 -171.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.722 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 96.6 m-85 -100.08 149.76 23.16 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.68 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.926 ' HG3' ' HE2' ' A' ' 71' ' ' MET . 32.9 tt0 -124.62 87.43 2.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.591 HG23 ' CZ3' ' A' ' 40' ' ' TRP . 26.8 mt -88.75 125.49 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.697 0.76 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 21.5 m -103.39 110.68 22.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.467 172.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HE2' HG21 ' A' ' 65' ' ' VAL . 31.8 p90 -112.75 145.29 40.8 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.836 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.5 tt0 -101.68 114.05 27.75 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 53.2 t -72.35 114.85 10.92 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -81.32 -25.14 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.411 -173.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.763 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.3 mt-10 -153.84 143.56 21.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -55.98 129.97 41.94 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.592 0.558 . . . . 0.0 110.866 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.916 ' HG ' HD22 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -85.1 163.75 18.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.586 0.708 . . . . 0.0 112.365 -169.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 t -113.17 -40.71 3.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.206 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.46 -167.74 1.66 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.311 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -89.84 135.57 33.56 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.236 1.017 . . . . 0.0 109.295 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.916 HD22 ' HG ' ' A' ' 34' ' ' LEU . 3.9 mm? -79.07 143.56 35.46 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.892 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 33.3 tt0 -116.12 135.61 53.77 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.673 173.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.626 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.7 m95 -123.39 125.76 45.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.763 ' HD2' HD12 ' A' ' 43' ' ' ILE . 23.6 ttmt -123.35 143.05 50.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.374 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.7 mt -103.49 108.34 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.358 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.763 HD12 ' HD2' ' A' ' 41' ' ' LYS . 3.8 mp -107.06 109.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.5 0.667 . . . . 0.0 109.427 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.765 ' CD2' ' HG3' ' A' ' 79' ' ' PRO . 22.9 t80 -89.9 109.59 20.6 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.214 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.766 ' O ' HG22 ' A' ' 93' ' ' THR . 25.3 t -69.71 96.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -72.63 -32.54 61.57 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.202 -1.475 . . . . 0.0 109.965 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.773 ' HB2' ' C ' ' A' ' 50' ' ' SER . 4.1 p -88.55 75.93 8.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.4 59.0 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 161.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -100.27 -45.69 5.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.331 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.773 ' C ' ' HB2' ' A' ' 47' ' ' SER . 49.4 m -103.42 -147.32 0.38 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.79 9.07 0.45 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.111 0.481 . . . . 0.0 110.476 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.19 -8.8 26.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.528 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.613 ' HB2' ' N ' ' A' ' 47' ' ' SER . 29.8 m-85 -95.8 1.9 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -168.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.32 104.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.026 0.917 . . . . 0.0 110.875 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 46.7 mt-30 -95.6 164.12 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.485 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.482 HG23 HG13 ' A' ' 43' ' ' ILE . 49.5 t -131.07 112.21 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.62 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 mm? -82.29 -55.32 4.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.052 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.65 153.42 30.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.72 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 26.2 p -133.44 109.86 9.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -97.99 135.4 32.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.922 -169.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.8 mt -105.25 103.23 12.73 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.201 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.71 131.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.588 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.45 -159.51 11.26 Favored Glycine 0 CA--C 1.494 -1.248 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.998 -164.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.708 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 37.1 Cg_endo -63.71 114.78 2.71 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.71 HG21 ' HE2' ' A' ' 28' ' ' PHE . 35.1 m -110.71 145.36 32.17 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.85 -174.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 136.86 26.69 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.701 2.267 . . . . 0.0 111.448 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -46.76 139.28 5.46 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 111.28 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.505 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 128.84 135.1 3.91 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.836 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.2 ptt180 -76.65 130.4 37.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.432 1.111 . . . . 0.0 111.062 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.505 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 12.5 p80 -149.98 143.61 25.31 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.038 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.926 ' HE2' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -93.02 146.44 23.62 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.566 0.698 . . . . 0.0 112.537 -174.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' N ' ' HG2' ' A' ' 71' ' ' MET . 3.0 p90 -133.6 160.74 36.6 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 1.7 p -118.75 139.32 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 121.734 0.778 . . . . 0.0 111.091 -172.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.722 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -121.96 125.87 47.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.95 -166.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.801 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.2 mt-30 -144.19 148.23 34.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.989 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.02 128.62 0.73 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.569 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 57' ' ' LEU . 6.0 p-10 -62.12 165.11 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.646 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.582 ' HB3' ' HD2' ' A' ' 79' ' ' PRO . . . -59.01 160.73 10.51 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -170.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.765 ' HG3' ' CD2' ' A' ' 44' ' ' TYR . 60.5 Cg_endo -67.67 178.67 3.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.75 2.967 . . . . 0.0 111.673 175.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 91.6 m-20 -72.13 119.45 74.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.249 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -64.07 -19.58 66.45 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.347 2.698 . . . . 0.0 111.756 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.19 -9.1 77.24 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.361 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.5 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 5.7 mt -94.1 -25.36 17.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.993 0.396 . . . . 0.0 110.91 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 89' ' ' ALA . 21.2 mt -78.7 127.84 79.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.797 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 96.3 Cg_endo -78.21 163.23 27.93 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.396 2.73 . . . . 0.0 112.231 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.66 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 15.2 t70 -44.53 -57.06 3.83 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.32 1.048 . . . . 0.0 113.614 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB2' ' HE2' ' B' ' 122' ' ' LYS . . . -74.22 -20.88 60.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.776 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.87 -33.82 22.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.356 0.598 . . . . 0.0 109.658 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -77.2 -42.51 37.24 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.752 -171.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.688 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.4 m -103.08 47.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.634 0.73 . . . . 0.0 112.075 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -119.98 0.55 Allowed Glycine 0 CA--C 1.504 -0.601 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.15 -169.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.485 HG12 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -112.88 141.15 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.981 ' HB ' HG11 ' A' ' 113' ' ' VAL . 24.2 m -143.08 167.96 20.86 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.2 t -134.42 139.08 48.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 170.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 111' ' ' TYR . 1.8 p -119.82 104.97 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.92 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.2 pp -101.27 131.51 47.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.385 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.2 mt -99.42 92.68 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.79 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.83 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 73.1 p -91.09 112.99 25.13 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 89.7 m -76.69 156.29 32.66 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.008 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.0 m -150.96 108.66 3.67 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -170.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.66 ' CZ ' HD11 ' A' ' 34' ' ' LEU . 79.5 t80 -126.76 132.77 50.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.424 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.3 mmm180 67.22 12.56 9.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.493 0.496 . . . . 0.0 111.998 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.6 56.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.118 174.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.816 ' CG ' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.2 149.17 43.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 23.8 mp0 -95.66 134.59 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.069 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 99' ' ' CYS . 53.4 p90 -120.52 -3.76 9.86 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -170.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.83 ' O ' ' HA ' ' A' ' 98' ' ' THR . 10.6 tt -155.48 161.21 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 O-C-N 121.209 -0.932 . . . . 0.0 109.058 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.795 ' HE ' ' HB ' ' A' ' 147' ' ' THR . 0.4 OUTLIER -153.91 99.47 2.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.92 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.3 p -87.16 101.79 11.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.088 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.8 86.52 1.55 Allowed Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 118.943 -1.598 . . . . 0.0 111.129 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.87 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.6 m-85 -73.91 115.2 13.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.276 -0.962 . . . . 0.0 109.538 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' A' ' 140' ' ' LEU . 3.3 m-85 -67.06 112.94 4.66 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.479 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.981 HG11 ' HB ' ' A' ' 93' ' ' THR . 2.4 p -104.31 111.31 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.485 HD22 HG12 ' A' ' 92' ' ' VAL . 1.6 t-20 -96.5 113.65 25.24 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.852 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.8 m-20 -94.65 109.15 21.11 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.48 0.657 . . . . 0.0 109.415 -170.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.47 124.41 40.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.828 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.581 ' CZ ' ' HD2' ' A' ' 127' ' ' PRO . 42.9 m-85 -39.39 149.43 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 29.8 p -87.58 -32.82 19.14 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.544 -174.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.511 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.2 mt-10 -87.78 126.39 34.98 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.262 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.575 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 22.0 m -56.27 -31.22 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.164 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.64 -37.89 76.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.595 0.712 . . . . 0.0 110.008 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.518 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 45.2 mt -71.29 -25.41 62.43 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.329 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -73.81 -36.94 65.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.598 0.713 . . . . 0.0 109.136 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.6 mm-40 -66.82 -36.78 83.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.982 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -143.42 87.99 8.19 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.679 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 115.04 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.664 2.243 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.581 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 89.2 Cg_exo -51.06 163.77 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.847 2.364 . . . . 0.0 111.783 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.476 HG13 ' HE2' ' A' ' 129' ' ' LYS . 40.5 t -51.87 -52.17 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.166 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.514 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 1.7 mmtt -116.96 121.24 32.89 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 121.435 0.636 . . . . 0.0 110.928 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.688 ' HB3' HG13 ' A' ' 90' ' ' VAL . 16.3 Cg_exo -35.32 131.73 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 1 C-N-CA 125.778 4.319 . . . . 0.0 114.34 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -105.42 109.27 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.127 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.695 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 40.2 m-85 -75.32 -17.26 60.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.94 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -84.2 -25.43 29.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.262 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 72.8 mmtt -95.51 6.16 49.69 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 115' ' ' ASN . 31.1 tp -92.36 127.84 37.99 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.578 -173.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.543 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 1.3 tt0 -111.6 114.46 27.53 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.771 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.9 ptt180 -90.46 111.44 22.71 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.413 0.625 . . . . 0.0 111.05 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 19.7 t30 -87.89 98.06 11.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.105 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.522 HG23 HG13 ' A' ' 11' ' ' VAL . 2.2 mp -73.43 101.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 112' ' ' TYR . 76.7 mt -63.0 89.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.325 0.583 . . . . 0.0 110.792 -176.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.87 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -77.83 -9.71 59.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.96 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.41 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 5.7 p -79.55 -15.6 57.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 172.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.421 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 47.3 t-20 -128.29 66.69 73.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.94 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 4.5 Cg_exo -83.05 105.01 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.03 1.82 . . . . 0.0 110.616 170.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.7 81.32 8.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.941 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.456 ' CG1' HG23 ' A' ' 109' ' ' VAL . 7.2 m -79.28 106.68 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.543 . . . . 0.0 111.722 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.795 ' HB ' ' HE ' ' A' ' 108' ' ' ARG . 42.0 m -110.45 105.34 14.29 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.714 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -113.13 123.82 51.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.597 0.713 . . . . 0.0 110.396 -175.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.02 168.24 9.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.728 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -104.11 111.92 24.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.816 ' HB ' ' CG ' ' A' ' 104' ' ' GLN . 18.3 pt -118.13 172.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.893 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 154' ' ' GLU . 3.4 p30 -101.98 97.67 7.98 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.595 1.188 . . . . 0.0 109.903 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.467 ' HA ' ' CD2' ' A' ' 101' ' ' TYR . 13.1 m95 -67.98 0.82 3.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.732 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' A' ' 152' ' ' ASN . 34.6 mt-10 -135.27 -166.97 1.92 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.584 -173.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -97.49 71.84 2.33 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.162 -178.157 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -166.84 131.11 2.0 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.045 0.423 . . . . 0.0 111.602 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.408 ' HE2' ' HB3' ' B' ' 120' ' ' MET . 75.4 mtp -84.21 146.19 27.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.576 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.82 94.83 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.139 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.504 ' HE2' ' HB2' ' A' ' 87' ' ' ALA . 12.9 mptt -73.99 -37.07 64.54 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.529 -0.395 . . . . 0.0 110.483 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -37.11 -53.07 1.02 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 tp -70.9 -29.08 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.58 ' O ' ' HG2' ' B' ' 129' ' ' ARG . 10.8 mm100 -65.69 -50.99 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.469 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.659 ' HB3' HG22 ' A' ' 94' ' ' VAL . 2.5 mm? -63.82 -40.59 96.97 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.3 ptm180 -67.94 -25.87 65.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.655 ' HB3' ' HB2' ' B' ' 133' ' ' GLU . 15.7 mmm180 -80.08 -28.04 39.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.621 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 65.2 mt -76.77 1.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.088 0.947 . . . . 0.0 109.263 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 6.6 tpt180 -99.64 -36.32 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.212 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.57 24.42 0.31 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.079 -172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' B' ' 129' ' ' ARG . 7.8 tp10 -76.55 -6.85 53.66 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.619 0.709 . . . . 0.0 111.395 176.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.747 ' HA ' HG22 ' A' ' 98' ' ' THR . 2.1 ptm180 -24.86 -52.89 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 0.0 113.4 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.572 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.103 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.494 0.187 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.769 ' HB2' ' CD1' ' A' ' 153' ' ' TRP . . . -100.4 -65.46 0.97 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -171.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.838 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.5 mptp? -101.17 -21.34 14.97 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -168.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.988 HG22 HD12 ' A' ' 38' ' ' LEU . 6.5 t -148.81 145.54 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.052 ' HG2' HD12 ' A' ' 31' ' ' ILE . 20.2 mm-40 -143.58 121.16 11.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.18 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 1.031 HG23 HD11 ' A' ' 107' ' ' ILE . 35.7 m -79.62 117.34 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 117.583 -1.647 . . . . 0.0 109.274 171.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -86.54 -73.38 0.46 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.522 -172.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.573 HD21 ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.21 109.94 21.87 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.942 -178.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.633 HG13 ' HE2' ' A' ' 111' ' ' TYR . 3.1 p -96.13 99.92 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.415 0.626 . . . . 0.0 109.352 169.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.974 HG21 ' HB3' ' A' ' 25' ' ' GLU . 4.1 m -91.19 98.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.829 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.675 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -76.43 129.67 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.471 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -99.59 -36.89 9.37 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.979 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.927 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 11.3 t70 -63.33 39.88 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.656 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.796 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -79.73 171.54 12.17 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.847 171.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.822 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.8 Cg_endo -52.65 103.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.5 1.466 . . . . 0.0 114.003 -146.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.557 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 14.9 m -133.37 169.77 13.09 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 112.863 -1.972 . . . . 0.0 109.183 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.1 Cg_exo -39.54 131.61 1.71 Allowed 'Trans proline' 0 C--O 1.21 -0.875 0 C-N-CA 122.943 2.429 . . . . 0.0 111.744 171.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.883 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 17.2 t80 -58.38 -17.86 23.46 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 133' ' ' SER . 7.1 m-30 -83.43 -3.99 58.08 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.781 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 33.0 p-10 -61.13 143.96 91.69 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 165.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.64 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 11.9 Cg_exo -83.37 135.99 7.44 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.643 2.229 . . . . 0.0 111.443 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.779 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 40.8 m-85 -50.49 113.38 0.87 Allowed 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 122.965 0.506 . . . . 0.0 111.351 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.927 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 24.4 mt-30 -112.65 103.82 11.87 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.315 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.593 ' CD1' HD13 ' A' ' 97' ' ' ILE . 91.2 m-85 -108.51 149.79 28.34 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.974 ' HB3' HG21 ' A' ' 10' ' ' VAL . 40.7 tt0 -123.54 87.35 2.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 168.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.546 ' CG2' HG13 ' A' ' 6' ' ' VAL . 15.9 mt -79.97 137.06 22.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.499 -173.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 58.6 m -115.52 104.7 11.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.619 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 28.2 p90 -106.47 146.78 30.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.659 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.894 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.5 tt0 -100.2 114.57 28.09 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.78 ' HG ' HG23 ' A' ' 65' ' ' VAL . 10.0 m -71.85 101.48 2.64 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 1.052 HD12 ' HG2' ' A' ' 5' ' ' GLN . 1.3 mt -64.71 -34.09 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.263 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 35.1 mt-10 -142.92 179.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.338 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.79 128.58 35.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.959 0.409 . . . . 0.0 110.204 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.823 HD13 ' CE2' ' A' ' 101' ' ' TYR . 4.0 mm? -88.54 149.03 23.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.985 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.1 p -114.92 -37.22 4.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.978 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.748 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.3 tt0 -105.97 -171.34 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.748 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 30.7 m-20 -100.52 142.61 31.76 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.507 0.67 . . . . 0.0 110.62 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.988 HD12 HG22 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -81.47 119.61 23.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.059 173.041 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.745 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.2 tt0 -102.57 88.04 3.14 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.802 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.823 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 61.7 m95 -80.76 119.75 23.75 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.789 ' HD2' HD11 ' A' ' 43' ' ' ILE . 11.6 ttmt -126.47 139.58 53.13 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.303 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.582 HG21 HG21 ' A' ' 95' ' ' VAL . 13.2 mt -103.22 109.21 26.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.789 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.2 mp -107.43 106.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.953 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.807 ' CE1' HG13 ' A' ' 113' ' ' VAL . 61.8 t80 -86.36 119.25 26.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.438 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.61 101.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.298 0.571 . . . . 0.0 109.625 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.23 88.79 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.549 ' HG ' ' HG2' ' A' ' 85' ' ' PRO . 41.2 t -128.79 128.16 43.41 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.766 0.793 . . . . 0.0 110.129 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -85.13 -2.59 58.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.232 170.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.76 -38.32 11.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.847 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 49.6 m -134.85 121.1 20.15 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.476 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.658 ' HB3' ' OE1' ' B' ' 125' ' ' GLN . 10.3 pt-20 -64.7 -14.11 57.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.269 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.69 1.77 11.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.61 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.557 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 89.9 m-85 -105.16 -0.81 26.19 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' B' ' 134' ' ' ARG . 31.6 p-10 -53.08 110.61 0.55 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.244 1.021 . . . . 0.0 111.488 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 4.4 mt-30 -92.58 170.01 10.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.426 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.411 HG21 HG13 ' A' ' 43' ' ' ILE . 54.8 t -130.84 107.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.888 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -76.08 -41.2 51.2 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.362 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -176.46 170.93 2.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 45.5 p -145.63 118.05 8.49 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.522 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -100.03 134.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.715 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.6 mt -108.91 104.04 13.2 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 9.0 t -119.7 107.44 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.699 ' CA ' ' HA ' ' A' ' 37' ' ' ASP . . . -102.3 -104.08 2.78 Favored Glycine 0 CA--C 1.475 -2.469 0 C-N-CA 118.831 -1.652 . . . . 0.0 112.926 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.48 113.45 0.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.127 1.884 . . . . 0.0 111.625 176.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.78 HG23 ' HG ' ' A' ' 30' ' ' CYS . 30.3 m -141.9 122.68 8.55 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.871 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.07 130.48 22.95 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.184 1.923 . . . . 0.0 110.495 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.94 133.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.936 0.773 . . . . 0.0 112.117 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.478 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 151.64 117.12 0.74 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -173.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.894 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 24.2 ttt180 -66.21 111.87 3.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.772 0.796 . . . . 0.0 110.816 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.478 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.7 p80 -145.67 160.81 41.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.87 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.673 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.97 141.64 46.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.515 0.674 . . . . 0.0 112.615 -174.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.2 p90 -131.69 160.21 36.11 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.24 138.22 50.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.695 0.76 . . . . 0.0 110.278 -173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.624 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -139.93 121.15 14.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.365 -160.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.779 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -137.81 157.55 46.2 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.97 159.28 26.34 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.82 179.14 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.887 0.851 . . . . 0.0 112.824 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -82.05 151.45 66.85 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.448 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.661 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 65.8 Cg_exo -53.79 153.6 19.06 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 123.995 3.13 . . . . 0.0 113.515 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HB2' HD11 ' A' ' 83' ' ' LEU . 17.3 m120 -71.63 113.58 20.99 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.24 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -65.71 -21.28 58.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.891 2.394 . . . . 0.0 111.623 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 5.0 83.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.219 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.443 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 35.1 mt -113.38 -20.34 11.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.561 0.22 . . . . 0.0 111.213 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.515 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 30.2 mt -84.62 129.51 56.9 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.557 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 1.2 Cg_endo -80.06 159.36 23.83 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.914 2.409 . . . . 0.0 112.128 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.75 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 4.7 m-20 -47.31 -50.19 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.444 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.27 69.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -169.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.557 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 44.0 m-20 -93.94 -17.99 22.39 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -172.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.29 -47.49 23.53 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-O 121.173 0.511 . . . . 0.0 111.824 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.543 HG12 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -92.39 47.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.67 -122.58 0.68 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.789 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.432 HG13 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -110.51 141.23 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 121.746 0.784 . . . . 0.0 112.456 -173.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.93 168.38 24.7 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.132 173.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.4 t -124.81 147.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.832 174.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 42' ' ' ILE . 9.6 p -129.7 107.3 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.889 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -103.01 135.43 44.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.272 -169.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.772 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 59.9 mt -102.18 93.07 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.803 0.811 . . . . 0.0 109.149 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 108' ' ' ARG . 51.9 p -93.96 114.93 27.23 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.592 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.889 ' SG ' HG23 ' A' ' 107' ' ' ILE . 7.0 p -84.82 137.32 33.24 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.947 175.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 51.9 m -118.8 114.94 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.255 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.823 ' CE2' HD13 ' A' ' 34' ' ' LEU . 45.3 t80 -127.32 126.3 42.34 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 101' ' ' TYR . 1.8 mmp_? 69.14 14.53 8.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.464 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.15 4.1 69.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -125.73 132.25 52.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.559 -0.82 . . . . 0.0 109.543 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.2 mp0 -76.26 142.06 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.009 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.711 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 2.8 p90 -115.68 -18.59 10.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 1.031 HD11 HG23 ' A' ' 6' ' ' VAL . 10.3 tt -159.7 156.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.656 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 10.6 ttp180 -145.38 124.85 13.13 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.889 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -101.4 102.2 13.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 122.158 0.98 . . . . 0.0 109.758 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.55 79.98 1.84 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.239 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.839 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 7.3 m-85 -79.72 123.13 27.39 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.552 ' CE2' HD21 ' B' ' 126' ' ' LEU . 5.8 m-85 -67.38 129.98 41.6 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.807 HG13 ' CE1' ' A' ' 44' ' ' TYR . 2.2 p -108.93 110.9 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.432 HD22 HG13 ' A' ' 92' ' ' VAL . 1.4 t-20 -96.72 121.17 38.28 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.21 -177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.679 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.4 m-80 -110.57 110.81 21.67 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.993 0.901 . . . . 0.0 109.017 -171.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -125.81 125.08 42.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.617 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.613 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 18.9 m-85 -39.97 146.61 0.11 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -85.49 -33.77 21.76 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.202 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -88.76 125.93 35.1 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.487 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -59.78 -28.21 67.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.789 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.14 -39.78 94.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.8 0.81 . . . . 0.0 109.614 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 77.6 mt -72.72 -27.87 62.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.713 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 43.3 mtp180 -76.4 -29.34 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.404 0.621 . . . . 0.0 109.412 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.31 -41.68 84.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.136 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -145.62 80.39 10.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.66 113.07 1.07 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.313 2.676 . . . . 0.0 112.455 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.613 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 52.7 Cg_exo -57.19 134.94 67.43 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.758 2.305 . . . . 0.0 110.702 174.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.51 HG11 ' HE2' ' A' ' 129' ' ' LYS . 3.4 p -56.02 -38.27 52.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.184 -171.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.51 ' HE2' HG11 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -91.09 107.72 23.15 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-O 121.088 0.471 . . . . 0.0 110.444 169.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.75 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 35.6 Cg_exo -45.93 140.18 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.593 3.529 . . . . 0.0 113.366 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.5 t0 -110.44 107.27 16.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.637 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 38.2 m-85 -77.48 -20.0 55.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.996 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.43 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 64.7 p -85.88 -21.55 27.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.483 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.3 mmtt -102.79 17.12 24.66 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 19.0 tp -99.62 132.32 45.03 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.015 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.36 118.11 31.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.883 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -93.37 105.38 17.45 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.28 0.562 . . . . 0.0 111.257 -177.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 12.6 t30 -85.55 98.18 10.48 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.461 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.675 HG23 HG13 ' A' ' 11' ' ' VAL . 1.5 mp -70.66 107.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.08 86.29 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.578 0.704 . . . . 0.0 110.446 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.839 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -76.49 -11.29 59.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.729 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.7 t -88.24 6.18 38.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.928 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.44 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 33.6 t-20 -139.16 64.92 34.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 1.8 Cg_endo -84.37 105.61 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.33 2.02 . . . . 0.0 111.264 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.47 ' HB3' HD11 ' B' ' 130' ' ' ILE . 5.5 tpt180 -84.24 85.4 7.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 3.3 p -87.63 110.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.894 -174.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.52 ' HB ' ' HE ' ' A' ' 108' ' ' ARG . 90.2 m -112.05 107.69 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.814 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.0 ptt180 -105.39 135.82 46.07 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.421 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -110.26 170.59 7.98 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.843 -174.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -104.96 120.17 40.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.683 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.618 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 40.5 pt -132.38 155.84 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.056 0.455 . . . . 0.0 110.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.416 HD21 ' N ' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -82.17 94.51 7.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.136 0.97 . . . . 0.0 110.686 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.838 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 9.8 m95 -69.34 -4.33 17.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.956 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.64 152.67 44.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -77.42 70.93 3.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.681 179.248 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.868 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 69.81 103.81 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.393 0.677 . . . . 0.0 111.157 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -79.19 123.55 27.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.779 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.06 167.72 43.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.106 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.496 ' C ' HD22 ' B' ' 126' ' ' LEU . 3.3 mptp? -97.7 -35.78 10.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -50.56 -32.95 20.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.139 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.538 HG21 ' N ' ' B' ' 125' ' ' GLN . 7.9 tp -69.37 -40.77 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 122.062 0.934 . . . . 0.0 109.576 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.658 ' OE1' ' HB3' ' A' ' 51' ' ' GLU . 6.6 tp-100 -71.69 -47.0 57.04 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.791 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.563 ' O ' HG13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -59.94 -44.96 94.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.186 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.15 -44.93 94.59 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.054 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -53.98 -45.7 71.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.471 ' HB3' HD22 ' A' ' 96' ' ' LEU . 2.0 mmp_? -69.01 -45.84 69.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.374 -176.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.656 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 14.9 mt -75.11 -30.08 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.441 . . . . 0.0 111.546 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -90.78 -4.56 56.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.611 0.72 . . . . 0.0 109.388 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.8 -94.88 1.66 Allowed Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.299 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -157.18 -72.49 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.632 0.729 . . . . 0.0 111.962 -156.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.57 ' HD3' HG12 ' A' ' 43' ' ' ILE . 6.7 tpm_? 51.96 -72.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.853 -164.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.572 ' HA ' ' HG2' ' A' ' 105' ' ' GLU . . . . . . . . 0 C--O 1.25 1.116 0 O-C-N 123.816 0.698 . . . . 0.0 110.636 -168.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.533 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -69.3 133.68 48.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 11.9 mmtt -100.64 -11.64 19.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.282 -175.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.71 122.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 0.0 110.772 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.524 ' HB2' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -121.3 100.18 6.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 171.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.974 HG11 ' CH2' ' A' ' 40' ' ' TRP . 1.1 m -79.45 140.17 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.306 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -120.13 -61.5 1.59 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.592 -164.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.659 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.2 t-20 -104.61 152.3 22.61 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.735 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 2.6 p -147.08 99.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.644 HG21 ' HB3' ' A' ' 25' ' ' GLU . 2.0 m -93.18 97.71 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.332 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.581 HG11 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 128.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.049 -178.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.93 HD13 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -98.59 -41.1 7.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.766 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' HB2' ' CB ' ' A' ' 23' ' ' GLN . 23.9 t0 -63.82 76.78 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.981 167.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -96.6 174.28 3.47 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.825 169.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.8 Cg_endo -51.71 104.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.797 1.665 . . . . 0.0 113.834 -157.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 37.3 m -135.01 171.03 9.69 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.46 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 89.8 Cg_exo -42.16 138.56 2.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.559 2.172 . . . . 0.0 112.148 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.794 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 28.2 t80 -55.83 -29.32 59.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.156 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.23 -19.69 53.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -62.02 132.47 93.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.2 Cg_exo -72.65 154.16 54.53 Favored 'Trans proline' 0 C--N 1.329 -0.467 0 C-N-CA 123.71 2.94 . . . . 0.0 113.577 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 78.2 m-85 -62.97 133.94 55.4 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.93 ' HG2' HD13 ' A' ' 12' ' ' LEU . 7.3 tt0 -136.68 83.05 1.98 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.633 -170.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.714 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 97.3 m-85 -97.05 153.98 17.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.125 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.644 ' HB3' HG21 ' A' ' 10' ' ' VAL . 36.7 tt0 -132.34 87.66 2.45 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 14.6 mt -88.11 122.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.706 0.765 . . . . 0.0 112.738 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.773 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 13.2 m -91.73 107.34 19.14 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.467 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.728 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 23.2 p90 -119.19 148.11 43.47 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.93 0.871 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.832 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 48.6 tt0 -103.45 114.93 29.59 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.39 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.666 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 5.0 t -73.36 107.08 5.46 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 171.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -74.98 -22.46 17.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.773 -173.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.625 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 1.5 mt-10 -154.87 167.1 31.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.985 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.32 143.68 55.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.79 0.329 . . . . 0.0 110.549 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.75 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 15.1 mt -95.21 152.67 18.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.091 0.472 . . . . 0.0 111.504 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.3 t -113.13 -35.56 5.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.666 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.808 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.0 tt0 -110.36 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.808 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 39.6 m-20 -98.29 141.6 30.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.573 0.701 . . . . 0.0 110.02 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.39 118.35 23.13 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.28 176.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.5 tt0 -105.72 90.13 3.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.86 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.974 ' CH2' HG11 ' A' ' 6' ' ' VAL . 16.5 m95 -78.58 153.28 31.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.835 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.9 ttmp? -153.31 140.59 19.55 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.213 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.13 115.32 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.82 HG12 HG13 ' A' ' 56' ' ' VAL . 88.0 mt -112.29 108.19 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.768 0.794 . . . . 0.0 109.855 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.634 ' CZ ' HG23 ' A' ' 93' ' ' THR . 76.7 t80 -88.18 130.91 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.084 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.753 HG13 ' CE2' ' A' ' 53' ' ' TYR . 7.1 t -77.52 97.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 122.071 0.939 . . . . 0.0 110.01 173.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.753 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -81.85 -2.94 90.7 Favored Glycine 0 C--O 1.214 -1.133 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.086 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.549 ' C ' ' H ' ' A' ' 49' ' ' GLU . 22.8 m -162.57 80.17 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.453 0.627 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.83 -0.73 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.141 0.576 . . . . 0.0 112.491 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' A' ' 47' ' ' SER . 1.7 mm-40 -95.49 -25.61 16.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.341 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.61 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 15.7 m -118.96 -153.36 0.53 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.783 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.2 pt-20 -149.27 20.89 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.807 0.813 . . . . 0.0 110.835 171.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.48 -34.58 10.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.988 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p90 -57.7 -49.17 77.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.738 -167.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.7 p-10 -34.95 105.3 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.235 1.585 . . . . 0.0 113.284 -158.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.542 ' CG ' HD11 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -93.04 167.44 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.975 -175.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.82 HG13 HG12 ' A' ' 43' ' ' ILE . 19.9 m -128.0 124.97 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 4.1 mm? -89.54 -31.0 17.82 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.167 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -175.39 159.27 2.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.064 170.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 35.2 p -136.71 112.42 9.45 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.49 132.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.823 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.638 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.1 mt -108.7 103.65 12.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.627 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.0 t -96.08 121.13 46.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -86.17 -152.61 20.66 Favored Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.569 -164.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.75 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.7 Cg_endo -47.2 117.91 2.52 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.778 1.652 . . . . 0.0 109.468 168.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 34' ' ' LEU . 2.4 p -140.12 129.13 13.36 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.654 -171.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.02 128.33 26.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.117 1.878 . . . . 0.0 111.092 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.666 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -40.52 145.83 0.16 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.077 0.86 . . . . 0.0 111.977 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.488 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 150.05 122.46 1.12 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.832 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.5 ttt180 -68.87 113.99 6.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.776 0.798 . . . . 0.0 109.789 175.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.1 p80 -150.89 150.95 31.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.164 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.773 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -91.73 134.31 34.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.92 -178.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.404 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -121.54 150.41 41.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.465 ' HB ' ' HE1' ' A' ' 71' ' ' MET . 4.5 p -112.94 139.81 36.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.662 0.744 . . . . 0.0 110.666 -172.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.714 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -127.47 119.19 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 -164.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 16.4 mt-30 -134.14 153.75 51.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -166.69 158.84 13.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.7 -175.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.686 0.755 . . . . 0.0 112.448 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -88.51 151.89 48.81 Favored Pre-proline 0 N--CA 1.438 -1.055 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.784 175.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.715 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.3 Cg_exo -61.25 173.37 2.57 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.653 2.902 . . . . 0.0 113.071 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.411 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.9 m-20 -87.14 115.73 63.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.185 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.48 -23.16 74.38 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.407 2.738 . . . . 0.0 112.294 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.46 -13.97 77.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.61 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.542 HD11 ' CG ' ' A' ' 55' ' ' GLN . 3.1 mt -90.06 -28.79 18.8 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.734 -0.274 . . . . 0.0 110.789 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 31.9 mt -75.33 125.96 88.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.469 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.8 Cg_endo -80.94 165.31 19.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.03 3.153 . . . . 0.0 113.462 171.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 8.7 t0 -42.74 -48.18 5.55 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.989 171.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.99 -20.93 51.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -168.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.424 ' OD2' HG11 ' A' ' 45' ' ' VAL . 12.8 t70 -89.96 -38.36 13.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.142 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -72.27 -41.27 66.91 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -163.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.77 47.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.59 -126.92 1.0 Allowed Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.222 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.558 HG11 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -104.66 132.65 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 122.162 0.982 . . . . 0.0 113.03 -172.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.808 ' HB ' HG13 ' A' ' 113' ' ' VAL . 15.8 m -133.07 167.44 20.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 113.0 -1.909 . . . . 0.0 106.976 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.634 HG12 HD23 ' A' ' 96' ' ' LEU . 37.0 t -133.6 141.47 44.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 120.877 0.37 . . . . 0.0 111.175 177.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.555 ' CG1' ' HD1' ' A' ' 44' ' ' TYR . 27.1 m -124.13 106.6 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -95.27 137.11 34.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.353 -174.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.835 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 9.1 mt -109.45 91.31 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.463 1.125 . . . . 0.0 108.89 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -90.51 125.69 35.68 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.624 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.653 ' HB2' HG21 ' A' ' 107' ' ' ILE . 72.0 m -90.03 153.53 20.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.248 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 18.5 m -150.1 113.5 4.94 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -168.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.579 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 55.4 t80 -128.05 124.04 36.1 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 31.4 mtp180 64.28 35.77 9.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.461 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.82 -1.96 87.28 Favored Glycine 0 C--N 1.317 -0.482 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.554 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -118.62 131.25 56.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.085 0.469 . . . . 0.0 109.932 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 24.0 mt-10 -89.3 136.1 33.21 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.292 -173.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.572 ' HZ ' HD12 ' A' ' 38' ' ' LEU . 51.7 p90 -122.91 0.99 9.27 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.0 tt -156.62 159.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 O-C-N 121.37 -0.831 . . . . 0.0 109.255 171.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.558 HH12 ' HA2' ' B' ' 132' ' ' GLY . 9.9 ttm180 -153.21 89.13 1.34 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.588 0.555 . . . . 0.0 109.683 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -86.93 100.86 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.352 1.073 . . . . 0.0 108.332 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 96' ' ' LEU . . . -91.02 87.48 1.36 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.437 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.971 ' HE2' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -74.57 116.67 15.52 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.477 ' CB ' HD13 ' A' ' 140' ' ' LEU . 7.1 m-85 -67.26 117.98 10.01 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.627 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.808 HG13 ' HB ' ' A' ' 93' ' ' THR . 9.0 p -99.7 110.24 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.558 ' ND2' HG11 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -91.61 114.27 26.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.867 -176.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 86.3 m-20 -99.48 106.38 18.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 124.72 39.38 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.35 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 28.1 m-85 -40.21 149.55 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.0 p -87.31 -33.64 19.15 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.783 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 17.1 mt-10 -86.63 134.16 33.64 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.716 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.578 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 90.6 m -57.17 -38.83 74.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -51.81 -39.51 58.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.053 0.93 . . . . 0.0 109.642 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 67.4 mt -84.13 -30.01 26.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.927 -173.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 23.4 mtp180 -77.63 -41.7 37.52 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.361 0.6 . . . . 0.0 110.025 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.742 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 2.8 pt-20 -79.09 -20.74 48.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.017 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.742 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.3 OUTLIER -150.11 82.45 6.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-O 121.719 0.771 . . . . 0.0 109.987 169.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 15.7 Cg_endo -56.18 121.46 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.788 2.992 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.542 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 17.5 Cg_exo -68.68 147.24 69.29 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.843 2.362 . . . . 0.0 110.583 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -28.99 45.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.616 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 2.1 mmtt -103.84 131.78 21.66 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.232 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 3.0 Cg_exo -70.06 140.94 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.527 2.818 . . . . 0.0 113.133 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.586 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 8.7 t0 -119.6 111.41 18.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.594 ' CE1' ' HB ' ' A' ' 84' ' ' ILE . 18.5 m-85 -78.51 -22.81 46.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.005 0.907 . . . . 0.0 110.293 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -80.25 -17.7 51.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.212 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . 75.8 mmtt -106.94 16.38 24.34 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 115' ' ' ASN . 15.2 tp -102.4 126.5 49.45 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.191 -170.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -112.13 118.0 34.15 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.794 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -95.57 107.06 19.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.5 0.667 . . . . 0.0 111.081 -172.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 6.3 t30 -91.03 104.91 17.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.94 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.581 HG23 HG11 ' A' ' 11' ' ' VAL . 3.6 mp -81.15 108.98 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.427 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD13 ' CB ' ' A' ' 112' ' ' TYR . 91.4 mt -64.58 89.95 0.07 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.155 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.971 ' HA ' ' HE2' ' A' ' 111' ' ' TYR . . . -79.6 -7.13 58.33 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.259 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 p -93.24 -1.88 55.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.741 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -141.67 75.64 21.55 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.402 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 57.2 Cg_endo -88.15 106.41 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.37 2.047 . . . . 0.0 111.533 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -80.69 80.1 7.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.983 0.421 . . . . 0.0 110.586 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.512 ' HB ' HG21 ' A' ' 109' ' ' VAL . 4.9 p -94.6 111.18 24.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 111.927 -173.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -108.65 106.36 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.467 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.733 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 3.6 ptt180 -113.45 131.42 56.03 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.541 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -118.44 168.63 10.47 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.673 -174.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.51 152.81 21.24 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.057 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 23.4 pt -143.07 174.71 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.12 96.32 10.26 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.388 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.581 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 18.4 m95 -74.2 -6.52 48.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.514 0.673 . . . . 0.0 109.949 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -121.52 179.02 4.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.158 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -114.93 68.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.315 -176.733 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.07 -58.98 1.95 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 4.9 tpt 63.94 149.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.876 0.846 . . . . 0.0 112.223 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.6 -33.73 5.64 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 2.5 mppt? 71.96 -59.54 0.55 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.796 0.839 . . . . 0.0 112.875 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -44.38 -52.91 7.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 tt -61.92 -36.05 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 111.623 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.812 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 9.2 mm100 -74.96 -39.04 61.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.591 0.71 . . . . 0.0 110.936 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.533 HD22 HG12 ' A' ' 45' ' ' VAL . 29.0 mt -63.22 -36.77 84.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.953 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -68.76 -33.74 74.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.998 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.812 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 8.5 mmm180 -48.74 -47.38 41.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.344 0.592 . . . . 0.0 109.437 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.795 ' HD3' ' HB2' ' B' ' 133' ' ' GLU . 4.4 mmp_? -73.91 -48.79 28.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.689 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.953 HG13 ' HA ' ' B' ' 127' ' ' ALA . 2.6 pp -66.87 -17.68 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . 0.532 ' HG2' HD13 ' B' ' 130' ' ' ILE . 34.7 mmt180 -95.98 -23.9 16.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.607 0.241 . . . . 0.0 110.951 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.558 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 176.14 75.48 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.458 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.795 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 1.2 pm0 -82.54 -56.2 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.88 0.848 . . . . 0.0 109.879 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.542 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 35.0 ttt180 -107.03 -47.41 3.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.377 -176.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.715 178.653 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HE1' ' HB2' ' A' ' 150' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.133 0.492 . . . . 0.0 110.312 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -90.5 149.17 22.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.822 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.85 -21.16 20.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -177.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.4 t -141.99 134.21 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.667 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.594 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -137.09 105.39 5.73 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.316 176.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.739 HG12 ' CD1' ' A' ' 28' ' ' PHE . 27.5 m -70.29 149.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.301 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 29' ' ' GLU . 53.5 m-80 -127.93 -59.34 1.19 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.073 -168.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.664 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.8 t-20 -104.01 150.84 23.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.139 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG13 ' OH ' ' A' ' 111' ' ' TYR . 3.3 p -145.64 98.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -91.88 97.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 122.403 1.096 . . . . 0.0 108.858 -177.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.54 133.45 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.193 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 1.051 HD12 ' HG2' ' A' ' 23' ' ' GLN . 8.7 mt -110.53 -42.62 4.04 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.626 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.767 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 2.9 p-10 -68.17 44.94 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.662 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.697 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.34 175.74 4.21 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.706 177.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.814 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.6 Cg_endo -49.78 103.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.562 1.593 . . . . 0.0 113.187 -150.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.675 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -148.89 172.0 5.67 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 111.648 -2.524 . . . . 0.0 107.627 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 59.6 Cg_exo -37.16 130.21 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.774 2.316 . . . . 0.0 112.969 174.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.746 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 8.9 t80 -55.43 -27.9 50.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.422 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -78.5 -14.22 59.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -69.93 138.43 87.69 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -73.34 133.07 18.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 112.76 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 88.8 m-85 -56.62 121.17 9.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.149 -176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 1.051 ' HG2' HD12 ' A' ' 12' ' ' LEU . 9.6 tt0 -128.92 92.35 3.38 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.949 -157.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 97' ' ' ILE . 83.9 m-85 -106.1 115.05 29.56 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.666 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.564 ' HB2' HD13 ' A' ' 12' ' ' LEU . 22.1 tt0 -90.35 83.71 5.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.436 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 36.6 mt -82.12 141.4 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.671 0.748 . . . . 0.0 111.931 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 20.9 m -125.24 107.31 10.6 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.266 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.739 ' CD1' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.6 166.79 10.15 Favored 'General case' 0 CA--C 1.472 -2.027 0 C-N-CA 118.713 -1.195 . . . . 0.0 110.916 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 29.9 tt0 -117.65 107.54 14.34 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.816 -1.993 . . . . 0.0 106.023 168.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.3 m -72.46 108.04 5.33 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -72.48 -33.62 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.307 -169.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.822 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 6.0 mt-10 -143.74 171.68 13.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 p-10 -76.53 131.72 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.099 0.476 . . . . 0.0 110.964 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD12 HG21 ' A' ' 65' ' ' VAL . 7.9 mt -87.1 153.47 21.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.26 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -112.6 -31.3 6.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.694 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 20.2 tt0 -122.33 -168.99 1.82 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.694 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.2 p-10 -92.94 147.59 22.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 110.36 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -95.59 122.87 38.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.219 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.636 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 22.9 tt0 -103.92 89.93 3.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.065 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.806 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 50.0 m95 -82.66 115.46 21.61 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.8 ttmt -118.02 138.98 51.84 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.052 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG21 HG22 ' A' ' 95' ' ' VAL . 4.8 mt -104.78 123.29 58.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -114.15 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.796 -175.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.623 ' CE2' HG12 ' A' ' 113' ' ' VAL . 46.4 t80 -89.0 117.22 27.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.321 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.845 HG11 ' CE2' ' A' ' 53' ' ' TYR . 3.8 t -66.6 111.54 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.803 173.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.694 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -81.32 -63.1 1.89 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.437 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.597 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 15.1 m -102.15 70.77 1.22 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB2' ' OD1' ' A' ' 88' ' ' ASP . . . -47.98 -28.4 2.73 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.61 0.569 . . . . 0.0 111.733 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' B' ' 122' ' ' LYS . 4.8 tt0 -67.64 -18.46 64.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.068 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.69 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 24.2 m -115.25 -152.45 0.5 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.7 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.1 pt-20 -154.89 22.48 0.44 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.742 0.782 . . . . 0.0 111.05 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -100.18 -31.61 11.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.368 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.845 ' CE2' HG11 ' A' ' 45' ' ' VAL . 12.1 p90 -63.38 -42.53 98.85 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 125.752 1.621 . . . . 0.0 113.242 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.6 p-10 -23.55 113.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.033 1.458 . . . . 0.0 114.256 -161.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.403 HE22 ' HA3' ' A' ' 46' ' ' GLY . 1.4 mp0 -96.64 166.76 11.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.256 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.91 118.53 50.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.568 ' HB3' ' CB ' ' A' ' 76' ' ' ALA . 3.9 mm? -87.72 -48.84 7.55 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.934 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -166.0 161.82 17.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.1 p -139.1 113.23 8.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG12 ' CZ ' ' A' ' 74' ' ' PHE . 3.3 p -98.86 130.64 47.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.7 mt -101.16 104.05 15.12 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.961 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.12 116.84 36.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -67.74 -168.34 4.12 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.304 -168.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -67.56 112.26 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 N-CA-C 109.573 -0.972 . . . . 0.0 109.573 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.686 HG21 HD12 ' A' ' 34' ' ' LEU . 27.4 m -110.68 117.37 50.84 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.525 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 59.6 Cg_endo -76.01 79.92 2.78 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 122.513 2.142 . . . . 0.0 113.09 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.601 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 52.43 174.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.629 -2.078 . . . . 0.0 112.494 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.74 117.53 3.35 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.107 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.811 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 ttt-85 -64.66 128.5 36.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.069 0.461 . . . . 0.0 110.312 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -164.84 158.23 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.103 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.488 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -113.37 144.46 42.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.411 0.624 . . . . 0.0 111.885 -175.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CE2' HG13 ' A' ' 60' ' ' VAL . 2.1 p90 -132.37 160.33 36.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.1 127.44 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.46 1.124 . . . . 0.0 111.065 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.64 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -108.33 145.4 34.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.148 -168.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.742 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 22.2 mt-30 -150.08 152.04 34.16 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -159.68 118.64 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.599 0.237 . . . . 0.0 111.633 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.62 123.36 19.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.246 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . . . -23.96 147.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 127.273 2.229 . . . . 0.0 116.962 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.594 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 38.7 Cg_endo -65.93 179.2 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.653 3.569 . . . . 0.0 112.722 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.41 122.12 85.47 Favored Pre-proline 0 CA--C 1.508 -0.654 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.393 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.45 -5.93 17.77 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.933 2.422 . . . . 0.0 111.471 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.17 -8.22 50.84 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.739 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.401 HD11 ' HG2' ' A' ' 55' ' ' GLN . 27.0 mt -97.46 -8.73 28.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.046 0.45 . . . . 0.0 110.404 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.578 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 21.8 mt -95.33 125.39 50.14 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.158 171.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.597 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.4 Cg_endo -79.84 162.92 23.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.696 2.931 . . . . 0.0 111.472 171.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.69 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 4.0 m-20 -46.5 -53.67 10.78 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.77 82.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.666 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 48' ' ' ALA . 61.1 m-20 -87.79 -16.89 32.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.682 -173.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.24 -46.13 29.57 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.643 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.43 HG12 ' CE2' ' A' ' 117' ' ' TYR . 0.1 OUTLIER -99.98 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.502 0.668 . . . . 0.0 112.053 -174.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.94 -132.47 1.55 Allowed Glycine 0 CA--C 1.498 -1.026 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.571 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.606 HG12 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.99 136.08 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.674 0.75 . . . . 0.0 112.785 -168.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.689 HG22 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.18 167.77 28.18 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.9 t -123.46 135.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.112 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 42' ' ' ILE . 14.3 p -115.86 105.55 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 171.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.811 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.3 pp -103.41 147.68 26.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.728 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.605 HD13 ' CD1' ' A' ' 24' ' ' PHE . 41.4 mt -112.26 102.87 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.667 0.746 . . . . 0.0 109.67 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.846 HG21 ' HB2' ' A' ' 108' ' ' ARG . 78.0 p -101.32 110.05 22.0 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.668 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 1.006 ' SG ' HG21 ' A' ' 107' ' ' ILE . 11.9 p -75.62 152.2 37.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.81 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 31.3 m -142.01 103.26 4.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.6 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 89.9 t80 -113.18 122.11 46.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 37.5 mtp180 68.58 23.17 7.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.107 0.479 . . . . 0.0 111.628 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.56 76.03 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.253 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -128.96 123.68 33.12 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.648 ' HG2' ' HG3' ' B' ' 134' ' ' ARG . 16.2 mp0 -82.25 136.19 35.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 -173.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 38' ' ' LEU . 52.3 p90 -128.62 -0.32 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 1.006 HG21 ' SG ' ' A' ' 99' ' ' CYS . 5.2 tt -157.63 160.34 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 O-C-N 121.178 -0.951 . . . . 0.0 108.799 169.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.846 ' HB2' HG21 ' A' ' 98' ' ' THR . 15.9 ttp180 -150.16 104.39 3.26 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.811 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.7 p -88.9 99.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.624 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.23 82.01 1.56 Allowed Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.251 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 1.03 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.7 m-85 -72.8 120.81 18.94 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.408 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.544 ' HB3' HD22 ' A' ' 140' ' ' LEU . 2.9 m-85 -66.84 123.7 20.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.623 HG12 ' CE2' ' A' ' 44' ' ' TYR . 2.5 p -107.96 111.26 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.678 ' HB2' HD21 ' A' ' 140' ' ' LEU . 0.5 OUTLIER -98.43 113.54 25.57 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.767 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 38.7 m-80 -97.31 132.14 43.33 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.353 0.597 . . . . 0.0 110.032 -174.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.32 134.46 22.76 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.786 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 31.7 m-85 -49.56 151.32 1.67 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.1 p -90.32 -34.42 15.72 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.013 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -75.32 121.98 23.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.769 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.9 m -50.3 -36.77 33.19 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.762 -172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -64.91 -40.16 94.65 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.615 0.722 . . . . 0.0 110.321 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.8 mt -73.36 -22.24 60.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.654 -176.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 10.4 mtt180 -78.73 -36.75 42.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.769 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.7 mm-40 -61.32 -44.13 97.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.012 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -145.73 85.95 7.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.059 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.16 115.67 2.73 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.047 2.498 . . . . 0.0 112.092 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.43 164.12 33.93 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.142 2.561 . . . . 0.0 111.498 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.01 -62.46 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.076 0.235 . . . . 0.0 110.708 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -67.77 125.79 91.77 Favored Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-O 121.731 0.777 . . . . 0.0 111.785 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.69 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 22.0 Cg_exo -70.27 139.2 37.92 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 124.215 3.277 . . . . 0.0 111.827 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.558 ' CG ' ' HG2' ' A' ' 134' ' ' LYS . 30.1 t0 -117.07 104.04 10.84 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.746 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 37.0 m-85 -74.01 -16.11 61.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.039 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.7 t -85.43 -21.51 28.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.283 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.558 ' HG2' ' CG ' ' A' ' 131' ' ' ASP . 47.0 mmtm -101.12 -0.5 36.04 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 15.6 tp -85.95 123.51 31.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.308 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.5 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 2.2 tt0 -108.39 116.93 32.89 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.814 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.56 119.63 38.37 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.74 -174.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.3 t30 -96.03 120.04 35.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.653 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.59 HG22 HG13 ' A' ' 11' ' ' VAL . 3.5 mm -88.34 102.13 12.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 114' ' ' ASN . 3.1 mm? -60.21 84.6 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 1.03 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -63.47 -15.49 57.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.347 168.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.47 -18.14 55.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.107 171.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.99 60.21 33.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.176 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 84.6 Cg_endo -91.36 105.97 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.815 1.677 . . . . 0.0 110.741 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.461 ' HB3' HD11 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -82.13 81.54 8.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 109' ' ' VAL . 17.0 m -78.55 114.54 19.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 111.56 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.829 HG22 HH21 ' A' ' 108' ' ' ARG . 53.7 m -120.4 105.31 10.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.398 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.792 ' HB3' HG13 ' A' ' 107' ' ' ILE . 1.7 ptt180 -106.01 133.87 50.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.51 0.671 . . . . 0.0 110.65 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' HD2' ' CA ' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -109.18 168.56 9.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.781 -176.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.533 ' HD2' ' O ' ' A' ' 150' ' ' HIS . 0.9 OUTLIER -103.51 139.7 38.51 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 173.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.1 pt -139.68 -177.9 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -102.41 82.64 2.2 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.428 0.633 . . . . 0.0 111.34 -172.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.688 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.1 m95 -69.05 -11.98 61.27 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.932 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.07 157.07 25.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.95 69.29 8.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.329 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.605 HD21 ' N ' ' A' ' 156' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.604 166.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 66.47 -175.52 0.19 Allowed 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.169 0.587 . . . . 0.0 111.144 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 54.6 mtm -112.35 -74.74 0.62 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.53 -178.97 19.33 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 171.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.525 ' HB3' ' CD2' ' B' ' 126' ' ' LEU . 12.0 mptt -81.23 -21.77 39.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.911 0.356 . . . . 0.0 110.214 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -35.23 -61.33 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.292 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.441 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 7.2 tt -69.39 -33.47 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.515 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 9.2 mm100 -63.23 -52.33 62.6 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.385 0.612 . . . . 0.0 110.822 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' B' ' 122' ' ' LYS . 1.9 mm? -64.69 -36.37 84.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.129 177.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.97 -37.32 73.97 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 99.7 mtt180 -59.23 -47.83 83.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 111.156 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.662 ' CZ ' ' HG2' ' B' ' 133' ' ' GLU . 18.1 mmm180 -74.44 -21.67 59.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.286 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.477 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 23.3 mt -93.19 -7.76 10.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.613 0.721 . . . . 0.0 109.885 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -80.93 -29.28 35.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.469 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.679 ' HA2' ' OXT' ' B' ' 135' ' ' ALA . . . 165.91 53.19 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.4 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.662 ' HG2' ' CZ ' ' B' ' 129' ' ' ARG . 2.0 tm-20 -70.03 -70.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 168.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.648 ' HG3' ' HG2' ' A' ' 105' ' ' GLU . 1.8 tpm_? -74.04 -51.53 15.54 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.893 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.679 ' OXT' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.9 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.78 142.5 28.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.872 0.367 . . . . 0.0 110.096 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.73 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -91.42 -17.16 26.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.215 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.434 HG13 ' HD2' ' A' ' 28' ' ' PHE . 2.4 t -137.71 130.05 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.594 0.711 . . . . 0.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.44 HE22 ' HD3' ' A' ' 148' ' ' ARG . 26.1 tp60 -122.88 101.71 7.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.679 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.655 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -78.08 132.23 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -116.5 -69.58 0.84 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.207 -163.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.651 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.9 t-20 -93.04 152.68 19.15 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.8 -177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' H ' ' ND2' ' A' ' 8' ' ' ASN . 7.4 p -146.4 107.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-O 122.244 1.021 . . . . 0.0 109.766 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.826 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.1 t -92.59 92.62 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.023 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG13 ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -76.45 120.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.309 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.999 HD13 ' HB3' ' A' ' 23' ' ' GLN . 4.6 mt -105.45 -40.11 5.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.647 -168.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.961 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 17.4 p-10 -67.01 38.25 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.454 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.599 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -78.46 174.53 5.88 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.601 178.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.816 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 4.3 Cg_endo -50.05 103.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.802 1.668 . . . . 0.0 113.639 -153.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.631 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.5 m -146.34 171.43 6.44 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 111.236 -2.711 . . . . 0.0 106.715 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.635 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 45.5 Cg_exo -38.13 143.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.804 2.336 . . . . 0.0 112.407 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.891 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.3 t80 -60.42 -31.25 70.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.705 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -75.23 -11.27 60.03 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.608 0.242 . . . . 0.0 110.571 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.635 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -67.86 117.32 47.17 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 121.882 0.849 . . . . 0.0 109.271 168.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.614 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 46.4 Cg_exo -60.04 169.08 5.15 Favored 'Trans proline' 0 C--N 1.327 -0.571 1 C-N-CA 125.434 4.09 . . . . 0.0 114.291 -173.055 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.839 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 99.1 m-85 -78.27 103.25 8.09 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.552 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.999 ' HB3' HD13 ' A' ' 12' ' ' LEU . 2.6 mp0 -104.81 109.8 21.9 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.508 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.708 ' CD2' HD12 ' A' ' 97' ' ' ILE . 83.2 m-85 -123.48 101.4 7.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 1.065 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.9 tt0 -86.16 82.65 7.98 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.344 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.1 mt -87.88 129.27 39.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.081 -176.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.3 m -103.01 104.73 14.94 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 20.7 p90 -112.6 141.87 45.85 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.64 0.733 . . . . 0.0 110.025 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.861 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.6 tt0 -101.7 117.87 35.76 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t -73.85 104.88 4.89 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.463 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -71.48 -30.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.573 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 40.3 mt-10 -149.63 146.4 27.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.069 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.24 138.88 57.85 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.739 0.649 . . . . 0.0 111.288 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.733 HD13 HD21 ' A' ' 38' ' ' LEU . 6.8 mt -95.35 151.08 19.58 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.876 -171.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.3 t -114.1 -25.75 8.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.307 0.575 . . . . 0.0 110.152 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.716 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 19.9 tt0 -121.39 -168.33 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.716 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.8 p-10 -94.41 135.4 35.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.506 0.669 . . . . 0.0 110.482 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -83.05 119.29 24.29 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.584 176.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 1.2 tm-20 -104.98 89.74 3.24 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.211 -171.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.625 ' O ' ' HA ' ' A' ' 59' ' ' SER . 9.6 m95 -82.25 139.93 33.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.0 ttmp? -138.92 145.69 40.16 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.831 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' A' ' 74' ' ' PHE . 49.3 mt -103.26 116.48 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.716 ' HB ' HD13 ' A' ' 96' ' ' LEU . 4.0 mp -113.92 107.25 22.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.864 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.0 t80 -92.78 115.45 28.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.667 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 t -59.29 107.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.65 12.77 61.24 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -134.13 62.1 1.66 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.754 -0.723 . . . . 0.0 112.443 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 -10.91 59.87 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.672 0.749 . . . . 0.0 108.982 165.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -100.12 -46.83 5.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.239 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.471 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 49.3 m -105.61 -134.38 0.33 Allowed 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 9.0 pt-20 -154.45 -19.72 0.13 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -90.46 2.86 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.495 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 23.3 m-85 -93.61 0.36 56.52 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -54.07 95.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.89 0.852 . . . . 0.0 110.57 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -94.83 169.35 10.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.064 -173.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.0 t -126.11 117.65 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.996 -167.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 mm? -85.88 -58.22 2.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.183 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -153.35 152.6 31.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.134 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.2 p -134.75 110.87 9.51 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG13 ' CE1' ' A' ' 72' ' ' PHE . 3.1 p -99.59 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.837 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 10.6 mt -105.89 104.65 14.41 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.303 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.25 113.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -164.9 4.21 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.497 -167.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 64.5 Cg_endo -68.29 113.88 3.24 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 120.812 1.008 . . . . 0.0 109.685 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.598 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 27.4 m -120.94 134.34 24.32 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.812 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.57 78.68 3.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.106 1.871 . . . . 0.0 113.168 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.532 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 51.0 -171.83 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.63 -2.077 . . . . 0.0 111.943 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.47 135.73 8.11 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.861 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.4 ttp180 -73.1 115.21 12.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.043 0.925 . . . . 0.0 111.195 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -114.38 118.03 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.231 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.66 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 20.5 ttp -87.82 103.3 15.51 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 173.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.496 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -110.02 128.39 55.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.04 -178.405 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.065 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -102.05 111.83 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 122.682 1.23 . . . . 0.0 111.376 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -72.61 143.42 48.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.652 -2.067 . . . . 0.0 109.614 179.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.932 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 25.3 mt-30 -152.55 145.2 24.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.23 134.5 2.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.631 ' O ' HD13 ' A' ' 57' ' ' LEU . 10.4 p-10 -55.84 159.62 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.731 0.3 . . . . 0.0 110.756 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -76.03 164.65 58.89 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 123.061 0.544 . . . . 0.0 111.642 -167.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 36.0 Cg_endo -59.57 163.38 13.11 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.116 2.544 . . . . 0.0 112.127 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.45 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.5 m-20 -69.52 117.17 50.25 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.989 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.4 Cg_endo -61.23 -22.18 73.89 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.678 2.919 . . . . 0.0 112.33 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.37 -10.97 69.95 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.086 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 24.0 mt -91.14 -31.28 16.28 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 122.685 -0.303 . . . . 0.0 110.491 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.558 HG21 ' OD1' ' A' ' 88' ' ' ASP . 17.0 mt -74.76 124.73 89.82 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' O ' HG22 ' A' ' 84' ' ' ILE . 94.1 Cg_endo -79.15 163.51 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.776 2.984 . . . . 0.0 112.075 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 12.7 t70 -44.92 -55.42 5.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.02 62.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.25 0.548 . . . . 0.0 111.108 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.558 ' OD1' HG21 ' A' ' 84' ' ' ILE . 10.9 t70 -97.25 -24.43 15.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.634 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -88.84 -46.26 9.09 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.34 49.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -170.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.79 -128.98 1.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.352 -168.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.756 HG22 ' ND2' ' A' ' 114' ' ' ASN . 21.5 t -109.89 133.61 54.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.598 -172.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.692 ' HB ' HG12 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -144.16 170.42 16.0 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' B' ' 126' ' ' LEU . 3.3 t -129.89 145.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 118.719 0.69 . . . . 0.0 111.737 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.549 HG22 ' CE1' ' A' ' 22' ' ' PHE . 7.7 p -132.08 108.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.876 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.6 pp -107.37 147.3 30.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.255 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 36.8 mt -114.91 105.6 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 109.303 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.765 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 56.6 p -100.49 116.57 32.74 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.977 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.68 ' HB2' HG23 ' A' ' 107' ' ' ILE . 76.4 m -81.83 123.22 28.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.11 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 28.3 m -113.32 120.29 40.62 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.567 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 61.3 t80 -123.22 117.35 25.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.255 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.567 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.1 mtp180 66.08 23.81 11.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.445 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.05 54.94 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.892 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -111.26 132.52 54.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.931 175.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 33.4 mt-10 -83.38 130.06 35.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.598 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 50.0 p90 -118.29 1.5 11.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.817 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.4 tt -157.97 155.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.698 HH22 ' HG3' ' A' ' 145' ' ' ARG . 2.8 tmm_? -151.14 113.38 4.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.876 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -104.6 100.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.308 1.052 . . . . 0.0 109.689 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.479 ' HA3' HH11 ' A' ' 108' ' ' ARG . . . -93.03 87.14 1.2 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.98 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.608 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 88.7 m-85 -76.13 146.58 39.15 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.558 ' HB2' HD13 ' A' ' 140' ' ' LEU . 6.6 m-85 -83.2 132.47 35.06 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.864 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.5 p -108.84 109.31 27.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.756 ' ND2' HG22 ' A' ' 92' ' ' VAL . 4.0 t-20 -97.51 108.47 21.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.187 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.659 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 42.7 m-80 -97.03 110.58 23.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.04 133.74 49.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.591 ' CG ' ' HB3' ' A' ' 122' ' ' LEU . 39.3 m-85 -42.69 157.49 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -95.74 -30.84 13.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.438 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.669 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 4.3 mm-40 -86.33 128.73 34.97 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.571 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.7 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.3 m -48.48 -46.45 38.2 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.08 0.4 . . . . 0.0 111.841 -172.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -53.59 -37.33 62.87 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.234 1.016 . . . . 0.0 110.115 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 48.2 mt -84.53 -24.74 29.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.919 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 60.9 mtp180 -78.48 -40.43 35.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.936 0.874 . . . . 0.0 108.689 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.725 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 12.6 pt-20 -73.38 -29.78 62.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.977 -177.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.725 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 1.8 p30 -153.73 90.79 3.31 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.006 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.8 Cg_endo -55.81 117.99 4.69 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 122.889 2.393 . . . . 0.0 111.45 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.437 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 32.5 Cg_exo -59.5 151.38 69.45 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.375 2.05 . . . . 0.0 110.224 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.9 p -48.74 -29.02 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.286 -170.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.502 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -118.28 110.96 38.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-O 122.264 1.03 . . . . 0.0 113.451 173.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.548 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.0 Cg_exo -44.29 139.93 6.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 125.386 4.057 . . . . 0.0 113.659 174.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.9 t70 -120.23 116.61 25.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.896 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.622 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.7 m-85 -79.18 -16.33 56.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.878 0.846 . . . . 0.0 111.026 -170.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.1 m -83.09 -24.78 32.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.344 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.669 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.3 mmtt -101.23 13.98 33.42 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 115' ' ' ASN . 24.4 tp -98.08 144.7 27.29 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.855 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -125.22 125.76 44.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.891 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 16.7 mtm105 -91.17 104.38 16.95 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.163 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.558 ' C ' HD21 ' A' ' 138' ' ' ASN . 0.1 OUTLIER -89.7 90.99 8.47 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 170.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.821 HD12 HH12 ' A' ' 137' ' ' ARG . 1.3 mm -71.57 115.41 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.898 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 112' ' ' TYR . 35.8 mt -78.73 75.22 5.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.851 0.834 . . . . 0.0 110.797 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.7 -19.99 61.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.472 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 p -73.65 -11.96 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.741 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.02 66.96 33.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.627 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.608 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 66.1 Cg_endo -87.64 105.92 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.822 1.682 . . . . 0.0 111.787 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.698 ' HG3' HH22 ' A' ' 108' ' ' ARG . 8.7 tpt180 -76.01 88.57 2.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.501 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.3 p -95.24 137.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.431 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.7 m -145.76 107.9 4.38 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.761 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.817 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 1.0 OUTLIER -96.86 149.98 21.25 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.423 0.63 . . . . 0.0 110.244 175.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -122.16 169.51 10.81 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.404 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -104.83 125.31 50.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.26 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.556 HD11 ' HB3' ' A' ' 101' ' ' TYR . 13.7 pt -135.96 173.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 154' ' ' GLU . 4.8 p30 -95.38 109.5 21.65 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.171 0.986 . . . . 0.0 109.675 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.73 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.3 m95 -82.41 15.58 2.43 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.067 171.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 152' ' ' ASN . 63.2 mm-40 -122.04 -164.18 1.14 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.559 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -127.67 71.15 1.34 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 171.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 156' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.769 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.46 79.14 6.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.837 -0.214 . . . . 0.0 110.72 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 90.4 mtp 58.29 -92.41 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.682 0.614 . . . . 0.0 111.89 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.58 -148.86 5.31 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.1 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.679 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 3.2 mppt? -71.59 -43.99 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 110.643 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.72 -55.01 15.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.012 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.414 ' HA ' ' HB2' ' B' ' 127' ' ' ALA . 14.4 tt -73.9 -26.02 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.14 -45.34 85.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 122.068 0.937 . . . . 0.0 110.161 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 24.6 mt -65.17 -43.52 91.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.648 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' B' ' 124' ' ' ILE . . . -59.28 -39.1 81.86 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.568 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -66.92 -47.02 73.01 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.459 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 0.9 OUTLIER -62.81 -39.98 95.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.639 HG12 ' NH1' ' A' ' 108' ' ' ARG . 5.1 mt -56.31 -60.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 113.099 -1.864 . . . . 0.0 112.533 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . 0.48 ' N ' HG23 ' B' ' 130' ' ' ILE . 12.4 mmm180 -53.49 -42.73 67.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 123.424 0.453 . . . . 0.0 110.991 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.754 ' HA2' ' NH2' ' B' ' 134' ' ' ARG . . . 155.8 70.36 0.01 OUTLIER Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.767 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.459 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 21.0 tt0 -108.25 -24.56 11.45 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.238 -175.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.754 ' NH2' ' HA2' ' B' ' 132' ' ' GLY . 0.0 OUTLIER -69.7 -75.46 0.11 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.785 0.802 . . . . 0.0 108.867 173.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.468 ' H ' ' HB2' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.423 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' HB3' ' A' ' 150' ' ' HIS . 21.9 ttt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.859 0.361 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.26 155.73 38.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.481 0.658 . . . . 0.0 112.273 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.677 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -95.14 -18.17 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.505 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.452 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.6 t -136.49 126.38 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.515 0.674 . . . . 0.0 110.241 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.571 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 18.7 tp60 -116.27 100.08 7.66 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.89 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -76.73 134.79 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.364 176.518 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.05 -62.72 1.56 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 -165.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.66 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.51 151.06 23.3 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.865 -176.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 3.6 p -144.63 99.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.5 170.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.626 HG21 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.15 95.39 4.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.165 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.705 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -67.31 125.3 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.699 177.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.975 HD13 ' HG2' ' A' ' 23' ' ' GLN . 7.3 mt -97.31 -52.31 3.86 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.184 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 7.7 t70 -74.49 78.64 1.93 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.733 1.254 . . . . 0.0 110.456 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.737 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -82.38 178.09 2.63 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.437 165.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.887 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.9 Cg_endo -48.0 104.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.839 1.693 . . . . 0.0 114.619 -149.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.533 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 8.2 m -131.76 170.45 11.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 112.767 -2.015 . . . . 0.0 108.495 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 51.6 Cg_exo -46.85 144.58 7.91 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 111.636 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.7 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 11.3 t80 -61.36 -37.14 82.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.85 -0.85 32.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.897 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.556 HD22 ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -89.2 131.35 41.03 Favored Pre-proline 0 N--CA 1.431 -1.388 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 171.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 31.8 Cg_exo -63.72 150.12 89.2 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 123.792 2.995 . . . . 0.0 114.364 -168.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 95.0 m-85 -66.12 139.15 58.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.103 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.975 ' HG2' HD13 ' A' ' 12' ' ' LEU . 7.8 tt0 -133.83 99.43 4.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.139 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.708 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.5 m-85 -103.37 155.72 18.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.294 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.702 ' HB2' HD11 ' A' ' 12' ' ' LEU . 39.5 tt0 -134.71 88.13 2.41 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.536 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 14.0 mt -86.85 131.52 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.941 0.877 . . . . 0.0 112.366 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 24.6 m -108.53 108.1 18.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.345 173.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.682 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 32.5 p90 -120.0 148.05 44.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.778 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.824 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 72.0 tt0 -106.76 115.01 29.45 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.64 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -72.68 111.64 8.02 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.571 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -77.67 -29.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.44 -174.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.599 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 42.2 mm-40 -151.81 154.77 36.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.437 0.46 . . . . 0.0 110.054 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.72 128.31 20.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.87 0.731 . . . . 0.0 111.256 -175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.09 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -83.46 146.63 28.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.563 -170.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.417 ' HB3' ' HH ' ' A' ' 101' ' ' TYR . 23.1 t -113.2 -23.17 10.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.384 -172.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.83 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 29.3 tt0 -129.51 -164.85 1.45 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.83 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.3 m-20 -95.27 137.17 34.7 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.611 HD12 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.592 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 47.8 tt0 -105.66 89.7 3.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.571 -171.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.633 ' O ' ' HA ' ' A' ' 59' ' ' SER . 23.4 m95 -80.34 124.67 29.06 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.7 ttmt -130.93 142.5 50.36 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.72 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 95' ' ' VAL . 12.5 mt -103.62 112.97 39.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.3 mp -104.43 105.74 19.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.669 ' CE2' HG11 ' A' ' 113' ' ' VAL . 33.5 t80 -90.42 111.87 23.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.795 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -53.43 109.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.253 0.549 . . . . 0.0 109.846 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.61 -45.56 52.5 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.452 -0.88 . . . . 0.0 110.97 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.834 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 91.4 p -128.1 125.02 38.41 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.358 0.599 . . . . 0.0 111.515 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -89.21 -0.1 57.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 161.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.558 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 4.8 mt-10 -88.5 -29.58 20.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.655 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.43 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 64.1 m -121.92 -107.88 0.35 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.593 173.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 7.0 pt-20 -179.98 -47.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.173 0.189 . . . . 0.0 111.327 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 38.0 mt-10 -72.83 1.15 9.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.088 0.47 . . . . 0.0 111.777 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 2.0 m-30 -80.73 -7.93 59.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -44.01 108.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.207 1.003 . . . . 0.0 111.057 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.611 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 40.8 mt-30 -92.71 169.44 10.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.512 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.67 110.35 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -172.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 77' ' ' ASP . 3.6 mm? -75.54 -54.61 6.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.614 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 19.3 p-10 -160.38 170.43 21.05 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 67.5 p -146.92 115.39 6.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.1 p -99.63 134.65 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.382 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.94 103.92 13.51 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.048 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.59 118.74 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.72 -162.33 24.69 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.219 -165.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.09 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 31.4 Cg_endo -63.5 117.36 4.32 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.784 1.656 . . . . 0.0 110.806 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 23.1 m -128.0 137.56 31.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.857 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -82.02 77.23 3.91 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.23 1.953 . . . . 0.0 114.082 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . 51.85 177.37 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.116 -1.856 . . . . 0.0 112.618 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 110.68 129.62 5.61 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 172.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.824 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.3 ptt180 -79.87 128.06 33.0 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.321 1.058 . . . . 0.0 109.787 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -154.12 143.77 21.66 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.395 -177.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -92.85 136.23 33.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.533 -176.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 6.4 p90 -121.36 160.09 24.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 168.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.46 134.13 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-O 121.882 0.849 . . . . 0.0 110.808 -171.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.708 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -115.95 129.75 56.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.345 -164.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 19.3 mt-30 -151.67 143.7 23.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.941 0.4 . . . . 0.0 110.542 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.11 138.43 2.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.835 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.614 ' O ' HD13 ' A' ' 57' ' ' LEU . 8.2 p-10 -72.96 156.19 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -174.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.63 ' HB1' ' CE1' ' A' ' 18' ' ' PHE . . . -44.1 156.93 0.3 Allowed Pre-proline 0 N--CA 1.443 -0.789 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.523 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 57.3 Cg_endo -66.97 170.57 12.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.841 3.027 . . . . 0.0 111.418 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.8 m-20 -66.55 117.83 48.07 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.0 Cg_endo -61.36 -25.74 80.6 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.544 2.829 . . . . 0.0 111.948 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.0 -11.29 82.77 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.311 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.611 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 25.2 mt -91.85 -21.91 20.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.644 0.259 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 10.1 mt -84.49 130.07 55.05 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.38 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 1.5 Cg_endo -79.96 161.19 23.95 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.123 2.549 . . . . 0.0 112.076 170.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.733 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -46.54 -53.32 11.56 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.07 69.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.178 0.513 . . . . 0.0 111.114 -167.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 9.8 m-20 -95.74 -19.88 19.32 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.754 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.04 -47.28 15.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.52 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.407 HG12 ' CE2' ' A' ' 117' ' ' TYR . 0.7 OUTLIER -96.5 48.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.702 0.763 . . . . 0.0 111.542 -176.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.83 -129.73 1.15 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.089 -166.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.725 HG12 HD21 ' A' ' 114' ' ' ASN . 0.6 OUTLIER -119.91 125.3 74.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.344 0.593 . . . . 0.0 111.524 -173.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.14 169.65 15.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.524 HG12 HD23 ' A' ' 96' ' ' LEU . 2.4 t -126.45 142.53 42.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.266 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 42' ' ' ILE . 9.8 p -127.35 107.47 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 122.14 0.972 . . . . 0.0 108.613 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.837 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -104.02 138.93 39.84 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.345 -171.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.628 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 mt -102.81 95.57 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.811 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.6 p -96.7 116.04 28.45 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.599 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 40' ' ' TRP . 76.3 m -82.32 118.16 22.94 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.553 176.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 56.6 m -99.31 113.48 25.81 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.771 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.653 ' HE2' ' CD1' ' A' ' 34' ' ' LEU . 38.2 t80 -123.63 121.72 36.28 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.624 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 34.8 mtp180 63.02 27.37 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.063 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.35 66.51 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.653 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.12 135.44 55.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.165 0.507 . . . . 0.0 110.477 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.569 ' HG3' ' HG1' ' A' ' 100' ' ' THR . 2.4 mp0 -82.18 128.96 34.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.611 ' HZ ' HD12 ' A' ' 38' ' ' LEU . 51.4 p90 -111.65 2.41 17.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.811 ' O ' ' HA ' ' A' ' 98' ' ' THR . 9.3 tt -156.93 158.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.729 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 31.3 ttp180 -151.1 107.51 3.48 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.837 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -96.86 99.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 118.699 -1.201 . . . . 0.0 108.339 171.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.705 ' HA3' HG22 ' B' ' 130' ' ' ILE . . . -87.42 79.51 1.77 Allowed Glycine 0 CA--C 1.483 -1.962 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.123 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.863 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.9 m-85 -71.58 116.05 11.48 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.122 -1.039 . . . . 0.0 109.082 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.622 ' HB3' HD11 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.96 114.58 5.88 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.689 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.669 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.4 p -101.97 110.45 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.725 HD21 HG12 ' A' ' 92' ' ' VAL . 2.0 t-20 -96.87 120.91 38.08 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 47.9 m-80 -108.12 108.95 20.24 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -169.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -127.45 125.01 39.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.18 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.579 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 29.6 m-85 -41.24 153.14 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -91.07 -32.81 15.74 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.749 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.542 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.39 130.04 35.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.788 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.611 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.7 m -56.31 -36.4 68.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.474 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.04 -37.82 78.78 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.564 0.697 . . . . 0.0 110.301 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.565 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 81.8 mt -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.647 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 mtp85 -75.63 -37.88 59.37 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.2 mm-40 -57.65 -37.43 73.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.821 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -160.23 98.53 1.44 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.973 177.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 13.2 Cg_endo -56.5 114.6 1.99 Allowed 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.061 2.508 . . . . 0.0 111.341 173.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HD2' ' HH ' ' A' ' 117' ' ' TYR . 52.6 Cg_exo -55.4 152.26 33.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.494 2.129 . . . . 0.0 110.794 176.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -51.12 -24.49 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.979 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.507 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 26.0 mttt -123.95 108.21 30.45 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 121.703 0.763 . . . . 0.0 111.676 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.733 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 8.9 Cg_exo -45.02 141.83 5.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 125.091 3.861 . . . . 0.0 113.456 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -114.41 114.79 26.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.644 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 14.5 m-85 -78.11 -16.89 57.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.67 0.748 . . . . 0.0 111.303 -168.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -85.47 -20.45 29.71 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.355 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.7 mmtt -101.96 5.38 40.74 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 115' ' ' ASN . 26.3 tp -86.82 143.68 27.37 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.362 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 2.3 tt0 -126.43 125.1 41.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.887 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.3 mtp-105 -83.68 104.34 13.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.889 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.596 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -98.32 103.5 15.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.705 HG23 HG13 ' A' ' 11' ' ' VAL . 1.5 mp -82.03 104.96 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.576 -173.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 112' ' ' TYR . 83.5 mt -65.84 91.4 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.852 0.834 . . . . 0.0 111.029 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.863 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.88 -15.26 59.74 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.562 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -77.87 -16.01 58.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.411 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -134.35 67.27 72.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.19 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.569 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 90.5 Cg_endo -91.92 108.29 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.551 2.168 . . . . 0.0 110.951 175.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.588 ' HG3' ' HB ' ' B' ' 130' ' ' ILE . 0.0 OUTLIER -75.53 80.29 2.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.504 -176.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.491 HG12 HG21 ' A' ' 109' ' ' VAL . 5.2 m -79.18 111.16 15.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.597 HG23 HH21 ' A' ' 108' ' ' ARG . 31.3 m -132.15 106.61 8.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.142 0.496 . . . . 0.0 110.333 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.682 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -108.36 133.23 52.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.243 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.66 169.99 8.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.993 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.402 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 9.2 m170 -102.47 116.97 33.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.162 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.7 pt -119.55 179.59 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.194 0.521 . . . . 0.0 109.844 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.416 ' H ' HD21 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -96.45 84.24 3.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 122.191 0.996 . . . . 0.0 112.242 -172.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.677 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 21.8 m95 -69.49 -9.27 53.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.321 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.543 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 4.5 mp0 -119.32 159.23 24.53 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.546 ' HA ' HH12 ' A' ' 102' ' ' ARG . 36.3 t70 -83.43 70.16 10.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.631 0.729 . . . . 0.0 110.245 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.543 ' ND2' ' HB2' ' A' ' 154' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.956 177.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.34 65.33 0.69 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.027 0.441 . . . . 0.0 110.718 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 57.8 mtp -91.12 138.49 31.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.32 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 92.77 0.75 Allowed Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.553 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.539 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.6 mmtt -60.89 -27.21 67.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.013 0.435 . . . . 0.0 110.42 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.16 -49.53 77.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.645 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . 0.497 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.7 tp -75.78 -27.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.052 0.453 . . . . 0.0 110.571 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.6 tm0? -56.48 -63.72 1.1 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.792 0.806 . . . . 0.0 109.905 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.587 ' O ' HG12 ' B' ' 130' ' ' ILE . 62.0 mt -58.99 -44.08 91.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.486 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.87 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -57.25 -32.55 66.68 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 123.566 0.541 . . . . 0.0 111.74 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 96.1 mtt180 -53.11 -53.48 49.71 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 1.05 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 5.1 tpp180 -62.94 -38.57 91.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.641 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.87 HG13 ' HA ' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -92.88 6.93 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -98.32 -39.08 8.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.981 0.419 . . . . 0.0 110.253 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 172.92 54.83 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.156 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 1.05 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 33.8 tt0 -133.0 6.43 3.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.402 0.62 . . . . 0.0 109.733 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -26.4 -75.33 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.301 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.665 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.872 176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ttt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.997 0.427 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.79 152.93 42.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.567 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.74 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 64.0 mmtt -100.3 -14.7 18.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.498 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.52 HG12 HD21 ' A' ' 38' ' ' LEU . 2.1 t -150.98 137.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.353 0.597 . . . . 0.0 112.503 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.877 ' HG2' HD12 ' A' ' 31' ' ' ILE . 23.8 mm-40 -128.53 115.4 18.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.951 172.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.655 HG21 ' CD1' ' A' ' 107' ' ' ILE . 5.0 m -78.13 134.71 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.234 -1.786 . . . . 0.0 108.107 167.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.72 -62.09 1.49 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.434 -166.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.463 ' C ' HD21 ' A' ' 8' ' ' ASN . 0.3 OUTLIER -103.64 99.87 9.69 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.168 177.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.529 HG13 ' OH ' ' A' ' 111' ' ' TYR . 3.0 p -95.84 97.86 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -93.54 97.06 6.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 122.236 1.017 . . . . 0.0 108.687 -174.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG13 HG23 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.15 135.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.659 -176.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.932 HD12 ' HG2' ' A' ' 23' ' ' GLN . 5.7 mt -106.48 -48.21 3.6 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -172.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.702 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.69 78.52 0.83 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.653 1.692 . . . . 0.0 109.659 167.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.712 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -85.91 178.32 2.38 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 112.22 -2.264 . . . . 0.0 107.023 162.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.847 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.2 Cg_endo -49.43 103.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 121.73 1.653 . . . . 0.0 113.242 -157.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.682 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.6 m -132.49 171.11 9.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.668 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.1 Cg_exo -43.18 135.79 5.66 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.313 2.009 . . . . 0.0 111.253 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.672 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 12.6 t80 -60.46 -26.66 66.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.325 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.17 -7.68 59.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.999 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.22 142.94 76.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 170.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.4 Cg_exo -77.55 136.7 15.77 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 123.407 2.738 . . . . 0.0 113.139 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.744 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 32.5 m-85 -57.43 116.43 3.33 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.532 0.682 . . . . 0.0 110.729 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.932 ' HG2' HD12 ' A' ' 12' ' ' LEU . 9.6 tt0 -116.39 106.47 13.66 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.941 -165.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.657 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 92.7 m-85 -110.32 154.01 24.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.564 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.639 ' HG3' ' HE1' ' A' ' 71' ' ' MET . 24.5 tt0 -121.69 87.06 2.68 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 167.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.487 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 74.8 mt -82.99 125.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.624 0.726 . . . . 0.0 112.281 -174.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 37.8 m -107.71 106.38 16.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.037 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.579 ' HB3' ' CG1' ' A' ' 6' ' ' VAL . 29.1 p90 -113.94 146.25 40.35 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.677 1.227 . . . . 0.0 110.924 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.921 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.1 tt0 -101.28 113.42 26.46 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.579 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.631 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -72.14 109.79 6.16 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.877 HD12 ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -70.53 -32.07 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.8 -2.0 . . . . 0.0 108.56 178.562 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.62 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 8.7 mm-40 -144.79 154.05 42.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.182 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.28 132.26 48.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.062 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 44.9 mt -83.06 158.63 22.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.682 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -113.1 -21.08 11.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.454 0.645 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.756 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.7 tt0 -126.44 -168.96 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.756 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.5 m-20 -90.63 149.91 21.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.697 HD23 HD13 ' A' ' 34' ' ' LEU . 4.7 tp -96.38 123.65 40.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.435 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 82.4 tt0 -107.9 92.11 3.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.699 -169.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.69 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 46.2 m95 -88.64 127.78 35.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 22.7 ttmt -124.11 140.59 52.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.032 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.511 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.2 mt -104.13 107.26 21.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.111 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.823 HG12 ' HB2' ' B' ' 135' ' ' ALA . 3.6 mp -103.01 112.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.443 -174.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 13.4 t80 -96.9 114.2 25.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.492 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.11 103.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.58 -44.91 96.41 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.607 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 43.9 t -134.36 135.32 42.61 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.532 0.682 . . . . 0.0 109.634 176.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -83.61 -11.21 57.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -32.2 25.24 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.938 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.66 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 74.9 m -144.5 117.02 8.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.021 0.915 . . . . 0.0 111.342 166.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.532 ' OE2' ' HD3' ' B' ' 128' ' ' ARG . 9.0 pt-20 -66.89 -14.82 63.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.276 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.2 -9.46 32.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.439 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.66 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 95.4 m-85 -90.89 6.43 44.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.463 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -53.63 103.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.909 0.862 . . . . 0.0 111.13 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -101.24 167.48 10.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.21 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.36 122.5 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.334 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 10.8 mp -81.67 -62.69 1.57 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -147.23 163.35 36.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.211 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 51.4 p -138.49 116.78 11.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -99.4 131.9 45.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.734 -172.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 12.5 mt -102.92 104.19 14.39 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.184 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.38 125.1 47.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' HG11 ' A' ' 65' ' ' VAL . . . -73.11 -166.21 10.2 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.319 -163.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 1.062 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 28.4 Cg_endo -60.57 114.7 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.233 1.289 . . . . 0.0 109.285 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 63' ' ' GLY . 28.2 m -116.9 120.99 33.31 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.661 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.83 131.0 37.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.517 2.145 . . . . 0.0 110.429 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.18 132.15 0.39 Allowed 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 124.26 0.975 . . . . 0.0 112.775 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 156.94 118.96 0.58 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -172.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.921 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.2 ttt180 -65.21 114.63 4.83 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.719 0.771 . . . . 0.0 111.214 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.425 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 5.9 p80 -149.07 156.2 41.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.128 -171.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.639 ' HE1' ' HG3' ' A' ' 25' ' ' GLU . 0.9 OUTLIER -106.05 151.18 25.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' N ' ' HG2' ' A' ' 71' ' ' MET . 1.3 p90 -140.75 160.75 39.36 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 171.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.467 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 2.6 p -117.35 136.98 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 122.168 0.985 . . . . 0.0 111.567 -172.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.657 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -118.07 138.14 52.44 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.49 -169.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.744 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 21.5 mt-30 -148.08 151.46 35.7 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB3' ' HB3' ' A' ' 57' ' ' LEU . . . -159.21 121.87 3.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.68 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.83 156.3 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.809 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.541 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.05 151.36 16.8 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.516 -169.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 64.3 Cg_endo -67.36 162.54 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.029 2.486 . . . . 0.0 110.16 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 24.0 m-80 -60.9 119.04 41.22 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 21.0 Cg_endo -66.76 -7.78 19.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.067 2.511 . . . . 0.0 110.796 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.46 1.3 55.8 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.978 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.27 -27.81 10.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.996 0.398 . . . . 0.0 110.638 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 89' ' ' ALA . 15.9 mt -80.82 128.64 70.94 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.991 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' O ' HG22 ' A' ' 84' ' ' ILE . 72.0 Cg_endo -81.88 161.29 18.61 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.066 1.844 . . . . 0.0 111.394 172.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.69 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.5 t70 -46.0 -48.7 16.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.88 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.994 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 7.5 m-20 -106.8 -8.38 16.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.409 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HA ' HG23 ' A' ' 84' ' ' ILE . . . -74.48 -43.8 54.39 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 111.178 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.6 46.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.593 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.31 -138.63 2.75 Favored Glycine 0 CA--C 1.508 -0.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.452 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.732 HG21 HD21 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -100.57 139.08 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -168.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.803 HG21 HG12 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -157.61 169.9 23.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.001 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.655 HG12 HD23 ' A' ' 96' ' ' LEU . 94.9 t -120.95 133.1 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 121.05 0.452 . . . . 0.0 111.63 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.511 ' CG2' HG23 ' A' ' 42' ' ' ILE . 3.0 p -117.15 107.13 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.719 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -106.27 151.02 25.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.702 -177.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 61.6 mt -110.51 100.86 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-O 121.709 0.766 . . . . 0.0 109.037 175.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.826 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 76.1 p -97.66 116.26 29.53 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.744 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.69 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 4.3 t -78.9 158.96 27.97 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.322 174.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.1 m -148.05 111.73 5.05 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.562 ' HB3' HD11 ' A' ' 151' ' ' ILE . 71.3 t80 -123.4 119.82 31.17 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 62.08 33.61 16.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.863 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.84 62.92 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.199 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.425 ' O ' HD12 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -132.72 133.32 43.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 0.0 110.98 175.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 3.1 mp0 -81.37 132.84 35.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.307 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.565 ' HZ ' HD13 ' A' ' 38' ' ' LEU . 55.0 p90 -125.73 2.06 7.47 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.826 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.3 tt -156.84 159.49 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.486 ' NH1' ' HA ' ' B' ' 130' ' ' ILE . 5.0 tmm_? -152.79 105.46 2.96 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.708 0.63 . . . . 0.0 109.559 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.3 p -95.0 102.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -89.99 102.65 2.93 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.82 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.943 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 10.3 m-85 -98.96 121.98 41.62 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.573 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.555 ' CB ' HD13 ' A' ' 140' ' ' LEU . 57.2 m-85 -68.97 115.86 8.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.295 176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.803 HG12 HG21 ' A' ' 93' ' ' THR . 1.8 p -101.27 109.71 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 122.32 1.057 . . . . 0.0 108.28 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.732 HD21 HG21 ' A' ' 92' ' ' VAL . 14.4 t-20 -97.14 104.4 16.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.727 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 31.8 m-80 -89.55 110.16 21.04 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.02 130.16 49.45 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.64 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 25.9 m-85 -38.55 150.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -84.44 -34.32 23.49 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.223 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 10.6 tt0 -86.51 119.43 26.76 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.249 -1.796 . . . . 0.0 108.504 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.842 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 99.2 m -54.89 -31.3 59.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.084 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.18 -32.29 70.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 92.0 mt -73.42 -27.05 61.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.253 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.842 ' HE ' ' HA ' ' A' ' 120' ' ' THR . 19.3 mtm180 -74.46 -38.18 63.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.616 0.722 . . . . 0.0 109.257 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.713 ' HG3' ' O ' ' A' ' 120' ' ' THR . 45.9 mt-10 -58.66 -39.64 81.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.339 -1.301 . . . . 0.0 111.126 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.4 p30 -146.8 86.13 6.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 18.7 Cg_endo -57.43 114.36 1.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.789 2.326 . . . . 0.0 111.318 176.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.505 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 54.0 Cg_exo -55.17 141.74 79.56 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.265 1.977 . . . . 0.0 109.899 175.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.75 -13.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.972 0.795 . . . . 0.0 112.454 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.496 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -124.63 100.22 34.89 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.162 0.982 . . . . 0.0 111.824 167.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.69 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.7 Cg_exo -44.77 144.83 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.827 1 C-N-CA 125.453 4.102 . . . . 0.0 113.378 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.2 t70 -113.65 111.67 22.22 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.672 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 9.9 m-85 -75.93 -11.39 59.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.546 1.165 . . . . 0.0 110.596 -170.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -90.3 -34.5 15.71 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.056 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 61.2 mmtt -92.79 17.67 10.09 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 33.1 tp -100.6 128.67 46.57 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.334 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.498 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -120.72 110.93 16.97 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.847 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.94 113.85 25.56 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.096 0.474 . . . . 0.0 111.681 -174.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.707 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 11.5 t30 -89.89 112.55 23.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 172.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.483 HG23 HG13 ' A' ' 11' ' ' VAL . 1.7 mp -83.71 103.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.313 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.555 HD13 ' CB ' ' A' ' 112' ' ' TYR . 86.3 mt -63.57 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.296 0.569 . . . . 0.0 110.938 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.943 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.08 -11.82 60.01 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.738 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -79.23 -3.33 45.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.574 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -143.79 71.08 17.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.94 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.3 Cg_endo -89.72 106.54 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.292 1.995 . . . . 0.0 111.234 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 81.22 8.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.038 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.714 HG13 HG21 ' A' ' 109' ' ' VAL . 32.4 m -77.36 131.52 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.423 HG22 ' CE1' ' A' ' 149' ' ' PHE . 86.2 m -151.09 110.71 4.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.516 0.674 . . . . 0.0 110.566 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.725 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 5.6 ptt-85 -108.46 138.51 44.64 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.798 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.3 OUTLIER -116.11 169.37 9.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.312 -176.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.466 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.3 pt -129.91 -177.2 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.631 0.729 . . . . 0.0 111.469 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.52 ' H ' HD21 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -98.15 84.22 3.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.972 -171.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TRP . . . . . 0.74 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 63.7 m95 -69.45 -7.44 37.93 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.483 -0.76 . . . . 0.0 111.345 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -131.68 153.99 49.44 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.37 71.0 1.74 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.072 0.939 . . . . 0.0 111.534 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 . . . . . 0 C--O 1.247 0.927 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.837 173.116 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.35 -38.43 2.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.437 0.161 . . . . 0.0 110.872 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 72.0 mtm 65.87 -75.51 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.995 0.809 . . . . 0.0 111.11 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.91 152.76 47.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' LYS . . . . . 0.655 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 39.5 mmtt -84.85 -36.27 21.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.075 0.464 . . . . 0.0 110.042 -171.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -31.11 -46.06 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.3 tt -73.82 -38.3 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.4 0.619 . . . . 0.0 110.489 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.612 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 1.6 tp-100 -66.36 -37.39 85.21 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.449 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.788 ' O ' ' HB ' ' B' ' 130' ' ' ILE . 20.0 mt -59.52 -50.32 74.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.299 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' B' ' 131' ' ' ARG . . . -62.65 -42.51 99.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.818 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.532 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 81.3 mtt180 -56.74 -65.1 0.67 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.349 0.595 . . . . 0.0 111.973 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.582 ' HD2' ' HG3' ' B' ' 133' ' ' GLU . 20.0 mmm180 -60.37 -30.5 69.61 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.118 -175.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.788 ' HB ' ' O ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -87.82 -7.48 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.215 -175.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' B' ' 127' ' ' ALA . 30.3 mmt180 -77.84 -36.32 50.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 141.13 65.12 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.42 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.582 ' HG3' ' HD2' ' B' ' 129' ' ' ARG . 6.7 mm-40 -80.13 -42.38 23.61 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' B' ' 133' ' ' GLU . 9.8 ptt180 60.7 128.32 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.068 1.413 . . . . 0.0 112.45 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.823 ' HB2' HG12 ' A' ' 43' ' ' ILE . . . . . . . . 0 C--N 1.304 -1.372 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.42 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.669 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.2 mptp? -96.6 -18.53 19.68 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.26 -176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.83 125.36 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.752 0.787 . . . . 0.0 110.71 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.546 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.36 100.05 7.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.786 176.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -77.96 131.84 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.403 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -111.73 -66.77 1.05 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.071 -166.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.54 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 65.5 t30 -102.76 154.05 19.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.82 -176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 9' ' ' VAL . 6.1 p -144.83 99.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 CA-C-O 122.104 0.955 . . . . 0.0 109.214 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -92.26 95.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.322 1.058 . . . . 0.0 108.572 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.85 127.72 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.763 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.913 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.2 mt -97.48 -39.05 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.318 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.641 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 9.8 t0 -70.91 65.13 0.34 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.316 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.637 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m-20 -84.84 173.44 7.15 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 162.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.0 Cg_endo -50.32 101.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 121.508 1.574 . . . . 0.0 113.101 -158.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.637 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 13.9 m -136.21 169.44 13.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.861 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 70.5 Cg_exo -38.31 137.47 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.18 2.587 . . . . 0.0 113.496 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.729 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 19.2 t80 -63.09 -20.76 65.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 21.4 m-85 -94.38 5.62 51.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 111.235 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.77 140.92 47.44 Favored Pre-proline 0 C--O 1.213 -0.831 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 14.3 Cg_exo -74.56 141.92 28.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.691 2.261 . . . . 0.0 112.185 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.783 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 94.8 m-85 -60.24 117.07 4.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 122.964 0.506 . . . . 0.0 110.015 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.913 ' HB3' HD12 ' A' ' 12' ' ' LEU . 39.3 mt-30 -115.5 111.27 20.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.32 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' A' ' 97' ' ' ILE . 70.0 m-85 -121.58 107.51 12.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.497 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.624 ' HB2' HD21 ' A' ' 12' ' ' LEU . 22.0 tt0 -90.14 85.05 6.17 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 14.4 mt -86.83 132.4 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.694 0.759 . . . . 0.0 112.114 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.7 m -108.47 106.85 17.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.294 174.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.3 p90 -118.79 150.92 38.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.529 0.681 . . . . 0.0 109.717 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.837 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 47.2 tt0 -107.46 111.04 23.14 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.49 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 29.1 t -72.96 108.1 5.69 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -74.55 -27.21 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.031 -173.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.598 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 8.2 mt-10 -143.8 179.62 7.05 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.88 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -73.57 146.63 44.59 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.021 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -106.73 157.03 18.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -174.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -113.97 -41.85 3.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.889 0.852 . . . . 0.0 110.545 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.803 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 33.2 tt0 -113.33 -165.84 1.03 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.042 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.803 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -98.51 143.59 28.76 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.819 0.819 . . . . 0.0 110.599 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.821 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.68 124.13 29.92 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.38 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.595 ' HB3' ' O ' ' A' ' 100' ' ' THR . 42.3 tt0 -107.55 90.15 3.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.929 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 59' ' ' SER . 24.5 m95 -81.67 122.74 28.01 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.6 ttmt -126.4 141.59 51.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.574 HG22 HG22 ' A' ' 95' ' ' VAL . 13.8 mt -102.9 120.13 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.673 ' HB ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -114.38 106.33 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.287 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.686 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.5 t80 -88.87 116.69 27.34 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.73 105.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.151 0.5 . . . . 0.0 109.899 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.44 -35.77 92.49 Favored Glycine 0 CA--C 1.501 -0.808 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.172 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.577 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.6 t -139.14 116.56 11.25 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.587 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -70.35 -1.2 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 167.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -96.3 -27.02 15.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 47' ' ' SER . 14.5 m -144.67 109.45 4.99 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.828 0.823 . . . . 0.0 111.091 171.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.838 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -70.08 -23.76 63.12 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.399 -166.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -67.4 -2.33 6.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 4.2 m-30 -85.71 -4.02 59.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.041 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.595 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.2 p-10 -42.53 112.32 0.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.316 1.055 . . . . 0.0 112.206 -175.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 3.1 mt-30 -91.36 168.49 11.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.923 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.42 114.25 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -173.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.1 mm? -82.73 -49.29 9.92 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.059 -174.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -163.92 164.04 23.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 27.8 p -141.43 117.46 10.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.2 p -100.29 132.76 45.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.624 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.36 105.93 15.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.638 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.23 113.81 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.65 -166.38 12.39 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.098 -168.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.021 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.8 Cg_endo -65.23 115.27 3.22 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.407 1.404 . . . . 0.0 110.365 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 31.1 m -131.99 141.36 41.19 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.614 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.55 79.11 3.31 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.082 1.854 . . . . 0.0 113.482 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.29 -171.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.015 -1.902 . . . . 0.0 112.343 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.94 122.79 2.62 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.947 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.9 ttt180 -87.69 118.24 27.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -161.06 166.0 28.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.41 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -108.64 139.46 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.174 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 9.8 p90 -126.69 160.91 29.39 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.14 106.42 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-O 123.06 1.41 . . . . 0.0 111.898 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 140.97 37.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.443 -2.162 . . . . 0.0 110.572 -176.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.783 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.0 mt-30 -150.68 149.84 30.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 165.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.593 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -158.65 132.14 7.48 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.457 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.719 ' O ' HD12 ' A' ' 57' ' ' LEU . 12.9 m-20 -67.18 143.19 56.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.163 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -52.2 157.22 2.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 124.704 1.201 . . . . 0.0 114.028 -173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.686 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.03 -179.92 3.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.97 3.113 . . . . 0.0 113.267 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 96.1 m-20 -82.18 119.17 74.4 Favored Pre-proline 0 CA--C 1.515 -0.388 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.263 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 16.1 Cg_endo -60.32 -25.18 79.64 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.538 2.826 . . . . 0.0 112.576 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.0 -15.86 81.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.417 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.422 ' CB ' HE21 ' A' ' 55' ' ' GLN . 31.3 mt -79.57 -25.94 41.47 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.242 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.69 129.29 49.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -80.06 164.02 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.746 2.964 . . . . 0.0 112.794 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.578 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 m-20 -45.12 -55.0 6.11 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.823 0.849 . . . . 0.0 113.071 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.0 -18.56 61.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.218 0.533 . . . . 0.0 110.596 -168.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.666 ' HA ' ' HZ1' ' B' ' 122' ' ' LYS . 40.2 t0 -92.36 -35.82 13.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -70.17 -45.38 66.84 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.381 0.61 . . . . 0.0 111.332 -171.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.19 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.77 0.795 . . . . 0.0 111.559 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.45 -160.14 10.09 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.433 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.536 HG12 ' OD1' ' A' ' 114' ' ' ASN . 4.7 m -94.87 144.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.907 ' HB ' HG13 ' A' ' 113' ' ' VAL . 2.8 m -151.15 170.24 19.92 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.597 HG23 HD13 ' B' ' 126' ' ' LEU . 3.9 t -132.7 144.6 36.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 118.939 0.79 . . . . 0.0 110.954 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 42' ' ' ILE . 10.5 p -129.04 105.48 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.916 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -104.13 135.51 45.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.792 -169.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 45.1 mt -103.29 99.82 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-O 121.919 0.866 . . . . 0.0 109.08 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.781 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 58.0 p -93.61 112.33 24.19 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.717 ' SG ' HD12 ' A' ' 38' ' ' LEU . 1.4 t -79.52 122.3 26.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 18.8 m -121.83 103.71 9.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.021 -167.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.677 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 61.4 t80 -109.14 120.28 42.05 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.413 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.677 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 15.5 mtp180 69.67 22.42 6.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.778 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.81 85.0 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -110.05 117.79 34.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.847 -0.676 . . . . 0.0 109.386 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 60.0 mt-10 -82.54 132.47 35.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.821 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.9 p90 -123.19 1.77 9.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.6 tt -159.24 157.86 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.625 ' HD2' ' O ' ' B' ' 130' ' ' ILE . 22.3 ttm180 -150.99 101.37 2.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.463 0.477 . . . . 0.0 109.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.916 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -84.52 98.66 6.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.228 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.17 77.25 2.12 Favored Glycine 0 CA--C 1.488 -1.606 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.586 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.993 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -74.06 115.9 14.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.137 -1.032 . . . . 0.0 109.121 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.565 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.7 m-85 -66.31 120.58 13.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.907 HG13 ' HB ' ' A' ' 93' ' ' THR . 2.6 p -103.18 110.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.536 ' OD1' HG12 ' A' ' 92' ' ' VAL . 5.0 t30 -92.43 110.76 22.17 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.184 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 39.1 m-80 -97.78 107.84 20.42 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.447 ' HG3' ' ND2' ' A' ' 114' ' ' ASN . 33.5 mt-10 -139.96 141.22 36.44 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.184 -176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.741 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 46.4 m-85 -47.97 151.93 0.86 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -174.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -86.81 -37.72 17.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.534 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.3 mt-10 -82.94 132.0 35.17 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.766 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 m -55.73 -36.17 66.95 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.55 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.85 -40.42 84.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.897 0.856 . . . . 0.0 109.991 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 46.0 mt -77.73 -23.09 49.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.799 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -80.15 -37.04 34.28 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.2 mm-40 -56.19 -43.1 78.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.769 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 21.8 p-10 -152.72 89.11 3.82 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.447 0.641 . . . . 0.0 109.854 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.5 Cg_endo -50.46 116.01 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.769 2.979 . . . . 0.0 112.865 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.741 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 77.7 Cg_exo -52.75 136.79 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.007 2.471 . . . . 0.0 111.249 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' HE2' ' A' ' 129' ' ' LYS . 22.5 t -51.68 -40.68 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.555 -173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.8 mmpt? -94.83 137.96 22.25 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-O 121.153 0.501 . . . . 0.0 110.798 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.578 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 11.8 Cg_exo -69.89 123.77 10.38 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.7 2.933 . . . . 0.0 112.332 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' HB2' ' HE1' ' A' ' 117' ' ' TYR . 1.6 m-20 -104.57 97.09 7.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.681 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.684 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 33.4 m-85 -68.0 -16.33 64.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.994 0.902 . . . . 0.0 110.549 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 2.9 p -83.3 -21.72 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.1 mmtt -104.58 5.12 33.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 132' ' ' PHE . 17.6 tp -87.82 137.83 31.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.556 -168.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 15' ' ' PRO . 13.6 tt0 -120.41 127.5 52.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.842 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 21.2 mtm-85 -90.46 104.93 17.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 15.3 t30 -89.75 98.75 11.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -78.73 100.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 112' ' ' TYR . 95.8 mt -62.2 92.57 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.706 0.765 . . . . 0.0 111.14 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.993 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -78.93 -8.82 59.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.419 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 p -80.66 -10.55 59.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.03 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.4 t-20 -142.27 62.97 14.41 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.513 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 4.7 Cg_exo -81.0 109.11 2.14 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.3 2.0 . . . . 0.0 111.098 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.651 ' HB3' HD13 ' B' ' 130' ' ' ILE . 15.0 tpt180 -82.23 82.61 7.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.98 106.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.2 m -116.46 105.65 12.72 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.601 0.715 . . . . 0.0 109.308 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.864 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.5 ptt180 -112.53 148.32 34.74 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.805 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.454 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -129.42 167.45 17.79 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.145 -173.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.1 123.14 47.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.931 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 101' ' ' TYR . 38.9 pt -121.45 158.73 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -87.25 103.22 15.23 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.495 1.14 . . . . 0.0 110.365 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.669 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 7.9 m95 -75.54 -3.56 34.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.64 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 . . . . . 0 N--CA 1.438 -1.048 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.212 -176.059 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.666 ' HZ1' ' HA ' ' A' ' 88' ' ' ASP . 9.5 mmmm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -40.59 -54.89 2.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.044 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.489 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.9 tp -69.06 -32.07 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.851 0.357 . . . . 0.0 111.247 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 58.5 mm-40 -58.07 -46.91 84.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 173.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.597 HD13 HG23 ' A' ' 94' ' ' VAL . 30.8 mt -68.35 -43.62 77.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.319 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.29 68.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.712 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 95.9 mtt180 -54.14 -57.65 10.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.838 ' HD3' ' HB2' ' A' ' 51' ' ' GLU . 6.1 tpt180 -61.4 -35.45 77.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.269 -171.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 145' ' ' ARG . 23.8 mt -76.83 -49.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.65 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' B' ' 131' ' ' ARG . 7.3 mmm180 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 111.534 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.927 0.394 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.934 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.58 -21.57 18.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 34' ' ' LEU . 3.4 t -137.53 129.22 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.772 0.796 . . . . 0.0 111.08 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp-100 -115.04 100.55 8.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.233 -1.349 . . . . 0.0 107.421 169.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 29.9 t -74.28 124.73 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -107.39 -65.65 1.09 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.09 0.947 . . . . 0.0 109.146 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.685 HD22 HG13 ' A' ' 10' ' ' VAL . 67.3 t30 -106.41 151.8 24.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.849 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 26' ' ' ILE . 3.2 p -146.77 99.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.367 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.99 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.4 m -93.67 107.11 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 109.979 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.889 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -78.72 136.6 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.568 -176.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 23' ' ' GLN . 7.6 mt -111.05 -42.14 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.32 -172.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 23' ' ' GLN . 4.2 p-10 -69.69 43.66 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.41 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 12' ' ' LEU . 1.2 m-20 -79.0 169.91 18.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.7 Cg_endo -53.02 100.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.048 1.165 . . . . 0.0 114.206 -138.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.666 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.6 m -136.76 171.22 9.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 112.008 -2.36 . . . . 0.0 107.482 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 62.4 Cg_exo -39.83 141.46 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.695 2.263 . . . . 0.0 112.912 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.017 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.0 t80 -60.31 -30.6 69.59 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.378 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -79.38 -6.17 56.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.089 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -77.59 119.94 79.46 Favored Pre-proline 0 CA--C 1.507 -0.682 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.217 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.545 ' C ' HH22 ' A' ' 137' ' ' ARG . 47.2 Cg_exo -60.57 154.43 54.28 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 123.844 3.03 . . . . 0.0 113.391 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.77 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 80.2 m-85 -62.93 133.36 54.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.686 ' HB3' HD12 ' A' ' 12' ' ' LEU . 39.8 mt-30 -132.27 89.86 2.72 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.307 0.575 . . . . 0.0 109.552 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' HD11 ' A' ' 97' ' ' ILE . 79.9 m-85 -100.44 109.14 21.27 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.56 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.99 ' HB3' HG23 ' A' ' 10' ' ' VAL . 31.8 tt0 -91.66 85.87 5.81 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.684 HG13 HG23 ' A' ' 9' ' ' VAL . 2.6 mp -81.85 140.06 17.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.764 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 11.3 m -115.25 107.16 14.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.327 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 17.6 p90 -121.27 153.41 37.7 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.897 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 21.9 tt0 -109.4 118.3 36.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 24.4 m -74.07 109.25 7.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.469 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -72.81 -31.4 36.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.962 -174.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.934 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 47.8 mt-10 -142.89 166.74 23.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.772 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.2 m-20 -61.71 131.2 49.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.767 HD12 ' CE1' ' A' ' 101' ' ' TYR . 2.1 mm? -85.51 152.29 23.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -113.54 -36.82 4.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.68 0.752 . . . . 0.0 110.126 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 13.7 tt0 -117.13 -167.37 1.29 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.449 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 5.3 m-20 -96.19 138.43 33.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.516 0.674 . . . . 0.0 111.316 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.714 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.47 120.02 29.45 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.922 178.242 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.8 tt0 -106.92 89.32 2.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.638 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.706 ' O ' ' HA ' ' A' ' 59' ' ' SER . 27.6 m95 -76.35 129.08 36.08 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 30.0 ttmt -133.38 142.48 48.4 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.903 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 95' ' ' VAL . 10.7 mt -103.22 121.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -114.29 105.71 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.119 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.823 ' CE2' HG11 ' A' ' 113' ' ' VAL . 28.3 t80 -89.72 124.55 34.72 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.898 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.01 111.54 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.376 0.608 . . . . 0.0 110.343 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 53' ' ' TYR . . . -70.76 -35.71 66.45 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -172.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 39.6 t -134.53 118.85 17.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.772 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -66.05 0.23 2.04 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.999 0.428 . . . . 0.0 110.01 167.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -102.12 -17.12 16.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.286 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 50.4 m -124.64 -171.69 2.4 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.775 0.798 . . . . 0.0 111.086 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.65 -3.31 1.15 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.516 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -94.25 -13.16 26.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.675 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.698 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 3.5 m-30 -84.92 -15.82 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.335 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 8.7 p-10 -42.44 115.48 0.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.134 0.968 . . . . 0.0 111.979 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.444 ' HG2' HD12 ' A' ' 83' ' ' LEU . 11.2 mp0 -91.17 166.85 12.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.943 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.81 107.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.0 mm? -74.92 -40.06 61.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.671 -171.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.34 176.26 2.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.887 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 58.1 p -151.49 115.28 4.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.84 132.42 45.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.918 -175.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 6.4 mt -102.73 106.26 16.85 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -92.98 120.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -84.16 -156.68 24.44 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.925 -165.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 38.6 Cg_endo -64.6 118.79 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.952 1.768 . . . . 0.0 110.53 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.626 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 28.5 m -134.8 141.87 40.22 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.514 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -86.17 75.33 2.98 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.421 2.08 . . . . 0.0 114.599 -173.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.634 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 48.19 -179.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.954 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 114.45 129.22 4.73 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.138 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.897 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.1 ptt-85 -75.87 126.21 30.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.421 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 4.9 p80 -153.68 141.6 20.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.936 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -95.55 137.75 34.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -177.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.7 p90 -135.68 146.37 47.71 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 13.8 p -104.26 125.65 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 122.318 1.056 . . . . 0.0 110.438 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.489 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 12.0 t80 -119.53 113.04 20.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.764 -163.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 38.3 mt-30 -138.46 149.99 46.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.476 -167.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' C ' ' HB3' ' A' ' 21' ' ' PRO . . . -169.34 146.07 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.351 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.656 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.1 p-10 -61.24 170.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.05 0.452 . . . . 0.0 111.413 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -71.12 164.22 58.82 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.688 -170.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.77 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 34.7 Cg_endo -60.92 168.21 7.59 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.355 2.703 . . . . 0.0 111.69 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 11.5 m120 -69.75 115.54 34.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.0 -175.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 13.2 Cg_endo -61.89 -26.68 79.31 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.225 2.617 . . . . 0.0 112.045 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.61 14.55 55.26 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.292 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 83' ' ' LEU . 15.6 mt -116.74 -33.75 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.391 0.139 . . . . 0.0 110.816 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 36.5 mt -73.71 129.89 84.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.127 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 95.0 Cg_endo -79.92 162.26 23.72 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.221 2.614 . . . . 0.0 112.699 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.734 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 12.1 m-20 -45.85 -52.54 11.19 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.673 0.789 . . . . 0.0 112.202 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.71 -28.61 65.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.835 ' HA ' ' NZ ' ' B' ' 122' ' ' LYS . 49.1 t0 -80.87 -38.97 27.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -65.45 -38.7 90.62 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -165.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -102.39 46.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 -138.85 3.0 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.118 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' B' ' 122' ' ' LYS . 1.1 t -97.13 135.87 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.059 0.933 . . . . 0.0 113.256 -172.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.699 ' HB ' HG13 ' A' ' 113' ' ' VAL . 1.7 m -140.51 168.82 18.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.769 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -125.54 143.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 118.318 0.508 . . . . 0.0 111.127 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 42' ' ' ILE . 7.3 p -131.06 108.23 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.65 154.91 18.46 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.983 -171.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.647 ' HB ' HG12 ' A' ' 109' ' ' VAL . 2.4 mt -117.39 105.07 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.825 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.0 p -100.62 114.8 28.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.227 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.566 ' HB2' HG22 ' A' ' 107' ' ' ILE . 62.6 m -79.68 115.76 19.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.452 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -108.54 101.91 11.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.991 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.767 ' CE1' HD12 ' A' ' 34' ' ' LEU . 87.1 t80 -104.31 127.83 52.02 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.599 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 37.0 mtp180 67.02 14.19 9.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.3 65.24 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.731 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.752 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -119.74 129.37 54.47 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.8 mp0 -83.6 133.68 34.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.418 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.714 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.5 p90 -121.47 -5.1 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.825 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.9 tt -156.17 158.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 174.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.98 HH22 ' HG3' ' A' ' 145' ' ' ARG . 4.3 tmm_? -150.87 107.68 3.54 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -174.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.2 p -102.64 101.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.188 0.994 . . . . 0.0 109.321 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.23 86.66 1.38 Allowed Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 119.762 -1.209 . . . . 0.0 111.499 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.771 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 17.1 m-85 -82.17 122.29 27.69 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.192 -1.004 . . . . 0.0 108.805 172.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 140' ' ' LEU . 31.6 m-85 -68.48 131.91 46.08 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.332 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.823 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.6 p -104.89 111.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.41 ' OD1' HG23 ' A' ' 92' ' ' VAL . 48.4 t30 -90.58 110.51 21.65 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.349 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 28.5 m-80 -102.68 107.34 18.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -131.91 130.03 41.06 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.612 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.7 m-85 -40.86 148.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.8 p -89.65 -29.27 18.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.771 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 30.2 mm-40 -91.31 140.0 30.2 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.556 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.0 m -52.05 -47.95 64.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 117.928 0.331 . . . . 0.0 111.206 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.27 -39.76 67.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.988 0.899 . . . . 0.0 110.045 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.5 mt -77.6 -30.34 52.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.376 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 52.1 mtp180 -76.83 -39.06 52.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.501 0.667 . . . . 0.0 109.516 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.746 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 1.5 pt-20 -80.85 -20.6 41.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.597 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.746 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -149.82 77.38 8.58 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.841 170.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 18.1 Cg_endo -57.03 118.42 5.28 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.634 2.889 . . . . 0.0 112.94 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 14.9 Cg_exo -71.63 147.81 51.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.065 2.51 . . . . 0.0 110.197 172.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.1 -27.75 43.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.866 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -89.12 122.21 68.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 0.0 111.271 175.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.734 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 36.5 Cg_exo -63.54 131.78 33.0 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 124.253 3.302 . . . . 0.0 112.588 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.0 t0 -114.05 105.28 13.03 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.727 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 42.6 m-85 -77.87 -19.86 54.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.846 0.832 . . . . 0.0 110.344 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.3 t -79.94 -29.91 39.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.804 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 71.6 mmtt -98.82 14.41 28.97 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 28.8 tp -99.68 143.91 29.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.213 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -124.91 129.95 51.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 1.017 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 10.0 mtm180 -95.5 106.01 18.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 4.4 t30 -96.35 99.71 11.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.889 HG21 HG11 ' A' ' 11' ' ' VAL . 10.0 mm -68.05 117.86 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.633 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . 62.4 mt -74.35 75.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.719 0.771 . . . . 0.0 110.334 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.771 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -68.85 -13.14 62.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.974 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -75.46 -12.77 60.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.457 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.412 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.5 t-20 -133.9 60.46 45.69 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 24.1 Cg_exo -68.84 105.24 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.549 1.499 . . . . 0.0 111.497 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.98 ' HG3' HH22 ' A' ' 108' ' ' ARG . 18.2 tpt85 -87.69 88.67 7.73 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.758 HG12 HG23 ' A' ' 109' ' ' VAL . 22.6 m -92.54 124.58 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.461 HG22 ' CE2' ' A' ' 149' ' ' PHE . 98.8 m -132.8 107.78 8.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.379 0.609 . . . . 0.0 109.708 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.731 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -106.64 140.33 39.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.418 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -126.18 118.7 25.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.458 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 143.49 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 110.812 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.752 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 46.6 pt -131.9 177.29 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 154' ' ' GLU . 6.8 p-10 -97.97 94.2 6.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.313 1.054 . . . . 0.0 109.425 176.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.0 m95 -71.73 4.55 3.13 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.178 -1.373 . . . . 0.0 108.897 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 152' ' ' ASN . 16.9 mt-10 . . . . . 0 N--CA 1.436 -1.13 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.622 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.835 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 75.7 mmtt . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 p30 13.18 -93.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' B' ' 127' ' ' ALA . 13.7 tt -62.03 -27.36 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.5 tm0? -63.84 -58.56 6.42 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 121.745 0.783 . . . . 0.0 110.196 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' B' ' 122' ' ' LYS . 1.2 mm? -64.23 -28.89 70.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.611 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . . . -62.33 -40.53 96.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.813 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -51.35 -53.88 31.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -70.47 -25.85 63.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.87 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.547 HG12 HH12 ' A' ' 108' ' ' ARG . 5.6 mt -65.47 -39.48 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.395 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.426 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.739 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 22.0 mmtt -101.02 -9.02 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.055 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.502 ' N ' HG13 ' A' ' 31' ' ' ILE . 2.7 t -142.95 126.96 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.417 0.627 . . . . 0.0 110.687 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.578 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 6.0 tp-100 -124.09 100.8 6.9 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.099 174.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.611 HG11 ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -82.48 131.43 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.127 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -115.81 -63.53 1.44 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.531 -162.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.691 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 57.7 t30 -100.07 148.88 24.07 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.852 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.3 p -146.08 102.23 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-O 121.797 0.808 . . . . 0.0 109.934 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.975 HG23 ' HB3' ' A' ' 25' ' ' GLU . 3.3 m -98.39 96.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.779 0.799 . . . . 0.0 109.804 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.865 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -74.96 129.43 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 122.017 0.913 . . . . 0.0 110.427 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.888 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.1 mt -98.82 -36.36 9.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.455 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.739 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 16.9 t70 -68.88 39.55 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.683 170.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.632 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -79.22 172.47 9.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.3 Cg_endo -50.38 101.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 120.841 1.336 . . . . 0.0 113.006 -152.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.661 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 21.2 m -141.95 171.62 7.07 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 112.193 -2.276 . . . . 0.0 107.676 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 67.2 Cg_exo -38.22 132.65 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.484 2.123 . . . . 0.0 112.301 175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.735 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 33.3 t80 -54.22 -28.13 39.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.868 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -86.84 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.74 0.305 . . . . 0.0 111.039 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.62 120.22 79.48 Favored Pre-proline 0 CA--C 1.513 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.721 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.4 Cg_exo -63.85 146.04 91.2 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 123.821 3.014 . . . . 0.0 113.161 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.761 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 37.8 m-85 -60.35 115.11 3.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.904 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.888 ' HB3' HD12 ' A' ' 12' ' ' LEU . 35.9 mt-30 -118.99 102.03 8.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.95 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.64 ' CD1' HD11 ' A' ' 97' ' ' ILE . 87.5 m-85 -109.65 111.4 22.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.462 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.975 ' HB3' HG23 ' A' ' 10' ' ' VAL . 30.6 tt0 -93.38 85.23 4.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.95 132.95 32.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 122.049 0.928 . . . . 0.0 112.609 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 25.5 m -104.15 107.17 17.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.173 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.588 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 27.5 p90 -117.53 148.2 42.09 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.925 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.861 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.9 tm-20 -101.94 111.33 23.55 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.4 t -72.4 108.63 5.6 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -75.03 -23.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.086 -171.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.739 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 50.3 mt-10 -155.37 148.31 24.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.62 131.47 50.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.949 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 4.7 tp -86.67 154.24 21.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.768 -168.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -113.18 -30.49 6.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.584 0.707 . . . . 0.0 110.372 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.811 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.8 tt0 -117.01 -167.51 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.811 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 4.6 p-10 -100.67 137.68 38.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.843 0.83 . . . . 0.0 111.523 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.26 122.25 27.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.112 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.633 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.9 tt0 -106.84 89.82 3.13 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.28 -176.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 59' ' ' SER . 15.1 m95 -78.0 135.8 37.85 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.7 ttmt -137.37 137.5 38.93 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.288 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.964 HG22 HG22 ' A' ' 95' ' ' VAL . 8.9 mt -102.46 110.16 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.6 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 49.9 mt -108.43 106.11 20.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.74 -172.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.845 ' CE2' HG11 ' A' ' 113' ' ' VAL . 25.3 t80 -89.49 108.53 19.7 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.867 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t -53.44 104.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.748 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.08 99.84 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.152 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 53' ' ' TYR . 29.4 t -131.78 128.81 39.6 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' B' ' 126' ' ' LEU . . . -75.93 -5.94 48.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.978 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -100.03 -35.52 9.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.537 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 8.9 m -122.35 97.41 5.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.056 0.931 . . . . 0.0 110.059 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' B' ' 128' ' ' ARG . 0.0 OUTLIER -67.65 -11.08 57.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.03 -172.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.73 -12.08 60.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.651 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 16.9 m-30 -87.65 10.25 18.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.273 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.486 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 4.9 p-10 -54.93 110.3 0.64 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.092 0.949 . . . . 0.0 111.162 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HG2' HD12 ' A' ' 83' ' ' LEU . 4.8 mt-30 -92.7 169.95 10.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.507 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.64 112.64 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -169.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 44' ' ' TYR . 3.7 mm? -76.34 -42.66 44.19 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.484 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 5.4 p-10 -170.6 173.95 5.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.489 171.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 50.8 p -145.36 117.56 8.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.63 128.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.459 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.9 mt -103.18 104.02 14.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.049 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.49 119.43 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -82.27 -151.67 9.74 Favored Glycine 0 CA--C 1.482 -1.979 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.158 -165.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.949 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 2.1 Cg_endo -46.35 117.14 1.83 Allowed 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.454 1.436 . . . . 0.0 109.144 167.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.413 HG13 ' SG ' ' A' ' 30' ' ' CYS . 2.6 p -133.66 120.98 15.86 Favored Pre-proline 0 C--N 1.288 -2.106 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.7 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.71 130.75 41.58 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.154 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -44.61 147.21 0.63 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.832 0.708 . . . . 0.0 111.255 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.84 130.29 2.25 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.09 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.861 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -74.43 116.97 15.71 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.789 0.804 . . . . 0.0 110.889 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -150.72 152.13 33.44 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.36 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.718 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.6 ttp -98.92 126.94 44.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.324 0.583 . . . . 0.0 111.116 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -117.95 133.18 56.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.3 p -101.95 127.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.433 1.111 . . . . 0.0 110.392 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.545 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 1.2 t80 -117.34 133.89 55.46 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.655 -1.612 . . . . 0.0 109.465 -164.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.739 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 9.2 mt-30 -151.69 150.36 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.047 0.451 . . . . 0.0 110.398 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -160.37 168.48 25.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.38 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.07 -175.32 0.07 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.844 0.831 . . . . 0.0 112.162 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -89.52 158.28 45.9 Favored Pre-proline 0 N--CA 1.438 -1.046 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.726 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.761 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 46.6 Cg_endo -65.41 168.57 14.21 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.042 2.495 . . . . 0.0 111.602 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 5.1 m-20 -79.56 115.3 52.42 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.3 Cg_endo -62.85 -19.91 69.93 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.634 2.889 . . . . 0.0 112.707 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.56 -5.06 79.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.349 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.491 HD12 ' HG2' ' A' ' 55' ' ' GLN . 9.3 mt -95.5 -27.82 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.965 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 44' ' ' TYR . 11.4 mt -82.66 130.86 56.79 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 0.0 112.339 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 84' ' ' ILE . 5.4 Cg_endo -81.13 156.6 19.94 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.22 2.614 . . . . 0.0 111.903 170.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.77 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.9 m-20 -47.25 -49.12 24.07 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.67 76.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.521 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.5 -17.27 23.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.085 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -71.59 -45.87 60.96 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.3 0.572 . . . . 0.0 111.258 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.74 45.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.95 -173.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.74 -135.5 2.03 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.838 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.521 HG23 ' OD1' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -98.94 135.27 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-O 122.164 0.983 . . . . 0.0 112.552 -170.8 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.16 167.62 24.57 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG11 HD11 ' B' ' 130' ' ' ILE . 4.6 t -112.83 141.96 26.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.586 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.964 HG22 HG22 ' A' ' 42' ' ' ILE . 3.8 p -125.61 101.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 158.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.6 ' CD1' ' HB ' ' A' ' 43' ' ' ILE . 1.1 pp -94.62 149.34 21.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.448 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.874 ' HB ' HG12 ' A' ' 109' ' ' VAL . 3.2 mt -114.74 101.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.352 0.596 . . . . 0.0 109.829 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 70.7 p -98.37 116.48 30.69 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.047 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.629 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.4 m -82.31 118.23 23.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 20.8 m -106.85 128.22 54.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.784 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 65.3 t80 -132.7 121.18 22.71 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.826 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 22.5 mtp180 67.65 26.17 8.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.292 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.02 6.01 82.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.414 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -116.44 115.28 25.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.083 -0.558 . . . . 0.0 109.836 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 44.0 mp0 -77.27 124.89 28.47 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.784 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 29.0 p90 -113.88 -4.2 13.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 98' ' ' THR . 7.7 tt -158.08 158.83 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.524 HH21 HG21 ' A' ' 147' ' ' THR . 24.4 ttp180 -150.71 106.81 3.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.336 0.397 . . . . 0.0 110.043 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.874 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.2 p -91.27 99.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.544 1.164 . . . . 0.0 108.455 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.507 ' HA3' HG12 ' B' ' 130' ' ' ILE . . . -80.49 95.8 1.6 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.231 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.975 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 4.4 m-85 -93.6 109.57 21.19 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.957 0.884 . . . . 0.0 109.245 174.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' N ' ' HD1' ' A' ' 112' ' ' TYR . 2.3 m-85 -76.15 114.88 15.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.286 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.845 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.1 p -88.09 108.67 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.521 ' OD1' HG23 ' A' ' 92' ' ' VAL . 6.7 t30 -95.56 103.61 15.48 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.477 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -91.97 121.41 33.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.288 0.566 . . . . 0.0 110.064 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.84 138.91 30.64 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.628 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 47.5 m-85 -48.8 156.65 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -92.12 -30.18 16.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.982 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.494 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 4.6 mm-40 -82.22 129.57 34.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.097 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.708 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.4 m -53.86 -40.83 66.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.991 0.182 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.01 -35.58 66.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.11 0.957 . . . . 0.0 110.179 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 82.4 mt -85.07 -22.0 29.13 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.785 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 47.3 mtp180 -83.17 -39.67 20.71 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.708 ' HG2' ' O ' ' A' ' 120' ' ' THR . 11.5 pt-20 -70.35 -31.7 69.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.725 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.61 ' OD1' ' HG3' ' A' ' 124' ' ' GLU . 1.2 p-10 -147.61 82.08 8.23 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.14 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 29.5 Cg_endo -61.75 117.86 4.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.551 2.834 . . . . 0.0 112.248 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.6 Cg_exo -69.04 161.05 47.44 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.915 2.41 . . . . 0.0 110.943 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.69 -25.36 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HD3' ' HD3' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -89.7 128.38 50.73 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 121.397 0.618 . . . . 0.0 110.788 172.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.77 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 1.1 Cg_endo -82.66 141.64 11.09 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.054 3.169 . . . . 0.0 112.15 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.1 t70 -124.85 112.18 16.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.231 0.538 . . . . 0.0 109.592 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.693 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.1 m-85 -79.4 -19.77 49.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.488 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.1 p -83.31 -24.06 32.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.494 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 73.3 mmtt -98.87 11.76 37.82 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.9 tp -95.91 133.45 40.08 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.806 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -116.16 120.47 39.12 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.757 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.35 109.05 21.23 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.644 -172.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.687 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 5.2 t30 -86.2 98.5 10.95 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.094 173.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.865 HG21 HG11 ' A' ' 11' ' ' VAL . 1.4 mp -72.65 108.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.165 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 112' ' ' TYR . 36.4 mt -64.51 91.81 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.222 0.534 . . . . 0.0 111.834 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.975 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -80.66 -12.19 59.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -80.14 -11.92 59.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.997 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -138.51 70.12 45.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.818 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.636 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 63.9 Cg_endo -81.83 104.97 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.207 1.272 . . . . 0.0 109.666 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.546 ' HG3' HG21 ' B' ' 130' ' ' ILE . 0.2 OUTLIER -83.66 81.76 8.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.255 0.55 . . . . 0.0 110.532 -175.076 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.779 HG22 HG23 ' A' ' 109' ' ' VAL . 3.9 t -86.4 104.43 13.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.961 -174.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.524 HG21 HH21 ' A' ' 108' ' ' ARG . 48.8 m -112.77 106.93 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.739 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -108.37 138.24 44.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.8 0.81 . . . . 0.0 110.891 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.3 136.1 54.84 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.88 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 141.61 46.22 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.707 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.03 172.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -90.94 106.33 18.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.17 0.986 . . . . 0.0 110.451 171.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.729 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 8.0 m95 -81.28 5.77 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.956 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 . . . . . 0 N--CA 1.428 -1.563 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.805 -173.481 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' B' ' 122' ' ' LYS . 11.5 mptt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.246 0.07 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -44.41 -45.16 8.85 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.321 0.388 . . . . 0.0 111.845 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 -43.07 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.257 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -53.41 -54.16 40.77 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.618 0.723 . . . . 0.0 111.278 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 48' ' ' ALA . 2.4 mm? -62.38 -37.4 85.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.481 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.96 75.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.429 HH21 ' CD ' ' A' ' 51' ' ' GLU . 10.4 mtm180 -59.02 -47.07 86.53 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -60.17 -41.6 93.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 145' ' ' ARG . 3.8 mp -90.45 -5.79 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.481 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.851 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 10.2 mptt -100.11 -22.05 15.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.438 HG23 HD21 ' A' ' 34' ' ' LEU . 3.6 t -139.28 131.94 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.871 0.843 . . . . 0.0 110.964 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.9 tp60 -125.67 100.14 6.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.851 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG22 ' CH2' ' A' ' 40' ' ' TRP . 11.6 t -70.79 146.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -131.16 -65.88 0.76 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.65 0.738 . . . . 0.0 109.594 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.666 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 62.2 t30 -104.82 148.21 26.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.105 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.2 p -146.73 105.23 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.107 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.049 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -98.02 97.81 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.554 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -70.91 116.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.892 178.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.73 ' H ' HD22 ' A' ' 12' ' ' LEU . 1.4 mm? -80.71 -31.49 36.1 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.62 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' HB3' ' CG ' ' A' ' 23' ' ' GLN . 7.3 p-10 -82.62 44.47 0.9 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.681 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' HB3' ' CD ' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -73.59 168.61 23.91 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 159.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 31.6 Cg_exo -51.47 101.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.569 0 CA-C-O 122.729 1.054 . . . . 0.0 113.3 -135.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.846 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 70.1 m -129.99 166.87 23.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.731 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 50.1 Cg_exo -46.38 133.48 15.92 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.685 174.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.103 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 20.2 t80 -55.4 -23.98 27.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.056 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -92.91 5.56 50.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.846 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -96.3 120.15 63.01 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 169.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 70.3 Cg_exo -55.29 144.43 71.52 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.747 2.298 . . . . 0.0 112.91 -167.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.846 ' HE1' ' HD3' ' A' ' 79' ' ' PRO . 84.3 m-85 -52.58 143.02 16.69 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.745 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.678 ' CG ' ' HB3' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -143.25 110.64 5.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.747 0.784 . . . . 0.0 109.599 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 97' ' ' ILE . 81.7 m-85 -114.0 103.52 11.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.461 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.049 ' HB3' HG23 ' A' ' 10' ' ' VAL . 33.6 tt0 -84.23 85.13 7.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.729 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 4.5 mt -82.47 141.94 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.001 0.905 . . . . 0.0 113.042 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.5 m -119.51 108.8 14.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.294 171.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 17.3 p90 -117.96 146.38 44.04 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.245 0.545 . . . . 0.0 109.655 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.856 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.6 tt0 -101.89 109.36 21.09 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.9 m -72.79 119.76 17.48 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -90.2 -28.01 5.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.253 -169.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 48.3 mt-10 -146.69 169.06 19.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.979 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.06 127.9 34.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.993 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -81.7 155.21 25.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.158 0.504 . . . . 0.0 109.658 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.6 p -113.42 -14.36 12.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.208 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 102' ' ' ARG . 7.7 tt0 -138.64 -167.52 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.65 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.813 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 22.2 m-20 -97.74 136.38 38.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 110.872 -175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 99' ' ' CYS . 0.2 OUTLIER -81.67 120.09 24.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.202 175.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 100' ' ' THR . 44.1 tt0 -105.65 90.12 3.3 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.093 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.729 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 31.0 m95 -74.12 109.41 7.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.731 ' HE2' HG13 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -116.31 129.61 56.36 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -173.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.711 HG22 HG22 ' A' ' 95' ' ' VAL . 7.7 mt -102.1 115.96 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 43' ' ' ILE . 2.9 mp -110.84 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.611 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.727 ' CE2' HG11 ' A' ' 113' ' ' VAL . 26.4 t80 -84.02 119.78 25.35 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.513 HG11 HD12 ' B' ' 126' ' ' LEU . 17.6 t -70.57 97.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -85.75 -4.54 85.02 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.643 ' HB2' ' C ' ' A' ' 50' ' ' SER . 3.7 p -115.19 68.04 0.7 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.056 0.455 . . . . 0.0 111.439 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' B' ' 122' ' ' LYS . . . -76.15 -8.82 57.87 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.81 0.814 . . . . 0.0 108.834 166.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -99.17 -49.62 4.43 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.48 -1.237 . . . . 0.0 109.863 172.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.643 ' C ' ' HB2' ' A' ' 47' ' ' SER . 3.5 m -103.01 -138.88 0.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.877 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.61 3.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.502 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -97.7 -7.26 31.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 111.814 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 37.4 m-85 -94.81 -0.98 53.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -170.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 18.5 p-10 -51.51 110.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.989 0.899 . . . . 0.0 110.592 172.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 80' ' ' ASN . 18.5 mp0 -91.71 168.26 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.247 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.731 HG13 ' HE2' ' A' ' 41' ' ' LYS . 2.5 t -126.09 110.86 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.193 -173.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -82.11 -57.58 3.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -172.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 7.7 t70 -170.35 162.35 8.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.71 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 12.1 p -130.19 119.4 22.9 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.0 p -101.59 129.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.3 mt -104.85 103.32 12.89 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.455 0.645 . . . . 0.0 110.967 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.02 119.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -87.96 -136.87 5.38 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.754 -1.212 . . . . 0.0 111.922 -162.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.993 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 5.7 Cg_endo -50.32 117.02 2.84 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.231 1.954 . . . . 0.0 111.324 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.473 HG21 ' HE2' ' A' ' 28' ' ' PHE . 13.0 m -121.41 111.67 33.25 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.187 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.8 61.49 5.51 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 123.353 2.702 . . . . 0.0 114.284 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.751 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.52 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 112.797 -2.001 . . . . 0.0 112.605 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 111.14 122.96 4.34 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 175.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 5.6 ptp85 -66.65 130.93 44.81 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.858 0.837 . . . . 0.0 110.005 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.461 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -151.58 158.2 43.21 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.099 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.2 138.11 51.91 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.296 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 11.2 p90 -137.49 148.82 46.33 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.3 p -106.67 119.27 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 122.316 1.055 . . . . 0.0 110.555 -174.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.517 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -111.11 154.27 24.53 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.468 -1.696 . . . . 0.0 109.217 -168.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.0 mt-30 -151.89 160.67 43.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -168.98 145.34 3.48 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 57' ' ' LEU . 6.5 m-20 -59.26 -177.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 112.24 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -84.4 155.12 63.02 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.846 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -66.83 157.52 60.9 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.684 2.256 . . . . 0.0 110.856 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.5 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 94.9 m-20 -63.12 117.84 37.16 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 -170.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.87 -13.42 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.41 2.74 . . . . 0.0 112.004 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.37 -1.1 69.44 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.569 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 83' ' ' LEU . 20.7 mt -103.87 -34.09 8.64 Favored 'General case' 0 CA--C 1.514 -0.421 0 O-C-N 122.928 -0.16 . . . . 0.0 111.286 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 36.4 mt -72.35 125.43 91.38 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.801 -175.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 95.8 Cg_endo -79.26 163.14 25.19 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.788 2.992 . . . . 0.0 111.932 170.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.716 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.8 m-20 -45.43 -54.08 7.84 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.176 0.99 . . . . 0.0 113.498 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.46 -8.64 58.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.512 0.196 . . . . 0.0 111.442 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.41 -38.77 11.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.997 0.427 . . . . 0.0 110.37 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.25 -46.16 35.51 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.915 -169.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.23 46.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.34 -134.53 2.03 Favored Glycine 0 CA--C 1.497 -1.057 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.657 HG23 ' HG3' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -104.49 130.77 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 CA-C-O 122.261 1.029 . . . . 0.0 113.574 -170.24 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.613 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -143.71 173.17 11.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.051 -1.886 . . . . 0.0 105.921 173.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.79 HG12 HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.0 143.52 39.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.704 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.711 HG22 HG22 ' A' ' 42' ' ' ILE . 9.9 p -121.78 104.43 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.921 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.75 126.81 48.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.711 -169.124 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 39.1 mt -95.18 102.0 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.099 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.775 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 67.8 p -91.14 109.81 21.07 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.844 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.609 ' HB2' HG22 ' A' ' 107' ' ' ILE . 61.5 m -73.44 109.1 6.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.894 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.584 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 16.1 m -103.68 101.87 11.72 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.529 -174.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.53 ' CE1' HD12 ' A' ' 34' ' ' LEU . 71.4 t80 -107.6 118.51 36.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 41.0 mtp180 72.97 19.63 3.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.96 0.504 . . . . 0.0 111.667 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.81 5.29 74.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.198 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.565 ' OE1' ' HB ' ' A' ' 151' ' ' ILE . 2.5 pt20 -120.65 127.96 52.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.0 mp0 -84.18 135.55 34.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.46 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.468 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 54.5 p90 -122.04 -1.5 9.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.1 tt -157.69 162.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.752 ' HG3' HG22 ' A' ' 98' ' ' THR . 9.0 ttm180 -149.2 99.39 2.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.921 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.25 100.55 8.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.823 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.61 79.58 1.74 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 119.413 -1.375 . . . . 0.0 111.116 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.906 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.7 m-85 -71.22 114.43 9.27 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.607 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.7 m-85 -66.59 110.84 3.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.727 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.8 p -92.53 109.99 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.648 ' OD1' HG13 ' A' ' 92' ' ' VAL . 26.6 t30 -95.82 108.13 20.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.499 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.687 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.3 m-80 -97.77 121.44 39.68 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.347 0.594 . . . . 0.0 110.086 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.86 140.36 32.88 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.855 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.546 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 46.5 m-85 -46.52 151.91 0.51 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.9 p -93.29 -29.92 15.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.345 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 70.5 mm-40 -76.37 125.56 29.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.625 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 16.7 m -55.72 -32.08 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.401 -172.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.45 -39.15 77.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.506 0.67 . . . . 0.0 110.013 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 81.8 mt -73.32 -23.69 60.28 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.626 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 22.0 mtt180 -74.45 -36.67 63.38 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 120' ' ' THR . 11.4 mm-40 -67.85 -44.23 77.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.776 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.6 p30 -138.13 82.05 25.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.729 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.4 Cg_endo -57.56 113.64 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.09 2.527 . . . . 0.0 111.579 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 24.2 Cg_exo -64.79 154.15 74.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.666 2.244 . . . . 0.0 111.593 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.1 p -46.76 -50.23 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 123.725 0.641 . . . . 0.0 112.428 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.7 mmtt -84.39 129.13 59.0 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 121.37 0.605 . . . . 0.0 111.055 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.716 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -72.06 125.18 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.653 2.902 . . . . 0.0 111.786 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -104.3 108.82 20.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.611 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 27.2 m-85 -77.91 -17.4 57.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.154 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 72.6 p -88.31 -15.07 36.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.911 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.1 mmtt -107.05 13.0 27.97 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 115' ' ' ASN . 18.3 tp -95.93 143.41 27.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.0 -172.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -124.29 124.05 41.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 1.103 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 25.7 mtm-85 -87.92 104.15 16.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.784 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.608 ' CG ' ' HG3' ' A' ' 15' ' ' PRO . 38.2 t-20 -90.34 89.38 7.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.461 HD12 HG23 ' A' ' 113' ' ' VAL . 1.3 mp -66.44 109.08 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 112' ' ' TYR . 89.6 mt -69.2 88.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.721 0.772 . . . . 0.0 110.433 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.906 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.63 -12.99 60.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.579 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.1 p -78.84 -12.01 60.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.72 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.47 64.21 57.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.661 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 98.6 Cg_endo -85.76 103.96 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.357 1.371 . . . . 0.0 109.902 172.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.632 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -84.47 80.35 9.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.306 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.659 HG12 HG23 ' A' ' 109' ' ' VAL . 26.7 m -76.88 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.739 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.445 HG22 ' CE1' ' A' ' 149' ' ' PHE . 97.7 m -138.82 107.56 5.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.467 0.651 . . . . 0.0 109.286 173.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.75 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 4.2 ptt180 -108.95 142.82 39.04 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.958 0.885 . . . . 0.0 111.321 -175.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -125.04 169.32 12.25 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.199 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.59 149.69 21.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.291 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.565 ' HB ' ' OE1' ' A' ' 104' ' ' GLN . 45.3 pt -142.29 168.33 14.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 154' ' ' GLU . 5.0 p-10 -96.55 89.84 5.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.313 1.054 . . . . 0.0 109.979 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.851 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 8.1 m95 -64.43 -1.57 1.81 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.681 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 152' ' ' ASN . 41.9 mt-10 . . . . . 0 N--CA 1.427 -1.625 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.26 -167.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.657 ' HG3' HG23 ' A' ' 92' ' ' VAL . 9.8 mmtp . . . . . 0 C--O 1.224 -0.243 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.06 -58.13 2.58 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.928 0.768 . . . . 0.0 112.05 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 8.1 tp -65.98 -37.75 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -60.46 -52.7 64.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.262 0.554 . . . . 0.0 110.509 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.624 HD22 ' O ' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -65.42 -44.12 88.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.032 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -40.49 82.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.29 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -59.31 -46.19 89.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 110.833 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -63.5 -39.15 93.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 145' ' ' ARG . 31.0 mt -76.44 -43.61 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.544 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -176.057 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.687 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.45 -18.01 27.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 -177.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 34' ' ' LEU . 2.7 t -139.97 139.4 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.482 0.658 . . . . 0.0 111.101 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.64 ' HB2' HD11 ' A' ' 31' ' ' ILE . 8.4 tp60 -140.39 102.82 4.43 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.894 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 28' ' ' PHE . 2.9 m -72.66 149.66 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.789 175.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.14 -63.02 1.02 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.447 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -105.31 112.41 25.51 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.244 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 9' ' ' VAL . 8.2 p -96.83 109.49 23.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -106.48 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 122.368 1.08 . . . . 0.0 108.965 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.586 HG12 ' CD2' ' A' ' 24' ' ' PHE . 18.4 m -77.29 123.15 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.333 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 25' ' ' GLU . 1.5 mt -89.63 -47.35 8.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.672 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.696 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 8.2 t0 -66.2 83.0 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.367 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.742 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.4 m-20 -100.7 174.4 2.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.31 -1.768 . . . . 0.0 107.021 164.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.887 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 3.2 Cg_endo -49.44 102.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.274 1.491 . . . . 0.0 113.123 -151.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.662 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 20.1 m -129.9 170.54 10.73 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 112.587 -2.097 . . . . 0.0 108.886 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.662 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.0 Cg_exo -40.77 139.49 1.29 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.888 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.728 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 44.7 t80 -68.36 -10.29 53.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -96.32 8.26 44.4 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.561 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -95.88 126.11 46.15 Favored Pre-proline 0 CA--C 1.508 -0.672 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 169.211 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.5 Cg_exo -64.97 154.09 75.03 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.254 2.636 . . . . 0.0 112.519 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' HE2' HH21 ' A' ' 137' ' ' ARG . 25.4 m-85 -65.28 128.41 35.74 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.256 174.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.707 ' HA ' ' HG2' ' A' ' 75' ' ' GLN . 33.5 mt-30 -125.76 102.74 7.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.798 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CD2' HG12 ' A' ' 11' ' ' VAL . 50.6 m-85 -105.77 144.92 31.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.597 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.7 tt0 -118.78 88.29 2.9 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 168.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.612 HD11 HD13 ' A' ' 97' ' ' ILE . 43.2 mt -84.51 119.52 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.939 0.876 . . . . 0.0 111.67 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 20.0 m -100.16 105.15 16.72 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.415 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.039 ' HB3' HG12 ' A' ' 6' ' ' VAL . 32.8 p90 -118.32 150.75 38.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.853 0.835 . . . . 0.0 110.343 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.8 tt0 -108.65 116.22 31.57 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.636 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 47.7 t -73.16 117.02 14.39 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -83.16 -28.85 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.832 -171.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.687 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 4.6 mt-10 -150.07 147.63 28.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.55 134.54 46.53 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.665 0.269 . . . . 0.0 111.238 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -94.31 157.79 15.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.288 -170.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.6 m -112.59 -39.58 4.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.037 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.833 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.6 tt0 -119.44 -168.28 1.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.297 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.833 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 3.2 m-20 -93.69 136.88 33.53 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.391 0.615 . . . . 0.0 110.205 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mm? -83.73 127.09 33.53 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.787 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 57.8 tt0 -116.68 90.23 3.29 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.628 -173.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.677 ' HZ3' HG21 ' A' ' 107' ' ' ILE . 35.7 m95 -84.21 133.65 34.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.5 ttmt -129.84 144.76 51.47 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.935 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.666 HD13 HG12 ' A' ' 97' ' ' ILE . 44.2 mm -102.02 107.45 21.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -102.13 113.6 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.831 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' HA ' HG12 ' A' ' 95' ' ' VAL . 34.4 t80 -95.16 122.24 37.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.111 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.79 HG13 ' CE2' ' A' ' 53' ' ' TYR . 4.8 t -72.51 98.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.698 0.761 . . . . 0.0 109.489 171.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.689 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -72.38 -55.13 7.07 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.383 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.585 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 44.4 m -119.8 73.17 0.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.7 0.4 . . . . 0.0 110.55 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -49.69 -19.06 0.55 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.337 0.589 . . . . 0.0 111.927 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' OE2' ' HE2' ' B' ' 122' ' ' LYS . 1.5 tp10 -71.46 -19.29 62.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.043 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.617 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 39.9 m -117.04 -151.2 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.768 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 8.5 pt-20 -154.25 19.01 0.49 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.669 0.747 . . . . 0.0 111.267 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 50' ' ' SER . 2.0 mp0 -98.18 -36.97 9.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.827 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.79 ' CE2' HG13 ' A' ' 45' ' ' VAL . 10.7 p90 -54.65 -41.79 70.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.593 -169.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 9.8 p-10 -30.71 105.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.212 0 O-C-N 125.134 1.521 . . . . 0.0 112.546 -165.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.723 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 24.0 mt-30 -95.12 165.86 12.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.905 -168.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -120.15 108.96 24.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.148 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.494 HD22 ' CG2' ' A' ' 42' ' ' ILE . 6.6 mp -73.31 -40.7 64.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.602 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -176.53 165.83 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.073 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.9 p -144.63 123.85 12.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.9 p -100.42 136.26 32.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.788 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.5 mt -110.71 105.72 14.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.023 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 89.3 t -96.4 118.15 42.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -76.35 -160.39 10.11 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.56 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.804 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.7 Cg_endo -67.9 115.28 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.397 1.398 . . . . 0.0 110.231 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.571 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 34.1 m -124.99 141.18 37.69 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.185 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -83.26 77.31 3.58 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 122.48 2.12 . . . . 0.0 113.575 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.696 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 44.98 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.012 -1.903 . . . . 0.0 112.357 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.39 139.43 9.77 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.496 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttt180 -77.69 116.88 18.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.797 0.808 . . . . 0.0 110.091 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -128.68 122.07 29.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.18 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.753 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -83.59 121.27 27.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.651 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.7 p90 -120.66 160.08 24.01 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.1 133.83 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 121.911 0.863 . . . . 0.0 110.093 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.651 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 2.7 t80 -135.44 107.57 7.19 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.951 -161.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.707 ' HG2' ' HA ' ' A' ' 23' ' ' GLN . 77.3 mt-30 -124.19 155.13 39.05 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -156.94 134.58 10.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.183 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 2.6 t0 -65.48 171.84 3.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -69.87 159.77 82.79 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.658 . . . . 0.0 111.304 -171.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 56.6 Cg_endo -66.75 172.87 8.86 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.343 2.696 . . . . 0.0 111.449 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 10.0 m-80 -70.97 121.37 83.87 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.014 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.5 Cg_endo -63.57 -12.84 33.06 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.154 2.569 . . . . 0.0 110.944 175.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.48 -19.18 46.04 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.714 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.723 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 12.4 mt -94.61 -1.56 53.02 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.594 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 24.8 mt -100.7 125.92 37.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.913 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 86.0 Cg_endo -79.28 158.76 26.29 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.017 2.478 . . . . 0.0 111.145 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.659 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 m-20 -47.53 -47.02 28.08 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.99 -37.21 47.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.798 175.033 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -68.68 -47.43 66.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.064 -167.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.3 m -101.93 46.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-O 122.208 1.004 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.88 -139.44 2.66 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.654 -163.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.761 HG13 ' HB2' ' B' ' 122' ' ' LYS . 12.4 p -122.44 145.73 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 121.875 0.845 . . . . 0.0 110.366 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.749 HG23 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -160.66 174.36 14.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.626 HG21 HD11 ' B' ' 130' ' ' ILE . 1.9 t -132.16 144.38 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.882 0.372 . . . . 0.0 111.686 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 29.3 m -124.74 105.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.838 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.4 pp -103.5 145.06 30.57 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.163 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 46.1 mt -102.83 100.77 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.615 0.722 . . . . 0.0 109.235 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 80.8 p -99.8 114.37 27.48 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.702 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 4.6 t -80.83 158.79 25.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.867 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -148.44 109.17 4.22 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -165.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 151' ' ' ILE . 56.1 t80 -124.0 120.83 33.58 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.517 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 43.1 mtp180 66.76 25.85 9.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.275 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.62 11.74 73.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.455 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -124.37 131.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.137 0.494 . . . . 0.0 110.078 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.2 mp0 -86.7 125.5 33.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.501 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.522 ' HZ ' ' CD1' ' A' ' 38' ' ' LEU . 54.8 p90 -119.82 2.58 11.08 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -168.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.844 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.0 tt -156.35 154.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.799 HH21 HG21 ' A' ' 147' ' ' THR . 0.3 OUTLIER -153.6 108.17 3.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -177.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 4.2 p -97.39 100.64 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 122.16 0.981 . . . . 0.0 109.26 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -83.43 84.11 1.58 Allowed Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.616 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.909 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 6.3 m-85 -80.52 116.17 20.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.126 . . . . 0.0 109.109 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.59 ' HA ' HG22 ' A' ' 94' ' ' VAL . 22.7 m-85 -68.4 135.99 52.61 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.749 HG13 HG23 ' A' ' 93' ' ' THR . 4.1 p -121.25 111.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 108.826 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -96.34 120.45 36.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.968 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.593 ' HB3' HD11 ' A' ' 135' ' ' LEU . 49.2 m-80 -100.42 118.82 37.44 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.535 0.683 . . . . 0.0 109.413 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.62 131.04 42.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.694 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.684 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 20.2 m-85 -43.88 151.48 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -92.56 -29.47 16.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.003 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 14.3 mm-40 -84.18 128.57 34.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.952 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.2 m -48.41 -45.96 36.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.048 0.218 . . . . 0.0 111.344 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.61 -31.38 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.766 0.793 . . . . 0.0 110.423 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.684 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 83.4 mt -84.6 -25.52 28.56 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.326 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 63.4 mtp180 -81.1 -36.63 30.14 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' THR . 9.6 pt-20 -74.01 -36.49 64.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.117 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' A' ' 124' ' ' GLU . 0.8 OUTLIER -142.88 80.58 13.73 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.096 176.254 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 19.0 Cg_endo -57.36 119.49 6.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.408 2.739 . . . . 0.0 112.045 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 16.8 Cg_exo -69.57 163.12 39.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.966 2.444 . . . . 0.0 111.737 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.29 -45.6 89.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 2.1 mmtt -89.5 129.87 45.61 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 121.385 0.612 . . . . 0.0 110.989 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.682 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.0 Cg_endo -79.21 147.72 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.966 3.111 . . . . 0.0 112.248 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.8 t0 -116.64 111.63 20.12 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.728 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 13.0 m-85 -77.92 -13.46 59.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.049 0.928 . . . . 0.0 109.659 -173.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -87.35 -24.05 24.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.186 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . 74.8 mmtt -98.92 9.6 43.15 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.7 tp -94.36 144.86 25.18 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.535 -172.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 4.1 tt0 -128.82 126.13 39.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.584 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.887 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -90.49 105.79 18.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.74 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.643 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.2 t30 -95.15 108.39 20.5 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.639 0.733 . . . . 0.0 109.434 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 139' ' ' ILE . 1.3 mp -85.19 109.71 18.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.058 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.58 85.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.673 . . . . 0.0 110.178 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.909 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.454 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.4 p -72.77 -16.36 61.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.11 68.67 76.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 46.1 Cg_endo -92.03 104.95 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.954 1.769 . . . . 0.0 110.327 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 18.4 tpt180 -85.98 92.5 8.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.16 0.505 . . . . 0.0 110.482 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.622 HG12 HG23 ' A' ' 109' ' ' VAL . 29.7 m -86.33 129.79 37.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.516 0.674 . . . . 0.0 111.446 -175.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.799 HG21 HH21 ' A' ' 108' ' ' ARG . 21.1 m -140.86 107.46 5.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.7 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -110.78 130.05 55.68 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.607 0.717 . . . . 0.0 110.701 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.05 142.55 46.83 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.922 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 137.18 42.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 110.892 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 101' ' ' TYR . 46.4 pt -131.74 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -93.21 92.56 7.8 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.038 0.923 . . . . 0.0 111.479 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.672 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 19.2 m95 -77.3 0.92 20.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.445 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.426 -1.673 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.778 178.218 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.761 ' HB2' HG13 ' A' ' 92' ' ' VAL . 22.1 mmtp . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -11.85 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 166.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.33 -36.2 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 17.4 mm100 -58.21 -52.37 65.86 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.92 0.867 . . . . 0.0 110.663 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.529 ' O ' HG13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -62.74 -40.88 98.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.042 177.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' B' ' 131' ' ' ARG . . . -63.24 -26.05 68.61 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.339 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 63.9 mtp85 -64.01 -52.05 61.36 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.819 0.343 . . . . 0.0 110.196 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.679 ' HD2' HD21 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -62.35 -36.86 83.53 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.77 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 49.4 mt -85.12 -3.01 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.863 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' ARG . . . . . 0.557 ' HA ' ' CZ ' ' B' ' 131' ' ' ARG . 1.4 tpm_? . . . . . 0 C--N 1.315 -0.934 0 O-C-N 121.18 -0.95 . . . . 0.0 109.995 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.702 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.07 -8.48 39.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.809 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.768 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 1.5 t -147.28 140.78 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.389 0.614 . . . . 0.0 110.999 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' A' ' 31' ' ' ILE . 5.8 tp-100 -136.85 99.95 4.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.653 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.934 HG12 ' HB3' ' A' ' 28' ' ' PHE . 5.1 m -72.05 145.25 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.262 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -125.93 -62.05 1.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.931 -165.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.679 HD22 HG13 ' A' ' 10' ' ' VAL . 64.8 t30 -102.9 152.51 21.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.832 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.8 p -145.45 99.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.093 HG23 ' HB2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -88.71 99.5 9.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.825 -174.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.761 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.43 118.42 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.897 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.665 HD21 ' HG3' ' A' ' 25' ' ' GLU . 2.8 mt -88.79 -45.28 9.89 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.154 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.71 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 2.9 t70 -74.31 72.3 1.78 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.12 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.923 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 74.5 m-20 -84.07 174.84 5.32 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.719 -2.037 . . . . 0.0 107.801 162.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.923 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.0 Cg_endo -49.12 102.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 CA-C-N 120.912 1.362 . . . . 0.0 113.176 -149.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.832 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 67.7 m -129.93 168.43 16.65 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.535 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.8 Cg_exo -43.17 132.69 6.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.417 2.078 . . . . 0.0 112.622 174.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 65.2 t80 -61.51 -9.14 5.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -95.76 -1.66 49.34 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.725 -0.61 . . . . 0.0 112.226 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.832 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.2 OUTLIER -97.04 134.85 22.38 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.26 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.542 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.2 Cg_exo -65.11 151.74 84.61 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.271 2.647 . . . . 0.0 113.007 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 27.5 m-85 -62.97 118.8 8.31 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.204 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.71 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.3 mt-30 -115.79 111.89 21.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.459 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CD1' HD11 ' A' ' 97' ' ' ILE . 93.9 m-85 -116.0 155.34 28.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.142 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.093 ' HB2' HG23 ' A' ' 10' ' ' VAL . 43.4 mt-10 -126.78 91.07 3.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 162.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 97' ' ' ILE . 10.6 mt -77.2 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.8 m -111.19 107.18 16.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.303 176.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.934 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -113.54 150.35 33.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 CA-C-O 122.153 0.977 . . . . 0.0 111.131 176.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.9 tt0 -103.51 105.63 15.93 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 172.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.6 m -70.57 126.44 29.63 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.658 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -87.04 -25.71 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -165.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.702 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 44.6 mt-10 -147.47 167.9 23.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.908 174.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -74.72 142.42 44.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.054 HD11 ' HE1' ' A' ' 101' ' ' TYR . 0.4 OUTLIER -107.21 156.38 18.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.879 -168.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.607 ' N ' HD13 ' A' ' 34' ' ' LEU . 15.2 m -115.38 -35.99 4.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.711 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 23.1 tt0 -104.3 -166.32 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -172.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.711 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.3 p-10 -101.19 138.67 37.91 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 121.641 -0.662 . . . . 0.0 111.416 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.45 128.99 35.22 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.19 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 32.7 tt0 -104.03 90.4 3.59 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' SER . 14.8 m95 -86.84 109.5 19.33 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 1.104 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.4 OUTLIER -118.51 160.26 22.06 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.992 173.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.882 HD12 ' HB3' ' A' ' 76' ' ' ALA . 48.8 mt -101.68 108.71 24.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.713 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 2.2 mp -98.2 105.62 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.757 ' CE1' HG11 ' A' ' 113' ' ' VAL . 40.4 t80 -90.67 109.07 20.25 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.642 HG11 HD23 ' B' ' 126' ' ' LEU . 40.5 t -65.19 98.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.497 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.34 42.75 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 171.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.78 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 16.8 p -85.63 87.5 7.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.982 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' B' ' 126' ' ' LEU . . . -84.1 -13.89 51.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -100.49 -36.6 9.14 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.439 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.667 ' C ' ' HB2' ' A' ' 47' ' ' SER . 50.6 m -103.64 -154.45 0.5 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.39 5.07 0.45 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -94.92 -8.25 37.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.78 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 19.5 m-85 -98.18 11.07 39.0 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -170.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -64.32 99.08 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.082 0.944 . . . . 0.0 110.314 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -95.76 169.64 9.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.511 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.488 HG11 ' HE2' ' A' ' 41' ' ' LYS . 23.5 t -127.94 112.42 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -172.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 44' ' ' TYR . 3.3 mm? -77.51 -52.04 9.74 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.863 -175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 35.0 t70 -168.46 153.8 6.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.061 173.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 1.104 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 21.3 p -124.79 120.46 31.8 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG13 ' HD1' ' A' ' 40' ' ' TRP . 4.4 p -101.87 139.06 23.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.736 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.61 105.35 14.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.293 0.568 . . . . 0.0 111.601 -173.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 21.9 t -116.24 110.84 32.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -97.48 -112.63 3.03 Favored Glycine 0 CA--C 1.487 -1.711 0 C-N-CA 118.665 -1.731 . . . . 0.0 113.417 -159.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.895 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 17.5 Cg_endo -58.71 115.9 2.87 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 121.071 1.181 . . . . 0.0 109.961 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 63' ' ' GLY . 27.5 m -130.31 122.38 19.99 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.987 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.88 126.84 18.15 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.999 1.799 . . . . 0.0 111.021 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -41.02 134.14 2.05 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.05 0.844 . . . . 0.0 112.004 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 136.41 135.16 3.38 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.884 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.3 ptt180 -66.28 139.1 58.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.604 0.716 . . . . 0.0 110.46 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 11.0 p80 -166.39 151.23 7.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.392 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.655 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 2.1 ttp -107.9 137.81 45.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.341 0.591 . . . . 0.0 111.627 -174.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.671 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.3 p90 -125.69 150.67 47.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.719 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.5 p -105.37 135.12 44.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.8 0.81 . . . . 0.0 110.754 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.671 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.7 t80 -135.47 118.95 16.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.449 -166.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -130.35 154.29 47.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.51 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.882 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -155.33 153.33 30.34 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.0 p-10 -64.35 -171.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.933 0.873 . . . . 0.0 113.137 -170.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -86.09 142.96 36.55 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.299 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.687 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.7 Cg_exo -57.76 149.36 69.25 Favored 'Trans proline' 0 CA--C 1.502 -1.123 0 C-N-CA 124.116 3.21 . . . . 0.0 112.824 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 9.8 t-20 -59.56 119.01 36.24 Favored Pre-proline 0 N--CA 1.428 -1.538 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.367 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.19 -10.99 22.97 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.996 2.464 . . . . 0.0 111.498 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.09 -8.81 58.7 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 33.7 mt -96.82 -17.38 20.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.549 0.214 . . . . 0.0 111.555 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 25.3 mt -88.48 129.29 49.78 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.293 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 2.5 Cg_endo -77.5 146.68 24.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.652 2.902 . . . . 0.0 111.625 170.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.638 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 3.1 m-20 -47.75 -40.3 20.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.278 1.431 . . . . 0.0 113.621 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.85 -29.95 58.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.605 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 29.8 m-20 -89.16 -21.58 23.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.807 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.34 -49.36 19.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 121.086 0.47 . . . . 0.0 111.86 -174.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.41 47.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.598 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.73 -128.89 1.13 Allowed Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.194 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.489 HG13 ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.04 138.28 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.516 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -147.64 166.26 27.94 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.143 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.853 HG12 HD23 ' A' ' 96' ' ' LEU . 5.5 t -126.77 131.85 70.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.049 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 42' ' ' ILE . 2.1 p -106.23 106.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.272 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -104.2 132.74 50.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 -174.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.715 ' HB ' HG12 ' A' ' 109' ' ' VAL . 50.8 mt -94.48 102.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.767 HG22 ' HG3' ' A' ' 108' ' ' ARG . 17.8 p -95.73 109.47 21.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.946 ' SG ' HG23 ' A' ' 107' ' ' ILE . 3.2 m -81.02 111.98 17.99 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.65 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 19.3 m -108.7 111.88 23.89 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.421 -170.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 1.054 ' HE1' HD11 ' A' ' 34' ' ' LEU . 60.8 t80 -117.49 120.67 38.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.702 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 54.7 mtp180 67.87 25.12 7.9 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.204 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.46 8.45 87.04 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.417 ' HB2' HD12 ' A' ' 151' ' ' ILE . 7.4 mt-30 -113.06 115.05 27.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.844 -0.678 . . . . 0.0 109.373 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 28.2 mp0 -78.99 118.64 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.693 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 36.3 p90 -105.63 -5.85 19.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.946 HG23 ' SG ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -160.57 161.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 121.433 -0.792 . . . . 0.0 109.584 173.324 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.767 ' HG3' HG22 ' A' ' 98' ' ' THR . 12.2 ttm180 -149.48 97.6 2.66 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.831 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -86.48 100.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.696 175.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 83.83 1.59 Allowed Glycine 0 CA--C 1.488 -1.633 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.227 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.891 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -76.13 118.13 18.56 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.78 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.546 ' HB3' HD12 ' A' ' 140' ' ' LEU . 4.2 m-85 -68.28 115.54 7.84 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.53 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.757 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.0 p -101.99 112.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.489 ' OD1' HG13 ' A' ' 92' ' ' VAL . 2.5 t30 -95.39 126.13 40.48 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.274 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 55.5 m-80 -113.33 108.47 17.28 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.929 0.871 . . . . 0.0 109.107 -169.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -125.18 137.94 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.042 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.534 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 39.7 m-85 -51.59 149.38 4.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 42.7 p -100.4 -24.24 14.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.495 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.841 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 18.7 mm-40 -81.28 120.49 24.98 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.743 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 29.1 m -45.94 -40.65 10.56 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.83 0.706 . . . . 0.0 112.058 -169.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.32 -37.49 77.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.351 0.596 . . . . 0.0 110.372 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -71.2 -28.68 64.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.094 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 51.5 mtt180 -70.02 -42.04 73.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.2 mm-40 -58.02 -42.84 86.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.039 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.431 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 4.1 p30 -152.17 87.66 4.23 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.68 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.6 Cg_endo -56.24 115.71 2.66 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.435 2.757 . . . . 0.0 112.509 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.19 151.25 85.76 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.76 2.307 . . . . 0.0 111.282 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.9 -27.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.679 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -91.63 127.58 49.79 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.626 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.638 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.0 Cg_exo -77.29 127.79 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.764 2.976 . . . . 0.0 111.556 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 134' ' ' LYS . 10.2 t70 -111.8 108.68 18.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.67 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 22.5 m-85 -77.19 -16.42 59.1 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.086 -171.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.5 t -82.62 -19.93 37.35 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.334 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.841 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.0 mmtt -107.33 15.08 25.36 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.494 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 16.3 tp -98.1 149.99 21.91 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.115 -171.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 1.6 tt0 -127.88 121.5 30.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.877 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -84.02 104.0 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.573 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 14.6 t30 -92.91 103.48 15.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.761 HG21 HG11 ' A' ' 11' ' ' VAL . 1.4 mp -81.79 104.15 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 112' ' ' TYR . 85.1 mt -64.74 86.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.686 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.891 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -71.83 -11.56 60.86 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.06 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -22.83 60.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.988 173.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -129.69 71.15 82.17 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.312 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.68 104.78 1.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.473 1.449 . . . . 0.0 109.933 167.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.628 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -81.15 81.68 7.28 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.656 HG12 HG23 ' A' ' 109' ' ' VAL . 16.1 m -81.94 117.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.299 0.571 . . . . 0.0 110.864 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.408 HG22 ' CE2' ' A' ' 149' ' ' PHE . 21.7 m -126.02 106.32 9.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.738 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -114.74 146.16 41.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.258 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.41 170.4 14.23 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.885 -173.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 115.04 29.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.246 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.9 pt -119.39 166.66 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -95.51 100.26 12.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.548 1.166 . . . . 0.0 111.013 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.768 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 19.4 m95 -73.01 -6.65 46.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.896 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.43 -1.458 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.068 -174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.471 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.5 mmtt . . . . . 0 CA--C 1.52 -0.184 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.11 -52.28 21.11 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.63 0.581 . . . . 0.0 111.806 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 9.7 tt -63.95 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.699 0.285 . . . . 0.0 111.186 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' B' ' 128' ' ' ARG . 59.8 mm-40 -63.88 -47.86 78.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.263 0.554 . . . . 0.0 111.029 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.642 HD23 HG11 ' A' ' 45' ' ' VAL . 43.3 mt -65.24 -46.17 81.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.825 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.18 -40.72 77.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.971 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 57.1 mtp180 -52.41 -52.59 53.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 111.457 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.68 -37.48 86.6 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.596 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 145' ' ' ARG . 13.0 mt -74.11 -51.6 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.073 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.505 -177.01 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.896 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.86 -17.33 28.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.28 -178.301 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.602 HG23 HD21 ' A' ' 34' ' ' LEU . 3.2 t -140.62 129.75 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.733 . . . . 0.0 111.289 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 23.0 tp60 -121.99 99.05 6.23 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 171.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -77.4 143.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.518 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -123.77 -65.98 1.03 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.173 -164.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.674 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -104.4 152.3 22.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.471 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.8 p -145.77 99.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.101 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.3 101.38 12.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.826 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -76.96 115.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.042 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.553 HD11 HG23 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -88.51 -38.72 14.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.524 -175.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.69 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.97 79.44 0.91 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.559 168.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -106.14 176.02 1.85 Allowed Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 111.371 -2.649 . . . . 0.0 106.38 170.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.86 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.1 Cg_endo -48.65 102.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.892 1.711 . . . . 0.0 113.291 -154.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.655 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.9 m -137.04 171.87 7.88 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 111.926 -2.397 . . . . 0.0 108.593 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 56.1 Cg_exo -39.94 139.09 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.828 2.352 . . . . 0.0 112.25 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.832 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 35.7 t80 -60.16 -27.57 67.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.705 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -83.58 -13.7 53.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.286 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -62.28 128.05 90.58 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.676 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.3 Cg_exo -68.0 153.82 74.22 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 123.772 2.981 . . . . 0.0 113.266 -172.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 19.6 m-85 -65.26 122.68 17.68 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.061 0.458 . . . . 0.0 109.961 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.763 ' HA ' ' HG3' ' A' ' 75' ' ' GLN . 80.8 mt-30 -127.07 92.91 3.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.48 -172.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CD1' HD11 ' A' ' 97' ' ' ILE . 92.2 m-85 -103.39 126.07 50.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.101 ' HB3' HG23 ' A' ' 10' ' ' VAL . 32.7 tt0 -105.44 87.25 2.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.759 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 3.3 mt -80.04 133.02 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.85 0.833 . . . . 0.0 112.192 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.1 m -109.73 104.74 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.193 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.749 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 17.8 p90 -118.3 146.44 44.32 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.958 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.6 tt0 -105.56 116.81 32.57 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -73.26 110.83 7.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -76.78 -29.49 17.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.05 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.896 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 5.8 mt-10 -149.54 147.51 28.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -52.82 133.31 37.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.762 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -87.66 157.23 19.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.578 -172.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -112.89 -34.41 5.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.946 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.714 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.1 tt0 -124.07 -167.88 1.71 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.714 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.93 145.01 24.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.499 0.666 . . . . 0.0 110.758 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.7 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -92.7 121.96 34.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.312 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 25.6 tt0 -102.58 93.51 5.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.626 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.759 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 23.0 m95 -84.33 111.44 19.42 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.753 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 31.2 ttmt -115.81 143.06 45.94 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.958 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.546 HG21 HD22 ' A' ' 57' ' ' LEU . 10.9 mt -102.95 106.8 20.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.469 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.541 HD12 ' HG2' ' A' ' 41' ' ' LYS . 3.0 mp -105.73 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.29 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.755 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.2 t80 -91.69 120.02 32.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.561 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' B' ' 126' ' ' LEU . 24.0 t -58.37 101.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 110.095 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.18 -37.24 94.27 Favored Glycine 0 CA--C 1.506 -0.512 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.109 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.75 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 66.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.03 54.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.198 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.09 -23.97 21.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 51.9 m -117.2 -154.91 0.57 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.85 164.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -134.0 -33.89 1.02 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.659 0.266 . . . . 0.0 110.913 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 51' ' ' GLU . 29.3 mt-10 -71.43 -3.93 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CD1' ' HB2' ' A' ' 47' ' ' SER . 96.8 m-85 -85.98 -1.86 57.73 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.446 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.22 111.85 0.54 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.133 0.968 . . . . 0.0 110.481 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 1.5 mt-30 -93.4 168.6 10.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.716 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.03 113.28 36.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.459 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 42' ' ' ILE . 10.9 mp -74.54 -50.32 18.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.499 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -170.83 -177.93 2.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.663 -177.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.589 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 36.1 p -152.69 124.32 7.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -100.54 135.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.0 mt -110.69 105.41 14.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.01 0.433 . . . . 0.0 110.573 -176.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.42 119.11 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -74.67 -164.21 11.41 Favored Glycine 0 CA--C 1.499 -0.911 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.385 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.762 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 53.4 Cg_endo -66.14 115.42 3.46 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.298 1.332 . . . . 0.0 110.194 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.592 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.4 m -123.04 138.4 29.71 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.849 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.41 78.18 2.55 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.363 2.042 . . . . 0.0 113.83 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.581 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 52.26 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.641 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.07 137.96 8.99 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.658 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.958 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 6.2 ptt180 -76.14 127.1 32.24 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.997 0.903 . . . . 0.0 109.474 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' THR . 39.9 m80 -123.65 135.25 53.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.683 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.1 ttp -109.22 99.56 8.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 5.8 p90 -108.67 142.31 39.35 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.694 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 3.4 p -104.96 130.55 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.492 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.643 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 5.1 t80 -132.86 132.04 41.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.817 -159.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.763 ' HG3' ' HA ' ' A' ' 23' ' ' GLN . 22.1 mp0 -145.28 156.05 43.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.106 0.479 . . . . 0.0 110.57 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.46 32.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.047 -0.978 . . . . 0.0 108.375 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.7 178.4 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.652 0.739 . . . . 0.0 112.28 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -68.76 159.94 79.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.199 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 57.4 Cg_endo -74.62 166.54 29.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.778 2.319 . . . . 0.0 110.503 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.564 ' HB2' HD12 ' A' ' 83' ' ' LEU . 3.7 m-20 -75.88 114.19 34.57 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.207 0.527 . . . . 0.0 111.161 -171.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 18.5 Cg_endo -64.33 -21.64 66.73 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.578 2.852 . . . . 0.0 112.131 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.38 -0.54 84.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.251 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 80' ' ' ASN . 35.0 mt -103.68 -20.57 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.571 0.224 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 27.9 mt -89.8 129.39 46.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.232 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 88' ' ' ASP . 88.1 Cg_endo -79.99 163.58 22.97 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.527 2.818 . . . . 0.0 111.732 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.669 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -45.64 -56.68 4.91 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.068 0.947 . . . . 0.0 113.268 -174.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -24.39 61.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 111.197 -167.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.548 ' CG ' ' HG2' ' A' ' 85' ' ' PRO . 1.4 m-20 -86.65 -24.97 25.09 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.476 -175.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.654 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -82.91 -46.87 12.44 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.016 -173.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -94.23 46.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-O 122.043 0.925 . . . . 0.0 111.275 -174.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.87 -124.71 0.8 Allowed Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.103 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.57 134.68 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 -168.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 169.93 17.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.461 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.67 HG23 HD13 ' B' ' 126' ' ' LEU . 3.5 t -127.17 152.31 35.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 118.37 0.532 . . . . 0.0 111.603 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.6 p -130.83 108.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.926 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.21 133.25 47.38 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.025 -172.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 33.9 mt -102.23 97.65 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.038 0.923 . . . . 0.0 108.797 174.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.805 HG22 ' HG3' ' A' ' 108' ' ' ARG . 49.4 p -91.72 114.11 26.56 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.258 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 61.4 m -81.99 105.69 13.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.919 0.866 . . . . 0.0 110.706 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.5 m -93.3 106.51 18.47 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.668 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.612 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 65.7 t80 -116.64 119.63 36.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.038 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.612 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.3 mtp180 64.88 23.71 12.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.2 -0.58 64.07 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.62 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.402 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -118.31 121.11 39.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 46.8 mt-10 -72.63 131.36 42.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.783 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.7 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.6 p90 -115.66 -1.85 12.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.1 tt -157.77 161.54 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 109.602 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.805 ' HG3' HG22 ' A' ' 98' ' ' THR . 17.7 ttm180 -150.71 95.78 2.27 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.926 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -83.15 100.36 6.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 118.776 -1.169 . . . . 0.0 108.558 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.503 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -87.78 78.65 1.79 Allowed Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.869 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.913 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -72.88 117.99 15.27 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.608 ' HB3' HD12 ' A' ' 140' ' ' LEU . 22.6 m-85 -67.55 130.34 42.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.9 p -112.02 111.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.498 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 65.3 t30 -94.46 116.78 29.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.386 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.654 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -108.39 108.53 19.53 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -171.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -131.5 129.07 40.63 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.392 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.8 m-85 -39.55 150.09 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 136' ' ' GLN . 68.7 p -92.46 -28.66 16.7 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.167 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.963 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.4 mm-40 -84.4 117.31 23.54 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.216 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.738 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.7 m -53.07 -34.36 56.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.039 -172.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -32.03 72.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.687 0.756 . . . . 0.0 110.283 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.4 mt -76.96 -24.38 52.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.123 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 123' ' ' ARG . 24.2 mtp-105 -78.57 -31.79 47.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.2 mm-40 -61.57 -39.02 89.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.328 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 6.0 p30 -157.96 95.28 1.99 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.113 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 10.8 Cg_endo -53.8 118.37 4.86 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.528 2.152 . . . . 0.0 110.965 175.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.511 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 73.7 Cg_exo -53.02 144.39 46.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.101 1.867 . . . . 0.0 109.424 172.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.52 -27.34 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.101 -166.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HE2' ' HB2' ' A' ' 129' ' ' LYS . 10.0 tppt? -116.35 107.1 47.78 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.655 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.669 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 75.9 Cg_exo -40.27 139.84 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 125.242 3.962 . . . . 0.0 113.881 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -110.59 106.15 15.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.774 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.5 m-85 -74.47 -12.58 60.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.581 -171.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -89.36 -21.1 23.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.271 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.963 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 70.9 mmtt -100.01 10.84 40.64 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 115' ' ' ASN . 21.3 tp -95.38 133.12 39.68 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.522 -171.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.488 ' HB2' HG22 ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.31 123.56 49.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.832 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -103.26 108.32 19.49 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.874 -174.161 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.86 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 2.5 p30 -92.77 104.66 16.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.862 0.839 . . . . 0.0 109.475 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.687 HG21 HG11 ' A' ' 11' ' ' VAL . 1.3 mp -70.96 108.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 112' ' ' TYR . 88.8 mt -67.04 86.57 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.685 0.755 . . . . 0.0 110.7 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.913 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.9 -15.31 60.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.318 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 p -81.97 -1.45 48.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -141.56 64.64 19.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.7 Cg_endo -93.18 106.18 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.059 1.839 . . . . 0.0 111.362 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' B' ' 130' ' ' ILE . 16.4 tpt180 -77.61 81.93 4.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.451 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 109' ' ' VAL . 3.0 m -76.92 103.46 4.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.3 0.571 . . . . 0.0 110.501 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' CE2' ' A' ' 149' ' ' PHE . 35.2 m -116.49 106.09 13.21 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.615 0.722 . . . . 0.0 109.362 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.2 ptt-85 -118.96 154.44 33.02 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.782 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -138.07 168.49 19.61 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.931 -172.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.17 144.65 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.94 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.607 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 22.1 pt -133.99 -172.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.47 0.653 . . . . 0.0 109.936 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 5.3 m-20 -98.31 92.7 5.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.38 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.622 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 15.2 m95 -78.46 -16.57 57.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.398 176.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.503 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 3.0 mp0 . . . . . 0 N--CA 1.433 -1.312 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.233 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.512 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 46.8 mmtm . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.88 -57.62 4.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.259 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.69 -35.62 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.292 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -54.82 -51.74 64.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.826 0.822 . . . . 0.0 110.497 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.67 HD13 HG23 ' A' ' 94' ' ' VAL . 44.5 mt -66.22 -43.65 86.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.611 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.88 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.68 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 128' ' ' ARG . 18.6 mtp180 -60.09 -49.02 79.29 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.894 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -60.62 -41.78 95.53 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.935 0.398 . . . . 0.0 111.133 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.576 HD13 ' HB3' ' A' ' 145' ' ' ARG . 7.0 mt -75.25 -43.88 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.213 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 . . . . . 0 C--N 1.33 -0.243 0 O-C-N 123.607 0.567 . . . . 0.0 111.05 -176.263 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.809 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.55 -19.89 24.45 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.507 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 4.0 t -140.96 130.49 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.755 0.788 . . . . 0.0 111.526 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 20.8 tp60 -125.06 100.55 6.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.57 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -74.4 144.59 12.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.76 177.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -123.29 -66.52 1.0 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.469 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.628 HD22 HG13 ' A' ' 10' ' ' VAL . 64.4 t30 -103.28 151.65 22.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.536 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.761 HG23 HG13 ' A' ' 26' ' ' ILE . 2.6 p -147.43 99.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.578 174.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.03 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -92.87 109.67 21.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.564 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.32 132.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -110.91 -68.8 0.91 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.733 0.777 . . . . 0.0 112.328 -162.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' HE21 ' A' ' 23' ' ' GLN . 1.9 m-20 -96.0 34.7 1.51 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.161 -162.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.715 ' HB3' ' NH2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -138.78 99.64 8.35 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 171.076 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 60.7 Cg_endo -124.99 92.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.27 1 C-N-CA 125.696 4.264 . . . . 0.0 106.139 108.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.663 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 7.5 m -153.83 168.98 10.65 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.188 -167.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 87.9 Cg_exo -38.3 132.26 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.814 2.343 . . . . 0.0 111.679 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.913 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 10.1 t80 -60.85 -22.19 63.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.401 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -84.87 -10.56 57.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.988 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.35 128.57 80.07 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 122.49 1.138 . . . . 0.0 108.728 167.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.65 152.83 32.44 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 124.76 3.64 . . . . 0.0 112.995 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HA ' HH21 ' A' ' 137' ' ' ARG . 27.1 m-85 -81.21 124.4 29.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.486 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 1.056 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.2 mp0 -113.32 114.07 26.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.682 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CG ' HD11 ' A' ' 97' ' ' ILE . 73.4 m-85 -120.97 114.41 21.48 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.03 ' HB3' HG23 ' A' ' 10' ' ' VAL . 33.1 tt0 -97.88 87.12 3.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.761 HG13 HG23 ' A' ' 9' ' ' VAL . 4.5 mp -82.63 140.51 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.929 0.871 . . . . 0.0 112.363 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 14.9 m -113.33 107.13 15.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.286 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.4 p90 -116.39 150.01 38.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.377 0.608 . . . . 0.0 109.565 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -105.42 112.21 25.22 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.481 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.682 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 4.2 t -72.97 108.16 5.72 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -73.76 -25.15 20.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.384 -174.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.809 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -152.8 158.0 41.61 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.409 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.6 129.16 40.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.508 . . . . 0.0 110.339 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.022 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -84.5 148.64 26.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.671 -170.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.527 ' N ' HD13 ' A' ' 34' ' ' LEU . 17.7 m -115.37 -25.99 7.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.893 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 35.8 tt0 -118.44 -163.41 0.95 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.893 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 8.8 m-20 -93.84 131.32 39.35 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.707 -0.621 . . . . 0.0 109.337 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.694 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.62 118.58 23.41 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 40.8 tt0 -102.31 127.61 49.22 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.585 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.9 m95 -115.72 127.52 55.2 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.7 ttmp? -123.71 146.54 48.19 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.053 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.62 HG21 HD22 ' A' ' 57' ' ' LEU . 44.1 mm -102.83 105.8 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.685 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.731 HD11 ' HD2' ' A' ' 41' ' ' LYS . 2.9 mp -103.1 110.8 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.584 ' CE2' HG11 ' A' ' 113' ' ' VAL . 32.2 t80 -95.86 110.78 22.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.256 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG11 HD23 ' B' ' 126' ' ' LEU . 22.9 t -61.53 101.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.425 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -74.34 -42.94 33.07 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.757 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 27.8 p -95.44 99.65 11.52 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' B' ' 122' ' ' LYS . . . -90.98 -5.07 55.91 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 161.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -99.83 -48.75 4.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.607 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.591 ' C ' ' HB2' ' A' ' 47' ' ' SER . 38.7 m -98.56 -157.43 0.6 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 170.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.42 -25.91 0.58 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.319 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -79.42 2.81 20.44 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.757 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 9.6 m-30 -88.51 -1.63 58.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.554 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -47.6 109.59 0.23 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.617 0.722 . . . . 0.0 110.536 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.695 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 55.2 mt-30 -91.58 166.04 13.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.812 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.51 112.1 28.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.286 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 42' ' ' ILE . 8.3 mp -82.18 -56.87 3.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.901 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.12 161.37 42.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.355 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.0 p -146.46 114.98 6.76 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.27 138.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 10.7 mt -110.88 103.2 11.68 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.107 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -97.2 122.79 49.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.3 -158.56 9.7 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.331 -162.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.022 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.6 Cg_endo -65.35 116.75 4.06 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.444 1.429 . . . . 0.0 110.097 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 63' ' ' GLY . 24.5 m -126.22 150.49 70.0 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.35 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.04 138.78 44.89 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.746 2.297 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -43.86 144.58 0.84 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.324 0.583 . . . . 0.0 112.138 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.03 126.97 2.7 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.891 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.4 ptt180 -70.93 130.79 42.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.375 1.083 . . . . 0.0 110.794 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -150.82 151.1 31.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.151 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -107.36 138.45 43.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.455 -172.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 6.2 p90 -139.51 152.27 46.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.2 p -111.51 107.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 122.647 1.213 . . . . 0.0 111.339 -169.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.2 t80 -108.91 121.45 45.14 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.637 -170.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 1.056 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 33.4 mt-30 -119.81 166.43 13.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.245 -172.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.73 132.6 6.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.848 0.295 . . . . 0.0 111.644 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.92 156.69 35.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.55 152.13 36.2 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.601 ' HD3' HD21 ' A' ' 57' ' ' LEU . 55.5 Cg_endo -72.38 177.4 7.39 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.853 3.035 . . . . 0.0 112.236 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -73.69 116.88 56.08 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.436 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.24 1.08 3.79 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 123.67 2.913 . . . . 0.0 112.654 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.51 -15.18 28.01 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.695 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 61.4 mt -97.86 -8.87 27.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.525 -0.837 . . . . 0.0 110.926 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.49 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 22.6 mt -96.07 129.6 33.5 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.051 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 3.4 Cg_exo -77.43 155.35 32.18 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.357 2.705 . . . . 0.0 111.673 169.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.764 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.1 p30 -47.52 -47.25 27.86 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.06 -28.13 68.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.423 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 10.7 m-20 -98.58 -21.78 16.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.429 -173.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -81.33 -46.5 14.61 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.242 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.753 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -95.25 46.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.468 0.652 . . . . 0.0 112.247 -174.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.7 -129.62 1.38 Allowed Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.075 -172.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.411 HG13 ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -98.27 135.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -168.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.48 167.86 28.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.368 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.656 HG12 HD23 ' A' ' 96' ' ' LEU . 69.4 t -118.66 128.7 75.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.354 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.19 106.51 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.769 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -105.75 148.43 27.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.056 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.795 ' HB ' HG12 ' A' ' 109' ' ' VAL . 45.6 mt -106.98 108.29 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 121.313 0.577 . . . . 0.0 109.528 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.857 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 41.8 p -101.92 114.25 28.18 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.189 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 64.1 m -79.32 158.0 27.58 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.282 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -151.14 119.68 6.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -167.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.772 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 34.6 t80 -138.29 124.14 19.97 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.615 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 61.1 mtp180 65.31 32.87 9.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.386 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.97 83.44 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.574 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -114.28 132.23 56.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.15 0.5 . . . . 0.0 110.068 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 31.7 mt-10 -93.89 130.12 40.07 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.146 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.694 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.7 p90 -118.44 -1.17 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -164.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.857 ' O ' ' HA ' ' A' ' 98' ' ' THR . 5.4 tt -156.47 160.29 2.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 120.883 -1.136 . . . . 0.0 109.388 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.661 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 13.5 ttp180 -148.08 102.22 3.36 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 123.93 0.769 . . . . 0.0 109.433 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.795 HG12 ' HB ' ' A' ' 97' ' ' ILE . 3.6 p -89.95 101.26 12.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.723 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.18 92.05 1.78 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 119.613 -1.279 . . . . 0.0 112.136 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.77 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 8.7 m-85 -83.95 126.09 32.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.895 -0.652 . . . . 0.0 109.943 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.5 m-85 -68.24 112.12 4.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.962 176.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.9 p -93.89 111.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.411 ' OD1' HG13 ' A' ' 92' ' ' VAL . 8.5 t30 -101.63 104.42 15.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.013 -176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.6 m-80 -94.3 110.27 22.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.255 -172.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.14 128.03 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.645 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.6 m-85 -39.29 154.12 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.5 p -98.19 -26.15 14.65 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.253 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.411 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 26.6 mm-40 -78.64 120.99 24.11 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.8 m -54.33 -32.02 55.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.543 -169.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -70.61 -36.17 73.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.682 0.753 . . . . 0.0 109.572 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 65.9 mt -74.88 -25.85 59.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.213 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 32.7 mtt180 -70.96 -36.7 72.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.995 0.903 . . . . 0.0 108.787 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 120' ' ' THR . 44.0 mm-40 -69.39 -40.92 77.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.972 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.0 p30 -146.51 91.06 5.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 0.0 111.218 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.6 Cg_endo -56.41 114.97 2.15 Favored 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 122.831 2.354 . . . . 0.0 111.244 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.534 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 50.9 Cg_exo -56.32 160.08 11.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.432 2.088 . . . . 0.0 111.072 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.508 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 11.7 p -51.25 -36.58 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -166.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.518 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 4.8 mmtt -116.19 116.0 40.09 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-O 121.896 0.855 . . . . 0.0 111.745 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.764 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_exo -47.4 141.74 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 125.018 3.812 . . . . 0.0 113.952 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -111.64 109.94 20.08 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 170.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.745 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 18.4 m-85 -70.93 -15.49 62.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.649 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -87.39 -17.81 31.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.641 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 47.7 mmtm -101.91 1.56 37.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.502 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 20.7 tp -86.63 139.79 30.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.125 -171.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 2.8 tt0 -121.34 116.61 25.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.913 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 4.2 mtp-105 -80.39 101.33 8.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.5 t30 -97.48 106.83 19.21 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.637 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 12.3 mt -95.6 114.11 31.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.945 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 112' ' ' TYR . 28.0 mt -73.54 90.05 1.73 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.329 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.77 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -75.45 -9.72 58.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.494 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 p -85.06 -3.37 58.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.679 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -137.12 70.44 55.94 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.584 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.4 Cg_endo -91.28 109.66 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.883 2.389 . . . . 0.0 112.07 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.403 ' CB ' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.36 81.38 7.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 109' ' ' VAL . 16.1 m -71.71 129.29 35.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.152 0.501 . . . . 0.0 111.301 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.547 HG21 HH21 ' A' ' 108' ' ' ARG . 63.5 m -141.09 105.4 4.83 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.736 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -118.52 143.95 46.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.883 0.849 . . . . 0.0 110.836 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HD1' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -125.36 168.42 13.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.715 -178.018 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.89 151.03 22.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.005 0.431 . . . . 0.0 111.107 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.772 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 27.9 pt -135.75 172.34 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.532 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 36.2 p-10 -94.69 86.56 4.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.545 1.164 . . . . 0.0 111.059 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 35.2 m95 -64.52 -16.61 62.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.556 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.562 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.592 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -48.33 -48.47 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.073 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tt -67.69 -39.83 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.196 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.618 ' NE2' HH11 ' B' ' 128' ' ' ARG . 17.6 mm-40 -63.41 -37.4 87.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 89.4 mt -67.23 -43.57 81.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.276 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.72 72.77 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.959 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.618 HH11 ' NE2' ' B' ' 125' ' ' GLN . 94.2 mtt180 -59.36 -47.05 86.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.14 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.9 -43.44 83.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.382 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.661 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 69.7 mt -68.04 -16.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.397 0.618 . . . . 0.0 110.645 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 20.8 tpt85 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.875 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.63 ' HG2' ' CD2' ' A' ' 153' ' ' TRP . 33.3 mmtt -99.9 -7.56 25.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.436 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.7 t -146.1 128.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.113 0.482 . . . . 0.0 110.575 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.604 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 6.3 tp-100 -125.09 103.98 8.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.532 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.738 HG23 ' CH2' ' A' ' 40' ' ' TRP . 2.3 t -65.78 128.85 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.884 0.849 . . . . 0.0 109.092 171.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -118.33 -54.33 2.29 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.852 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.743 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 40.4 t-20 -104.96 128.9 53.43 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.116 -174.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HB ' ' OH ' ' A' ' 111' ' ' TYR . 2.2 t -129.11 99.53 4.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.403 169.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.946 HG23 ' HB3' ' A' ' 25' ' ' GLU . 1.5 m -95.4 101.37 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.444 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.982 HG11 HG21 ' A' ' 139' ' ' ILE . 2.5 t -83.99 117.88 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.325 1.06 . . . . 0.0 108.851 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -86.33 -36.09 19.47 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.341 -175.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 36.7 t0 -74.14 58.28 0.69 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.982 168.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.571 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -82.44 174.48 6.01 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 113.139 -1.846 . . . . 0.0 106.376 160.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.747 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.0 Cg_endo -49.91 103.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.82 1.686 . . . . 0.0 113.065 -153.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.646 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 15.7 m -139.33 171.16 8.47 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.428 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.2 Cg_exo -40.64 132.49 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.458 2.105 . . . . 0.0 111.941 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.771 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 36.6 t80 -57.96 -27.1 63.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.266 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 18.9 m-85 -87.06 -3.3 59.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.139 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -76.24 125.56 87.64 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 164.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.587 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 38.5 Cg_exo -62.89 150.58 87.98 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 123.264 2.643 . . . . 0.0 112.855 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.6 m-85 -62.65 103.55 0.43 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.804 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.635 ' H ' ' CB ' ' A' ' 13' ' ' ASP . 30.9 mt-30 -106.91 103.02 12.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.237 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 97' ' ' ILE . 82.9 m-85 -104.57 155.6 18.69 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.946 ' HB3' HG23 ' A' ' 10' ' ' VAL . 12.7 tt0 -130.51 87.34 2.49 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.523 ' CG2' HG22 ' A' ' 6' ' ' VAL . 23.3 mt -78.06 138.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.782 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.743 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 5.5 m -119.29 109.78 16.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.254 171.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.679 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 19.2 p90 -112.27 140.74 46.73 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.561 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.944 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.0 tt0 -101.75 114.82 29.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.5 m -72.2 113.4 9.19 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -73.83 -24.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.109 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.516 -173.272 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 40.0 mt-10 -150.78 164.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.81 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.46 133.72 50.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.2 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.063 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -95.5 152.57 18.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.112 -172.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.503 ' N ' HD13 ' A' ' 34' ' ' LEU . 11.8 p -115.58 -33.11 5.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.707 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.9 tt0 -108.17 -163.13 0.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -173.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.707 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 12.4 m-20 -89.73 163.12 15.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.604 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -114.58 119.78 37.94 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.1 mp0 -91.19 126.73 36.36 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.017 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.738 ' CH2' HG23 ' A' ' 6' ' ' VAL . 53.5 m95 -120.36 125.81 48.94 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.844 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.1 ttmt -128.72 143.67 50.98 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.649 -173.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.723 HG22 HG22 ' A' ' 95' ' ' VAL . 12.8 mt -103.69 106.98 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.844 HD11 ' HD2' ' A' ' 41' ' ' LYS . 74.0 mt -107.12 106.8 21.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.739 0.781 . . . . 0.0 109.987 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' HG11 ' A' ' 113' ' ' VAL . 58.3 t80 -90.62 131.67 36.19 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.743 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.94 101.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.578 0.704 . . . . 0.0 110.639 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.08 -40.22 97.93 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.548 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.891 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 89.8 p -132.57 118.66 19.49 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.663 0.268 . . . . 0.0 110.854 172.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HB3' ' NZ ' ' B' ' 122' ' ' LYS . . . -78.21 -3.62 43.6 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 163.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -99.44 -17.09 18.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.769 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 53.2 m -131.41 -148.33 0.35 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.87 -32.7 0.27 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 118.854 0.752 . . . . 0.0 112.507 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.84 1.35 20.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.891 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 3.2 m-30 -82.35 -17.7 44.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.311 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p-10 -42.38 115.62 0.72 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 111.895 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' CG ' HD12 ' A' ' 83' ' ' LEU . 12.4 mp0 -92.7 165.62 12.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.04 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 HG12 ' A' ' 43' ' ' ILE . 37.5 t -130.24 110.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.4 mm? -79.52 -40.33 29.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.618 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 21.1 t70 -174.43 157.8 2.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 21.0 p -140.12 117.44 11.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.3 p -98.65 141.2 16.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.764 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.487 ' CD1' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -110.63 104.96 13.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.882 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 94.5 t -83.37 154.16 3.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -96.48 -162.41 32.73 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 118.633 -1.746 . . . . 0.0 112.456 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.063 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 45.0 Cg_endo -66.3 118.92 5.91 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.928 1.752 . . . . 0.0 109.91 173.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' H ' ' CB ' ' A' ' 34' ' ' LEU . 35.8 m -121.15 131.94 24.34 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.398 -173.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.07 138.26 51.46 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.486 2.124 . . . . 0.0 110.789 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -40.58 141.5 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.063 0.852 . . . . 0.0 112.433 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.05 149.24 7.51 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.944 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 9.4 ptt180 -75.72 143.63 41.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.028 0.918 . . . . 0.0 111.157 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -137.85 136.09 36.82 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.607 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.31 123.8 48.6 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.608 0.718 . . . . 0.0 110.763 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.67 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.6 p90 -127.97 144.12 51.1 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.365 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 p -105.42 125.9 60.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.109 0.956 . . . . 0.0 110.213 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.67 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 7.3 t80 -126.6 113.1 16.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.025 -162.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 6.4 mt-30 -130.55 154.25 48.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -158.13 154.32 27.26 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.31 -174.93 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.839 0.828 . . . . 0.0 113.056 -171.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -81.94 150.49 65.44 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.476 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.771 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 46.7 Cg_exo -62.77 173.75 3.48 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 123.389 2.726 . . . . 0.0 112.495 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.3 m-20 -81.8 115.6 58.14 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.525 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.08 -9.69 26.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.267 2.645 . . . . 0.0 112.236 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 6.46 64.98 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.698 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.491 HD12 ' CG ' ' A' ' 55' ' ' GLN . 10.3 mt -108.9 -37.68 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.548 0.213 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 49.3 mt -69.57 130.08 90.87 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 73.2 Cg_endo -79.69 161.62 24.61 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 0.0 112.468 171.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.609 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.0 OUTLIER -46.31 -52.74 12.12 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.787 0.835 . . . . 0.0 112.974 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . . . -75.0 -23.03 58.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.983 -170.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.765 ' HA ' ' HZ1' ' B' ' 122' ' ' LYS . 12.9 t0 -82.68 -27.3 31.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 0.0 110.591 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 130' ' ' PRO . . . -73.94 -40.4 63.1 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.759 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.38 44.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 114' ' ' ASN . . . -174.77 -129.56 1.2 Allowed Glycine 0 CA--C 1.496 -1.113 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.992 -173.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.62 HG23 ' HG3' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -103.04 120.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.187 0.994 . . . . 0.0 113.433 -165.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.863 ' HB ' HG13 ' A' ' 113' ' ' VAL . 5.2 m -135.35 169.12 17.97 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.488 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.556 HG12 HD23 ' A' ' 96' ' ' LEU . 8.3 t -130.89 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 118.049 0.386 . . . . 0.0 110.638 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.723 HG22 HG22 ' A' ' 42' ' ' ILE . 7.6 p -131.78 107.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.876 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -97.26 130.21 44.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.664 -168.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.759 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 49.1 mt -95.36 93.75 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.794 HG22 ' HG3' ' A' ' 108' ' ' ARG . 32.4 p -92.35 112.94 25.07 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.677 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.05 ' SG ' HG22 ' A' ' 107' ' ' ILE . 23.5 p -75.52 159.14 31.61 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 28.2 m -150.95 103.65 3.08 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -171.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.996 ' HE2' HD11 ' A' ' 34' ' ' LEU . 51.0 t80 -118.9 125.52 49.68 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 16.4 mmt180 67.18 14.46 9.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.898 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.26 4.55 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.595 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.73 138.22 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 6.8 mt-10 -87.45 127.62 35.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.539 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.604 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.9 p90 -116.95 1.73 12.66 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.05 HG22 ' SG ' ' A' ' 99' ' ' CYS . 4.8 tt -154.44 153.98 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.381 -0.825 . . . . 0.0 109.2 167.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.94 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 4.1 ttm-85 -143.63 91.2 2.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.582 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.907 HG23 HG12 ' A' ' 146' ' ' VAL . 0.5 OUTLIER -83.39 100.95 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.266 1.031 . . . . 0.0 108.294 175.143 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA3' HD11 ' B' ' 130' ' ' ILE . . . -89.72 81.73 1.43 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.791 -1.195 . . . . 0.0 111.158 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.533 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 27.4 m-85 -69.73 115.1 8.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.663 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.4 m-85 -66.93 111.37 3.75 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.863 HG13 ' HB ' ' A' ' 93' ' ' THR . 1.5 p -91.47 109.33 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.606 ' OD1' HG13 ' A' ' 92' ' ' VAL . 3.0 t30 -96.7 113.66 25.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.431 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.529 ' HB3' HD11 ' A' ' 135' ' ' LEU . 57.6 m-80 -101.82 108.84 20.46 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.861 0.839 . . . . 0.0 109.151 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.16 132.46 39.85 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.814 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.663 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 50.6 m-85 -49.01 155.5 0.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -172.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.556 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 18.3 p -92.27 -28.89 16.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.257 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.577 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 21.7 mm-40 -80.81 122.96 27.84 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.298 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.589 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 21.2 m -51.75 -34.09 37.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.336 -170.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.23 -37.33 80.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.652 0.739 . . . . 0.0 109.438 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 55.8 mt -78.77 -19.28 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.551 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 45.9 mtt180 -77.58 -35.11 53.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.7 mm-40 -74.45 -38.08 63.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.438 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.2 p30 -142.3 83.23 12.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 110.441 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 16.3 Cg_endo -57.39 114.97 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.141 2.561 . . . . 0.0 111.918 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.658 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 34.7 Cg_exo -62.72 142.77 90.54 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.0 110.347 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 128' ' ' VAL . 7.5 t -55.94 -32.84 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.511 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 1.3 mmtt -79.4 133.09 60.56 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 121.132 0.491 . . . . 0.0 110.875 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.609 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 6.4 Cg_endo -77.45 129.32 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.588 2.859 . . . . 0.0 112.433 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.2 t70 -125.63 108.03 11.16 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.885 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.715 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.5 m-85 -78.5 -16.83 57.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.273 1.035 . . . . 0.0 110.579 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.413 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 31.0 t -83.11 -27.95 29.81 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.301 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.577 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 71.9 mmtt -100.8 11.62 39.19 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.3 tp -94.55 129.08 41.5 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.885 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.556 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 9.7 tt0 -112.72 120.06 40.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.747 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.06 107.12 19.44 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.639 -174.008 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 16.5 t30 -78.74 102.88 8.32 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.828 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.982 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -76.89 105.83 6.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.911 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 112' ' ' TYR . 83.9 mt -67.11 90.99 0.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.757 0.789 . . . . 0.0 111.336 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.533 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.21 -19.51 43.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.454 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 p -80.14 -17.32 52.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.949 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 16.9 m120 -131.31 61.5 59.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.709 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.72 116.5 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.81 1.673 . . . . 0.0 111.058 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.682 ' HG3' HG12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.84 81.11 7.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.387 0.613 . . . . 0.0 109.942 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.907 HG12 HG23 ' A' ' 109' ' ' VAL . 19.4 m -89.36 137.39 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.771 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.5 m -149.18 108.76 4.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.487 0.661 . . . . 0.0 110.008 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -101.64 140.75 35.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.0 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -118.11 168.51 10.49 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.798 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.83 114.54 28.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.413 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.736 HD11 ' HB3' ' A' ' 101' ' ' TYR . 42.3 pt -118.69 -173.47 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.518 0.675 . . . . 0.0 110.971 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 5.3 m-20 -96.07 92.74 6.59 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.726 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.63 ' CD2' ' HG2' ' A' ' 3' ' ' LYS . 37.8 m95 -77.28 -12.5 59.96 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 109.838 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.434 -1.271 0 CA-C-O 121.832 0.825 . . . . 0.0 110.595 -172.202 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.765 ' HZ1' ' HA ' ' A' ' 88' ' ' ASP . 75.5 mmtt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -24.79 -66.72 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.778 1.299 . . . . 0.0 114.001 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.74 -35.61 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' B' ' 128' ' ' ARG . 44.4 mm-40 -66.5 -50.11 64.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.954 0.407 . . . . 0.0 111.899 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 94' ' ' VAL . 1.5 mm? -68.3 -33.96 75.28 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.18 90.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.549 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 49.9 mtp180 -51.77 -56.41 14.0 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.28 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.792 ' HD2' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -56.93 -42.69 80.45 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 -176.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.94 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 1.7 mp -70.13 -50.2 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 123.747 0.654 . . . . 0.0 112.543 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -174.221 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.906 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -90.68 -20.58 22.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 -176.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.492 ' HB ' ' CZ3' ' A' ' 153' ' ' TRP . 3.0 t -136.64 129.51 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.482 0.658 . . . . 0.0 110.275 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.8 tp60 -115.54 99.59 7.46 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -73.12 134.03 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -120.24 -64.88 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.89 0.852 . . . . 0.0 109.465 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.696 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 64.9 t30 -105.09 150.0 25.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.587 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 9' ' ' VAL . 5.9 p -145.57 102.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.957 0.885 . . . . 0.0 109.322 173.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -95.75 100.22 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.513 1.149 . . . . 0.0 109.667 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 139' ' ' ILE . 2.1 m -79.18 126.87 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.184 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.859 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -102.76 -34.75 8.9 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.745 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.721 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 26.0 t70 -59.34 28.79 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.874 -1.966 . . . . 0.0 112.566 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.626 ' OD1' ' HD3' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -82.22 172.48 9.47 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.871 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 24.2 Cg_exo -54.37 101.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.323 1.349 . . . . 0.0 113.658 -136.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.563 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.8 m -138.44 168.51 15.64 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.252 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 82.6 Cg_exo -36.49 132.86 0.36 Allowed 'Trans proline' 0 CA--C 1.504 -1.011 0 C-N-CA 123.31 2.673 . . . . 0.0 112.07 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.734 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 16.5 t80 -51.27 -24.25 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.786 0.679 . . . . 0.0 112.535 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -86.32 0.85 53.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.934 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.498 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 31.2 p-10 -63.56 138.73 97.45 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 165.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.718 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 16.6 Cg_exo -78.89 145.71 20.06 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 122.843 2.362 . . . . 0.0 111.715 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.81 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 53.5 m-85 -60.65 126.22 26.61 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.859 ' HB3' HD12 ' A' ' 12' ' ' LEU . 34.5 mt-30 -125.72 99.36 5.94 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.759 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 67.9 m-85 -107.92 102.37 11.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.88 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 10' ' ' VAL . 29.5 tt0 -85.94 83.7 7.73 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.685 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 7.3 mt -84.91 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.57 0.7 . . . . 0.0 112.441 -176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.4 m -111.68 107.45 16.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.323 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.479 ' HB3' HG13 ' A' ' 6' ' ' VAL . 27.7 p90 -121.21 148.14 44.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 37.0 tt0 -106.01 112.66 25.8 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.739 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 41.5 t -73.49 109.41 6.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.524 ' C ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -78.63 -29.0 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.641 -173.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.906 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 1.8 mt-10 -149.66 148.15 28.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.4 p-10 -56.27 135.04 53.7 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 111.691 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.06 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 93.3 mt -82.74 160.47 22.31 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.356 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.6 t -113.17 -21.62 10.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.803 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.886 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.5 tt0 -137.89 -168.52 2.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.886 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 17.6 m-20 -95.12 137.4 34.23 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.418 0.628 . . . . 0.0 109.69 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.732 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.31 118.95 23.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.602 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.8 tt0 -108.63 89.76 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.878 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 15.0 m95 -78.22 126.54 30.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.9 ttmp? -126.15 141.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.048 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -102.88 107.9 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.745 ' HB ' HD12 ' A' ' 96' ' ' LEU . 40.1 mt -111.74 104.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.839 0.828 . . . . 0.0 109.034 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.836 ' CE2' HG11 ' A' ' 113' ' ' VAL . 17.0 t80 -86.81 115.42 24.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.195 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HD11 ' B' ' 126' ' ' LEU . 6.8 t -62.27 101.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.237 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.49 56.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.832 ' HB3' ' CG ' ' A' ' 53' ' ' TYR . 14.8 p -96.94 88.36 4.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.857 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HB1' ' HG3' ' B' ' 122' ' ' LYS . . . -80.41 -17.72 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -100.3 -23.47 14.78 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.028 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.742 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 48.7 m -110.32 -147.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -155.96 -5.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.76 1.44 53.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.832 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 4.2 m-30 -91.33 -14.42 30.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.369 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -40.81 113.99 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.449 1.119 . . . . 0.0 112.605 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.491 HE21 ' HD1' ' A' ' 44' ' ' TYR . 16.0 mt-30 -92.71 163.09 13.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.219 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 43' ' ' ILE . 39.4 t -132.6 115.67 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 57' ' ' LEU . 3.3 mm? -84.2 -45.26 13.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.655 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -170.5 165.75 8.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 61.9 p -141.8 117.53 10.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -100.0 136.6 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.639 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.2 mt -107.9 104.84 14.4 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.99 110.76 23.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -71.7 -170.19 12.28 Favored Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.889 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.06 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 35.2 Cg_endo -62.12 115.11 2.63 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 121.259 1.306 . . . . 0.0 109.994 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 34.0 m -123.94 140.25 34.22 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.342 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.55 76.81 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.987 1.791 . . . . 0.0 113.463 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.54 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.64 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.039 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.21 124.89 3.56 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.992 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.854 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 31.9 ttt180 -79.53 118.19 21.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.446 0.641 . . . . 0.0 109.501 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -150.74 143.92 24.81 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.394 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -96.86 134.23 40.44 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.361 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -127.0 150.02 49.62 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.15 101.67 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-O 123.189 1.471 . . . . 0.0 111.448 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.759 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -76.13 137.26 39.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 112.494 -2.139 . . . . 0.0 109.841 -176.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.81 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.0 mt-30 -151.84 152.28 32.42 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.034 0.445 . . . . 0.0 109.941 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.44 155.89 6.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.0 p-10 -62.34 179.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.53 0.605 . . . . 0.0 111.983 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -77.06 158.65 79.75 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.68 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 38.8 Cg_endo -63.73 164.73 20.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.5 2.134 . . . . 0.0 110.817 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.21 115.97 37.48 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.599 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -66.74 -12.76 37.24 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.098 2.532 . . . . 0.0 112.519 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.86 -5.54 61.08 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.105 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 83' ' ' LEU . 20.7 mt -96.45 -37.11 10.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 122.613 -0.345 . . . . 0.0 110.592 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 19.2 mt -72.35 127.7 89.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.05 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.62 162.55 24.46 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.902 2.401 . . . . 0.0 112.423 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.845 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 t70 -43.72 -54.53 5.04 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.055 0.942 . . . . 0.0 113.487 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB1' ' NZ ' ' B' ' 122' ' ' LYS . . . -64.45 -28.51 69.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.071 0.462 . . . . 0.0 111.369 -168.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -97.19 -21.33 17.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.578 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.77 -48.22 12.8 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.679 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -92.87 47.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 112.68 -175.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.48 -127.23 1.11 Allowed Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.067 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.451 HG23 ' HG2' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -100.41 136.04 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.426 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -151.84 166.77 30.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.579 HG23 ' HG ' ' B' ' 126' ' ' LEU . 15.2 t -121.98 138.86 50.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.555 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.95 106.99 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.929 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -104.65 139.83 38.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.236 -170.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.791 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 34.5 mt -109.67 96.63 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.911 0.862 . . . . 0.0 109.097 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 72.7 p -96.07 116.26 28.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.884 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.596 ' HB2' HG22 ' A' ' 107' ' ' ILE . 75.0 m -80.59 104.49 11.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.493 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 23.7 m -85.6 102.19 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.175 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.636 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 32.7 t80 -117.98 126.11 51.68 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.929 -0.482 . . . . 0.0 110.26 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 53.8 mtp85 60.39 28.82 18.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.848 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.35 -20.22 51.33 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.752 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.693 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 4.0 pt20 -111.57 142.99 43.15 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.637 0.732 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.9 mt-10 -93.79 119.72 33.12 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.212 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.732 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 43.9 p90 -104.53 -0.52 27.7 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.821 ' O ' ' HA ' ' A' ' 98' ' ' THR . 6.1 tt -157.58 160.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.697 ' HG3' ' HB2' ' A' ' 96' ' ' LEU . 10.5 ttp180 -151.48 119.24 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 123.674 0.609 . . . . 0.0 109.776 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.929 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.6 p -96.01 100.05 10.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.515 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.62 73.42 2.49 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 119.252 -1.452 . . . . 0.0 110.961 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.872 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.8 m-85 -67.67 115.62 7.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.996 -1.102 . . . . 0.0 109.087 175.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.532 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.8 m-85 -67.68 113.26 5.32 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.836 HG11 ' CE2' ' A' ' 44' ' ' TYR . 5.3 p -93.8 110.56 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -95.25 108.61 20.77 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.611 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.677 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 37.8 m-80 -101.79 107.49 18.71 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -129.14 124.01 33.59 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.276 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 29.0 m-85 -42.13 153.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.631 HG23 ' HB2' ' A' ' 136' ' ' GLN . 17.9 p -96.49 -27.75 14.73 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.607 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.537 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -79.48 120.86 24.46 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.505 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 5.8 m -55.49 -30.8 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.986 -170.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.25 -39.73 93.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.878 0.847 . . . . 0.0 109.866 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 66.1 mt -76.68 -24.98 53.2 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.268 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 39.4 mtt180 -72.49 -32.8 66.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.1 mm-40 -71.9 -41.13 68.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.922 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.9 p30 -148.98 102.84 3.37 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 122.051 0.929 . . . . 0.0 111.452 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 33.6 Cg_endo -66.47 113.94 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.425 2.75 . . . . 0.0 110.98 172.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 33.0 Cg_exo -59.8 157.79 31.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.592 2.195 . . . . 0.0 111.094 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.07 -21.9 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.683 -169.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.554 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 1.9 mmpt? -128.36 103.86 20.02 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 122.012 0.91 . . . . 0.0 112.133 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.845 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 12.6 Cg_exo -44.28 140.27 5.83 Favored 'Trans proline' 0 N--CA 1.455 -0.737 1 C-N-CA 125.553 4.169 . . . . 0.0 113.82 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.0 t70 -111.6 114.67 27.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.368 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.627 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.6 m-85 -78.63 -7.13 57.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.21 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.6 p -96.69 -34.56 11.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.537 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 72.2 mmtt -81.78 -17.22 48.38 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.644 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 32.6 tp -66.67 139.65 57.86 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.744 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.631 ' HB2' HG23 ' A' ' 118' ' ' THR . 3.9 tt0 -129.02 121.95 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.769 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.78 108.98 20.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.743 0.782 . . . . 0.0 112.236 -175.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.456 ' CB ' ' HG3' ' A' ' 15' ' ' PRO . 5.0 t30 -91.33 101.54 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.603 170.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.617 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 6.3 mm -68.96 106.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 112' ' ' TYR . 66.4 mt -66.72 87.38 0.13 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.922 0.868 . . . . 0.0 111.2 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.872 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.51 -4.85 57.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.162 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.2 p -83.23 -11.65 57.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.576 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 63.3 t30 -143.9 59.86 7.58 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.408 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 13.9 Cg_exo -71.8 105.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.698 1.599 . . . . 0.0 110.658 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.7 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -79.91 81.35 6.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.156 0.503 . . . . 0.0 110.143 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.9 m -80.38 141.67 14.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.205 0.526 . . . . 0.0 111.084 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.488 HG21 HH21 ' A' ' 108' ' ' ARG . 54.2 m -148.83 105.87 3.6 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.753 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -115.46 140.28 49.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 110.381 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -119.43 169.94 9.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.788 -175.272 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.98 111.57 24.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.693 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 22.3 pt -115.06 -173.91 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 121.377 0.608 . . . . 0.0 110.596 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.44 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 4.0 p-10 -88.57 114.45 25.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.793 1.282 . . . . 0.0 109.733 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 59.8 m95 -96.06 -8.46 33.43 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.529 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.218 -174.742 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.507 ' NZ ' ' HB1' ' A' ' 87' ' ' ALA . 13.6 mptt . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -37.04 -59.22 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 12.8 tt -68.92 -32.68 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -62.93 -56.04 20.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.584 HD11 HG11 ' A' ' 45' ' ' VAL . 2.1 mm? -69.48 -29.59 67.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.869 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.3 77.42 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 90.7 mtt180 -53.34 -46.5 69.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.306 0.574 . . . . 0.0 110.312 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.697 ' HG3' HD21 ' A' ' 96' ' ' LEU . 21.4 tpt180 -65.93 -35.66 81.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.518 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 145' ' ' ARG . 18.1 mt -94.72 -22.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 . . . . . 0 C--N 1.324 -0.527 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.432 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.821 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.88 -8.81 51.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.623 -175.178 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.635 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 38.8 t -148.15 138.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.048 ' HG2' HD11 ' A' ' 31' ' ' ILE . 14.4 mm-40 -124.03 101.29 7.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.73 167.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 81.6 t -72.67 102.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -88.5 -60.7 1.89 Allowed 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.722 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.742 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 64.7 t30 -107.51 150.59 26.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.217 -1.81 . . . . 0.0 110.386 -171.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 26' ' ' ILE . 2.6 p -145.81 99.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.791 169.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -92.21 107.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.653 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -77.55 119.82 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.677 -178.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 23' ' ' GLN . 2.4 mt -89.31 -47.79 7.8 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.093 -171.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 9.5 t70 -78.58 73.65 5.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.046 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.612 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t30 -81.72 176.7 3.57 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 111.726 -2.488 . . . . 0.0 106.614 169.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.99 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 3.0 Cg_endo -46.74 104.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.68 1.636 . . . . 0.0 113.374 -147.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 1.007 ' HB3' HD22 ' A' ' 20' ' ' ASN . 75.1 m -126.5 168.82 13.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.493 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -40.69 132.56 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.298 1.998 . . . . 0.0 111.031 173.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.718 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 7.9 t80 -58.11 -25.36 61.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.753 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 133' ' ' SER . 5.2 m-85 -89.83 3.95 51.34 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.86 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 1.007 HD22 ' HB3' ' A' ' 16' ' ' SER . 3.8 p30 -97.25 142.72 24.96 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.618 170.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.627 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 6.3 Cg_endo -42.29 151.17 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.16 1 C-N-CA 126.551 4.834 . . . . 0.0 115.877 -178.336 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.859 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 45.8 m-85 -84.5 120.22 26.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.655 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.92 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.5 mp0 -110.4 121.7 45.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.684 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 82.6 m-85 -125.59 104.34 8.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.219 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.689 ' CB ' HD21 ' A' ' 12' ' ' LEU . 35.5 tt0 -88.14 86.27 7.07 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.656 HG13 HG23 ' A' ' 9' ' ' VAL . 4.6 mt -83.51 134.01 27.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.192 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.5 m -109.1 109.01 19.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.553 172.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.636 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 13.7 p90 -123.37 148.56 45.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.892 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.883 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.3 tt0 -108.39 112.49 24.94 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 110.44 7.4 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.048 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.2 mt -72.04 -35.94 55.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.695 -171.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.821 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 23.9 mt-10 -143.35 172.02 13.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 p-10 -71.62 144.24 49.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.36 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.047 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 62.5 mt -95.88 161.08 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -112.47 -25.02 9.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.122 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.51 -168.14 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.122 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.12 140.84 29.08 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.77 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -81.73 119.18 23.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.935 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.736 ' HG2' HD22 ' A' ' 61' ' ' LEU . 24.3 mt-10 -101.96 89.29 3.59 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.442 -173.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.577 ' CH2' HG21 ' A' ' 26' ' ' ILE . 19.1 m95 -77.65 151.59 34.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.699 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 0.6 OUTLIER -153.23 134.05 13.88 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.554 -0.459 . . . . 0.0 109.85 -179.112 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 33.0 mt -103.18 120.54 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.656 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -119.04 106.24 19.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.839 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.771 ' CE2' HG11 ' A' ' 113' ' ' VAL . 56.0 t80 -89.15 126.0 35.28 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.856 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.941 HG22 ' HE2' ' A' ' 53' ' ' TYR . 31.4 t -73.52 117.94 18.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.195 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -92.98 -59.24 1.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 119.846 -1.169 . . . . 0.0 112.092 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.708 ' H ' ' CB ' ' A' ' 53' ' ' TYR . 7.4 m -105.26 72.39 0.98 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -48.19 -21.27 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.552 0.532 . . . . 0.0 111.62 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG3' ' HE2' ' B' ' 122' ' ' LYS . 5.2 tt0 -85.71 -31.99 22.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.388 0.675 . . . . 0.0 112.23 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.7 m -95.62 -27.59 15.24 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.996 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER 64.25 11.63 6.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.865 1.266 . . . . 0.0 112.489 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -99.11 -13.06 19.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.452 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.996 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 29.3 p90 -73.17 -46.51 50.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.563 -1.653 . . . . 0.0 114.416 -161.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.616 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 7.6 p-10 -30.8 113.76 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 125.011 1.445 . . . . 0.0 114.388 -154.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.605 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 14.1 mt-30 -95.84 170.78 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.607 -169.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.612 HG13 ' HE2' ' A' ' 41' ' ' LYS . 2.3 t -130.49 116.03 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.863 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.3 mm? -92.56 -56.66 2.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.289 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 15.2 t70 -162.5 156.63 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.998 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.699 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 36.6 p -132.96 121.82 23.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG11 ' CE1' ' A' ' 72' ' ' PHE . 3.6 p -111.2 137.32 44.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.736 HD22 ' HG2' ' A' ' 39' ' ' GLU . 7.8 mt -108.99 105.06 14.42 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.458 -176.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.01 114.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -68.59 -176.08 11.23 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.011 -167.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.047 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 43.6 Cg_endo -65.15 114.71 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.146 1.231 . . . . 0.0 110.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 63' ' ' GLY . 34.6 m -123.84 140.35 34.31 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.034 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 60.5 Cg_endo -80.55 79.5 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.292 1.994 . . . . 0.0 113.589 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 53.25 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.633 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.03 128.06 3.89 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.703 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.883 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 51.0 ttt180 -87.23 115.92 24.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.698 0.761 . . . . 0.0 109.345 175.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.531 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.1 p80 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.484 -172.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -94.16 136.51 34.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.795 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -121.29 153.03 38.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.33 121.0 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.622 1.201 . . . . 0.0 111.989 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.684 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -95.23 141.01 29.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.329 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.92 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 76.6 mt-30 -152.08 152.54 32.5 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 167.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -169.39 126.98 0.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.747 ' O ' HD12 ' A' ' 57' ' ' LEU . 29.4 t70 -64.53 147.99 51.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.685 0.279 . . . . 0.0 111.445 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -37.17 152.37 0.12 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.859 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 32.9 Cg_endo -64.04 -179.78 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 125.087 3.858 . . . . 0.0 113.344 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -92.84 119.19 67.99 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.206 0.527 . . . . 0.0 110.99 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -66.97 -23.24 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.273 2.649 . . . . 0.0 112.501 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.58 -2.85 90.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.953 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 53.2 mt -108.05 1.99 22.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.573 0.225 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.569 HD11 ' HE1' ' A' ' 44' ' ' TYR . 10.1 mt -109.5 123.52 36.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 91.5 Cg_endo -80.02 163.85 22.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.687 2.925 . . . . 0.0 112.22 168.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 10.3 t70 -44.46 -55.03 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.112 0.965 . . . . 0.0 113.195 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.49 70.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.164 0.507 . . . . 0.0 111.607 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 35.5 m-20 -94.45 -8.6 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.638 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.545 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -88.35 -47.77 8.14 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 121.123 0.487 . . . . 0.0 111.955 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -101.94 44.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.523 0.678 . . . . 0.0 111.906 -174.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.88 -124.13 0.71 Allowed Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.597 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.88 130.12 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-O 122.236 1.017 . . . . 0.0 111.91 -169.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.471 HG22 HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -146.77 170.67 16.52 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.416 -1.72 . . . . 0.0 107.719 179.11 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.52 ' CG2' ' HB3' ' B' ' 126' ' ' LEU . 3.0 t -128.58 151.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.56 0.219 . . . . 0.0 111.481 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 95' ' ' VAL . 7.8 p -131.29 107.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.941 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.9 pp -102.52 140.56 36.64 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.433 -170.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 24' ' ' PHE . 58.7 mt -112.44 106.47 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.47 0.652 . . . . 0.0 109.393 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 62.9 p -93.86 119.47 32.84 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.46 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.642 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.1 m -85.39 128.78 34.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 169.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.7 m -122.65 119.9 32.11 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.386 -171.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.656 ' HB3' HD11 ' A' ' 151' ' ' ILE . 75.2 t80 -124.89 122.85 38.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.537 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.638 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 48.4 mtp180 69.53 28.09 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.062 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.13 -0.7 82.0 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.265 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -121.69 128.64 52.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.203 0.525 . . . . 0.0 110.519 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.3 mp0 -79.84 139.75 37.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.946 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.77 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 42.6 p90 -124.1 -0.63 8.34 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.795 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.4 tt -159.12 158.86 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.617 -0.677 . . . . 0.0 109.185 174.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.562 ' HG3' HG22 ' A' ' 98' ' ' THR . 16.3 ttm180 -151.37 102.56 2.92 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -176.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.941 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.62 99.17 7.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.292 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.646 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -83.72 78.04 2.05 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.889 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.9 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -73.56 113.27 10.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.434 ' CB ' HD12 ' A' ' 140' ' ' LEU . 18.3 m-85 -67.3 127.57 33.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.222 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.771 HG11 ' CE2' ' A' ' 44' ' ' TYR . 7.7 p -109.53 111.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.37 1.081 . . . . 0.0 108.088 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -89.47 111.06 21.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.271 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.525 ' HB3' HD11 ' A' ' 135' ' ' LEU . 22.9 m120 -99.29 107.71 20.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -173.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.54 131.63 34.12 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.836 -175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 55.7 m-85 -39.7 151.74 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.3 p -88.97 -33.88 17.06 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.328 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.647 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 6.5 mm-40 -82.46 122.42 28.0 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.875 177.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -55.75 -33.38 64.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.673 -171.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.92 -37.92 87.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.705 0.764 . . . . 0.0 109.549 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.0 mt -74.11 -23.35 59.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.557 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -76.29 -31.24 58.11 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 120' ' ' THR . 30.9 mm-40 -77.97 -33.95 51.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.46 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 1.9 p30 -144.67 87.57 7.44 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.106 0.479 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 11.6 Cg_endo -53.62 117.93 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.764 2.309 . . . . 0.0 110.727 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 77.3 Cg_exo -53.39 160.12 5.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.624 2.216 . . . . 0.0 110.798 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.49 -38.87 9.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 O-C-N 123.658 0.599 . . . . 0.0 111.494 -168.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.719 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 4.6 mmtt -124.44 127.6 25.21 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.719 ' HD2' ' HD3' ' A' ' 129' ' ' LYS . 7.5 Cg_exo -41.31 134.22 3.07 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.613 3.542 . . . . 0.0 113.257 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 25.0 t70 -114.52 114.46 25.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.718 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.2 m-85 -78.57 -16.93 56.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.08 -168.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.436 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -83.32 -28.65 28.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.241 177.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.647 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 66.0 mmtt -98.56 11.46 38.28 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 115' ' ' ASN . 26.2 tp -91.05 147.11 23.3 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.894 -177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.447 ' OE1' ' HB2' ' A' ' 15' ' ' PRO . 5.1 tt0 -124.88 123.06 39.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.85 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.0 mtp-105 -82.73 103.6 12.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.99 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 2.1 t30 -99.47 105.0 16.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.944 0.878 . . . . 0.0 108.808 171.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.704 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -78.41 111.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.731 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.434 HD12 ' CB ' ' A' ' 112' ' ' TYR . 69.3 mt -68.16 86.91 0.27 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.9 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.62 -11.41 59.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 p -78.96 -10.66 59.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.069 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.497 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 17.1 m120 -133.06 58.4 34.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.065 -174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 6.0 Cg_exo -80.43 105.28 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.814 1.676 . . . . 0.0 111.053 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.714 ' HB3' HD13 ' B' ' 130' ' ' ILE . 12.6 tpp180 -82.45 81.16 8.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.512 HG12 HG23 ' A' ' 109' ' ' VAL . 6.1 m -83.26 104.77 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.609 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.427 HG22 ' CE1' ' A' ' 149' ' ' PHE . 21.4 m -111.48 106.8 15.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.687 0.756 . . . . 0.0 109.595 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.795 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.0 ptt180 -113.82 146.04 40.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.386 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.1 169.37 15.4 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.241 -173.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.0 130.31 53.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.687 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.4 pt -129.08 -177.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.535 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 13.5 p30 -103.38 87.54 2.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.673 0.749 . . . . 0.0 111.37 -174.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.635 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 37.3 m95 -73.15 -1.18 16.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.401 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -173.163 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.682 ' HE2' ' HG3' ' A' ' 49' ' ' GLU . 23.2 mmtp . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.856 -0.053 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -37.26 -53.06 1.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.489 0.493 . . . . 0.0 111.804 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.76 -30.22 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.573 0.225 . . . . 0.0 111.408 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.638 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 9.1 mm100 -60.95 -52.33 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.291 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.681 ' CD1' HG11 ' A' ' 45' ' ' VAL . 2.4 mm? -67.07 -39.99 86.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.05 88.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.29 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 9.3 ptm180 -66.42 -35.89 81.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.78 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -64.7 -38.92 92.62 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.714 HD13 ' HB3' ' A' ' 145' ' ' ARG . 14.8 mt -76.05 -50.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.95 -174.321 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 1.144 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.82 -20.42 23.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.98 -175.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.855 HG21 HD21 ' A' ' 38' ' ' LEU . 4.0 t -141.72 130.07 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.7 tp60 -121.66 100.2 6.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.064 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -79.61 146.4 7.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.366 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -129.14 -65.57 0.86 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.202 -165.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.684 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.61 150.45 23.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.779 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.632 HG23 HG13 ' A' ' 26' ' ' ILE . 3.5 p -146.18 100.05 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 169.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.987 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -87.6 103.73 13.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.687 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -77.86 109.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.713 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.974 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.7 mt -89.72 -44.64 9.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.989 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.932 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.6 OUTLIER -69.32 75.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.622 1.677 . . . . 0.0 109.597 167.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.1 t30 -85.37 177.9 2.65 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.138 163.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.8 Cg_endo -48.83 103.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 121.916 1.72 . . . . 0.0 113.603 -154.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.69 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.4 m -129.78 171.24 9.2 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.425 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.69 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 83.7 Cg_exo -42.84 138.82 3.64 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.685 2.257 . . . . 0.0 112.106 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.727 ' CE1' ' HG2' ' A' ' 79' ' ' PRO . 43.9 t80 -58.11 -29.62 65.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.659 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -89.12 1.3 55.82 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -78.66 144.52 65.12 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.281 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 12.1 Cg_exo -79.54 137.48 13.03 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 123.221 2.614 . . . . 0.0 112.831 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 25.3 m-85 -55.24 146.24 19.52 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.931 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.974 ' HG2' HD12 ' A' ' 12' ' ' LEU . 33.5 tt0 -136.46 92.44 2.77 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.206 -167.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' HD12 ' A' ' 42' ' ' ILE . 52.9 m-85 -113.27 108.38 17.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.329 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.987 ' HB3' HG23 ' A' ' 10' ' ' VAL . 38.4 tt0 -96.27 88.1 4.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 9' ' ' VAL . 3.2 mt -81.43 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.185 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.7 m -108.4 106.48 16.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.935 170.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 39.1 p90 -121.22 146.14 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.829 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.4 tt0 -102.36 110.52 22.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.519 ' HB2' ' C ' ' A' ' 67' ' ' ALA . 20.7 m -72.8 115.36 12.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -80.68 -31.38 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.856 -171.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.144 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 34.8 mt-10 -145.28 168.24 20.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.759 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.4 p-10 -73.45 131.57 41.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 111.798 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.773 HD11 HD22 ' A' ' 38' ' ' LEU . 75.6 mt -83.15 159.21 22.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.497 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 p -112.25 -19.65 12.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.643 0.735 . . . . 0.0 109.215 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -136.97 -172.45 3.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.516 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.94 151.48 33.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.481 0.658 . . . . 0.0 110.761 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.855 HD21 HG21 ' A' ' 4' ' ' VAL . 4.6 tp -107.46 123.16 47.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 23.3 tt0 -106.03 135.58 47.23 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.868 -174.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.596 ' CE3' ' SG ' ' A' ' 99' ' ' CYS . 19.1 m95 -132.14 124.52 29.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.837 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.0 ttmp? -125.49 146.62 49.56 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.812 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.599 HD13 HG12 ' A' ' 97' ' ' ILE . 18.9 mm -102.75 106.87 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 87.6 mt -103.02 106.94 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.801 0.81 . . . . 0.0 109.886 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 79' ' ' PRO . 18.8 t80 -87.46 115.61 25.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.756 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG11 HD12 ' B' ' 126' ' ' LEU . 10.0 t -66.38 99.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 121.378 0.608 . . . . 0.0 109.712 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -57.91 -43.45 94.86 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.231 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.687 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 46.7 t -123.69 109.38 13.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' B' ' 126' ' ' LEU . . . -70.97 -5.66 32.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.419 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' HZ2' ' B' ' 122' ' ' LYS . 3.2 mt-10 -100.89 -22.09 14.92 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.163 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.52 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.9 m -116.07 -150.32 0.46 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.989 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' B' ' 129' ' ' ARG . 8.9 pt-20 -150.69 -33.28 0.17 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.767 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.78 2.57 5.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.389 0.614 . . . . 0.0 111.401 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.687 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 95.8 m-85 -94.58 4.28 54.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.53 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.53 110.17 0.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.012 0.91 . . . . 0.0 109.938 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 4.4 mt-30 -96.02 166.69 11.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.306 -176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.666 HG22 ' HD3' ' A' ' 41' ' ' LYS . 42.3 t -127.31 106.26 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.971 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.61 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 4.0 mt -75.16 -48.23 24.6 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.741 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -170.48 165.3 8.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.843 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 p -141.9 128.92 20.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.4 p -99.5 133.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.946 -173.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.36 105.13 14.67 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.733 0.777 . . . . 0.0 110.099 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 98.3 t -83.56 155.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.47 -163.19 37.08 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.826 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.666 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 61.1 Cg_endo -89.83 118.21 0.75 Allowed 'Trans proline' 0 N--CA 1.424 -2.565 0 C-N-CA 122.057 1.838 . . . . 0.0 110.284 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' H ' HD12 ' A' ' 34' ' ' LEU . 33.8 m -119.51 134.0 23.81 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.489 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.8 Cg_endo -79.13 83.51 2.25 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 113.453 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.519 ' C ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.04 -171.35 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.653 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.01 132.32 7.36 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 14.8 ttp180 -75.08 113.69 12.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.458 0.647 . . . . 0.0 110.286 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -111.39 129.1 56.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 ttp -106.66 111.84 24.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 168.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 4.8 p90 -126.13 141.09 52.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.739 0.781 . . . . 0.0 109.326 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 2.2 p -101.41 116.71 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.536 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -119.28 132.28 55.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.281 -168.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 44.6 mt-30 -125.15 160.45 29.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.699 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 57' ' ' LEU . . . -153.48 137.63 16.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.035 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 20.6 t70 -57.4 162.1 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -62.61 158.42 50.65 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 121.509 0.671 . . . . 0.0 111.526 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.727 ' HG2' ' CE1' ' A' ' 18' ' ' PHE . 28.9 Cg_endo -62.28 171.41 5.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.813 2.342 . . . . 0.0 111.702 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.87 115.28 62.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.603 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.56 -16.2 53.23 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.631 2.888 . . . . 0.0 112.816 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.84 -18.3 56.54 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.127 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 46.5 mt -91.9 -15.22 28.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.683 0.278 . . . . 0.0 111.385 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 17.1 mt -91.42 127.61 50.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.447 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.4 ' O ' HG22 ' A' ' 84' ' ' ILE . 98.5 Cg_endo -80.68 160.01 21.86 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.726 2.284 . . . . 0.0 111.81 171.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.728 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 6.5 m-20 -46.45 -50.02 17.45 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.419 0.687 . . . . 0.0 112.615 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.17 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.538 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.02 -19.63 21.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.929 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.9 -46.36 30.51 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.147 0.499 . . . . 0.0 111.635 -175.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.667 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -98.17 48.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.289 1.042 . . . . 0.0 110.492 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.58 -137.75 2.27 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.391 -161.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' B' ' 122' ' ' LYS . 9.8 p -130.46 145.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.714 0.769 . . . . 0.0 110.835 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.625 HG23 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -157.33 174.59 15.19 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.742 HG12 HD23 ' A' ' 96' ' ' LEU . 2.2 t -124.17 145.01 31.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.511 -0.475 . . . . 0.0 112.152 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.523 HG11 ' CZ ' ' A' ' 22' ' ' PHE . 27.7 m -116.78 105.17 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.792 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.57 136.27 41.7 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.922 -173.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.872 ' HB ' HG12 ' A' ' 109' ' ' VAL . 25.7 mt -95.79 103.14 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 108' ' ' ARG . 58.1 p -97.04 110.8 23.27 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.75 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.733 ' SG ' HG23 ' A' ' 107' ' ' ILE . 4.7 m -85.6 143.88 28.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.891 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -135.16 129.35 33.67 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -172.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 153' ' ' TRP . 84.3 t80 -135.84 118.1 15.59 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.78 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 29.2 mtp180 67.66 27.12 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.779 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.08 70.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.363 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -117.16 120.66 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.012 0.434 . . . . 0.0 110.354 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.2 mp0 -76.85 124.89 28.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CD2' HG22 ' A' ' 107' ' ' ILE . 34.3 p90 -110.37 -8.66 14.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -168.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.747 ' O ' ' HA ' ' A' ' 98' ' ' THR . 1.7 tt -158.89 162.4 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 119.443 1.02 . . . . 0.0 110.332 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.869 ' HG3' HG22 ' A' ' 98' ' ' THR . 14.1 ttm180 -146.53 105.59 3.88 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.872 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.2 p -95.22 100.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.235 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.76 80.99 1.78 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.878 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.888 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 9.6 m-85 -77.34 116.63 18.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.625 ' HE2' ' HA ' ' B' ' 123' ' ' ASP . 20.5 m-85 -68.0 133.11 48.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.446 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.625 HG13 HG23 ' A' ' 93' ' ' THR . 7.2 p -113.95 110.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.14 130.0 40.51 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.603 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 40.3 m-80 -111.14 113.45 25.98 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -171.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -123.96 124.87 43.54 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.519 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 17.0 m-85 -44.73 151.88 0.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.851 0.834 . . . . 0.0 112.658 173.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -92.43 -34.08 14.28 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.602 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.672 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 2.0 tm-20 -78.76 122.95 26.67 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.977 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 6.1 m -52.57 -34.94 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.465 -171.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.11 -35.65 66.6 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 43.2 mt -71.72 -27.76 63.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.483 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 17.9 mtt180 -73.07 -32.46 65.04 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.3 mm-40 -67.58 -38.68 84.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.917 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 21.6 p-10 -157.47 96.07 2.05 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 121.306 0.574 . . . . 0.0 110.57 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.5 Cg_endo -56.14 117.61 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.954 2.436 . . . . 0.0 111.368 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.79 153.51 43.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.128 1.885 . . . . 0.0 110.353 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.1 p -42.14 -41.01 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.851 0.72 . . . . 0.0 112.104 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -110.4 109.75 58.25 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 122.293 1.044 . . . . 0.0 113.334 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.728 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.6 Cg_exo -45.54 140.33 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.778 1 C-N-CA 125.54 4.16 . . . . 0.0 113.892 175.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.62 112.84 22.73 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.696 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 3.6 m-85 -77.98 -18.38 56.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.812 0.815 . . . . 0.0 110.847 -168.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -13.25 50.3 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.3 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.9 mmtt -104.09 12.67 33.73 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.7 tp -99.83 133.38 44.27 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.392 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.94 122.09 41.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.971 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.864 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.69 110.93 23.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.484 0.659 . . . . 0.0 111.501 -175.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.835 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 3.4 t30 -95.03 109.32 21.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.64 176.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -81.54 114.67 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.227 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.432 HD12 ' CB ' ' A' ' 112' ' ' TYR . 80.8 mt -69.78 85.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 110.772 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.888 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -72.13 -20.11 61.67 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.528 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.7 p -78.83 -8.55 58.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.767 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -135.07 69.34 70.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.016 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 77.2 Cg_endo -89.84 114.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.36 2.04 . . . . 0.0 111.608 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.543 ' CB ' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -82.21 81.76 7.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.202 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 109' ' ' VAL . 26.8 m -78.24 130.04 36.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.6 m -148.82 106.88 3.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.254 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -112.73 147.13 37.47 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.983 0.897 . . . . 0.0 110.705 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 170.41 11.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.45 -173.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.91 119.94 34.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.994 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 18.0 pt -120.26 -173.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.0 109.766 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 4.8 m-20 -108.2 91.6 3.71 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.437 -176.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.624 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 17.9 m95 -78.78 -13.51 59.77 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.303 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.441 -0.901 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.772 -173.248 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.604 ' C ' HD22 ' B' ' 126' ' ' LEU . 4.0 mptp? . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.625 ' HA ' ' HE2' ' A' ' 112' ' ' TYR . 1.2 p30 -37.73 -49.93 1.18 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 7.1 tp -65.2 -40.73 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 111.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.653 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 2.9 mm-40 -65.2 -35.78 82.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 110.648 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.604 HD22 ' C ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -64.03 -42.58 97.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.48 -33.03 73.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.96 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 10.4 mmm180 -54.59 -49.33 70.66 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.22 0.533 . . . . 0.0 110.006 173.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HD2' ' HB2' ' A' ' 51' ' ' GLU . 6.2 mmp_? -69.18 -30.63 68.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.135 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.649 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 56.7 mt -75.08 -15.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.049 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.582 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.761 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 2.7 mmtt -100.15 -7.1 25.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.532 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.3 t -139.57 123.24 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.329 0.585 . . . . 0.0 110.553 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp60 -117.0 100.5 7.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.834 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.3 m -79.64 135.73 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -117.16 -63.61 1.42 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.003 -164.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.593 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.0 t-20 -103.96 152.7 21.68 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.644 -174.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -146.89 100.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.037 HG23 ' HB2' ' A' ' 25' ' ' GLU . 1.0 OUTLIER -94.18 97.58 7.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.012 -177.132 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.563 HG13 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -73.62 132.91 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.158 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.113 HD12 ' HG2' ' A' ' 23' ' ' GLN . 7.0 mt -103.85 -65.04 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.384 -169.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.66 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -88.15 55.04 3.28 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.382 1.087 . . . . 0.0 111.748 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 1.091 ' HA ' HD13 ' A' ' 139' ' ' ILE . 27.0 p-10 -81.42 -176.21 0.74 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 161.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.853 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.3 Cg_endo -41.67 104.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 122.428 2.085 . . . . 0.0 114.95 -125.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.671 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.2 m -139.61 172.72 5.98 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 110.305 -3.134 . . . . 0.0 107.054 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 85.3 Cg_exo -41.26 136.56 2.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.139 1.893 . . . . 0.0 111.964 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.711 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 28.6 t80 -60.18 -27.27 66.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.158 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -78.71 -14.32 59.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.706 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -72.95 134.21 81.3 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 22.9 Cg_exo -71.81 146.18 47.51 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.738 2.959 . . . . 0.0 113.599 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.749 ' N ' HH12 ' A' ' 137' ' ' ARG . 62.4 m-85 -55.71 124.86 18.86 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.587 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 1.113 ' HG2' HD12 ' A' ' 12' ' ' LEU . 8.7 tt0 -125.56 100.28 6.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.455 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.661 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.9 m-85 -111.39 155.53 22.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.442 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.037 ' HB2' HG23 ' A' ' 10' ' ' VAL . 59.2 mt-10 -126.27 91.28 3.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 163.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.571 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 6.7 mt -83.72 127.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 122.065 0.936 . . . . 0.0 112.432 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.3 m -101.21 106.42 17.64 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.526 173.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.834 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 25.1 p90 -110.86 141.62 44.0 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.526 0.679 . . . . 0.0 109.913 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.6 tt0 -102.83 113.46 26.9 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.7 m -71.87 122.32 20.55 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -87.41 -23.94 6.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.639 -169.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.23 178.13 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.74 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.919 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 21.9 t70 -78.49 123.47 27.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.414 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.008 HD11 HD23 ' A' ' 38' ' ' LEU . 1.9 mt -81.34 154.96 26.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.033 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -111.81 -35.07 5.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.297 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.709 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 30.5 tt0 -116.47 -169.06 1.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.085 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.709 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -88.38 151.76 22.37 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.669 0.747 . . . . 0.0 109.666 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.008 HD23 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.74 123.32 42.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.651 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 18.5 tt0 -97.05 132.75 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.336 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.775 ' HB2' HG12 ' A' ' 60' ' ' VAL . 69.3 m95 -130.48 109.42 10.68 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.305 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.915 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 4.6 ptpp? -126.0 154.81 42.4 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.217 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 76' ' ' ALA . 37.0 mt -103.37 118.71 50.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.266 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 2.5 mp -102.46 105.97 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' HD1' ' CG1' ' A' ' 95' ' ' VAL . 76.7 t80 -83.6 114.33 21.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG11 HD12 ' B' ' 126' ' ' LEU . 4.1 t -62.11 98.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -35.37 40.58 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.746 ' HB2' ' C ' ' A' ' 50' ' ' SER . 6.7 p -99.21 88.49 3.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.708 -0.746 . . . . 0.0 112.321 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -90.5 -16.89 28.06 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 163.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -89.43 -42.69 11.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.238 -1.347 . . . . 0.0 109.566 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.746 ' C ' ' HB2' ' A' ' 47' ' ' SER . 57.7 m -106.64 -146.76 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -150.62 -4.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -95.62 3.05 54.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.745 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 6.7 m-30 -90.12 -15.46 31.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 119.169 -0.443 . . . . 0.0 111.419 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.6 p-10 -41.64 111.59 0.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.295 1.045 . . . . 0.0 111.564 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 53' ' ' TYR . 14.4 mt-30 -93.45 166.56 12.21 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.173 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG22 HG13 ' A' ' 43' ' ' ILE . 54.6 t -130.94 103.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.6 mm? -70.57 -37.22 73.94 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -171.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 24.8 t0 -177.5 154.11 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.01 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.915 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 97.6 p -130.07 110.32 11.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.775 HG12 ' HB2' ' A' ' 40' ' ' TRP . 11.7 p -99.2 139.84 20.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.895 -166.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 mt -108.22 103.68 12.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.547 0.689 . . . . 0.0 111.353 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 30.6 t -85.34 155.05 3.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.76 -164.57 40.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.654 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.706 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.6 Cg_endo -69.97 114.57 3.78 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.238 1.292 . . . . 0.0 109.967 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.64 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.3 m -108.85 119.33 49.33 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.036 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.919 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 70.7 Cg_endo -84.26 77.48 3.18 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.725 2.283 . . . . 0.0 113.654 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 51.39 169.15 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.796 -2.002 . . . . 0.0 112.554 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.32 123.0 3.22 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.072 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.903 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 11.2 ttt180 -74.76 122.33 23.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.499 0.666 . . . . 0.0 110.852 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.512 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.0 p80 -154.35 146.13 23.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.163 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.687 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 5.5 ttp -97.78 130.2 44.74 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.213 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.3 p90 -112.26 153.44 27.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.65 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.7 p -111.16 132.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.845 0.831 . . . . 0.0 110.224 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.661 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -117.13 130.94 56.95 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.933 -165.001 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.731 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.7 mt-30 -141.6 153.78 45.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -164.51 157.85 17.61 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.526 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.71 -177.22 0.22 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.683 0.754 . . . . 0.0 112.56 -172.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -89.7 147.77 38.46 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.868 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.8 Cg_exo -55.43 154.99 22.08 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 123.521 2.814 . . . . 0.0 113.106 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -77.91 118.42 72.04 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.403 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.43 -13.73 41.31 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.523 2.816 . . . . 0.0 112.778 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.62 -4.93 57.94 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.898 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.79 -25.5 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.55 0.214 . . . . 0.0 110.769 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 85' ' ' PRO . 41.1 mt -84.66 130.3 53.73 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.919 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 84' ' ' ILE . 62.6 Cg_endo -80.11 164.62 22.11 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.36 2.706 . . . . 0.0 112.359 170.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.69 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 7.5 t70 -43.94 -58.04 3.0 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.669 1.187 . . . . 0.0 113.768 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -8.11 59.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.133 -165.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 56.5 m-20 -94.44 -22.37 18.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.681 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HB2' ' CG2' ' A' ' 84' ' ' ILE . . . -85.64 -47.16 10.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.629 -176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -101.34 46.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.814 0.816 . . . . 0.0 111.049 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.89 -157.68 8.57 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.48 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' B' ' 122' ' ' LYS . 10.0 p -97.36 144.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.67 0.748 . . . . 0.0 109.533 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.62 171.6 19.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -171.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -133.68 146.68 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.787 0.722 . . . . 0.0 111.944 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 22' ' ' PHE . 27.2 m -121.8 106.31 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.926 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -102.17 125.01 48.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.127 -173.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 50.4 mt -96.0 101.94 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 45.2 p -98.67 117.0 32.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.38 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 62.4 m -80.66 152.46 28.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.612 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 11.7 m -145.56 119.02 9.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.706 ' HB3' HD11 ' A' ' 151' ' ' ILE . 35.1 t80 -135.43 128.75 32.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 4.5 mmp_? 67.0 12.84 9.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.416 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.48 1.14 57.88 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.825 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -116.6 150.3 38.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 17.2 mp0 -99.72 134.41 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.847 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.793 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 52.4 p90 -120.01 -2.94 10.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -170.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.814 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.5 tt -156.75 159.92 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.834 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 17.7 ttp180 -151.6 99.94 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.845 0.716 . . . . 0.0 109.306 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.926 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.4 p -85.44 101.49 9.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.258 175.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.79 78.08 2.04 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.722 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.973 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -73.7 114.2 11.7 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.455 -0.872 . . . . 0.0 109.015 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.525 ' HA ' HG22 ' A' ' 94' ' ' VAL . 23.5 m-85 -67.72 126.39 29.24 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.532 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.442 HG11 ' HE1' ' A' ' 44' ' ' TYR . 7.5 p -111.49 111.23 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 26.3 t-20 -92.87 117.74 30.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.472 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.487 ' HB3' HD11 ' A' ' 135' ' ' LEU . 22.6 m120 -109.5 108.65 19.21 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.81 0.814 . . . . 0.0 109.883 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -137.48 139.24 40.45 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.33 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.689 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 62.0 m-85 -46.76 152.42 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -174.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.403 HG22 ' HG3' ' A' ' 136' ' ' GLN . 30.3 p -91.27 -38.29 12.76 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.063 -1.426 . . . . 0.0 108.846 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.918 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -78.25 125.49 29.43 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.062 -174.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.591 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 4.9 m -47.76 -43.11 27.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.824 0.702 . . . . 0.0 111.697 -168.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.19 -35.88 82.46 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.627 0.727 . . . . 0.0 110.266 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 56.3 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.44 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 7.2 mtt180 -74.54 -37.33 63.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.8 mm-40 -63.6 -43.43 96.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.705 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.3 p30 -144.35 82.03 10.91 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.11 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.2 Cg_endo -50.19 116.87 2.71 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.491 2.794 . . . . 0.0 112.326 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.689 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 69.0 Cg_exo -54.54 137.64 73.33 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.713 2.276 . . . . 0.0 111.088 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.618 HG12 ' HE2' ' A' ' 129' ' ' LYS . 36.7 t -50.04 -40.36 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.987 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.618 ' HE2' HG12 ' A' ' 128' ' ' VAL . 2.0 mmpt? -103.35 136.51 19.21 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 111.121 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.69 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -64.39 131.27 29.39 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.749 2.966 . . . . 0.0 113.022 -175.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 23.7 t70 -114.21 114.34 25.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 171.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.711 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 20.6 m-85 -79.22 -15.45 58.01 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.847 -169.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 -28.18 26.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.521 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.918 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 69.7 mmtt -101.68 10.93 39.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 115' ' ' ASN . 27.0 tp -89.23 138.54 31.34 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.516 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.403 ' HG3' HG22 ' A' ' 118' ' ' THR . 9.1 tt0 -113.45 123.03 49.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.853 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -93.02 106.74 18.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.249 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.5 t30 -92.23 105.88 18.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.946 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.091 HD13 ' HA ' ' A' ' 14' ' ' ASN . 1.1 mp -80.66 107.18 12.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.433 HD12 ' CB ' ' A' ' 112' ' ' TYR . 85.9 mt -67.81 84.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.968 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.973 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -73.05 -12.81 61.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.673 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 -9.51 59.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.906 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.49 70.47 76.5 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.783 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 72.1 Cg_endo -89.28 105.02 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.543 1.496 . . . . 0.0 110.404 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' HB3' HG21 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -83.67 81.06 8.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.306 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 146' ' ' VAL . 6.7 m -77.06 104.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 0.0 111.261 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.468 HG21 HH21 ' A' ' 108' ' ' ARG . 26.5 m -109.4 105.05 14.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.742 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -116.78 133.3 56.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.531 0.681 . . . . 0.0 110.533 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HD1' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.34 167.79 11.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.913 -175.132 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.58 123.14 47.01 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 101' ' ' TYR . 45.1 pt -119.26 -174.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.505 0.669 . . . . 0.0 109.873 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 3.9 m-20 -90.73 105.71 18.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.032 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.761 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 11.8 m95 -86.47 2.41 47.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.435 -1.203 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.78 176.751 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.7 ' O ' HD22 ' B' ' 126' ' ' LEU . 27.4 mmtp . . . . . 0 CA--C 1.518 -0.262 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -36.66 -51.76 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.7 0.625 . . . . 0.0 112.292 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.7 -40.62 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.618 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 5.5 mm100 -54.6 -51.08 66.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 174.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.7 HD22 ' O ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -65.28 -43.99 89.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.989 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.64 -37.47 81.61 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.304 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -61.39 -39.12 89.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.5 mmt180 -73.09 -28.39 62.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.084 0.468 . . . . 0.0 110.003 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.834 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 31.1 mt -82.76 -8.5 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.723 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.458 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.775 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.62 -20.92 21.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.266 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.621 HG23 HD21 ' A' ' 34' ' ' LEU . 4.3 t -140.71 130.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 111.396 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 3.5 tp-100 -123.72 99.71 6.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.656 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -75.87 142.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.073 177.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -127.21 -71.84 0.66 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.263 -163.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -105.42 100.75 10.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.519 -171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.472 HG13 ' OH ' ' A' ' 111' ' ' TYR . 2.4 p -100.45 105.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.826 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.5 m -99.33 98.27 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.917 0.865 . . . . 0.0 109.435 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 132.58 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.111 -176.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.01 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -101.65 -40.07 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.048 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 37.1 t0 -67.05 64.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.73 165.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.904 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 48.6 m-20 -83.06 172.95 8.29 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.121 -1.854 . . . . 0.0 108.148 160.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.904 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.4 Cg_endo -50.88 102.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.374 1.383 . . . . 0.0 113.181 -153.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.593 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 17.9 m -132.02 170.96 9.98 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.815 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 68.7 Cg_exo -42.44 140.86 2.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.416 2.077 . . . . 0.0 111.768 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.722 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 6.3 t80 -59.6 -32.12 70.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.043 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -81.68 -9.75 59.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.0 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -63.0 126.23 88.5 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 26.0 Cg_exo -68.25 146.1 68.44 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 123.347 2.698 . . . . 0.0 112.845 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.792 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 87.1 m-85 -52.04 135.72 30.56 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.178 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 1.01 ' HG2' HD12 ' A' ' 12' ' ' LEU . 6.6 tt0 -140.42 84.93 1.98 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.451 -171.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.734 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 96.6 m-85 -100.08 149.76 23.16 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.68 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.826 ' HB3' HG23 ' A' ' 10' ' ' VAL . 32.9 tt0 -124.62 87.43 2.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.619 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 26.8 mt -88.75 125.49 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.697 0.76 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 21.5 m -103.39 110.68 22.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.467 172.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.733 ' HE2' HG21 ' A' ' 65' ' ' VAL . 31.8 p90 -112.75 145.29 40.8 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.895 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.5 tt0 -101.68 114.05 27.75 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 53.2 t -72.35 114.85 10.92 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -81.32 -25.14 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.411 -173.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.775 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.3 mt-10 -153.84 143.56 21.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -55.98 129.97 41.94 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.592 0.558 . . . . 0.0 110.866 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.896 ' HG ' HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -85.1 163.75 18.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.586 0.708 . . . . 0.0 112.365 -169.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 t -113.17 -40.71 3.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.206 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.46 -167.74 1.66 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.311 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 6.4 m-20 -89.84 135.57 33.56 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.236 1.017 . . . . 0.0 109.295 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.896 HD21 ' HG ' ' A' ' 34' ' ' LEU . 3.9 mm? -79.07 143.56 35.46 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.892 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 33.3 tt0 -116.12 135.61 53.77 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.673 173.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.646 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.7 m95 -123.39 125.76 45.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.759 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.6 ttmt -123.35 143.05 50.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.374 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.489 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.7 mt -103.49 108.34 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.358 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.759 HD11 ' HD2' ' A' ' 41' ' ' LYS . 3.8 mp -107.06 109.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.5 0.667 . . . . 0.0 109.427 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.78 ' CD2' ' HG3' ' A' ' 79' ' ' PRO . 22.9 t80 -89.9 109.59 20.6 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.214 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 93' ' ' THR . 25.3 t -69.71 96.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -72.63 -32.54 61.57 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.202 -1.475 . . . . 0.0 109.965 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.789 ' HB2' ' C ' ' A' ' 50' ' ' SER . 4.1 p -88.55 75.93 8.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.4 59.0 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 161.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -100.27 -45.69 5.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.331 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.789 ' C ' ' HB2' ' A' ' 47' ' ' SER . 49.4 m -103.42 -147.32 0.38 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.79 9.07 0.45 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.111 0.481 . . . . 0.0 110.476 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.19 -8.8 26.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.528 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.637 ' HB2' ' N ' ' A' ' 47' ' ' SER . 29.8 m-85 -95.8 1.9 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -168.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.32 104.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.026 0.917 . . . . 0.0 110.875 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.526 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 46.7 mt-30 -95.6 164.12 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.485 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 43' ' ' ILE . 49.5 t -131.07 112.21 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.639 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 mm? -82.29 -55.32 4.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.052 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.65 153.42 30.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.72 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 26.2 p -133.44 109.86 9.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -97.99 135.4 32.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.922 -169.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.8 mt -105.25 103.23 12.73 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.201 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.71 131.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.45 -159.51 11.26 Favored Glycine 0 CA--C 1.494 -1.248 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.998 -164.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.692 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 37.1 Cg_endo -63.71 114.78 2.71 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.733 HG21 ' HE2' ' A' ' 28' ' ' PHE . 35.1 m -110.71 145.36 32.17 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.85 -174.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 136.86 26.69 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.701 2.267 . . . . 0.0 111.448 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -46.76 139.28 5.46 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 111.28 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.84 135.1 3.91 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -174.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.895 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.2 ptt180 -76.65 130.4 37.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.432 1.111 . . . . 0.0 111.062 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -149.98 143.61 25.31 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.038 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.648 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.2 OUTLIER -93.02 146.44 23.62 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.566 0.698 . . . . 0.0 112.537 -174.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.56 ' N ' ' HG2' ' A' ' 71' ' ' MET . 3.0 p90 -133.6 160.74 36.6 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 1.7 p -118.75 139.32 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 121.734 0.778 . . . . 0.0 111.091 -172.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.734 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -121.96 125.87 47.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.95 -166.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.792 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.2 mt-30 -144.19 148.23 34.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.989 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.02 128.62 0.73 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.569 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.608 ' O ' HD12 ' A' ' 57' ' ' LEU . 6.0 p-10 -62.12 165.11 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.646 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.532 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -59.01 160.73 10.51 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -170.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.78 ' HG3' ' CD2' ' A' ' 44' ' ' TYR . 60.5 Cg_endo -67.67 178.67 3.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.75 2.967 . . . . 0.0 111.673 175.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 91.6 m-20 -72.13 119.45 74.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.249 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -64.07 -19.58 66.45 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.347 2.698 . . . . 0.0 111.756 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.19 -9.1 77.24 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.361 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.526 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 5.7 mt -94.1 -25.36 17.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.993 0.396 . . . . 0.0 110.91 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 21.2 mt -78.7 127.84 79.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.797 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 96.3 Cg_endo -78.21 163.23 27.93 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.396 2.73 . . . . 0.0 112.231 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.676 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 15.2 t70 -44.53 -57.06 3.83 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.32 1.048 . . . . 0.0 113.614 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' B' ' 122' ' ' LYS . . . -74.22 -20.88 60.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.776 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.87 -33.82 22.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.356 0.598 . . . . 0.0 109.658 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -77.2 -42.51 37.24 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.752 -171.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.4 m -103.08 47.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.634 0.73 . . . . 0.0 112.075 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -119.98 0.55 Allowed Glycine 0 CA--C 1.504 -0.601 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.15 -169.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.88 141.15 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 1.01 ' HB ' HG13 ' A' ' 113' ' ' VAL . 24.2 m -143.08 167.96 20.86 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 112' ' ' TYR . 3.2 t -134.42 139.08 48.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 170.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 111' ' ' TYR . 1.8 p -119.82 104.97 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.2 pp -101.27 131.51 47.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.385 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.737 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.2 mt -99.42 92.68 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.79 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 73.1 p -91.09 112.99 25.13 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 89.7 m -76.69 156.29 32.66 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.008 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.0 m -150.96 108.66 3.67 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -170.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.685 ' CZ ' HD12 ' A' ' 34' ' ' LEU . 79.5 t80 -126.76 132.77 50.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.3 mmm180 67.22 12.56 9.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.493 0.496 . . . . 0.0 111.998 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.6 56.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.118 174.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.803 ' CG ' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.2 149.17 43.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.124 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 23.8 mp0 -95.66 134.59 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.069 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 99' ' ' CYS . 53.4 p90 -120.52 -3.76 9.86 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -170.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.828 ' O ' ' HA ' ' A' ' 98' ' ' THR . 10.6 tt -155.48 161.21 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 O-C-N 121.209 -0.932 . . . . 0.0 109.058 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.834 HH21 HG21 ' A' ' 147' ' ' THR . 0.4 OUTLIER -153.91 99.47 2.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.927 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.3 p -87.16 101.79 11.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.088 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -86.8 86.52 1.55 Allowed Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 118.943 -1.598 . . . . 0.0 111.129 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.884 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.6 m-85 -73.91 115.2 13.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.276 -0.962 . . . . 0.0 109.538 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 140' ' ' LEU . 3.3 m-85 -67.06 112.94 4.66 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.479 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.01 HG13 ' HB ' ' A' ' 93' ' ' THR . 2.4 p -104.31 111.31 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -96.5 113.65 25.24 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.852 -173.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.8 m-20 -94.65 109.15 21.11 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.48 0.657 . . . . 0.0 109.415 -170.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.47 124.41 40.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.828 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.607 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 42.9 m-85 -39.39 149.43 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 136' ' ' GLN . 29.8 p -87.58 -32.82 19.14 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.544 -174.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.2 mt-10 -87.78 126.39 34.98 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.262 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.596 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 22.0 m -56.27 -31.22 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.164 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.64 -37.89 76.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.595 0.712 . . . . 0.0 110.008 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 45.2 mt -71.29 -25.41 62.43 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.329 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -73.81 -36.94 65.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.598 0.713 . . . . 0.0 109.136 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.6 mm-40 -66.82 -36.78 83.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.982 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -143.42 87.99 8.19 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.679 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 115.04 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.664 2.243 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.607 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 89.2 Cg_exo -51.06 163.77 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.847 2.364 . . . . 0.0 111.783 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 129' ' ' LYS . 40.5 t -51.87 -52.17 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.166 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.559 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 1.7 mmtt -116.96 121.24 32.89 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 121.435 0.636 . . . . 0.0 110.928 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.676 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 16.3 Cg_exo -35.32 131.73 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 1 C-N-CA 125.778 4.319 . . . . 0.0 114.34 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 117' ' ' TYR . 17.0 t70 -105.42 109.27 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.71 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 40.2 m-85 -75.32 -17.26 60.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.94 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -84.2 -25.43 29.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.262 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 72.8 mmtt -95.51 6.16 49.69 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 115' ' ' ASN . 31.1 tp -92.36 127.84 37.99 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.578 -173.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.492 ' HB2' HG22 ' A' ' 118' ' ' THR . 4.6 tt0 -111.6 114.46 27.53 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.782 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.9 ptt180 -90.46 111.44 22.71 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.413 0.625 . . . . 0.0 111.05 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 19.7 t30 -87.89 98.06 11.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.105 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.539 HG21 HG11 ' A' ' 11' ' ' VAL . 2.2 mp -73.43 101.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 112' ' ' TYR . 76.7 mt -63.0 89.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.325 0.583 . . . . 0.0 110.792 -176.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.884 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -77.83 -9.71 59.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.96 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 5.7 p -79.55 -15.6 57.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 172.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.422 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 47.3 t-20 -128.29 66.69 73.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.94 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 142' ' ' SER . 4.5 Cg_exo -83.05 105.01 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.03 1.82 . . . . 0.0 110.616 170.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -83.7 81.32 8.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.46 ' CG1' HG23 ' A' ' 109' ' ' VAL . 7.2 m -79.28 106.68 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.543 . . . . 0.0 111.722 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.834 HG21 HH21 ' A' ' 108' ' ' ARG . 42.0 m -110.45 105.34 14.29 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -113.13 123.82 51.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.597 0.713 . . . . 0.0 110.396 -175.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.02 168.24 9.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.728 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.11 111.92 24.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.803 ' HB ' ' CG ' ' A' ' 104' ' ' GLN . 18.3 pt -118.13 172.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.893 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 154' ' ' GLU . 5.7 p-10 -101.98 97.67 7.98 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.595 1.188 . . . . 0.0 109.903 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.488 ' HA ' ' CD2' ' A' ' 101' ' ' TYR . 13.1 m95 -67.98 0.82 3.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.732 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 152' ' ' ASN . 34.6 mt-10 . . . . . 0 N--CA 1.437 -1.102 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.584 -173.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.6 ' HE2' ' HB1' ' A' ' 87' ' ' ALA . 12.9 mptt . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -37.11 -53.07 1.02 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 tp -70.9 -29.08 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' B' ' 129' ' ' ARG . 71.9 mm-40 -65.69 -50.99 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.469 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.593 ' O ' HG13 ' B' ' 130' ' ' ILE . 2.5 mm? -63.82 -40.59 96.97 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.3 ptm180 -67.94 -25.87 65.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 15.7 mmm180 -80.08 -28.04 39.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.638 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 65.2 mt -76.77 1.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.088 0.947 . . . . 0.0 109.263 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 6.6 tpt180 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.212 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.783 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.869 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.5 mptp? -101.17 -21.34 14.97 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -168.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 38' ' ' LEU . 6.5 t -148.81 145.54 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.095 ' HG2' HD11 ' A' ' 31' ' ' ILE . 20.2 mm-40 -143.58 121.16 11.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.18 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.958 HG22 HD13 ' A' ' 107' ' ' ILE . 35.7 m -79.62 117.34 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 117.583 -1.647 . . . . 0.0 109.274 171.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.54 -73.38 0.46 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.522 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -107.21 109.94 21.87 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.942 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.1 p -96.13 99.92 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.415 0.626 . . . . 0.0 109.352 169.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.985 HG23 ' HB3' ' A' ' 25' ' ' GLU . 4.1 m -91.19 98.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.829 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -76.43 129.67 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.471 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -99.59 -36.89 9.37 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.979 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.992 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 11.3 t70 -63.33 39.88 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.656 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.807 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.1 m-20 -79.73 171.54 12.17 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.847 171.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.831 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.8 Cg_endo -52.65 103.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.5 1.466 . . . . 0.0 114.003 -146.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.567 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 14.9 m -133.37 169.77 13.09 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 112.863 -1.972 . . . . 0.0 109.183 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.1 Cg_exo -39.54 131.61 1.71 Allowed 'Trans proline' 0 C--O 1.21 -0.875 0 C-N-CA 122.943 2.429 . . . . 0.0 111.744 171.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.91 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 17.2 t80 -58.38 -17.86 23.46 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 133' ' ' SER . 7.1 m-30 -83.43 -3.99 58.08 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.781 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 33.0 p-10 -61.13 143.96 91.69 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 165.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.679 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 11.9 Cg_exo -83.37 135.99 7.44 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.643 2.229 . . . . 0.0 111.443 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.778 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 40.8 m-85 -50.49 113.38 0.87 Allowed 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 122.965 0.506 . . . . 0.0 111.351 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.992 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 24.4 mt-30 -112.65 103.82 11.87 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.315 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.603 ' CD1' HD11 ' A' ' 97' ' ' ILE . 91.2 m-85 -108.51 149.79 28.34 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.985 ' HB3' HG23 ' A' ' 10' ' ' VAL . 40.7 tt0 -123.54 87.35 2.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 168.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.449 HG21 HG11 ' A' ' 6' ' ' VAL . 15.9 mt -79.97 137.06 22.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.499 -173.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 58.6 m -115.52 104.7 11.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.619 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.921 ' HB3' HG12 ' A' ' 6' ' ' VAL . 28.2 p90 -106.47 146.78 30.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.659 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.5 tt0 -100.2 114.57 28.09 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.721 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 10.0 m -71.85 101.48 2.64 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.095 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.3 mt -64.71 -34.09 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.263 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 35.1 mt-10 -142.92 179.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.338 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.79 128.58 35.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.959 0.409 . . . . 0.0 110.204 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.836 HD12 ' CE2' ' A' ' 101' ' ' TYR . 4.0 mm? -88.54 149.03 23.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.985 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.1 p -114.92 -37.22 4.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.978 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.3 tt0 -105.97 -171.34 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.743 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 30.7 m-20 -100.52 142.61 31.76 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.507 0.67 . . . . 0.0 110.62 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -81.47 119.61 23.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.059 173.041 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.754 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.2 tt0 -102.57 88.04 3.14 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.802 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.825 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 61.7 m95 -80.76 119.75 23.75 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.774 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 11.6 ttmt -126.47 139.58 53.13 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.303 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.671 HG22 HG22 ' A' ' 95' ' ' VAL . 13.2 mt -103.22 109.21 26.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.759 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.2 mp -107.43 106.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.953 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.768 ' CE1' HG11 ' A' ' 113' ' ' VAL . 61.8 t80 -86.36 119.25 26.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.438 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.61 101.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.298 0.571 . . . . 0.0 109.625 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.23 88.79 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.523 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 41.2 t -128.79 128.16 43.41 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.766 0.793 . . . . 0.0 110.129 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -85.13 -2.59 58.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.232 170.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.76 -38.32 11.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.847 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.575 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 49.6 m -134.85 121.1 20.15 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.476 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.67 ' HB3' ' OE1' ' B' ' 125' ' ' GLN . 10.3 pt-20 -64.7 -14.11 57.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.269 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.69 1.77 11.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.61 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 89.9 m-85 -105.16 -0.81 26.19 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 31.6 p-10 -53.08 110.61 0.55 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.244 1.021 . . . . 0.0 111.488 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 4.4 mt-30 -92.58 170.01 10.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.426 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 43' ' ' ILE . 54.8 t -130.84 107.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.888 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' N ' HD22 ' A' ' 57' ' ' LEU . 3.7 mm? -76.08 -41.2 51.2 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.362 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -176.46 170.93 2.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 45.5 p -145.63 118.05 8.49 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -100.03 134.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.715 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.6 mt -108.91 104.04 13.2 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 9.0 t -119.7 107.44 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.714 ' CA ' ' HA ' ' A' ' 37' ' ' ASP . . . -102.3 -104.08 2.78 Favored Glycine 0 CA--C 1.475 -2.469 0 C-N-CA 118.831 -1.652 . . . . 0.0 112.926 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.48 113.45 0.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.127 1.884 . . . . 0.0 111.625 176.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 63' ' ' GLY . 30.3 m -141.9 122.68 8.55 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.871 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.07 130.48 22.95 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.184 1.923 . . . . 0.0 110.495 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.721 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.94 133.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.936 0.773 . . . . 0.0 112.117 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 151.64 117.12 0.74 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -173.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.932 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 24.2 ttt180 -66.21 111.87 3.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.772 0.796 . . . . 0.0 110.816 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.7 p80 -145.67 160.81 41.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.87 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.667 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.97 141.64 46.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.515 0.674 . . . . 0.0 112.615 -174.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.627 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.2 p90 -131.69 160.21 36.11 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.8 p -119.24 138.22 50.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.695 0.76 . . . . 0.0 110.278 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.627 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -139.93 121.15 14.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.365 -160.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.778 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -137.81 157.55 46.2 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.97 159.28 26.34 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.82 179.14 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.887 0.851 . . . . 0.0 112.824 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -82.05 151.45 66.85 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.448 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.65 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 65.8 Cg_exo -53.79 153.6 19.06 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 123.995 3.13 . . . . 0.0 113.515 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.438 ' HB2' HD12 ' A' ' 83' ' ' LEU . 17.3 m120 -71.63 113.58 20.99 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.24 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -65.71 -21.28 58.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.891 2.394 . . . . 0.0 111.623 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 5.0 83.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.219 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.474 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 35.1 mt -113.38 -20.34 11.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.561 0.22 . . . . 0.0 111.213 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.572 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 30.2 mt -84.62 129.51 56.9 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 1.2 Cg_endo -80.06 159.36 23.83 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.914 2.409 . . . . 0.0 112.128 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.762 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 4.7 m-20 -47.31 -50.19 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.444 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.27 69.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -169.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.555 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 44.0 m-20 -93.94 -17.99 22.39 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -172.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.29 -47.49 23.53 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-O 121.173 0.511 . . . . 0.0 111.824 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -92.39 47.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.282 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.67 -122.58 0.68 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.789 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.51 141.23 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 121.746 0.784 . . . . 0.0 112.456 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.93 168.38 24.7 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.132 173.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.491 HG11 HD11 ' B' ' 130' ' ' ILE . 3.4 t -124.81 147.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.832 174.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.671 HG22 HG22 ' A' ' 42' ' ' ILE . 9.6 p -129.7 107.3 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -103.01 135.43 44.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.272 -169.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.774 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 59.9 mt -102.18 93.07 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.803 0.811 . . . . 0.0 109.149 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 108' ' ' ARG . 51.9 p -93.96 114.93 27.23 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.592 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.954 ' SG ' HG22 ' A' ' 107' ' ' ILE . 7.0 p -84.82 137.32 33.24 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.947 175.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 51.9 m -118.8 114.94 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.255 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.836 ' CE2' HD12 ' A' ' 34' ' ' LEU . 45.3 t80 -127.32 126.3 42.34 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 102' ' ' ARG . 1.8 mmp_? 69.14 14.53 8.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.464 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.15 4.1 69.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -125.73 132.25 52.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.559 -0.82 . . . . 0.0 109.543 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.2 mp0 -76.26 142.06 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.009 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.737 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 2.8 p90 -115.68 -18.59 10.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.958 HD13 HG22 ' A' ' 6' ' ' VAL . 10.3 tt -159.7 156.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.682 HH21 HG21 ' A' ' 147' ' ' THR . 10.6 ttp180 -145.38 124.85 13.13 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -101.4 102.2 13.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 122.158 0.98 . . . . 0.0 109.758 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.55 79.98 1.84 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.239 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.854 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 7.3 m-85 -79.72 123.13 27.39 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.566 ' CE2' HD23 ' B' ' 126' ' ' LEU . 5.8 m-85 -67.38 129.98 41.6 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.768 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.2 p -108.93 110.9 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -96.72 121.17 38.28 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.21 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.691 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.4 m-80 -110.57 110.81 21.67 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.993 0.901 . . . . 0.0 109.017 -171.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -125.81 125.08 42.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.617 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.632 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 18.9 m-85 -39.97 146.61 0.11 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -85.49 -33.77 21.76 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.202 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -88.76 125.93 35.1 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.487 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -59.78 -28.21 67.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.789 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.14 -39.78 94.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.8 0.81 . . . . 0.0 109.614 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 77.6 mt -72.72 -27.87 62.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.713 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 43.3 mtp180 -76.4 -29.34 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.404 0.621 . . . . 0.0 109.412 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.31 -41.68 84.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.136 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -145.62 80.39 10.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.66 113.07 1.07 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.313 2.676 . . . . 0.0 112.455 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.632 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 52.7 Cg_exo -57.19 134.94 67.43 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.758 2.305 . . . . 0.0 110.702 174.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.527 HG13 ' HE2' ' A' ' 129' ' ' LYS . 3.4 p -56.02 -38.27 52.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.184 -171.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.527 ' HE2' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -91.09 107.72 23.15 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-O 121.088 0.471 . . . . 0.0 110.444 169.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.762 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 35.6 Cg_exo -45.93 140.18 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.593 3.529 . . . . 0.0 113.366 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.5 t0 -110.44 107.27 16.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.648 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 38.2 m-85 -77.48 -20.0 55.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.996 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 64.7 p -85.88 -21.55 27.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.483 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.3 mmtt -102.79 17.12 24.66 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.0 tp -99.62 132.32 45.03 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.015 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.36 118.11 31.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.91 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -93.37 105.38 17.45 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.28 0.562 . . . . 0.0 111.257 -177.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 12.6 t30 -85.55 98.18 10.48 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.461 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.754 HG21 HG11 ' A' ' 11' ' ' VAL . 1.5 mp -70.66 107.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.08 86.29 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.578 0.704 . . . . 0.0 110.446 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -76.49 -11.29 59.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.729 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.7 t -88.24 6.18 38.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.928 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.437 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 33.6 t-20 -139.16 64.92 34.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 1.8 Cg_endo -84.37 105.61 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.33 2.02 . . . . 0.0 111.264 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.517 ' HB3' HD13 ' B' ' 130' ' ' ILE . 5.5 tpt180 -84.24 85.4 7.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 3.3 p -87.63 110.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.894 -174.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.682 HG21 HH21 ' A' ' 108' ' ' ARG . 90.2 m -112.05 107.69 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.814 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.0 ptt180 -105.39 135.82 46.07 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.422 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -110.26 170.59 7.98 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.843 -174.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -104.96 120.17 40.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.683 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.63 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 40.5 pt -132.38 155.84 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.056 0.455 . . . . 0.0 110.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.17 94.51 7.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.136 0.97 . . . . 0.0 110.686 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.869 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 9.8 m95 -69.34 -4.33 17.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.956 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.431 -1.402 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.465 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.503 ' C ' HD22 ' B' ' 126' ' ' LEU . 3.3 mptp? . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -50.56 -32.95 20.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.139 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.43 HG23 ' N ' ' B' ' 125' ' ' GLN . 7.9 tp -69.37 -40.77 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 122.062 0.934 . . . . 0.0 109.576 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.68 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 6.6 tp-100 -71.69 -47.0 57.04 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.791 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.566 HD23 ' CE2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -59.94 -44.96 94.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.186 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.15 -44.93 94.59 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.054 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -53.98 -45.7 71.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.489 ' HB3' HD21 ' A' ' 96' ' ' LEU . 2.0 mmp_? -69.01 -45.84 69.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.374 -176.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 14.9 mt -75.11 -30.08 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.441 . . . . 0.0 111.546 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 . . . . . 0 C--N 1.315 -0.909 0 CA-C-O 121.611 0.72 . . . . 0.0 109.388 176.674 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.546 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.67 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 11.9 mmtt -100.64 -11.64 19.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.282 -175.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.71 122.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 0.0 110.772 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.2 tp60 -121.3 100.18 6.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.742 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.1 m -79.45 140.17 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.306 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -120.13 -61.5 1.59 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.592 -164.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.681 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 65.4 t30 -104.61 152.3 22.61 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.735 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 2.6 p -147.08 99.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.843 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.0 m -93.18 97.71 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.332 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 128.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.049 -178.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.934 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -98.59 -41.1 7.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.766 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.603 ' HB2' ' CB ' ' A' ' 23' ' ' GLN . 23.9 t0 -63.82 76.78 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.981 167.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.445 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t30 -96.6 174.28 3.47 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.825 169.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.8 Cg_endo -51.71 104.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.797 1.665 . . . . 0.0 113.834 -157.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 37.3 m -135.01 171.03 9.69 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.46 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 89.8 Cg_exo -42.16 138.56 2.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.559 2.172 . . . . 0.0 112.148 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.834 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 28.2 t80 -55.83 -29.32 59.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.156 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.23 -19.69 53.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -62.02 132.47 93.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.2 Cg_exo -72.65 154.16 54.53 Favored 'Trans proline' 0 C--N 1.329 -0.467 0 C-N-CA 123.71 2.94 . . . . 0.0 113.577 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 78.2 m-85 -62.97 133.94 55.4 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.934 ' HG2' HD12 ' A' ' 12' ' ' LEU . 37.4 tt0 -136.68 83.05 1.98 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.633 -170.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.738 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 97.3 m-85 -97.05 153.98 17.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.125 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.843 ' HB3' HG23 ' A' ' 10' ' ' VAL . 36.7 tt0 -132.34 87.66 2.45 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 14.6 mt -88.11 122.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.706 0.765 . . . . 0.0 112.738 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.802 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 13.2 m -91.73 107.34 19.14 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.467 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.742 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 23.2 p90 -119.19 148.11 43.47 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.93 0.871 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.83 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 48.6 tt0 -103.45 114.93 29.59 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.39 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 5.0 t -73.36 107.08 5.46 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 171.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -74.98 -22.46 17.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.773 -173.058 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.67 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 1.5 mt-10 -154.87 167.1 31.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.985 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.32 143.68 55.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.79 0.329 . . . . 0.0 110.549 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.783 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 15.1 mt -95.21 152.67 18.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.091 0.472 . . . . 0.0 111.504 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.3 t -113.13 -35.56 5.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.666 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.795 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.0 tt0 -110.36 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.795 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 39.6 m-20 -98.29 141.6 30.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.573 0.701 . . . . 0.0 110.02 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.39 118.35 23.13 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.28 176.155 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.5 tt0 -105.72 90.13 3.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.86 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.604 ' CH2' HG11 ' A' ' 6' ' ' VAL . 16.5 m95 -78.58 153.28 31.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.838 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.9 ttmp? -153.31 140.59 19.55 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.213 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.13 115.32 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.842 HG12 HG12 ' A' ' 56' ' ' VAL . 88.0 mt -112.29 108.19 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.768 0.794 . . . . 0.0 109.855 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.649 ' CZ ' HG21 ' A' ' 93' ' ' THR . 76.7 t80 -88.18 130.91 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.084 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 53' ' ' TYR . 7.1 t -77.52 97.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 122.071 0.939 . . . . 0.0 110.01 173.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.786 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -81.85 -2.94 90.7 Favored Glycine 0 C--O 1.214 -1.133 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.086 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.544 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 22.8 m -162.57 80.17 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.453 0.627 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.83 -0.73 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.141 0.576 . . . . 0.0 112.491 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 47' ' ' SER . 1.7 mm-40 -95.49 -25.61 16.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.341 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.609 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 15.7 m -118.96 -153.36 0.53 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.769 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.2 pt-20 -149.27 20.89 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.807 0.813 . . . . 0.0 110.835 171.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.48 -34.58 10.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.988 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.769 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p90 -57.7 -49.17 77.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.738 -167.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.7 p-10 -34.95 105.3 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.235 1.585 . . . . 0.0 113.284 -158.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.551 ' CG ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -93.04 167.44 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.975 -175.753 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.842 HG12 HG12 ' A' ' 43' ' ' ILE . 19.9 m -128.0 124.97 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.546 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 4.1 mm? -89.54 -31.0 17.82 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.167 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -175.39 159.27 2.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.064 170.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 35.2 p -136.71 112.42 9.45 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.49 132.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.823 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.1 mt -108.7 103.65 12.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.627 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.0 t -96.08 121.13 46.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -86.17 -152.61 20.66 Favored Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.569 -164.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.7 Cg_endo -47.2 117.91 2.52 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.778 1.652 . . . . 0.0 109.468 168.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 34' ' ' LEU . 2.4 p -140.12 129.13 13.36 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.654 -171.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.02 128.33 26.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.117 1.878 . . . . 0.0 111.092 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -40.52 145.83 0.16 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.077 0.86 . . . . 0.0 111.977 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.05 122.46 1.12 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.83 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.5 ttt180 -68.87 113.99 6.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.776 0.798 . . . . 0.0 109.789 175.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -150.89 150.95 31.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.164 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.802 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -91.73 134.31 34.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.92 -178.182 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.404 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -121.54 150.41 41.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.94 139.81 36.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.662 0.744 . . . . 0.0 110.666 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.738 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -127.47 119.19 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 -164.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 85.1 mt-30 -134.14 153.75 51.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -166.69 158.84 13.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.7 -175.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.686 0.755 . . . . 0.0 112.448 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -88.51 151.89 48.81 Favored Pre-proline 0 N--CA 1.438 -1.055 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.784 175.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.711 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.3 Cg_exo -61.25 173.37 2.57 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.653 2.902 . . . . 0.0 113.071 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.9 m-20 -87.14 115.73 63.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.185 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.48 -23.16 74.38 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.407 2.738 . . . . 0.0 112.294 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.46 -13.97 77.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.61 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.551 HD12 ' CG ' ' A' ' 55' ' ' GLN . 3.1 mt -90.06 -28.79 18.8 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.734 -0.274 . . . . 0.0 110.789 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.786 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 31.9 mt -75.33 125.96 88.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.483 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.8 Cg_endo -80.94 165.31 19.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.03 3.153 . . . . 0.0 113.462 171.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 8.7 t0 -42.74 -48.18 5.55 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.989 171.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.99 -20.93 51.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -168.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.446 ' HB3' HG23 ' A' ' 84' ' ' ILE . 12.8 t70 -89.96 -38.36 13.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.142 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -72.27 -41.27 66.91 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -163.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.77 47.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.59 -126.92 1.0 Allowed Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.222 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.66 132.65 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 122.162 0.982 . . . . 0.0 113.03 -172.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 113' ' ' VAL . 15.8 m -133.07 167.44 20.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 113.0 -1.909 . . . . 0.0 106.976 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 96' ' ' LEU . 37.0 t -133.6 141.47 44.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 120.877 0.37 . . . . 0.0 111.175 177.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 22' ' ' PHE . 27.1 m -124.13 106.6 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.722 HD23 HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.27 137.11 34.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.353 -174.181 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.838 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 9.1 mt -109.45 91.31 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.463 1.125 . . . . 0.0 108.89 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -90.51 125.69 35.68 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.624 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.659 ' HB2' HG22 ' A' ' 107' ' ' ILE . 72.0 m -90.03 153.53 20.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.248 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 18.5 m -150.1 113.5 4.94 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -168.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.661 ' HB3' HD11 ' A' ' 151' ' ' ILE . 55.4 t80 -128.05 124.04 36.1 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 31.4 mtp180 64.28 35.77 9.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.461 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.82 -1.96 87.28 Favored Glycine 0 C--N 1.317 -0.482 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.554 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -118.62 131.25 56.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.085 0.469 . . . . 0.0 109.932 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 24.0 mt-10 -89.3 136.1 33.21 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.292 -173.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 51.7 p90 -122.91 0.99 9.27 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.828 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.0 tt -156.62 159.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 O-C-N 121.37 -0.831 . . . . 0.0 109.255 171.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' CZ ' ' HZ ' ' A' ' 149' ' ' PHE . 9.9 ttm180 -153.21 89.13 1.34 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.588 0.555 . . . . 0.0 109.683 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.738 HG12 ' HB ' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -86.93 100.86 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.352 1.073 . . . . 0.0 108.332 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 96' ' ' LEU . . . -91.02 87.48 1.36 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.437 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.996 ' HE2' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -74.57 116.67 15.52 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.488 ' CB ' HD12 ' A' ' 140' ' ' LEU . 7.1 m-85 -67.26 117.98 10.01 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.627 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.748 HG13 ' HB ' ' A' ' 93' ' ' THR . 9.0 p -99.7 110.24 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -91.61 114.27 26.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.867 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 86.3 m-20 -99.48 106.38 18.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 124.72 39.38 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.35 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 28.1 m-85 -40.21 149.55 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.0 p -87.31 -33.64 19.15 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.783 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 17.1 mt-10 -86.63 134.16 33.64 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.716 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.585 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 90.6 m -57.17 -38.83 74.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -51.81 -39.51 58.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.053 0.93 . . . . 0.0 109.642 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -84.13 -30.01 26.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.927 -173.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 23.4 mtp180 -77.63 -41.7 37.52 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.361 0.6 . . . . 0.0 110.025 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.628 ' HG3' ' OD1' ' A' ' 125' ' ' ASN . 2.8 pt-20 -79.09 -20.74 48.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.017 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.628 ' OD1' ' HG3' ' A' ' 124' ' ' GLU . 0.8 OUTLIER -150.11 82.45 6.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-O 121.719 0.771 . . . . 0.0 109.987 169.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 15.7 Cg_endo -56.18 121.46 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.788 2.992 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.565 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 17.5 Cg_exo -68.68 147.24 69.29 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.843 2.362 . . . . 0.0 110.583 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -28.99 45.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.616 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 2.1 mmtt -103.84 131.78 21.66 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.232 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.59 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_exo -70.06 140.94 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.527 2.818 . . . . 0.0 113.133 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 8.7 t0 -119.6 111.41 18.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.605 ' CE1' ' HB ' ' A' ' 84' ' ' ILE . 18.5 m-85 -78.51 -22.81 46.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.005 0.907 . . . . 0.0 110.293 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -80.25 -17.7 51.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.212 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.8 mmtt -106.94 16.38 24.34 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.2 tp -102.4 126.5 49.45 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.191 -170.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -112.13 118.0 34.15 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.834 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -95.57 107.06 19.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.5 0.667 . . . . 0.0 111.081 -172.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 6.3 t30 -91.03 104.91 17.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.94 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.546 HD13 ' O ' ' A' ' 13' ' ' ASP . 3.6 mp -81.15 108.98 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.427 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.488 HD12 ' CB ' ' A' ' 112' ' ' TYR . 91.4 mt -64.58 89.95 0.07 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.155 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.996 ' HA ' ' HE2' ' A' ' 111' ' ' TYR . . . -79.6 -7.13 58.33 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.259 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 p -93.24 -1.88 55.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.741 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -141.67 75.64 21.55 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.402 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 57.2 Cg_endo -88.15 106.41 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.37 2.047 . . . . 0.0 111.533 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -80.69 80.1 7.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.983 0.421 . . . . 0.0 110.586 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.541 ' HB ' HG23 ' A' ' 109' ' ' VAL . 4.9 p -94.6 111.18 24.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 111.927 -173.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -108.65 106.36 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.467 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 3.6 ptt180 -113.45 131.42 56.03 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.527 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -118.44 168.63 10.47 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.673 -174.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.51 152.81 21.24 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.057 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 101' ' ' TYR . 23.4 pt -143.07 174.71 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -92.12 96.32 10.26 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.388 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.604 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 18.4 m95 -74.2 -6.52 48.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.514 0.673 . . . . 0.0 109.949 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 . . . . . 0 N--CA 1.441 -0.899 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.158 175.631 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 2.5 mppt? . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -44.38 -52.91 7.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 tt -61.92 -36.05 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 111.623 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.857 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 64.9 mm-40 -74.96 -39.04 61.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.591 0.71 . . . . 0.0 110.936 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.568 HD23 HG11 ' A' ' 45' ' ' VAL . 29.0 mt -63.22 -36.77 84.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.936 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -68.76 -33.74 74.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.998 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.857 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 8.5 mmm180 -48.74 -47.38 41.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.344 0.592 . . . . 0.0 109.437 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.41 ' HG3' HG22 ' A' ' 45' ' ' VAL . 4.4 mmp_? -73.91 -48.79 28.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.689 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.936 HG13 ' HA ' ' B' ' 127' ' ' ALA . 2.6 pp -66.87 -17.68 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' ARG . . . . . 0.471 ' HG2' HD12 ' B' ' 130' ' ' ILE . 34.7 mmt180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.607 0.241 . . . . 0.0 110.951 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.844 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.85 -21.16 20.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -177.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 3.4 t -141.99 134.21 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.667 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 31' ' ' ILE . 7.7 tp60 -137.09 105.39 5.73 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.316 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.754 HG12 ' CD1' ' A' ' 28' ' ' PHE . 27.5 m -70.29 149.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.301 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -127.93 -59.34 1.19 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.073 -168.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 65.7 t30 -104.01 150.84 23.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.139 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.3 p -145.64 98.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.88 97.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 122.403 1.096 . . . . 0.0 108.858 -177.044 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.54 133.45 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.193 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.01 HD12 ' HG2' ' A' ' 23' ' ' GLN . 8.7 mt -110.53 -42.62 4.04 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.626 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 2.9 p-10 -68.17 44.94 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.662 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.675 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -77.34 175.74 4.21 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.706 177.572 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.6 Cg_endo -49.78 103.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.562 1.593 . . . . 0.0 113.187 -150.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.675 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -148.89 172.0 5.67 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 111.648 -2.524 . . . . 0.0 107.627 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 59.6 Cg_exo -37.16 130.21 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.774 2.316 . . . . 0.0 112.969 174.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.758 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 8.9 t80 -55.43 -27.9 50.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.422 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -78.5 -14.22 59.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -69.93 138.43 87.69 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.312 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -73.34 133.07 18.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 112.76 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.708 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 88.8 m-85 -56.62 121.17 9.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.149 -176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 1.01 ' HG2' HD12 ' A' ' 12' ' ' LEU . 53.3 tt0 -128.92 92.35 3.38 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.949 -157.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' A' ' 97' ' ' ILE . 83.9 m-85 -106.1 115.05 29.56 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.666 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' A' ' 12' ' ' LEU . 22.1 tt0 -90.35 83.71 5.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.523 HG21 HG11 ' A' ' 6' ' ' VAL . 36.6 mt -82.12 141.4 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.671 0.748 . . . . 0.0 111.931 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 20.9 m -125.24 107.31 10.6 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.266 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.754 ' CD1' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.6 166.79 10.15 Favored 'General case' 0 CA--C 1.472 -2.027 0 C-N-CA 118.713 -1.195 . . . . 0.0 110.916 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 29.9 tt0 -117.65 107.54 14.34 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.816 -1.993 . . . . 0.0 106.023 168.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.3 m -72.46 108.04 5.33 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.597 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -72.48 -33.62 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.307 -169.182 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.844 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 6.0 mt-10 -143.74 171.68 13.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 p-10 -76.53 131.72 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.099 0.476 . . . . 0.0 110.964 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD12 HG22 ' A' ' 65' ' ' VAL . 7.9 mt -87.1 153.47 21.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.26 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -112.6 -31.3 6.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.695 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 20.2 tt0 -122.33 -168.99 1.82 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.695 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.2 p-10 -92.94 147.59 22.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 110.36 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.592 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -95.59 122.87 38.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.219 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.657 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 22.9 tt0 -103.92 89.93 3.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.065 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.822 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 50.0 m95 -82.66 115.46 21.61 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.8 ttmt -118.02 138.98 51.84 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.052 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.613 HG22 HG22 ' A' ' 95' ' ' VAL . 4.8 mt -104.78 123.29 58.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -114.15 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.796 -175.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.616 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.4 t80 -89.0 117.22 27.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.321 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.855 HG13 ' CE2' ' A' ' 53' ' ' TYR . 3.8 t -66.6 111.54 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.803 173.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.739 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -81.32 -63.1 1.89 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.437 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.613 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 15.1 m -102.15 70.77 1.22 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -47.98 -28.4 2.73 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.61 0.569 . . . . 0.0 111.733 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' B' ' 122' ' ' LYS . 4.8 tt0 -67.64 -18.46 64.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.068 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.691 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 24.2 m -115.25 -152.45 0.5 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.683 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.1 pt-20 -154.89 22.48 0.44 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.742 0.782 . . . . 0.0 111.05 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -100.18 -31.61 11.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.368 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.855 ' CE2' HG13 ' A' ' 45' ' ' VAL . 12.1 p90 -63.38 -42.53 98.85 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 125.752 1.621 . . . . 0.0 113.242 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.6 p-10 -23.55 113.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.033 1.458 . . . . 0.0 114.256 -161.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' HG2' HD12 ' A' ' 83' ' ' LEU . 1.4 mp0 -96.64 166.76 11.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.256 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.91 118.53 50.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.65 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.9 mm? -87.72 -48.84 7.55 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.934 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -166.0 161.82 17.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.1 p -139.1 113.23 8.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -98.86 130.64 47.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.7 mt -101.16 104.05 15.12 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.961 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.12 116.84 36.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -67.74 -168.34 4.12 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.304 -168.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -67.56 112.26 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 N-CA-C 109.573 -0.972 . . . . 0.0 109.573 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.735 HG22 HD12 ' A' ' 34' ' ' LEU . 27.4 m -110.68 117.37 50.84 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.525 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 59.6 Cg_endo -76.01 79.92 2.78 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 122.513 2.142 . . . . 0.0 113.09 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 52.43 174.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.629 -2.078 . . . . 0.0 112.494 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.74 117.53 3.35 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.107 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 ttt-85 -64.66 128.5 36.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.069 0.461 . . . . 0.0 110.312 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -164.84 158.23 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.103 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.486 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -113.37 144.46 42.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.411 0.624 . . . . 0.0 111.885 -175.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD1' ' HE1' ' A' ' 28' ' ' PHE . 2.1 p90 -132.37 160.33 36.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.1 127.44 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.46 1.124 . . . . 0.0 111.065 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -108.33 145.4 34.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.148 -168.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.5 mt-30 -150.08 152.04 34.16 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -159.68 118.64 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.599 0.237 . . . . 0.0 111.633 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.62 123.36 19.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.246 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -23.96 147.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 127.273 2.229 . . . . 0.0 116.962 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 38.7 Cg_endo -65.93 179.2 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.653 3.569 . . . . 0.0 112.722 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.41 122.12 85.47 Favored Pre-proline 0 CA--C 1.508 -0.654 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.393 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.45 -5.93 17.77 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.933 2.422 . . . . 0.0 111.471 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.17 -8.22 50.84 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.739 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 55' ' ' GLN . 27.0 mt -97.46 -8.73 28.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.046 0.45 . . . . 0.0 110.404 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.607 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 21.8 mt -95.33 125.39 50.14 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.158 171.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.613 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.4 Cg_endo -79.84 162.92 23.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.696 2.931 . . . . 0.0 111.472 171.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.774 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 4.0 m-20 -46.5 -53.67 10.78 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.77 82.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.666 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.495 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 61.1 m-20 -87.79 -16.89 32.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.682 -173.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.24 -46.13 29.57 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.643 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.98 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.502 0.668 . . . . 0.0 112.053 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.94 -132.47 1.55 Allowed Glycine 0 CA--C 1.498 -1.026 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.571 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.466 HG13 ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.99 136.08 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.674 0.75 . . . . 0.0 112.785 -168.075 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.18 167.77 28.18 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.354 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.533 HG23 ' HG ' ' B' ' 126' ' ' LEU . 20.9 t -123.46 135.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.112 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.613 HG22 HG22 ' A' ' 42' ' ' ILE . 14.3 p -115.86 105.55 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 171.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.818 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.3 pp -103.41 147.68 26.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.728 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 109' ' ' VAL . 41.4 mt -112.26 102.87 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.667 0.746 . . . . 0.0 109.67 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 108' ' ' ARG . 78.0 p -101.32 110.05 22.0 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.668 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.005 ' SG ' HG22 ' A' ' 107' ' ' ILE . 11.9 p -75.62 152.2 37.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.81 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 31.3 m -142.01 103.26 4.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.616 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 89.9 t80 -113.18 122.11 46.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 37.5 mtp180 68.58 23.17 7.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.107 0.479 . . . . 0.0 111.628 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.56 76.03 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.253 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -128.96 123.68 33.12 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 16.2 mp0 -82.25 136.19 35.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 -173.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 52.3 p90 -128.62 -0.32 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.005 HG22 ' SG ' ' A' ' 99' ' ' CYS . 5.2 tt -157.63 160.34 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 O-C-N 121.178 -0.951 . . . . 0.0 108.799 169.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.849 ' HB2' HG22 ' A' ' 98' ' ' THR . 15.9 ttp180 -150.16 104.39 3.26 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.818 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.7 p -88.9 99.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.624 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -88.23 82.01 1.56 Allowed Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.251 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.999 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.7 m-85 -72.8 120.81 18.94 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.408 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB3' HD23 ' A' ' 140' ' ' LEU . 2.9 m-85 -66.84 123.7 20.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.5 p -107.96 111.26 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.723 ' HB2' HD21 ' A' ' 140' ' ' LEU . 12.5 t30 -98.43 113.54 25.57 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.767 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 38.7 m-80 -97.31 132.14 43.33 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.353 0.597 . . . . 0.0 110.032 -174.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.32 134.46 22.76 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.786 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 31.7 m-85 -49.56 151.32 1.67 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.1 p -90.32 -34.42 15.72 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.013 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 9.1 mm-40 -75.32 121.98 23.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.791 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.9 m -50.3 -36.77 33.19 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.762 -172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -64.91 -40.16 94.65 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.615 0.722 . . . . 0.0 110.321 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.8 mt -73.36 -22.24 60.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.654 -176.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 10.4 mtt180 -78.73 -36.75 42.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.791 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.7 mm-40 -61.32 -44.13 97.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.012 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -145.73 85.95 7.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.059 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.16 115.67 2.73 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.047 2.498 . . . . 0.0 112.092 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.43 164.12 33.93 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.142 2.561 . . . . 0.0 111.498 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.01 -62.46 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.076 0.235 . . . . 0.0 110.708 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -67.77 125.79 91.77 Favored Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-O 121.731 0.777 . . . . 0.0 111.785 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.774 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 22.0 Cg_exo -70.27 139.2 37.92 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 124.215 3.277 . . . . 0.0 111.827 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.588 ' CG ' ' HG2' ' A' ' 134' ' ' LYS . 30.1 t0 -117.07 104.04 10.84 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.758 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 37.0 m-85 -74.01 -16.11 61.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.039 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.7 t -85.43 -21.51 28.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.283 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.588 ' HG2' ' CG ' ' A' ' 131' ' ' ASP . 47.0 mmtm -101.12 -0.5 36.04 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.6 tp -85.95 123.51 31.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.308 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.493 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 6.3 tt0 -108.39 116.93 32.89 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.837 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.56 119.63 38.37 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.74 -174.27 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.613 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.3 t30 -96.03 120.04 35.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.653 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.568 HG21 HG11 ' A' ' 11' ' ' VAL . 3.5 mm -88.34 102.13 12.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' A' ' 114' ' ' ASN . 3.1 mm? -60.21 84.6 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.999 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -63.47 -15.49 57.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.347 168.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.47 -18.14 55.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.107 171.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.99 60.21 33.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.176 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 84.6 Cg_endo -91.36 105.97 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.815 1.677 . . . . 0.0 110.741 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -82.13 81.54 8.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.554 HG12 HG23 ' A' ' 109' ' ' VAL . 17.0 m -78.55 114.54 19.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 111.56 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.657 HG21 HH21 ' A' ' 108' ' ' ARG . 53.7 m -120.4 105.31 10.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.398 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.771 ' HB3' HG13 ' A' ' 107' ' ' ILE . 1.7 ptt180 -106.01 133.87 50.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.51 0.671 . . . . 0.0 110.65 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HD2' ' CA ' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -109.18 168.56 9.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.781 -176.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.51 139.7 38.51 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 173.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.1 pt -139.68 -177.9 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.533 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 5.9 m-20 -102.41 82.64 2.2 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.428 0.633 . . . . 0.0 111.34 -172.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.723 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.1 m95 -69.05 -11.98 61.27 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.932 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.413 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' B' ' 126' ' ' LEU . 12.0 mptt . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -35.23 -61.33 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.292 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 7.2 tt -69.39 -33.47 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.515 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 67.0 mm-40 -63.23 -52.33 62.6 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.385 0.612 . . . . 0.0 110.822 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 94' ' ' VAL . 1.9 mm? -64.69 -36.37 84.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.129 177.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.97 -37.32 73.97 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 99.7 mtt180 -59.23 -47.83 83.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 111.156 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' B' ' 129' ' ' ARG . 18.1 mmm180 -74.44 -21.67 59.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.286 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.523 HD11 HG21 ' A' ' 94' ' ' VAL . 23.3 mt -93.19 -7.76 10.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.613 0.721 . . . . 0.0 109.885 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.469 174.334 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.872 0.367 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.757 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -91.42 -17.16 26.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.215 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.4 t -137.71 130.05 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.594 0.711 . . . . 0.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 6.0 tp-100 -122.88 101.71 7.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.679 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -78.08 132.23 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -116.5 -69.58 0.84 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.207 -163.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.662 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 57.7 t30 -93.04 152.68 19.15 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.8 -177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.4 p -146.4 107.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-O 122.244 1.021 . . . . 0.0 109.766 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.1 t -92.59 92.62 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.023 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.536 HG12 ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -76.45 120.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.309 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.005 HD12 ' HB3' ' A' ' 23' ' ' GLN . 4.6 mt -105.45 -40.11 5.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.647 -168.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 1.001 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 17.4 p-10 -67.01 38.25 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.454 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.601 ' HA ' ' HB ' ' A' ' 139' ' ' ILE . 0.9 OUTLIER -78.46 174.53 5.88 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.601 178.242 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.855 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 4.3 Cg_endo -50.05 103.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.802 1.668 . . . . 0.0 113.639 -153.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.5 m -146.34 171.43 6.44 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 111.236 -2.711 . . . . 0.0 106.715 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.646 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 45.5 Cg_exo -38.13 143.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.804 2.336 . . . . 0.0 112.407 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.908 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.3 t80 -60.42 -31.25 70.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.705 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -75.23 -11.27 60.03 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.608 0.242 . . . . 0.0 110.571 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.646 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -67.86 117.32 47.17 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 121.882 0.849 . . . . 0.0 109.271 168.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 46.4 Cg_exo -60.04 169.08 5.15 Favored 'Trans proline' 0 C--N 1.327 -0.571 1 C-N-CA 125.434 4.09 . . . . 0.0 114.291 -173.055 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.798 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 99.1 m-85 -78.27 103.25 8.09 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.552 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 1.005 ' HB3' HD12 ' A' ' 12' ' ' LEU . 2.6 mp0 -104.81 109.8 21.9 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.508 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.716 ' CD2' HD11 ' A' ' 97' ' ' ILE . 83.2 m-85 -123.48 101.4 7.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 1.102 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.9 tt0 -86.16 82.65 7.98 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.344 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.1 mt -87.88 129.27 39.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.081 -176.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.3 m -103.01 104.73 14.94 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 20.7 p90 -112.6 141.87 45.85 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.64 0.733 . . . . 0.0 110.025 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.864 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.6 tt0 -101.7 117.87 35.76 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t -73.85 104.88 4.89 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.473 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -71.48 -30.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.573 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.596 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 40.3 mt-10 -149.63 146.4 27.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.069 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.4 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 p-10 -60.24 138.88 57.85 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.739 0.649 . . . . 0.0 111.288 -170.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 38' ' ' LEU . 6.8 mt -95.35 151.08 19.58 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.876 -171.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.3 t -114.1 -25.75 8.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.307 0.575 . . . . 0.0 110.152 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.725 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 19.9 tt0 -121.39 -168.33 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.725 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.8 p-10 -94.41 135.4 35.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.506 0.669 . . . . 0.0 110.482 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -83.05 119.29 24.29 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.584 176.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 1.2 tm-20 -104.98 89.74 3.24 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.211 -171.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' O ' ' HA ' ' A' ' 59' ' ' SER . 9.6 m95 -82.25 139.93 33.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.0 ttmp? -138.92 145.69 40.16 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.831 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.26 116.48 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.682 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 4.0 mp -113.92 107.25 22.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.818 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.0 t80 -92.78 115.45 28.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.667 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 t -59.29 107.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.65 12.77 61.24 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -134.13 62.1 1.66 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.754 -0.723 . . . . 0.0 112.443 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB1' ' HG3' ' B' ' 122' ' ' LYS . . . -79.64 -10.91 59.87 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.672 0.749 . . . . 0.0 108.982 165.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -100.12 -46.83 5.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.239 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.488 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 49.3 m -105.61 -134.38 0.33 Allowed 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 9.0 pt-20 -154.45 -19.72 0.13 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -90.46 2.86 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 23.3 m-85 -93.61 0.36 56.52 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -54.07 95.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.89 0.852 . . . . 0.0 110.57 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -94.83 169.35 10.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.064 -173.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.0 t -126.11 117.65 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.996 -167.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.723 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 mm? -85.88 -58.22 2.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.183 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -153.35 152.6 31.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.134 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.2 p -134.75 110.87 9.51 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 72' ' ' PHE . 3.1 p -99.59 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.837 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 10.6 mt -105.89 104.65 14.41 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.303 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.25 113.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -164.9 4.21 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.497 -167.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 64.5 Cg_endo -68.29 113.88 3.24 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 120.812 1.008 . . . . 0.0 109.685 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.713 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 27.4 m -120.94 134.34 24.32 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.812 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 59.7 Cg_endo -81.57 78.68 3.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.106 1.871 . . . . 0.0 113.168 -176.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 51.0 -171.83 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.63 -2.077 . . . . 0.0 111.943 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.47 135.73 8.11 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.864 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.4 ttp180 -73.1 115.21 12.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.043 0.925 . . . . 0.0 111.195 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -114.38 118.03 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.231 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.695 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 20.5 ttp -87.82 103.3 15.51 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 173.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.497 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -110.02 128.39 55.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.04 -178.405 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.102 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -102.05 111.83 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 122.682 1.23 . . . . 0.0 111.376 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -72.61 143.42 48.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.652 -2.067 . . . . 0.0 109.614 179.058 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.917 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 25.3 mt-30 -152.55 145.2 24.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.23 134.5 2.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.4 p-10 -55.84 159.62 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.731 0.3 . . . . 0.0 110.756 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -76.03 164.65 58.89 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 123.061 0.544 . . . . 0.0 111.642 -167.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 36.0 Cg_endo -59.57 163.38 13.11 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.116 2.544 . . . . 0.0 112.127 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.5 m-20 -69.52 117.17 50.25 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.989 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.4 Cg_endo -61.23 -22.18 73.89 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.678 2.919 . . . . 0.0 112.33 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.37 -10.97 69.95 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.086 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.47 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 24.0 mt -91.14 -31.28 16.28 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 122.685 -0.303 . . . . 0.0 110.491 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 17.0 mt -74.76 124.73 89.82 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.42 ' O ' HG22 ' A' ' 84' ' ' ILE . 94.1 Cg_endo -79.15 163.51 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.776 2.984 . . . . 0.0 112.075 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.555 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 12.7 t70 -44.92 -55.42 5.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.02 62.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.25 0.548 . . . . 0.0 111.108 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 84' ' ' ILE . 10.9 t70 -97.25 -24.43 15.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.634 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -88.84 -46.26 9.09 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -101.34 49.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -170.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.79 -128.98 1.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.352 -168.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.594 HG22 ' OD1' ' A' ' 114' ' ' ASN . 21.5 t -109.89 133.61 54.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.598 -172.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.649 ' HB ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -144.16 170.42 16.0 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.616 HG23 HD13 ' B' ' 126' ' ' LEU . 3.3 t -129.89 145.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 118.719 0.69 . . . . 0.0 111.737 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.515 HG21 ' CE1' ' A' ' 22' ' ' PHE . 7.7 p -132.08 108.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.877 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.6 pp -107.37 147.3 30.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.255 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.716 HD11 ' CD2' ' A' ' 24' ' ' PHE . 36.8 mt -114.91 105.6 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 109.303 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.768 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 56.6 p -100.49 116.57 32.74 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.977 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.675 ' HB2' HG22 ' A' ' 107' ' ' ILE . 76.4 m -81.83 123.22 28.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.11 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 28.3 m -113.32 120.29 40.62 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.676 ' HB3' HD11 ' A' ' 151' ' ' ILE . 61.3 t80 -123.22 117.35 25.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.255 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.586 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.1 mtp180 66.08 23.81 11.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.445 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.05 54.94 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.892 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 13.9 mp0 -111.26 132.52 54.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.931 175.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 33.4 mt-10 -83.38 130.06 35.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.595 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.0 p90 -118.29 1.5 11.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.846 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.4 tt -157.97 155.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.739 HH22 ' HG3' ' A' ' 145' ' ' ARG . 2.8 tmm_? -151.14 113.38 4.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -104.6 100.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.308 1.052 . . . . 0.0 109.689 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.504 ' HA3' HH11 ' A' ' 108' ' ' ARG . . . -93.03 87.14 1.2 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.98 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 88.7 m-85 -76.13 146.58 39.15 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 140' ' ' LEU . 6.6 m-85 -83.2 132.47 35.06 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.818 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.5 p -108.84 109.31 27.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.594 ' OD1' HG22 ' A' ' 92' ' ' VAL . 6.4 t30 -97.51 108.47 21.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.187 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.673 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 42.7 m-80 -97.03 110.58 23.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.04 133.74 49.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 39.3 m-85 -42.69 157.49 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -95.74 -30.84 13.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.438 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.67 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 4.3 mm-40 -86.33 128.73 34.97 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.571 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.707 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.3 m -48.48 -46.45 38.2 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.08 0.4 . . . . 0.0 111.841 -172.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -53.59 -37.33 62.87 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.234 1.016 . . . . 0.0 110.115 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.59 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 48.2 mt -84.53 -24.74 29.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.919 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 60.9 mtp180 -78.48 -40.43 35.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.936 0.874 . . . . 0.0 108.689 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 120' ' ' THR . 12.6 pt-20 -73.38 -29.78 62.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.977 -177.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.592 ' OD1' ' HG3' ' A' ' 124' ' ' GLU . 1.6 p-10 -153.73 90.79 3.31 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.006 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.81 117.99 4.69 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 122.889 2.393 . . . . 0.0 111.45 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.466 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 32.5 Cg_exo -59.5 151.38 69.45 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.375 2.05 . . . . 0.0 110.224 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.9 p -48.74 -29.02 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.286 -170.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -118.28 110.96 38.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-O 122.264 1.03 . . . . 0.0 113.451 173.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.629 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 7.0 Cg_exo -44.29 139.93 6.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 125.386 4.057 . . . . 0.0 113.659 174.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.9 t70 -120.23 116.61 25.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.896 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.633 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.7 m-85 -79.18 -16.33 56.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.878 0.846 . . . . 0.0 111.026 -170.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.1 m -83.09 -24.78 32.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.344 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.67 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.3 mmtt -101.23 13.98 33.42 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 115' ' ' ASN . 24.4 tp -98.08 144.7 27.29 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.855 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -125.22 125.76 44.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.908 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 16.7 mtm105 -91.17 104.38 16.95 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.163 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -89.7 90.99 8.47 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 170.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.853 HD11 HH12 ' A' ' 137' ' ' ARG . 1.3 mm -71.57 115.41 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.898 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 112' ' ' TYR . 35.8 mt -78.73 75.22 5.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.851 0.834 . . . . 0.0 110.797 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -71.7 -19.99 61.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.472 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 p -73.65 -11.96 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.741 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.02 66.96 33.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.627 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.613 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 66.1 Cg_endo -87.64 105.92 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.822 1.682 . . . . 0.0 111.787 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.739 ' HG3' HH22 ' A' ' 108' ' ' ARG . 8.7 tpt180 -76.01 88.57 2.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.501 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.3 p -95.24 137.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.431 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.7 m -145.76 107.9 4.38 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.761 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.846 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 1.0 OUTLIER -96.86 149.98 21.25 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.423 0.63 . . . . 0.0 110.244 175.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -122.16 169.51 10.81 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.404 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.83 125.31 50.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.26 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 101' ' ' TYR . 13.7 pt -135.96 173.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 154' ' ' GLU . 8.0 p-10 -95.38 109.5 21.65 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.171 0.986 . . . . 0.0 109.675 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.757 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.3 m95 -82.41 15.58 2.43 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.067 171.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 152' ' ' ASN . 63.2 mm-40 . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.559 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.693 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 3.2 mppt? . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 121.185 0.516 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.72 -55.01 15.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.012 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.457 ' HA ' ' HB3' ' B' ' 127' ' ' ALA . 14.4 tt -73.9 -26.02 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -65.14 -45.34 85.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 122.068 0.937 . . . . 0.0 110.161 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 24.6 mt -65.17 -43.52 91.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.648 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' B' ' 124' ' ' ILE . . . -59.28 -39.1 81.86 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.568 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -66.92 -47.02 73.01 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -39.98 95.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.642 HG12 ' NH1' ' A' ' 108' ' ' ARG . 5.1 mt -56.31 -60.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 113.099 -1.864 . . . . 0.0 112.533 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' ARG . . . . . 0.454 ' N ' HG22 ' B' ' 130' ' ' ILE . 12.4 mmm180 . . . . . 0 CA--C 1.515 -0.377 0 O-C-N 123.424 0.453 . . . . 0.0 110.991 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' C ' ' HE3' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.481 0.658 . . . . 0.0 112.273 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.711 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -95.14 -18.17 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.505 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.6 t -136.49 126.38 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.515 0.674 . . . . 0.0 110.241 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.588 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 4.7 tp-100 -116.27 100.08 7.66 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.89 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -76.73 134.79 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.364 176.518 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -115.05 -62.72 1.56 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 -165.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.683 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.51 151.06 23.3 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.865 -176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.6 p -144.63 99.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.5 170.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.15 95.39 4.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.165 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -67.31 125.3 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.699 177.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.99 HD12 ' HG2' ' A' ' 23' ' ' GLN . 7.3 mt -97.31 -52.31 3.86 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.184 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.71 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 7.7 t70 -74.49 78.64 1.93 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.733 1.254 . . . . 0.0 110.456 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.715 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -82.38 178.09 2.63 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.437 165.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.895 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.9 Cg_endo -48.0 104.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.839 1.693 . . . . 0.0 114.619 -149.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.564 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.2 m -131.76 170.45 11.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 112.767 -2.015 . . . . 0.0 108.495 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 51.6 Cg_exo -46.85 144.58 7.91 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 111.636 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.712 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 11.3 t80 -61.36 -37.14 82.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.85 -0.85 32.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.897 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -89.2 131.35 41.03 Favored Pre-proline 0 N--CA 1.431 -1.388 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 171.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -63.72 150.12 89.2 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 123.792 2.995 . . . . 0.0 114.364 -168.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 95.0 m-85 -66.12 139.15 58.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.103 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.99 ' HG2' HD12 ' A' ' 12' ' ' LEU . 7.8 tt0 -133.83 99.43 4.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.139 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.721 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.5 m-85 -103.37 155.72 18.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.294 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' ' 12' ' ' LEU . 39.5 tt0 -134.71 88.13 2.41 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.569 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 14.0 mt -86.85 131.52 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.941 0.877 . . . . 0.0 112.366 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 24.6 m -108.53 108.1 18.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.345 173.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 32.5 p90 -120.0 148.05 44.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.778 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.875 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 72.0 tt0 -106.76 115.01 29.45 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.64 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -72.68 111.64 8.02 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -77.67 -29.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.44 -174.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.619 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 42.2 mm-40 -151.81 154.77 36.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.437 0.46 . . . . 0.0 110.054 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.72 128.31 20.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.87 0.731 . . . . 0.0 111.256 -175.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.032 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -83.46 146.63 28.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.563 -170.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -113.2 -23.17 10.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.384 -172.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.834 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 29.3 tt0 -129.51 -164.85 1.45 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.834 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.3 m-20 -95.27 137.17 34.7 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.597 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.6 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 47.8 tt0 -105.66 89.7 3.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.571 -171.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.67 ' O ' ' HA ' ' A' ' 59' ' ' SER . 23.4 m95 -80.34 124.67 29.06 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.7 ttmt -130.93 142.5 50.36 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.72 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.716 HG22 HG22 ' A' ' 95' ' ' VAL . 12.5 mt -103.62 112.97 39.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.3 mp -104.43 105.74 19.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.647 ' CE2' HG11 ' A' ' 113' ' ' VAL . 33.5 t80 -90.42 111.87 23.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.795 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -53.43 109.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.253 0.549 . . . . 0.0 109.846 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.61 -45.56 52.5 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.452 -0.88 . . . . 0.0 110.97 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.834 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 91.4 p -128.1 125.02 38.41 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.358 0.599 . . . . 0.0 111.515 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -89.21 -0.1 57.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 161.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.584 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 4.8 mt-10 -88.5 -29.58 20.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.655 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 64.1 m -121.92 -107.88 0.35 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.593 173.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 7.0 pt-20 -179.98 -47.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.173 0.189 . . . . 0.0 111.327 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 38.0 mt-10 -72.83 1.15 9.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.088 0.47 . . . . 0.0 111.777 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 2.0 m-30 -80.73 -7.93 59.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -44.01 108.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.207 1.003 . . . . 0.0 111.057 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.644 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 40.8 mt-30 -92.71 169.44 10.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.512 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' CG1' ' HD3' ' A' ' 41' ' ' LYS . 46.1 t -130.67 110.35 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -172.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.6 mm? -75.54 -54.61 6.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.614 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 19.3 p-10 -160.38 170.43 21.05 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 67.5 p -146.92 115.39 6.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.1 p -99.63 134.65 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.382 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.7 OUTLIER -105.94 103.92 13.51 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.048 -175.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.59 118.74 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -79.72 -162.33 24.69 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.219 -165.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.032 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 31.4 Cg_endo -63.5 117.36 4.32 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.784 1.656 . . . . 0.0 110.806 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 23.1 m -128.0 137.56 31.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.857 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -82.02 77.23 3.91 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.23 1.953 . . . . 0.0 114.082 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . 51.85 177.37 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.116 -1.856 . . . . 0.0 112.618 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.68 129.62 5.61 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 172.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.875 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.3 ptt180 -79.87 128.06 33.0 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.321 1.058 . . . . 0.0 109.787 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -154.12 143.77 21.66 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.395 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.53 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -92.85 136.23 33.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.533 -176.361 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 6.4 p90 -121.36 160.09 24.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 168.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.46 134.13 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-O 121.882 0.849 . . . . 0.0 110.808 -171.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -115.95 129.75 56.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.345 -164.206 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 64.6 mt-30 -151.67 143.7 23.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.941 0.4 . . . . 0.0 110.542 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -169.11 138.43 2.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.835 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.639 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.2 p-10 -72.96 156.19 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -174.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -44.1 156.93 0.3 Allowed Pre-proline 0 N--CA 1.443 -0.789 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.532 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 57.3 Cg_endo -66.97 170.57 12.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.841 3.027 . . . . 0.0 111.418 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.8 m-20 -66.55 117.83 48.07 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.0 Cg_endo -61.36 -25.74 80.6 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.544 2.829 . . . . 0.0 111.948 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.0 -11.29 82.77 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.311 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.644 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 25.2 mt -91.85 -21.91 20.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.644 0.259 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.515 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 10.1 mt -84.49 130.07 55.05 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.38 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 1.5 Cg_endo -79.96 161.19 23.95 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.123 2.549 . . . . 0.0 112.076 170.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.729 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -46.54 -53.32 11.56 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.07 69.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.178 0.513 . . . . 0.0 111.114 -167.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 9.8 m-20 -95.74 -19.88 19.32 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.754 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.04 -47.28 15.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.52 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.748 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -96.5 48.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.702 0.763 . . . . 0.0 111.542 -176.572 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.83 -129.73 1.15 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.089 -166.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.426 HG13 ' OD1' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -119.91 125.3 74.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.344 0.593 . . . . 0.0 111.524 -173.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.14 169.65 15.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.611 HG23 HD13 ' B' ' 126' ' ' LEU . 2.4 t -126.45 142.53 42.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.266 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 42' ' ' ILE . 9.8 p -127.35 107.47 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 122.14 0.972 . . . . 0.0 108.613 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -104.02 138.93 39.84 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.345 -171.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 mt -102.81 95.57 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.819 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.6 p -96.7 116.04 28.45 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.599 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 40' ' ' TRP . 76.3 m -82.32 118.16 22.94 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.553 176.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 56.6 m -99.31 113.48 25.81 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.771 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.71 ' HB3' HD11 ' A' ' 151' ' ' ILE . 38.2 t80 -123.63 121.72 36.28 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.629 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 34.8 mtp180 63.02 27.37 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.063 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.35 66.51 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.653 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -121.12 135.44 55.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.165 0.507 . . . . 0.0 110.477 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 2.4 mp0 -82.18 128.96 34.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.597 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 51.4 p90 -111.65 2.41 17.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 98' ' ' THR . 9.3 tt -156.93 158.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.845 HH21 HG21 ' A' ' 147' ' ' THR . 31.3 ttp180 -151.1 107.51 3.48 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -96.86 99.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 118.699 -1.201 . . . . 0.0 108.339 171.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.737 ' HA3' HG21 ' B' ' 130' ' ' ILE . . . -87.42 79.51 1.77 Allowed Glycine 0 CA--C 1.483 -1.962 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.123 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.871 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.9 m-85 -71.58 116.05 11.48 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.122 -1.039 . . . . 0.0 109.082 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.722 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.96 114.58 5.88 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.689 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.647 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.4 p -101.97 110.45 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.468 HD21 ' HG3' ' A' ' 116' ' ' GLU . 2.3 t30 -96.87 120.91 38.08 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 21.9 m120 -108.12 108.95 20.24 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -169.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.468 ' HG3' HD21 ' A' ' 114' ' ' ASN . 73.0 mt-10 -127.45 125.01 39.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.18 -170.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 29.6 m-85 -41.24 153.14 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -91.07 -32.81 15.74 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.749 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.562 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.39 130.04 35.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.788 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.631 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.7 m -56.31 -36.4 68.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.474 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.04 -37.82 78.78 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.564 0.697 . . . . 0.0 110.301 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 81.8 mt -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.647 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 mtp85 -75.63 -37.88 59.37 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.2 mm-40 -57.65 -37.43 73.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.821 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 22.0 p-10 -160.23 98.53 1.44 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.973 177.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 13.2 Cg_endo -56.5 114.6 1.99 Allowed 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.061 2.508 . . . . 0.0 111.341 173.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.4 152.26 33.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.494 2.129 . . . . 0.0 110.794 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -51.12 -24.49 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.979 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 26.0 mttt -123.95 108.21 30.45 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 121.703 0.763 . . . . 0.0 111.676 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.748 ' HB3' HG13 ' A' ' 90' ' ' VAL . 8.9 Cg_exo -45.02 141.83 5.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 125.091 3.861 . . . . 0.0 113.456 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -114.41 114.79 26.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.655 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 14.5 m-85 -78.11 -16.89 57.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.67 0.748 . . . . 0.0 111.303 -168.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -85.47 -20.45 29.71 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.355 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.7 mmtt -101.96 5.38 40.74 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 115' ' ' ASN . 26.3 tp -86.82 143.68 27.37 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.362 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.465 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 2.3 tt0 -126.43 125.1 41.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.895 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.3 mtp-105 -83.68 104.34 13.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.889 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -98.32 103.5 15.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.695 HG21 HG11 ' A' ' 11' ' ' VAL . 1.5 mp -82.03 104.96 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.576 -173.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.722 HD12 ' HB3' ' A' ' 112' ' ' TYR . 83.5 mt -65.84 91.4 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.852 0.834 . . . . 0.0 111.029 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.871 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.88 -15.26 59.74 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.562 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -77.87 -16.01 58.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.411 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -134.35 67.27 72.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.19 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.578 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 90.5 Cg_endo -91.92 108.29 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.551 2.168 . . . . 0.0 110.951 175.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.614 ' NE ' ' HA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -75.53 80.29 2.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.504 -176.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 109' ' ' VAL . 5.2 m -79.18 111.16 15.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.845 HG21 HH21 ' A' ' 108' ' ' ARG . 31.3 m -132.15 106.61 8.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.142 0.496 . . . . 0.0 110.333 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -108.36 133.23 52.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.243 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.66 169.99 8.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.993 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -102.47 116.97 33.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.162 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.7 pt -119.55 179.59 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.194 0.521 . . . . 0.0 109.844 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -96.45 84.24 3.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 122.191 0.996 . . . . 0.0 112.242 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.711 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 21.8 m95 -69.49 -9.27 53.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.321 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.51 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 4.5 mp0 . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.6 mmtt . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.013 0.435 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.16 -49.53 77.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.645 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' ILE . . . . . 0.495 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.7 tp -75.78 -27.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.052 0.453 . . . . 0.0 110.571 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.6 tm0? -56.48 -63.72 1.1 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.792 0.806 . . . . 0.0 109.905 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.611 HD13 HG23 ' A' ' 94' ' ' VAL . 62.0 mt -58.99 -44.08 91.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.486 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.892 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -57.25 -32.55 66.68 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 123.566 0.541 . . . . 0.0 111.74 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 96.1 mtt180 -53.11 -53.48 49.71 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -62.94 -38.57 91.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.641 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.892 HG13 ' HA ' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -92.88 6.93 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.004 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 120.981 0.419 . . . . 0.0 110.253 171.968 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.721 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 64.0 mmtt -100.3 -14.7 18.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.498 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 38' ' ' LEU . 2.1 t -150.98 137.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.353 0.597 . . . . 0.0 112.503 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.776 ' HG2' HD11 ' A' ' 31' ' ' ILE . 23.8 mm-40 -128.53 115.4 18.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.951 172.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.912 HG12 ' HB3' ' A' ' 28' ' ' PHE . 5.0 m -78.13 134.71 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.234 -1.786 . . . . 0.0 108.107 167.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -120.72 -62.09 1.49 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.434 -166.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -103.64 99.87 9.69 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.168 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.643 HG11 HG21 ' A' ' 109' ' ' VAL . 3.0 p -95.84 97.86 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -93.54 97.06 6.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 122.236 1.017 . . . . 0.0 108.687 -174.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.15 135.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.659 -176.193 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.934 HD12 ' HG2' ' A' ' 23' ' ' GLN . 5.7 mt -106.48 -48.21 3.6 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -172.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.69 78.52 0.83 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.653 1.692 . . . . 0.0 109.659 167.447 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.673 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -85.91 178.32 2.38 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 112.22 -2.264 . . . . 0.0 107.023 162.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.848 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.2 Cg_endo -49.43 103.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 121.73 1.653 . . . . 0.0 113.242 -157.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.692 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.6 m -132.49 171.11 9.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.668 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.1 Cg_exo -43.18 135.79 5.66 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.313 2.009 . . . . 0.0 111.253 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 12.6 t80 -60.46 -26.66 66.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.325 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.17 -7.68 59.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.999 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.22 142.94 76.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 170.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.4 Cg_exo -77.55 136.7 15.77 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 123.407 2.738 . . . . 0.0 113.139 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 32.5 m-85 -57.43 116.43 3.33 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.532 0.682 . . . . 0.0 110.729 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.934 ' HG2' HD12 ' A' ' 12' ' ' LEU . 54.3 tt0 -116.39 106.47 13.66 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.941 -165.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.674 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 92.7 m-85 -110.32 154.01 24.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.564 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 24.5 tt0 -121.69 87.06 2.68 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 167.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.503 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 74.8 mt -82.99 125.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.624 0.726 . . . . 0.0 112.281 -174.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 37.8 m -107.71 106.38 16.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.037 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.912 ' HB3' HG12 ' A' ' 6' ' ' VAL . 29.1 p90 -113.94 146.25 40.35 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.677 1.227 . . . . 0.0 110.924 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.982 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.1 tt0 -101.28 113.42 26.46 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.579 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.665 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -72.14 109.79 6.16 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.776 HD11 ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -70.53 -32.07 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.8 -2.0 . . . . 0.0 108.56 178.562 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 8.7 mm-40 -144.79 154.05 42.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.182 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.28 132.26 48.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.031 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 44.9 mt -83.06 158.63 22.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.682 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -113.1 -21.08 11.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.454 0.645 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.7 tt0 -126.44 -168.96 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.759 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.5 m-20 -90.63 149.91 21.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 34' ' ' LEU . 4.7 tp -96.38 123.65 40.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.435 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 82.4 tt0 -107.9 92.11 3.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.699 -169.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.687 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 46.2 m95 -88.64 127.78 35.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 22.7 ttmt -124.11 140.59 52.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.032 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.568 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.2 mt -104.13 107.26 21.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.111 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.6 mp -103.01 112.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.443 -174.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' A' ' 57' ' ' LEU . 13.4 t80 -96.9 114.2 25.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.492 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.11 103.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.58 -44.91 96.41 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.607 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 43.9 t -134.36 135.32 42.61 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.532 0.682 . . . . 0.0 109.634 176.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -83.61 -11.21 57.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -32.2 25.24 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.938 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.682 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 74.9 m -144.5 117.02 8.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.021 0.915 . . . . 0.0 111.342 166.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' OE2' ' HD3' ' B' ' 128' ' ' ARG . 9.0 pt-20 -66.89 -14.82 63.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.276 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.2 -9.46 32.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.439 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.682 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 95.4 m-85 -90.89 6.43 44.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.463 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -53.63 103.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.909 0.862 . . . . 0.0 111.13 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -101.24 167.48 10.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.21 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.36 122.5 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.334 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.71 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 10.8 mp -81.67 -62.69 1.57 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.2 m-20 -147.23 163.35 36.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.211 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 51.4 p -138.49 116.78 11.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -99.4 131.9 45.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.734 -172.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 12.5 mt -102.92 104.19 14.39 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.184 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.38 125.1 47.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -73.11 -166.21 10.2 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.319 -163.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.031 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 28.4 Cg_endo -60.57 114.7 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.233 1.289 . . . . 0.0 109.285 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 63' ' ' GLY . 28.2 m -116.9 120.99 33.31 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.661 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.83 131.0 37.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.517 2.145 . . . . 0.0 110.429 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.18 132.15 0.39 Allowed 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 124.26 0.975 . . . . 0.0 112.775 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.94 118.96 0.58 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.982 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.2 ttt180 -65.21 114.63 4.83 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.719 0.771 . . . . 0.0 111.214 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.412 ' HE1' HG21 ' A' ' 65' ' ' VAL . 29.7 p-80 -149.07 156.2 41.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.128 -171.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.9 OUTLIER -106.05 151.18 25.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.516 ' N ' ' HG2' ' A' ' 71' ' ' MET . 1.3 p90 -140.75 160.75 39.36 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 171.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.461 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 2.6 p -117.35 136.98 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 122.168 0.985 . . . . 0.0 111.567 -172.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.674 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -118.07 138.14 52.44 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.49 -169.479 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.714 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 71.1 mt-30 -148.08 151.46 35.7 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.71 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -159.21 121.87 3.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.68 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.83 156.3 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.809 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.05 151.36 16.8 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.516 -169.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 64.3 Cg_endo -67.36 162.54 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.029 2.486 . . . . 0.0 110.16 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 24.0 m-80 -60.9 119.04 41.22 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 21.0 Cg_endo -66.76 -7.78 19.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.067 2.511 . . . . 0.0 110.796 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.46 1.3 55.8 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.978 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.27 -27.81 10.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.996 0.398 . . . . 0.0 110.638 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 89' ' ' ALA . 15.9 mt -80.82 128.64 70.94 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.991 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 84' ' ' ILE . 72.0 Cg_endo -81.88 161.29 18.61 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.066 1.844 . . . . 0.0 111.394 172.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.687 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.5 t70 -46.0 -48.7 16.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.88 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.994 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 7.5 m-20 -106.8 -8.38 16.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.409 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -74.48 -43.8 54.39 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 111.178 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -100.6 46.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.593 -174.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.31 -138.63 2.75 Favored Glycine 0 CA--C 1.508 -0.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.452 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.507 HG23 ' OD1' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -100.57 139.08 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -168.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.847 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -157.61 169.9 23.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.001 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.689 HG12 HD23 ' A' ' 96' ' ' LEU . 94.9 t -120.95 133.1 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 121.05 0.452 . . . . 0.0 111.63 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 42' ' ' ILE . 3.0 p -117.15 107.13 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.711 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -106.27 151.02 25.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.702 -177.038 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.736 ' HB ' HG12 ' A' ' 109' ' ' VAL . 61.6 mt -110.51 100.86 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-O 121.709 0.766 . . . . 0.0 109.037 175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.831 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 76.1 p -97.66 116.26 29.53 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.744 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.687 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 4.3 t -78.9 158.96 27.97 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.322 174.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.1 m -148.05 111.73 5.05 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.707 ' HB3' HD11 ' A' ' 151' ' ' ILE . 71.3 t80 -123.4 119.82 31.17 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 62.08 33.61 16.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.863 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.84 62.92 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.199 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -132.72 133.32 43.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 0.0 110.98 175.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 3.1 mp0 -81.37 132.84 35.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.307 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.0 p90 -125.73 2.06 7.47 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.831 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.3 tt -156.84 159.49 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' HA ' ' B' ' 130' ' ' ILE . 5.0 tmm_? -152.79 105.46 2.96 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.708 0.63 . . . . 0.0 109.559 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.736 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.3 p -95.0 102.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -89.99 102.65 2.93 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.82 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.967 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 10.3 m-85 -98.96 121.98 41.62 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.573 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.572 ' CB ' HD12 ' A' ' 140' ' ' LEU . 57.2 m-85 -68.97 115.86 8.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.295 176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.847 HG13 HG23 ' A' ' 93' ' ' THR . 1.8 p -101.27 109.71 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 122.32 1.057 . . . . 0.0 108.28 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.507 ' OD1' HG23 ' A' ' 92' ' ' VAL . 8.6 t30 -97.14 104.4 16.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.727 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.616 ' HB3' HD11 ' A' ' 135' ' ' LEU . 31.8 m-80 -89.55 110.16 21.04 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.02 130.16 49.45 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.69 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 25.9 m-85 -38.55 150.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -84.44 -34.32 23.49 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.223 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.519 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 10.6 tt0 -86.51 119.43 26.76 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.249 -1.796 . . . . 0.0 108.504 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.859 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 99.2 m -54.89 -31.3 59.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.084 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.18 -32.29 70.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 92.0 mt -73.42 -27.05 61.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.253 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.859 ' HE ' ' HA ' ' A' ' 120' ' ' THR . 19.3 mtm180 -74.46 -38.18 63.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.616 0.722 . . . . 0.0 109.257 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.722 ' HG3' ' O ' ' A' ' 120' ' ' THR . 45.9 mt-10 -58.66 -39.64 81.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.339 -1.301 . . . . 0.0 111.126 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.4 p30 -146.8 86.13 6.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 18.7 Cg_endo -57.43 114.36 1.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.789 2.326 . . . . 0.0 111.318 176.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.532 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 54.0 Cg_exo -55.17 141.74 79.56 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.265 1.977 . . . . 0.0 109.899 175.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.75 -13.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.972 0.795 . . . . 0.0 112.454 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -124.63 100.22 34.89 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.162 0.982 . . . . 0.0 111.824 167.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.69 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 7.7 Cg_exo -44.77 144.83 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.827 1 C-N-CA 125.453 4.102 . . . . 0.0 113.378 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.2 t70 -113.65 111.67 22.22 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.684 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 9.9 m-85 -75.93 -11.39 59.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.546 1.165 . . . . 0.0 110.596 -170.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -90.3 -34.5 15.71 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.056 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 61.2 mmtt -92.79 17.67 10.09 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 33.1 tp -100.6 128.67 46.57 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.334 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -120.72 110.93 16.97 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.848 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.94 113.85 25.56 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.096 0.474 . . . . 0.0 111.681 -174.685 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 11.5 t30 -89.89 112.55 23.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 172.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.514 HG21 HG11 ' A' ' 11' ' ' VAL . 1.7 mp -83.71 103.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.313 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.572 HD12 ' CB ' ' A' ' 112' ' ' TYR . 86.3 mt -63.57 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.296 0.569 . . . . 0.0 110.938 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.967 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.08 -11.82 60.01 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.738 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -79.23 -3.33 45.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.574 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -143.79 71.08 17.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.94 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.3 Cg_endo -89.72 106.54 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.292 1.995 . . . . 0.0 111.234 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 81.22 8.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.038 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 109' ' ' VAL . 32.4 m -77.36 131.52 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 86.2 m -151.09 110.71 4.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.516 0.674 . . . . 0.0 110.566 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 5.6 ptt-85 -108.46 138.51 44.64 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.798 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 169.37 9.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.312 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.466 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.3 pt -129.91 -177.2 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.631 0.729 . . . . 0.0 111.469 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -98.15 84.22 3.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.972 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TRP . . . . . 0.721 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 63.7 m95 -69.45 -7.44 37.93 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.483 -0.76 . . . . 0.0 111.345 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.822 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 122' ' ' LYS . . . . . 0.663 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 39.5 mmtt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.075 0.464 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.488 ' HA ' HD12 ' B' ' 126' ' ' LEU . 16.0 t70 -31.11 -46.06 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 177.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.3 tt -73.82 -38.3 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.4 0.619 . . . . 0.0 110.489 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 1.6 tp-100 -66.36 -37.39 85.21 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.449 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.801 ' O ' ' HB ' ' B' ' 130' ' ' ILE . 20.0 mt -59.52 -50.32 74.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.299 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' B' ' 131' ' ' ARG . . . -62.65 -42.51 99.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.818 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.554 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 81.3 mtt180 -56.74 -65.1 0.67 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.349 0.595 . . . . 0.0 111.973 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ARG . . . . . 0.459 ' HD3' ' HB2' ' A' ' 51' ' ' GLU . 20.0 mmm180 -60.37 -30.5 69.61 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.118 -175.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -87.82 -7.48 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.215 -175.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 131' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' B' ' 127' ' ' ALA . 30.3 mmt180 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.513 0.673 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -102.31 155.93 17.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.669 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.2 mptp? -96.6 -18.53 19.68 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.26 -176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.83 125.36 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.752 0.787 . . . . 0.0 110.71 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.546 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.36 100.05 7.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.786 176.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -77.96 131.84 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.403 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -111.73 -66.77 1.05 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.071 -166.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.54 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 65.5 t30 -102.76 154.05 19.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.82 -176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 9' ' ' VAL . 6.1 p -144.83 99.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 CA-C-O 122.104 0.955 . . . . 0.0 109.214 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -92.26 95.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.322 1.058 . . . . 0.0 108.572 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.85 127.72 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.763 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.913 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.2 mt -97.48 -39.05 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.318 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.641 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 9.8 t0 -70.91 65.13 0.34 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.316 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.637 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m-20 -84.84 173.44 7.15 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 162.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.0 Cg_endo -50.32 101.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 121.508 1.574 . . . . 0.0 113.101 -158.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.637 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 13.9 m -136.21 169.44 13.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.861 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 70.5 Cg_exo -38.31 137.47 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.18 2.587 . . . . 0.0 113.496 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.729 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 19.2 t80 -63.09 -20.76 65.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 21.4 m-85 -94.38 5.62 51.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 111.235 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.77 140.92 47.44 Favored Pre-proline 0 C--O 1.213 -0.831 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 14.3 Cg_exo -74.56 141.92 28.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.691 2.261 . . . . 0.0 112.185 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.783 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 94.8 m-85 -60.24 117.07 4.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 122.964 0.506 . . . . 0.0 110.015 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.913 ' HB3' HD12 ' A' ' 12' ' ' LEU . 39.3 mt-30 -115.5 111.27 20.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.32 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' A' ' 97' ' ' ILE . 70.0 m-85 -121.58 107.51 12.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.497 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.624 ' HB2' HD21 ' A' ' 12' ' ' LEU . 22.0 tt0 -90.14 85.05 6.17 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 14.4 mt -86.83 132.4 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.694 0.759 . . . . 0.0 112.114 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.7 m -108.47 106.85 17.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.294 174.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.3 p90 -118.79 150.92 38.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.529 0.681 . . . . 0.0 109.717 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.837 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 47.2 tt0 -107.46 111.04 23.14 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.49 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 29.1 t -72.96 108.1 5.69 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -74.55 -27.21 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.031 -173.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.598 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 8.2 mt-10 -143.8 179.62 7.05 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.88 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -73.57 146.63 44.59 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.021 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -106.73 157.03 18.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -174.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -113.97 -41.85 3.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.889 0.852 . . . . 0.0 110.545 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.803 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 33.2 tt0 -113.33 -165.84 1.03 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.042 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.803 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -98.51 143.59 28.76 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.819 0.819 . . . . 0.0 110.599 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.821 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.68 124.13 29.92 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.38 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.595 ' HB3' ' O ' ' A' ' 100' ' ' THR . 42.3 tt0 -107.55 90.15 3.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.929 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 59' ' ' SER . 24.5 m95 -81.67 122.74 28.01 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.6 ttmt -126.4 141.59 51.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.574 HG22 HG22 ' A' ' 95' ' ' VAL . 13.8 mt -102.9 120.13 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.673 ' HB ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -114.38 106.33 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.287 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.686 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.5 t80 -88.87 116.69 27.34 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.73 105.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.151 0.5 . . . . 0.0 109.899 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.44 -35.77 92.49 Favored Glycine 0 CA--C 1.501 -0.808 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.172 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.577 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.6 t -139.14 116.56 11.25 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.587 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -70.35 -1.2 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 167.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -96.3 -27.02 15.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 47' ' ' SER . 14.5 m -144.67 109.45 4.99 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.828 0.823 . . . . 0.0 111.091 171.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.838 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -70.08 -23.76 63.12 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.399 -166.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -67.4 -2.33 6.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 4.2 m-30 -85.71 -4.02 59.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.041 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.595 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.2 p-10 -42.53 112.32 0.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.316 1.055 . . . . 0.0 112.206 -175.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 3.1 mt-30 -91.36 168.49 11.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.923 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.42 114.25 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -173.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.1 mm? -82.73 -49.29 9.92 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.059 -174.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -163.92 164.04 23.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 27.8 p -141.43 117.46 10.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.2 p -100.29 132.76 45.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.624 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.36 105.93 15.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.638 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.23 113.81 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.65 -166.38 12.39 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.098 -168.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.021 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.8 Cg_endo -65.23 115.27 3.22 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.407 1.404 . . . . 0.0 110.365 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 31.1 m -131.99 141.36 41.19 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.614 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.55 79.11 3.31 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.082 1.854 . . . . 0.0 113.482 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.29 -171.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.015 -1.902 . . . . 0.0 112.343 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.94 122.79 2.62 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.947 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.9 ttt180 -87.69 118.24 27.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 36.5 p-80 -161.06 166.0 28.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.41 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -108.64 139.46 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.174 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 9.8 p90 -126.69 160.91 29.39 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.14 106.42 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-O 123.06 1.41 . . . . 0.0 111.898 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 140.97 37.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.443 -2.162 . . . . 0.0 110.572 -176.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.783 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.0 mt-30 -150.68 149.84 30.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 165.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.593 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -158.65 132.14 7.48 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.457 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.719 ' O ' HD12 ' A' ' 57' ' ' LEU . 12.9 m-20 -67.18 143.19 56.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.163 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -52.2 157.22 2.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 124.704 1.201 . . . . 0.0 114.028 -173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.686 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.03 -179.92 3.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.97 3.113 . . . . 0.0 113.267 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 96.1 m-20 -82.18 119.17 74.4 Favored Pre-proline 0 CA--C 1.515 -0.388 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.263 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 16.1 Cg_endo -60.32 -25.18 79.64 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.538 2.826 . . . . 0.0 112.576 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.0 -15.86 81.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.417 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.422 ' CB ' HE21 ' A' ' 55' ' ' GLN . 31.3 mt -79.57 -25.94 41.47 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.242 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.69 129.29 49.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -80.06 164.02 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.746 2.964 . . . . 0.0 112.794 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.578 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 m-20 -45.12 -55.0 6.11 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.823 0.849 . . . . 0.0 113.071 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.0 -18.56 61.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.218 0.533 . . . . 0.0 110.596 -168.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.666 ' HA ' ' HZ1' ' B' ' 122' ' ' LYS . 40.2 t0 -92.36 -35.82 13.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -70.17 -45.38 66.84 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.381 0.61 . . . . 0.0 111.332 -171.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.19 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.77 0.795 . . . . 0.0 111.559 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.45 -160.14 10.09 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.433 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.536 HG12 ' OD1' ' A' ' 114' ' ' ASN . 4.7 m -94.87 144.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.907 ' HB ' HG13 ' A' ' 113' ' ' VAL . 2.8 m -151.15 170.24 19.92 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.597 HG23 HD13 ' B' ' 126' ' ' LEU . 3.9 t -132.7 144.6 36.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 118.939 0.79 . . . . 0.0 110.954 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 42' ' ' ILE . 10.5 p -129.04 105.48 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.916 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -104.13 135.51 45.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.792 -169.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 45.1 mt -103.29 99.82 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-O 121.919 0.866 . . . . 0.0 109.08 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.781 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 58.0 p -93.61 112.33 24.19 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.717 ' SG ' HD12 ' A' ' 38' ' ' LEU . 1.4 t -79.52 122.3 26.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 18.8 m -121.83 103.71 9.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.021 -167.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.677 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 61.4 t80 -109.14 120.28 42.05 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.413 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.677 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 15.5 mtp180 69.67 22.42 6.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.778 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.81 85.0 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -110.05 117.79 34.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.847 -0.676 . . . . 0.0 109.386 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 60.0 mt-10 -82.54 132.47 35.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.821 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.9 p90 -123.19 1.77 9.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.6 tt -159.24 157.86 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.73 HH12 ' HA2' ' B' ' 132' ' ' GLY . 22.3 ttm180 -150.99 101.37 2.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.463 0.477 . . . . 0.0 109.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.916 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -84.52 98.66 6.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.228 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.17 77.25 2.12 Favored Glycine 0 CA--C 1.488 -1.606 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.586 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.993 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -74.06 115.9 14.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.137 -1.032 . . . . 0.0 109.121 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.565 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.7 m-85 -66.31 120.58 13.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.907 HG13 ' HB ' ' A' ' 93' ' ' THR . 2.6 p -103.18 110.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.536 ' OD1' HG12 ' A' ' 92' ' ' VAL . 5.0 t30 -92.43 110.76 22.17 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.184 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 39.1 m-80 -97.78 107.84 20.42 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.447 ' HG3' ' ND2' ' A' ' 114' ' ' ASN . 33.5 mt-10 -139.96 141.22 36.44 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.184 -176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.741 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 46.4 m-85 -47.97 151.93 0.86 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -174.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -86.81 -37.72 17.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.534 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.3 mt-10 -82.94 132.0 35.17 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.766 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 m -55.73 -36.17 66.95 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.55 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.85 -40.42 84.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.897 0.856 . . . . 0.0 109.991 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 46.0 mt -77.73 -23.09 49.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.799 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -80.15 -37.04 34.28 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.2 mm-40 -56.19 -43.1 78.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.769 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 21.8 p-10 -152.72 89.11 3.82 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.447 0.641 . . . . 0.0 109.854 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.5 Cg_endo -50.46 116.01 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.769 2.979 . . . . 0.0 112.865 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.741 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 77.7 Cg_exo -52.75 136.79 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.007 2.471 . . . . 0.0 111.249 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' HE2' ' A' ' 129' ' ' LYS . 22.5 t -51.68 -40.68 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.555 -173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.8 mmpt? -94.83 137.96 22.25 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-O 121.153 0.501 . . . . 0.0 110.798 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.578 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 11.8 Cg_exo -69.89 123.77 10.38 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.7 2.933 . . . . 0.0 112.332 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' HB2' ' HE1' ' A' ' 117' ' ' TYR . 1.6 m-20 -104.57 97.09 7.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.681 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.684 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 33.4 m-85 -68.0 -16.33 64.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.994 0.902 . . . . 0.0 110.549 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 2.9 p -83.3 -21.72 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.1 mmtt -104.58 5.12 33.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 132' ' ' PHE . 17.6 tp -87.82 137.83 31.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.556 -168.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 15' ' ' PRO . 13.6 tt0 -120.41 127.5 52.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.842 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 21.2 mtm-85 -90.46 104.93 17.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 15.3 t30 -89.75 98.75 11.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -78.73 100.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 112' ' ' TYR . 95.8 mt -62.2 92.57 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.706 0.765 . . . . 0.0 111.14 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.993 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -78.93 -8.82 59.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.419 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 p -80.66 -10.55 59.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.03 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.4 t-20 -142.27 62.97 14.41 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.513 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 4.7 Cg_exo -81.0 109.11 2.14 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.3 2.0 . . . . 0.0 111.098 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.651 ' HB3' HD13 ' B' ' 130' ' ' ILE . 15.0 tpt180 -82.23 82.61 7.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.98 106.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.2 m -116.46 105.65 12.72 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.601 0.715 . . . . 0.0 109.308 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.864 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.5 ptt180 -112.53 148.32 34.74 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.805 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.454 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -129.42 167.45 17.79 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.145 -173.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.1 123.14 47.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.931 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 101' ' ' TYR . 38.9 pt -121.45 158.73 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -87.25 103.22 15.23 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.495 1.14 . . . . 0.0 110.365 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.669 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 7.9 m95 -75.54 -3.56 34.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.64 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -114.41 -173.55 2.31 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.212 -176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -114.32 71.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.327 178.573 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.47 80.23 7.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 110.101 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 45.6 ttp -87.76 -32.93 18.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.128 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 85.07 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.304 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.666 ' HZ1' ' HA ' ' A' ' 88' ' ' ASP . 9.5 mmmm -69.24 -50.67 45.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 109.993 -175.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -40.59 -54.89 2.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.044 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.489 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.9 tp -69.06 -32.07 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.851 0.357 . . . . 0.0 111.247 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 58.5 mm-40 -58.07 -46.91 84.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 173.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.597 HD13 HG23 ' A' ' 94' ' ' VAL . 30.8 mt -68.35 -43.62 77.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.319 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.29 68.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.712 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 95.9 mtt180 -54.14 -57.65 10.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 1.088 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 6.1 tpt180 -61.4 -35.45 77.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.269 -171.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 145' ' ' ARG . 23.8 mt -76.83 -49.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.65 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' B' ' 131' ' ' ARG . 7.3 mmm180 -53.22 -44.92 68.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 111.534 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.73 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 171.9 59.88 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.182 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 1.088 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 6.3 tp10 -128.59 -31.45 2.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.909 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.593 ' HG2' HG21 ' A' ' 98' ' ' THR . 17.6 tpt180 -57.84 -48.69 79.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.478 172.285 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.578 0.228 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -82.84 131.2 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 0.0 110.706 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.934 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.58 -21.57 18.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 34' ' ' LEU . 3.4 t -137.53 129.22 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.772 0.796 . . . . 0.0 111.08 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp-100 -115.04 100.55 8.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.233 -1.349 . . . . 0.0 107.421 169.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 29.9 t -74.28 124.73 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -107.39 -65.65 1.09 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.09 0.947 . . . . 0.0 109.146 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.685 HD22 HG13 ' A' ' 10' ' ' VAL . 67.3 t30 -106.41 151.8 24.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.849 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 26' ' ' ILE . 3.2 p -146.77 99.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.367 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.99 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.4 m -93.67 107.11 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 109.979 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.889 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -78.72 136.6 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.568 -176.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 23' ' ' GLN . 7.6 mt -111.05 -42.14 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.32 -172.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 23' ' ' GLN . 4.2 p-10 -69.69 43.66 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.41 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 12' ' ' LEU . 1.2 m-20 -79.0 169.91 18.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.7 Cg_endo -53.02 100.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.048 1.165 . . . . 0.0 114.206 -138.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.666 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.6 m -136.76 171.22 9.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 112.008 -2.36 . . . . 0.0 107.482 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 62.4 Cg_exo -39.83 141.46 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.695 2.263 . . . . 0.0 112.912 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.017 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.0 t80 -60.31 -30.6 69.59 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.378 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -79.38 -6.17 56.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.089 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -77.59 119.94 79.46 Favored Pre-proline 0 CA--C 1.507 -0.682 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.217 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.545 ' C ' HH22 ' A' ' 137' ' ' ARG . 47.2 Cg_exo -60.57 154.43 54.28 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 123.844 3.03 . . . . 0.0 113.391 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.77 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 80.2 m-85 -62.93 133.36 54.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.686 ' HB3' HD12 ' A' ' 12' ' ' LEU . 39.8 mt-30 -132.27 89.86 2.72 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.307 0.575 . . . . 0.0 109.552 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' HD11 ' A' ' 97' ' ' ILE . 79.9 m-85 -100.44 109.14 21.27 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.56 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.99 ' HB3' HG23 ' A' ' 10' ' ' VAL . 31.8 tt0 -91.66 85.87 5.81 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.684 HG13 HG23 ' A' ' 9' ' ' VAL . 2.6 mp -81.85 140.06 17.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.764 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 11.3 m -115.25 107.16 14.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.327 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 17.6 p90 -121.27 153.41 37.7 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.897 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 21.9 tt0 -109.4 118.3 36.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 24.4 m -74.07 109.25 7.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.469 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -72.81 -31.4 36.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.962 -174.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.934 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 47.8 mt-10 -142.89 166.74 23.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.772 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.2 m-20 -61.71 131.2 49.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.767 HD12 ' CE1' ' A' ' 101' ' ' TYR . 2.1 mm? -85.51 152.29 23.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -113.54 -36.82 4.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.68 0.752 . . . . 0.0 110.126 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 13.7 tt0 -117.13 -167.37 1.29 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.449 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 5.3 m-20 -96.19 138.43 33.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.516 0.674 . . . . 0.0 111.316 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.714 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.47 120.02 29.45 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.922 178.242 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.8 tt0 -106.92 89.32 2.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.638 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.706 ' O ' ' HA ' ' A' ' 59' ' ' SER . 27.6 m95 -76.35 129.08 36.08 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 30.0 ttmt -133.38 142.48 48.4 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.903 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 95' ' ' VAL . 10.7 mt -103.22 121.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -114.29 105.71 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.119 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.823 ' CE2' HG11 ' A' ' 113' ' ' VAL . 28.3 t80 -89.72 124.55 34.72 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.898 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.01 111.54 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.376 0.608 . . . . 0.0 110.343 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 53' ' ' TYR . . . -70.76 -35.71 66.45 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -172.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 39.6 t -134.53 118.85 17.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.772 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -66.05 0.23 2.04 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.999 0.428 . . . . 0.0 110.01 167.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -102.12 -17.12 16.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.286 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 50.4 m -124.64 -171.69 2.4 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.775 0.798 . . . . 0.0 111.086 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.65 -3.31 1.15 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.516 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -94.25 -13.16 26.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.675 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.698 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 3.5 m-30 -84.92 -15.82 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.335 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 8.7 p-10 -42.44 115.48 0.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.134 0.968 . . . . 0.0 111.979 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.444 ' HG2' HD12 ' A' ' 83' ' ' LEU . 11.2 mp0 -91.17 166.85 12.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.943 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.81 107.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.0 mm? -74.92 -40.06 61.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.671 -171.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.34 176.26 2.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.887 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 58.1 p -151.49 115.28 4.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.84 132.42 45.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.918 -175.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 6.4 mt -102.73 106.26 16.85 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -92.98 120.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -84.16 -156.68 24.44 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.925 -165.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 38.6 Cg_endo -64.6 118.79 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.952 1.768 . . . . 0.0 110.53 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.626 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 28.5 m -134.8 141.87 40.22 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.514 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -86.17 75.33 2.98 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.421 2.08 . . . . 0.0 114.599 -173.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.634 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 48.19 -179.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.954 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 114.45 129.22 4.73 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.138 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.897 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.1 ptt-85 -75.87 126.21 30.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.421 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 4.9 p80 -153.68 141.6 20.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.936 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -95.55 137.75 34.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -177.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.7 p90 -135.68 146.37 47.71 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 13.8 p -104.26 125.65 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 122.318 1.056 . . . . 0.0 110.438 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.489 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 12.0 t80 -119.53 113.04 20.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.764 -163.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 38.3 mt-30 -138.46 149.99 46.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.476 -167.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' C ' ' HB3' ' A' ' 21' ' ' PRO . . . -169.34 146.07 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.351 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.656 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.1 p-10 -61.24 170.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.05 0.452 . . . . 0.0 111.413 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -71.12 164.22 58.82 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.688 -170.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.77 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 34.7 Cg_endo -60.92 168.21 7.59 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.355 2.703 . . . . 0.0 111.69 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 11.5 m120 -69.75 115.54 34.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.0 -175.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 13.2 Cg_endo -61.89 -26.68 79.31 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.225 2.617 . . . . 0.0 112.045 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.61 14.55 55.26 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.292 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 83' ' ' LEU . 15.6 mt -116.74 -33.75 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.391 0.139 . . . . 0.0 110.816 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 36.5 mt -73.71 129.89 84.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.127 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 95.0 Cg_endo -79.92 162.26 23.72 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.221 2.614 . . . . 0.0 112.699 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.734 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 12.1 m-20 -45.85 -52.54 11.19 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.673 0.789 . . . . 0.0 112.202 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.71 -28.61 65.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.835 ' HA ' ' NZ ' ' B' ' 122' ' ' LYS . 49.1 t0 -80.87 -38.97 27.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -65.45 -38.7 90.62 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -165.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -102.39 46.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 -138.85 3.0 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.118 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' B' ' 122' ' ' LYS . 1.1 t -97.13 135.87 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.059 0.933 . . . . 0.0 113.256 -172.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.699 ' HB ' HG13 ' A' ' 113' ' ' VAL . 1.7 m -140.51 168.82 18.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.769 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -125.54 143.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 118.318 0.508 . . . . 0.0 111.127 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 42' ' ' ILE . 7.3 p -131.06 108.23 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.65 154.91 18.46 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.983 -171.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.647 ' HB ' HG12 ' A' ' 109' ' ' VAL . 2.4 mt -117.39 105.07 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.825 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.0 p -100.62 114.8 28.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.227 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.566 ' HB2' HG22 ' A' ' 107' ' ' ILE . 62.6 m -79.68 115.76 19.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.452 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -108.54 101.91 11.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.991 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.767 ' CE1' HD12 ' A' ' 34' ' ' LEU . 87.1 t80 -104.31 127.83 52.02 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.599 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 37.0 mtp180 67.02 14.19 9.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.3 65.24 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.731 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.752 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -119.74 129.37 54.47 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.8 mp0 -83.6 133.68 34.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.418 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.714 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.5 p90 -121.47 -5.1 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.825 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.9 tt -156.17 158.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 174.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.98 HH22 ' HG3' ' A' ' 145' ' ' ARG . 4.3 tmm_? -150.87 107.68 3.54 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -174.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.2 p -102.64 101.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.188 0.994 . . . . 0.0 109.321 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.23 86.66 1.38 Allowed Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 119.762 -1.209 . . . . 0.0 111.499 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.771 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 17.1 m-85 -82.17 122.29 27.69 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.192 -1.004 . . . . 0.0 108.805 172.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 140' ' ' LEU . 31.6 m-85 -68.48 131.91 46.08 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.332 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.823 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.6 p -104.89 111.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.41 ' OD1' HG23 ' A' ' 92' ' ' VAL . 48.4 t30 -90.58 110.51 21.65 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.349 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 28.5 m-80 -102.68 107.34 18.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -131.91 130.03 41.06 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.612 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.7 m-85 -40.86 148.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.8 p -89.65 -29.27 18.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.771 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 30.2 mm-40 -91.31 140.0 30.2 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.556 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.0 m -52.05 -47.95 64.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 117.928 0.331 . . . . 0.0 111.206 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.27 -39.76 67.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.988 0.899 . . . . 0.0 110.045 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.5 mt -77.6 -30.34 52.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.376 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 52.1 mtp180 -76.83 -39.06 52.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.501 0.667 . . . . 0.0 109.516 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.746 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 1.5 pt-20 -80.85 -20.6 41.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.597 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.746 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -149.82 77.38 8.58 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.841 170.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 18.1 Cg_endo -57.03 118.42 5.28 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.634 2.889 . . . . 0.0 112.94 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 14.9 Cg_exo -71.63 147.81 51.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.065 2.51 . . . . 0.0 110.197 172.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.1 -27.75 43.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.866 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -89.12 122.21 68.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 0.0 111.271 175.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.734 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 36.5 Cg_exo -63.54 131.78 33.0 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 124.253 3.302 . . . . 0.0 112.588 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.0 t0 -114.05 105.28 13.03 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.727 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 42.6 m-85 -77.87 -19.86 54.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.846 0.832 . . . . 0.0 110.344 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.3 t -79.94 -29.91 39.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.804 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 71.6 mmtt -98.82 14.41 28.97 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 28.8 tp -99.68 143.91 29.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.213 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -124.91 129.95 51.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 1.017 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 10.0 mtm180 -95.5 106.01 18.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 4.4 t30 -96.35 99.71 11.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.889 HG21 HG11 ' A' ' 11' ' ' VAL . 10.0 mm -68.05 117.86 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.633 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . 62.4 mt -74.35 75.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.719 0.771 . . . . 0.0 110.334 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.771 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -68.85 -13.14 62.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.974 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -75.46 -12.77 60.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.457 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.412 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.5 t-20 -133.9 60.46 45.69 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 24.1 Cg_exo -68.84 105.24 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.549 1.499 . . . . 0.0 111.497 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.98 ' HG3' HH22 ' A' ' 108' ' ' ARG . 18.2 tpt85 -87.69 88.67 7.73 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.758 HG12 HG23 ' A' ' 109' ' ' VAL . 22.6 m -92.54 124.58 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.461 HG22 ' CE2' ' A' ' 149' ' ' PHE . 98.8 m -132.8 107.78 8.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.379 0.609 . . . . 0.0 109.708 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.731 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -106.64 140.33 39.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.418 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -126.18 118.7 25.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.458 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 143.49 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 110.812 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.752 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 46.6 pt -131.9 177.29 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 154' ' ' GLU . 6.8 p-10 -97.97 94.2 6.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.313 1.054 . . . . 0.0 109.425 176.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.0 m95 -71.73 4.55 3.13 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.178 -1.373 . . . . 0.0 108.897 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 152' ' ' ASN . 16.9 mt-10 -133.29 151.93 51.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.622 -173.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.06 70.12 9.98 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.0 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.842 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.673 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.715 -0.154 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -161.43 -174.07 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 73.5 mtm -72.54 -65.35 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.6 -64.74 0.11 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.835 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 75.7 mmtt -148.44 -61.85 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 p30 13.18 -93.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' B' ' 127' ' ' ALA . 13.7 tt -62.03 -27.36 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.5 tm0? -63.84 -58.56 6.42 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 121.745 0.783 . . . . 0.0 110.196 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' B' ' 122' ' ' LYS . 1.2 mm? -64.23 -28.89 70.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.611 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . . . -62.33 -40.53 96.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.813 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -51.35 -53.88 31.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.562 ' O ' ' HB3' ' B' ' 133' ' ' GLU . 16.6 mmm180 -70.47 -25.85 63.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.87 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.547 HG12 HH12 ' A' ' 108' ' ' ARG . 5.6 mt -65.47 -39.48 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.395 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.62 31.6 5.49 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.426 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 178.67 37.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.173 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -59.5 -62.55 1.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.903 175.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.07 -31.2 1.01 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.175 -174.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.305 179.338 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' HE2' ' A' ' 3' ' ' LYS . 24.0 ptm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.789 0.328 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -93.22 141.58 28.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.739 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 22.0 mmtt -101.02 -9.02 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.055 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.502 ' N ' HG13 ' A' ' 31' ' ' ILE . 2.7 t -142.95 126.96 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.417 0.627 . . . . 0.0 110.687 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.578 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 6.0 tp-100 -124.09 100.8 6.9 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.099 174.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.611 HG11 ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -82.48 131.43 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.127 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -115.81 -63.53 1.44 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.531 -162.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.691 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 57.7 t30 -100.07 148.88 24.07 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.852 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.3 p -146.08 102.23 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-O 121.797 0.808 . . . . 0.0 109.934 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.975 HG23 ' HB3' ' A' ' 25' ' ' GLU . 3.3 m -98.39 96.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.779 0.799 . . . . 0.0 109.804 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.865 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -74.96 129.43 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 122.017 0.913 . . . . 0.0 110.427 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.888 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.1 mt -98.82 -36.36 9.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.455 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.739 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 16.9 t70 -68.88 39.55 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.683 170.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.632 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -79.22 172.47 9.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.3 Cg_endo -50.38 101.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 120.841 1.336 . . . . 0.0 113.006 -152.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.661 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 21.2 m -141.95 171.62 7.07 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 112.193 -2.276 . . . . 0.0 107.676 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 67.2 Cg_exo -38.22 132.65 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.484 2.123 . . . . 0.0 112.301 175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.735 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 33.3 t80 -54.22 -28.13 39.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.868 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -86.84 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.74 0.305 . . . . 0.0 111.039 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.62 120.22 79.48 Favored Pre-proline 0 CA--C 1.513 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.721 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.4 Cg_exo -63.85 146.04 91.2 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 123.821 3.014 . . . . 0.0 113.161 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.761 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 37.8 m-85 -60.35 115.11 3.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.904 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.888 ' HB3' HD12 ' A' ' 12' ' ' LEU . 35.9 mt-30 -118.99 102.03 8.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.95 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.64 ' CD1' HD11 ' A' ' 97' ' ' ILE . 87.5 m-85 -109.65 111.4 22.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.462 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.975 ' HB3' HG23 ' A' ' 10' ' ' VAL . 30.6 tt0 -93.38 85.23 4.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.95 132.95 32.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 122.049 0.928 . . . . 0.0 112.609 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 25.5 m -104.15 107.17 17.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.173 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.588 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 27.5 p90 -117.53 148.2 42.09 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.925 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.861 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.9 tm-20 -101.94 111.33 23.55 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.4 t -72.4 108.63 5.6 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -75.03 -23.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.086 -171.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.739 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 50.3 mt-10 -155.37 148.31 24.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.62 131.47 50.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.949 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 4.7 tp -86.67 154.24 21.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.768 -168.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -113.18 -30.49 6.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.584 0.707 . . . . 0.0 110.372 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.811 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.8 tt0 -117.01 -167.51 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.811 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 4.6 p-10 -100.67 137.68 38.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.843 0.83 . . . . 0.0 111.523 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.26 122.25 27.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.112 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.633 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.9 tt0 -106.84 89.82 3.13 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.28 -176.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 59' ' ' SER . 15.1 m95 -78.0 135.8 37.85 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.7 ttmt -137.37 137.5 38.93 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.288 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.964 HG22 HG22 ' A' ' 95' ' ' VAL . 8.9 mt -102.46 110.16 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.6 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 49.9 mt -108.43 106.11 20.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.74 -172.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.845 ' CE2' HG11 ' A' ' 113' ' ' VAL . 25.3 t80 -89.49 108.53 19.7 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.867 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t -53.44 104.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.748 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.08 99.84 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.152 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 53' ' ' TYR . 29.4 t -131.78 128.81 39.6 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' B' ' 126' ' ' LEU . . . -75.93 -5.94 48.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.978 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -100.03 -35.52 9.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.537 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 8.9 m -122.35 97.41 5.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.056 0.931 . . . . 0.0 110.059 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' B' ' 128' ' ' ARG . 0.0 OUTLIER -67.65 -11.08 57.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.03 -172.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.73 -12.08 60.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.651 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 16.9 m-30 -87.65 10.25 18.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.273 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.486 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 4.9 p-10 -54.93 110.3 0.64 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.092 0.949 . . . . 0.0 111.162 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HG2' HD12 ' A' ' 83' ' ' LEU . 4.8 mt-30 -92.7 169.95 10.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.507 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.64 112.64 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -169.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 44' ' ' TYR . 3.7 mm? -76.34 -42.66 44.19 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.484 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 5.4 p-10 -170.6 173.95 5.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.489 171.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 50.8 p -145.36 117.56 8.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.63 128.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.459 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.9 mt -103.18 104.02 14.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.049 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.49 119.43 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -82.27 -151.67 9.74 Favored Glycine 0 CA--C 1.482 -1.979 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.158 -165.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.949 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 2.1 Cg_endo -46.35 117.14 1.83 Allowed 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.454 1.436 . . . . 0.0 109.144 167.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.413 HG13 ' SG ' ' A' ' 30' ' ' CYS . 2.6 p -133.66 120.98 15.86 Favored Pre-proline 0 C--N 1.288 -2.106 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.7 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.71 130.75 41.58 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.154 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -44.61 147.21 0.63 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.832 0.708 . . . . 0.0 111.255 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.84 130.29 2.25 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.09 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.861 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -74.43 116.97 15.71 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.789 0.804 . . . . 0.0 110.889 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -150.72 152.13 33.44 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.36 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.718 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.6 ttp -98.92 126.94 44.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.324 0.583 . . . . 0.0 111.116 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -117.95 133.18 56.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.3 p -101.95 127.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.433 1.111 . . . . 0.0 110.392 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.545 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 1.2 t80 -117.34 133.89 55.46 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.655 -1.612 . . . . 0.0 109.465 -164.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.739 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 9.2 mt-30 -151.69 150.36 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.047 0.451 . . . . 0.0 110.398 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -160.37 168.48 25.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.38 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.07 -175.32 0.07 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.844 0.831 . . . . 0.0 112.162 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -89.52 158.28 45.9 Favored Pre-proline 0 N--CA 1.438 -1.046 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.726 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.761 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 46.6 Cg_endo -65.41 168.57 14.21 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.042 2.495 . . . . 0.0 111.602 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 5.1 m-20 -79.56 115.3 52.42 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.3 Cg_endo -62.85 -19.91 69.93 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.634 2.889 . . . . 0.0 112.707 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.56 -5.06 79.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.349 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.491 HD12 ' HG2' ' A' ' 55' ' ' GLN . 9.3 mt -95.5 -27.82 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.965 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 44' ' ' TYR . 11.4 mt -82.66 130.86 56.79 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 0.0 112.339 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 84' ' ' ILE . 5.4 Cg_endo -81.13 156.6 19.94 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.22 2.614 . . . . 0.0 111.903 170.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.77 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.9 m-20 -47.25 -49.12 24.07 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.67 76.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.521 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.5 -17.27 23.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.085 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -71.59 -45.87 60.96 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.3 0.572 . . . . 0.0 111.258 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.74 45.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.95 -173.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.74 -135.5 2.03 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.838 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.521 HG23 ' OD1' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -98.94 135.27 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-O 122.164 0.983 . . . . 0.0 112.552 -170.8 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.16 167.62 24.57 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG11 HD11 ' B' ' 130' ' ' ILE . 4.6 t -112.83 141.96 26.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.586 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.964 HG22 HG22 ' A' ' 42' ' ' ILE . 3.8 p -125.61 101.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 158.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.6 ' CD1' ' HB ' ' A' ' 43' ' ' ILE . 1.1 pp -94.62 149.34 21.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.448 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.874 ' HB ' HG12 ' A' ' 109' ' ' VAL . 3.2 mt -114.74 101.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.352 0.596 . . . . 0.0 109.829 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 70.7 p -98.37 116.48 30.69 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.047 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.629 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.4 m -82.31 118.23 23.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 20.8 m -106.85 128.22 54.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.784 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 65.3 t80 -132.7 121.18 22.71 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.826 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 22.5 mtp180 67.65 26.17 8.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.292 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.02 6.01 82.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.414 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -116.44 115.28 25.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.083 -0.558 . . . . 0.0 109.836 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 44.0 mp0 -77.27 124.89 28.47 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.784 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 29.0 p90 -113.88 -4.2 13.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 98' ' ' THR . 7.7 tt -158.08 158.83 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.557 HH22 ' HA2' ' B' ' 132' ' ' GLY . 24.4 ttp180 -150.71 106.81 3.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.336 0.397 . . . . 0.0 110.043 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.874 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.2 p -91.27 99.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.544 1.164 . . . . 0.0 108.455 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.507 ' HA3' HG12 ' B' ' 130' ' ' ILE . . . -80.49 95.8 1.6 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.231 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.975 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 4.4 m-85 -93.6 109.57 21.19 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.957 0.884 . . . . 0.0 109.245 174.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' N ' ' HD1' ' A' ' 112' ' ' TYR . 2.3 m-85 -76.15 114.88 15.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.286 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.845 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.1 p -88.09 108.67 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.521 ' OD1' HG23 ' A' ' 92' ' ' VAL . 6.7 t30 -95.56 103.61 15.48 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.477 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -91.97 121.41 33.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.288 0.566 . . . . 0.0 110.064 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.84 138.91 30.64 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.628 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 47.5 m-85 -48.8 156.65 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -92.12 -30.18 16.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.982 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.494 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 4.6 mm-40 -82.22 129.57 34.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.097 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.708 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.4 m -53.86 -40.83 66.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.991 0.182 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.01 -35.58 66.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.11 0.957 . . . . 0.0 110.179 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 82.4 mt -85.07 -22.0 29.13 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.785 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 47.3 mtp180 -83.17 -39.67 20.71 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.708 ' HG2' ' O ' ' A' ' 120' ' ' THR . 11.5 pt-20 -70.35 -31.7 69.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.725 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.61 ' OD1' ' HG3' ' A' ' 124' ' ' GLU . 1.2 p-10 -147.61 82.08 8.23 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.14 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 29.5 Cg_endo -61.75 117.86 4.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.551 2.834 . . . . 0.0 112.248 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.6 Cg_exo -69.04 161.05 47.44 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.915 2.41 . . . . 0.0 110.943 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.69 -25.36 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HD3' ' HD3' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -89.7 128.38 50.73 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 121.397 0.618 . . . . 0.0 110.788 172.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.77 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 1.1 Cg_endo -82.66 141.64 11.09 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.054 3.169 . . . . 0.0 112.15 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.1 t70 -124.85 112.18 16.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.231 0.538 . . . . 0.0 109.592 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.693 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.1 m-85 -79.4 -19.77 49.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.488 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.1 p -83.31 -24.06 32.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.494 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 73.3 mmtt -98.87 11.76 37.82 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.9 tp -95.91 133.45 40.08 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.806 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -116.16 120.47 39.12 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.757 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.35 109.05 21.23 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.644 -172.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.687 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 5.2 t30 -86.2 98.5 10.95 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.094 173.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.865 HG21 HG11 ' A' ' 11' ' ' VAL . 1.4 mp -72.65 108.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.165 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 112' ' ' TYR . 36.4 mt -64.51 91.81 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.222 0.534 . . . . 0.0 111.834 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.975 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -80.66 -12.19 59.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -80.14 -11.92 59.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.997 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -138.51 70.12 45.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.818 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.636 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 63.9 Cg_endo -81.83 104.97 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.207 1.272 . . . . 0.0 109.666 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.546 ' HG3' HG21 ' B' ' 130' ' ' ILE . 0.2 OUTLIER -83.66 81.76 8.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.255 0.55 . . . . 0.0 110.532 -175.076 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.779 HG22 HG23 ' A' ' 109' ' ' VAL . 3.9 t -86.4 104.43 13.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.961 -174.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.524 HG21 HH21 ' A' ' 108' ' ' ARG . 48.8 m -112.77 106.93 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.739 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -108.37 138.24 44.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.8 0.81 . . . . 0.0 110.891 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.3 136.1 54.84 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.88 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 141.61 46.22 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.707 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.03 172.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.623 HD21 ' H ' ' A' ' 156' ' ' ASN . 17.4 p-10 -90.94 106.33 18.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.17 0.986 . . . . 0.0 110.451 171.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.729 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 8.0 m95 -81.28 5.77 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.956 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -130.25 -172.52 2.81 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.805 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.49 70.33 3.09 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.44 0.638 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.623 ' H ' HD21 ' A' ' 152' ' ' ASN . 93.6 m-20 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.44 48.86 1.01 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.224 0.535 . . . . 0.0 110.745 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 43.4 mtp -105.09 -64.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.149 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.63 136.61 15.16 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.284 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' B' ' 122' ' ' LYS . 11.5 mptt -91.95 -31.84 15.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.246 0.07 . . . . 0.0 110.906 -177.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -44.41 -45.16 8.85 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.321 0.388 . . . . 0.0 111.845 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 -43.07 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.257 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -53.41 -54.16 40.77 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.618 0.723 . . . . 0.0 111.278 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 48' ' ' ALA . 2.4 mm? -62.38 -37.4 85.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.481 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.96 75.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.429 HH21 ' CD ' ' A' ' 51' ' ' GLU . 10.4 mtm180 -59.02 -47.07 86.53 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.75 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 10.8 mmm180 -60.17 -41.6 93.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 145' ' ' ARG . 3.8 mp -90.45 -5.79 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -68.48 -44.83 73.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.557 ' HA2' HH22 ' A' ' 108' ' ' ARG . . . -175.46 25.65 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.36 -0.924 . . . . 0.0 113.638 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.75 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 0.4 OUTLIER -113.84 75.49 0.93 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.766 0.793 . . . . 0.0 108.873 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.462 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 19.1 mtm180 -53.46 -75.74 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.208 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.383 -177.253 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' HD12 ' A' ' 31' ' ' ILE . 39.2 ttp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.393 0.145 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . -91.04 -62.12 1.52 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.851 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 10.2 mptt -100.11 -22.05 15.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.438 HG23 HD21 ' A' ' 34' ' ' LEU . 3.6 t -139.28 131.94 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.871 0.843 . . . . 0.0 110.964 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.9 tp60 -125.67 100.14 6.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.851 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG22 ' CH2' ' A' ' 40' ' ' TRP . 11.6 t -70.79 146.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -131.16 -65.88 0.76 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.65 0.738 . . . . 0.0 109.594 -172.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.666 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 62.2 t30 -104.82 148.21 26.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.105 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.2 p -146.73 105.23 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.107 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.049 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -98.02 97.81 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.554 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -70.91 116.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.892 178.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.73 ' H ' HD22 ' A' ' 12' ' ' LEU . 1.4 mm? -80.71 -31.49 36.1 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.62 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' HB3' ' CG ' ' A' ' 23' ' ' GLN . 7.3 p-10 -82.62 44.47 0.9 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.681 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' HB3' ' CD ' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -73.59 168.61 23.91 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 159.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 31.6 Cg_exo -51.47 101.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.569 0 CA-C-O 122.729 1.054 . . . . 0.0 113.3 -135.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.846 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 70.1 m -129.99 166.87 23.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.731 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 50.1 Cg_exo -46.38 133.48 15.92 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.685 174.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.103 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 20.2 t80 -55.4 -23.98 27.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.056 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -92.91 5.56 50.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.846 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -96.3 120.15 63.01 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 169.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 70.3 Cg_exo -55.29 144.43 71.52 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.747 2.298 . . . . 0.0 112.91 -167.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.846 ' HE1' ' HD3' ' A' ' 79' ' ' PRO . 84.3 m-85 -52.58 143.02 16.69 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.745 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.678 ' CG ' ' HB3' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -143.25 110.64 5.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.747 0.784 . . . . 0.0 109.599 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 97' ' ' ILE . 81.7 m-85 -114.0 103.52 11.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.461 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.049 ' HB3' HG23 ' A' ' 10' ' ' VAL . 33.6 tt0 -84.23 85.13 7.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.729 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 4.5 mt -82.47 141.94 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.001 0.905 . . . . 0.0 113.042 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.5 m -119.51 108.8 14.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.294 171.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 17.3 p90 -117.96 146.38 44.04 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.245 0.545 . . . . 0.0 109.655 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.856 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.6 tt0 -101.89 109.36 21.09 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.9 m -72.79 119.76 17.48 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -90.2 -28.01 5.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.253 -169.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 48.3 mt-10 -146.69 169.06 19.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.979 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.06 127.9 34.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.993 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -81.7 155.21 25.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.158 0.504 . . . . 0.0 109.658 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.6 p -113.42 -14.36 12.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.208 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 102' ' ' ARG . 7.7 tt0 -138.64 -167.52 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.65 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.813 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 22.2 m-20 -97.74 136.38 38.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 110.872 -175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 99' ' ' CYS . 0.2 OUTLIER -81.67 120.09 24.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.202 175.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 100' ' ' THR . 44.1 tt0 -105.65 90.12 3.3 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.093 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.729 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 31.0 m95 -74.12 109.41 7.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.731 ' HE2' HG13 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -116.31 129.61 56.36 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -173.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.711 HG22 HG22 ' A' ' 95' ' ' VAL . 7.7 mt -102.1 115.96 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 43' ' ' ILE . 2.9 mp -110.84 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.611 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.727 ' CE2' HG11 ' A' ' 113' ' ' VAL . 26.4 t80 -84.02 119.78 25.35 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.513 HG11 HD12 ' B' ' 126' ' ' LEU . 17.6 t -70.57 97.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -85.75 -4.54 85.02 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.643 ' HB2' ' C ' ' A' ' 50' ' ' SER . 3.7 p -115.19 68.04 0.7 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.056 0.455 . . . . 0.0 111.439 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' B' ' 122' ' ' LYS . . . -76.15 -8.82 57.87 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.81 0.814 . . . . 0.0 108.834 166.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -99.17 -49.62 4.43 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.48 -1.237 . . . . 0.0 109.863 172.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.643 ' C ' ' HB2' ' A' ' 47' ' ' SER . 3.5 m -103.01 -138.88 0.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.877 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.61 3.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.502 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -97.7 -7.26 31.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 111.814 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 37.4 m-85 -94.81 -0.98 53.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -170.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 18.5 p-10 -51.51 110.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.989 0.899 . . . . 0.0 110.592 172.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 80' ' ' ASN . 18.5 mp0 -91.71 168.26 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.247 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.731 HG13 ' HE2' ' A' ' 41' ' ' LYS . 2.5 t -126.09 110.86 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.193 -173.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -82.11 -57.58 3.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -172.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 7.7 t70 -170.35 162.35 8.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.71 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 12.1 p -130.19 119.4 22.9 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.0 p -101.59 129.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.3 mt -104.85 103.32 12.89 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.455 0.645 . . . . 0.0 110.967 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.02 119.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -87.96 -136.87 5.38 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.754 -1.212 . . . . 0.0 111.922 -162.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.993 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 5.7 Cg_endo -50.32 117.02 2.84 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.231 1.954 . . . . 0.0 111.324 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.473 HG21 ' HE2' ' A' ' 28' ' ' PHE . 13.0 m -121.41 111.67 33.25 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.187 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.8 61.49 5.51 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 123.353 2.702 . . . . 0.0 114.284 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.751 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.52 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 112.797 -2.001 . . . . 0.0 112.605 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 111.14 122.96 4.34 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 175.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 5.6 ptp85 -66.65 130.93 44.81 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.858 0.837 . . . . 0.0 110.005 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.461 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -151.58 158.2 43.21 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.099 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.2 138.11 51.91 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.296 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 11.2 p90 -137.49 148.82 46.33 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.3 p -106.67 119.27 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 122.316 1.055 . . . . 0.0 110.555 -174.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.517 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -111.11 154.27 24.53 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.468 -1.696 . . . . 0.0 109.217 -168.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.0 mt-30 -151.89 160.67 43.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -168.98 145.34 3.48 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 57' ' ' LEU . 6.5 m-20 -59.26 -177.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 112.24 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -84.4 155.12 63.02 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.846 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -66.83 157.52 60.9 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.684 2.256 . . . . 0.0 110.856 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.5 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 94.9 m-20 -63.12 117.84 37.16 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 -170.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.87 -13.42 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.41 2.74 . . . . 0.0 112.004 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.37 -1.1 69.44 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.569 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 83' ' ' LEU . 20.7 mt -103.87 -34.09 8.64 Favored 'General case' 0 CA--C 1.514 -0.421 0 O-C-N 122.928 -0.16 . . . . 0.0 111.286 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 36.4 mt -72.35 125.43 91.38 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.801 -175.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 95.8 Cg_endo -79.26 163.14 25.19 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.788 2.992 . . . . 0.0 111.932 170.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.716 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.8 m-20 -45.43 -54.08 7.84 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.176 0.99 . . . . 0.0 113.498 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.46 -8.64 58.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.512 0.196 . . . . 0.0 111.442 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.41 -38.77 11.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.997 0.427 . . . . 0.0 110.37 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.25 -46.16 35.51 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.915 -169.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.23 46.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.34 -134.53 2.03 Favored Glycine 0 CA--C 1.497 -1.057 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.657 HG23 ' HG3' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -104.49 130.77 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 CA-C-O 122.261 1.029 . . . . 0.0 113.574 -170.24 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.613 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -143.71 173.17 11.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.051 -1.886 . . . . 0.0 105.921 173.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.79 HG12 HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.0 143.52 39.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.704 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.711 HG22 HG22 ' A' ' 42' ' ' ILE . 9.9 p -121.78 104.43 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.921 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.75 126.81 48.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.711 -169.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 39.1 mt -95.18 102.0 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.099 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.775 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 67.8 p -91.14 109.81 21.07 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.844 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.609 ' HB2' HG22 ' A' ' 107' ' ' ILE . 61.5 m -73.44 109.1 6.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.894 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.584 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 16.1 m -103.68 101.87 11.72 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.529 -174.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.53 ' CE1' HD12 ' A' ' 34' ' ' LEU . 71.4 t80 -107.6 118.51 36.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 41.0 mtp180 72.97 19.63 3.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.96 0.504 . . . . 0.0 111.667 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.81 5.29 74.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.198 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.565 ' OE1' ' HB ' ' A' ' 151' ' ' ILE . 2.5 pt20 -120.65 127.96 52.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.554 ' OE2' ' HB3' ' B' ' 135' ' ' ALA . 4.0 mp0 -84.18 135.55 34.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.46 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.468 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 54.5 p90 -122.04 -1.5 9.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.1 tt -157.69 162.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.752 ' HG3' HG22 ' A' ' 98' ' ' THR . 9.0 ttm180 -149.2 99.39 2.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.921 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.25 100.55 8.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.823 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.61 79.58 1.74 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 119.413 -1.375 . . . . 0.0 111.116 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.906 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.7 m-85 -71.22 114.43 9.27 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.607 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.7 m-85 -66.59 110.84 3.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.727 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.8 p -92.53 109.99 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.648 ' OD1' HG13 ' A' ' 92' ' ' VAL . 26.6 t30 -95.82 108.13 20.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.499 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.687 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.3 m-80 -97.77 121.44 39.68 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.347 0.594 . . . . 0.0 110.086 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.86 140.36 32.88 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.855 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.546 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 46.5 m-85 -46.52 151.91 0.51 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.9 p -93.29 -29.92 15.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.345 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 70.5 mm-40 -76.37 125.56 29.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.625 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 16.7 m -55.72 -32.08 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.401 -172.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.45 -39.15 77.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.506 0.67 . . . . 0.0 110.013 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 81.8 mt -73.32 -23.69 60.28 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.626 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 22.0 mtt180 -74.45 -36.67 63.38 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 120' ' ' THR . 11.4 mm-40 -67.85 -44.23 77.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.776 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.6 p30 -138.13 82.05 25.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.729 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.4 Cg_endo -57.56 113.64 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.09 2.527 . . . . 0.0 111.579 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 24.2 Cg_exo -64.79 154.15 74.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.666 2.244 . . . . 0.0 111.593 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.1 p -46.76 -50.23 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 123.725 0.641 . . . . 0.0 112.428 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 1.7 mmtt -84.39 129.13 59.0 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 121.37 0.605 . . . . 0.0 111.055 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.716 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -72.06 125.18 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.653 2.902 . . . . 0.0 111.786 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -104.3 108.82 20.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.611 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 27.2 m-85 -77.91 -17.4 57.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.154 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 72.6 p -88.31 -15.07 36.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.911 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.1 mmtt -107.05 13.0 27.97 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 115' ' ' ASN . 18.3 tp -95.93 143.41 27.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.0 -172.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -124.29 124.05 41.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 1.103 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 25.7 mtm-85 -87.92 104.15 16.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.784 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.608 ' CG ' ' HG3' ' A' ' 15' ' ' PRO . 38.2 t-20 -90.34 89.38 7.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.461 HD12 HG23 ' A' ' 113' ' ' VAL . 1.3 mp -66.44 109.08 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 112' ' ' TYR . 89.6 mt -69.2 88.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.721 0.772 . . . . 0.0 110.433 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.906 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.63 -12.99 60.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.579 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.1 p -78.84 -12.01 60.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.72 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.47 64.21 57.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.661 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 98.6 Cg_endo -85.76 103.96 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.357 1.371 . . . . 0.0 109.902 172.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.632 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -84.47 80.35 9.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.306 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.659 HG12 HG23 ' A' ' 109' ' ' VAL . 26.7 m -76.88 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.739 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.445 HG22 ' CE1' ' A' ' 149' ' ' PHE . 97.7 m -138.82 107.56 5.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.467 0.651 . . . . 0.0 109.286 173.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.75 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 4.2 ptt180 -108.95 142.82 39.04 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.958 0.885 . . . . 0.0 111.321 -175.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -125.04 169.32 12.25 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.199 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.59 149.69 21.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.291 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.565 ' HB ' ' OE1' ' A' ' 104' ' ' GLN . 45.3 pt -142.29 168.33 14.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 154' ' ' GLU . 5.0 p-10 -96.55 89.84 5.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.313 1.054 . . . . 0.0 109.979 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.851 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 8.1 m95 -64.43 -1.57 1.81 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.681 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 152' ' ' ASN . 41.9 mt-10 -135.02 161.58 34.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.26 -167.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -83.68 70.18 10.28 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.152 176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.638 -178.191 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.4 ' N ' ' NE2' ' B' ' 125' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.23 91.4 1.67 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 111.934 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 68.6 mtm -133.93 -66.34 0.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -116.78 136.79 13.02 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.876 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.657 ' HG3' HG23 ' A' ' 92' ' ' VAL . 9.8 mmtp -66.31 -34.48 78.09 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.06 -58.13 2.58 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.928 0.768 . . . . 0.0 112.05 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 8.1 tp -65.98 -37.75 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.4 ' NE2' ' N ' ' B' ' 118' ' ' GLY . 72.9 mm-40 -60.46 -52.7 64.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.262 0.554 . . . . 0.0 110.509 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.624 HD22 ' O ' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -65.42 -44.12 88.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.032 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -40.49 82.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.29 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -59.31 -46.19 89.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 110.833 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.845 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 11.6 tpt180 -63.5 -39.15 93.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 145' ' ' ARG . 31.0 mt -76.44 -43.61 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.544 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -61.29 -30.13 70.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.52 72.86 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.795 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.845 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 36.1 tt0 -131.24 -28.48 1.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.191 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.42 ' C ' ' HD3' ' B' ' 134' ' ' ARG . 3.3 tmt_? -56.53 -52.97 62.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.554 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . 0 C--O 1.248 0.986 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.733 0.301 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -83.87 137.95 33.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.687 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.45 -18.01 27.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 -177.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 34' ' ' LEU . 2.7 t -139.97 139.4 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.482 0.658 . . . . 0.0 111.101 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.64 ' HB2' HD11 ' A' ' 31' ' ' ILE . 8.4 tp60 -140.39 102.82 4.43 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.894 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 28' ' ' PHE . 2.9 m -72.66 149.66 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.789 175.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.14 -63.02 1.02 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.447 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -105.31 112.41 25.51 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.244 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 9' ' ' VAL . 8.2 p -96.83 109.49 23.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -106.48 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 122.368 1.08 . . . . 0.0 108.965 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.586 HG12 ' CD2' ' A' ' 24' ' ' PHE . 18.4 m -77.29 123.15 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.333 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 25' ' ' GLU . 1.5 mt -89.63 -47.35 8.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.672 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.696 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 8.2 t0 -66.2 83.0 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.367 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.742 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.4 m-20 -100.7 174.4 2.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.31 -1.768 . . . . 0.0 107.021 164.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.887 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 3.2 Cg_endo -49.44 102.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.274 1.491 . . . . 0.0 113.123 -151.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.662 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 20.1 m -129.9 170.54 10.73 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 112.587 -2.097 . . . . 0.0 108.886 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.662 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.0 Cg_exo -40.77 139.49 1.29 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.888 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.728 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 44.7 t80 -68.36 -10.29 53.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -96.32 8.26 44.4 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.561 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -95.88 126.11 46.15 Favored Pre-proline 0 CA--C 1.508 -0.672 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 169.211 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.5 Cg_exo -64.97 154.09 75.03 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.254 2.636 . . . . 0.0 112.519 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' HE2' HH21 ' A' ' 137' ' ' ARG . 25.4 m-85 -65.28 128.41 35.74 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.256 174.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.707 ' HA ' ' HG2' ' A' ' 75' ' ' GLN . 33.5 mt-30 -125.76 102.74 7.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.798 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CD2' HG12 ' A' ' 11' ' ' VAL . 50.6 m-85 -105.77 144.92 31.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.597 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.7 tt0 -118.78 88.29 2.9 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 168.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.612 HD11 HD13 ' A' ' 97' ' ' ILE . 43.2 mt -84.51 119.52 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.939 0.876 . . . . 0.0 111.67 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 20.0 m -100.16 105.15 16.72 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.415 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.039 ' HB3' HG12 ' A' ' 6' ' ' VAL . 32.8 p90 -118.32 150.75 38.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.853 0.835 . . . . 0.0 110.343 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.8 tt0 -108.65 116.22 31.57 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.636 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 47.7 t -73.16 117.02 14.39 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -83.16 -28.85 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.832 -171.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.687 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 4.6 mt-10 -150.07 147.63 28.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.55 134.54 46.53 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.665 0.269 . . . . 0.0 111.238 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -94.31 157.79 15.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.288 -170.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.6 m -112.59 -39.58 4.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.037 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.833 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.6 tt0 -119.44 -168.28 1.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.297 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.833 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 3.2 m-20 -93.69 136.88 33.53 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.391 0.615 . . . . 0.0 110.205 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mm? -83.73 127.09 33.53 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.787 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 57.8 tt0 -116.68 90.23 3.29 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.628 -173.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.677 ' HZ3' HG21 ' A' ' 107' ' ' ILE . 35.7 m95 -84.21 133.65 34.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.5 ttmt -129.84 144.76 51.47 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.935 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.666 HD13 HG12 ' A' ' 97' ' ' ILE . 44.2 mm -102.02 107.45 21.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -102.13 113.6 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.831 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' HA ' HG12 ' A' ' 95' ' ' VAL . 34.4 t80 -95.16 122.24 37.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.111 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.79 HG13 ' CE2' ' A' ' 53' ' ' TYR . 4.8 t -72.51 98.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.698 0.761 . . . . 0.0 109.489 171.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.689 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -72.38 -55.13 7.07 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.383 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.585 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 44.4 m -119.8 73.17 0.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.7 0.4 . . . . 0.0 110.55 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -49.69 -19.06 0.55 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.337 0.589 . . . . 0.0 111.927 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' OE2' ' HE2' ' B' ' 122' ' ' LYS . 1.5 tp10 -71.46 -19.29 62.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.043 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.617 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 39.9 m -117.04 -151.2 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.768 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 8.5 pt-20 -154.25 19.01 0.49 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.669 0.747 . . . . 0.0 111.267 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 50' ' ' SER . 2.0 mp0 -98.18 -36.97 9.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.827 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.79 ' CE2' HG13 ' A' ' 45' ' ' VAL . 10.7 p90 -54.65 -41.79 70.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.593 -169.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 9.8 p-10 -30.71 105.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.212 0 O-C-N 125.134 1.521 . . . . 0.0 112.546 -165.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.723 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 24.0 mt-30 -95.12 165.86 12.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.905 -168.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -120.15 108.96 24.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.148 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD22 ' CG2' ' A' ' 42' ' ' ILE . 6.6 mp -73.31 -40.7 64.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.602 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -176.53 165.83 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.073 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.9 p -144.63 123.85 12.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.9 p -100.42 136.26 32.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.788 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.5 mt -110.71 105.72 14.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.023 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 89.3 t -96.4 118.15 42.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -76.35 -160.39 10.11 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.56 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.804 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.7 Cg_endo -67.9 115.28 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.397 1.398 . . . . 0.0 110.231 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 34.1 m -124.99 141.18 37.69 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.185 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -83.26 77.31 3.58 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 122.48 2.12 . . . . 0.0 113.575 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.696 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 44.98 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.012 -1.903 . . . . 0.0 112.357 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.39 139.43 9.77 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.496 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttt180 -77.69 116.88 18.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.797 0.808 . . . . 0.0 110.091 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -128.68 122.07 29.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.18 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.753 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -83.59 121.27 27.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.651 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.7 p90 -120.66 160.08 24.01 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.1 133.83 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 121.911 0.863 . . . . 0.0 110.093 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.651 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 2.7 t80 -135.44 107.57 7.19 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.951 -161.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.707 ' HG2' ' HA ' ' A' ' 23' ' ' GLN . 77.3 mt-30 -124.19 155.13 39.05 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -156.94 134.58 10.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.183 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 2.6 t0 -65.48 171.84 3.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -69.87 159.77 82.79 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.658 . . . . 0.0 111.304 -171.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 56.6 Cg_endo -66.75 172.87 8.86 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.343 2.696 . . . . 0.0 111.449 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 10.0 m-80 -70.97 121.37 83.87 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.014 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.5 Cg_endo -63.57 -12.84 33.06 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.154 2.569 . . . . 0.0 110.944 175.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.48 -19.18 46.04 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.714 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.723 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 12.4 mt -94.61 -1.56 53.02 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.594 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 24.8 mt -100.7 125.92 37.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.913 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 86.0 Cg_endo -79.28 158.76 26.29 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.017 2.478 . . . . 0.0 111.145 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.659 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 m-20 -47.53 -47.02 28.08 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.99 -37.21 47.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.798 175.033 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -68.68 -47.43 66.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.064 -167.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.3 m -101.93 46.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-O 122.208 1.004 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.88 -139.44 2.66 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.654 -163.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.761 HG13 ' HB2' ' B' ' 122' ' ' LYS . 12.4 p -122.44 145.73 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 121.875 0.845 . . . . 0.0 110.366 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.749 HG23 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -160.66 174.36 14.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.626 HG21 HD11 ' B' ' 130' ' ' ILE . 1.9 t -132.16 144.38 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.882 0.372 . . . . 0.0 111.686 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 29.3 m -124.74 105.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.838 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.4 pp -103.5 145.06 30.57 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.163 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 46.1 mt -102.83 100.77 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.615 0.722 . . . . 0.0 109.235 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 80.8 p -99.8 114.37 27.48 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.702 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 4.6 t -80.83 158.79 25.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.867 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -148.44 109.17 4.22 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -165.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 151' ' ' ILE . 56.1 t80 -124.0 120.83 33.58 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.517 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 43.1 mtp180 66.76 25.85 9.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.275 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.62 11.74 73.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.455 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -124.37 131.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.137 0.494 . . . . 0.0 110.078 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' B' ' 134' ' ' ARG . 37.2 mp0 -86.7 125.5 33.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.501 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.522 ' HZ ' ' CD1' ' A' ' 38' ' ' LEU . 54.8 p90 -119.82 2.58 11.08 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -168.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.844 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.0 tt -156.35 154.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.799 HH21 HG21 ' A' ' 147' ' ' THR . 0.3 OUTLIER -153.6 108.17 3.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -177.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 4.2 p -97.39 100.64 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 122.16 0.981 . . . . 0.0 109.26 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -83.43 84.11 1.58 Allowed Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.616 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.909 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 6.3 m-85 -80.52 116.17 20.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.126 . . . . 0.0 109.109 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.59 ' HA ' HG22 ' A' ' 94' ' ' VAL . 22.7 m-85 -68.4 135.99 52.61 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.749 HG13 HG23 ' A' ' 93' ' ' THR . 4.1 p -121.25 111.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 108.826 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -96.34 120.45 36.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.968 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.593 ' HB3' HD11 ' A' ' 135' ' ' LEU . 49.2 m-80 -100.42 118.82 37.44 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.535 0.683 . . . . 0.0 109.413 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.62 131.04 42.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.694 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.684 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 20.2 m-85 -43.88 151.48 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -92.56 -29.47 16.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.003 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 14.3 mm-40 -84.18 128.57 34.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.952 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.2 m -48.41 -45.96 36.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.048 0.218 . . . . 0.0 111.344 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.61 -31.38 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.766 0.793 . . . . 0.0 110.423 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.684 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 83.4 mt -84.6 -25.52 28.56 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.326 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 63.4 mtp180 -81.1 -36.63 30.14 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' THR . 9.6 pt-20 -74.01 -36.49 64.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.117 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' A' ' 124' ' ' GLU . 0.8 OUTLIER -142.88 80.58 13.73 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.096 176.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 19.0 Cg_endo -57.36 119.49 6.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.408 2.739 . . . . 0.0 112.045 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 16.8 Cg_exo -69.57 163.12 39.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.966 2.444 . . . . 0.0 111.737 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.29 -45.6 89.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 2.1 mmtt -89.5 129.87 45.61 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 121.385 0.612 . . . . 0.0 110.989 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.682 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.0 Cg_endo -79.21 147.72 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.966 3.111 . . . . 0.0 112.248 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.8 t0 -116.64 111.63 20.12 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.728 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 13.0 m-85 -77.92 -13.46 59.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.049 0.928 . . . . 0.0 109.659 -173.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -87.35 -24.05 24.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.186 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . 74.8 mmtt -98.92 9.6 43.15 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.7 tp -94.36 144.86 25.18 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.535 -172.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 4.1 tt0 -128.82 126.13 39.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.584 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.887 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -90.49 105.79 18.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.74 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.643 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.2 t30 -95.15 108.39 20.5 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.639 0.733 . . . . 0.0 109.434 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 139' ' ' ILE . 1.3 mp -85.19 109.71 18.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.058 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.58 85.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.673 . . . . 0.0 110.178 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.909 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.454 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.4 p -72.77 -16.36 61.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.11 68.67 76.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 46.1 Cg_endo -92.03 104.95 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.954 1.769 . . . . 0.0 110.327 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 18.4 tpt180 -85.98 92.5 8.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.16 0.505 . . . . 0.0 110.482 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.622 HG12 HG23 ' A' ' 109' ' ' VAL . 29.7 m -86.33 129.79 37.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.516 0.674 . . . . 0.0 111.446 -175.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.799 HG21 HH21 ' A' ' 108' ' ' ARG . 21.1 m -140.86 107.46 5.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.7 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -110.78 130.05 55.68 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.607 0.717 . . . . 0.0 110.701 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.05 142.55 46.83 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.922 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 137.18 42.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 110.892 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 101' ' ' TYR . 46.4 pt -131.74 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -93.21 92.56 7.8 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.038 0.923 . . . . 0.0 111.479 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.672 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 19.2 m95 -77.3 0.92 20.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.445 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -104.0 168.71 8.94 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.778 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -96.76 67.95 2.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.094 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.51 163.48 16.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 58.9 ttp -61.04 -75.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 110.325 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.68 ' O ' HG11 ' A' ' 92' ' ' VAL . . . -128.39 37.41 2.27 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.761 ' HB2' HG13 ' A' ' 92' ' ' VAL . 22.1 mmtp 65.12 -25.84 0.09 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.729 1.212 . . . . 0.0 112.518 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' B' ' 121' ' ' GLY . 0.9 OUTLIER -11.85 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 166.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.33 -36.2 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 17.4 mm100 -58.21 -52.37 65.86 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.92 0.867 . . . . 0.0 110.663 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.529 ' O ' HG13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -62.74 -40.88 98.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.042 177.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' B' ' 131' ' ' ARG . . . -63.24 -26.05 68.61 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.339 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 63.9 mtp85 -64.01 -52.05 61.36 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.819 0.343 . . . . 0.0 110.196 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.679 ' HD2' HD21 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -62.35 -36.86 83.53 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.77 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 49.4 mt -85.12 -3.01 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.863 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' ARG . . . . . 0.557 ' HA ' ' CZ ' ' B' ' 131' ' ' ARG . 1.4 tpm_? -90.97 -40.63 11.57 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.18 -0.95 . . . . 0.0 109.995 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 170.0 54.43 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.291 -1.433 . . . . 0.0 113.18 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.661 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 2.8 tp10 -88.5 -52.07 5.37 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.471 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 38.5 ptt180 44.18 115.83 0.0 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-O 123.382 1.563 . . . . 0.0 115.162 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.283 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.567 -176.378 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' HB3' ' A' ' 150' ' ' HIS . 13.7 ptp . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.29 126.79 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.857 0.361 . . . . 0.0 110.74 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.702 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.07 -8.48 39.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.809 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.768 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 1.5 t -147.28 140.78 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.389 0.614 . . . . 0.0 110.999 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' A' ' 31' ' ' ILE . 5.8 tp-100 -136.85 99.95 4.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.653 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.934 HG12 ' HB3' ' A' ' 28' ' ' PHE . 5.1 m -72.05 145.25 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.262 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -125.93 -62.05 1.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.931 -165.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.679 HD22 HG13 ' A' ' 10' ' ' VAL . 64.8 t30 -102.9 152.51 21.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.832 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.8 p -145.45 99.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.093 HG23 ' HB2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -88.71 99.5 9.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.825 -174.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.761 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.43 118.42 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.897 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.665 HD21 ' HG3' ' A' ' 25' ' ' GLU . 2.8 mt -88.79 -45.28 9.89 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.154 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.71 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 2.9 t70 -74.31 72.3 1.78 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.12 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.923 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 74.5 m-20 -84.07 174.84 5.32 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.719 -2.037 . . . . 0.0 107.801 162.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.923 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.0 Cg_endo -49.12 102.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 CA-C-N 120.912 1.362 . . . . 0.0 113.176 -149.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.832 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 67.7 m -129.93 168.43 16.65 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.535 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.8 Cg_exo -43.17 132.69 6.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.417 2.078 . . . . 0.0 112.622 174.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 65.2 t80 -61.51 -9.14 5.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -95.76 -1.66 49.34 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.725 -0.61 . . . . 0.0 112.226 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.832 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.2 OUTLIER -97.04 134.85 22.38 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.26 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.542 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.2 Cg_exo -65.11 151.74 84.61 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.271 2.647 . . . . 0.0 113.007 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 27.5 m-85 -62.97 118.8 8.31 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.204 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.71 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 33.3 mt-30 -115.79 111.89 21.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.459 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CD1' HD11 ' A' ' 97' ' ' ILE . 93.9 m-85 -116.0 155.34 28.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.142 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.093 ' HB2' HG23 ' A' ' 10' ' ' VAL . 43.4 mt-10 -126.78 91.07 3.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 162.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 97' ' ' ILE . 10.6 mt -77.2 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.8 m -111.19 107.18 16.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.303 176.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.934 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -113.54 150.35 33.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 CA-C-O 122.153 0.977 . . . . 0.0 111.131 176.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.9 tt0 -103.51 105.63 15.93 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 172.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.6 m -70.57 126.44 29.63 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.658 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -87.04 -25.71 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -165.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.702 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 44.6 mt-10 -147.47 167.9 23.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.908 174.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -74.72 142.42 44.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.054 HD11 ' HE1' ' A' ' 101' ' ' TYR . 0.4 OUTLIER -107.21 156.38 18.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.879 -168.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.607 ' N ' HD13 ' A' ' 34' ' ' LEU . 15.2 m -115.38 -35.99 4.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.711 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 23.1 tt0 -104.3 -166.32 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -172.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.711 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.3 p-10 -101.19 138.67 37.91 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 121.641 -0.662 . . . . 0.0 111.416 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.45 128.99 35.22 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.19 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 32.7 tt0 -104.03 90.4 3.59 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' SER . 14.8 m95 -86.84 109.5 19.33 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 1.104 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.4 OUTLIER -118.51 160.26 22.06 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.992 173.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.882 HD12 ' HB3' ' A' ' 76' ' ' ALA . 48.8 mt -101.68 108.71 24.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.713 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 2.2 mp -98.2 105.62 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.757 ' CE1' HG11 ' A' ' 113' ' ' VAL . 40.4 t80 -90.67 109.07 20.25 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.642 HG11 HD23 ' B' ' 126' ' ' LEU . 40.5 t -65.19 98.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.497 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.34 42.75 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 171.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.78 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 16.8 p -85.63 87.5 7.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.982 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' B' ' 126' ' ' LEU . . . -84.1 -13.89 51.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -100.49 -36.6 9.14 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.439 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.667 ' C ' ' HB2' ' A' ' 47' ' ' SER . 50.6 m -103.64 -154.45 0.5 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.39 5.07 0.45 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -94.92 -8.25 37.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.78 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 19.5 m-85 -98.18 11.07 39.0 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -170.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -64.32 99.08 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.082 0.944 . . . . 0.0 110.314 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -95.76 169.64 9.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.511 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.488 HG11 ' HE2' ' A' ' 41' ' ' LYS . 23.5 t -127.94 112.42 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -172.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 44' ' ' TYR . 3.3 mm? -77.51 -52.04 9.74 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.863 -175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 35.0 t70 -168.46 153.8 6.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.061 173.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 1.104 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 21.3 p -124.79 120.46 31.8 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG13 ' HD1' ' A' ' 40' ' ' TRP . 4.4 p -101.87 139.06 23.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.736 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.61 105.35 14.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.293 0.568 . . . . 0.0 111.601 -173.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 21.9 t -116.24 110.84 32.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -97.48 -112.63 3.03 Favored Glycine 0 CA--C 1.487 -1.711 0 C-N-CA 118.665 -1.731 . . . . 0.0 113.417 -159.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.895 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 17.5 Cg_endo -58.71 115.9 2.87 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 121.071 1.181 . . . . 0.0 109.961 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 63' ' ' GLY . 27.5 m -130.31 122.38 19.99 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.987 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.88 126.84 18.15 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.999 1.799 . . . . 0.0 111.021 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -41.02 134.14 2.05 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.05 0.844 . . . . 0.0 112.004 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 136.41 135.16 3.38 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.884 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.3 ptt180 -66.28 139.1 58.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.604 0.716 . . . . 0.0 110.46 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 11.0 p80 -166.39 151.23 7.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.392 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.655 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 2.1 ttp -107.9 137.81 45.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.341 0.591 . . . . 0.0 111.627 -174.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.671 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.3 p90 -125.69 150.67 47.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.719 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.5 p -105.37 135.12 44.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.8 0.81 . . . . 0.0 110.754 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.671 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.7 t80 -135.47 118.95 16.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.449 -166.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -130.35 154.29 47.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.51 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.882 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -155.33 153.33 30.34 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.0 p-10 -64.35 -171.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.933 0.873 . . . . 0.0 113.137 -170.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -86.09 142.96 36.55 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.299 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.687 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.7 Cg_exo -57.76 149.36 69.25 Favored 'Trans proline' 0 CA--C 1.502 -1.123 0 C-N-CA 124.116 3.21 . . . . 0.0 112.824 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 9.8 t-20 -59.56 119.01 36.24 Favored Pre-proline 0 N--CA 1.428 -1.538 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.367 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.19 -10.99 22.97 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.996 2.464 . . . . 0.0 111.498 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.09 -8.81 58.7 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 33.7 mt -96.82 -17.38 20.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.549 0.214 . . . . 0.0 111.555 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 25.3 mt -88.48 129.29 49.78 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.293 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 2.5 Cg_endo -77.5 146.68 24.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.652 2.902 . . . . 0.0 111.625 170.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.638 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 3.1 m-20 -47.75 -40.3 20.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.278 1.431 . . . . 0.0 113.621 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.85 -29.95 58.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.605 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 29.8 m-20 -89.16 -21.58 23.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.807 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.34 -49.36 19.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 121.086 0.47 . . . . 0.0 111.86 -174.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.41 47.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.598 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.73 -128.89 1.13 Allowed Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.194 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.489 HG13 ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.04 138.28 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.516 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -147.64 166.26 27.94 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.143 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.853 HG12 HD23 ' A' ' 96' ' ' LEU . 5.5 t -126.77 131.85 70.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.049 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 42' ' ' ILE . 2.1 p -106.23 106.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.272 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -104.2 132.74 50.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 -174.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.715 ' HB ' HG12 ' A' ' 109' ' ' VAL . 50.8 mt -94.48 102.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.767 HG22 ' HG3' ' A' ' 108' ' ' ARG . 17.8 p -95.73 109.47 21.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.946 ' SG ' HG23 ' A' ' 107' ' ' ILE . 3.2 m -81.02 111.98 17.99 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.65 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 19.3 m -108.7 111.88 23.89 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.421 -170.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 1.054 ' HE1' HD11 ' A' ' 34' ' ' LEU . 60.8 t80 -117.49 120.67 38.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.702 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 54.7 mtp180 67.87 25.12 7.9 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.204 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.46 8.45 87.04 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.417 ' HB2' HD12 ' A' ' 151' ' ' ILE . 7.4 mt-30 -113.06 115.05 27.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.844 -0.678 . . . . 0.0 109.373 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 28.2 mp0 -78.99 118.64 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.693 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 36.3 p90 -105.63 -5.85 19.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.946 HG23 ' SG ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -160.57 161.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 121.433 -0.792 . . . . 0.0 109.584 173.324 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.767 ' HG3' HG22 ' A' ' 98' ' ' THR . 12.2 ttm180 -149.48 97.6 2.66 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.831 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -86.48 100.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.696 175.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 83.83 1.59 Allowed Glycine 0 CA--C 1.488 -1.633 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.227 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.891 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -76.13 118.13 18.56 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.78 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.546 ' HB3' HD12 ' A' ' 140' ' ' LEU . 4.2 m-85 -68.28 115.54 7.84 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.53 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.757 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.0 p -101.99 112.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.489 ' OD1' HG13 ' A' ' 92' ' ' VAL . 2.5 t30 -95.39 126.13 40.48 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.274 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 55.5 m-80 -113.33 108.47 17.28 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.929 0.871 . . . . 0.0 109.107 -169.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -125.18 137.94 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.042 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.534 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 39.7 m-85 -51.59 149.38 4.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 42.7 p -100.4 -24.24 14.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.495 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.841 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 18.7 mm-40 -81.28 120.49 24.98 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.743 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 29.1 m -45.94 -40.65 10.56 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.83 0.706 . . . . 0.0 112.058 -169.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.32 -37.49 77.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.351 0.596 . . . . 0.0 110.372 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -71.2 -28.68 64.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.094 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 51.5 mtt180 -70.02 -42.04 73.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.2 mm-40 -58.02 -42.84 86.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.039 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.431 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 4.1 p30 -152.17 87.66 4.23 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.68 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.6 Cg_endo -56.24 115.71 2.66 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.435 2.757 . . . . 0.0 112.509 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.19 151.25 85.76 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.76 2.307 . . . . 0.0 111.282 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.9 -27.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.679 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -91.63 127.58 49.79 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.626 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.638 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.0 Cg_exo -77.29 127.79 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.764 2.976 . . . . 0.0 111.556 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 134' ' ' LYS . 10.2 t70 -111.8 108.68 18.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.67 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 22.5 m-85 -77.19 -16.42 59.1 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.086 -171.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.5 t -82.62 -19.93 37.35 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.334 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.841 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.0 mmtt -107.33 15.08 25.36 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.494 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 16.3 tp -98.1 149.99 21.91 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.115 -171.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 1.6 tt0 -127.88 121.5 30.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.877 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -84.02 104.0 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.573 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 14.6 t30 -92.91 103.48 15.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.761 HG21 HG11 ' A' ' 11' ' ' VAL . 1.4 mp -81.79 104.15 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 112' ' ' TYR . 85.1 mt -64.74 86.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.686 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.891 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -71.83 -11.56 60.86 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.06 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -22.83 60.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.988 173.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -129.69 71.15 82.17 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.312 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.68 104.78 1.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.473 1.449 . . . . 0.0 109.933 167.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.628 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -81.15 81.68 7.28 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.656 HG12 HG23 ' A' ' 109' ' ' VAL . 16.1 m -81.94 117.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.299 0.571 . . . . 0.0 110.864 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.408 HG22 ' CE2' ' A' ' 149' ' ' PHE . 21.7 m -126.02 106.32 9.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.738 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -114.74 146.16 41.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.258 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.41 170.4 14.23 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.885 -173.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.475 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -103.74 115.04 29.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.246 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.9 pt -119.39 166.66 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -95.51 100.26 12.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.548 1.166 . . . . 0.0 111.013 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.768 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 19.4 m95 -73.01 -6.65 46.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.896 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.47 160.33 35.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.068 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -94.17 65.87 3.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.408 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.52 -98.64 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.706 0.253 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 7.8 tpt 63.6 153.52 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.51 0.671 . . . . 0.0 111.954 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.31 168.94 45.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.541 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.471 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.5 mmtt -127.79 -61.1 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.989 0.394 . . . . 0.0 110.363 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.11 -52.28 21.11 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.63 0.581 . . . . 0.0 111.806 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 9.7 tt -63.95 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.699 0.285 . . . . 0.0 111.186 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.425 HE21 ' HB3' ' B' ' 125' ' ' GLN . 9.0 mm100 -63.88 -47.86 78.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.263 0.554 . . . . 0.0 111.029 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.642 HD23 HG11 ' A' ' 45' ' ' VAL . 43.3 mt -65.24 -46.17 81.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.825 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.18 -40.72 77.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.971 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 57.1 mtp180 -52.41 -52.59 53.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 111.457 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.671 ' HA ' ' CB ' ' B' ' 133' ' ' GLU . 12.9 tpt180 -62.68 -37.48 86.6 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.596 -173.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 145' ' ' ARG . 13.0 mt -74.11 -51.6 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.073 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -50.27 -37.35 35.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.505 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.555 ' HA2' ' NH1' ' A' ' 108' ' ' ARG . . . 154.09 64.16 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.673 176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.671 ' CB ' ' HA ' ' B' ' 129' ' ' ARG . 4.9 tp10 -100.72 -43.01 6.27 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.319 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -59.4 2.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.567 ' C ' HH22 ' A' ' 108' ' ' ARG . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 117.459 -1.257 . . . . 0.0 108.614 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.741 0.305 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -84.45 135.56 34.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.896 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.86 -17.33 28.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.28 -178.301 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.602 HG23 HD21 ' A' ' 34' ' ' LEU . 3.2 t -140.62 129.75 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.733 . . . . 0.0 111.289 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 23.0 tp60 -121.99 99.05 6.23 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 171.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -77.4 143.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.518 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -123.77 -65.98 1.03 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.173 -164.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.674 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -104.4 152.3 22.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.471 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.8 p -145.77 99.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.101 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.3 101.38 12.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.826 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -76.96 115.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.042 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.553 HD11 HG23 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -88.51 -38.72 14.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.524 -175.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.69 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.97 79.44 0.91 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.559 168.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -106.14 176.02 1.85 Allowed Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 111.371 -2.649 . . . . 0.0 106.38 170.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.86 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.1 Cg_endo -48.65 102.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.892 1.711 . . . . 0.0 113.291 -154.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.655 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.9 m -137.04 171.87 7.88 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 111.926 -2.397 . . . . 0.0 108.593 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 56.1 Cg_exo -39.94 139.09 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.828 2.352 . . . . 0.0 112.25 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.832 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 35.7 t80 -60.16 -27.57 67.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.705 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -83.58 -13.7 53.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.286 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -62.28 128.05 90.58 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.676 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.3 Cg_exo -68.0 153.82 74.22 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 123.772 2.981 . . . . 0.0 113.266 -172.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 19.6 m-85 -65.26 122.68 17.68 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.061 0.458 . . . . 0.0 109.961 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.763 ' HA ' ' HG3' ' A' ' 75' ' ' GLN . 80.8 mt-30 -127.07 92.91 3.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.48 -172.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CD1' HD11 ' A' ' 97' ' ' ILE . 92.2 m-85 -103.39 126.07 50.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.101 ' HB3' HG23 ' A' ' 10' ' ' VAL . 32.7 tt0 -105.44 87.25 2.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.759 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 3.3 mt -80.04 133.02 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.85 0.833 . . . . 0.0 112.192 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.1 m -109.73 104.74 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.193 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.749 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 17.8 p90 -118.3 146.44 44.32 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.958 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.6 tt0 -105.56 116.81 32.57 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -73.26 110.83 7.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -76.78 -29.49 17.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.05 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.896 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 5.8 mt-10 -149.54 147.51 28.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -52.82 133.31 37.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.762 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -87.66 157.23 19.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.578 -172.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -112.89 -34.41 5.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.946 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.714 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.1 tt0 -124.07 -167.88 1.71 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.714 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.93 145.01 24.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.499 0.666 . . . . 0.0 110.758 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.7 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -92.7 121.96 34.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.312 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 25.6 tt0 -102.58 93.51 5.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.626 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.759 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 23.0 m95 -84.33 111.44 19.42 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.753 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 31.2 ttmt -115.81 143.06 45.94 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.958 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.546 HG21 HD22 ' A' ' 57' ' ' LEU . 10.9 mt -102.95 106.8 20.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.469 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.541 HD12 ' HG2' ' A' ' 41' ' ' LYS . 3.0 mp -105.73 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.29 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.755 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.2 t80 -91.69 120.02 32.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.561 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' B' ' 126' ' ' LEU . 24.0 t -58.37 101.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 110.095 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.18 -37.24 94.27 Favored Glycine 0 CA--C 1.506 -0.512 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.109 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.75 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 66.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.03 54.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.198 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.09 -23.97 21.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 51.9 m -117.2 -154.91 0.57 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.85 164.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -134.0 -33.89 1.02 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.659 0.266 . . . . 0.0 110.913 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 51' ' ' GLU . 29.3 mt-10 -71.43 -3.93 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CD1' ' HB2' ' A' ' 47' ' ' SER . 96.8 m-85 -85.98 -1.86 57.73 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.446 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.22 111.85 0.54 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.133 0.968 . . . . 0.0 110.481 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 1.5 mt-30 -93.4 168.6 10.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.716 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.03 113.28 36.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.459 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 42' ' ' ILE . 10.9 mp -74.54 -50.32 18.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.499 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -170.83 -177.93 2.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.663 -177.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.589 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 36.1 p -152.69 124.32 7.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -100.54 135.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.0 mt -110.69 105.41 14.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.01 0.433 . . . . 0.0 110.573 -176.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.42 119.11 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -74.67 -164.21 11.41 Favored Glycine 0 CA--C 1.499 -0.911 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.385 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.762 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 53.4 Cg_endo -66.14 115.42 3.46 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.298 1.332 . . . . 0.0 110.194 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.592 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.4 m -123.04 138.4 29.71 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.849 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.41 78.18 2.55 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.363 2.042 . . . . 0.0 113.83 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.581 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 52.26 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.641 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.07 137.96 8.99 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.658 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.958 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 6.2 ptt180 -76.14 127.1 32.24 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.997 0.903 . . . . 0.0 109.474 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' THR . 39.9 m80 -123.65 135.25 53.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.683 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.1 ttp -109.22 99.56 8.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 5.8 p90 -108.67 142.31 39.35 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.694 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 3.4 p -104.96 130.55 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.492 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.643 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 5.1 t80 -132.86 132.04 41.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.817 -159.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.763 ' HG3' ' HA ' ' A' ' 23' ' ' GLN . 22.1 mp0 -145.28 156.05 43.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.106 0.479 . . . . 0.0 110.57 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.46 32.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.047 -0.978 . . . . 0.0 108.375 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.7 178.4 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.652 0.739 . . . . 0.0 112.28 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -68.76 159.94 79.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.199 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 57.4 Cg_endo -74.62 166.54 29.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.778 2.319 . . . . 0.0 110.503 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.564 ' HB2' HD12 ' A' ' 83' ' ' LEU . 3.7 m-20 -75.88 114.19 34.57 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.207 0.527 . . . . 0.0 111.161 -171.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 18.5 Cg_endo -64.33 -21.64 66.73 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.578 2.852 . . . . 0.0 112.131 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.38 -0.54 84.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.251 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 80' ' ' ASN . 35.0 mt -103.68 -20.57 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.571 0.224 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 27.9 mt -89.8 129.39 46.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.232 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 88' ' ' ASP . 88.1 Cg_endo -79.99 163.58 22.97 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.527 2.818 . . . . 0.0 111.732 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.669 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -45.64 -56.68 4.91 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.068 0.947 . . . . 0.0 113.268 -174.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -24.39 61.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 111.197 -167.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.548 ' CG ' ' HG2' ' A' ' 85' ' ' PRO . 1.4 m-20 -86.65 -24.97 25.09 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.476 -175.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.654 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -82.91 -46.87 12.44 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.016 -173.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -94.23 46.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-O 122.043 0.925 . . . . 0.0 111.275 -174.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.87 -124.71 0.8 Allowed Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.103 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.57 134.68 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 -168.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 169.93 17.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.461 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.67 HG23 HD13 ' B' ' 126' ' ' LEU . 3.5 t -127.17 152.31 35.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 118.37 0.532 . . . . 0.0 111.603 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.6 p -130.83 108.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.926 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.21 133.25 47.38 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.025 -172.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 33.9 mt -102.23 97.65 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.038 0.923 . . . . 0.0 108.797 174.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.805 HG22 ' HG3' ' A' ' 108' ' ' ARG . 49.4 p -91.72 114.11 26.56 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.258 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 61.4 m -81.99 105.69 13.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.919 0.866 . . . . 0.0 110.706 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.5 m -93.3 106.51 18.47 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.668 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.612 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 65.7 t80 -116.64 119.63 36.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.038 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.612 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.3 mtp180 64.88 23.71 12.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.2 -0.58 64.07 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.62 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.402 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -118.31 121.11 39.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' B' ' 134' ' ' ARG . 46.8 mt-10 -72.63 131.36 42.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.783 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.7 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.6 p90 -115.66 -1.85 12.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.1 tt -157.77 161.54 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 109.602 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.805 ' HG3' HG22 ' A' ' 98' ' ' THR . 17.7 ttm180 -150.71 95.78 2.27 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.926 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -83.15 100.36 6.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 118.776 -1.169 . . . . 0.0 108.558 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.503 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -87.78 78.65 1.79 Allowed Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.869 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.913 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -72.88 117.99 15.27 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.608 ' HB3' HD12 ' A' ' 140' ' ' LEU . 22.6 m-85 -67.55 130.34 42.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.9 p -112.02 111.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.498 ' HB3' ' OD1' ' A' ' 138' ' ' ASN . 65.3 t30 -94.46 116.78 29.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.386 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.654 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -108.39 108.53 19.53 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -171.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -131.5 129.07 40.63 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.392 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.8 m-85 -39.55 150.09 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 136' ' ' GLN . 68.7 p -92.46 -28.66 16.7 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.167 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.963 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.4 mm-40 -84.4 117.31 23.54 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.216 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.738 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.7 m -53.07 -34.36 56.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.039 -172.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -32.03 72.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.687 0.756 . . . . 0.0 110.283 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.4 mt -76.96 -24.38 52.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.123 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 123' ' ' ARG . 24.2 mtp-105 -78.57 -31.79 47.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.2 mm-40 -61.57 -39.02 89.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.328 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 6.0 p30 -157.96 95.28 1.99 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.113 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 10.8 Cg_endo -53.8 118.37 4.86 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.528 2.152 . . . . 0.0 110.965 175.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.511 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 73.7 Cg_exo -53.02 144.39 46.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.101 1.867 . . . . 0.0 109.424 172.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.52 -27.34 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.101 -166.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HE2' ' HB2' ' A' ' 129' ' ' LYS . 10.0 tppt? -116.35 107.1 47.78 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.655 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.669 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 75.9 Cg_exo -40.27 139.84 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 125.242 3.962 . . . . 0.0 113.881 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -110.59 106.15 15.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.774 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.5 m-85 -74.47 -12.58 60.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.581 -171.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -89.36 -21.1 23.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.271 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.963 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 70.9 mmtt -100.01 10.84 40.64 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 115' ' ' ASN . 21.3 tp -95.38 133.12 39.68 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.522 -171.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.488 ' HB2' HG22 ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.31 123.56 49.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.832 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -103.26 108.32 19.49 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.874 -174.161 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.86 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 2.5 p30 -92.77 104.66 16.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.862 0.839 . . . . 0.0 109.475 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.687 HG21 HG11 ' A' ' 11' ' ' VAL . 1.3 mp -70.96 108.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 112' ' ' TYR . 88.8 mt -67.04 86.57 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.685 0.755 . . . . 0.0 110.7 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.913 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.9 -15.31 60.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.318 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 p -81.97 -1.45 48.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -141.56 64.64 19.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.7 Cg_endo -93.18 106.18 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.059 1.839 . . . . 0.0 111.362 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' B' ' 130' ' ' ILE . 16.4 tpt180 -77.61 81.93 4.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.451 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 109' ' ' VAL . 3.0 m -76.92 103.46 4.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.3 0.571 . . . . 0.0 110.501 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' CE2' ' A' ' 149' ' ' PHE . 35.2 m -116.49 106.09 13.21 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.615 0.722 . . . . 0.0 109.362 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.2 ptt-85 -118.96 154.44 33.02 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.782 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -138.07 168.49 19.61 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.931 -172.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.17 144.65 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.94 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.607 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 22.1 pt -133.99 -172.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.47 0.653 . . . . 0.0 109.936 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 5.3 m-20 -98.31 92.7 5.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.38 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.622 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 15.2 m95 -78.46 -16.57 57.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.398 176.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.503 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 3.0 mp0 -112.9 153.64 27.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.233 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.81 72.49 9.88 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.916 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.3 m120 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.112 174.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.2 -25.57 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 51.7 ttp 73.4 -58.08 0.61 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.624 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.43 120.46 21.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.791 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.512 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 46.8 mmtm -73.39 -32.7 64.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.711 0.291 . . . . 0.0 110.876 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.88 -57.62 4.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.259 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.69 -35.62 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.292 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.8 mm100 -54.82 -51.74 64.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.826 0.822 . . . . 0.0 110.497 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.67 HD13 HG23 ' A' ' 94' ' ' VAL . 44.5 mt -66.22 -43.65 86.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.611 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.88 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.68 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 128' ' ' ARG . 18.6 mtp180 -60.09 -49.02 79.29 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.894 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.704 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 4.8 mmt180 -60.62 -41.78 95.53 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.935 0.398 . . . . 0.0 111.133 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.576 HD13 ' HB3' ' A' ' 145' ' ' ARG . 7.0 mt -75.25 -43.88 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.213 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -52.14 -53.68 39.86 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.607 0.567 . . . . 0.0 111.05 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.579 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . -176.03 57.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.587 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.704 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 3.2 mm-40 -102.27 -48.18 4.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.643 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.633 ' HG2' ' H ' ' B' ' 135' ' ' ALA . 41.5 ttp180 57.43 -178.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 112.749 172.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.633 ' H ' ' HG2' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--N 1.309 -1.169 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.092 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -87.35 138.66 31.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.026 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.809 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.55 -19.89 24.45 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 4.0 t -140.96 130.49 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.755 0.788 . . . . 0.0 111.526 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 20.8 tp60 -125.06 100.55 6.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.57 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -74.4 144.59 12.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.76 177.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -123.29 -66.52 1.0 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.469 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.628 HD22 HG13 ' A' ' 10' ' ' VAL . 64.4 t30 -103.28 151.65 22.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.536 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.761 HG23 HG13 ' A' ' 26' ' ' ILE . 2.6 p -147.43 99.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.578 174.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.03 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -92.87 109.67 21.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.564 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.32 132.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -110.91 -68.8 0.91 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.733 0.777 . . . . 0.0 112.328 -162.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' HE21 ' A' ' 23' ' ' GLN . 1.9 m-20 -96.0 34.7 1.51 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.161 -162.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.715 ' HB3' ' NH2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -138.78 99.64 8.35 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 171.076 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 60.7 Cg_endo -124.99 92.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.27 1 C-N-CA 125.696 4.264 . . . . 0.0 106.139 108.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.663 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 7.5 m -153.83 168.98 10.65 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.188 -167.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 87.9 Cg_exo -38.3 132.26 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.814 2.343 . . . . 0.0 111.679 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.913 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 10.1 t80 -60.85 -22.19 63.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.401 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -84.87 -10.56 57.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.988 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.35 128.57 80.07 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 122.49 1.138 . . . . 0.0 108.728 167.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.65 152.83 32.44 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 124.76 3.64 . . . . 0.0 112.995 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HA ' HH21 ' A' ' 137' ' ' ARG . 27.1 m-85 -81.21 124.4 29.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.486 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.056 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.2 mp0 -113.32 114.07 26.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.682 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CG ' HD11 ' A' ' 97' ' ' ILE . 73.4 m-85 -120.97 114.41 21.48 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.03 ' HB3' HG23 ' A' ' 10' ' ' VAL . 33.1 tt0 -97.88 87.12 3.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.761 HG13 HG23 ' A' ' 9' ' ' VAL . 4.5 mp -82.63 140.51 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.929 0.871 . . . . 0.0 112.363 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 14.9 m -113.33 107.13 15.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.286 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.4 p90 -116.39 150.01 38.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.377 0.608 . . . . 0.0 109.565 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -105.42 112.21 25.22 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.481 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.682 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 4.2 t -72.97 108.16 5.72 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -73.76 -25.15 20.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.384 -174.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.809 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -152.8 158.0 41.61 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.409 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.6 129.16 40.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.508 . . . . 0.0 110.339 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.022 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -84.5 148.64 26.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.671 -170.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.527 ' N ' HD13 ' A' ' 34' ' ' LEU . 17.7 m -115.37 -25.99 7.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.893 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 35.8 tt0 -118.44 -163.41 0.95 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.893 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 8.8 m-20 -93.84 131.32 39.35 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.707 -0.621 . . . . 0.0 109.337 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.694 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.62 118.58 23.41 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 40.8 tt0 -102.31 127.61 49.22 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.585 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.9 m95 -115.72 127.52 55.2 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.7 ttmp? -123.71 146.54 48.19 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.053 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.62 HG21 HD22 ' A' ' 57' ' ' LEU . 44.1 mm -102.83 105.8 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.685 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.731 HD11 ' HD2' ' A' ' 41' ' ' LYS . 2.9 mp -103.1 110.8 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.584 ' CE2' HG11 ' A' ' 113' ' ' VAL . 32.2 t80 -95.86 110.78 22.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.256 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG11 HD23 ' B' ' 126' ' ' LEU . 22.9 t -61.53 101.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -74.34 -42.94 33.07 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.757 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 27.8 p -95.44 99.65 11.52 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' B' ' 122' ' ' LYS . . . -90.98 -5.07 55.91 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 161.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -99.83 -48.75 4.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.607 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.591 ' C ' ' HB2' ' A' ' 47' ' ' SER . 38.7 m -98.56 -157.43 0.6 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 170.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.42 -25.91 0.58 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.319 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -79.42 2.81 20.44 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.757 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 9.6 m-30 -88.51 -1.63 58.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.554 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -47.6 109.59 0.23 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.617 0.722 . . . . 0.0 110.536 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.695 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 55.2 mt-30 -91.58 166.04 13.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.812 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.51 112.1 28.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.286 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 42' ' ' ILE . 8.3 mp -82.18 -56.87 3.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.901 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.12 161.37 42.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.355 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.0 p -146.46 114.98 6.76 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.27 138.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 10.7 mt -110.88 103.2 11.68 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.107 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -97.2 122.79 49.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.3 -158.56 9.7 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.331 -162.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.022 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.6 Cg_endo -65.35 116.75 4.06 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.444 1.429 . . . . 0.0 110.097 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 63' ' ' GLY . 24.5 m -126.22 150.49 70.0 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.35 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.04 138.78 44.89 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.746 2.297 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -43.86 144.58 0.84 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.324 0.583 . . . . 0.0 112.138 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.03 126.97 2.7 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.891 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.4 ptt180 -70.93 130.79 42.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.375 1.083 . . . . 0.0 110.794 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -150.82 151.1 31.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.151 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -107.36 138.45 43.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.455 -172.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 6.2 p90 -139.51 152.27 46.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.2 p -111.51 107.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 122.647 1.213 . . . . 0.0 111.339 -169.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.2 t80 -108.91 121.45 45.14 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.637 -170.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 1.056 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 33.4 mt-30 -119.81 166.43 13.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.245 -172.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.73 132.6 6.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.848 0.295 . . . . 0.0 111.644 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.92 156.69 35.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.55 152.13 36.2 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.601 ' HD3' HD21 ' A' ' 57' ' ' LEU . 55.5 Cg_endo -72.38 177.4 7.39 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.853 3.035 . . . . 0.0 112.236 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -73.69 116.88 56.08 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.436 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.24 1.08 3.79 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 123.67 2.913 . . . . 0.0 112.654 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.51 -15.18 28.01 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.695 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 61.4 mt -97.86 -8.87 27.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.525 -0.837 . . . . 0.0 110.926 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.49 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 22.6 mt -96.07 129.6 33.5 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.051 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 3.4 Cg_exo -77.43 155.35 32.18 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.357 2.705 . . . . 0.0 111.673 169.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.764 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.1 p30 -47.52 -47.25 27.86 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.06 -28.13 68.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.423 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 10.7 m-20 -98.58 -21.78 16.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.429 -173.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -81.33 -46.5 14.61 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.242 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.753 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -95.25 46.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.468 0.652 . . . . 0.0 112.247 -174.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.7 -129.62 1.38 Allowed Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.075 -172.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.411 HG13 ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -98.27 135.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -168.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.48 167.86 28.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.368 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.656 HG12 HD23 ' A' ' 96' ' ' LEU . 69.4 t -118.66 128.7 75.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.354 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.19 106.51 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.769 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -105.75 148.43 27.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.056 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.795 ' HB ' HG12 ' A' ' 109' ' ' VAL . 45.6 mt -106.98 108.29 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 121.313 0.577 . . . . 0.0 109.528 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.857 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 41.8 p -101.92 114.25 28.18 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.189 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 64.1 m -79.32 158.0 27.58 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.282 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -151.14 119.68 6.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -167.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.772 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 34.6 t80 -138.29 124.14 19.97 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.615 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 61.1 mtp180 65.31 32.87 9.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.386 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.97 83.44 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.574 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -114.28 132.23 56.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.15 0.5 . . . . 0.0 110.068 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 31.7 mt-10 -93.89 130.12 40.07 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.146 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.694 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.7 p90 -118.44 -1.17 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -164.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.857 ' O ' ' HA ' ' A' ' 98' ' ' THR . 5.4 tt -156.47 160.29 2.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 120.883 -1.136 . . . . 0.0 109.388 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.661 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 13.5 ttp180 -148.08 102.22 3.36 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 123.93 0.769 . . . . 0.0 109.433 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.795 HG12 ' HB ' ' A' ' 97' ' ' ILE . 3.6 p -89.95 101.26 12.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.723 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.18 92.05 1.78 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 119.613 -1.279 . . . . 0.0 112.136 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.77 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 8.7 m-85 -83.95 126.09 32.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.895 -0.652 . . . . 0.0 109.943 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.5 m-85 -68.24 112.12 4.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.962 176.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.9 p -93.89 111.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.411 ' OD1' HG13 ' A' ' 92' ' ' VAL . 8.5 t30 -101.63 104.42 15.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.013 -176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.6 m-80 -94.3 110.27 22.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.255 -172.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.14 128.03 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.645 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.6 m-85 -39.29 154.12 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.5 p -98.19 -26.15 14.65 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.253 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.411 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 26.6 mm-40 -78.64 120.99 24.11 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.8 m -54.33 -32.02 55.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.543 -169.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -70.61 -36.17 73.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.682 0.753 . . . . 0.0 109.572 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 65.9 mt -74.88 -25.85 59.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.213 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 32.7 mtt180 -70.96 -36.7 72.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.995 0.903 . . . . 0.0 108.787 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 120' ' ' THR . 44.0 mm-40 -69.39 -40.92 77.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.972 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.0 p30 -146.51 91.06 5.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 0.0 111.218 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.6 Cg_endo -56.41 114.97 2.15 Favored 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 122.831 2.354 . . . . 0.0 111.244 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.534 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 50.9 Cg_exo -56.32 160.08 11.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.432 2.088 . . . . 0.0 111.072 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.508 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 11.7 p -51.25 -36.58 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -166.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.518 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 4.8 mmtt -116.19 116.0 40.09 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-O 121.896 0.855 . . . . 0.0 111.745 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.764 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_exo -47.4 141.74 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 125.018 3.812 . . . . 0.0 113.952 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -111.64 109.94 20.08 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 170.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.745 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 18.4 m-85 -70.93 -15.49 62.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.649 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -87.39 -17.81 31.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.641 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 47.7 mmtm -101.91 1.56 37.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.502 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 20.7 tp -86.63 139.79 30.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.125 -171.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 2.8 tt0 -121.34 116.61 25.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.913 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 4.2 mtp-105 -80.39 101.33 8.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.5 t30 -97.48 106.83 19.21 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.637 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 12.3 mt -95.6 114.11 31.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.945 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 112' ' ' TYR . 28.0 mt -73.54 90.05 1.73 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.329 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.77 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -75.45 -9.72 58.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.494 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 p -85.06 -3.37 58.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.679 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -137.12 70.44 55.94 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.584 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.4 Cg_endo -91.28 109.66 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.883 2.389 . . . . 0.0 112.07 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.403 ' CB ' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.36 81.38 7.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 109' ' ' VAL . 16.1 m -71.71 129.29 35.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.152 0.501 . . . . 0.0 111.301 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.547 HG21 HH21 ' A' ' 108' ' ' ARG . 63.5 m -141.09 105.4 4.83 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.736 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -118.52 143.95 46.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.883 0.849 . . . . 0.0 110.836 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HD1' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -125.36 168.42 13.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.715 -178.018 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.89 151.03 22.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.005 0.431 . . . . 0.0 111.107 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.772 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 27.9 pt -135.75 172.34 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.532 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 36.2 p-10 -94.69 86.56 4.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.545 1.164 . . . . 0.0 111.059 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 35.2 m95 -64.52 -16.61 62.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.556 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -132.49 167.99 18.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.6 70.6 6.11 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.614 -166.128 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.48 69.53 4.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 0.0 110.5 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 10.6 tpt -75.71 117.38 17.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 143.05 3.26 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.775 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.592 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 0.0 OUTLIER -74.27 -23.39 59.11 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -48.33 -48.47 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.073 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tt -67.69 -39.83 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.196 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.618 ' NE2' HH11 ' B' ' 128' ' ' ARG . 17.6 mm-40 -63.41 -37.4 87.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 89.4 mt -67.23 -43.57 81.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.276 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.72 72.77 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.959 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.618 HH11 ' NE2' ' B' ' 125' ' ' GLN . 94.2 mtt180 -59.36 -47.05 86.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.14 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.64 ' O ' ' HG3' ' B' ' 133' ' ' GLU . 4.4 mmp_? -66.9 -43.44 83.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.382 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.661 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 69.7 mt -68.04 -16.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.397 0.618 . . . . 0.0 110.645 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 20.8 tpt85 -81.39 -26.26 35.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.875 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.654 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 156.41 84.74 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.788 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.649 ' OE1' ' HG2' ' B' ' 134' ' ' ARG . 0.0 OUTLIER -93.68 -56.51 2.87 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 165.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.649 ' HG2' ' OE1' ' B' ' 133' ' ' GLU . 19.5 mmm180 -72.2 -68.49 0.46 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 173.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.823 174.904 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' CE ' ' HB3' ' A' ' 150' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -80.04 150.69 30.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.63 ' HG2' ' CD2' ' A' ' 153' ' ' TRP . 33.3 mmtt -99.9 -7.56 25.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.436 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.7 t -146.1 128.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.113 0.482 . . . . 0.0 110.575 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.604 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 6.3 tp-100 -125.09 103.98 8.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.532 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.738 HG23 ' CH2' ' A' ' 40' ' ' TRP . 2.3 t -65.78 128.85 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.884 0.849 . . . . 0.0 109.092 171.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -118.33 -54.33 2.29 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.852 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.743 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 40.4 t-20 -104.96 128.9 53.43 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.116 -174.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HB ' ' OH ' ' A' ' 111' ' ' TYR . 2.2 t -129.11 99.53 4.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.403 169.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.946 HG23 ' HB3' ' A' ' 25' ' ' GLU . 1.5 m -95.4 101.37 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.444 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.982 HG11 HG21 ' A' ' 139' ' ' ILE . 2.5 t -83.99 117.88 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.325 1.06 . . . . 0.0 108.851 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -86.33 -36.09 19.47 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.341 -175.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 36.7 t0 -74.14 58.28 0.69 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.982 168.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.571 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -82.44 174.48 6.01 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 113.139 -1.846 . . . . 0.0 106.376 160.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.747 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.0 Cg_endo -49.91 103.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.82 1.686 . . . . 0.0 113.065 -153.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.646 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 15.7 m -139.33 171.16 8.47 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.428 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.2 Cg_exo -40.64 132.49 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.458 2.105 . . . . 0.0 111.941 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.771 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 36.6 t80 -57.96 -27.1 63.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.266 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 18.9 m-85 -87.06 -3.3 59.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.139 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -76.24 125.56 87.64 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 164.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.587 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 38.5 Cg_exo -62.89 150.58 87.98 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 123.264 2.643 . . . . 0.0 112.855 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.6 m-85 -62.65 103.55 0.43 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.804 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.635 ' H ' ' CB ' ' A' ' 13' ' ' ASP . 30.9 mt-30 -106.91 103.02 12.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.237 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 97' ' ' ILE . 82.9 m-85 -104.57 155.6 18.69 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.946 ' HB3' HG23 ' A' ' 10' ' ' VAL . 12.7 tt0 -130.51 87.34 2.49 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.523 ' CG2' HG22 ' A' ' 6' ' ' VAL . 23.3 mt -78.06 138.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.782 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.743 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 5.5 m -119.29 109.78 16.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.254 171.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.679 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 19.2 p90 -112.27 140.74 46.73 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.561 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.944 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.0 tt0 -101.75 114.82 29.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.5 m -72.2 113.4 9.19 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -73.83 -24.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.109 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.516 -173.272 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 40.0 mt-10 -150.78 164.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.81 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.46 133.72 50.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.2 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.063 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -95.5 152.57 18.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.112 -172.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.503 ' N ' HD13 ' A' ' 34' ' ' LEU . 11.8 p -115.58 -33.11 5.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.707 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.9 tt0 -108.17 -163.13 0.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -173.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.707 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 12.4 m-20 -89.73 163.12 15.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.604 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -114.58 119.78 37.94 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.1 mp0 -91.19 126.73 36.36 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.017 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.738 ' CH2' HG23 ' A' ' 6' ' ' VAL . 53.5 m95 -120.36 125.81 48.94 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.844 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.1 ttmt -128.72 143.67 50.98 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.649 -173.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.723 HG22 HG22 ' A' ' 95' ' ' VAL . 12.8 mt -103.69 106.98 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.844 HD11 ' HD2' ' A' ' 41' ' ' LYS . 74.0 mt -107.12 106.8 21.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.739 0.781 . . . . 0.0 109.987 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' HG11 ' A' ' 113' ' ' VAL . 58.3 t80 -90.62 131.67 36.19 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.743 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.94 101.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.578 0.704 . . . . 0.0 110.639 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.08 -40.22 97.93 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.548 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.891 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 89.8 p -132.57 118.66 19.49 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.663 0.268 . . . . 0.0 110.854 172.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HB3' ' NZ ' ' B' ' 122' ' ' LYS . . . -78.21 -3.62 43.6 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 163.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -99.44 -17.09 18.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.769 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 53.2 m -131.41 -148.33 0.35 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.87 -32.7 0.27 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 118.854 0.752 . . . . 0.0 112.507 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.84 1.35 20.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.891 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 3.2 m-30 -82.35 -17.7 44.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.311 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p-10 -42.38 115.62 0.72 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 111.895 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' CG ' HD12 ' A' ' 83' ' ' LEU . 12.4 mp0 -92.7 165.62 12.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.04 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 HG12 ' A' ' 43' ' ' ILE . 37.5 t -130.24 110.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.4 mm? -79.52 -40.33 29.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.618 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 21.1 t70 -174.43 157.8 2.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 21.0 p -140.12 117.44 11.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.3 p -98.65 141.2 16.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.764 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.487 ' CD1' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -110.63 104.96 13.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.882 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 94.5 t -83.37 154.16 3.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -96.48 -162.41 32.73 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 118.633 -1.746 . . . . 0.0 112.456 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.063 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 45.0 Cg_endo -66.3 118.92 5.91 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.928 1.752 . . . . 0.0 109.91 173.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' H ' ' CB ' ' A' ' 34' ' ' LEU . 35.8 m -121.15 131.94 24.34 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.398 -173.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.07 138.26 51.46 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.486 2.124 . . . . 0.0 110.789 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -40.58 141.5 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.063 0.852 . . . . 0.0 112.433 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.05 149.24 7.51 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.944 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 9.4 ptt180 -75.72 143.63 41.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.028 0.918 . . . . 0.0 111.157 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -137.85 136.09 36.82 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.607 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.31 123.8 48.6 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.608 0.718 . . . . 0.0 110.763 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.67 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.6 p90 -127.97 144.12 51.1 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.365 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 p -105.42 125.9 60.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.109 0.956 . . . . 0.0 110.213 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.67 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 7.3 t80 -126.6 113.1 16.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.025 -162.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 6.4 mt-30 -130.55 154.25 48.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -158.13 154.32 27.26 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.31 -174.93 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.839 0.828 . . . . 0.0 113.056 -171.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -81.94 150.49 65.44 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.476 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.771 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 46.7 Cg_exo -62.77 173.75 3.48 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 123.389 2.726 . . . . 0.0 112.495 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.3 m-20 -81.8 115.6 58.14 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.525 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.08 -9.69 26.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.267 2.645 . . . . 0.0 112.236 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 6.46 64.98 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.698 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.491 HD12 ' CG ' ' A' ' 55' ' ' GLN . 10.3 mt -108.9 -37.68 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.548 0.213 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 49.3 mt -69.57 130.08 90.87 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 73.2 Cg_endo -79.69 161.62 24.61 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 0.0 112.468 171.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.609 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.0 OUTLIER -46.31 -52.74 12.12 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.787 0.835 . . . . 0.0 112.974 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . . . -75.0 -23.03 58.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.983 -170.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.765 ' HA ' ' HZ1' ' B' ' 122' ' ' LYS . 12.9 t0 -82.68 -27.3 31.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 0.0 110.591 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 130' ' ' PRO . . . -73.94 -40.4 63.1 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.759 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.38 44.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 114' ' ' ASN . . . -174.77 -129.56 1.2 Allowed Glycine 0 CA--C 1.496 -1.113 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.992 -173.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.62 HG23 ' HG3' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -103.04 120.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.187 0.994 . . . . 0.0 113.433 -165.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.863 ' HB ' HG13 ' A' ' 113' ' ' VAL . 5.2 m -135.35 169.12 17.97 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.488 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.556 HG12 HD23 ' A' ' 96' ' ' LEU . 8.3 t -130.89 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 118.049 0.386 . . . . 0.0 110.638 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.723 HG22 HG22 ' A' ' 42' ' ' ILE . 7.6 p -131.78 107.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.876 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -97.26 130.21 44.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.664 -168.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.759 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 49.1 mt -95.36 93.75 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.794 HG22 ' HG3' ' A' ' 108' ' ' ARG . 32.4 p -92.35 112.94 25.07 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.677 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 1.05 ' SG ' HG22 ' A' ' 107' ' ' ILE . 23.5 p -75.52 159.14 31.61 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 28.2 m -150.95 103.65 3.08 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -171.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.996 ' HE2' HD11 ' A' ' 34' ' ' LEU . 51.0 t80 -118.9 125.52 49.68 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 16.4 mmt180 67.18 14.46 9.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.898 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.26 4.55 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.595 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.73 138.22 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 6.8 mt-10 -87.45 127.62 35.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.539 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.604 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.9 p90 -116.95 1.73 12.66 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.05 HG22 ' SG ' ' A' ' 99' ' ' CYS . 4.8 tt -154.44 153.98 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.381 -0.825 . . . . 0.0 109.2 167.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.94 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 4.1 ttm-85 -143.63 91.2 2.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.582 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.907 HG23 HG12 ' A' ' 146' ' ' VAL . 0.5 OUTLIER -83.39 100.95 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.266 1.031 . . . . 0.0 108.294 175.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA3' HD11 ' B' ' 130' ' ' ILE . . . -89.72 81.73 1.43 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.791 -1.195 . . . . 0.0 111.158 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.533 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 27.4 m-85 -69.73 115.1 8.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.663 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.4 m-85 -66.93 111.37 3.75 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.863 HG13 ' HB ' ' A' ' 93' ' ' THR . 1.5 p -91.47 109.33 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.606 ' OD1' HG13 ' A' ' 92' ' ' VAL . 3.0 t30 -96.7 113.66 25.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.431 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.529 ' HB3' HD11 ' A' ' 135' ' ' LEU . 57.6 m-80 -101.82 108.84 20.46 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.861 0.839 . . . . 0.0 109.151 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.16 132.46 39.85 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.814 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.663 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 50.6 m-85 -49.01 155.5 0.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -172.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.556 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 18.3 p -92.27 -28.89 16.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.257 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.577 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 21.7 mm-40 -80.81 122.96 27.84 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.298 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.589 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 21.2 m -51.75 -34.09 37.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.336 -170.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.23 -37.33 80.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.652 0.739 . . . . 0.0 109.438 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 55.8 mt -78.77 -19.28 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.551 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 45.9 mtt180 -77.58 -35.11 53.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.7 mm-40 -74.45 -38.08 63.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.438 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.2 p30 -142.3 83.23 12.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 110.441 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 16.3 Cg_endo -57.39 114.97 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.141 2.561 . . . . 0.0 111.918 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.658 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 34.7 Cg_exo -62.72 142.77 90.54 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.0 110.347 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 128' ' ' VAL . 7.5 t -55.94 -32.84 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.511 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 1.3 mmtt -79.4 133.09 60.56 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 121.132 0.491 . . . . 0.0 110.875 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.609 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 6.4 Cg_endo -77.45 129.32 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.588 2.859 . . . . 0.0 112.433 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.2 t70 -125.63 108.03 11.16 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.885 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.715 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.5 m-85 -78.5 -16.83 57.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.273 1.035 . . . . 0.0 110.579 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.413 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 31.0 t -83.11 -27.95 29.81 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.301 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.577 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 71.9 mmtt -100.8 11.62 39.19 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.3 tp -94.55 129.08 41.5 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.885 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.556 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 9.7 tt0 -112.72 120.06 40.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.747 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.06 107.12 19.44 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.639 -174.008 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 16.5 t30 -78.74 102.88 8.32 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.828 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.982 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -76.89 105.83 6.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.911 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 112' ' ' TYR . 83.9 mt -67.11 90.99 0.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.757 0.789 . . . . 0.0 111.336 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.533 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.21 -19.51 43.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.454 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 p -80.14 -17.32 52.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.949 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 16.9 m120 -131.31 61.5 59.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.709 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.72 116.5 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.81 1.673 . . . . 0.0 111.058 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.682 ' HG3' HG12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.84 81.11 7.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.387 0.613 . . . . 0.0 109.942 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.907 HG12 HG23 ' A' ' 109' ' ' VAL . 19.4 m -89.36 137.39 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.771 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.5 m -149.18 108.76 4.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.487 0.661 . . . . 0.0 110.008 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -101.64 140.75 35.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.0 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -118.11 168.51 10.49 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.798 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.425 ' HB3' ' CE ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -104.83 114.54 28.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.413 176.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.736 HD11 ' HB3' ' A' ' 101' ' ' TYR . 42.3 pt -118.69 -173.47 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.518 0.675 . . . . 0.0 110.971 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 5.3 m-20 -96.07 92.74 6.59 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.726 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.63 ' CD2' ' HG2' ' A' ' 3' ' ' LYS . 37.8 m95 -77.28 -12.5 59.96 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 109.838 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.7 150.49 50.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.832 0.825 . . . . 0.0 110.595 -172.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.49 71.21 9.56 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.286 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.451 -174.622 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 CA-C-O 120.285 -0.175 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.767 ' HA ' ' NE2' ' B' ' 125' ' ' GLN . . . -79.94 84.71 5.66 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.065 0.46 . . . . 0.0 111.137 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 5.8 ttp -161.33 126.59 3.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.967 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.55 -153.78 19.29 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.436 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.765 ' HZ1' ' HA ' ' A' ' 88' ' ' ASP . 75.5 mmtt -129.6 -72.52 0.58 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -24.79 -66.72 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.778 1.299 . . . . 0.0 114.001 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.74 -35.61 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.767 ' NE2' ' HA ' ' B' ' 119' ' ' ALA . 44.4 mm-40 -66.5 -50.11 64.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.954 0.407 . . . . 0.0 111.899 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 94' ' ' VAL . 1.5 mm? -68.3 -33.96 75.28 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.18 90.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.549 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 49.9 mtp180 -51.77 -56.41 14.0 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.28 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.845 ' HD3' ' HB3' ' B' ' 133' ' ' GLU . 0.1 OUTLIER -56.93 -42.69 80.45 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 -176.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.94 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 1.7 mp -70.13 -50.2 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 123.747 0.654 . . . . 0.0 112.543 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -59.41 -46.57 88.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 175.68 55.29 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.709 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.845 ' HB3' ' HD3' ' B' ' 129' ' ' ARG . 9.1 tp10 -96.97 -2.66 43.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.518 ' HB2' ' OE2' ' A' ' 105' ' ' GLU . 18.6 ptt180 -36.22 147.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 112.592 -2.095 . . . . 0.0 114.024 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.245 176.661 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.925 0.393 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -77.43 138.19 39.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.906 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -90.68 -20.58 22.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 -176.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.492 ' HB ' ' CZ3' ' A' ' 153' ' ' TRP . 3.0 t -136.64 129.51 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.482 0.658 . . . . 0.0 110.275 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.8 tp60 -115.54 99.59 7.46 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -73.12 134.03 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -120.24 -64.88 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.89 0.852 . . . . 0.0 109.465 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.696 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 64.9 t30 -105.09 150.0 25.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.587 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 9' ' ' VAL . 5.9 p -145.57 102.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.957 0.885 . . . . 0.0 109.322 173.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -95.75 100.22 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.513 1.149 . . . . 0.0 109.667 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 139' ' ' ILE . 2.1 m -79.18 126.87 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.184 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.859 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -102.76 -34.75 8.9 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.745 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.721 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 26.0 t70 -59.34 28.79 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.874 -1.966 . . . . 0.0 112.566 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.626 ' OD1' ' HD3' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -82.22 172.48 9.47 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.871 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 24.2 Cg_exo -54.37 101.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.323 1.349 . . . . 0.0 113.658 -136.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.563 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.8 m -138.44 168.51 15.64 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.252 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 82.6 Cg_exo -36.49 132.86 0.36 Allowed 'Trans proline' 0 CA--C 1.504 -1.011 0 C-N-CA 123.31 2.673 . . . . 0.0 112.07 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.734 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 16.5 t80 -51.27 -24.25 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.786 0.679 . . . . 0.0 112.535 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -86.32 0.85 53.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.934 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.498 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 31.2 p-10 -63.56 138.73 97.45 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 165.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.718 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 16.6 Cg_exo -78.89 145.71 20.06 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 122.843 2.362 . . . . 0.0 111.715 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.81 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 53.5 m-85 -60.65 126.22 26.61 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.859 ' HB3' HD12 ' A' ' 12' ' ' LEU . 34.5 mt-30 -125.72 99.36 5.94 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.759 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 67.9 m-85 -107.92 102.37 11.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.88 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 10' ' ' VAL . 29.5 tt0 -85.94 83.7 7.73 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.685 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 7.3 mt -84.91 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.57 0.7 . . . . 0.0 112.441 -176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.4 m -111.68 107.45 16.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.323 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.479 ' HB3' HG13 ' A' ' 6' ' ' VAL . 27.7 p90 -121.21 148.14 44.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 37.0 tt0 -106.01 112.66 25.8 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.739 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 41.5 t -73.49 109.41 6.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.524 ' C ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -78.63 -29.0 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.641 -173.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.906 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 1.8 mt-10 -149.66 148.15 28.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.4 p-10 -56.27 135.04 53.7 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 111.691 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.06 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 93.3 mt -82.74 160.47 22.31 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.356 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.6 t -113.17 -21.62 10.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.803 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.886 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.5 tt0 -137.89 -168.52 2.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.886 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 17.6 m-20 -95.12 137.4 34.23 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.418 0.628 . . . . 0.0 109.69 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.732 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.31 118.95 23.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.602 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.8 tt0 -108.63 89.76 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.878 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 15.0 m95 -78.22 126.54 30.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.9 ttmp? -126.15 141.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.048 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -102.88 107.9 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.745 ' HB ' HD12 ' A' ' 96' ' ' LEU . 40.1 mt -111.74 104.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.839 0.828 . . . . 0.0 109.034 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.836 ' CE2' HG11 ' A' ' 113' ' ' VAL . 17.0 t80 -86.81 115.42 24.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.195 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HD11 ' B' ' 126' ' ' LEU . 6.8 t -62.27 101.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.237 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.49 56.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.832 ' HB3' ' CG ' ' A' ' 53' ' ' TYR . 14.8 p -96.94 88.36 4.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.857 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HB1' ' HG3' ' B' ' 122' ' ' LYS . . . -80.41 -17.72 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -100.3 -23.47 14.78 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.028 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.742 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 48.7 m -110.32 -147.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -155.96 -5.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.76 1.44 53.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.832 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 4.2 m-30 -91.33 -14.42 30.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.369 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -40.81 113.99 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.449 1.119 . . . . 0.0 112.605 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.491 HE21 ' HD1' ' A' ' 44' ' ' TYR . 16.0 mt-30 -92.71 163.09 13.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.219 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 43' ' ' ILE . 39.4 t -132.6 115.67 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 57' ' ' LEU . 3.3 mm? -84.2 -45.26 13.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.655 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -170.5 165.75 8.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 61.9 p -141.8 117.53 10.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -100.0 136.6 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.639 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.2 mt -107.9 104.84 14.4 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.99 110.76 23.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -71.7 -170.19 12.28 Favored Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.889 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.06 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 35.2 Cg_endo -62.12 115.11 2.63 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 121.259 1.306 . . . . 0.0 109.994 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 34.0 m -123.94 140.25 34.22 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.342 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.55 76.81 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.987 1.791 . . . . 0.0 113.463 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.54 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.64 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.039 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.21 124.89 3.56 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.992 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.854 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 31.9 ttt180 -79.53 118.19 21.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.446 0.641 . . . . 0.0 109.501 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -150.74 143.92 24.81 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.394 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -96.86 134.23 40.44 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.361 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -127.0 150.02 49.62 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.15 101.67 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-O 123.189 1.471 . . . . 0.0 111.448 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.759 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -76.13 137.26 39.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 112.494 -2.139 . . . . 0.0 109.841 -176.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.81 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.0 mt-30 -151.84 152.28 32.42 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.034 0.445 . . . . 0.0 109.941 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.44 155.89 6.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.0 p-10 -62.34 179.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.53 0.605 . . . . 0.0 111.983 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -77.06 158.65 79.75 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.68 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 38.8 Cg_endo -63.73 164.73 20.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.5 2.134 . . . . 0.0 110.817 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.21 115.97 37.48 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.599 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -66.74 -12.76 37.24 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.098 2.532 . . . . 0.0 112.519 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.86 -5.54 61.08 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.105 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 83' ' ' LEU . 20.7 mt -96.45 -37.11 10.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 122.613 -0.345 . . . . 0.0 110.592 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 19.2 mt -72.35 127.7 89.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.05 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.62 162.55 24.46 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.902 2.401 . . . . 0.0 112.423 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.845 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 t70 -43.72 -54.53 5.04 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.055 0.942 . . . . 0.0 113.487 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB1' ' NZ ' ' B' ' 122' ' ' LYS . . . -64.45 -28.51 69.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.071 0.462 . . . . 0.0 111.369 -168.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -97.19 -21.33 17.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.578 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.77 -48.22 12.8 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.679 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -92.87 47.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 112.68 -175.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.48 -127.23 1.11 Allowed Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.067 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.451 HG23 ' HG2' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -100.41 136.04 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.426 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -151.84 166.77 30.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.579 HG23 ' HG ' ' B' ' 126' ' ' LEU . 15.2 t -121.98 138.86 50.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.555 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.95 106.99 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.929 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -104.65 139.83 38.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.236 -170.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.791 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 34.5 mt -109.67 96.63 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.911 0.862 . . . . 0.0 109.097 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 72.7 p -96.07 116.26 28.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.884 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.596 ' HB2' HG22 ' A' ' 107' ' ' ILE . 75.0 m -80.59 104.49 11.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.493 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 23.7 m -85.6 102.19 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.175 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.636 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 32.7 t80 -117.98 126.11 51.68 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.929 -0.482 . . . . 0.0 110.26 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 53.8 mtp85 60.39 28.82 18.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.848 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.35 -20.22 51.33 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.752 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.693 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 4.0 pt20 -111.57 142.99 43.15 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.637 0.732 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.9 mt-10 -93.79 119.72 33.12 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.212 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.732 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 43.9 p90 -104.53 -0.52 27.7 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.821 ' O ' ' HA ' ' A' ' 98' ' ' THR . 6.1 tt -157.58 160.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.697 ' HG3' ' HB2' ' A' ' 96' ' ' LEU . 10.5 ttp180 -151.48 119.24 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 123.674 0.609 . . . . 0.0 109.776 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.929 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.6 p -96.01 100.05 10.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.515 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.62 73.42 2.49 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 119.252 -1.452 . . . . 0.0 110.961 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.872 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.8 m-85 -67.67 115.62 7.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.996 -1.102 . . . . 0.0 109.087 175.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.532 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.8 m-85 -67.68 113.26 5.32 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.836 HG11 ' CE2' ' A' ' 44' ' ' TYR . 5.3 p -93.8 110.56 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -95.25 108.61 20.77 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.611 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.677 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 37.8 m-80 -101.79 107.49 18.71 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -129.14 124.01 33.59 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.276 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 29.0 m-85 -42.13 153.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.631 HG23 ' HB2' ' A' ' 136' ' ' GLN . 17.9 p -96.49 -27.75 14.73 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.607 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.537 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -79.48 120.86 24.46 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.505 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 5.8 m -55.49 -30.8 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.986 -170.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.25 -39.73 93.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.878 0.847 . . . . 0.0 109.866 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 66.1 mt -76.68 -24.98 53.2 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.268 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 39.4 mtt180 -72.49 -32.8 66.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.1 mm-40 -71.9 -41.13 68.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.922 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.9 p30 -148.98 102.84 3.37 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 122.051 0.929 . . . . 0.0 111.452 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 33.6 Cg_endo -66.47 113.94 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.425 2.75 . . . . 0.0 110.98 172.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 33.0 Cg_exo -59.8 157.79 31.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.592 2.195 . . . . 0.0 111.094 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.07 -21.9 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.683 -169.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.554 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 1.9 mmpt? -128.36 103.86 20.02 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 122.012 0.91 . . . . 0.0 112.133 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.845 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 12.6 Cg_exo -44.28 140.27 5.83 Favored 'Trans proline' 0 N--CA 1.455 -0.737 1 C-N-CA 125.553 4.169 . . . . 0.0 113.82 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.0 t70 -111.6 114.67 27.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.368 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.627 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.6 m-85 -78.63 -7.13 57.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.21 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.6 p -96.69 -34.56 11.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.537 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 72.2 mmtt -81.78 -17.22 48.38 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.644 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 32.6 tp -66.67 139.65 57.86 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.744 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.631 ' HB2' HG23 ' A' ' 118' ' ' THR . 3.9 tt0 -129.02 121.95 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.769 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.78 108.98 20.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.743 0.782 . . . . 0.0 112.236 -175.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.456 ' CB ' ' HG3' ' A' ' 15' ' ' PRO . 5.0 t30 -91.33 101.54 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.603 170.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.617 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 6.3 mm -68.96 106.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 112' ' ' TYR . 66.4 mt -66.72 87.38 0.13 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.922 0.868 . . . . 0.0 111.2 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.872 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.51 -4.85 57.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.162 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.2 p -83.23 -11.65 57.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.576 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 63.3 t30 -143.9 59.86 7.58 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.408 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 13.9 Cg_exo -71.8 105.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.698 1.599 . . . . 0.0 110.658 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.7 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -79.91 81.35 6.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.156 0.503 . . . . 0.0 110.143 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.9 m -80.38 141.67 14.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.205 0.526 . . . . 0.0 111.084 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.488 HG21 HH21 ' A' ' 108' ' ' ARG . 54.2 m -148.83 105.87 3.6 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.753 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -115.46 140.28 49.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 110.381 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -119.43 169.94 9.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.788 -175.272 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.98 111.57 24.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.693 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 22.3 pt -115.06 -173.91 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 121.377 0.608 . . . . 0.0 110.596 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.44 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 4.0 p-10 -88.57 114.45 25.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.793 1.282 . . . . 0.0 109.733 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 59.8 m95 -96.06 -8.46 33.43 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.529 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -131.3 177.76 7.23 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.218 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.95 71.55 4.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.52 0.676 . . . . 0.0 109.181 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.5 m120 . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.954 -178.068 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.17 -173.66 2.33 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.801 -0.235 . . . . 0.0 110.475 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 83.3 mtp 70.94 176.33 0.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 123.697 0.623 . . . . 0.0 111.489 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 122' ' ' LYS . . . 79.43 -20.82 4.76 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.983 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.507 ' NZ ' ' HB1' ' A' ' 87' ' ' ALA . 13.6 mptt 73.43 -47.52 0.66 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.816 0.846 . . . . 0.0 111.679 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -37.04 -59.22 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 12.8 tt -68.92 -32.68 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -62.93 -56.04 20.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.584 HD11 HG11 ' A' ' 45' ' ' VAL . 2.1 mm? -69.48 -29.59 67.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.869 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.3 77.42 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 90.7 mtt180 -53.34 -46.5 69.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.306 0.574 . . . . 0.0 110.312 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.767 ' HD2' ' HB3' ' B' ' 133' ' ' GLU . 21.4 tpt180 -65.93 -35.66 81.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.518 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 145' ' ' ARG . 18.1 mt -94.72 -22.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -67.64 -33.16 74.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.477 ' HA2' ' OXT' ' B' ' 135' ' ' ALA . . . 153.04 71.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.829 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.767 ' HB3' ' HD2' ' B' ' 129' ' ' ARG . 16.1 tp10 -110.08 -49.31 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.421 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 19.1 tpt180 -65.83 -51.34 59.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.477 ' OXT' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.245 0.835 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.798 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.651 0.263 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.82 126.17 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.821 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.88 -8.81 51.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.623 -175.178 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.635 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 38.8 t -148.15 138.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.048 ' HG2' HD11 ' A' ' 31' ' ' ILE . 14.4 mm-40 -124.03 101.29 7.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.73 167.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 81.6 t -72.67 102.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -88.5 -60.7 1.89 Allowed 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.722 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.742 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 64.7 t30 -107.51 150.59 26.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.217 -1.81 . . . . 0.0 110.386 -171.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 26' ' ' ILE . 2.6 p -145.81 99.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.791 169.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -92.21 107.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.653 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -77.55 119.82 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.677 -178.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 23' ' ' GLN . 2.4 mt -89.31 -47.79 7.8 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.093 -171.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 9.5 t70 -78.58 73.65 5.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.046 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.612 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t30 -81.72 176.7 3.57 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 111.726 -2.488 . . . . 0.0 106.614 169.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.99 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 3.0 Cg_endo -46.74 104.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.68 1.636 . . . . 0.0 113.374 -147.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 1.007 ' HB3' HD22 ' A' ' 20' ' ' ASN . 75.1 m -126.5 168.82 13.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.493 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -40.69 132.56 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.298 1.998 . . . . 0.0 111.031 173.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.718 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 7.9 t80 -58.11 -25.36 61.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.753 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 133' ' ' SER . 5.2 m-85 -89.83 3.95 51.34 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.86 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 1.007 HD22 ' HB3' ' A' ' 16' ' ' SER . 3.8 p30 -97.25 142.72 24.96 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.618 170.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.627 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 6.3 Cg_endo -42.29 151.17 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.16 1 C-N-CA 126.551 4.834 . . . . 0.0 115.877 -178.336 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.859 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 45.8 m-85 -84.5 120.22 26.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.655 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.92 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.5 mp0 -110.4 121.7 45.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.684 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 82.6 m-85 -125.59 104.34 8.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.219 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.689 ' CB ' HD21 ' A' ' 12' ' ' LEU . 35.5 tt0 -88.14 86.27 7.07 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG13 HG23 ' A' ' 9' ' ' VAL . 4.6 mt -83.51 134.01 27.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.192 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.5 m -109.1 109.01 19.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.553 172.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.636 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 13.7 p90 -123.37 148.56 45.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.892 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.883 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.3 tt0 -108.39 112.49 24.94 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 110.44 7.4 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.048 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.2 mt -72.04 -35.94 55.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.695 -171.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.821 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 23.9 mt-10 -143.35 172.02 13.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.419 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 p-10 -71.62 144.24 49.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.36 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.047 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 62.5 mt -95.88 161.08 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -112.47 -25.02 9.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.122 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.51 -168.14 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.122 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.12 140.84 29.08 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.77 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -81.73 119.18 23.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.935 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.736 ' HG2' HD22 ' A' ' 61' ' ' LEU . 24.3 mt-10 -101.96 89.29 3.59 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.442 -173.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.577 ' CH2' HG21 ' A' ' 26' ' ' ILE . 19.1 m95 -77.65 151.59 34.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.699 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 0.6 OUTLIER -153.23 134.05 13.88 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.554 -0.459 . . . . 0.0 109.85 -179.112 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 33.0 mt -103.18 120.54 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.656 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -119.04 106.24 19.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.839 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.771 ' CE2' HG11 ' A' ' 113' ' ' VAL . 56.0 t80 -89.15 126.0 35.28 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.856 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.941 HG22 ' HE2' ' A' ' 53' ' ' TYR . 31.4 t -73.52 117.94 18.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.195 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -92.98 -59.24 1.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 119.846 -1.169 . . . . 0.0 112.092 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.708 ' H ' ' CB ' ' A' ' 53' ' ' TYR . 7.4 m -105.26 72.39 0.98 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -48.19 -21.27 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.552 0.532 . . . . 0.0 111.62 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG3' ' HE2' ' B' ' 122' ' ' LYS . 5.2 tt0 -85.71 -31.99 22.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.388 0.675 . . . . 0.0 112.23 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.7 m -95.62 -27.59 15.24 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.996 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER 64.25 11.63 6.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.865 1.266 . . . . 0.0 112.489 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -99.11 -13.06 19.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.452 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.996 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 29.3 p90 -73.17 -46.51 50.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.563 -1.653 . . . . 0.0 114.416 -161.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.616 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 7.6 p-10 -30.8 113.76 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 125.011 1.445 . . . . 0.0 114.388 -154.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.605 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 14.1 mt-30 -95.84 170.78 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.607 -169.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.612 HG13 ' HE2' ' A' ' 41' ' ' LYS . 2.3 t -130.49 116.03 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.863 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.3 mm? -92.56 -56.66 2.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.289 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 15.2 t70 -162.5 156.63 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.998 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.699 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 36.6 p -132.96 121.82 23.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG11 ' CE1' ' A' ' 72' ' ' PHE . 3.6 p -111.2 137.32 44.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.736 HD22 ' HG2' ' A' ' 39' ' ' GLU . 7.8 mt -108.99 105.06 14.42 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.458 -176.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.01 114.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -68.59 -176.08 11.23 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.011 -167.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.047 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 43.6 Cg_endo -65.15 114.71 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.146 1.231 . . . . 0.0 110.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 63' ' ' GLY . 34.6 m -123.84 140.35 34.31 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.034 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 60.5 Cg_endo -80.55 79.5 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.292 1.994 . . . . 0.0 113.589 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 53.25 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.633 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.03 128.06 3.89 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.703 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.883 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 51.0 ttt180 -87.23 115.92 24.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.698 0.761 . . . . 0.0 109.345 175.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.531 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.1 p80 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.484 -172.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -94.16 136.51 34.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.795 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -121.29 153.03 38.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.33 121.0 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.622 1.201 . . . . 0.0 111.989 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.684 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -95.23 141.01 29.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.329 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.92 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 76.6 mt-30 -152.08 152.54 32.5 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 167.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -169.39 126.98 0.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.747 ' O ' HD12 ' A' ' 57' ' ' LEU . 29.4 t70 -64.53 147.99 51.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.685 0.279 . . . . 0.0 111.445 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -37.17 152.37 0.12 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.859 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 32.9 Cg_endo -64.04 -179.78 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 125.087 3.858 . . . . 0.0 113.344 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -92.84 119.19 67.99 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.206 0.527 . . . . 0.0 110.99 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -66.97 -23.24 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.273 2.649 . . . . 0.0 112.501 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.58 -2.85 90.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.953 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 53.2 mt -108.05 1.99 22.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.573 0.225 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.569 HD11 ' HE1' ' A' ' 44' ' ' TYR . 10.1 mt -109.5 123.52 36.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 91.5 Cg_endo -80.02 163.85 22.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.687 2.925 . . . . 0.0 112.22 168.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 10.3 t70 -44.46 -55.03 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.112 0.965 . . . . 0.0 113.195 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.49 70.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.164 0.507 . . . . 0.0 111.607 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 35.5 m-20 -94.45 -8.6 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.638 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.545 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -88.35 -47.77 8.14 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 121.123 0.487 . . . . 0.0 111.955 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -101.94 44.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.523 0.678 . . . . 0.0 111.906 -174.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.88 -124.13 0.71 Allowed Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.597 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.88 130.12 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-O 122.236 1.017 . . . . 0.0 111.91 -169.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.471 HG22 HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -146.77 170.67 16.52 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.416 -1.72 . . . . 0.0 107.719 179.11 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.52 ' CG2' ' HB3' ' B' ' 126' ' ' LEU . 3.0 t -128.58 151.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.56 0.219 . . . . 0.0 111.481 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 95' ' ' VAL . 7.8 p -131.29 107.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.941 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.9 pp -102.52 140.56 36.64 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.433 -170.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 24' ' ' PHE . 58.7 mt -112.44 106.47 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.47 0.652 . . . . 0.0 109.393 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 62.9 p -93.86 119.47 32.84 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.46 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.642 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.1 m -85.39 128.78 34.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 169.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.7 m -122.65 119.9 32.11 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.386 -171.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.656 ' HB3' HD11 ' A' ' 151' ' ' ILE . 75.2 t80 -124.89 122.85 38.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.537 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.638 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 48.4 mtp180 69.53 28.09 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.062 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.13 -0.7 82.0 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.265 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -121.69 128.64 52.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.203 0.525 . . . . 0.0 110.519 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.3 mp0 -79.84 139.75 37.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.946 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.77 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 42.6 p90 -124.1 -0.63 8.34 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.795 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.4 tt -159.12 158.86 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.617 -0.677 . . . . 0.0 109.185 174.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.562 ' HG3' HG22 ' A' ' 98' ' ' THR . 16.3 ttm180 -151.37 102.56 2.92 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -176.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.941 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.62 99.17 7.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.292 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.646 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -83.72 78.04 2.05 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.889 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.9 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -73.56 113.27 10.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.434 ' CB ' HD12 ' A' ' 140' ' ' LEU . 18.3 m-85 -67.3 127.57 33.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.222 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.771 HG11 ' CE2' ' A' ' 44' ' ' TYR . 7.7 p -109.53 111.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.37 1.081 . . . . 0.0 108.088 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -89.47 111.06 21.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.271 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.525 ' HB3' HD11 ' A' ' 135' ' ' LEU . 22.9 m120 -99.29 107.71 20.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -173.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.54 131.63 34.12 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.836 -175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 55.7 m-85 -39.7 151.74 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.3 p -88.97 -33.88 17.06 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.328 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.647 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 6.5 mm-40 -82.46 122.42 28.0 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.875 177.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -55.75 -33.38 64.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.673 -171.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.92 -37.92 87.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.705 0.764 . . . . 0.0 109.549 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.0 mt -74.11 -23.35 59.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.557 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -76.29 -31.24 58.11 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 120' ' ' THR . 30.9 mm-40 -77.97 -33.95 51.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.46 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 1.9 p30 -144.67 87.57 7.44 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.106 0.479 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 11.6 Cg_endo -53.62 117.93 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.764 2.309 . . . . 0.0 110.727 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 77.3 Cg_exo -53.39 160.12 5.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.624 2.216 . . . . 0.0 110.798 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.49 -38.87 9.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 O-C-N 123.658 0.599 . . . . 0.0 111.494 -168.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.719 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 4.6 mmtt -124.44 127.6 25.21 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.719 ' HD2' ' HD3' ' A' ' 129' ' ' LYS . 7.5 Cg_exo -41.31 134.22 3.07 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.613 3.542 . . . . 0.0 113.257 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 25.0 t70 -114.52 114.46 25.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.718 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.2 m-85 -78.57 -16.93 56.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.08 -168.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.436 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -83.32 -28.65 28.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.241 177.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.647 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 66.0 mmtt -98.56 11.46 38.28 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 115' ' ' ASN . 26.2 tp -91.05 147.11 23.3 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.894 -177.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.447 ' OE1' ' HB2' ' A' ' 15' ' ' PRO . 5.1 tt0 -124.88 123.06 39.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.85 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.0 mtp-105 -82.73 103.6 12.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.99 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 2.1 t30 -99.47 105.0 16.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.944 0.878 . . . . 0.0 108.808 171.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.704 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -78.41 111.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.731 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.434 HD12 ' CB ' ' A' ' 112' ' ' TYR . 69.3 mt -68.16 86.91 0.27 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.9 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.62 -11.41 59.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 p -78.96 -10.66 59.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.069 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.497 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 17.1 m120 -133.06 58.4 34.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.065 -174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 6.0 Cg_exo -80.43 105.28 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.814 1.676 . . . . 0.0 111.053 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.714 ' HB3' HD13 ' B' ' 130' ' ' ILE . 12.6 tpp180 -82.45 81.16 8.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.512 HG12 HG23 ' A' ' 109' ' ' VAL . 6.1 m -83.26 104.77 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.609 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.427 HG22 ' CE1' ' A' ' 149' ' ' PHE . 21.4 m -111.48 106.8 15.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.687 0.756 . . . . 0.0 109.595 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.795 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.0 ptt180 -113.82 146.04 40.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.386 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.1 169.37 15.4 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.241 -173.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.0 130.31 53.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.687 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.4 pt -129.08 -177.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.535 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 13.5 p30 -103.38 87.54 2.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.673 0.749 . . . . 0.0 111.37 -174.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.635 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 37.3 m95 -73.15 -1.18 16.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.401 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -129.79 162.75 27.74 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.79 70.88 3.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.623 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.156 174.306 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.64 151.92 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.259 0.552 . . . . 0.0 111.496 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.513 ' O ' ' HE3' ' B' ' 122' ' ' LYS . 49.3 ttp -74.24 -32.88 63.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.63 105.13 1.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.592 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.682 ' HE2' ' HG3' ' A' ' 49' ' ' GLU . 23.2 mmtp -73.91 -33.7 64.08 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.93 -0.159 . . . . 0.0 110.856 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -37.26 -53.06 1.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.489 0.493 . . . . 0.0 111.804 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.76 -30.22 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.573 0.225 . . . . 0.0 111.408 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.638 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 9.1 mm100 -60.95 -52.33 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.291 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.681 ' CD1' HG11 ' A' ' 45' ' ' VAL . 2.4 mm? -67.07 -39.99 86.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.05 88.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.29 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 9.3 ptm180 -66.42 -35.89 81.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.78 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.786 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 23.0 tpt180 -64.7 -38.92 92.62 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.714 HD13 ' HB3' ' A' ' 145' ' ' ARG . 14.8 mt -76.05 -50.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -51.26 -43.2 61.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.95 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.37 57.66 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.065 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.786 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 26.2 mm-40 -103.83 -50.55 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' B' ' 133' ' ' GLU . 9.7 ptm180 47.31 -179.99 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.294 175.373 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.669 0.271 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.21 127.48 32.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 110.193 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 1.144 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.82 -20.42 23.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.98 -175.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.855 HG21 HD21 ' A' ' 38' ' ' LEU . 4.0 t -141.72 130.07 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.7 tp60 -121.66 100.2 6.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.064 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -79.61 146.4 7.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.366 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -129.14 -65.57 0.86 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.202 -165.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.684 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.61 150.45 23.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.779 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.632 HG23 HG13 ' A' ' 26' ' ' ILE . 3.5 p -146.18 100.05 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 169.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.987 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -87.6 103.73 13.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.687 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -77.86 109.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.713 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.974 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.7 mt -89.72 -44.64 9.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.989 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.932 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.6 OUTLIER -69.32 75.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.622 1.677 . . . . 0.0 109.597 167.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.1 t30 -85.37 177.9 2.65 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.138 163.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.8 Cg_endo -48.83 103.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 121.916 1.72 . . . . 0.0 113.603 -154.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.69 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.4 m -129.78 171.24 9.2 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.425 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.69 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 83.7 Cg_exo -42.84 138.82 3.64 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.685 2.257 . . . . 0.0 112.106 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.727 ' CE1' ' HG2' ' A' ' 79' ' ' PRO . 43.9 t80 -58.11 -29.62 65.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.659 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -89.12 1.3 55.82 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -78.66 144.52 65.12 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.281 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 12.1 Cg_exo -79.54 137.48 13.03 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 123.221 2.614 . . . . 0.0 112.831 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 25.3 m-85 -55.24 146.24 19.52 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.931 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.974 ' HG2' HD12 ' A' ' 12' ' ' LEU . 33.5 tt0 -136.46 92.44 2.77 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.206 -167.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' HD12 ' A' ' 42' ' ' ILE . 52.9 m-85 -113.27 108.38 17.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.329 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.987 ' HB3' HG23 ' A' ' 10' ' ' VAL . 38.4 tt0 -96.27 88.1 4.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 9' ' ' VAL . 3.2 mt -81.43 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.185 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.7 m -108.4 106.48 16.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.935 170.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 39.1 p90 -121.22 146.14 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.829 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.4 tt0 -102.36 110.52 22.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.519 ' HB2' ' C ' ' A' ' 67' ' ' ALA . 20.7 m -72.8 115.36 12.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -80.68 -31.38 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.856 -171.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.144 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 34.8 mt-10 -145.28 168.24 20.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.759 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.4 p-10 -73.45 131.57 41.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 111.798 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.773 HD11 HD22 ' A' ' 38' ' ' LEU . 75.6 mt -83.15 159.21 22.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.497 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 p -112.25 -19.65 12.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.643 0.735 . . . . 0.0 109.215 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -136.97 -172.45 3.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.516 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.94 151.48 33.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.481 0.658 . . . . 0.0 110.761 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.855 HD21 HG21 ' A' ' 4' ' ' VAL . 4.6 tp -107.46 123.16 47.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 23.3 tt0 -106.03 135.58 47.23 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.868 -174.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.596 ' CE3' ' SG ' ' A' ' 99' ' ' CYS . 19.1 m95 -132.14 124.52 29.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.837 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.0 ttmp? -125.49 146.62 49.56 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.812 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.599 HD13 HG12 ' A' ' 97' ' ' ILE . 18.9 mm -102.75 106.87 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 87.6 mt -103.02 106.94 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.801 0.81 . . . . 0.0 109.886 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 79' ' ' PRO . 18.8 t80 -87.46 115.61 25.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.756 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG11 HD12 ' B' ' 126' ' ' LEU . 10.0 t -66.38 99.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 121.378 0.608 . . . . 0.0 109.712 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -57.91 -43.45 94.86 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.231 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.687 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 46.7 t -123.69 109.38 13.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' B' ' 126' ' ' LEU . . . -70.97 -5.66 32.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.419 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' HZ2' ' B' ' 122' ' ' LYS . 3.2 mt-10 -100.89 -22.09 14.92 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.163 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.52 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.9 m -116.07 -150.32 0.46 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.989 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' B' ' 129' ' ' ARG . 8.9 pt-20 -150.69 -33.28 0.17 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.767 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.78 2.57 5.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.389 0.614 . . . . 0.0 111.401 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.687 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 95.8 m-85 -94.58 4.28 54.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.53 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.53 110.17 0.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.012 0.91 . . . . 0.0 109.938 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 4.4 mt-30 -96.02 166.69 11.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.306 -176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.666 HG22 ' HD3' ' A' ' 41' ' ' LYS . 42.3 t -127.31 106.26 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.971 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.61 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 4.0 mt -75.16 -48.23 24.6 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.741 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -170.48 165.3 8.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.843 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 p -141.9 128.92 20.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.4 p -99.5 133.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.946 -173.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.36 105.13 14.67 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.733 0.777 . . . . 0.0 110.099 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 98.3 t -83.56 155.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.47 -163.19 37.08 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.826 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.666 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 61.1 Cg_endo -89.83 118.21 0.75 Allowed 'Trans proline' 0 N--CA 1.424 -2.565 0 C-N-CA 122.057 1.838 . . . . 0.0 110.284 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' H ' HD12 ' A' ' 34' ' ' LEU . 33.8 m -119.51 134.0 23.81 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.489 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.8 Cg_endo -79.13 83.51 2.25 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 113.453 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.519 ' C ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.04 -171.35 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.653 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.01 132.32 7.36 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 14.8 ttp180 -75.08 113.69 12.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.458 0.647 . . . . 0.0 110.286 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -111.39 129.1 56.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 ttp -106.66 111.84 24.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 168.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 4.8 p90 -126.13 141.09 52.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.739 0.781 . . . . 0.0 109.326 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 2.2 p -101.41 116.71 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.536 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -119.28 132.28 55.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.281 -168.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 44.6 mt-30 -125.15 160.45 29.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.699 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 57' ' ' LEU . . . -153.48 137.63 16.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.035 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 20.6 t70 -57.4 162.1 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -62.61 158.42 50.65 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 121.509 0.671 . . . . 0.0 111.526 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.727 ' HG2' ' CE1' ' A' ' 18' ' ' PHE . 28.9 Cg_endo -62.28 171.41 5.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.813 2.342 . . . . 0.0 111.702 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.87 115.28 62.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.603 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.56 -16.2 53.23 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.631 2.888 . . . . 0.0 112.816 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.84 -18.3 56.54 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.127 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 46.5 mt -91.9 -15.22 28.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.683 0.278 . . . . 0.0 111.385 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 17.1 mt -91.42 127.61 50.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.447 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.4 ' O ' HG22 ' A' ' 84' ' ' ILE . 98.5 Cg_endo -80.68 160.01 21.86 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.726 2.284 . . . . 0.0 111.81 171.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.728 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 6.5 m-20 -46.45 -50.02 17.45 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.419 0.687 . . . . 0.0 112.615 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.17 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.538 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.02 -19.63 21.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.929 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.9 -46.36 30.51 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.147 0.499 . . . . 0.0 111.635 -175.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.667 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -98.17 48.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.289 1.042 . . . . 0.0 110.492 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.58 -137.75 2.27 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.391 -161.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' B' ' 122' ' ' LYS . 9.8 p -130.46 145.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.714 0.769 . . . . 0.0 110.835 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.625 HG23 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -157.33 174.59 15.19 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.742 HG12 HD23 ' A' ' 96' ' ' LEU . 2.2 t -124.17 145.01 31.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.511 -0.475 . . . . 0.0 112.152 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.523 HG11 ' CZ ' ' A' ' 22' ' ' PHE . 27.7 m -116.78 105.17 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.792 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.57 136.27 41.7 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.922 -173.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.872 ' HB ' HG12 ' A' ' 109' ' ' VAL . 25.7 mt -95.79 103.14 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 108' ' ' ARG . 58.1 p -97.04 110.8 23.27 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.75 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.733 ' SG ' HG23 ' A' ' 107' ' ' ILE . 4.7 m -85.6 143.88 28.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.891 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -135.16 129.35 33.67 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -172.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 153' ' ' TRP . 84.3 t80 -135.84 118.1 15.59 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.78 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 29.2 mtp180 67.66 27.12 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.779 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.08 70.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.363 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -117.16 120.66 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.012 0.434 . . . . 0.0 110.354 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.679 ' OE1' ' HD2' ' B' ' 134' ' ' ARG . 41.2 mp0 -76.85 124.89 28.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CD2' HG22 ' A' ' 107' ' ' ILE . 34.3 p90 -110.37 -8.66 14.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -168.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.747 ' O ' ' HA ' ' A' ' 98' ' ' THR . 1.7 tt -158.89 162.4 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 119.443 1.02 . . . . 0.0 110.332 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.869 ' HG3' HG22 ' A' ' 98' ' ' THR . 14.1 ttm180 -146.53 105.59 3.88 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.872 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.2 p -95.22 100.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.235 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.76 80.99 1.78 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.878 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.888 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 9.6 m-85 -77.34 116.63 18.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.625 ' HE2' ' HA ' ' B' ' 123' ' ' ASP . 20.5 m-85 -68.0 133.11 48.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.446 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.625 HG13 HG23 ' A' ' 93' ' ' THR . 7.2 p -113.95 110.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.14 130.0 40.51 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.603 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 40.3 m-80 -111.14 113.45 25.98 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -171.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -123.96 124.87 43.54 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.519 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 17.0 m-85 -44.73 151.88 0.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.851 0.834 . . . . 0.0 112.658 173.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -92.43 -34.08 14.28 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.602 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.672 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 2.0 tm-20 -78.76 122.95 26.67 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.977 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 6.1 m -52.57 -34.94 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.465 -171.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.11 -35.65 66.6 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 43.2 mt -71.72 -27.76 63.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.483 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 17.9 mtt180 -73.07 -32.46 65.04 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.3 mm-40 -67.58 -38.68 84.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.917 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 21.6 p-10 -157.47 96.07 2.05 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 121.306 0.574 . . . . 0.0 110.57 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.5 Cg_endo -56.14 117.61 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.954 2.436 . . . . 0.0 111.368 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.79 153.51 43.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.128 1.885 . . . . 0.0 110.353 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.1 p -42.14 -41.01 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.851 0.72 . . . . 0.0 112.104 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -110.4 109.75 58.25 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 122.293 1.044 . . . . 0.0 113.334 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.728 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.6 Cg_exo -45.54 140.33 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.778 1 C-N-CA 125.54 4.16 . . . . 0.0 113.892 175.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.62 112.84 22.73 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.696 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 3.6 m-85 -77.98 -18.38 56.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.812 0.815 . . . . 0.0 110.847 -168.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -13.25 50.3 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.3 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.9 mmtt -104.09 12.67 33.73 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.7 tp -99.83 133.38 44.27 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.392 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.94 122.09 41.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.971 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.864 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.69 110.93 23.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.484 0.659 . . . . 0.0 111.501 -175.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.835 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 3.4 t30 -95.03 109.32 21.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.64 176.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -81.54 114.67 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.227 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.432 HD12 ' CB ' ' A' ' 112' ' ' TYR . 80.8 mt -69.78 85.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 110.772 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.888 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -72.13 -20.11 61.67 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.528 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.7 p -78.83 -8.55 58.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.767 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -135.07 69.34 70.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.016 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 77.2 Cg_endo -89.84 114.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.36 2.04 . . . . 0.0 111.608 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.543 ' CB ' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -82.21 81.76 7.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.202 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 109' ' ' VAL . 26.8 m -78.24 130.04 36.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.6 m -148.82 106.88 3.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.254 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -112.73 147.13 37.47 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.983 0.897 . . . . 0.0 110.705 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 170.41 11.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.45 -173.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.91 119.94 34.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.994 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 18.0 pt -120.26 -173.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.0 109.766 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 4.8 m-20 -108.2 91.6 3.71 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.437 -176.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.624 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 17.9 m95 -78.78 -13.51 59.77 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.303 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -128.2 173.89 9.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.772 -173.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -102.08 71.87 1.29 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.182 175.782 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -134.85 27.11 3.62 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.72 -0.283 . . . . 0.0 111.075 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 71.0 mtp 69.5 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.688 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.86 162.15 17.98 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.604 ' C ' HD22 ' B' ' 126' ' ' LEU . 4.0 mptp? -81.67 -50.0 9.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.625 ' HA ' ' HE2' ' A' ' 112' ' ' TYR . 1.2 p30 -37.73 -49.93 1.18 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 7.1 tp -65.2 -40.73 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 111.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.653 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 2.9 mm-40 -65.2 -35.78 82.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 110.648 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.604 HD22 ' C ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -64.03 -42.58 97.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.48 -33.03 73.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.96 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 10.4 mmm180 -54.59 -49.33 70.66 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.22 0.533 . . . . 0.0 110.006 173.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.71 ' HD3' ' HB2' ' B' ' 133' ' ' GLU . 6.2 mmp_? -69.18 -30.63 68.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.135 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.649 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 56.7 mt -75.08 -15.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -94.32 -20.05 20.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.65 39.6 0.22 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 119.6 -1.286 . . . . 0.0 114.373 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.71 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 5.3 tp10 -138.06 72.34 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.478 0.656 . . . . 0.0 109.552 172.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.679 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 10.8 ptt180 -69.0 -58.28 4.31 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.605 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.542 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.244 0.799 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.288 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.389 0.138 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.582 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -64.15 119.82 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.219 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.761 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 2.7 mmtt -100.15 -7.1 25.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.532 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.3 t -139.57 123.24 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.329 0.585 . . . . 0.0 110.553 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp60 -117.0 100.5 7.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.834 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.3 m -79.64 135.73 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -117.16 -63.61 1.42 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.003 -164.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.593 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.0 t-20 -103.96 152.7 21.68 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.644 -174.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -146.89 100.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.037 HG23 ' HB2' ' A' ' 25' ' ' GLU . 1.0 OUTLIER -94.18 97.58 7.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.012 -177.132 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.563 HG13 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -73.62 132.91 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.158 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.113 HD12 ' HG2' ' A' ' 23' ' ' GLN . 7.0 mt -103.85 -65.04 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.384 -169.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.66 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -88.15 55.04 3.28 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.382 1.087 . . . . 0.0 111.748 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 1.091 ' HA ' HD13 ' A' ' 139' ' ' ILE . 27.0 p-10 -81.42 -176.21 0.74 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 161.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.853 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.3 Cg_endo -41.67 104.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 122.428 2.085 . . . . 0.0 114.95 -125.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.671 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.2 m -139.61 172.72 5.98 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 110.305 -3.134 . . . . 0.0 107.054 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 85.3 Cg_exo -41.26 136.56 2.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.139 1.893 . . . . 0.0 111.964 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.711 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 28.6 t80 -60.18 -27.27 66.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.158 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -78.71 -14.32 59.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.706 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -72.95 134.21 81.3 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 22.9 Cg_exo -71.81 146.18 47.51 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.738 2.959 . . . . 0.0 113.599 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.749 ' N ' HH12 ' A' ' 137' ' ' ARG . 62.4 m-85 -55.71 124.86 18.86 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.587 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.113 ' HG2' HD12 ' A' ' 12' ' ' LEU . 8.7 tt0 -125.56 100.28 6.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.455 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.661 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.9 m-85 -111.39 155.53 22.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.442 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.037 ' HB2' HG23 ' A' ' 10' ' ' VAL . 59.2 mt-10 -126.27 91.28 3.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 163.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.571 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 6.7 mt -83.72 127.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 122.065 0.936 . . . . 0.0 112.432 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.3 m -101.21 106.42 17.64 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.526 173.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.834 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 25.1 p90 -110.86 141.62 44.0 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.526 0.679 . . . . 0.0 109.913 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.6 tt0 -102.83 113.46 26.9 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.7 m -71.87 122.32 20.55 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -87.41 -23.94 6.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.639 -169.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.23 178.13 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.74 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.919 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 21.9 t70 -78.49 123.47 27.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.414 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.008 HD11 HD23 ' A' ' 38' ' ' LEU . 1.9 mt -81.34 154.96 26.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.033 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -111.81 -35.07 5.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.297 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.709 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 30.5 tt0 -116.47 -169.06 1.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.085 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.709 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -88.38 151.76 22.37 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.669 0.747 . . . . 0.0 109.666 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.008 HD23 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.74 123.32 42.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.651 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 18.5 tt0 -97.05 132.75 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.336 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.775 ' HB2' HG12 ' A' ' 60' ' ' VAL . 69.3 m95 -130.48 109.42 10.68 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.305 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.915 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 4.6 ptpp? -126.0 154.81 42.4 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.217 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 76' ' ' ALA . 37.0 mt -103.37 118.71 50.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.266 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 2.5 mp -102.46 105.97 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' HD1' ' CG1' ' A' ' 95' ' ' VAL . 76.7 t80 -83.6 114.33 21.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG11 HD12 ' B' ' 126' ' ' LEU . 4.1 t -62.11 98.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -35.37 40.58 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.746 ' HB2' ' C ' ' A' ' 50' ' ' SER . 6.7 p -99.21 88.49 3.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.708 -0.746 . . . . 0.0 112.321 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -90.5 -16.89 28.06 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 163.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -89.43 -42.69 11.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.238 -1.347 . . . . 0.0 109.566 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.746 ' C ' ' HB2' ' A' ' 47' ' ' SER . 57.7 m -106.64 -146.76 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -150.62 -4.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -95.62 3.05 54.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.745 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 6.7 m-30 -90.12 -15.46 31.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 119.169 -0.443 . . . . 0.0 111.419 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.6 p-10 -41.64 111.59 0.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.295 1.045 . . . . 0.0 111.564 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 53' ' ' TYR . 14.4 mt-30 -93.45 166.56 12.21 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.173 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG22 HG13 ' A' ' 43' ' ' ILE . 54.6 t -130.94 103.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.6 mm? -70.57 -37.22 73.94 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -171.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 24.8 t0 -177.5 154.11 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.01 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.915 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 97.6 p -130.07 110.32 11.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.775 HG12 ' HB2' ' A' ' 40' ' ' TRP . 11.7 p -99.2 139.84 20.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.895 -166.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 mt -108.22 103.68 12.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.547 0.689 . . . . 0.0 111.353 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 30.6 t -85.34 155.05 3.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.76 -164.57 40.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.654 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.706 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.6 Cg_endo -69.97 114.57 3.78 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.238 1.292 . . . . 0.0 109.967 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.64 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.3 m -108.85 119.33 49.33 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.036 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.919 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 70.7 Cg_endo -84.26 77.48 3.18 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.725 2.283 . . . . 0.0 113.654 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 51.39 169.15 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.796 -2.002 . . . . 0.0 112.554 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.32 123.0 3.22 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.072 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.903 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 11.2 ttt180 -74.76 122.33 23.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.499 0.666 . . . . 0.0 110.852 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.512 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.0 p80 -154.35 146.13 23.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.163 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.687 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 5.5 ttp -97.78 130.2 44.74 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.213 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.3 p90 -112.26 153.44 27.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.65 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.7 p -111.16 132.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.845 0.831 . . . . 0.0 110.224 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.661 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -117.13 130.94 56.95 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.933 -165.001 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.731 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.7 mt-30 -141.6 153.78 45.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -164.51 157.85 17.61 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.526 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.71 -177.22 0.22 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.683 0.754 . . . . 0.0 112.56 -172.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -89.7 147.77 38.46 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.868 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.8 Cg_exo -55.43 154.99 22.08 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 123.521 2.814 . . . . 0.0 113.106 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -77.91 118.42 72.04 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.403 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.43 -13.73 41.31 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.523 2.816 . . . . 0.0 112.778 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.62 -4.93 57.94 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.898 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.79 -25.5 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.55 0.214 . . . . 0.0 110.769 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 85' ' ' PRO . 41.1 mt -84.66 130.3 53.73 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.919 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 84' ' ' ILE . 62.6 Cg_endo -80.11 164.62 22.11 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.36 2.706 . . . . 0.0 112.359 170.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.69 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 7.5 t70 -43.94 -58.04 3.0 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.669 1.187 . . . . 0.0 113.768 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -8.11 59.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.133 -165.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 56.5 m-20 -94.44 -22.37 18.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.681 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HB2' ' CG2' ' A' ' 84' ' ' ILE . . . -85.64 -47.16 10.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.629 -176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -101.34 46.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.814 0.816 . . . . 0.0 111.049 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.89 -157.68 8.57 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.48 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' B' ' 122' ' ' LYS . 10.0 p -97.36 144.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.67 0.748 . . . . 0.0 109.533 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.62 171.6 19.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -171.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -133.68 146.68 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.787 0.722 . . . . 0.0 111.944 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 22' ' ' PHE . 27.2 m -121.8 106.31 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.926 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -102.17 125.01 48.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.127 -173.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 50.4 mt -96.0 101.94 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 45.2 p -98.67 117.0 32.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.38 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 62.4 m -80.66 152.46 28.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.612 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 11.7 m -145.56 119.02 9.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.706 ' HB3' HD11 ' A' ' 151' ' ' ILE . 35.1 t80 -135.43 128.75 32.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 4.5 mmp_? 67.0 12.84 9.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.416 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.48 1.14 57.88 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.825 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -116.6 150.3 38.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 17.2 mp0 -99.72 134.41 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.847 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.793 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 52.4 p90 -120.01 -2.94 10.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -170.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.814 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.5 tt -156.75 159.92 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.834 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 17.7 ttp180 -151.6 99.94 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.845 0.716 . . . . 0.0 109.306 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.926 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.4 p -85.44 101.49 9.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.258 175.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.79 78.08 2.04 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.722 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.973 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -73.7 114.2 11.7 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.455 -0.872 . . . . 0.0 109.015 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.525 ' HA ' HG22 ' A' ' 94' ' ' VAL . 23.5 m-85 -67.72 126.39 29.24 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.532 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.442 HG11 ' HE1' ' A' ' 44' ' ' TYR . 7.5 p -111.49 111.23 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 26.3 t-20 -92.87 117.74 30.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.472 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.487 ' HB3' HD11 ' A' ' 135' ' ' LEU . 22.6 m120 -109.5 108.65 19.21 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.81 0.814 . . . . 0.0 109.883 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -137.48 139.24 40.45 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.33 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.689 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 62.0 m-85 -46.76 152.42 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -174.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.403 HG22 ' HG3' ' A' ' 136' ' ' GLN . 30.3 p -91.27 -38.29 12.76 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.063 -1.426 . . . . 0.0 108.846 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.918 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -78.25 125.49 29.43 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.062 -174.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.591 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 4.9 m -47.76 -43.11 27.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.824 0.702 . . . . 0.0 111.697 -168.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.19 -35.88 82.46 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.627 0.727 . . . . 0.0 110.266 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 56.3 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.44 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 7.2 mtt180 -74.54 -37.33 63.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.8 mm-40 -63.6 -43.43 96.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.705 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.3 p30 -144.35 82.03 10.91 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.11 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.2 Cg_endo -50.19 116.87 2.71 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.491 2.794 . . . . 0.0 112.326 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.689 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 69.0 Cg_exo -54.54 137.64 73.33 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.713 2.276 . . . . 0.0 111.088 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.618 HG12 ' HE2' ' A' ' 129' ' ' LYS . 36.7 t -50.04 -40.36 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.987 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.618 ' HE2' HG12 ' A' ' 128' ' ' VAL . 2.0 mmpt? -103.35 136.51 19.21 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 111.121 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.69 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -64.39 131.27 29.39 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.749 2.966 . . . . 0.0 113.022 -175.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 23.7 t70 -114.21 114.34 25.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 171.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.711 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 20.6 m-85 -79.22 -15.45 58.01 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.847 -169.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 -28.18 26.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.521 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.918 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 69.7 mmtt -101.68 10.93 39.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 115' ' ' ASN . 27.0 tp -89.23 138.54 31.34 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.516 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.403 ' HG3' HG22 ' A' ' 118' ' ' THR . 9.1 tt0 -113.45 123.03 49.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.853 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -93.02 106.74 18.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.249 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.5 t30 -92.23 105.88 18.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.946 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.091 HD13 ' HA ' ' A' ' 14' ' ' ASN . 1.1 mp -80.66 107.18 12.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.433 HD12 ' CB ' ' A' ' 112' ' ' TYR . 85.9 mt -67.81 84.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.968 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.973 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -73.05 -12.81 61.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.673 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 -9.51 59.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.906 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.49 70.47 76.5 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.783 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 72.1 Cg_endo -89.28 105.02 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.543 1.496 . . . . 0.0 110.404 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' HB3' HG21 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -83.67 81.06 8.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.306 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 146' ' ' VAL . 6.7 m -77.06 104.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 0.0 111.261 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.468 HG21 HH21 ' A' ' 108' ' ' ARG . 26.5 m -109.4 105.05 14.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.742 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -116.78 133.3 56.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.531 0.681 . . . . 0.0 110.533 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HD1' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.34 167.79 11.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.913 -175.132 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.58 123.14 47.01 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 101' ' ' TYR . 45.1 pt -119.26 -174.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.505 0.669 . . . . 0.0 109.873 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 3.9 m-20 -90.73 105.71 18.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.032 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.761 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 11.8 m95 -86.47 2.41 47.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -115.03 -179.45 3.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.78 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.93 71.9 0.79 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.529 0.68 . . . . 0.0 109.915 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.21 177.547 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 60.16 68.64 0.76 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.797 0.439 . . . . 0.0 111.494 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 66.9 mtp -54.93 -73.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.487 0.661 . . . . 0.0 109.592 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.6 154.35 19.68 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.7 ' O ' HD22 ' B' ' 126' ' ' LEU . 27.4 mmtp -64.79 -20.88 66.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.191 0.496 . . . . 0.0 111.395 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -36.66 -51.76 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.7 0.625 . . . . 0.0 112.292 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.7 -40.62 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.618 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 5.5 mm100 -54.6 -51.08 66.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 174.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.7 HD22 ' O ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -65.28 -43.99 89.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.989 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.64 -37.47 81.61 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.304 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -61.39 -39.12 89.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.5 mmt180 -73.09 -28.39 62.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.084 0.468 . . . . 0.0 110.003 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.834 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 31.1 mt -82.76 -8.5 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.22 -24.35 18.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.723 177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' B' ' 135' ' ' ALA . . . 164.02 59.02 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.709 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.547 ' OE2' ' HD3' ' B' ' 134' ' ' ARG . 0.2 OUTLIER -76.52 -42.61 42.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.547 ' HD3' ' OE2' ' B' ' 133' ' ' GLU . 3.5 mpt_? -103.28 -75.97 0.6 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.622 169.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.564 ' O ' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.748 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.616 0.246 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -88.75 130.16 35.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.775 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.62 -20.92 21.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.621 HG23 HD21 ' A' ' 34' ' ' LEU . 4.3 t -140.71 130.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 111.396 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 3.5 tp-100 -123.72 99.71 6.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.656 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -75.87 142.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.073 177.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -127.21 -71.84 0.66 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.263 -163.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -105.42 100.75 10.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.519 -171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG13 ' OH ' ' A' ' 111' ' ' TYR . 2.4 p -100.45 105.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.826 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.5 m -99.33 98.27 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.917 0.865 . . . . 0.0 109.435 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 132.58 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.111 -176.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.01 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -101.65 -40.07 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.048 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 37.1 t0 -67.05 64.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.73 165.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.904 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 48.6 m-20 -83.06 172.95 8.29 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.121 -1.854 . . . . 0.0 108.148 160.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.904 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.4 Cg_endo -50.88 102.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.374 1.383 . . . . 0.0 113.181 -153.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.593 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 17.9 m -132.02 170.96 9.98 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.815 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 68.7 Cg_exo -42.44 140.86 2.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.416 2.077 . . . . 0.0 111.768 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.722 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 6.3 t80 -59.6 -32.12 70.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.043 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -81.68 -9.75 59.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.0 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -63.0 126.23 88.5 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 26.0 Cg_exo -68.25 146.1 68.44 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 123.347 2.698 . . . . 0.0 112.845 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.792 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 87.1 m-85 -52.04 135.72 30.56 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.178 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.01 ' HG2' HD12 ' A' ' 12' ' ' LEU . 6.6 tt0 -140.42 84.93 1.98 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.451 -171.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.734 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 96.6 m-85 -100.08 149.76 23.16 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.68 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.826 ' HB3' HG23 ' A' ' 10' ' ' VAL . 32.9 tt0 -124.62 87.43 2.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.619 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 26.8 mt -88.75 125.49 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.697 0.76 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 21.5 m -103.39 110.68 22.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.467 172.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.733 ' HE2' HG21 ' A' ' 65' ' ' VAL . 31.8 p90 -112.75 145.29 40.8 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.895 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.5 tt0 -101.68 114.05 27.75 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 53.2 t -72.35 114.85 10.92 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -81.32 -25.14 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.411 -173.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.775 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.3 mt-10 -153.84 143.56 21.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -55.98 129.97 41.94 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.592 0.558 . . . . 0.0 110.866 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.896 ' HG ' HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -85.1 163.75 18.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.586 0.708 . . . . 0.0 112.365 -169.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 t -113.17 -40.71 3.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.206 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.46 -167.74 1.66 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.311 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 6.4 m-20 -89.84 135.57 33.56 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.236 1.017 . . . . 0.0 109.295 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.896 HD21 ' HG ' ' A' ' 34' ' ' LEU . 3.9 mm? -79.07 143.56 35.46 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.892 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 33.3 tt0 -116.12 135.61 53.77 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.673 173.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.646 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.7 m95 -123.39 125.76 45.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.759 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.6 ttmt -123.35 143.05 50.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.374 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.489 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.7 mt -103.49 108.34 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.358 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.759 HD11 ' HD2' ' A' ' 41' ' ' LYS . 3.8 mp -107.06 109.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.5 0.667 . . . . 0.0 109.427 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.78 ' CD2' ' HG3' ' A' ' 79' ' ' PRO . 22.9 t80 -89.9 109.59 20.6 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.214 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 93' ' ' THR . 25.3 t -69.71 96.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -72.63 -32.54 61.57 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.202 -1.475 . . . . 0.0 109.965 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.789 ' HB2' ' C ' ' A' ' 50' ' ' SER . 4.1 p -88.55 75.93 8.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.4 59.0 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 161.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -100.27 -45.69 5.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.331 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.789 ' C ' ' HB2' ' A' ' 47' ' ' SER . 49.4 m -103.42 -147.32 0.38 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.79 9.07 0.45 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.111 0.481 . . . . 0.0 110.476 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.19 -8.8 26.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.528 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.637 ' HB2' ' N ' ' A' ' 47' ' ' SER . 29.8 m-85 -95.8 1.9 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -168.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.32 104.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.026 0.917 . . . . 0.0 110.875 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.526 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 46.7 mt-30 -95.6 164.12 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.485 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 43' ' ' ILE . 49.5 t -131.07 112.21 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.639 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 mm? -82.29 -55.32 4.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.052 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.65 153.42 30.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.72 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 26.2 p -133.44 109.86 9.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -97.99 135.4 32.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.922 -169.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.8 mt -105.25 103.23 12.73 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.201 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.71 131.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.45 -159.51 11.26 Favored Glycine 0 CA--C 1.494 -1.248 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.998 -164.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.692 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 37.1 Cg_endo -63.71 114.78 2.71 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.733 HG21 ' HE2' ' A' ' 28' ' ' PHE . 35.1 m -110.71 145.36 32.17 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.85 -174.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 136.86 26.69 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.701 2.267 . . . . 0.0 111.448 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -46.76 139.28 5.46 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 111.28 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.84 135.1 3.91 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -174.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.895 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.2 ptt180 -76.65 130.4 37.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.432 1.111 . . . . 0.0 111.062 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -149.98 143.61 25.31 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.038 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.648 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.2 OUTLIER -93.02 146.44 23.62 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.566 0.698 . . . . 0.0 112.537 -174.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.56 ' N ' ' HG2' ' A' ' 71' ' ' MET . 3.0 p90 -133.6 160.74 36.6 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 1.7 p -118.75 139.32 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 121.734 0.778 . . . . 0.0 111.091 -172.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.734 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -121.96 125.87 47.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.95 -166.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.792 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.2 mt-30 -144.19 148.23 34.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.989 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.02 128.62 0.73 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.569 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.608 ' O ' HD12 ' A' ' 57' ' ' LEU . 6.0 p-10 -62.12 165.11 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.646 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.532 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -59.01 160.73 10.51 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -170.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.78 ' HG3' ' CD2' ' A' ' 44' ' ' TYR . 60.5 Cg_endo -67.67 178.67 3.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.75 2.967 . . . . 0.0 111.673 175.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 91.6 m-20 -72.13 119.45 74.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.249 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -64.07 -19.58 66.45 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.347 2.698 . . . . 0.0 111.756 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.19 -9.1 77.24 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.361 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.526 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 5.7 mt -94.1 -25.36 17.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.993 0.396 . . . . 0.0 110.91 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 21.2 mt -78.7 127.84 79.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.797 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 96.3 Cg_endo -78.21 163.23 27.93 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.396 2.73 . . . . 0.0 112.231 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.676 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 15.2 t70 -44.53 -57.06 3.83 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.32 1.048 . . . . 0.0 113.614 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' B' ' 122' ' ' LYS . . . -74.22 -20.88 60.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.776 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.87 -33.82 22.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.356 0.598 . . . . 0.0 109.658 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -77.2 -42.51 37.24 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.752 -171.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.4 m -103.08 47.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.634 0.73 . . . . 0.0 112.075 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -119.98 0.55 Allowed Glycine 0 CA--C 1.504 -0.601 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.15 -169.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.88 141.15 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.01 ' HB ' HG13 ' A' ' 113' ' ' VAL . 24.2 m -143.08 167.96 20.86 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 112' ' ' TYR . 3.2 t -134.42 139.08 48.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 170.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 111' ' ' TYR . 1.8 p -119.82 104.97 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.2 pp -101.27 131.51 47.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.385 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.737 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.2 mt -99.42 92.68 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.79 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 73.1 p -91.09 112.99 25.13 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 89.7 m -76.69 156.29 32.66 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.008 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.0 m -150.96 108.66 3.67 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -170.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.685 ' CZ ' HD12 ' A' ' 34' ' ' LEU . 79.5 t80 -126.76 132.77 50.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.3 mmm180 67.22 12.56 9.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.493 0.496 . . . . 0.0 111.998 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.6 56.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.118 174.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.803 ' CG ' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.2 149.17 43.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.124 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 23.8 mp0 -95.66 134.59 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.069 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 99' ' ' CYS . 53.4 p90 -120.52 -3.76 9.86 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -170.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.828 ' O ' ' HA ' ' A' ' 98' ' ' THR . 10.6 tt -155.48 161.21 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 O-C-N 121.209 -0.932 . . . . 0.0 109.058 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.834 HH21 HG21 ' A' ' 147' ' ' THR . 0.4 OUTLIER -153.91 99.47 2.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.927 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.3 p -87.16 101.79 11.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.088 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -86.8 86.52 1.55 Allowed Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 118.943 -1.598 . . . . 0.0 111.129 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.884 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.6 m-85 -73.91 115.2 13.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.276 -0.962 . . . . 0.0 109.538 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 140' ' ' LEU . 3.3 m-85 -67.06 112.94 4.66 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.479 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.01 HG13 ' HB ' ' A' ' 93' ' ' THR . 2.4 p -104.31 111.31 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -96.5 113.65 25.24 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.852 -173.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.8 m-20 -94.65 109.15 21.11 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.48 0.657 . . . . 0.0 109.415 -170.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.47 124.41 40.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.828 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.607 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 42.9 m-85 -39.39 149.43 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 136' ' ' GLN . 29.8 p -87.58 -32.82 19.14 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.544 -174.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.2 mt-10 -87.78 126.39 34.98 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.262 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.596 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 22.0 m -56.27 -31.22 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.164 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.64 -37.89 76.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.595 0.712 . . . . 0.0 110.008 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 45.2 mt -71.29 -25.41 62.43 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.329 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -73.81 -36.94 65.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.598 0.713 . . . . 0.0 109.136 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.6 mm-40 -66.82 -36.78 83.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.982 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -143.42 87.99 8.19 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.679 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 115.04 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.664 2.243 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.607 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 89.2 Cg_exo -51.06 163.77 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.847 2.364 . . . . 0.0 111.783 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 129' ' ' LYS . 40.5 t -51.87 -52.17 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.166 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.559 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 1.7 mmtt -116.96 121.24 32.89 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 121.435 0.636 . . . . 0.0 110.928 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.676 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 16.3 Cg_exo -35.32 131.73 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 1 C-N-CA 125.778 4.319 . . . . 0.0 114.34 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 117' ' ' TYR . 17.0 t70 -105.42 109.27 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.71 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 40.2 m-85 -75.32 -17.26 60.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.94 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -84.2 -25.43 29.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.262 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 72.8 mmtt -95.51 6.16 49.69 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 115' ' ' ASN . 31.1 tp -92.36 127.84 37.99 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.578 -173.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.492 ' HB2' HG22 ' A' ' 118' ' ' THR . 4.6 tt0 -111.6 114.46 27.53 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.782 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.9 ptt180 -90.46 111.44 22.71 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.413 0.625 . . . . 0.0 111.05 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 19.7 t30 -87.89 98.06 11.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.105 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.539 HG21 HG11 ' A' ' 11' ' ' VAL . 2.2 mp -73.43 101.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 112' ' ' TYR . 76.7 mt -63.0 89.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.325 0.583 . . . . 0.0 110.792 -176.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.884 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -77.83 -9.71 59.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.96 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 5.7 p -79.55 -15.6 57.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 172.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.422 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 47.3 t-20 -128.29 66.69 73.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.94 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 142' ' ' SER . 4.5 Cg_exo -83.05 105.01 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.03 1.82 . . . . 0.0 110.616 170.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -83.7 81.32 8.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.46 ' CG1' HG23 ' A' ' 109' ' ' VAL . 7.2 m -79.28 106.68 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.543 . . . . 0.0 111.722 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.834 HG21 HH21 ' A' ' 108' ' ' ARG . 42.0 m -110.45 105.34 14.29 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -113.13 123.82 51.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.597 0.713 . . . . 0.0 110.396 -175.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.02 168.24 9.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.728 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.11 111.92 24.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.803 ' HB ' ' CG ' ' A' ' 104' ' ' GLN . 18.3 pt -118.13 172.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.893 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 154' ' ' GLU . 5.7 p-10 -101.98 97.67 7.98 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.595 1.188 . . . . 0.0 109.903 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.488 ' HA ' ' CD2' ' A' ' 101' ' ' TYR . 13.1 m95 -67.98 0.82 3.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.732 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 152' ' ' ASN . 34.6 mt-10 -135.27 -166.97 1.92 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.584 -173.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -97.49 71.84 2.33 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.162 -178.157 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -166.84 131.11 2.0 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.045 0.423 . . . . 0.0 111.602 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 75.4 mtp -84.21 146.19 27.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.576 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.82 94.83 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.139 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.6 ' HE2' ' HB1' ' A' ' 87' ' ' ALA . 12.9 mptt -73.99 -37.07 64.54 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.529 -0.395 . . . . 0.0 110.483 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -37.11 -53.07 1.02 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 tp -70.9 -29.08 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' B' ' 129' ' ' ARG . 71.9 mm-40 -65.69 -50.99 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.469 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.593 ' O ' HG13 ' B' ' 130' ' ' ILE . 2.5 mm? -63.82 -40.59 96.97 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.3 ptm180 -67.94 -25.87 65.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.66 ' HB3' ' HB2' ' B' ' 133' ' ' GLU . 15.7 mmm180 -80.08 -28.04 39.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.638 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 65.2 mt -76.77 1.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.088 0.947 . . . . 0.0 109.263 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 6.6 tpt180 -99.64 -36.32 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.212 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.57 24.42 0.31 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.079 -172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' B' ' 129' ' ' ARG . 7.8 tp10 -76.55 -6.85 53.66 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.619 0.709 . . . . 0.0 111.395 176.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.785 ' HA ' HG21 ' A' ' 98' ' ' THR . 2.1 ptm180 -24.86 -52.89 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 0.0 113.4 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.565 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.103 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' SD ' ' HA ' ' A' ' 150' ' ' HIS . 9.8 ttt . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.494 0.187 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.783 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . -100.4 -65.46 0.97 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -171.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.869 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.5 mptp? -101.17 -21.34 14.97 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -168.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 38' ' ' LEU . 6.5 t -148.81 145.54 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.095 ' HG2' HD11 ' A' ' 31' ' ' ILE . 20.2 mm-40 -143.58 121.16 11.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.18 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.958 HG22 HD13 ' A' ' 107' ' ' ILE . 35.7 m -79.62 117.34 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 117.583 -1.647 . . . . 0.0 109.274 171.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.54 -73.38 0.46 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.522 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -107.21 109.94 21.87 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.942 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.1 p -96.13 99.92 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.415 0.626 . . . . 0.0 109.352 169.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.985 HG23 ' HB3' ' A' ' 25' ' ' GLU . 4.1 m -91.19 98.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.829 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -76.43 129.67 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.471 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -99.59 -36.89 9.37 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.979 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.992 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 11.3 t70 -63.33 39.88 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.656 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.807 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.1 m-20 -79.73 171.54 12.17 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.847 171.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.831 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.8 Cg_endo -52.65 103.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.5 1.466 . . . . 0.0 114.003 -146.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.567 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 14.9 m -133.37 169.77 13.09 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 112.863 -1.972 . . . . 0.0 109.183 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.1 Cg_exo -39.54 131.61 1.71 Allowed 'Trans proline' 0 C--O 1.21 -0.875 0 C-N-CA 122.943 2.429 . . . . 0.0 111.744 171.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.91 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 17.2 t80 -58.38 -17.86 23.46 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 133' ' ' SER . 7.1 m-30 -83.43 -3.99 58.08 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.781 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 33.0 p-10 -61.13 143.96 91.69 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 165.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.679 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 11.9 Cg_exo -83.37 135.99 7.44 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.643 2.229 . . . . 0.0 111.443 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.778 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 40.8 m-85 -50.49 113.38 0.87 Allowed 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 122.965 0.506 . . . . 0.0 111.351 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.992 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 24.4 mt-30 -112.65 103.82 11.87 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.315 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.603 ' CD1' HD11 ' A' ' 97' ' ' ILE . 91.2 m-85 -108.51 149.79 28.34 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.985 ' HB3' HG23 ' A' ' 10' ' ' VAL . 40.7 tt0 -123.54 87.35 2.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 168.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG21 HG11 ' A' ' 6' ' ' VAL . 15.9 mt -79.97 137.06 22.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.499 -173.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 58.6 m -115.52 104.7 11.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.619 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.921 ' HB3' HG12 ' A' ' 6' ' ' VAL . 28.2 p90 -106.47 146.78 30.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.659 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.5 tt0 -100.2 114.57 28.09 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.721 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 10.0 m -71.85 101.48 2.64 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.095 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.3 mt -64.71 -34.09 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.263 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 35.1 mt-10 -142.92 179.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.338 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.79 128.58 35.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.959 0.409 . . . . 0.0 110.204 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.836 HD12 ' CE2' ' A' ' 101' ' ' TYR . 4.0 mm? -88.54 149.03 23.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.985 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.1 p -114.92 -37.22 4.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.978 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.3 tt0 -105.97 -171.34 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.743 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 30.7 m-20 -100.52 142.61 31.76 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.507 0.67 . . . . 0.0 110.62 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -81.47 119.61 23.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.059 173.041 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.754 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.2 tt0 -102.57 88.04 3.14 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.802 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.825 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 61.7 m95 -80.76 119.75 23.75 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.774 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 11.6 ttmt -126.47 139.58 53.13 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.303 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.671 HG22 HG22 ' A' ' 95' ' ' VAL . 13.2 mt -103.22 109.21 26.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.759 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.2 mp -107.43 106.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.953 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.768 ' CE1' HG11 ' A' ' 113' ' ' VAL . 61.8 t80 -86.36 119.25 26.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.438 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.61 101.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.298 0.571 . . . . 0.0 109.625 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.23 88.79 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.523 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 41.2 t -128.79 128.16 43.41 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.766 0.793 . . . . 0.0 110.129 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -85.13 -2.59 58.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.232 170.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.76 -38.32 11.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.847 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.575 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 49.6 m -134.85 121.1 20.15 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.476 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.67 ' HB3' ' OE1' ' B' ' 125' ' ' GLN . 10.3 pt-20 -64.7 -14.11 57.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.269 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.69 1.77 11.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.61 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 89.9 m-85 -105.16 -0.81 26.19 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.498 ' OD2' ' HD2' ' B' ' 134' ' ' ARG . 31.6 p-10 -53.08 110.61 0.55 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.244 1.021 . . . . 0.0 111.488 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 4.4 mt-30 -92.58 170.01 10.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.426 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 43' ' ' ILE . 54.8 t -130.84 107.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.888 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' N ' HD22 ' A' ' 57' ' ' LEU . 3.7 mm? -76.08 -41.2 51.2 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.362 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -176.46 170.93 2.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 45.5 p -145.63 118.05 8.49 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -100.03 134.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.715 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.6 mt -108.91 104.04 13.2 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 9.0 t -119.7 107.44 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.714 ' CA ' ' HA ' ' A' ' 37' ' ' ASP . . . -102.3 -104.08 2.78 Favored Glycine 0 CA--C 1.475 -2.469 0 C-N-CA 118.831 -1.652 . . . . 0.0 112.926 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.48 113.45 0.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.127 1.884 . . . . 0.0 111.625 176.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 63' ' ' GLY . 30.3 m -141.9 122.68 8.55 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.871 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.07 130.48 22.95 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.184 1.923 . . . . 0.0 110.495 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.721 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.94 133.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.936 0.773 . . . . 0.0 112.117 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 151.64 117.12 0.74 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -173.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.932 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 24.2 ttt180 -66.21 111.87 3.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.772 0.796 . . . . 0.0 110.816 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.7 p80 -145.67 160.81 41.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.87 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.667 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.97 141.64 46.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.515 0.674 . . . . 0.0 112.615 -174.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.627 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.2 p90 -131.69 160.21 36.11 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.8 p -119.24 138.22 50.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.695 0.76 . . . . 0.0 110.278 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.627 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -139.93 121.15 14.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.365 -160.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.778 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -137.81 157.55 46.2 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.97 159.28 26.34 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.82 179.14 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.887 0.851 . . . . 0.0 112.824 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -82.05 151.45 66.85 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.448 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.65 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 65.8 Cg_exo -53.79 153.6 19.06 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 123.995 3.13 . . . . 0.0 113.515 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.438 ' HB2' HD12 ' A' ' 83' ' ' LEU . 17.3 m120 -71.63 113.58 20.99 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.24 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -65.71 -21.28 58.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.891 2.394 . . . . 0.0 111.623 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 5.0 83.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.219 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.474 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 35.1 mt -113.38 -20.34 11.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.561 0.22 . . . . 0.0 111.213 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.572 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 30.2 mt -84.62 129.51 56.9 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 1.2 Cg_endo -80.06 159.36 23.83 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.914 2.409 . . . . 0.0 112.128 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.762 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 4.7 m-20 -47.31 -50.19 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.444 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.27 69.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -169.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.555 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 44.0 m-20 -93.94 -17.99 22.39 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -172.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.29 -47.49 23.53 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-O 121.173 0.511 . . . . 0.0 111.824 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -92.39 47.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.282 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.67 -122.58 0.68 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.789 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.51 141.23 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 121.746 0.784 . . . . 0.0 112.456 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.93 168.38 24.7 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.132 173.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.491 HG11 HD11 ' B' ' 130' ' ' ILE . 3.4 t -124.81 147.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.832 174.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.671 HG22 HG22 ' A' ' 42' ' ' ILE . 9.6 p -129.7 107.3 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -103.01 135.43 44.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.272 -169.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.774 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 59.9 mt -102.18 93.07 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.803 0.811 . . . . 0.0 109.149 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 108' ' ' ARG . 51.9 p -93.96 114.93 27.23 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.592 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.954 ' SG ' HG22 ' A' ' 107' ' ' ILE . 7.0 p -84.82 137.32 33.24 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.947 175.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 51.9 m -118.8 114.94 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.255 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.836 ' CE2' HD12 ' A' ' 34' ' ' LEU . 45.3 t80 -127.32 126.3 42.34 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 102' ' ' ARG . 1.8 mmp_? 69.14 14.53 8.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.464 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.15 4.1 69.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -125.73 132.25 52.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.559 -0.82 . . . . 0.0 109.543 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.2 mp0 -76.26 142.06 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.009 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.737 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 2.8 p90 -115.68 -18.59 10.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.958 HD13 HG22 ' A' ' 6' ' ' VAL . 10.3 tt -159.7 156.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.682 HH21 HG21 ' A' ' 147' ' ' THR . 10.6 ttp180 -145.38 124.85 13.13 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -101.4 102.2 13.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 122.158 0.98 . . . . 0.0 109.758 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.55 79.98 1.84 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.239 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.854 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 7.3 m-85 -79.72 123.13 27.39 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.566 ' CE2' HD23 ' B' ' 126' ' ' LEU . 5.8 m-85 -67.38 129.98 41.6 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.768 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.2 p -108.93 110.9 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -96.72 121.17 38.28 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.21 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.691 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.4 m-80 -110.57 110.81 21.67 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.993 0.901 . . . . 0.0 109.017 -171.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -125.81 125.08 42.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.617 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.632 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 18.9 m-85 -39.97 146.61 0.11 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -85.49 -33.77 21.76 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.202 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -88.76 125.93 35.1 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.487 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -59.78 -28.21 67.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.789 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.14 -39.78 94.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.8 0.81 . . . . 0.0 109.614 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 77.6 mt -72.72 -27.87 62.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.713 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 43.3 mtp180 -76.4 -29.34 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.404 0.621 . . . . 0.0 109.412 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.31 -41.68 84.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.136 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -145.62 80.39 10.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.66 113.07 1.07 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.313 2.676 . . . . 0.0 112.455 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.632 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 52.7 Cg_exo -57.19 134.94 67.43 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.758 2.305 . . . . 0.0 110.702 174.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.527 HG13 ' HE2' ' A' ' 129' ' ' LYS . 3.4 p -56.02 -38.27 52.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.184 -171.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.527 ' HE2' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -91.09 107.72 23.15 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-O 121.088 0.471 . . . . 0.0 110.444 169.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.762 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 35.6 Cg_exo -45.93 140.18 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.593 3.529 . . . . 0.0 113.366 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.5 t0 -110.44 107.27 16.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.648 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 38.2 m-85 -77.48 -20.0 55.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.996 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 64.7 p -85.88 -21.55 27.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.483 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.3 mmtt -102.79 17.12 24.66 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.0 tp -99.62 132.32 45.03 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.015 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.36 118.11 31.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.91 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -93.37 105.38 17.45 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.28 0.562 . . . . 0.0 111.257 -177.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 12.6 t30 -85.55 98.18 10.48 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.461 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.754 HG21 HG11 ' A' ' 11' ' ' VAL . 1.5 mp -70.66 107.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.08 86.29 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.578 0.704 . . . . 0.0 110.446 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -76.49 -11.29 59.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.729 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.7 t -88.24 6.18 38.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.928 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.437 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 33.6 t-20 -139.16 64.92 34.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 1.8 Cg_endo -84.37 105.61 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.33 2.02 . . . . 0.0 111.264 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.517 ' HB3' HD13 ' B' ' 130' ' ' ILE . 5.5 tpt180 -84.24 85.4 7.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 3.3 p -87.63 110.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.894 -174.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.682 HG21 HH21 ' A' ' 108' ' ' ARG . 90.2 m -112.05 107.69 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.814 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.0 ptt180 -105.39 135.82 46.07 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.422 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -110.26 170.59 7.98 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.843 -174.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.4 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -104.96 120.17 40.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.683 174.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.63 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 40.5 pt -132.38 155.84 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.056 0.455 . . . . 0.0 110.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.17 94.51 7.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.136 0.97 . . . . 0.0 110.686 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.869 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 9.8 m95 -69.34 -4.33 17.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.956 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.64 152.67 44.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -77.42 70.93 3.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.681 179.248 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.868 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 69.81 103.81 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.393 0.677 . . . . 0.0 111.157 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -79.19 123.55 27.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.779 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.06 167.72 43.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.106 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.503 ' C ' HD22 ' B' ' 126' ' ' LEU . 3.3 mptp? -97.7 -35.78 10.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -50.56 -32.95 20.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.139 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.43 HG23 ' N ' ' B' ' 125' ' ' GLN . 7.9 tp -69.37 -40.77 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 122.062 0.934 . . . . 0.0 109.576 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.68 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 6.6 tp-100 -71.69 -47.0 57.04 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.791 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.566 HD23 ' CE2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -59.94 -44.96 94.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.186 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.15 -44.93 94.59 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.054 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -53.98 -45.7 71.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.489 ' HB3' HD21 ' A' ' 96' ' ' LEU . 2.0 mmp_? -69.01 -45.84 69.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.374 -176.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 14.9 mt -75.11 -30.08 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.441 . . . . 0.0 111.546 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -90.78 -4.56 56.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.611 0.72 . . . . 0.0 109.388 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.8 -94.88 1.66 Allowed Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.299 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -157.18 -72.49 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.632 0.729 . . . . 0.0 111.962 -156.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.577 ' HD3' HG21 ' A' ' 43' ' ' ILE . 6.7 tpm_? 51.96 -72.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.853 -164.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.586 ' HA ' ' HG2' ' A' ' 105' ' ' GLU . . . . . . . . 0 C--O 1.25 1.116 0 O-C-N 123.816 0.698 . . . . 0.0 110.636 -168.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.546 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -69.3 133.68 48.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.67 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 11.9 mmtt -100.64 -11.64 19.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.282 -175.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.71 122.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 0.0 110.772 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.2 tp60 -121.3 100.18 6.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.742 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.1 m -79.45 140.17 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.306 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -120.13 -61.5 1.59 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.592 -164.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.681 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 65.4 t30 -104.61 152.3 22.61 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.735 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 2.6 p -147.08 99.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.843 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.0 m -93.18 97.71 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.332 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 128.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.049 -178.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.934 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -98.59 -41.1 7.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.766 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.603 ' HB2' ' CB ' ' A' ' 23' ' ' GLN . 23.9 t0 -63.82 76.78 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.981 167.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t30 -96.6 174.28 3.47 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.825 169.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.8 Cg_endo -51.71 104.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.797 1.665 . . . . 0.0 113.834 -157.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 37.3 m -135.01 171.03 9.69 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.46 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 89.8 Cg_exo -42.16 138.56 2.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.559 2.172 . . . . 0.0 112.148 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.834 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 28.2 t80 -55.83 -29.32 59.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.156 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.23 -19.69 53.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -62.02 132.47 93.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.2 Cg_exo -72.65 154.16 54.53 Favored 'Trans proline' 0 C--N 1.329 -0.467 0 C-N-CA 123.71 2.94 . . . . 0.0 113.577 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 78.2 m-85 -62.97 133.94 55.4 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.934 ' HG2' HD12 ' A' ' 12' ' ' LEU . 37.4 tt0 -136.68 83.05 1.98 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.633 -170.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.738 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 97.3 m-85 -97.05 153.98 17.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.125 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.843 ' HB3' HG23 ' A' ' 10' ' ' VAL . 36.7 tt0 -132.34 87.66 2.45 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 14.6 mt -88.11 122.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.706 0.765 . . . . 0.0 112.738 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.802 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 13.2 m -91.73 107.34 19.14 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.467 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.742 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 23.2 p90 -119.19 148.11 43.47 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.93 0.871 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.83 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 48.6 tt0 -103.45 114.93 29.59 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.39 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 5.0 t -73.36 107.08 5.46 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 171.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -74.98 -22.46 17.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.773 -173.058 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.67 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 1.5 mt-10 -154.87 167.1 31.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.985 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.32 143.68 55.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.79 0.329 . . . . 0.0 110.549 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.783 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 15.1 mt -95.21 152.67 18.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.091 0.472 . . . . 0.0 111.504 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.3 t -113.13 -35.56 5.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.666 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.795 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.0 tt0 -110.36 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.795 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 39.6 m-20 -98.29 141.6 30.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.573 0.701 . . . . 0.0 110.02 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.39 118.35 23.13 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.28 176.155 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.5 tt0 -105.72 90.13 3.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.86 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.604 ' CH2' HG11 ' A' ' 6' ' ' VAL . 16.5 m95 -78.58 153.28 31.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.838 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.9 ttmp? -153.31 140.59 19.55 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.213 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.13 115.32 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.842 HG12 HG12 ' A' ' 56' ' ' VAL . 88.0 mt -112.29 108.19 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.768 0.794 . . . . 0.0 109.855 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.649 ' CZ ' HG21 ' A' ' 93' ' ' THR . 76.7 t80 -88.18 130.91 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.084 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 53' ' ' TYR . 7.1 t -77.52 97.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 122.071 0.939 . . . . 0.0 110.01 173.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.786 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -81.85 -2.94 90.7 Favored Glycine 0 C--O 1.214 -1.133 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.086 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.544 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 22.8 m -162.57 80.17 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.453 0.627 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.83 -0.73 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.141 0.576 . . . . 0.0 112.491 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 47' ' ' SER . 1.7 mm-40 -95.49 -25.61 16.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.341 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.609 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 15.7 m -118.96 -153.36 0.53 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.769 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.2 pt-20 -149.27 20.89 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.807 0.813 . . . . 0.0 110.835 171.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.48 -34.58 10.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.988 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.769 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p90 -57.7 -49.17 77.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.738 -167.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.7 p-10 -34.95 105.3 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.235 1.585 . . . . 0.0 113.284 -158.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.551 ' CG ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -93.04 167.44 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.975 -175.753 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.842 HG12 HG12 ' A' ' 43' ' ' ILE . 19.9 m -128.0 124.97 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.546 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 4.1 mm? -89.54 -31.0 17.82 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.167 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -175.39 159.27 2.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.064 170.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 35.2 p -136.71 112.42 9.45 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.49 132.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.823 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.1 mt -108.7 103.65 12.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.627 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.0 t -96.08 121.13 46.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -86.17 -152.61 20.66 Favored Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.569 -164.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.7 Cg_endo -47.2 117.91 2.52 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.778 1.652 . . . . 0.0 109.468 168.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 34' ' ' LEU . 2.4 p -140.12 129.13 13.36 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.654 -171.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.02 128.33 26.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.117 1.878 . . . . 0.0 111.092 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -40.52 145.83 0.16 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.077 0.86 . . . . 0.0 111.977 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.05 122.46 1.12 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.83 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.5 ttt180 -68.87 113.99 6.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.776 0.798 . . . . 0.0 109.789 175.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -150.89 150.95 31.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.164 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.802 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -91.73 134.31 34.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.92 -178.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.404 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -121.54 150.41 41.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.94 139.81 36.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.662 0.744 . . . . 0.0 110.666 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.738 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -127.47 119.19 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 -164.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 85.1 mt-30 -134.14 153.75 51.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -166.69 158.84 13.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.7 -175.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.686 0.755 . . . . 0.0 112.448 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -88.51 151.89 48.81 Favored Pre-proline 0 N--CA 1.438 -1.055 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.784 175.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.711 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.3 Cg_exo -61.25 173.37 2.57 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.653 2.902 . . . . 0.0 113.071 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.9 m-20 -87.14 115.73 63.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.185 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.48 -23.16 74.38 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.407 2.738 . . . . 0.0 112.294 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.46 -13.97 77.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.61 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.551 HD12 ' CG ' ' A' ' 55' ' ' GLN . 3.1 mt -90.06 -28.79 18.8 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.734 -0.274 . . . . 0.0 110.789 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.786 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 31.9 mt -75.33 125.96 88.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.483 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.8 Cg_endo -80.94 165.31 19.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.03 3.153 . . . . 0.0 113.462 171.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 8.7 t0 -42.74 -48.18 5.55 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.989 171.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.99 -20.93 51.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -168.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.446 ' HB3' HG23 ' A' ' 84' ' ' ILE . 12.8 t70 -89.96 -38.36 13.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.142 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -72.27 -41.27 66.91 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -163.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.77 47.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.59 -126.92 1.0 Allowed Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.222 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.66 132.65 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 122.162 0.982 . . . . 0.0 113.03 -172.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 113' ' ' VAL . 15.8 m -133.07 167.44 20.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 113.0 -1.909 . . . . 0.0 106.976 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 96' ' ' LEU . 37.0 t -133.6 141.47 44.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 120.877 0.37 . . . . 0.0 111.175 177.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 22' ' ' PHE . 27.1 m -124.13 106.6 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.722 HD23 HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.27 137.11 34.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.353 -174.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.838 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 9.1 mt -109.45 91.31 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.463 1.125 . . . . 0.0 108.89 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -90.51 125.69 35.68 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.624 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.659 ' HB2' HG22 ' A' ' 107' ' ' ILE . 72.0 m -90.03 153.53 20.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.248 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 18.5 m -150.1 113.5 4.94 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -168.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.661 ' HB3' HD11 ' A' ' 151' ' ' ILE . 55.4 t80 -128.05 124.04 36.1 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 31.4 mtp180 64.28 35.77 9.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.461 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.82 -1.96 87.28 Favored Glycine 0 C--N 1.317 -0.482 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.554 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -118.62 131.25 56.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.085 0.469 . . . . 0.0 109.932 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 24.0 mt-10 -89.3 136.1 33.21 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.292 -173.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 51.7 p90 -122.91 0.99 9.27 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.828 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.0 tt -156.62 159.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 O-C-N 121.37 -0.831 . . . . 0.0 109.255 171.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.567 HH12 ' HA2' ' B' ' 132' ' ' GLY . 9.9 ttm180 -153.21 89.13 1.34 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.588 0.555 . . . . 0.0 109.683 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.738 HG12 ' HB ' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -86.93 100.86 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.352 1.073 . . . . 0.0 108.332 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 96' ' ' LEU . . . -91.02 87.48 1.36 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.437 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.996 ' HE2' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -74.57 116.67 15.52 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.488 ' CB ' HD12 ' A' ' 140' ' ' LEU . 7.1 m-85 -67.26 117.98 10.01 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.627 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.748 HG13 ' HB ' ' A' ' 93' ' ' THR . 9.0 p -99.7 110.24 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -91.61 114.27 26.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.867 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 86.3 m-20 -99.48 106.38 18.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 124.72 39.38 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.35 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 28.1 m-85 -40.21 149.55 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.0 p -87.31 -33.64 19.15 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.783 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 17.1 mt-10 -86.63 134.16 33.64 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.716 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.585 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 90.6 m -57.17 -38.83 74.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -51.81 -39.51 58.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.053 0.93 . . . . 0.0 109.642 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -84.13 -30.01 26.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.927 -173.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 23.4 mtp180 -77.63 -41.7 37.52 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.361 0.6 . . . . 0.0 110.025 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.628 ' HG3' ' OD1' ' A' ' 125' ' ' ASN . 2.8 pt-20 -79.09 -20.74 48.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.017 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.628 ' OD1' ' HG3' ' A' ' 124' ' ' GLU . 0.8 OUTLIER -150.11 82.45 6.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-O 121.719 0.771 . . . . 0.0 109.987 169.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 15.7 Cg_endo -56.18 121.46 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.788 2.992 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.565 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 17.5 Cg_exo -68.68 147.24 69.29 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.843 2.362 . . . . 0.0 110.583 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -28.99 45.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.616 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 2.1 mmtt -103.84 131.78 21.66 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.232 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.59 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_exo -70.06 140.94 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.527 2.818 . . . . 0.0 113.133 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 8.7 t0 -119.6 111.41 18.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.605 ' CE1' ' HB ' ' A' ' 84' ' ' ILE . 18.5 m-85 -78.51 -22.81 46.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.005 0.907 . . . . 0.0 110.293 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -80.25 -17.7 51.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.212 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.8 mmtt -106.94 16.38 24.34 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.2 tp -102.4 126.5 49.45 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.191 -170.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -112.13 118.0 34.15 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.834 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -95.57 107.06 19.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.5 0.667 . . . . 0.0 111.081 -172.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 6.3 t30 -91.03 104.91 17.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.94 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.546 HD13 ' O ' ' A' ' 13' ' ' ASP . 3.6 mp -81.15 108.98 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.427 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.488 HD12 ' CB ' ' A' ' 112' ' ' TYR . 91.4 mt -64.58 89.95 0.07 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.155 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.996 ' HA ' ' HE2' ' A' ' 111' ' ' TYR . . . -79.6 -7.13 58.33 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.259 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 p -93.24 -1.88 55.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.741 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -141.67 75.64 21.55 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.402 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 57.2 Cg_endo -88.15 106.41 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.37 2.047 . . . . 0.0 111.533 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -80.69 80.1 7.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.983 0.421 . . . . 0.0 110.586 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.541 ' HB ' HG23 ' A' ' 109' ' ' VAL . 4.9 p -94.6 111.18 24.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 111.927 -173.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -108.65 106.36 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.467 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 3.6 ptt180 -113.45 131.42 56.03 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.527 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -118.44 168.63 10.47 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.673 -174.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.51 152.81 21.24 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.057 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 101' ' ' TYR . 23.4 pt -143.07 174.71 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -92.12 96.32 10.26 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.388 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.604 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 18.4 m95 -74.2 -6.52 48.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.514 0.673 . . . . 0.0 109.949 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -121.52 179.02 4.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.158 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -114.93 68.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.315 -176.733 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.07 -58.98 1.95 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 4.9 tpt 63.94 149.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.876 0.846 . . . . 0.0 112.223 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.6 -33.73 5.64 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 2.5 mppt? 71.96 -59.54 0.55 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.796 0.839 . . . . 0.0 112.875 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -44.38 -52.91 7.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 tt -61.92 -36.05 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 111.623 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.857 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 64.9 mm-40 -74.96 -39.04 61.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.591 0.71 . . . . 0.0 110.936 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.568 HD23 HG11 ' A' ' 45' ' ' VAL . 29.0 mt -63.22 -36.77 84.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.936 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -68.76 -33.74 74.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.998 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.857 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 8.5 mmm180 -48.74 -47.38 41.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.344 0.592 . . . . 0.0 109.437 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.858 ' HD3' ' HB2' ' B' ' 133' ' ' GLU . 4.4 mmp_? -73.91 -48.79 28.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.689 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.936 HG13 ' HA ' ' B' ' 127' ' ' ALA . 2.6 pp -66.87 -17.68 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' ARG . . . . . 0.471 ' HG2' HD12 ' B' ' 130' ' ' ILE . 34.7 mmt180 -95.98 -23.9 16.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.607 0.241 . . . . 0.0 110.951 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.567 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 176.14 75.48 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.458 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.858 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 1.2 pm0 -82.54 -56.2 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.88 0.848 . . . . 0.0 109.879 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.547 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 35.0 ttt180 -107.03 -47.41 3.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.377 -176.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.715 178.653 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.133 0.492 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -90.5 149.17 22.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.844 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.85 -21.16 20.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -177.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 3.4 t -141.99 134.21 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.667 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.597 ' HB2' HD11 ' A' ' 31' ' ' ILE . 7.7 tp60 -137.09 105.39 5.73 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.316 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.754 HG12 ' CD1' ' A' ' 28' ' ' PHE . 27.5 m -70.29 149.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.301 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -127.93 -59.34 1.19 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.073 -168.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 65.7 t30 -104.01 150.84 23.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.139 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.3 p -145.64 98.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.88 97.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 122.403 1.096 . . . . 0.0 108.858 -177.044 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.54 133.45 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.193 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.01 HD12 ' HG2' ' A' ' 23' ' ' GLN . 8.7 mt -110.53 -42.62 4.04 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.626 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 2.9 p-10 -68.17 44.94 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.662 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.675 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -77.34 175.74 4.21 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.706 177.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.6 Cg_endo -49.78 103.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.562 1.593 . . . . 0.0 113.187 -150.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.675 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -148.89 172.0 5.67 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 111.648 -2.524 . . . . 0.0 107.627 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 59.6 Cg_exo -37.16 130.21 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.774 2.316 . . . . 0.0 112.969 174.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.758 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 8.9 t80 -55.43 -27.9 50.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.422 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -78.5 -14.22 59.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -69.93 138.43 87.69 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.312 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -73.34 133.07 18.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 112.76 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.708 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 88.8 m-85 -56.62 121.17 9.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.149 -176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.01 ' HG2' HD12 ' A' ' 12' ' ' LEU . 53.3 tt0 -128.92 92.35 3.38 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.949 -157.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' A' ' 97' ' ' ILE . 83.9 m-85 -106.1 115.05 29.56 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.666 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' A' ' 12' ' ' LEU . 22.1 tt0 -90.35 83.71 5.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.523 HG21 HG11 ' A' ' 6' ' ' VAL . 36.6 mt -82.12 141.4 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.671 0.748 . . . . 0.0 111.931 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 20.9 m -125.24 107.31 10.6 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.266 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.754 ' CD1' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.6 166.79 10.15 Favored 'General case' 0 CA--C 1.472 -2.027 0 C-N-CA 118.713 -1.195 . . . . 0.0 110.916 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 29.9 tt0 -117.65 107.54 14.34 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.816 -1.993 . . . . 0.0 106.023 168.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.3 m -72.46 108.04 5.33 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.597 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -72.48 -33.62 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.307 -169.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.844 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 6.0 mt-10 -143.74 171.68 13.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 p-10 -76.53 131.72 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.099 0.476 . . . . 0.0 110.964 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD12 HG22 ' A' ' 65' ' ' VAL . 7.9 mt -87.1 153.47 21.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.26 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -112.6 -31.3 6.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.695 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 20.2 tt0 -122.33 -168.99 1.82 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.695 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.2 p-10 -92.94 147.59 22.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 110.36 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.592 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -95.59 122.87 38.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.219 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.657 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 22.9 tt0 -103.92 89.93 3.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.065 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.822 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 50.0 m95 -82.66 115.46 21.61 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.8 ttmt -118.02 138.98 51.84 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.052 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.613 HG22 HG22 ' A' ' 95' ' ' VAL . 4.8 mt -104.78 123.29 58.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -114.15 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.796 -175.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.616 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.4 t80 -89.0 117.22 27.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.321 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.855 HG13 ' CE2' ' A' ' 53' ' ' TYR . 3.8 t -66.6 111.54 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.803 173.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.739 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -81.32 -63.1 1.89 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.437 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.613 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 15.1 m -102.15 70.77 1.22 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -47.98 -28.4 2.73 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.61 0.569 . . . . 0.0 111.733 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' B' ' 122' ' ' LYS . 4.8 tt0 -67.64 -18.46 64.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.068 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.691 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 24.2 m -115.25 -152.45 0.5 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.683 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.1 pt-20 -154.89 22.48 0.44 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.742 0.782 . . . . 0.0 111.05 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -100.18 -31.61 11.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.368 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.855 ' CE2' HG13 ' A' ' 45' ' ' VAL . 12.1 p90 -63.38 -42.53 98.85 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 125.752 1.621 . . . . 0.0 113.242 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.6 p-10 -23.55 113.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.033 1.458 . . . . 0.0 114.256 -161.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' HG2' HD12 ' A' ' 83' ' ' LEU . 1.4 mp0 -96.64 166.76 11.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.256 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.91 118.53 50.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.65 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.9 mm? -87.72 -48.84 7.55 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.934 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -166.0 161.82 17.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.1 p -139.1 113.23 8.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -98.86 130.64 47.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.7 mt -101.16 104.05 15.12 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.961 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.12 116.84 36.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -67.74 -168.34 4.12 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.304 -168.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -67.56 112.26 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 N-CA-C 109.573 -0.972 . . . . 0.0 109.573 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.735 HG22 HD12 ' A' ' 34' ' ' LEU . 27.4 m -110.68 117.37 50.84 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.525 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 59.6 Cg_endo -76.01 79.92 2.78 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 122.513 2.142 . . . . 0.0 113.09 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 52.43 174.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.629 -2.078 . . . . 0.0 112.494 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.74 117.53 3.35 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.107 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 ttt-85 -64.66 128.5 36.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.069 0.461 . . . . 0.0 110.312 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -164.84 158.23 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.103 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.486 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -113.37 144.46 42.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.411 0.624 . . . . 0.0 111.885 -175.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD1' ' HE1' ' A' ' 28' ' ' PHE . 2.1 p90 -132.37 160.33 36.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.1 127.44 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.46 1.124 . . . . 0.0 111.065 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -108.33 145.4 34.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.148 -168.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.5 mt-30 -150.08 152.04 34.16 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -159.68 118.64 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.599 0.237 . . . . 0.0 111.633 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.62 123.36 19.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.246 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -23.96 147.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 127.273 2.229 . . . . 0.0 116.962 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 38.7 Cg_endo -65.93 179.2 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.653 3.569 . . . . 0.0 112.722 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.41 122.12 85.47 Favored Pre-proline 0 CA--C 1.508 -0.654 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.393 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.45 -5.93 17.77 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.933 2.422 . . . . 0.0 111.471 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.17 -8.22 50.84 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.739 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 55' ' ' GLN . 27.0 mt -97.46 -8.73 28.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.046 0.45 . . . . 0.0 110.404 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.607 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 21.8 mt -95.33 125.39 50.14 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.158 171.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.613 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.4 Cg_endo -79.84 162.92 23.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.696 2.931 . . . . 0.0 111.472 171.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.774 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 4.0 m-20 -46.5 -53.67 10.78 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.77 82.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.666 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.495 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 61.1 m-20 -87.79 -16.89 32.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.682 -173.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.24 -46.13 29.57 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.643 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.98 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.502 0.668 . . . . 0.0 112.053 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.94 -132.47 1.55 Allowed Glycine 0 CA--C 1.498 -1.026 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.571 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.466 HG13 ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.99 136.08 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.674 0.75 . . . . 0.0 112.785 -168.075 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.18 167.77 28.18 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.354 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.533 HG23 ' HG ' ' B' ' 126' ' ' LEU . 20.9 t -123.46 135.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.112 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.613 HG22 HG22 ' A' ' 42' ' ' ILE . 14.3 p -115.86 105.55 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 171.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.818 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.3 pp -103.41 147.68 26.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.728 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 109' ' ' VAL . 41.4 mt -112.26 102.87 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.667 0.746 . . . . 0.0 109.67 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 108' ' ' ARG . 78.0 p -101.32 110.05 22.0 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.668 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 1.005 ' SG ' HG22 ' A' ' 107' ' ' ILE . 11.9 p -75.62 152.2 37.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.81 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 31.3 m -142.01 103.26 4.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.616 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 89.9 t80 -113.18 122.11 46.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 37.5 mtp180 68.58 23.17 7.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.107 0.479 . . . . 0.0 111.628 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.56 76.03 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.253 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -128.96 123.68 33.12 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.665 ' HG2' ' HG3' ' B' ' 134' ' ' ARG . 16.2 mp0 -82.25 136.19 35.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 -173.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 52.3 p90 -128.62 -0.32 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.005 HG22 ' SG ' ' A' ' 99' ' ' CYS . 5.2 tt -157.63 160.34 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 O-C-N 121.178 -0.951 . . . . 0.0 108.799 169.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.849 ' HB2' HG22 ' A' ' 98' ' ' THR . 15.9 ttp180 -150.16 104.39 3.26 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.818 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.7 p -88.9 99.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.624 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -88.23 82.01 1.56 Allowed Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.251 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.999 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.7 m-85 -72.8 120.81 18.94 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.408 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB3' HD23 ' A' ' 140' ' ' LEU . 2.9 m-85 -66.84 123.7 20.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.5 p -107.96 111.26 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.723 ' HB2' HD21 ' A' ' 140' ' ' LEU . 12.5 t30 -98.43 113.54 25.57 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.767 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 38.7 m-80 -97.31 132.14 43.33 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.353 0.597 . . . . 0.0 110.032 -174.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.32 134.46 22.76 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.786 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 31.7 m-85 -49.56 151.32 1.67 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.1 p -90.32 -34.42 15.72 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.013 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 9.1 mm-40 -75.32 121.98 23.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.791 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.9 m -50.3 -36.77 33.19 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.762 -172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -64.91 -40.16 94.65 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.615 0.722 . . . . 0.0 110.321 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.8 mt -73.36 -22.24 60.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.654 -176.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 10.4 mtt180 -78.73 -36.75 42.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.791 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.7 mm-40 -61.32 -44.13 97.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.012 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -145.73 85.95 7.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.059 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.16 115.67 2.73 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.047 2.498 . . . . 0.0 112.092 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.43 164.12 33.93 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.142 2.561 . . . . 0.0 111.498 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.01 -62.46 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.076 0.235 . . . . 0.0 110.708 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -67.77 125.79 91.77 Favored Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-O 121.731 0.777 . . . . 0.0 111.785 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.774 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 22.0 Cg_exo -70.27 139.2 37.92 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 124.215 3.277 . . . . 0.0 111.827 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.588 ' CG ' ' HG2' ' A' ' 134' ' ' LYS . 30.1 t0 -117.07 104.04 10.84 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.758 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 37.0 m-85 -74.01 -16.11 61.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.039 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.7 t -85.43 -21.51 28.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.283 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.588 ' HG2' ' CG ' ' A' ' 131' ' ' ASP . 47.0 mmtm -101.12 -0.5 36.04 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.6 tp -85.95 123.51 31.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.308 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.493 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 6.3 tt0 -108.39 116.93 32.89 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.837 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.56 119.63 38.37 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.74 -174.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.613 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.3 t30 -96.03 120.04 35.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.653 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.568 HG21 HG11 ' A' ' 11' ' ' VAL . 3.5 mm -88.34 102.13 12.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' A' ' 114' ' ' ASN . 3.1 mm? -60.21 84.6 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.999 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -63.47 -15.49 57.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.347 168.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.47 -18.14 55.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.107 171.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.99 60.21 33.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.176 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 84.6 Cg_endo -91.36 105.97 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.815 1.677 . . . . 0.0 110.741 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -82.13 81.54 8.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.554 HG12 HG23 ' A' ' 109' ' ' VAL . 17.0 m -78.55 114.54 19.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 111.56 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.657 HG21 HH21 ' A' ' 108' ' ' ARG . 53.7 m -120.4 105.31 10.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.398 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.771 ' HB3' HG13 ' A' ' 107' ' ' ILE . 1.7 ptt180 -106.01 133.87 50.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.51 0.671 . . . . 0.0 110.65 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HD2' ' CA ' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -109.18 168.56 9.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.781 -176.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.51 139.7 38.51 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 173.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.1 pt -139.68 -177.9 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.533 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 5.9 m-20 -102.41 82.64 2.2 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.428 0.633 . . . . 0.0 111.34 -172.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.723 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.1 m95 -69.05 -11.98 61.27 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.932 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.07 157.07 25.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.95 69.29 8.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.329 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.604 166.429 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 66.47 -175.52 0.19 Allowed 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.169 0.587 . . . . 0.0 111.144 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 54.6 mtm -112.35 -74.74 0.62 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.53 -178.97 19.33 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 171.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' B' ' 126' ' ' LEU . 12.0 mptt -81.23 -21.77 39.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.911 0.356 . . . . 0.0 110.214 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -35.23 -61.33 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.292 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 7.2 tt -69.39 -33.47 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.515 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 9.2 mm100 -63.23 -52.33 62.6 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.385 0.612 . . . . 0.0 110.822 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 94' ' ' VAL . 1.9 mm? -64.69 -36.37 84.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.129 177.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.97 -37.32 73.97 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 99.7 mtt180 -59.23 -47.83 83.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 111.156 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.679 ' CZ ' ' HG2' ' B' ' 133' ' ' GLU . 18.1 mmm180 -74.44 -21.67 59.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.286 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.523 HD11 HG21 ' A' ' 94' ' ' VAL . 23.3 mt -93.19 -7.76 10.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.613 0.721 . . . . 0.0 109.885 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -80.93 -29.28 35.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.469 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.692 ' HA2' ' OXT' ' B' ' 135' ' ' ALA . . . 165.91 53.19 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.4 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.679 ' HG2' ' CZ ' ' B' ' 129' ' ' ARG . 2.0 tm-20 -70.03 -70.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 168.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.665 ' HG3' ' HG2' ' A' ' 105' ' ' GLU . 1.8 tpm_? -74.04 -51.53 15.54 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.893 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.692 ' OXT' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.9 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.78 142.5 28.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.872 0.367 . . . . 0.0 110.096 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.757 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -91.42 -17.16 26.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.215 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.4 t -137.71 130.05 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.594 0.711 . . . . 0.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 6.0 tp-100 -122.88 101.71 7.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.679 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -78.08 132.23 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -116.5 -69.58 0.84 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.207 -163.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.662 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 57.7 t30 -93.04 152.68 19.15 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.8 -177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.4 p -146.4 107.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-O 122.244 1.021 . . . . 0.0 109.766 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.1 t -92.59 92.62 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.023 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.536 HG12 ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -76.45 120.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.309 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.005 HD12 ' HB3' ' A' ' 23' ' ' GLN . 4.6 mt -105.45 -40.11 5.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.647 -168.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 1.001 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 17.4 p-10 -67.01 38.25 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.454 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' HA ' ' HB ' ' A' ' 139' ' ' ILE . 0.9 OUTLIER -78.46 174.53 5.88 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.601 178.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.855 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 4.3 Cg_endo -50.05 103.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.802 1.668 . . . . 0.0 113.639 -153.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.5 m -146.34 171.43 6.44 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 111.236 -2.711 . . . . 0.0 106.715 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.646 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 45.5 Cg_exo -38.13 143.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.804 2.336 . . . . 0.0 112.407 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.908 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.3 t80 -60.42 -31.25 70.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.705 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -75.23 -11.27 60.03 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.608 0.242 . . . . 0.0 110.571 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.646 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -67.86 117.32 47.17 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 121.882 0.849 . . . . 0.0 109.271 168.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 46.4 Cg_exo -60.04 169.08 5.15 Favored 'Trans proline' 0 C--N 1.327 -0.571 1 C-N-CA 125.434 4.09 . . . . 0.0 114.291 -173.055 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.798 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 99.1 m-85 -78.27 103.25 8.09 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.552 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 1.005 ' HB3' HD12 ' A' ' 12' ' ' LEU . 2.6 mp0 -104.81 109.8 21.9 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.508 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.716 ' CD2' HD11 ' A' ' 97' ' ' ILE . 83.2 m-85 -123.48 101.4 7.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 1.102 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.9 tt0 -86.16 82.65 7.98 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.344 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.1 mt -87.88 129.27 39.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.081 -176.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.3 m -103.01 104.73 14.94 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 20.7 p90 -112.6 141.87 45.85 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.64 0.733 . . . . 0.0 110.025 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.864 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.6 tt0 -101.7 117.87 35.76 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t -73.85 104.88 4.89 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.473 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -71.48 -30.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.573 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.596 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 40.3 mt-10 -149.63 146.4 27.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.069 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 p-10 -60.24 138.88 57.85 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.739 0.649 . . . . 0.0 111.288 -170.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 38' ' ' LEU . 6.8 mt -95.35 151.08 19.58 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.876 -171.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.3 t -114.1 -25.75 8.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.307 0.575 . . . . 0.0 110.152 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.725 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 19.9 tt0 -121.39 -168.33 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.725 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.8 p-10 -94.41 135.4 35.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.506 0.669 . . . . 0.0 110.482 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -83.05 119.29 24.29 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.584 176.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 1.2 tm-20 -104.98 89.74 3.24 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.211 -171.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' O ' ' HA ' ' A' ' 59' ' ' SER . 9.6 m95 -82.25 139.93 33.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.0 ttmp? -138.92 145.69 40.16 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.831 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.26 116.48 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.682 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 4.0 mp -113.92 107.25 22.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.818 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.0 t80 -92.78 115.45 28.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.667 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 t -59.29 107.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.65 12.77 61.24 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -134.13 62.1 1.66 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.754 -0.723 . . . . 0.0 112.443 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB1' ' HG3' ' B' ' 122' ' ' LYS . . . -79.64 -10.91 59.87 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.672 0.749 . . . . 0.0 108.982 165.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -100.12 -46.83 5.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.239 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.488 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 49.3 m -105.61 -134.38 0.33 Allowed 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 9.0 pt-20 -154.45 -19.72 0.13 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -90.46 2.86 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 23.3 m-85 -93.61 0.36 56.52 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -54.07 95.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.89 0.852 . . . . 0.0 110.57 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -94.83 169.35 10.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.064 -173.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.0 t -126.11 117.65 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.996 -167.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.723 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 mm? -85.88 -58.22 2.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.183 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -153.35 152.6 31.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.134 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.2 p -134.75 110.87 9.51 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 72' ' ' PHE . 3.1 p -99.59 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.837 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 10.6 mt -105.89 104.65 14.41 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.303 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.25 113.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -164.9 4.21 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.497 -167.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 64.5 Cg_endo -68.29 113.88 3.24 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 120.812 1.008 . . . . 0.0 109.685 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.713 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 27.4 m -120.94 134.34 24.32 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.812 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 59.7 Cg_endo -81.57 78.68 3.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.106 1.871 . . . . 0.0 113.168 -176.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 51.0 -171.83 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.63 -2.077 . . . . 0.0 111.943 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.47 135.73 8.11 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.864 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.4 ttp180 -73.1 115.21 12.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.043 0.925 . . . . 0.0 111.195 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -114.38 118.03 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.231 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.695 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 20.5 ttp -87.82 103.3 15.51 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 173.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.497 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -110.02 128.39 55.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.04 -178.405 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.102 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -102.05 111.83 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 122.682 1.23 . . . . 0.0 111.376 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -72.61 143.42 48.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.652 -2.067 . . . . 0.0 109.614 179.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.917 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 25.3 mt-30 -152.55 145.2 24.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.23 134.5 2.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.4 p-10 -55.84 159.62 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.731 0.3 . . . . 0.0 110.756 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -76.03 164.65 58.89 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 123.061 0.544 . . . . 0.0 111.642 -167.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 36.0 Cg_endo -59.57 163.38 13.11 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.116 2.544 . . . . 0.0 112.127 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.5 m-20 -69.52 117.17 50.25 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.989 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.4 Cg_endo -61.23 -22.18 73.89 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.678 2.919 . . . . 0.0 112.33 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.37 -10.97 69.95 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.086 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.47 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 24.0 mt -91.14 -31.28 16.28 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 122.685 -0.303 . . . . 0.0 110.491 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 17.0 mt -74.76 124.73 89.82 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' O ' HG22 ' A' ' 84' ' ' ILE . 94.1 Cg_endo -79.15 163.51 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.776 2.984 . . . . 0.0 112.075 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.555 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 12.7 t70 -44.92 -55.42 5.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.02 62.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.25 0.548 . . . . 0.0 111.108 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 84' ' ' ILE . 10.9 t70 -97.25 -24.43 15.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.634 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -88.84 -46.26 9.09 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -101.34 49.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -170.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.79 -128.98 1.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.352 -168.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.594 HG22 ' OD1' ' A' ' 114' ' ' ASN . 21.5 t -109.89 133.61 54.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.598 -172.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.649 ' HB ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -144.16 170.42 16.0 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.616 HG23 HD13 ' B' ' 126' ' ' LEU . 3.3 t -129.89 145.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 118.719 0.69 . . . . 0.0 111.737 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.515 HG21 ' CE1' ' A' ' 22' ' ' PHE . 7.7 p -132.08 108.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.877 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.6 pp -107.37 147.3 30.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.255 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.716 HD11 ' CD2' ' A' ' 24' ' ' PHE . 36.8 mt -114.91 105.6 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 109.303 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.768 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 56.6 p -100.49 116.57 32.74 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.977 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.675 ' HB2' HG22 ' A' ' 107' ' ' ILE . 76.4 m -81.83 123.22 28.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.11 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 28.3 m -113.32 120.29 40.62 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.676 ' HB3' HD11 ' A' ' 151' ' ' ILE . 61.3 t80 -123.22 117.35 25.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.255 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.586 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.1 mtp180 66.08 23.81 11.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.445 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.05 54.94 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.892 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 13.9 mp0 -111.26 132.52 54.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.931 175.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 33.4 mt-10 -83.38 130.06 35.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.595 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.0 p90 -118.29 1.5 11.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.846 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.4 tt -157.97 155.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.739 HH22 ' HG3' ' A' ' 145' ' ' ARG . 2.8 tmm_? -151.14 113.38 4.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -104.6 100.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.308 1.052 . . . . 0.0 109.689 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.504 ' HA3' HH11 ' A' ' 108' ' ' ARG . . . -93.03 87.14 1.2 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.98 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 88.7 m-85 -76.13 146.58 39.15 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 140' ' ' LEU . 6.6 m-85 -83.2 132.47 35.06 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.818 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.5 p -108.84 109.31 27.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.594 ' OD1' HG22 ' A' ' 92' ' ' VAL . 6.4 t30 -97.51 108.47 21.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.187 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.673 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 42.7 m-80 -97.03 110.58 23.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.04 133.74 49.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 39.3 m-85 -42.69 157.49 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -95.74 -30.84 13.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.438 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.67 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 4.3 mm-40 -86.33 128.73 34.97 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.571 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.707 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.3 m -48.48 -46.45 38.2 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.08 0.4 . . . . 0.0 111.841 -172.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -53.59 -37.33 62.87 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.234 1.016 . . . . 0.0 110.115 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.59 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 48.2 mt -84.53 -24.74 29.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.919 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 60.9 mtp180 -78.48 -40.43 35.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.936 0.874 . . . . 0.0 108.689 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 120' ' ' THR . 12.6 pt-20 -73.38 -29.78 62.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.977 -177.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.592 ' OD1' ' HG3' ' A' ' 124' ' ' GLU . 1.6 p-10 -153.73 90.79 3.31 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.006 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.81 117.99 4.69 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 122.889 2.393 . . . . 0.0 111.45 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.466 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 32.5 Cg_exo -59.5 151.38 69.45 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.375 2.05 . . . . 0.0 110.224 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.9 p -48.74 -29.02 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.286 -170.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -118.28 110.96 38.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-O 122.264 1.03 . . . . 0.0 113.451 173.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.629 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 7.0 Cg_exo -44.29 139.93 6.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 125.386 4.057 . . . . 0.0 113.659 174.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.9 t70 -120.23 116.61 25.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.896 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.633 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.7 m-85 -79.18 -16.33 56.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.878 0.846 . . . . 0.0 111.026 -170.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.1 m -83.09 -24.78 32.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.344 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.67 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.3 mmtt -101.23 13.98 33.42 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 115' ' ' ASN . 24.4 tp -98.08 144.7 27.29 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.855 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -125.22 125.76 44.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.908 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 16.7 mtm105 -91.17 104.38 16.95 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.163 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -89.7 90.99 8.47 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 170.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.853 HD11 HH12 ' A' ' 137' ' ' ARG . 1.3 mm -71.57 115.41 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.898 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 112' ' ' TYR . 35.8 mt -78.73 75.22 5.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.851 0.834 . . . . 0.0 110.797 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -71.7 -19.99 61.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.472 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 p -73.65 -11.96 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.741 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.02 66.96 33.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.627 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.613 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 66.1 Cg_endo -87.64 105.92 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.822 1.682 . . . . 0.0 111.787 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.739 ' HG3' HH22 ' A' ' 108' ' ' ARG . 8.7 tpt180 -76.01 88.57 2.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.501 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.3 p -95.24 137.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.431 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.7 m -145.76 107.9 4.38 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.761 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.846 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 1.0 OUTLIER -96.86 149.98 21.25 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.423 0.63 . . . . 0.0 110.244 175.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -122.16 169.51 10.81 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.404 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.83 125.31 50.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.26 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 101' ' ' TYR . 13.7 pt -135.96 173.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 154' ' ' GLU . 8.0 p-10 -95.38 109.5 21.65 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.171 0.986 . . . . 0.0 109.675 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.757 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.3 m95 -82.41 15.58 2.43 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.067 171.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 152' ' ' ASN . 63.2 mm-40 -122.04 -164.18 1.14 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.559 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -127.67 71.15 1.34 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 171.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.769 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.46 79.14 6.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.837 -0.214 . . . . 0.0 110.72 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 90.4 mtp 58.29 -92.41 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.682 0.614 . . . . 0.0 111.89 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.58 -148.86 5.31 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.1 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.693 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 3.2 mppt? -71.59 -43.99 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 110.643 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.72 -55.01 15.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.012 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.457 ' HA ' ' HB3' ' B' ' 127' ' ' ALA . 14.4 tt -73.9 -26.02 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -65.14 -45.34 85.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 122.068 0.937 . . . . 0.0 110.161 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 24.6 mt -65.17 -43.52 91.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.648 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' B' ' 124' ' ' ILE . . . -59.28 -39.1 81.86 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.568 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -66.92 -47.02 73.01 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.483 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 0.9 OUTLIER -62.81 -39.98 95.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.642 HG12 ' NH1' ' A' ' 108' ' ' ARG . 5.1 mt -56.31 -60.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 113.099 -1.864 . . . . 0.0 112.533 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' ARG . . . . . 0.454 ' N ' HG22 ' B' ' 130' ' ' ILE . 12.4 mmm180 -53.49 -42.73 67.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 123.424 0.453 . . . . 0.0 110.991 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.762 ' HA2' ' NH2' ' B' ' 134' ' ' ARG . . . 155.8 70.36 0.01 OUTLIER Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.767 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 21.0 tt0 -108.25 -24.56 11.45 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.238 -175.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.762 ' NH2' ' HA2' ' B' ' 132' ' ' GLY . 0.0 OUTLIER -69.7 -75.46 0.11 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.785 0.802 . . . . 0.0 108.867 173.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.407 ' H ' ' HB2' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.423 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 150' ' ' HIS . 21.9 ttt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.859 0.361 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' C ' ' HE3' ' A' ' 3' ' ' LYS . . . -67.26 155.73 38.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.481 0.658 . . . . 0.0 112.273 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.711 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -95.14 -18.17 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.505 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.6 t -136.49 126.38 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.515 0.674 . . . . 0.0 110.241 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.588 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 4.7 tp-100 -116.27 100.08 7.66 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.89 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -76.73 134.79 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.364 176.518 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -115.05 -62.72 1.56 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 -165.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.683 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.51 151.06 23.3 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.865 -176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.6 p -144.63 99.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.5 170.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.15 95.39 4.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.165 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -67.31 125.3 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.699 177.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.99 HD12 ' HG2' ' A' ' 23' ' ' GLN . 7.3 mt -97.31 -52.31 3.86 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.184 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.71 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 7.7 t70 -74.49 78.64 1.93 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.733 1.254 . . . . 0.0 110.456 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.715 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -82.38 178.09 2.63 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.437 165.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.895 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.9 Cg_endo -48.0 104.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.839 1.693 . . . . 0.0 114.619 -149.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.564 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.2 m -131.76 170.45 11.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 112.767 -2.015 . . . . 0.0 108.495 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 51.6 Cg_exo -46.85 144.58 7.91 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 111.636 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.712 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 11.3 t80 -61.36 -37.14 82.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.85 -0.85 32.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.897 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -89.2 131.35 41.03 Favored Pre-proline 0 N--CA 1.431 -1.388 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 171.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -63.72 150.12 89.2 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 123.792 2.995 . . . . 0.0 114.364 -168.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 95.0 m-85 -66.12 139.15 58.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.103 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.99 ' HG2' HD12 ' A' ' 12' ' ' LEU . 7.8 tt0 -133.83 99.43 4.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.139 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.721 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.5 m-85 -103.37 155.72 18.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.294 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' ' 12' ' ' LEU . 39.5 tt0 -134.71 88.13 2.41 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.569 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 14.0 mt -86.85 131.52 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.941 0.877 . . . . 0.0 112.366 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 24.6 m -108.53 108.1 18.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.345 173.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 32.5 p90 -120.0 148.05 44.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.778 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.875 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 72.0 tt0 -106.76 115.01 29.45 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.64 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -72.68 111.64 8.02 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -77.67 -29.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.44 -174.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.619 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 42.2 mm-40 -151.81 154.77 36.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.437 0.46 . . . . 0.0 110.054 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.72 128.31 20.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.87 0.731 . . . . 0.0 111.256 -175.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.032 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -83.46 146.63 28.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.563 -170.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -113.2 -23.17 10.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.384 -172.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.834 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 29.3 tt0 -129.51 -164.85 1.45 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.834 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.3 m-20 -95.27 137.17 34.7 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.597 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.6 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 47.8 tt0 -105.66 89.7 3.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.571 -171.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.67 ' O ' ' HA ' ' A' ' 59' ' ' SER . 23.4 m95 -80.34 124.67 29.06 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.7 ttmt -130.93 142.5 50.36 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.72 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.716 HG22 HG22 ' A' ' 95' ' ' VAL . 12.5 mt -103.62 112.97 39.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.3 mp -104.43 105.74 19.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.647 ' CE2' HG11 ' A' ' 113' ' ' VAL . 33.5 t80 -90.42 111.87 23.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.795 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -53.43 109.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.253 0.549 . . . . 0.0 109.846 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.61 -45.56 52.5 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.452 -0.88 . . . . 0.0 110.97 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.834 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 91.4 p -128.1 125.02 38.41 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.358 0.599 . . . . 0.0 111.515 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -89.21 -0.1 57.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 161.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.584 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 4.8 mt-10 -88.5 -29.58 20.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.655 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 64.1 m -121.92 -107.88 0.35 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.593 173.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 7.0 pt-20 -179.98 -47.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.173 0.189 . . . . 0.0 111.327 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 38.0 mt-10 -72.83 1.15 9.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.088 0.47 . . . . 0.0 111.777 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 2.0 m-30 -80.73 -7.93 59.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -44.01 108.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.207 1.003 . . . . 0.0 111.057 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.644 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 40.8 mt-30 -92.71 169.44 10.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.512 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' CG1' ' HD3' ' A' ' 41' ' ' LYS . 46.1 t -130.67 110.35 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -172.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.6 mm? -75.54 -54.61 6.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.614 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 19.3 p-10 -160.38 170.43 21.05 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 67.5 p -146.92 115.39 6.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.1 p -99.63 134.65 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.382 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.7 OUTLIER -105.94 103.92 13.51 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.048 -175.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.59 118.74 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -79.72 -162.33 24.69 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.219 -165.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.032 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 31.4 Cg_endo -63.5 117.36 4.32 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.784 1.656 . . . . 0.0 110.806 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 23.1 m -128.0 137.56 31.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.857 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -82.02 77.23 3.91 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.23 1.953 . . . . 0.0 114.082 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . 51.85 177.37 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.116 -1.856 . . . . 0.0 112.618 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.68 129.62 5.61 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 172.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.875 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.3 ptt180 -79.87 128.06 33.0 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.321 1.058 . . . . 0.0 109.787 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -154.12 143.77 21.66 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.395 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.53 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -92.85 136.23 33.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.533 -176.361 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 6.4 p90 -121.36 160.09 24.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 168.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.46 134.13 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-O 121.882 0.849 . . . . 0.0 110.808 -171.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -115.95 129.75 56.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.345 -164.206 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 64.6 mt-30 -151.67 143.7 23.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.941 0.4 . . . . 0.0 110.542 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -169.11 138.43 2.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.835 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.639 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.2 p-10 -72.96 156.19 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -174.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -44.1 156.93 0.3 Allowed Pre-proline 0 N--CA 1.443 -0.789 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.532 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 57.3 Cg_endo -66.97 170.57 12.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.841 3.027 . . . . 0.0 111.418 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.8 m-20 -66.55 117.83 48.07 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.0 Cg_endo -61.36 -25.74 80.6 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.544 2.829 . . . . 0.0 111.948 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.0 -11.29 82.77 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.311 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.644 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 25.2 mt -91.85 -21.91 20.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.644 0.259 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.515 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 10.1 mt -84.49 130.07 55.05 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.38 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 1.5 Cg_endo -79.96 161.19 23.95 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.123 2.549 . . . . 0.0 112.076 170.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.729 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -46.54 -53.32 11.56 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.07 69.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.178 0.513 . . . . 0.0 111.114 -167.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 9.8 m-20 -95.74 -19.88 19.32 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.754 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.04 -47.28 15.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.52 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.748 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -96.5 48.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.702 0.763 . . . . 0.0 111.542 -176.572 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.83 -129.73 1.15 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.089 -166.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.426 HG13 ' OD1' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -119.91 125.3 74.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.344 0.593 . . . . 0.0 111.524 -173.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.14 169.65 15.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.611 HG23 HD13 ' B' ' 126' ' ' LEU . 2.4 t -126.45 142.53 42.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.266 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 42' ' ' ILE . 9.8 p -127.35 107.47 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 122.14 0.972 . . . . 0.0 108.613 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -104.02 138.93 39.84 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.345 -171.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 mt -102.81 95.57 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.819 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.6 p -96.7 116.04 28.45 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.599 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 40' ' ' TRP . 76.3 m -82.32 118.16 22.94 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.553 176.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 56.6 m -99.31 113.48 25.81 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.771 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.71 ' HB3' HD11 ' A' ' 151' ' ' ILE . 38.2 t80 -123.63 121.72 36.28 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.629 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 34.8 mtp180 63.02 27.37 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.063 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.35 66.51 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.653 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -121.12 135.44 55.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.165 0.507 . . . . 0.0 110.477 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 2.4 mp0 -82.18 128.96 34.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.597 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 51.4 p90 -111.65 2.41 17.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 98' ' ' THR . 9.3 tt -156.93 158.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.845 HH21 HG21 ' A' ' 147' ' ' THR . 31.3 ttp180 -151.1 107.51 3.48 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -96.86 99.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 118.699 -1.201 . . . . 0.0 108.339 171.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.737 ' HA3' HG21 ' B' ' 130' ' ' ILE . . . -87.42 79.51 1.77 Allowed Glycine 0 CA--C 1.483 -1.962 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.123 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.871 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.9 m-85 -71.58 116.05 11.48 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.122 -1.039 . . . . 0.0 109.082 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.722 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.96 114.58 5.88 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.689 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.647 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.4 p -101.97 110.45 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.468 HD21 ' HG3' ' A' ' 116' ' ' GLU . 2.3 t30 -96.87 120.91 38.08 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 21.9 m120 -108.12 108.95 20.24 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -169.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.468 ' HG3' HD21 ' A' ' 114' ' ' ASN . 73.0 mt-10 -127.45 125.01 39.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.18 -170.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 29.6 m-85 -41.24 153.14 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -91.07 -32.81 15.74 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.749 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.562 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.39 130.04 35.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.788 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.631 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.7 m -56.31 -36.4 68.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.474 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.04 -37.82 78.78 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.564 0.697 . . . . 0.0 110.301 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 81.8 mt -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.647 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 mtp85 -75.63 -37.88 59.37 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.2 mm-40 -57.65 -37.43 73.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.821 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 22.0 p-10 -160.23 98.53 1.44 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.973 177.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 13.2 Cg_endo -56.5 114.6 1.99 Allowed 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.061 2.508 . . . . 0.0 111.341 173.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.4 152.26 33.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.494 2.129 . . . . 0.0 110.794 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -51.12 -24.49 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.979 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 26.0 mttt -123.95 108.21 30.45 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 121.703 0.763 . . . . 0.0 111.676 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.748 ' HB3' HG13 ' A' ' 90' ' ' VAL . 8.9 Cg_exo -45.02 141.83 5.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 125.091 3.861 . . . . 0.0 113.456 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -114.41 114.79 26.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.655 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 14.5 m-85 -78.11 -16.89 57.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.67 0.748 . . . . 0.0 111.303 -168.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -85.47 -20.45 29.71 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.355 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.7 mmtt -101.96 5.38 40.74 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 115' ' ' ASN . 26.3 tp -86.82 143.68 27.37 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.362 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.465 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 2.3 tt0 -126.43 125.1 41.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.895 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.3 mtp-105 -83.68 104.34 13.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.889 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -98.32 103.5 15.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.695 HG21 HG11 ' A' ' 11' ' ' VAL . 1.5 mp -82.03 104.96 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.576 -173.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.722 HD12 ' HB3' ' A' ' 112' ' ' TYR . 83.5 mt -65.84 91.4 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.852 0.834 . . . . 0.0 111.029 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.871 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.88 -15.26 59.74 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.562 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -77.87 -16.01 58.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.411 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -134.35 67.27 72.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.19 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.578 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 90.5 Cg_endo -91.92 108.29 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.551 2.168 . . . . 0.0 110.951 175.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.614 ' NE ' ' HA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -75.53 80.29 2.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.504 -176.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 109' ' ' VAL . 5.2 m -79.18 111.16 15.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.845 HG21 HH21 ' A' ' 108' ' ' ARG . 31.3 m -132.15 106.61 8.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.142 0.496 . . . . 0.0 110.333 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -108.36 133.23 52.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.243 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.66 169.99 8.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.993 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.403 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 9.2 m170 -102.47 116.97 33.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.162 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.7 pt -119.55 179.59 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.194 0.521 . . . . 0.0 109.844 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -96.45 84.24 3.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 122.191 0.996 . . . . 0.0 112.242 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.711 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 21.8 m95 -69.49 -9.27 53.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.321 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.51 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 4.5 mp0 -119.32 159.23 24.53 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.583 ' HA ' HH12 ' A' ' 102' ' ' ARG . 36.3 t70 -83.43 70.16 10.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.631 0.729 . . . . 0.0 110.245 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 154' ' ' GLU . 26.5 p-10 . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.956 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.34 65.33 0.69 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.027 0.441 . . . . 0.0 110.718 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 57.8 mtp -91.12 138.49 31.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.32 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 92.77 0.75 Allowed Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.553 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.6 mmtt -60.89 -27.21 67.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.013 0.435 . . . . 0.0 110.42 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.16 -49.53 77.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.645 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' ILE . . . . . 0.495 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.7 tp -75.78 -27.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.052 0.453 . . . . 0.0 110.571 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.6 tm0? -56.48 -63.72 1.1 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.792 0.806 . . . . 0.0 109.905 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.611 HD13 HG23 ' A' ' 94' ' ' VAL . 62.0 mt -58.99 -44.08 91.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.486 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.892 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -57.25 -32.55 66.68 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 123.566 0.541 . . . . 0.0 111.74 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 96.1 mtt180 -53.11 -53.48 49.71 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 1.074 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 5.1 tpp180 -62.94 -38.57 91.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.641 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.892 HG13 ' HA ' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -92.88 6.93 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.004 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -98.32 -39.08 8.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.981 0.419 . . . . 0.0 110.253 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.402 ' CA ' HH12 ' A' ' 108' ' ' ARG . . . 172.92 54.83 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.156 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 1.074 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 33.8 tt0 -133.0 6.43 3.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.402 0.62 . . . . 0.0 109.733 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.659 ' HG3' ' H ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -26.4 -75.33 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.301 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.659 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.872 176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ttt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.997 0.427 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.79 152.93 42.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.567 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.721 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 64.0 mmtt -100.3 -14.7 18.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.498 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 38' ' ' LEU . 2.1 t -150.98 137.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.353 0.597 . . . . 0.0 112.503 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.776 ' HG2' HD11 ' A' ' 31' ' ' ILE . 23.8 mm-40 -128.53 115.4 18.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.951 172.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.912 HG12 ' HB3' ' A' ' 28' ' ' PHE . 5.0 m -78.13 134.71 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.234 -1.786 . . . . 0.0 108.107 167.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -120.72 -62.09 1.49 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.434 -166.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -103.64 99.87 9.69 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.168 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.643 HG11 HG21 ' A' ' 109' ' ' VAL . 3.0 p -95.84 97.86 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -93.54 97.06 6.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 122.236 1.017 . . . . 0.0 108.687 -174.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.15 135.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.659 -176.193 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.934 HD12 ' HG2' ' A' ' 23' ' ' GLN . 5.7 mt -106.48 -48.21 3.6 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -172.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.69 78.52 0.83 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.653 1.692 . . . . 0.0 109.659 167.447 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.673 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -85.91 178.32 2.38 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 112.22 -2.264 . . . . 0.0 107.023 162.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.848 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.2 Cg_endo -49.43 103.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 121.73 1.653 . . . . 0.0 113.242 -157.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.692 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.6 m -132.49 171.11 9.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.668 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.1 Cg_exo -43.18 135.79 5.66 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.313 2.009 . . . . 0.0 111.253 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 12.6 t80 -60.46 -26.66 66.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.325 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.17 -7.68 59.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.999 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.22 142.94 76.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 170.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.4 Cg_exo -77.55 136.7 15.77 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 123.407 2.738 . . . . 0.0 113.139 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 32.5 m-85 -57.43 116.43 3.33 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.532 0.682 . . . . 0.0 110.729 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.934 ' HG2' HD12 ' A' ' 12' ' ' LEU . 54.3 tt0 -116.39 106.47 13.66 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.941 -165.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.674 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 92.7 m-85 -110.32 154.01 24.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.564 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 24.5 tt0 -121.69 87.06 2.68 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 167.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.503 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 74.8 mt -82.99 125.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.624 0.726 . . . . 0.0 112.281 -174.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 37.8 m -107.71 106.38 16.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.037 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.912 ' HB3' HG12 ' A' ' 6' ' ' VAL . 29.1 p90 -113.94 146.25 40.35 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.677 1.227 . . . . 0.0 110.924 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.982 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.1 tt0 -101.28 113.42 26.46 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.579 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.665 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -72.14 109.79 6.16 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.776 HD11 ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -70.53 -32.07 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.8 -2.0 . . . . 0.0 108.56 178.562 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 8.7 mm-40 -144.79 154.05 42.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.182 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.28 132.26 48.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.031 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 44.9 mt -83.06 158.63 22.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.682 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -113.1 -21.08 11.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.454 0.645 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.7 tt0 -126.44 -168.96 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.759 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.5 m-20 -90.63 149.91 21.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 34' ' ' LEU . 4.7 tp -96.38 123.65 40.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.435 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 82.4 tt0 -107.9 92.11 3.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.699 -169.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.687 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 46.2 m95 -88.64 127.78 35.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 22.7 ttmt -124.11 140.59 52.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.032 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.568 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.2 mt -104.13 107.26 21.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.111 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.831 HG12 ' HB3' ' B' ' 135' ' ' ALA . 3.6 mp -103.01 112.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.443 -174.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' A' ' 57' ' ' LEU . 13.4 t80 -96.9 114.2 25.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.492 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.11 103.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.58 -44.91 96.41 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.607 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 43.9 t -134.36 135.32 42.61 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.532 0.682 . . . . 0.0 109.634 176.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -83.61 -11.21 57.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -32.2 25.24 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.938 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.682 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 74.9 m -144.5 117.02 8.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.021 0.915 . . . . 0.0 111.342 166.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' OE2' ' HD3' ' B' ' 128' ' ' ARG . 9.0 pt-20 -66.89 -14.82 63.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.276 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.2 -9.46 32.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.439 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.682 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 95.4 m-85 -90.89 6.43 44.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.463 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -53.63 103.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.909 0.862 . . . . 0.0 111.13 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -101.24 167.48 10.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.21 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.36 122.5 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.334 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.71 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 10.8 mp -81.67 -62.69 1.57 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.2 m-20 -147.23 163.35 36.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.211 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 51.4 p -138.49 116.78 11.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -99.4 131.9 45.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.734 -172.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 12.5 mt -102.92 104.19 14.39 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.184 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.38 125.1 47.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -73.11 -166.21 10.2 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.319 -163.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.031 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 28.4 Cg_endo -60.57 114.7 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.233 1.289 . . . . 0.0 109.285 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 63' ' ' GLY . 28.2 m -116.9 120.99 33.31 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.661 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.83 131.0 37.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.517 2.145 . . . . 0.0 110.429 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.18 132.15 0.39 Allowed 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 124.26 0.975 . . . . 0.0 112.775 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.94 118.96 0.58 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.982 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.2 ttt180 -65.21 114.63 4.83 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.719 0.771 . . . . 0.0 111.214 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.412 ' HE1' HG21 ' A' ' 65' ' ' VAL . 29.7 p-80 -149.07 156.2 41.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.128 -171.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.9 OUTLIER -106.05 151.18 25.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.516 ' N ' ' HG2' ' A' ' 71' ' ' MET . 1.3 p90 -140.75 160.75 39.36 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 171.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.461 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 2.6 p -117.35 136.98 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 122.168 0.985 . . . . 0.0 111.567 -172.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.674 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -118.07 138.14 52.44 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.49 -169.479 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.714 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 71.1 mt-30 -148.08 151.46 35.7 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.71 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -159.21 121.87 3.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.68 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.83 156.3 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.809 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.05 151.36 16.8 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.516 -169.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 64.3 Cg_endo -67.36 162.54 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.029 2.486 . . . . 0.0 110.16 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 24.0 m-80 -60.9 119.04 41.22 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 21.0 Cg_endo -66.76 -7.78 19.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.067 2.511 . . . . 0.0 110.796 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.46 1.3 55.8 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.978 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.27 -27.81 10.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.996 0.398 . . . . 0.0 110.638 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 89' ' ' ALA . 15.9 mt -80.82 128.64 70.94 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.991 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 84' ' ' ILE . 72.0 Cg_endo -81.88 161.29 18.61 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.066 1.844 . . . . 0.0 111.394 172.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.687 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.5 t70 -46.0 -48.7 16.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.88 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.994 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 7.5 m-20 -106.8 -8.38 16.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.409 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -74.48 -43.8 54.39 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 111.178 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -100.6 46.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.593 -174.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.31 -138.63 2.75 Favored Glycine 0 CA--C 1.508 -0.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.452 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.507 HG23 ' OD1' ' A' ' 114' ' ' ASN . 0.9 OUTLIER -100.57 139.08 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -168.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.847 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -157.61 169.9 23.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.001 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.689 HG12 HD23 ' A' ' 96' ' ' LEU . 94.9 t -120.95 133.1 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 121.05 0.452 . . . . 0.0 111.63 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 42' ' ' ILE . 3.0 p -117.15 107.13 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.711 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -106.27 151.02 25.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.702 -177.038 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.736 ' HB ' HG12 ' A' ' 109' ' ' VAL . 61.6 mt -110.51 100.86 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-O 121.709 0.766 . . . . 0.0 109.037 175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.831 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 76.1 p -97.66 116.26 29.53 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.744 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.687 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 4.3 t -78.9 158.96 27.97 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.322 174.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.1 m -148.05 111.73 5.05 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.707 ' HB3' HD11 ' A' ' 151' ' ' ILE . 71.3 t80 -123.4 119.82 31.17 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 62.08 33.61 16.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.863 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.84 62.92 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.199 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -132.72 133.32 43.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 0.0 110.98 175.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 3.1 mp0 -81.37 132.84 35.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.307 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.0 p90 -125.73 2.06 7.47 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.831 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.3 tt -156.84 159.49 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' HA ' ' B' ' 130' ' ' ILE . 5.0 tmm_? -152.79 105.46 2.96 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.708 0.63 . . . . 0.0 109.559 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.736 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.3 p -95.0 102.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -89.99 102.65 2.93 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.82 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.967 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 10.3 m-85 -98.96 121.98 41.62 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.573 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.572 ' CB ' HD12 ' A' ' 140' ' ' LEU . 57.2 m-85 -68.97 115.86 8.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.295 176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.847 HG13 HG23 ' A' ' 93' ' ' THR . 1.8 p -101.27 109.71 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 122.32 1.057 . . . . 0.0 108.28 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.507 ' OD1' HG23 ' A' ' 92' ' ' VAL . 8.6 t30 -97.14 104.4 16.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.727 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.616 ' HB3' HD11 ' A' ' 135' ' ' LEU . 31.8 m-80 -89.55 110.16 21.04 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.02 130.16 49.45 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.69 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 25.9 m-85 -38.55 150.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -84.44 -34.32 23.49 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.223 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.519 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 10.6 tt0 -86.51 119.43 26.76 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.249 -1.796 . . . . 0.0 108.504 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.859 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 99.2 m -54.89 -31.3 59.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.084 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.18 -32.29 70.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 92.0 mt -73.42 -27.05 61.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.253 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.859 ' HE ' ' HA ' ' A' ' 120' ' ' THR . 19.3 mtm180 -74.46 -38.18 63.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.616 0.722 . . . . 0.0 109.257 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.722 ' HG3' ' O ' ' A' ' 120' ' ' THR . 45.9 mt-10 -58.66 -39.64 81.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.339 -1.301 . . . . 0.0 111.126 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.4 p30 -146.8 86.13 6.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 18.7 Cg_endo -57.43 114.36 1.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.789 2.326 . . . . 0.0 111.318 176.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.532 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 54.0 Cg_exo -55.17 141.74 79.56 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.265 1.977 . . . . 0.0 109.899 175.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.75 -13.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.972 0.795 . . . . 0.0 112.454 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -124.63 100.22 34.89 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.162 0.982 . . . . 0.0 111.824 167.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.69 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 7.7 Cg_exo -44.77 144.83 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.827 1 C-N-CA 125.453 4.102 . . . . 0.0 113.378 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.2 t70 -113.65 111.67 22.22 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.684 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 9.9 m-85 -75.93 -11.39 59.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.546 1.165 . . . . 0.0 110.596 -170.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -90.3 -34.5 15.71 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.056 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 61.2 mmtt -92.79 17.67 10.09 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 33.1 tp -100.6 128.67 46.57 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.334 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -120.72 110.93 16.97 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.848 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.94 113.85 25.56 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.096 0.474 . . . . 0.0 111.681 -174.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 11.5 t30 -89.89 112.55 23.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 172.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.514 HG21 HG11 ' A' ' 11' ' ' VAL . 1.7 mp -83.71 103.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.313 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.572 HD12 ' CB ' ' A' ' 112' ' ' TYR . 86.3 mt -63.57 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.296 0.569 . . . . 0.0 110.938 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.967 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.08 -11.82 60.01 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.738 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -79.23 -3.33 45.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.574 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -143.79 71.08 17.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.94 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.3 Cg_endo -89.72 106.54 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.292 1.995 . . . . 0.0 111.234 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 81.22 8.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.038 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 109' ' ' VAL . 32.4 m -77.36 131.52 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 86.2 m -151.09 110.71 4.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.516 0.674 . . . . 0.0 110.566 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 5.6 ptt-85 -108.46 138.51 44.64 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.798 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 169.37 9.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.312 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.466 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.3 pt -129.91 -177.2 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.631 0.729 . . . . 0.0 111.469 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -98.15 84.22 3.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.972 -171.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TRP . . . . . 0.721 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 63.7 m95 -69.45 -7.44 37.93 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.483 -0.76 . . . . 0.0 111.345 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -131.68 153.99 49.44 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.37 71.0 1.74 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.072 0.939 . . . . 0.0 111.534 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 . . . . . 0 C--O 1.247 0.927 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.837 173.116 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.35 -38.43 2.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.437 0.161 . . . . 0.0 110.872 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 72.0 mtm 65.87 -75.51 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.995 0.809 . . . . 0.0 111.11 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.91 152.76 47.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' LYS . . . . . 0.663 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 39.5 mmtt -84.85 -36.27 21.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.075 0.464 . . . . 0.0 110.042 -171.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.488 ' HA ' HD12 ' B' ' 126' ' ' LEU . 16.0 t70 -31.11 -46.06 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 177.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.3 tt -73.82 -38.3 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.4 0.619 . . . . 0.0 110.489 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 1.6 tp-100 -66.36 -37.39 85.21 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.449 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.801 ' O ' ' HB ' ' B' ' 130' ' ' ILE . 20.0 mt -59.52 -50.32 74.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.299 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' B' ' 131' ' ' ARG . . . -62.65 -42.51 99.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.818 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.554 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 81.3 mtt180 -56.74 -65.1 0.67 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.349 0.595 . . . . 0.0 111.973 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.614 ' HD2' ' HG3' ' B' ' 133' ' ' GLU . 20.0 mmm180 -60.37 -30.5 69.61 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.118 -175.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -87.82 -7.48 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.215 -175.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 131' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' B' ' 127' ' ' ALA . 30.3 mmt180 -77.84 -36.32 50.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 141.13 65.12 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.42 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.614 ' HG3' ' HD2' ' B' ' 129' ' ' ARG . 6.7 mm-40 -80.13 -42.38 23.61 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' B' ' 133' ' ' GLU . 9.8 ptt180 60.7 128.32 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.068 1.413 . . . . 0.0 112.45 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.831 ' HB3' HG12 ' A' ' 43' ' ' ILE . . . . . . . . 0 C--N 1.304 -1.372 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.42 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.669 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.2 mptp? -96.6 -18.53 19.68 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.26 -176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.83 125.36 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.752 0.787 . . . . 0.0 110.71 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.546 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.36 100.05 7.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.786 176.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -77.96 131.84 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.403 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -111.73 -66.77 1.05 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.071 -166.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.54 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.4 t-20 -102.76 154.05 19.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.82 -176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 9' ' ' VAL . 6.1 p -144.83 99.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 CA-C-O 122.104 0.955 . . . . 0.0 109.214 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -92.26 95.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.322 1.058 . . . . 0.0 108.572 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.85 127.72 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.763 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.913 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.2 mt -97.48 -39.05 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.318 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.641 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 9.8 t0 -70.91 65.13 0.34 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.316 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.637 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -84.84 173.44 7.15 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 162.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.0 Cg_endo -50.32 101.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 121.508 1.574 . . . . 0.0 113.101 -158.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.637 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 13.9 m -136.21 169.44 13.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.861 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 70.5 Cg_exo -38.31 137.47 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.18 2.587 . . . . 0.0 113.496 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.729 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 19.2 t80 -63.09 -20.76 65.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 21.4 m-85 -94.38 5.62 51.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 111.235 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.77 140.92 47.44 Favored Pre-proline 0 C--O 1.213 -0.831 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 14.3 Cg_exo -74.56 141.92 28.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.691 2.261 . . . . 0.0 112.185 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.783 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 94.8 m-85 -60.24 117.07 4.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 122.964 0.506 . . . . 0.0 110.015 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.913 ' HB3' HD12 ' A' ' 12' ' ' LEU . 39.3 mt-30 -115.5 111.27 20.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.32 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' A' ' 97' ' ' ILE . 70.0 m-85 -121.58 107.51 12.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.497 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.624 ' HB2' HD21 ' A' ' 12' ' ' LEU . 22.0 tt0 -90.14 85.05 6.17 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 14.4 mt -86.83 132.4 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.694 0.759 . . . . 0.0 112.114 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.7 m -108.47 106.85 17.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.294 174.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.3 p90 -118.79 150.92 38.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.529 0.681 . . . . 0.0 109.717 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.837 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 47.2 tt0 -107.46 111.04 23.14 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.49 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 29.1 t -72.96 108.1 5.69 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -74.55 -27.21 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.031 -173.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.598 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 8.2 mt-10 -143.8 179.62 7.05 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.88 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -73.57 146.63 44.59 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.021 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -106.73 157.03 18.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -174.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -113.97 -41.85 3.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.889 0.852 . . . . 0.0 110.545 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.803 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 33.2 tt0 -113.33 -165.84 1.03 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.042 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.803 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -98.51 143.59 28.76 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.819 0.819 . . . . 0.0 110.599 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.821 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.68 124.13 29.92 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.38 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.595 ' HB3' ' O ' ' A' ' 100' ' ' THR . 42.3 tt0 -107.55 90.15 3.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.929 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 59' ' ' SER . 24.5 m95 -81.67 122.74 28.01 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.6 ttmt -126.4 141.59 51.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.574 HG22 HG22 ' A' ' 95' ' ' VAL . 13.8 mt -102.9 120.13 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.673 ' HB ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -114.38 106.33 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.287 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.686 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.5 t80 -88.87 116.69 27.34 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.73 105.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.151 0.5 . . . . 0.0 109.899 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.44 -35.77 92.49 Favored Glycine 0 CA--C 1.501 -0.808 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.172 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.577 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.6 t -139.14 116.56 11.25 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.587 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -70.35 -1.2 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 167.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -96.3 -27.02 15.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 47' ' ' SER . 14.5 m -144.67 109.45 4.99 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.828 0.823 . . . . 0.0 111.091 171.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.838 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -70.08 -23.76 63.12 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.399 -166.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -67.4 -2.33 6.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 4.2 m-30 -85.71 -4.02 59.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.041 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.595 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.2 p-10 -42.53 112.32 0.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.316 1.055 . . . . 0.0 112.206 -175.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 3.1 mt-30 -91.36 168.49 11.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.923 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.42 114.25 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -173.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.1 mm? -82.73 -49.29 9.92 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.059 -174.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -163.92 164.04 23.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 27.8 p -141.43 117.46 10.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.2 p -100.29 132.76 45.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.624 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.36 105.93 15.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.638 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.23 113.81 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.65 -166.38 12.39 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.098 -168.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.021 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.8 Cg_endo -65.23 115.27 3.22 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.407 1.404 . . . . 0.0 110.365 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 31.1 m -131.99 141.36 41.19 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.614 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.55 79.11 3.31 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.082 1.854 . . . . 0.0 113.482 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.29 -171.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.015 -1.902 . . . . 0.0 112.343 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.94 122.79 2.62 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.947 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.9 ttt180 -87.69 118.24 27.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -161.06 166.0 28.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.41 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -108.64 139.46 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.174 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 9.8 p90 -126.69 160.91 29.39 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.14 106.42 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-O 123.06 1.41 . . . . 0.0 111.898 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 140.97 37.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.443 -2.162 . . . . 0.0 110.572 -176.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.783 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.0 mt-30 -150.68 149.84 30.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 165.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.593 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -158.65 132.14 7.48 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.457 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.719 ' O ' HD12 ' A' ' 57' ' ' LEU . 12.9 m-20 -67.18 143.19 56.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.163 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -52.2 157.22 2.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 124.704 1.201 . . . . 0.0 114.028 -173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.686 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.03 -179.92 3.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.97 3.113 . . . . 0.0 113.267 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 96.1 m-20 -82.18 119.17 74.4 Favored Pre-proline 0 CA--C 1.515 -0.388 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.263 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 16.1 Cg_endo -60.32 -25.18 79.64 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.538 2.826 . . . . 0.0 112.576 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.0 -15.86 81.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.417 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.422 ' CB ' HE21 ' A' ' 55' ' ' GLN . 31.3 mt -79.57 -25.94 41.47 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.242 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.69 129.29 49.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -80.06 164.02 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.746 2.964 . . . . 0.0 112.794 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.578 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 m-20 -45.12 -55.0 6.11 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.823 0.849 . . . . 0.0 113.071 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.0 -18.56 61.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.218 0.533 . . . . 0.0 110.596 -168.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.666 ' HA ' ' HZ1' ' B' ' 122' ' ' LYS . 40.2 t0 -92.36 -35.82 13.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -70.17 -45.38 66.84 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.381 0.61 . . . . 0.0 111.332 -171.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.19 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.77 0.795 . . . . 0.0 111.559 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.45 -160.14 10.09 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.433 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.686 HG12 ' ND2' ' A' ' 114' ' ' ASN . 4.7 m -94.87 144.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.907 ' HB ' HG13 ' A' ' 113' ' ' VAL . 2.8 m -151.15 170.24 19.92 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.597 HG23 HD13 ' B' ' 126' ' ' LEU . 3.9 t -132.7 144.6 36.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 118.939 0.79 . . . . 0.0 110.954 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 42' ' ' ILE . 10.5 p -129.04 105.48 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.916 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -104.13 135.51 45.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.792 -169.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 45.1 mt -103.29 99.82 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-O 121.919 0.866 . . . . 0.0 109.08 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.781 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 58.0 p -93.61 112.33 24.19 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.717 ' SG ' HD12 ' A' ' 38' ' ' LEU . 1.4 t -79.52 122.3 26.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 18.8 m -121.83 103.71 9.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.021 -167.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.677 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 61.4 t80 -109.14 120.28 42.05 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.413 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.677 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 15.5 mtp180 69.67 22.42 6.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.778 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.81 85.0 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -110.05 117.79 34.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.847 -0.676 . . . . 0.0 109.386 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 60.0 mt-10 -82.54 132.47 35.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.821 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.9 p90 -123.19 1.77 9.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.6 tt -159.24 157.86 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.625 ' HD2' ' O ' ' B' ' 130' ' ' ILE . 22.3 ttm180 -150.99 101.37 2.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.463 0.477 . . . . 0.0 109.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.916 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -84.52 98.66 6.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.228 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.17 77.25 2.12 Favored Glycine 0 CA--C 1.488 -1.606 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.586 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.993 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -74.06 115.9 14.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.137 -1.032 . . . . 0.0 109.121 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.565 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.7 m-85 -66.31 120.58 13.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.907 HG13 ' HB ' ' A' ' 93' ' ' THR . 2.6 p -103.18 110.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.686 ' ND2' HG12 ' A' ' 92' ' ' VAL . 6.0 t-20 -92.43 110.76 22.17 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.184 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 39.1 m-80 -97.78 107.84 20.42 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.96 141.22 36.44 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.184 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.741 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 46.4 m-85 -47.97 151.93 0.86 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -174.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -86.81 -37.72 17.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.534 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.3 mt-10 -82.94 132.0 35.17 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.766 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 m -55.73 -36.17 66.95 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.55 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.85 -40.42 84.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.897 0.856 . . . . 0.0 109.991 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 46.0 mt -77.73 -23.09 49.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.799 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -80.15 -37.04 34.28 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.2 mm-40 -56.19 -43.1 78.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.769 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.478 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -152.72 89.11 3.82 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.447 0.641 . . . . 0.0 109.854 177.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.5 Cg_endo -50.46 116.01 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.769 2.979 . . . . 0.0 112.865 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.741 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 77.7 Cg_exo -52.75 136.79 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.007 2.471 . . . . 0.0 111.249 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' HE2' ' A' ' 129' ' ' LYS . 22.5 t -51.68 -40.68 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.555 -173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 1.8 mmpt? -94.83 137.96 22.25 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-O 121.153 0.501 . . . . 0.0 110.798 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.578 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 11.8 Cg_exo -69.89 123.77 10.38 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.7 2.933 . . . . 0.0 112.332 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' HB2' ' HE1' ' A' ' 117' ' ' TYR . 1.6 m-20 -104.57 97.09 7.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.681 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.684 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 33.4 m-85 -68.0 -16.33 64.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.994 0.902 . . . . 0.0 110.549 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 2.9 p -83.3 -21.72 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.1 mmtt -104.58 5.12 33.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 132' ' ' PHE . 17.6 tp -87.82 137.83 31.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.556 -168.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.56 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 4.5 tt0 -120.41 127.5 52.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.842 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 21.2 mtm-85 -90.46 104.93 17.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 15.3 t30 -89.75 98.75 11.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -78.73 100.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 112' ' ' TYR . 95.8 mt -62.2 92.57 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.706 0.765 . . . . 0.0 111.14 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.993 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -78.93 -8.82 59.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.419 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 p -80.66 -10.55 59.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.03 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.4 t-20 -142.27 62.97 14.41 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.513 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 4.7 Cg_exo -81.0 109.11 2.14 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.3 2.0 . . . . 0.0 111.098 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.651 ' HB3' HD13 ' B' ' 130' ' ' ILE . 15.0 tpt180 -82.23 82.61 7.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.98 106.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.2 m -116.46 105.65 12.72 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.601 0.715 . . . . 0.0 109.308 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.864 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.5 ptt180 -112.53 148.32 34.74 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.805 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.454 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -129.42 167.45 17.79 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.145 -173.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -106.1 123.14 47.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.931 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 101' ' ' TYR . 38.9 pt -121.45 158.73 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -87.25 103.22 15.23 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.495 1.14 . . . . 0.0 110.365 172.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.669 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 7.9 m95 -75.54 -3.56 34.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.64 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 . . . . . 0 N--CA 1.438 -1.048 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.212 -176.059 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.666 ' HZ1' ' HA ' ' A' ' 88' ' ' ASP . 9.5 mmmm . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -40.59 -54.89 2.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.044 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.489 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.9 tp -69.06 -32.07 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.851 0.357 . . . . 0.0 111.247 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 8.4 mm100 -58.07 -46.91 84.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 173.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.597 HD13 HG23 ' A' ' 94' ' ' VAL . 30.8 mt -68.35 -43.62 77.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.319 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.29 68.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.712 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 95.9 mtt180 -54.14 -57.65 10.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.838 ' HD3' ' HB2' ' A' ' 51' ' ' GLU . 6.1 tpt180 -61.4 -35.45 77.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.269 -171.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 145' ' ' ARG . 23.8 mt -76.83 -49.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.65 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' B' ' 131' ' ' ARG . 7.3 mmm180 . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 111.534 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.927 0.394 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.934 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.58 -21.57 18.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 34' ' ' LEU . 3.4 t -137.53 129.22 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.772 0.796 . . . . 0.0 111.08 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp-100 -115.04 100.55 8.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.233 -1.349 . . . . 0.0 107.421 169.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 29.9 t -74.28 124.73 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -107.39 -65.65 1.09 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.09 0.947 . . . . 0.0 109.146 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.666 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.9 t-20 -106.41 151.8 24.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.849 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 26' ' ' ILE . 3.2 p -146.77 99.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.367 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.99 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.4 m -93.67 107.11 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 109.979 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.889 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -78.72 136.6 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.568 -176.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 23' ' ' GLN . 7.6 mt -111.05 -42.14 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.32 -172.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 23' ' ' GLN . 4.2 p-10 -69.69 43.66 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.41 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -79.0 169.91 18.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.7 Cg_endo -53.02 100.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.048 1.165 . . . . 0.0 114.206 -138.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.666 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.6 m -136.76 171.22 9.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 112.008 -2.36 . . . . 0.0 107.482 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 62.4 Cg_exo -39.83 141.46 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.695 2.263 . . . . 0.0 112.912 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.017 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.0 t80 -60.31 -30.6 69.59 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.378 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -79.38 -6.17 56.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.089 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -77.59 119.94 79.46 Favored Pre-proline 0 CA--C 1.507 -0.682 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.545 ' C ' HH22 ' A' ' 137' ' ' ARG . 47.2 Cg_exo -60.57 154.43 54.28 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 123.844 3.03 . . . . 0.0 113.391 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.77 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 80.2 m-85 -62.93 133.36 54.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.686 ' HB3' HD12 ' A' ' 12' ' ' LEU . 39.9 mt-30 -132.27 89.86 2.72 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.307 0.575 . . . . 0.0 109.552 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' HD11 ' A' ' 97' ' ' ILE . 79.9 m-85 -100.44 109.14 21.27 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.56 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.99 ' HB3' HG23 ' A' ' 10' ' ' VAL . 31.8 tt0 -91.66 85.87 5.81 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.684 HG13 HG23 ' A' ' 9' ' ' VAL . 2.6 mp -81.85 140.06 17.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.764 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 11.3 m -115.25 107.16 14.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.327 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 17.6 p90 -121.27 153.41 37.7 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.897 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 21.9 tt0 -109.4 118.3 36.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 24.4 m -74.07 109.25 7.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.469 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -72.81 -31.4 36.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.962 -174.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.934 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 47.8 mt-10 -142.89 166.74 23.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.772 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.2 m-20 -61.71 131.2 49.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.767 HD12 ' CE1' ' A' ' 101' ' ' TYR . 2.1 mm? -85.51 152.29 23.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -113.54 -36.82 4.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.68 0.752 . . . . 0.0 110.126 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 13.7 tt0 -117.13 -167.37 1.29 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.449 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 5.3 m-20 -96.19 138.43 33.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.516 0.674 . . . . 0.0 111.316 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.714 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.47 120.02 29.45 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.922 178.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.8 tt0 -106.92 89.32 2.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.638 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.706 ' O ' ' HA ' ' A' ' 59' ' ' SER . 27.6 m95 -76.35 129.08 36.08 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 30.0 ttmt -133.38 142.48 48.4 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.903 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 95' ' ' VAL . 10.7 mt -103.22 121.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -114.29 105.71 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.119 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.823 ' CE2' HG11 ' A' ' 113' ' ' VAL . 28.3 t80 -89.72 124.55 34.72 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.898 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.01 111.54 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.376 0.608 . . . . 0.0 110.343 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 53' ' ' TYR . . . -70.76 -35.71 66.45 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -172.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 39.6 t -134.53 118.85 17.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.772 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -66.05 0.23 2.04 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.999 0.428 . . . . 0.0 110.01 167.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -102.12 -17.12 16.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.286 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 50.4 m -124.64 -171.69 2.4 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.775 0.798 . . . . 0.0 111.086 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.65 -3.31 1.15 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.516 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -94.25 -13.16 26.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.675 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.698 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 3.5 m-30 -84.92 -15.82 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.335 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 8.7 p-10 -42.44 115.48 0.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.134 0.968 . . . . 0.0 111.979 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.444 ' HG2' HD12 ' A' ' 83' ' ' LEU . 11.2 mp0 -91.17 166.85 12.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.943 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.81 107.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.0 mm? -74.92 -40.06 61.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.671 -171.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.34 176.26 2.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.887 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 58.1 p -151.49 115.28 4.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.84 132.42 45.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.918 -175.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 6.4 mt -102.73 106.26 16.85 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -92.98 120.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -84.16 -156.68 24.44 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.925 -165.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 38.6 Cg_endo -64.6 118.79 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.952 1.768 . . . . 0.0 110.53 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.626 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 28.5 m -134.8 141.87 40.22 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.514 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -86.17 75.33 2.98 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.421 2.08 . . . . 0.0 114.599 -173.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.634 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 48.19 -179.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.954 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 114.45 129.22 4.73 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.138 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.897 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.1 ptt-85 -75.87 126.21 30.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.421 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 4.9 p80 -153.68 141.6 20.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.936 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -95.55 137.75 34.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -177.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.7 p90 -135.68 146.37 47.71 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 13.8 p -104.26 125.65 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 122.318 1.056 . . . . 0.0 110.438 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.489 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 12.0 t80 -119.53 113.04 20.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.764 -163.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 38.3 mt-30 -138.46 149.99 46.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.476 -167.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' C ' ' HB3' ' A' ' 21' ' ' PRO . . . -169.34 146.07 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.351 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.656 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.1 p-10 -61.24 170.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.05 0.452 . . . . 0.0 111.413 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -71.12 164.22 58.82 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.688 -170.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.77 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 34.7 Cg_endo -60.92 168.21 7.59 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.355 2.703 . . . . 0.0 111.69 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 11.5 m120 -69.75 115.54 34.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.0 -175.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 13.2 Cg_endo -61.89 -26.68 79.31 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.225 2.617 . . . . 0.0 112.045 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.61 14.55 55.26 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.292 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 83' ' ' LEU . 15.6 mt -116.74 -33.75 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.391 0.139 . . . . 0.0 110.816 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 36.5 mt -73.71 129.89 84.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.127 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 95.0 Cg_endo -79.92 162.26 23.72 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.221 2.614 . . . . 0.0 112.699 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.734 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 12.1 m-20 -45.85 -52.54 11.19 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.673 0.789 . . . . 0.0 112.202 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.71 -28.61 65.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.835 ' HA ' ' NZ ' ' B' ' 122' ' ' LYS . 49.1 t0 -80.87 -38.97 27.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -65.45 -38.7 90.62 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -165.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -102.39 46.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 -138.85 3.0 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.118 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.563 HG23 ' ND2' ' A' ' 114' ' ' ASN . 1.1 t -97.13 135.87 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.059 0.933 . . . . 0.0 113.256 -172.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.699 ' HB ' HG13 ' A' ' 113' ' ' VAL . 1.7 m -140.51 168.82 18.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.769 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -125.54 143.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 118.318 0.508 . . . . 0.0 111.127 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 42' ' ' ILE . 7.3 p -131.06 108.23 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.65 154.91 18.46 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.983 -171.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.647 ' HB ' HG12 ' A' ' 109' ' ' VAL . 2.4 mt -117.39 105.07 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.825 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.0 p -100.62 114.8 28.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.227 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.566 ' HB2' HG22 ' A' ' 107' ' ' ILE . 62.6 m -79.68 115.76 19.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.452 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -108.54 101.91 11.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.991 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.767 ' CE1' HD12 ' A' ' 34' ' ' LEU . 87.1 t80 -104.31 127.83 52.02 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.599 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 37.0 mtp180 67.02 14.19 9.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.3 65.24 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.731 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.752 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -119.74 129.37 54.47 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.8 mp0 -83.6 133.68 34.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.418 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.714 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.5 p90 -121.47 -5.1 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.825 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.9 tt -156.17 158.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 174.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.98 HH22 ' HG3' ' A' ' 145' ' ' ARG . 4.3 tmm_? -150.87 107.68 3.54 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -174.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.2 p -102.64 101.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.188 0.994 . . . . 0.0 109.321 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.23 86.66 1.38 Allowed Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 119.762 -1.209 . . . . 0.0 111.499 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.771 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 17.1 m-85 -82.17 122.29 27.69 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.192 -1.004 . . . . 0.0 108.805 172.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 140' ' ' LEU . 31.6 m-85 -68.48 131.91 46.08 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.332 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.823 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.6 p -104.89 111.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.563 ' ND2' HG23 ' A' ' 92' ' ' VAL . 3.0 t-20 -90.58 110.51 21.65 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.349 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 28.5 m-80 -102.68 107.34 18.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -131.91 130.03 41.06 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.612 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.7 m-85 -40.86 148.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.8 p -89.65 -29.27 18.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.771 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 30.2 mm-40 -91.31 140.0 30.2 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.556 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.0 m -52.05 -47.95 64.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 117.928 0.331 . . . . 0.0 111.206 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.27 -39.76 67.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.988 0.899 . . . . 0.0 110.045 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.5 mt -77.6 -30.34 52.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.376 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 52.1 mtp180 -76.83 -39.06 52.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.501 0.667 . . . . 0.0 109.516 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.746 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 1.5 pt-20 -80.85 -20.6 41.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.597 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.746 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -149.82 77.38 8.58 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.841 170.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 18.1 Cg_endo -57.03 118.42 5.28 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.634 2.889 . . . . 0.0 112.94 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 14.9 Cg_exo -71.63 147.81 51.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.065 2.51 . . . . 0.0 110.197 172.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.1 -27.75 43.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.866 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -89.12 122.21 68.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 0.0 111.271 175.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.734 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 36.5 Cg_exo -63.54 131.78 33.0 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 124.253 3.302 . . . . 0.0 112.588 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.0 t0 -114.05 105.28 13.03 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.727 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 42.6 m-85 -77.87 -19.86 54.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.846 0.832 . . . . 0.0 110.344 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.3 t -79.94 -29.91 39.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.804 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 71.6 mmtt -98.82 14.41 28.97 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 28.8 tp -99.68 143.91 29.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.213 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.91 129.95 51.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 1.017 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 10.0 mtm180 -95.5 106.01 18.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 4.4 t30 -96.35 99.71 11.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.889 HG21 HG11 ' A' ' 11' ' ' VAL . 10.0 mm -68.05 117.86 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.633 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . 62.4 mt -74.35 75.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.719 0.771 . . . . 0.0 110.334 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.771 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -68.85 -13.14 62.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.974 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -75.46 -12.77 60.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.457 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.412 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.5 t-20 -133.9 60.46 45.69 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 24.1 Cg_exo -68.84 105.24 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.549 1.499 . . . . 0.0 111.497 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.98 ' HG3' HH22 ' A' ' 108' ' ' ARG . 18.2 tpt85 -87.69 88.67 7.73 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.758 HG12 HG23 ' A' ' 109' ' ' VAL . 22.6 m -92.54 124.58 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.461 HG22 ' CE2' ' A' ' 149' ' ' PHE . 98.8 m -132.8 107.78 8.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.379 0.609 . . . . 0.0 109.708 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.731 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -106.64 140.33 39.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.418 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -126.18 118.7 25.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.458 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.85 143.49 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 110.812 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.752 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 46.6 pt -131.9 177.29 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 154' ' ' GLU . 3.1 p30 -97.97 94.2 6.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.313 1.054 . . . . 0.0 109.425 176.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.0 m95 -71.73 4.55 3.13 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.178 -1.373 . . . . 0.0 108.897 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 152' ' ' ASN . 16.9 mt-10 . . . . . 0 N--CA 1.436 -1.13 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.622 -173.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.835 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 75.7 mmtt . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 p30 13.18 -93.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' B' ' 127' ' ' ALA . 13.7 tt -62.03 -27.36 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.5 tm0? -63.84 -58.56 6.42 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 121.745 0.783 . . . . 0.0 110.196 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' B' ' 122' ' ' LYS . 1.2 mm? -64.23 -28.89 70.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.611 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . . . -62.33 -40.53 96.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.813 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -51.35 -53.88 31.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -70.47 -25.85 63.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.87 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.547 HG12 HH12 ' A' ' 108' ' ' ARG . 5.6 mt -65.47 -39.48 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.395 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.519 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.426 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.739 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 22.0 mmtt -101.02 -9.02 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.055 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.502 ' N ' HG13 ' A' ' 31' ' ' ILE . 2.7 t -142.95 126.96 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.417 0.627 . . . . 0.0 110.687 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.578 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 6.0 tp-100 -124.09 100.8 6.9 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.099 174.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.611 HG11 ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -82.48 131.43 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.127 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -115.81 -63.53 1.44 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.531 -162.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.691 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -100.07 148.88 24.07 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.852 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.3 p -146.08 102.23 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-O 121.797 0.808 . . . . 0.0 109.934 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.975 HG23 ' HB3' ' A' ' 25' ' ' GLU . 3.3 m -98.39 96.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.779 0.799 . . . . 0.0 109.804 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.865 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -74.96 129.43 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 122.017 0.913 . . . . 0.0 110.427 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.888 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.1 mt -98.82 -36.36 9.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.455 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.739 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 16.9 t70 -68.88 39.55 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.683 170.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.632 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -79.22 172.47 9.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.3 Cg_endo -50.38 101.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 120.841 1.336 . . . . 0.0 113.006 -152.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.661 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 21.2 m -141.95 171.62 7.07 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 112.193 -2.276 . . . . 0.0 107.676 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 67.2 Cg_exo -38.22 132.65 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.484 2.123 . . . . 0.0 112.301 175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.735 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 33.3 t80 -54.22 -28.13 39.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.868 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -86.84 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.74 0.305 . . . . 0.0 111.039 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.62 120.22 79.48 Favored Pre-proline 0 CA--C 1.513 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.721 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.4 Cg_exo -63.85 146.04 91.2 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 123.821 3.014 . . . . 0.0 113.161 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.761 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 37.8 m-85 -60.35 115.11 3.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.904 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.888 ' HB3' HD12 ' A' ' 12' ' ' LEU . 37.0 mt-30 -118.99 102.03 8.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.95 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.64 ' CD1' HD11 ' A' ' 97' ' ' ILE . 87.5 m-85 -109.65 111.4 22.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.462 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.975 ' HB3' HG23 ' A' ' 10' ' ' VAL . 30.6 tt0 -93.38 85.23 4.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.95 132.95 32.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 122.049 0.928 . . . . 0.0 112.609 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 25.5 m -104.15 107.17 17.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.173 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.588 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 27.5 p90 -117.53 148.2 42.09 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.925 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.861 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.9 tm-20 -101.94 111.33 23.55 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.4 t -72.4 108.63 5.6 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -75.03 -23.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.086 -171.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.739 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 50.3 mt-10 -155.37 148.31 24.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.62 131.47 50.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.949 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 4.7 tp -86.67 154.24 21.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.768 -168.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -113.18 -30.49 6.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.584 0.707 . . . . 0.0 110.372 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.811 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.8 tt0 -117.01 -167.51 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.811 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 4.6 p-10 -100.67 137.68 38.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.843 0.83 . . . . 0.0 111.523 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.26 122.25 27.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.112 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.633 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.9 tt0 -106.84 89.82 3.13 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.28 -176.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 59' ' ' SER . 15.1 m95 -78.0 135.8 37.85 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.7 ttmt -137.37 137.5 38.93 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.288 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.964 HG22 HG22 ' A' ' 95' ' ' VAL . 8.9 mt -102.46 110.16 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.6 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 49.9 mt -108.43 106.11 20.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.74 -172.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.845 ' CE2' HG11 ' A' ' 113' ' ' VAL . 25.3 t80 -89.49 108.53 19.7 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.867 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t -53.44 104.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.748 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.08 99.84 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.152 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 53' ' ' TYR . 29.4 t -131.78 128.81 39.6 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' B' ' 126' ' ' LEU . . . -75.93 -5.94 48.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.978 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -100.03 -35.52 9.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.537 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 8.9 m -122.35 97.41 5.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.056 0.931 . . . . 0.0 110.059 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' B' ' 128' ' ' ARG . 0.0 OUTLIER -67.65 -11.08 57.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.03 -172.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.73 -12.08 60.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.651 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 16.9 m-30 -87.65 10.25 18.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.273 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.486 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 4.9 p-10 -54.93 110.3 0.64 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.092 0.949 . . . . 0.0 111.162 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HG2' HD12 ' A' ' 83' ' ' LEU . 4.8 mt-30 -92.7 169.95 10.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.507 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.64 112.64 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -169.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 44' ' ' TYR . 3.7 mm? -76.34 -42.66 44.19 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.484 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 5.4 p-10 -170.6 173.95 5.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.489 171.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 50.8 p -145.36 117.56 8.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.63 128.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.459 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.9 mt -103.18 104.02 14.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.049 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.49 119.43 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -82.27 -151.67 9.74 Favored Glycine 0 CA--C 1.482 -1.979 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.158 -165.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.949 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 2.1 Cg_endo -46.35 117.14 1.83 Allowed 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.454 1.436 . . . . 0.0 109.144 167.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.413 HG13 ' SG ' ' A' ' 30' ' ' CYS . 2.6 p -133.66 120.98 15.86 Favored Pre-proline 0 C--N 1.288 -2.106 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.7 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.71 130.75 41.58 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.154 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -44.61 147.21 0.63 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.832 0.708 . . . . 0.0 111.255 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 144.84 130.29 2.25 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.09 -174.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.861 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -74.43 116.97 15.71 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.789 0.804 . . . . 0.0 110.889 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 8.2 p80 -150.72 152.13 33.44 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.36 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.718 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.6 ttp -98.92 126.94 44.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.324 0.583 . . . . 0.0 111.116 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -117.95 133.18 56.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.3 p -101.95 127.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.433 1.111 . . . . 0.0 110.392 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.545 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 1.2 t80 -117.34 133.89 55.46 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.655 -1.612 . . . . 0.0 109.465 -164.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.739 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 66.8 mt-30 -151.69 150.36 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.047 0.451 . . . . 0.0 110.398 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -160.37 168.48 25.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.38 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.07 -175.32 0.07 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.844 0.831 . . . . 0.0 112.162 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -89.52 158.28 45.9 Favored Pre-proline 0 N--CA 1.438 -1.046 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.726 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.761 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 46.6 Cg_endo -65.41 168.57 14.21 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.042 2.495 . . . . 0.0 111.602 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 5.1 m-20 -79.56 115.3 52.42 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.3 Cg_endo -62.85 -19.91 69.93 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.634 2.889 . . . . 0.0 112.707 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.56 -5.06 79.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.349 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.491 HD12 ' HG2' ' A' ' 55' ' ' GLN . 9.3 mt -95.5 -27.82 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.965 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 44' ' ' TYR . 11.4 mt -82.66 130.86 56.79 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 0.0 112.339 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 84' ' ' ILE . 5.4 Cg_endo -81.13 156.6 19.94 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.22 2.614 . . . . 0.0 111.903 170.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.77 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.9 m-20 -47.25 -49.12 24.07 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.67 76.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.521 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.5 -17.27 23.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.085 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -71.59 -45.87 60.96 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.3 0.572 . . . . 0.0 111.258 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.74 45.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.95 -173.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.74 -135.5 2.03 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.838 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.885 HG23 HD22 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -98.94 135.27 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-O 122.164 0.983 . . . . 0.0 112.552 -170.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.16 167.62 24.57 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG11 HD11 ' B' ' 130' ' ' ILE . 4.6 t -112.83 141.96 26.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.586 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.964 HG22 HG22 ' A' ' 42' ' ' ILE . 3.8 p -125.61 101.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 158.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.6 ' CD1' ' HB ' ' A' ' 43' ' ' ILE . 1.1 pp -94.62 149.34 21.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.448 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.874 ' HB ' HG12 ' A' ' 109' ' ' VAL . 3.2 mt -114.74 101.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.352 0.596 . . . . 0.0 109.829 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 70.7 p -98.37 116.48 30.69 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.047 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.629 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.4 m -82.31 118.23 23.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 20.8 m -106.85 128.22 54.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.784 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 65.3 t80 -132.7 121.18 22.71 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.826 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 22.5 mtp180 67.65 26.17 8.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.292 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.02 6.01 82.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.414 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -116.44 115.28 25.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.083 -0.558 . . . . 0.0 109.836 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 44.0 mp0 -77.27 124.89 28.47 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.784 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 29.0 p90 -113.88 -4.2 13.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 98' ' ' THR . 7.7 tt -158.08 158.83 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.524 HH21 HG21 ' A' ' 147' ' ' THR . 24.4 ttp180 -150.71 106.81 3.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.336 0.397 . . . . 0.0 110.043 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.874 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.2 p -91.27 99.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.544 1.164 . . . . 0.0 108.455 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.507 ' HA3' HG12 ' B' ' 130' ' ' ILE . . . -80.49 95.8 1.6 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.231 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.975 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 4.4 m-85 -93.6 109.57 21.19 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.957 0.884 . . . . 0.0 109.245 174.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' N ' ' HD1' ' A' ' 112' ' ' TYR . 2.3 m-85 -76.15 114.88 15.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.286 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.845 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.1 p -88.09 108.67 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.885 HD22 HG23 ' A' ' 92' ' ' VAL . 16.4 t-20 -95.56 103.61 15.48 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.477 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -91.97 121.41 33.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.288 0.566 . . . . 0.0 110.064 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.84 138.91 30.64 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.628 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 47.5 m-85 -48.8 156.65 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -92.12 -30.18 16.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.982 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.494 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 4.6 mm-40 -82.22 129.57 34.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.097 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.708 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.4 m -53.86 -40.83 66.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.991 0.182 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.01 -35.58 66.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.11 0.957 . . . . 0.0 110.179 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 82.4 mt -85.07 -22.0 29.13 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.785 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 47.3 mtp180 -83.17 -39.67 20.71 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.76 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 11.5 pt-20 -70.35 -31.7 69.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.725 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.76 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 1.2 p30 -147.61 82.08 8.23 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.14 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 29.5 Cg_endo -61.75 117.86 4.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.551 2.834 . . . . 0.0 112.248 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.6 Cg_exo -69.04 161.05 47.44 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.915 2.41 . . . . 0.0 110.943 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.69 -25.36 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HD3' ' HD3' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -89.7 128.38 50.73 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 121.397 0.618 . . . . 0.0 110.788 172.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.77 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 1.1 Cg_endo -82.66 141.64 11.09 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.054 3.169 . . . . 0.0 112.15 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.1 t70 -124.85 112.18 16.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.231 0.538 . . . . 0.0 109.592 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.693 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.1 m-85 -79.4 -19.77 49.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.488 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.1 p -83.31 -24.06 32.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.494 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 73.3 mmtt -98.87 11.76 37.82 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.9 tp -95.91 133.45 40.08 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.806 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.16 120.47 39.12 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.757 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.35 109.05 21.23 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.644 -172.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.687 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -86.2 98.5 10.95 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.094 173.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.865 HG21 HG11 ' A' ' 11' ' ' VAL . 1.4 mp -72.65 108.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.165 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 112' ' ' TYR . 36.4 mt -64.51 91.81 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.222 0.534 . . . . 0.0 111.834 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.975 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -80.66 -12.19 59.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -80.14 -11.92 59.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.997 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -138.51 70.12 45.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.818 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.636 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 63.9 Cg_endo -81.83 104.97 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.207 1.272 . . . . 0.0 109.666 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.546 ' HG3' HG21 ' B' ' 130' ' ' ILE . 0.2 OUTLIER -83.66 81.76 8.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.255 0.55 . . . . 0.0 110.532 -175.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.779 HG22 HG23 ' A' ' 109' ' ' VAL . 3.9 t -86.4 104.43 13.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.961 -174.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.524 HG21 HH21 ' A' ' 108' ' ' ARG . 48.8 m -112.77 106.93 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.739 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -108.37 138.24 44.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.8 0.81 . . . . 0.0 110.891 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.3 136.1 54.84 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.88 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.474 ' O ' ' HD2' ' A' ' 150' ' ' HIS . 0.8 OUTLIER -73.79 141.61 46.22 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.707 175.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.03 172.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.61 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -90.94 106.33 18.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.17 0.986 . . . . 0.0 110.451 171.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.729 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 8.0 m95 -81.28 5.77 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.956 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 . . . . . 0 N--CA 1.428 -1.563 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.805 -173.481 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' B' ' 122' ' ' LYS . 11.5 mptt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.246 0.07 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -44.41 -45.16 8.85 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.321 0.388 . . . . 0.0 111.845 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 -43.07 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.257 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.43 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.5 mm100 -53.41 -54.16 40.77 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.618 0.723 . . . . 0.0 111.278 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 48' ' ' ALA . 2.4 mm? -62.38 -37.4 85.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.481 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.96 75.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.429 HH21 ' CD ' ' A' ' 51' ' ' GLU . 10.4 mtm180 -59.02 -47.07 86.53 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -60.17 -41.6 93.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 145' ' ' ARG . 3.8 mp -90.45 -5.79 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.481 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.851 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 10.2 mptt -100.11 -22.05 15.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.438 HG23 HD21 ' A' ' 34' ' ' LEU . 3.6 t -139.28 131.94 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.871 0.843 . . . . 0.0 110.964 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.772 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -125.67 100.14 6.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.851 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG22 ' CH2' ' A' ' 40' ' ' TRP . 11.6 t -70.79 146.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.42 HD21 ' CB ' ' A' ' 29' ' ' GLU . 59.8 m-80 -131.16 -65.88 0.76 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.65 0.738 . . . . 0.0 109.594 -172.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.666 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.8 t-20 -104.82 148.21 26.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.105 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.2 p -146.73 105.23 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.107 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.049 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -98.02 97.81 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.554 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -70.91 116.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.892 178.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.73 HD22 ' H ' ' A' ' 12' ' ' LEU . 1.4 mm? -80.71 -31.49 36.1 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.62 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' HB3' ' CG ' ' A' ' 23' ' ' GLN . 7.3 p-10 -82.62 44.47 0.9 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.681 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' HB3' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -73.59 168.61 23.91 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 159.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 31.6 Cg_exo -51.47 101.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.569 0 CA-C-O 122.729 1.054 . . . . 0.0 113.3 -135.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.846 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 70.1 m -129.99 166.87 23.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.731 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 50.1 Cg_exo -46.38 133.48 15.92 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.685 174.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.103 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 20.2 t80 -55.4 -23.98 27.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.056 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -92.91 5.56 50.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.846 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -96.3 120.15 63.01 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 169.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 70.3 Cg_exo -55.29 144.43 71.52 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.747 2.298 . . . . 0.0 112.91 -167.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.846 ' HE1' ' HD3' ' A' ' 79' ' ' PRO . 84.3 m-85 -52.58 143.02 16.69 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.745 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.678 ' CG ' ' HB3' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -143.25 110.64 5.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.747 0.784 . . . . 0.0 109.599 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 97' ' ' ILE . 81.7 m-85 -114.0 103.52 11.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.461 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.049 ' HB3' HG23 ' A' ' 10' ' ' VAL . 33.6 tt0 -84.23 85.13 7.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.729 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 4.5 mt -82.47 141.94 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.001 0.905 . . . . 0.0 113.042 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.5 m -119.51 108.8 14.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.294 171.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 17.3 p90 -117.96 146.38 44.04 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.245 0.545 . . . . 0.0 109.655 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.856 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.6 tt0 -101.89 109.36 21.09 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.9 m -72.79 119.76 17.48 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -90.2 -28.01 5.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.253 -169.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 48.3 mt-10 -146.69 169.06 19.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.979 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.06 127.9 34.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.993 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -81.7 155.21 25.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.158 0.504 . . . . 0.0 109.658 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.6 p -113.42 -14.36 12.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.208 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 102' ' ' ARG . 7.7 tt0 -138.64 -167.52 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.65 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.813 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 22.2 m-20 -97.74 136.38 38.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 110.872 -175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 99' ' ' CYS . 0.2 OUTLIER -81.67 120.09 24.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.202 175.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 100' ' ' THR . 44.1 tt0 -105.65 90.12 3.3 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.093 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.729 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 31.0 m95 -74.12 109.41 7.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.731 ' HE2' HG13 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -116.31 129.61 56.36 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -173.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.711 HG22 HG22 ' A' ' 95' ' ' VAL . 7.7 mt -102.1 115.96 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 43' ' ' ILE . 2.9 mp -110.84 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.611 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.727 ' CE2' HG11 ' A' ' 113' ' ' VAL . 26.4 t80 -84.02 119.78 25.35 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.513 HG11 HD12 ' B' ' 126' ' ' LEU . 17.6 t -70.57 97.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -85.75 -4.54 85.02 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.643 ' HB2' ' C ' ' A' ' 50' ' ' SER . 3.7 p -115.19 68.04 0.7 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.056 0.455 . . . . 0.0 111.439 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' B' ' 122' ' ' LYS . . . -76.15 -8.82 57.87 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.81 0.814 . . . . 0.0 108.834 166.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -99.17 -49.62 4.43 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.48 -1.237 . . . . 0.0 109.863 172.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.643 ' C ' ' HB2' ' A' ' 47' ' ' SER . 3.5 m -103.01 -138.88 0.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.877 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.61 3.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.502 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -97.7 -7.26 31.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 111.814 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 37.4 m-85 -94.81 -0.98 53.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -170.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 18.5 p-10 -51.51 110.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.989 0.899 . . . . 0.0 110.592 172.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 80' ' ' ASN . 18.5 mp0 -91.71 168.26 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.247 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.731 HG13 ' HE2' ' A' ' 41' ' ' LYS . 2.5 t -126.09 110.86 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.193 -173.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -82.11 -57.58 3.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -172.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 7.7 t70 -170.35 162.35 8.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.71 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 12.1 p -130.19 119.4 22.9 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.0 p -101.59 129.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.3 mt -104.85 103.32 12.89 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.455 0.645 . . . . 0.0 110.967 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.02 119.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -87.96 -136.87 5.38 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.754 -1.212 . . . . 0.0 111.922 -162.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.993 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 5.7 Cg_endo -50.32 117.02 2.84 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.231 1.954 . . . . 0.0 111.324 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.473 HG21 ' HE2' ' A' ' 28' ' ' PHE . 13.0 m -121.41 111.67 33.25 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.187 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.8 61.49 5.51 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 123.353 2.702 . . . . 0.0 114.284 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.751 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.52 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 112.797 -2.001 . . . . 0.0 112.605 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 111.14 122.96 4.34 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 175.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 5.6 ptp85 -66.65 130.93 44.81 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.858 0.837 . . . . 0.0 110.005 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.461 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -151.58 158.2 43.21 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.099 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.2 138.11 51.91 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.296 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 11.2 p90 -137.49 148.82 46.33 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.3 p -106.67 119.27 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 122.316 1.055 . . . . 0.0 110.555 -174.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.517 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -111.11 154.27 24.53 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.468 -1.696 . . . . 0.0 109.217 -168.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.0 mt-30 -151.89 160.67 43.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -168.98 145.34 3.48 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 57' ' ' LEU . 6.5 m-20 -59.26 -177.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 112.24 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -84.4 155.12 63.02 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.846 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -66.83 157.52 60.9 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.684 2.256 . . . . 0.0 110.856 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.5 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 94.9 m-20 -63.12 117.84 37.16 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 -170.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.87 -13.42 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.41 2.74 . . . . 0.0 112.004 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.37 -1.1 69.44 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.569 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 83' ' ' LEU . 20.7 mt -103.87 -34.09 8.64 Favored 'General case' 0 CA--C 1.514 -0.421 0 O-C-N 122.928 -0.16 . . . . 0.0 111.286 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 36.4 mt -72.35 125.43 91.38 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.801 -175.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 95.8 Cg_endo -79.26 163.14 25.19 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.788 2.992 . . . . 0.0 111.932 170.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.716 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.8 m-20 -45.43 -54.08 7.84 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.176 0.99 . . . . 0.0 113.498 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.46 -8.64 58.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.512 0.196 . . . . 0.0 111.442 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.41 -38.77 11.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.997 0.427 . . . . 0.0 110.37 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.25 -46.16 35.51 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.915 -169.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.23 46.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.34 -134.53 2.03 Favored Glycine 0 CA--C 1.497 -1.057 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.799 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -104.49 130.77 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 CA-C-O 122.261 1.029 . . . . 0.0 113.574 -170.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.613 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -143.71 173.17 11.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.051 -1.886 . . . . 0.0 105.921 173.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.79 HG12 HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.0 143.52 39.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.704 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.711 HG22 HG22 ' A' ' 42' ' ' ILE . 9.9 p -121.78 104.43 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.921 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.75 126.81 48.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.711 -169.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 39.1 mt -95.18 102.0 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.099 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.775 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 67.8 p -91.14 109.81 21.07 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.844 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.609 ' HB2' HG22 ' A' ' 107' ' ' ILE . 61.5 m -73.44 109.1 6.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.894 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.584 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 16.1 m -103.68 101.87 11.72 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.529 -174.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.53 ' CE1' HD12 ' A' ' 34' ' ' LEU . 71.4 t80 -107.6 118.51 36.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 41.0 mtp180 72.97 19.63 3.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.96 0.504 . . . . 0.0 111.667 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.81 5.29 74.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.198 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.676 HE22 ' ND2' ' A' ' 152' ' ' ASN . 2.5 pt20 -120.65 127.96 52.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 4.0 mp0 -84.18 135.55 34.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.46 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.468 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 54.5 p90 -122.04 -1.5 9.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.1 tt -157.69 162.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.752 ' HG3' HG22 ' A' ' 98' ' ' THR . 9.0 ttm180 -149.2 99.39 2.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.921 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.25 100.55 8.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.823 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.61 79.58 1.74 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 119.413 -1.375 . . . . 0.0 111.116 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.906 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.7 m-85 -71.22 114.43 9.27 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.607 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.7 m-85 -66.59 110.84 3.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.727 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.8 p -92.53 109.99 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.799 ' ND2' HG13 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -95.82 108.13 20.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.499 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.687 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.3 m-80 -97.77 121.44 39.68 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.347 0.594 . . . . 0.0 110.086 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.86 140.36 32.88 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.855 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.546 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 46.5 m-85 -46.52 151.91 0.51 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.9 p -93.29 -29.92 15.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.345 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 70.5 mm-40 -76.37 125.56 29.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.625 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 16.7 m -55.72 -32.08 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.401 -172.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.45 -39.15 77.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.506 0.67 . . . . 0.0 110.013 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 81.8 mt -73.32 -23.69 60.28 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.626 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 22.0 mtt180 -74.45 -36.67 63.38 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 120' ' ' THR . 11.4 mm-40 -67.85 -44.23 77.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.776 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.6 p30 -138.13 82.05 25.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.729 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.4 Cg_endo -57.56 113.64 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.09 2.527 . . . . 0.0 111.579 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 24.2 Cg_exo -64.79 154.15 74.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.666 2.244 . . . . 0.0 111.593 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.1 p -46.76 -50.23 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 123.725 0.641 . . . . 0.0 112.428 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.7 mmtt -84.39 129.13 59.0 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 121.37 0.605 . . . . 0.0 111.055 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.716 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -72.06 125.18 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.653 2.902 . . . . 0.0 111.786 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -104.3 108.82 20.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.611 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 27.2 m-85 -77.91 -17.4 57.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.154 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 72.6 p -88.31 -15.07 36.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.911 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.1 mmtt -107.05 13.0 27.97 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 115' ' ' ASN . 18.3 tp -95.93 143.41 27.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.0 -172.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -124.29 124.05 41.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 1.103 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 25.7 mtm-85 -87.92 104.15 16.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.784 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.608 ' CG ' ' HG3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -90.34 89.38 7.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.461 HD12 HG23 ' A' ' 113' ' ' VAL . 1.3 mp -66.44 109.08 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 112' ' ' TYR . 89.6 mt -69.2 88.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.721 0.772 . . . . 0.0 110.433 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.906 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.63 -12.99 60.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.579 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.1 p -78.84 -12.01 60.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.72 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.47 64.21 57.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.661 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 98.6 Cg_endo -85.76 103.96 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.357 1.371 . . . . 0.0 109.902 172.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.632 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -84.47 80.35 9.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.306 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.659 HG12 HG23 ' A' ' 109' ' ' VAL . 26.7 m -76.88 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.739 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.445 HG22 ' CE1' ' A' ' 149' ' ' PHE . 97.7 m -138.82 107.56 5.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.467 0.651 . . . . 0.0 109.286 173.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.75 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 4.2 ptt180 -108.95 142.82 39.04 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.958 0.885 . . . . 0.0 111.321 -175.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -125.04 169.32 12.25 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.199 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.465 ' HD2' ' O ' ' A' ' 150' ' ' HIS . 1.1 p-80 -93.59 149.69 21.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.291 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.565 ' HB ' ' OE1' ' A' ' 104' ' ' GLN . 45.3 pt -142.29 168.33 14.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.676 ' ND2' HE22 ' A' ' 104' ' ' GLN . 3.2 p30 -96.55 89.84 5.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.313 1.054 . . . . 0.0 109.979 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.851 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 8.1 m95 -64.43 -1.57 1.81 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.681 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 152' ' ' ASN . 41.9 mt-10 . . . . . 0 N--CA 1.427 -1.625 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.26 -167.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.657 ' HG3' HG23 ' A' ' 92' ' ' VAL . 9.8 mmtp . . . . . 0 C--O 1.224 -0.243 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.06 -58.13 2.58 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.928 0.768 . . . . 0.0 112.05 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 8.1 tp -65.98 -37.75 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -60.46 -52.7 64.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.262 0.554 . . . . 0.0 110.509 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.624 HD22 ' O ' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -65.42 -44.12 88.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.032 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -40.49 82.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.29 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -59.31 -46.19 89.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 110.833 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -63.5 -39.15 93.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 145' ' ' ARG . 31.0 mt -76.44 -43.61 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.544 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -176.057 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.687 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.45 -18.01 27.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 -177.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 34' ' ' LEU . 2.7 t -139.97 139.4 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.482 0.658 . . . . 0.0 111.101 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.658 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -140.39 102.82 4.43 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.894 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 28' ' ' PHE . 2.9 m -72.66 149.66 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.789 175.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.14 -63.02 1.02 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.447 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.641 HD22 ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.31 112.41 25.51 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.244 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.641 ' N ' HD22 ' A' ' 8' ' ' ASN . 8.2 p -96.83 109.49 23.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -106.48 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 122.368 1.08 . . . . 0.0 108.965 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.586 HG12 ' CD2' ' A' ' 24' ' ' PHE . 18.4 m -77.29 123.15 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.333 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 25' ' ' GLU . 1.5 mt -89.63 -47.35 8.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.672 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.696 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 8.2 t0 -66.2 83.0 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.367 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.742 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -100.7 174.4 2.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.31 -1.768 . . . . 0.0 107.021 164.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.887 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 3.2 Cg_endo -49.44 102.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.274 1.491 . . . . 0.0 113.123 -151.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.662 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 20.1 m -129.9 170.54 10.73 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 112.587 -2.097 . . . . 0.0 108.886 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.662 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.0 Cg_exo -40.77 139.49 1.29 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.888 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.728 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 44.7 t80 -68.36 -10.29 53.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -96.32 8.26 44.4 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.561 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -95.88 126.11 46.15 Favored Pre-proline 0 CA--C 1.508 -0.672 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 169.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.5 Cg_exo -64.97 154.09 75.03 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.254 2.636 . . . . 0.0 112.519 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' HE2' HH21 ' A' ' 137' ' ' ARG . 25.4 m-85 -65.28 128.41 35.74 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.256 174.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.707 ' HA ' ' HG2' ' A' ' 75' ' ' GLN . 33.1 mt-30 -125.76 102.74 7.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.798 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CD2' HG12 ' A' ' 11' ' ' VAL . 50.6 m-85 -105.77 144.92 31.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.597 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.7 tt0 -118.78 88.29 2.9 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 168.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.612 HD11 HD13 ' A' ' 97' ' ' ILE . 43.2 mt -84.51 119.52 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.939 0.876 . . . . 0.0 111.67 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 20.0 m -100.16 105.15 16.72 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.415 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.039 ' HB3' HG12 ' A' ' 6' ' ' VAL . 32.8 p90 -118.32 150.75 38.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.853 0.835 . . . . 0.0 110.343 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.8 tt0 -108.65 116.22 31.57 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.636 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 47.7 t -73.16 117.02 14.39 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -83.16 -28.85 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.832 -171.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.687 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 4.6 mt-10 -150.07 147.63 28.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.55 134.54 46.53 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.665 0.269 . . . . 0.0 111.238 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -94.31 157.79 15.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.288 -170.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.6 m -112.59 -39.58 4.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.037 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.833 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.6 tt0 -119.44 -168.28 1.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.297 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.833 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 3.2 m-20 -93.69 136.88 33.53 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.391 0.615 . . . . 0.0 110.205 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mm? -83.73 127.09 33.53 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.787 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 57.8 tt0 -116.68 90.23 3.29 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.628 -173.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.677 ' HZ3' HG21 ' A' ' 107' ' ' ILE . 35.7 m95 -84.21 133.65 34.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.5 ttmt -129.84 144.76 51.47 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.935 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.666 HD13 HG12 ' A' ' 97' ' ' ILE . 44.2 mm -102.02 107.45 21.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -102.13 113.6 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.831 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' HA ' HG12 ' A' ' 95' ' ' VAL . 34.4 t80 -95.16 122.24 37.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.111 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.79 HG13 ' CE2' ' A' ' 53' ' ' TYR . 4.8 t -72.51 98.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.698 0.761 . . . . 0.0 109.489 171.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.689 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -72.38 -55.13 7.07 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.383 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.585 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 44.4 m -119.8 73.17 0.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.7 0.4 . . . . 0.0 110.55 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -49.69 -19.06 0.55 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.337 0.589 . . . . 0.0 111.927 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' OE2' ' HE2' ' B' ' 122' ' ' LYS . 1.5 tp10 -71.46 -19.29 62.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.043 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.617 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 39.9 m -117.04 -151.2 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.768 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 8.5 pt-20 -154.25 19.01 0.49 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.669 0.747 . . . . 0.0 111.267 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 50' ' ' SER . 2.0 mp0 -98.18 -36.97 9.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.827 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.79 ' CE2' HG13 ' A' ' 45' ' ' VAL . 10.7 p90 -54.65 -41.79 70.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.593 -169.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 9.8 p-10 -30.71 105.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.212 0 O-C-N 125.134 1.521 . . . . 0.0 112.546 -165.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.723 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 24.0 mt-30 -95.12 165.86 12.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.905 -168.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -120.15 108.96 24.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.148 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.494 HD22 ' CG2' ' A' ' 42' ' ' ILE . 6.6 mp -73.31 -40.7 64.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.602 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -176.53 165.83 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.073 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.9 p -144.63 123.85 12.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.9 p -100.42 136.26 32.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.788 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.5 mt -110.71 105.72 14.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.023 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 89.3 t -96.4 118.15 42.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -76.35 -160.39 10.11 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.56 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.804 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.7 Cg_endo -67.9 115.28 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.397 1.398 . . . . 0.0 110.231 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.571 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 34.1 m -124.99 141.18 37.69 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.185 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -83.26 77.31 3.58 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 122.48 2.12 . . . . 0.0 113.575 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.696 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 44.98 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.012 -1.903 . . . . 0.0 112.357 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.39 139.43 9.77 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.496 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttt180 -77.69 116.88 18.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.797 0.808 . . . . 0.0 110.091 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -128.68 122.07 29.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.18 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.753 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -83.59 121.27 27.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.651 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.7 p90 -120.66 160.08 24.01 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.1 133.83 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 121.911 0.863 . . . . 0.0 110.093 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.651 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 2.7 t80 -135.44 107.57 7.19 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.951 -161.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.707 ' HG2' ' HA ' ' A' ' 23' ' ' GLN . 77.3 mt-30 -124.19 155.13 39.05 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -156.94 134.58 10.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.183 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 2.6 t0 -65.48 171.84 3.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -69.87 159.77 82.79 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.658 . . . . 0.0 111.304 -171.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 56.6 Cg_endo -66.75 172.87 8.86 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.343 2.696 . . . . 0.0 111.449 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 10.0 m-80 -70.97 121.37 83.87 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.014 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.5 Cg_endo -63.57 -12.84 33.06 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.154 2.569 . . . . 0.0 110.944 175.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.48 -19.18 46.04 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.714 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.723 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 12.4 mt -94.61 -1.56 53.02 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.594 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 24.8 mt -100.7 125.92 37.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.913 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 86.0 Cg_endo -79.28 158.76 26.29 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.017 2.478 . . . . 0.0 111.145 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.659 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 m-20 -47.53 -47.02 28.08 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.99 -37.21 47.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.798 175.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -68.68 -47.43 66.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.064 -167.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.3 m -101.93 46.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-O 122.208 1.004 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.88 -139.44 2.66 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.654 -163.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.761 HG13 ' HB2' ' B' ' 122' ' ' LYS . 12.4 p -122.44 145.73 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 121.875 0.845 . . . . 0.0 110.366 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.749 HG23 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -160.66 174.36 14.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.626 HG21 HD11 ' B' ' 130' ' ' ILE . 1.9 t -132.16 144.38 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.882 0.372 . . . . 0.0 111.686 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 29.3 m -124.74 105.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.838 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.4 pp -103.5 145.06 30.57 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.163 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 46.1 mt -102.83 100.77 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.615 0.722 . . . . 0.0 109.235 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 80.8 p -99.8 114.37 27.48 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.702 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 4.6 t -80.83 158.79 25.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.867 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -148.44 109.17 4.22 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -165.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 151' ' ' ILE . 56.1 t80 -124.0 120.83 33.58 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.517 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 43.1 mtp180 66.76 25.85 9.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.275 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.62 11.74 73.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.455 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.37 131.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.137 0.494 . . . . 0.0 110.078 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 37.2 mp0 -86.7 125.5 33.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.501 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.522 ' HZ ' ' CD1' ' A' ' 38' ' ' LEU . 54.8 p90 -119.82 2.58 11.08 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -168.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.844 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.0 tt -156.35 154.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.799 HH21 HG21 ' A' ' 147' ' ' THR . 0.3 OUTLIER -153.6 108.17 3.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -177.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 4.2 p -97.39 100.64 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 122.16 0.981 . . . . 0.0 109.26 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -83.43 84.11 1.58 Allowed Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.616 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.909 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 6.3 m-85 -80.52 116.17 20.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.126 . . . . 0.0 109.109 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.59 ' HA ' HG22 ' A' ' 94' ' ' VAL . 22.7 m-85 -68.4 135.99 52.61 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.749 HG13 HG23 ' A' ' 93' ' ' THR . 4.1 p -121.25 111.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 108.826 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -96.34 120.45 36.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.968 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.593 ' HB3' HD11 ' A' ' 135' ' ' LEU . 49.2 m-80 -100.42 118.82 37.44 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.535 0.683 . . . . 0.0 109.413 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.62 131.04 42.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.694 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.684 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 20.2 m-85 -43.88 151.48 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -92.56 -29.47 16.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.003 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 14.3 mm-40 -84.18 128.57 34.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.952 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.2 m -48.41 -45.96 36.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.048 0.218 . . . . 0.0 111.344 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.61 -31.38 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.766 0.793 . . . . 0.0 110.423 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.684 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 83.4 mt -84.6 -25.52 28.56 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.326 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 63.4 mtp180 -81.1 -36.63 30.14 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' THR . 9.6 pt-20 -74.01 -36.49 64.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.117 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.657 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.6 OUTLIER -142.88 80.58 13.73 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.096 176.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 19.0 Cg_endo -57.36 119.49 6.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.408 2.739 . . . . 0.0 112.045 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 16.8 Cg_exo -69.57 163.12 39.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.966 2.444 . . . . 0.0 111.737 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.29 -45.6 89.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 2.1 mmtt -89.5 129.87 45.61 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 121.385 0.612 . . . . 0.0 110.989 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.682 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.0 Cg_endo -79.21 147.72 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.966 3.111 . . . . 0.0 112.248 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.8 t0 -116.64 111.63 20.12 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.728 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 13.0 m-85 -77.92 -13.46 59.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.049 0.928 . . . . 0.0 109.659 -173.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -87.35 -24.05 24.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.186 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . 74.8 mmtt -98.92 9.6 43.15 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.7 tp -94.36 144.86 25.18 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.535 -172.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 1.1 tt0 -128.82 126.13 39.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.584 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.887 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -90.49 105.79 18.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.74 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.643 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.2 t30 -95.15 108.39 20.5 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.639 0.733 . . . . 0.0 109.434 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 139' ' ' ILE . 1.3 mp -85.19 109.71 18.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.058 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.58 85.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.673 . . . . 0.0 110.178 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.909 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.454 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.4 p -72.77 -16.36 61.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.11 68.67 76.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 46.1 Cg_endo -92.03 104.95 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.954 1.769 . . . . 0.0 110.327 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 18.4 tpt180 -85.98 92.5 8.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.16 0.505 . . . . 0.0 110.482 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.622 HG12 HG23 ' A' ' 109' ' ' VAL . 29.7 m -86.33 129.79 37.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.516 0.674 . . . . 0.0 111.446 -175.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.799 HG21 HH21 ' A' ' 108' ' ' ARG . 21.1 m -140.86 107.46 5.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.7 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -110.78 130.05 55.68 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.607 0.717 . . . . 0.0 110.701 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.05 142.55 46.83 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.922 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 137.18 42.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 110.892 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 101' ' ' TYR . 46.4 pt -131.74 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 92.56 7.8 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.038 0.923 . . . . 0.0 111.479 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.672 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 19.2 m95 -77.3 0.92 20.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.445 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.426 -1.673 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.778 178.218 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.761 ' HB2' HG13 ' A' ' 92' ' ' VAL . 22.1 mmtp . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -11.85 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 166.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.33 -36.2 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 17.4 mm100 -58.21 -52.37 65.86 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.92 0.867 . . . . 0.0 110.663 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.529 ' O ' HG13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -62.74 -40.88 98.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.042 177.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' B' ' 131' ' ' ARG . . . -63.24 -26.05 68.61 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.339 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 63.9 mtp85 -64.01 -52.05 61.36 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.819 0.343 . . . . 0.0 110.196 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.679 ' HD2' HD21 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -62.35 -36.86 83.53 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.77 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 49.4 mt -85.12 -3.01 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.863 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' B' ' 131' ' ' ARG . 1.4 tpm_? . . . . . 0 C--N 1.315 -0.934 0 O-C-N 121.18 -0.95 . . . . 0.0 109.995 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.857 0.361 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.702 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.07 -8.48 39.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.809 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.768 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 1.5 t -147.28 140.78 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.389 0.614 . . . . 0.0 110.999 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' A' ' 31' ' ' ILE . 22.9 tp60 -136.85 99.95 4.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.653 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.934 HG12 ' HB3' ' A' ' 28' ' ' PHE . 5.1 m -72.05 145.25 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.262 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -125.93 -62.05 1.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.931 -165.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.444 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.6 t-20 -102.9 152.51 21.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.832 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.8 p -145.45 99.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.093 HG23 ' HB2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -88.71 99.5 9.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.825 -174.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.761 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.43 118.42 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.897 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.665 HD21 ' HG3' ' A' ' 25' ' ' GLU . 2.8 mt -88.79 -45.28 9.89 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.154 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.71 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 2.9 t70 -74.31 72.3 1.78 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.12 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.923 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.7 m120 -84.07 174.84 5.32 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.719 -2.037 . . . . 0.0 107.801 162.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.923 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.0 Cg_endo -49.12 102.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 CA-C-N 120.912 1.362 . . . . 0.0 113.176 -149.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.832 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 67.7 m -129.93 168.43 16.65 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.535 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.8 Cg_exo -43.17 132.69 6.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.417 2.078 . . . . 0.0 112.622 174.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 65.2 t80 -61.51 -9.14 5.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -95.76 -1.66 49.34 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.725 -0.61 . . . . 0.0 112.226 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.832 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.2 OUTLIER -97.04 134.85 22.38 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.542 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.2 Cg_exo -65.11 151.74 84.61 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.271 2.647 . . . . 0.0 113.007 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 27.5 m-85 -62.97 118.8 8.31 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.204 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.71 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 7.8 mt-30 -115.79 111.89 21.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.459 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CD1' HD11 ' A' ' 97' ' ' ILE . 93.9 m-85 -116.0 155.34 28.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.142 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.093 ' HB2' HG23 ' A' ' 10' ' ' VAL . 43.4 mt-10 -126.78 91.07 3.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 162.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 97' ' ' ILE . 10.6 mt -77.2 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.8 m -111.19 107.18 16.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.303 176.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.934 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -113.54 150.35 33.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 CA-C-O 122.153 0.977 . . . . 0.0 111.131 176.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.9 tt0 -103.51 105.63 15.93 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 172.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.6 m -70.57 126.44 29.63 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.658 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -87.04 -25.71 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -165.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.702 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 44.6 mt-10 -147.47 167.9 23.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.908 174.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -74.72 142.42 44.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.054 HD11 ' HE1' ' A' ' 101' ' ' TYR . 0.4 OUTLIER -107.21 156.38 18.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.879 -168.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.607 ' N ' HD13 ' A' ' 34' ' ' LEU . 15.2 m -115.38 -35.99 4.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.711 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 23.1 tt0 -104.3 -166.32 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -172.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.711 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.3 p-10 -101.19 138.67 37.91 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 121.641 -0.662 . . . . 0.0 111.416 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.45 128.99 35.22 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.19 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 32.7 tt0 -104.03 90.4 3.59 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' SER . 14.8 m95 -86.84 109.5 19.33 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 1.104 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.4 OUTLIER -118.51 160.26 22.06 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.992 173.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.882 HD12 ' HB3' ' A' ' 76' ' ' ALA . 48.8 mt -101.68 108.71 24.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.713 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 2.2 mp -98.2 105.62 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.757 ' CE1' HG11 ' A' ' 113' ' ' VAL . 40.4 t80 -90.67 109.07 20.25 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.642 HG11 HD23 ' B' ' 126' ' ' LEU . 40.5 t -65.19 98.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.497 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.34 42.75 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 171.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.78 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 16.8 p -85.63 87.5 7.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.982 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' B' ' 126' ' ' LEU . . . -84.1 -13.89 51.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -100.49 -36.6 9.14 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.439 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.667 ' C ' ' HB2' ' A' ' 47' ' ' SER . 50.6 m -103.64 -154.45 0.5 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.39 5.07 0.45 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -94.92 -8.25 37.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.78 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 19.5 m-85 -98.18 11.07 39.0 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -170.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -64.32 99.08 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.082 0.944 . . . . 0.0 110.314 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -95.76 169.64 9.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.511 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.488 HG11 ' HE2' ' A' ' 41' ' ' LYS . 23.5 t -127.94 112.42 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -172.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 44' ' ' TYR . 3.3 mm? -77.51 -52.04 9.74 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.863 -175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 35.0 t70 -168.46 153.8 6.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.061 173.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 1.104 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 21.3 p -124.79 120.46 31.8 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG13 ' HD1' ' A' ' 40' ' ' TRP . 4.4 p -101.87 139.06 23.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.736 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.61 105.35 14.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.293 0.568 . . . . 0.0 111.601 -173.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 21.9 t -116.24 110.84 32.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -97.48 -112.63 3.03 Favored Glycine 0 CA--C 1.487 -1.711 0 C-N-CA 118.665 -1.731 . . . . 0.0 113.417 -159.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.895 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 17.5 Cg_endo -58.71 115.9 2.87 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 121.071 1.181 . . . . 0.0 109.961 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 63' ' ' GLY . 27.5 m -130.31 122.38 19.99 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.987 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.88 126.84 18.15 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.999 1.799 . . . . 0.0 111.021 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -41.02 134.14 2.05 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.05 0.844 . . . . 0.0 112.004 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 136.41 135.16 3.38 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.884 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.3 ptt180 -66.28 139.1 58.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.604 0.716 . . . . 0.0 110.46 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 11.0 p80 -166.39 151.23 7.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.392 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.655 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 2.1 ttp -107.9 137.81 45.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.341 0.591 . . . . 0.0 111.627 -174.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.671 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.3 p90 -125.69 150.67 47.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.719 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.5 p -105.37 135.12 44.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.8 0.81 . . . . 0.0 110.754 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.671 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.7 t80 -135.47 118.95 16.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.449 -166.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -130.35 154.29 47.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.51 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.882 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -155.33 153.33 30.34 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.0 p-10 -64.35 -171.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.933 0.873 . . . . 0.0 113.137 -170.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -86.09 142.96 36.55 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.299 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.687 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.7 Cg_exo -57.76 149.36 69.25 Favored 'Trans proline' 0 CA--C 1.502 -1.123 0 C-N-CA 124.116 3.21 . . . . 0.0 112.824 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 9.8 t-20 -59.56 119.01 36.24 Favored Pre-proline 0 N--CA 1.428 -1.538 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.367 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.19 -10.99 22.97 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.996 2.464 . . . . 0.0 111.498 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.09 -8.81 58.7 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 33.7 mt -96.82 -17.38 20.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.549 0.214 . . . . 0.0 111.555 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 25.3 mt -88.48 129.29 49.78 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.293 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 2.5 Cg_endo -77.5 146.68 24.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.652 2.902 . . . . 0.0 111.625 170.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.638 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 3.1 m-20 -47.75 -40.3 20.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.278 1.431 . . . . 0.0 113.621 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.85 -29.95 58.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.605 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 29.8 m-20 -89.16 -21.58 23.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.807 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.34 -49.36 19.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 121.086 0.47 . . . . 0.0 111.86 -174.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.41 47.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.598 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.73 -128.89 1.13 Allowed Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.194 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.641 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.04 138.28 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.516 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -147.64 166.26 27.94 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.853 HG12 HD23 ' A' ' 96' ' ' LEU . 5.5 t -126.77 131.85 70.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.049 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 42' ' ' ILE . 2.1 p -106.23 106.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.272 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -104.2 132.74 50.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 -174.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.715 ' HB ' HG12 ' A' ' 109' ' ' VAL . 50.8 mt -94.48 102.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.767 HG22 ' HG3' ' A' ' 108' ' ' ARG . 17.8 p -95.73 109.47 21.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.946 ' SG ' HG23 ' A' ' 107' ' ' ILE . 3.2 m -81.02 111.98 17.99 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.65 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 19.3 m -108.7 111.88 23.89 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.421 -170.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 1.054 ' HE1' HD11 ' A' ' 34' ' ' LEU . 60.8 t80 -117.49 120.67 38.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.702 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 54.7 mtp180 67.87 25.12 7.9 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.204 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.46 8.45 87.04 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.417 ' HB2' HD12 ' A' ' 151' ' ' ILE . 2.3 mt-30 -113.06 115.05 27.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.844 -0.678 . . . . 0.0 109.373 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 28.2 mp0 -78.99 118.64 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.693 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 36.3 p90 -105.63 -5.85 19.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.946 HG23 ' SG ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -160.57 161.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 121.433 -0.792 . . . . 0.0 109.584 173.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.767 ' HG3' HG22 ' A' ' 98' ' ' THR . 12.2 ttm180 -149.48 97.6 2.66 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.831 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -86.48 100.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.696 175.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 83.83 1.59 Allowed Glycine 0 CA--C 1.488 -1.633 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.227 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.891 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -76.13 118.13 18.56 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.78 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.546 ' HB3' HD12 ' A' ' 140' ' ' LEU . 4.2 m-85 -68.28 115.54 7.84 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.53 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.757 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.0 p -101.99 112.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.641 ' ND2' HG13 ' A' ' 92' ' ' VAL . 1.7 t-20 -95.39 126.13 40.48 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.274 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 55.5 m-80 -113.33 108.47 17.28 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.929 0.871 . . . . 0.0 109.107 -169.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -125.18 137.94 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.042 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.534 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 39.7 m-85 -51.59 149.38 4.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 42.7 p -100.4 -24.24 14.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.495 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.841 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 18.7 mm-40 -81.28 120.49 24.98 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.743 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 29.1 m -45.94 -40.65 10.56 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.83 0.706 . . . . 0.0 112.058 -169.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.32 -37.49 77.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.351 0.596 . . . . 0.0 110.372 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -71.2 -28.68 64.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.094 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 51.5 mtt180 -70.02 -42.04 73.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.2 mm-40 -58.02 -42.84 86.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.039 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.431 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 4.1 p30 -152.17 87.66 4.23 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.68 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.6 Cg_endo -56.24 115.71 2.66 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.435 2.757 . . . . 0.0 112.509 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.19 151.25 85.76 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.76 2.307 . . . . 0.0 111.282 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.9 -27.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.679 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -91.63 127.58 49.79 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.626 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.638 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.0 Cg_exo -77.29 127.79 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.764 2.976 . . . . 0.0 111.556 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 134' ' ' LYS . 10.2 t70 -111.8 108.68 18.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.67 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 22.5 m-85 -77.19 -16.42 59.1 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.086 -171.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.5 t -82.62 -19.93 37.35 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.334 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.841 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.0 mmtt -107.33 15.08 25.36 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.494 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 16.3 tp -98.1 149.99 21.91 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.115 -171.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 1.6 tt0 -127.88 121.5 30.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.877 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -84.02 104.0 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.573 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 14.6 t30 -92.91 103.48 15.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.761 HG21 HG11 ' A' ' 11' ' ' VAL . 1.4 mp -81.79 104.15 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 112' ' ' TYR . 85.1 mt -64.74 86.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.686 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.891 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -71.83 -11.56 60.86 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.06 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -22.83 60.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.988 173.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -129.69 71.15 82.17 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.312 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.68 104.78 1.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.473 1.449 . . . . 0.0 109.933 167.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.628 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -81.15 81.68 7.28 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.656 HG12 HG23 ' A' ' 109' ' ' VAL . 16.1 m -81.94 117.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.299 0.571 . . . . 0.0 110.864 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.408 HG22 ' CE2' ' A' ' 149' ' ' PHE . 21.7 m -126.02 106.32 9.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.738 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -114.74 146.16 41.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.258 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.41 170.4 14.23 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.885 -173.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -103.74 115.04 29.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.246 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.9 pt -119.39 166.66 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.638 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -95.51 100.26 12.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.548 1.166 . . . . 0.0 111.013 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.768 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 19.4 m95 -73.01 -6.65 46.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.896 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.43 -1.458 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.068 -174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.471 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.5 mmtt . . . . . 0 CA--C 1.52 -0.184 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.11 -52.28 21.11 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.63 0.581 . . . . 0.0 111.806 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 9.7 tt -63.95 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.699 0.285 . . . . 0.0 111.186 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.425 HE21 ' HB3' ' B' ' 125' ' ' GLN . 9.0 mm100 -63.88 -47.86 78.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.263 0.554 . . . . 0.0 111.029 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.642 HD23 HG11 ' A' ' 45' ' ' VAL . 43.3 mt -65.24 -46.17 81.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.825 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.18 -40.72 77.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.971 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 57.1 mtp180 -52.41 -52.59 53.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 111.457 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -62.68 -37.48 86.6 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.596 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 145' ' ' ARG . 13.0 mt -74.11 -51.6 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.073 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.505 -177.01 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.896 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.86 -17.33 28.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.28 -178.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.602 HG23 HD21 ' A' ' 34' ' ' LEU . 3.2 t -140.62 129.75 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.733 . . . . 0.0 111.289 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 23.0 tp60 -121.99 99.05 6.23 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 171.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -77.4 143.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.518 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.427 HD21 ' CB ' ' A' ' 29' ' ' GLU . 28.0 m-80 -123.77 -65.98 1.03 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.173 -164.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.674 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -104.4 152.3 22.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.471 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.8 p -145.77 99.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.101 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.3 101.38 12.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.826 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -76.96 115.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.042 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.553 HD11 HG23 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -88.51 -38.72 14.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.524 -175.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.69 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.97 79.44 0.91 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.559 168.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -106.14 176.02 1.85 Allowed Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 111.371 -2.649 . . . . 0.0 106.38 170.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.86 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.1 Cg_endo -48.65 102.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.892 1.711 . . . . 0.0 113.291 -154.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.655 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.9 m -137.04 171.87 7.88 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 111.926 -2.397 . . . . 0.0 108.593 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 56.1 Cg_exo -39.94 139.09 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.828 2.352 . . . . 0.0 112.25 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.832 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 35.7 t80 -60.16 -27.57 67.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.705 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -83.58 -13.7 53.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.286 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -62.28 128.05 90.58 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.676 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.3 Cg_exo -68.0 153.82 74.22 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 123.772 2.981 . . . . 0.0 113.266 -172.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 19.6 m-85 -65.26 122.68 17.68 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.061 0.458 . . . . 0.0 109.961 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.763 ' HA ' ' HG3' ' A' ' 75' ' ' GLN . 19.7 mt-30 -127.07 92.91 3.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.48 -172.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CD1' HD11 ' A' ' 97' ' ' ILE . 92.2 m-85 -103.39 126.07 50.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.101 ' HB3' HG23 ' A' ' 10' ' ' VAL . 32.7 tt0 -105.44 87.25 2.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.759 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 3.3 mt -80.04 133.02 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.85 0.833 . . . . 0.0 112.192 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.1 m -109.73 104.74 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.193 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.749 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 17.8 p90 -118.3 146.44 44.32 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.958 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.6 tt0 -105.56 116.81 32.57 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -73.26 110.83 7.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -76.78 -29.49 17.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.05 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.896 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 5.8 mt-10 -149.54 147.51 28.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -52.82 133.31 37.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.762 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -87.66 157.23 19.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.578 -172.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -112.89 -34.41 5.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.946 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.714 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.1 tt0 -124.07 -167.88 1.71 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.714 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.93 145.01 24.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.499 0.666 . . . . 0.0 110.758 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.7 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -92.7 121.96 34.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.312 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 25.6 tt0 -102.58 93.51 5.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.626 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.759 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 23.0 m95 -84.33 111.44 19.42 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.753 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 31.2 ttmt -115.81 143.06 45.94 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.958 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.546 HG21 HD22 ' A' ' 57' ' ' LEU . 10.9 mt -102.95 106.8 20.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.469 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.541 HD12 ' HG2' ' A' ' 41' ' ' LYS . 3.0 mp -105.73 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.29 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.755 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.2 t80 -91.69 120.02 32.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.561 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' B' ' 126' ' ' LEU . 24.0 t -58.37 101.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 110.095 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.18 -37.24 94.27 Favored Glycine 0 CA--C 1.506 -0.512 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.109 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.75 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 66.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.03 54.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.198 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.09 -23.97 21.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 51.9 m -117.2 -154.91 0.57 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.85 164.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -134.0 -33.89 1.02 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.659 0.266 . . . . 0.0 110.913 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 51' ' ' GLU . 29.3 mt-10 -71.43 -3.93 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CD1' ' HB2' ' A' ' 47' ' ' SER . 96.8 m-85 -85.98 -1.86 57.73 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.446 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.22 111.85 0.54 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.133 0.968 . . . . 0.0 110.481 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 1.5 mt-30 -93.4 168.6 10.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.716 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.03 113.28 36.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.459 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 42' ' ' ILE . 10.9 mp -74.54 -50.32 18.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.499 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -170.83 -177.93 2.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.663 -177.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.589 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 36.1 p -152.69 124.32 7.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -100.54 135.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.0 mt -110.69 105.41 14.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.01 0.433 . . . . 0.0 110.573 -176.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.42 119.11 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -74.67 -164.21 11.41 Favored Glycine 0 CA--C 1.499 -0.911 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.385 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.762 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 53.4 Cg_endo -66.14 115.42 3.46 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.298 1.332 . . . . 0.0 110.194 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.592 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.4 m -123.04 138.4 29.71 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.849 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.41 78.18 2.55 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.363 2.042 . . . . 0.0 113.83 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.581 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 52.26 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.641 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 106.07 137.96 8.99 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.658 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.958 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 6.2 ptt180 -76.14 127.1 32.24 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.997 0.903 . . . . 0.0 109.474 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.552 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 22.5 m-70 -123.65 135.25 53.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.683 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.1 ttp -109.22 99.56 8.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 5.8 p90 -108.67 142.31 39.35 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.694 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 3.4 p -104.96 130.55 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.492 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.643 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 5.1 t80 -132.86 132.04 41.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.817 -159.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.763 ' HG3' ' HA ' ' A' ' 23' ' ' GLN . 22.1 mp0 -145.28 156.05 43.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.106 0.479 . . . . 0.0 110.57 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.46 32.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.047 -0.978 . . . . 0.0 108.375 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.7 178.4 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.652 0.739 . . . . 0.0 112.28 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -68.76 159.94 79.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.199 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 57.4 Cg_endo -74.62 166.54 29.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.778 2.319 . . . . 0.0 110.503 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.564 ' HB2' HD12 ' A' ' 83' ' ' LEU . 3.7 m-20 -75.88 114.19 34.57 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.207 0.527 . . . . 0.0 111.161 -171.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 18.5 Cg_endo -64.33 -21.64 66.73 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.578 2.852 . . . . 0.0 112.131 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.38 -0.54 84.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.251 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 80' ' ' ASN . 35.0 mt -103.68 -20.57 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.571 0.224 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 27.9 mt -89.8 129.39 46.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.232 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 88' ' ' ASP . 88.1 Cg_endo -79.99 163.58 22.97 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.527 2.818 . . . . 0.0 111.732 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.669 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -45.64 -56.68 4.91 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.068 0.947 . . . . 0.0 113.268 -174.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -24.39 61.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 111.197 -167.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.548 ' CG ' ' HG2' ' A' ' 85' ' ' PRO . 1.4 m-20 -86.65 -24.97 25.09 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.476 -175.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.654 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -82.91 -46.87 12.44 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.016 -173.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -94.23 46.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-O 122.043 0.925 . . . . 0.0 111.275 -174.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.87 -124.71 0.8 Allowed Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.103 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.495 HG23 ' ND2' ' A' ' 114' ' ' ASN . 1.1 t -114.57 134.68 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 -168.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 169.93 17.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.461 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.67 HG23 HD13 ' B' ' 126' ' ' LEU . 3.5 t -127.17 152.31 35.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 118.37 0.532 . . . . 0.0 111.603 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.6 p -130.83 108.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.926 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.21 133.25 47.38 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.025 -172.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 33.9 mt -102.23 97.65 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.038 0.923 . . . . 0.0 108.797 174.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.805 HG22 ' HG3' ' A' ' 108' ' ' ARG . 49.4 p -91.72 114.11 26.56 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.258 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 61.4 m -81.99 105.69 13.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.919 0.866 . . . . 0.0 110.706 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.5 m -93.3 106.51 18.47 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.668 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.612 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 65.7 t80 -116.64 119.63 36.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.038 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.612 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.3 mtp180 64.88 23.71 12.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.2 -0.58 64.07 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.62 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.402 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -118.31 121.11 39.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 46.8 mt-10 -72.63 131.36 42.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.783 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.7 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.6 p90 -115.66 -1.85 12.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.1 tt -157.77 161.54 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 109.602 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.805 ' HG3' HG22 ' A' ' 98' ' ' THR . 17.7 ttm180 -150.71 95.78 2.27 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.926 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -83.15 100.36 6.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 118.776 -1.169 . . . . 0.0 108.558 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.503 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -87.78 78.65 1.79 Allowed Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.869 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.913 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -72.88 117.99 15.27 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.608 ' HB3' HD12 ' A' ' 140' ' ' LEU . 22.6 m-85 -67.55 130.34 42.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.9 p -112.02 111.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.652 ' HB3' ' ND2' ' A' ' 138' ' ' ASN . 3.9 t-20 -94.46 116.78 29.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.386 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.654 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -108.39 108.53 19.53 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -171.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -131.5 129.07 40.63 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.392 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.8 m-85 -39.55 150.09 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 136' ' ' GLN . 68.7 p -92.46 -28.66 16.7 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.167 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.963 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.4 mm-40 -84.4 117.31 23.54 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.216 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.738 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.7 m -53.07 -34.36 56.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.039 -172.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -32.03 72.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.687 0.756 . . . . 0.0 110.283 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.4 mt -76.96 -24.38 52.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.123 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 123' ' ' ARG . 24.2 mtp-105 -78.57 -31.79 47.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.2 mm-40 -61.57 -39.02 89.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.328 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 6.0 p30 -157.96 95.28 1.99 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.113 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 10.8 Cg_endo -53.8 118.37 4.86 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.528 2.152 . . . . 0.0 110.965 175.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.511 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 73.7 Cg_exo -53.02 144.39 46.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.101 1.867 . . . . 0.0 109.424 172.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.52 -27.34 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.101 -166.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 129' ' ' LYS . 10.0 tppt? -116.35 107.1 47.78 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.655 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.669 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 75.9 Cg_exo -40.27 139.84 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 125.242 3.962 . . . . 0.0 113.881 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -110.59 106.15 15.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.774 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.5 m-85 -74.47 -12.58 60.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.581 -171.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -89.36 -21.1 23.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.271 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.963 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 70.9 mmtt -100.01 10.84 40.64 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 115' ' ' ASN . 21.3 tp -95.38 133.12 39.68 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.522 -171.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.488 ' HB2' HG22 ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.31 123.56 49.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.832 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -103.26 108.32 19.49 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.874 -174.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.86 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p-10 -92.77 104.66 16.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.862 0.839 . . . . 0.0 109.475 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.687 HG21 HG11 ' A' ' 11' ' ' VAL . 1.3 mp -70.96 108.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 112' ' ' TYR . 88.8 mt -67.04 86.57 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.685 0.755 . . . . 0.0 110.7 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.913 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.9 -15.31 60.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.318 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 p -81.97 -1.45 48.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -141.56 64.64 19.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.7 Cg_endo -93.18 106.18 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.059 1.839 . . . . 0.0 111.362 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' B' ' 130' ' ' ILE . 16.4 tpt180 -77.61 81.93 4.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.451 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 109' ' ' VAL . 3.0 m -76.92 103.46 4.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.3 0.571 . . . . 0.0 110.501 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' CE2' ' A' ' 149' ' ' PHE . 35.2 m -116.49 106.09 13.21 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.615 0.722 . . . . 0.0 109.362 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.2 ptt-85 -118.96 154.44 33.02 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.782 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -138.07 168.49 19.61 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.931 -172.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.17 144.65 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.94 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.607 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 22.1 pt -133.99 -172.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.47 0.653 . . . . 0.0 109.936 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -98.31 92.7 5.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.38 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.622 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 15.2 m95 -78.46 -16.57 57.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.398 176.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.503 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 3.0 mp0 . . . . . 0 N--CA 1.433 -1.312 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.233 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.512 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 46.8 mmtm . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.88 -57.62 4.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.259 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.69 -35.62 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.292 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.8 mm100 -54.82 -51.74 64.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.826 0.822 . . . . 0.0 110.497 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.67 HD13 HG23 ' A' ' 94' ' ' VAL . 44.5 mt -66.22 -43.65 86.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.611 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.88 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.68 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 128' ' ' ARG . 18.6 mtp180 -60.09 -49.02 79.29 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.894 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -60.62 -41.78 95.53 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.935 0.398 . . . . 0.0 111.133 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.576 HD13 ' HB3' ' A' ' 145' ' ' ARG . 7.0 mt -75.25 -43.88 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.213 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 . . . . . 0 C--N 1.33 -0.243 0 O-C-N 123.607 0.567 . . . . 0.0 111.05 -176.263 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.809 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.55 -19.89 24.45 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.507 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 4.0 t -140.96 130.49 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.755 0.788 . . . . 0.0 111.526 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 20.8 tp60 -125.06 100.55 6.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.57 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -74.4 144.59 12.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.76 177.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -123.29 -66.52 1.0 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.469 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.5 t-20 -103.28 151.65 22.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.536 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.761 HG23 HG13 ' A' ' 26' ' ' ILE . 2.6 p -147.43 99.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.578 174.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.03 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -92.87 109.67 21.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.564 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.32 132.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -110.91 -68.8 0.91 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.733 0.777 . . . . 0.0 112.328 -162.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' HE21 ' A' ' 23' ' ' GLN . 1.9 m-20 -96.0 34.7 1.51 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.161 -162.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.715 ' HB3' ' NH2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -138.78 99.64 8.35 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 171.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 60.7 Cg_endo -124.99 92.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.27 1 C-N-CA 125.696 4.264 . . . . 0.0 106.139 108.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.663 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 7.5 m -153.83 168.98 10.65 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.188 -167.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 87.9 Cg_exo -38.3 132.26 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.814 2.343 . . . . 0.0 111.679 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.913 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 10.1 t80 -60.85 -22.19 63.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.401 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -84.87 -10.56 57.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.988 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.671 HD22 ' NH1' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -77.35 128.57 80.07 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 122.49 1.138 . . . . 0.0 108.728 167.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.65 152.83 32.44 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 124.76 3.64 . . . . 0.0 112.995 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HA ' HH21 ' A' ' 137' ' ' ARG . 27.1 m-85 -81.21 124.4 29.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.486 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 1.056 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.2 mp0 -113.32 114.07 26.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.682 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CG ' HD11 ' A' ' 97' ' ' ILE . 73.4 m-85 -120.97 114.41 21.48 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.03 ' HB3' HG23 ' A' ' 10' ' ' VAL . 33.1 tt0 -97.88 87.12 3.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.761 HG13 HG23 ' A' ' 9' ' ' VAL . 4.5 mp -82.63 140.51 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.929 0.871 . . . . 0.0 112.363 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 14.9 m -113.33 107.13 15.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.286 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.4 p90 -116.39 150.01 38.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.377 0.608 . . . . 0.0 109.565 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -105.42 112.21 25.22 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.481 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.682 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 4.2 t -72.97 108.16 5.72 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -73.76 -25.15 20.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.384 -174.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.809 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -152.8 158.0 41.61 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.409 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.6 129.16 40.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.508 . . . . 0.0 110.339 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.022 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -84.5 148.64 26.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.671 -170.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.527 ' N ' HD13 ' A' ' 34' ' ' LEU . 17.7 m -115.37 -25.99 7.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.893 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 35.8 tt0 -118.44 -163.41 0.95 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.893 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 8.8 m-20 -93.84 131.32 39.35 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.707 -0.621 . . . . 0.0 109.337 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.694 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.62 118.58 23.41 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 40.8 tt0 -102.31 127.61 49.22 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.585 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.9 m95 -115.72 127.52 55.2 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.7 ttmp? -123.71 146.54 48.19 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.053 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.62 HG21 HD22 ' A' ' 57' ' ' LEU . 44.1 mm -102.83 105.8 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.685 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.731 HD11 ' HD2' ' A' ' 41' ' ' LYS . 2.9 mp -103.1 110.8 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.584 ' CE2' HG11 ' A' ' 113' ' ' VAL . 32.2 t80 -95.86 110.78 22.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.256 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG11 HD23 ' B' ' 126' ' ' LEU . 22.9 t -61.53 101.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.425 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -74.34 -42.94 33.07 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.757 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 27.8 p -95.44 99.65 11.52 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' B' ' 122' ' ' LYS . . . -90.98 -5.07 55.91 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 161.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -99.83 -48.75 4.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.607 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.591 ' C ' ' HB2' ' A' ' 47' ' ' SER . 38.7 m -98.56 -157.43 0.6 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 170.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HB3' HE22 ' B' ' 125' ' ' GLN . 12.9 pt-20 -143.42 -25.91 0.58 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.319 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -79.42 2.81 20.44 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.757 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 9.6 m-30 -88.51 -1.63 58.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.554 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -47.6 109.59 0.23 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.617 0.722 . . . . 0.0 110.536 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.695 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 55.2 mt-30 -91.58 166.04 13.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.812 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.51 112.1 28.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.286 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 42' ' ' ILE . 8.3 mp -82.18 -56.87 3.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.901 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.12 161.37 42.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.355 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.0 p -146.46 114.98 6.76 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.27 138.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 10.7 mt -110.88 103.2 11.68 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.107 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -97.2 122.79 49.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.3 -158.56 9.7 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.331 -162.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.022 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.6 Cg_endo -65.35 116.75 4.06 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.444 1.429 . . . . 0.0 110.097 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 63' ' ' GLY . 24.5 m -126.22 150.49 70.0 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.35 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.04 138.78 44.89 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.746 2.297 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -43.86 144.58 0.84 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.324 0.583 . . . . 0.0 112.138 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 134.03 126.97 2.7 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -174.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.891 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.4 ptt180 -70.93 130.79 42.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.375 1.083 . . . . 0.0 110.794 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.518 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 9.0 p80 -150.82 151.1 31.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.151 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -107.36 138.45 43.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.455 -172.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 6.2 p90 -139.51 152.27 46.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.2 p -111.51 107.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 122.647 1.213 . . . . 0.0 111.339 -169.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.2 t80 -108.91 121.45 45.14 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.637 -170.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 1.056 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 33.4 mt-30 -119.81 166.43 13.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.245 -172.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.73 132.6 6.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.848 0.295 . . . . 0.0 111.644 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.92 156.69 35.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.55 152.13 36.2 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.601 ' HD3' HD21 ' A' ' 57' ' ' LEU . 55.5 Cg_endo -72.38 177.4 7.39 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.853 3.035 . . . . 0.0 112.236 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -73.69 116.88 56.08 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.436 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.24 1.08 3.79 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 123.67 2.913 . . . . 0.0 112.654 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.51 -15.18 28.01 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.695 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 61.4 mt -97.86 -8.87 27.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.525 -0.837 . . . . 0.0 110.926 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.49 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 22.6 mt -96.07 129.6 33.5 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.051 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 3.4 Cg_exo -77.43 155.35 32.18 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.357 2.705 . . . . 0.0 111.673 169.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.764 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.1 p30 -47.52 -47.25 27.86 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.06 -28.13 68.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.423 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 10.7 m-20 -98.58 -21.78 16.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.429 -173.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -81.33 -46.5 14.61 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.242 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.753 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -95.25 46.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.468 0.652 . . . . 0.0 112.247 -174.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.7 -129.62 1.38 Allowed Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.075 -172.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.666 HG13 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -98.27 135.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -168.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.48 167.86 28.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.368 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.656 HG12 HD23 ' A' ' 96' ' ' LEU . 69.4 t -118.66 128.7 75.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.354 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.19 106.51 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.769 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -105.75 148.43 27.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.056 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.795 ' HB ' HG12 ' A' ' 109' ' ' VAL . 45.6 mt -106.98 108.29 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 121.313 0.577 . . . . 0.0 109.528 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.857 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 41.8 p -101.92 114.25 28.18 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.189 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 64.1 m -79.32 158.0 27.58 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.282 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -151.14 119.68 6.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -167.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.772 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 34.6 t80 -138.29 124.14 19.97 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.615 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 61.1 mtp180 65.31 32.87 9.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.386 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.97 83.44 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.574 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -114.28 132.23 56.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.15 0.5 . . . . 0.0 110.068 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 31.7 mt-10 -93.89 130.12 40.07 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.146 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.694 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.7 p90 -118.44 -1.17 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -164.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.857 ' O ' ' HA ' ' A' ' 98' ' ' THR . 5.4 tt -156.47 160.29 2.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 120.883 -1.136 . . . . 0.0 109.388 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.661 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 13.5 ttp180 -148.08 102.22 3.36 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 123.93 0.769 . . . . 0.0 109.433 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.795 HG12 ' HB ' ' A' ' 97' ' ' ILE . 3.6 p -89.95 101.26 12.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.723 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.18 92.05 1.78 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 119.613 -1.279 . . . . 0.0 112.136 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.77 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 8.7 m-85 -83.95 126.09 32.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.895 -0.652 . . . . 0.0 109.943 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.5 m-85 -68.24 112.12 4.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.962 176.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.9 p -93.89 111.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.666 HD21 HG13 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -101.63 104.42 15.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.013 -176.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.6 m-80 -94.3 110.27 22.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.255 -172.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.14 128.03 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.645 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.6 m-85 -39.29 154.12 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.5 p -98.19 -26.15 14.65 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.253 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.411 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 26.6 mm-40 -78.64 120.99 24.11 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.8 m -54.33 -32.02 55.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.543 -169.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -70.61 -36.17 73.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.682 0.753 . . . . 0.0 109.572 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 65.9 mt -74.88 -25.85 59.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.213 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 32.7 mtt180 -70.96 -36.7 72.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.995 0.903 . . . . 0.0 108.787 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 120' ' ' THR . 44.0 mm-40 -69.39 -40.92 77.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.972 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.0 p30 -146.51 91.06 5.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 0.0 111.218 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.6 Cg_endo -56.41 114.97 2.15 Favored 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 122.831 2.354 . . . . 0.0 111.244 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.534 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 50.9 Cg_exo -56.32 160.08 11.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.432 2.088 . . . . 0.0 111.072 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.508 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 11.7 p -51.25 -36.58 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -166.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.518 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 4.8 mmtt -116.19 116.0 40.09 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-O 121.896 0.855 . . . . 0.0 111.745 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.764 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_exo -47.4 141.74 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 125.018 3.812 . . . . 0.0 113.952 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -111.64 109.94 20.08 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 170.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.745 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 18.4 m-85 -70.93 -15.49 62.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.649 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -87.39 -17.81 31.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.641 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 47.7 mmtm -101.91 1.56 37.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.502 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 20.7 tp -86.63 139.79 30.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.125 -171.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 2.8 tt0 -121.34 116.61 25.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.913 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 4.2 mtp-105 -80.39 101.33 8.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -97.48 106.83 19.21 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.637 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 12.3 mt -95.6 114.11 31.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.945 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 112' ' ' TYR . 28.0 mt -73.54 90.05 1.73 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.329 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.77 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -75.45 -9.72 58.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.494 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 p -85.06 -3.37 58.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.679 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -137.12 70.44 55.94 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.584 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.4 Cg_endo -91.28 109.66 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.883 2.389 . . . . 0.0 112.07 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.403 ' CB ' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.36 81.38 7.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 109' ' ' VAL . 16.1 m -71.71 129.29 35.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.152 0.501 . . . . 0.0 111.301 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.547 HG21 HH21 ' A' ' 108' ' ' ARG . 63.5 m -141.09 105.4 4.83 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.736 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -118.52 143.95 46.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.883 0.849 . . . . 0.0 110.836 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HD1' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -125.36 168.42 13.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.715 -178.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.89 151.03 22.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.005 0.431 . . . . 0.0 111.107 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.772 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 27.9 pt -135.75 172.34 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.532 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -94.69 86.56 4.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.545 1.164 . . . . 0.0 111.059 -178.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 35.2 m95 -64.52 -16.61 62.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.556 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.592 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -48.33 -48.47 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.073 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tt -67.69 -39.83 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.196 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.519 HE22 ' HB3' ' A' ' 51' ' ' GLU . 3.5 mm100 -63.41 -37.4 87.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 89.4 mt -67.23 -43.57 81.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.276 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.72 72.77 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.959 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.36 -47.05 86.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.14 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.9 -43.44 83.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.382 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.661 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 69.7 mt -68.04 -16.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.397 0.618 . . . . 0.0 110.645 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 20.8 tpt85 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.875 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.63 ' HG2' ' CD2' ' A' ' 153' ' ' TRP . 33.3 mmtt -99.9 -7.56 25.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.436 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.7 t -146.1 128.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.113 0.482 . . . . 0.0 110.575 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.604 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 24.0 tp60 -125.09 103.98 8.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.532 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.738 HG23 ' CH2' ' A' ' 40' ' ' TRP . 2.3 t -65.78 128.85 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.884 0.849 . . . . 0.0 109.092 171.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.4 HD21 ' CB ' ' A' ' 29' ' ' GLU . 81.8 m-20 -118.33 -54.33 2.29 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.852 -170.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.821 HD21 HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -104.96 128.9 53.43 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.116 -174.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.758 ' N ' HD22 ' A' ' 8' ' ' ASN . 2.2 t -129.11 99.53 4.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.403 169.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.946 HG23 ' HB3' ' A' ' 25' ' ' GLU . 1.5 m -95.4 101.37 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.444 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.982 HG11 HG21 ' A' ' 139' ' ' ILE . 2.5 t -83.99 117.88 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.325 1.06 . . . . 0.0 108.851 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -86.33 -36.09 19.47 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.341 -175.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 36.7 t0 -74.14 58.28 0.69 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.982 168.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.571 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -82.44 174.48 6.01 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 113.139 -1.846 . . . . 0.0 106.376 160.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.747 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.0 Cg_endo -49.91 103.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.82 1.686 . . . . 0.0 113.065 -153.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.646 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 15.7 m -139.33 171.16 8.47 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.428 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.2 Cg_exo -40.64 132.49 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.458 2.105 . . . . 0.0 111.941 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.771 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 36.6 t80 -57.96 -27.1 63.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.266 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 18.9 m-85 -87.06 -3.3 59.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.139 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -76.24 125.56 87.64 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 164.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.587 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 38.5 Cg_exo -62.89 150.58 87.98 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 123.264 2.643 . . . . 0.0 112.855 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.6 m-85 -62.65 103.55 0.43 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.804 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.635 ' H ' ' CB ' ' A' ' 13' ' ' ASP . 33.6 mt-30 -106.91 103.02 12.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.237 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 97' ' ' ILE . 82.9 m-85 -104.57 155.6 18.69 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.946 ' HB3' HG23 ' A' ' 10' ' ' VAL . 12.7 tt0 -130.51 87.34 2.49 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.523 ' CG2' HG22 ' A' ' 6' ' ' VAL . 23.3 mt -78.06 138.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.782 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.743 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 5.5 m -119.29 109.78 16.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.254 171.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.679 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 19.2 p90 -112.27 140.74 46.73 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.561 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.944 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.0 tt0 -101.75 114.82 29.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.5 m -72.2 113.4 9.19 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -73.83 -24.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.109 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.516 -173.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 40.0 mt-10 -150.78 164.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.81 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.46 133.72 50.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.2 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.063 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -95.5 152.57 18.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.112 -172.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.503 ' N ' HD13 ' A' ' 34' ' ' LEU . 11.8 p -115.58 -33.11 5.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.707 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.9 tt0 -108.17 -163.13 0.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -173.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.707 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 12.4 m-20 -89.73 163.12 15.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.604 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -114.58 119.78 37.94 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.1 mp0 -91.19 126.73 36.36 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.017 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.738 ' CH2' HG23 ' A' ' 6' ' ' VAL . 53.5 m95 -120.36 125.81 48.94 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.844 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.1 ttmt -128.72 143.67 50.98 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.649 -173.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.723 HG22 HG22 ' A' ' 95' ' ' VAL . 12.8 mt -103.69 106.98 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.844 HD11 ' HD2' ' A' ' 41' ' ' LYS . 74.0 mt -107.12 106.8 21.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.739 0.781 . . . . 0.0 109.987 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' HG11 ' A' ' 113' ' ' VAL . 58.3 t80 -90.62 131.67 36.19 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.743 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.94 101.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.578 0.704 . . . . 0.0 110.639 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.08 -40.22 97.93 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.548 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.891 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 89.8 p -132.57 118.66 19.49 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.663 0.268 . . . . 0.0 110.854 172.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HB3' ' NZ ' ' B' ' 122' ' ' LYS . . . -78.21 -3.62 43.6 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 163.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -99.44 -17.09 18.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.769 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 53.2 m -131.41 -148.33 0.35 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.87 -32.7 0.27 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 118.854 0.752 . . . . 0.0 112.507 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.84 1.35 20.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.891 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 3.2 m-30 -82.35 -17.7 44.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.311 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p-10 -42.38 115.62 0.72 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 111.895 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' CG ' HD12 ' A' ' 83' ' ' LEU . 12.4 mp0 -92.7 165.62 12.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.04 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 HG12 ' A' ' 43' ' ' ILE . 37.5 t -130.24 110.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.4 mm? -79.52 -40.33 29.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.618 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 21.1 t70 -174.43 157.8 2.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 21.0 p -140.12 117.44 11.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.3 p -98.65 141.2 16.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.764 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.487 ' CD1' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -110.63 104.96 13.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.882 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 94.5 t -83.37 154.16 3.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -96.48 -162.41 32.73 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 118.633 -1.746 . . . . 0.0 112.456 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.063 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 45.0 Cg_endo -66.3 118.92 5.91 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.928 1.752 . . . . 0.0 109.91 173.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' H ' ' CB ' ' A' ' 34' ' ' LEU . 35.8 m -121.15 131.94 24.34 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.398 -173.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.07 138.26 51.46 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.486 2.124 . . . . 0.0 110.789 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -40.58 141.5 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.063 0.852 . . . . 0.0 112.433 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.05 149.24 7.51 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.944 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 9.4 ptt180 -75.72 143.63 41.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.028 0.918 . . . . 0.0 111.157 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.581 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 91.6 m-70 -137.85 136.09 36.82 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.607 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.31 123.8 48.6 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.608 0.718 . . . . 0.0 110.763 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.67 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.6 p90 -127.97 144.12 51.1 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.365 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 p -105.42 125.9 60.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.109 0.956 . . . . 0.0 110.213 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.67 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 7.3 t80 -126.6 113.1 16.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.025 -162.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.2 mt-30 -130.55 154.25 48.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -158.13 154.32 27.26 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.31 -174.93 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.839 0.828 . . . . 0.0 113.056 -171.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -81.94 150.49 65.44 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.476 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.771 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 46.7 Cg_exo -62.77 173.75 3.48 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 123.389 2.726 . . . . 0.0 112.495 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.3 m-20 -81.8 115.6 58.14 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.525 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.08 -9.69 26.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.267 2.645 . . . . 0.0 112.236 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 6.46 64.98 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.698 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.491 HD12 ' CG ' ' A' ' 55' ' ' GLN . 10.3 mt -108.9 -37.68 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.548 0.213 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 49.3 mt -69.57 130.08 90.87 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 73.2 Cg_endo -79.69 161.62 24.61 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 0.0 112.468 171.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.609 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.0 OUTLIER -46.31 -52.74 12.12 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.787 0.835 . . . . 0.0 112.974 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . . . -75.0 -23.03 58.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.983 -170.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.765 ' HA ' ' HZ1' ' B' ' 122' ' ' LYS . 12.9 t0 -82.68 -27.3 31.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 0.0 110.591 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 130' ' ' PRO . . . -73.94 -40.4 63.1 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.759 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.38 44.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 114' ' ' ASN . . . -174.77 -129.56 1.2 Allowed Glycine 0 CA--C 1.496 -1.113 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.992 -173.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.756 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -103.04 120.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.187 0.994 . . . . 0.0 113.433 -165.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.863 ' HB ' HG13 ' A' ' 113' ' ' VAL . 5.2 m -135.35 169.12 17.97 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.488 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.556 HG12 HD23 ' A' ' 96' ' ' LEU . 8.3 t -130.89 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 118.049 0.386 . . . . 0.0 110.638 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.723 HG22 HG22 ' A' ' 42' ' ' ILE . 7.6 p -131.78 107.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.876 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -97.26 130.21 44.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.664 -168.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.759 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 49.1 mt -95.36 93.75 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.794 HG22 ' HG3' ' A' ' 108' ' ' ARG . 32.4 p -92.35 112.94 25.07 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.677 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.05 ' SG ' HG22 ' A' ' 107' ' ' ILE . 23.5 p -75.52 159.14 31.61 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 28.2 m -150.95 103.65 3.08 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -171.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.996 ' HE2' HD11 ' A' ' 34' ' ' LEU . 51.0 t80 -118.9 125.52 49.68 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 16.4 mmt180 67.18 14.46 9.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.898 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.26 4.55 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.595 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.73 138.22 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 6.8 mt-10 -87.45 127.62 35.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.539 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.604 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.9 p90 -116.95 1.73 12.66 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.05 HG22 ' SG ' ' A' ' 99' ' ' CYS . 4.8 tt -154.44 153.98 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.381 -0.825 . . . . 0.0 109.2 167.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.94 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 4.1 ttm-85 -143.63 91.2 2.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.582 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.907 HG23 HG12 ' A' ' 146' ' ' VAL . 0.5 OUTLIER -83.39 100.95 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.266 1.031 . . . . 0.0 108.294 175.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA3' HD11 ' B' ' 130' ' ' ILE . . . -89.72 81.73 1.43 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.791 -1.195 . . . . 0.0 111.158 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.533 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 27.4 m-85 -69.73 115.1 8.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.663 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.4 m-85 -66.93 111.37 3.75 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.863 HG13 ' HB ' ' A' ' 93' ' ' THR . 1.5 p -91.47 109.33 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.756 ' ND2' HG13 ' A' ' 92' ' ' VAL . 1.7 t-20 -96.7 113.66 25.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.431 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.529 ' HB3' HD11 ' A' ' 135' ' ' LEU . 57.6 m-80 -101.82 108.84 20.46 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.861 0.839 . . . . 0.0 109.151 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.16 132.46 39.85 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.814 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.663 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 50.6 m-85 -49.01 155.5 0.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -172.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.556 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 18.3 p -92.27 -28.89 16.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.257 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.577 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 21.7 mm-40 -80.81 122.96 27.84 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.298 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.589 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 21.2 m -51.75 -34.09 37.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.336 -170.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.23 -37.33 80.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.652 0.739 . . . . 0.0 109.438 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 55.8 mt -78.77 -19.28 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.551 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 45.9 mtt180 -77.58 -35.11 53.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.7 mm-40 -74.45 -38.08 63.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.438 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.2 p30 -142.3 83.23 12.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 110.441 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 16.3 Cg_endo -57.39 114.97 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.141 2.561 . . . . 0.0 111.918 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.658 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 34.7 Cg_exo -62.72 142.77 90.54 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.0 110.347 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 128' ' ' VAL . 7.5 t -55.94 -32.84 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.511 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.3 mmtt -79.4 133.09 60.56 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 121.132 0.491 . . . . 0.0 110.875 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.609 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 6.4 Cg_endo -77.45 129.32 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.588 2.859 . . . . 0.0 112.433 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.2 t70 -125.63 108.03 11.16 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.885 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.715 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.5 m-85 -78.5 -16.83 57.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.273 1.035 . . . . 0.0 110.579 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.413 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 31.0 t -83.11 -27.95 29.81 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.301 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.577 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 71.9 mmtt -100.8 11.62 39.19 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.3 tp -94.55 129.08 41.5 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.885 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.556 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 3.2 tt0 -112.72 120.06 40.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.747 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.06 107.12 19.44 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.639 -174.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 16.5 t30 -78.74 102.88 8.32 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.828 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.982 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -76.89 105.83 6.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.911 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 112' ' ' TYR . 83.9 mt -67.11 90.99 0.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.757 0.789 . . . . 0.0 111.336 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.533 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.21 -19.51 43.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.454 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 p -80.14 -17.32 52.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.949 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 16.9 m120 -131.31 61.5 59.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.709 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.72 116.5 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.81 1.673 . . . . 0.0 111.058 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.682 ' HG3' HG12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.84 81.11 7.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.387 0.613 . . . . 0.0 109.942 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.907 HG12 HG23 ' A' ' 109' ' ' VAL . 19.4 m -89.36 137.39 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.771 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.5 m -149.18 108.76 4.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.487 0.661 . . . . 0.0 110.008 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -101.64 140.75 35.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.0 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -118.11 168.51 10.49 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.798 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -104.83 114.54 28.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.413 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.736 HD11 ' HB3' ' A' ' 101' ' ' TYR . 42.3 pt -118.69 -173.47 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.518 0.675 . . . . 0.0 110.971 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -96.07 92.74 6.59 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.726 -177.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.63 ' CD2' ' HG2' ' A' ' 3' ' ' LYS . 37.8 m95 -77.28 -12.5 59.96 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 109.838 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.434 -1.271 0 CA-C-O 121.832 0.825 . . . . 0.0 110.595 -172.202 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.765 ' HZ1' ' HA ' ' A' ' 88' ' ' ASP . 75.5 mmtt . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -24.79 -66.72 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.778 1.299 . . . . 0.0 114.001 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.74 -35.61 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' B' ' 128' ' ' ARG . 7.4 mm100 -66.5 -50.11 64.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.954 0.407 . . . . 0.0 111.899 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 94' ' ' VAL . 1.5 mm? -68.3 -33.96 75.28 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.18 90.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.549 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 49.9 mtp180 -51.77 -56.41 14.0 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.28 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.792 ' HD2' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -56.93 -42.69 80.45 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 -176.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.94 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 1.7 mp -70.13 -50.2 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 123.747 0.654 . . . . 0.0 112.543 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -174.221 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.906 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -90.68 -20.58 22.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 -176.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.492 ' HB ' ' CZ3' ' A' ' 153' ' ' TRP . 3.0 t -136.64 129.51 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.482 0.658 . . . . 0.0 110.275 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.781 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -115.54 99.59 7.46 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -73.12 134.03 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -120.24 -64.88 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.89 0.852 . . . . 0.0 109.465 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.696 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.2 t-20 -105.09 150.0 25.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.587 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 9' ' ' VAL . 5.9 p -145.57 102.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.957 0.885 . . . . 0.0 109.322 173.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -95.75 100.22 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.513 1.149 . . . . 0.0 109.667 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 139' ' ' ILE . 2.1 m -79.18 126.87 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.184 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.859 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -102.76 -34.75 8.9 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.745 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.721 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 26.0 t70 -59.34 28.79 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.874 -1.966 . . . . 0.0 112.566 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.626 ' OD1' ' HD3' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -82.22 172.48 9.47 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.871 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 24.2 Cg_exo -54.37 101.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.323 1.349 . . . . 0.0 113.658 -136.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.563 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.8 m -138.44 168.51 15.64 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.252 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 82.6 Cg_exo -36.49 132.86 0.36 Allowed 'Trans proline' 0 CA--C 1.504 -1.011 0 C-N-CA 123.31 2.673 . . . . 0.0 112.07 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.734 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 16.5 t80 -51.27 -24.25 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.786 0.679 . . . . 0.0 112.535 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -86.32 0.85 53.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.934 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.498 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 31.2 p-10 -63.56 138.73 97.45 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 165.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.718 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 16.6 Cg_exo -78.89 145.71 20.06 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 122.843 2.362 . . . . 0.0 111.715 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.81 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 53.5 m-85 -60.65 126.22 26.61 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.859 ' HB3' HD12 ' A' ' 12' ' ' LEU . 34.5 mt-30 -125.72 99.36 5.94 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.759 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 67.9 m-85 -107.92 102.37 11.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.88 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 10' ' ' VAL . 29.5 tt0 -85.94 83.7 7.73 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.685 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 7.3 mt -84.91 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.57 0.7 . . . . 0.0 112.441 -176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.4 m -111.68 107.45 16.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.323 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.479 ' HB3' HG13 ' A' ' 6' ' ' VAL . 27.7 p90 -121.21 148.14 44.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 37.0 tt0 -106.01 112.66 25.8 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.739 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 41.5 t -73.49 109.41 6.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.524 ' C ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -78.63 -29.0 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.641 -173.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.906 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 1.8 mt-10 -149.66 148.15 28.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.4 p-10 -56.27 135.04 53.7 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 111.691 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.06 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 93.3 mt -82.74 160.47 22.31 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.356 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.6 t -113.17 -21.62 10.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.803 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.886 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.5 tt0 -137.89 -168.52 2.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.886 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 17.6 m-20 -95.12 137.4 34.23 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.418 0.628 . . . . 0.0 109.69 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.732 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.31 118.95 23.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.602 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.8 tt0 -108.63 89.76 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.878 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 15.0 m95 -78.22 126.54 30.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.9 ttmp? -126.15 141.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.048 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -102.88 107.9 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.745 ' HB ' HD12 ' A' ' 96' ' ' LEU . 40.1 mt -111.74 104.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.839 0.828 . . . . 0.0 109.034 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.836 ' CE2' HG11 ' A' ' 113' ' ' VAL . 17.0 t80 -86.81 115.42 24.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.195 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HD11 ' B' ' 126' ' ' LEU . 6.8 t -62.27 101.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.237 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.49 56.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.832 ' HB3' ' CG ' ' A' ' 53' ' ' TYR . 14.8 p -96.94 88.36 4.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.857 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HB1' ' HG3' ' B' ' 122' ' ' LYS . . . -80.41 -17.72 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -100.3 -23.47 14.78 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.028 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.742 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 48.7 m -110.32 -147.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -155.96 -5.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.76 1.44 53.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.832 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 4.2 m-30 -91.33 -14.42 30.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.369 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -40.81 113.99 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.449 1.119 . . . . 0.0 112.605 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 14.8 mt-30 -92.71 163.09 13.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.219 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 43' ' ' ILE . 39.4 t -132.6 115.67 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.3 mm? -84.2 -45.26 13.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.655 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -170.5 165.75 8.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 61.9 p -141.8 117.53 10.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -100.0 136.6 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.639 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.2 mt -107.9 104.84 14.4 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.99 110.76 23.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -71.7 -170.19 12.28 Favored Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.889 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.06 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 35.2 Cg_endo -62.12 115.11 2.63 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 121.259 1.306 . . . . 0.0 109.994 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 34.0 m -123.94 140.25 34.22 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.342 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.55 76.81 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.987 1.791 . . . . 0.0 113.463 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.54 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.64 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.039 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.21 124.89 3.56 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.992 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.854 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 31.9 ttt180 -79.53 118.19 21.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.446 0.641 . . . . 0.0 109.501 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -150.74 143.92 24.81 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.394 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -96.86 134.23 40.44 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.361 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -127.0 150.02 49.62 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.15 101.67 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-O 123.189 1.471 . . . . 0.0 111.448 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.759 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -76.13 137.26 39.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 112.494 -2.139 . . . . 0.0 109.841 -176.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.81 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 24.1 mt-30 -151.84 152.28 32.42 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.034 0.445 . . . . 0.0 109.941 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.44 155.89 6.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.0 p-10 -62.34 179.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.53 0.605 . . . . 0.0 111.983 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -77.06 158.65 79.75 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.68 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 38.8 Cg_endo -63.73 164.73 20.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.5 2.134 . . . . 0.0 110.817 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.21 115.97 37.48 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.599 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -66.74 -12.76 37.24 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.098 2.532 . . . . 0.0 112.519 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.86 -5.54 61.08 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.105 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.454 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 20.7 mt -96.45 -37.11 10.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 122.613 -0.345 . . . . 0.0 110.592 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 19.2 mt -72.35 127.7 89.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.05 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.62 162.55 24.46 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.902 2.401 . . . . 0.0 112.423 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.845 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 t70 -43.72 -54.53 5.04 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.055 0.942 . . . . 0.0 113.487 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB1' ' NZ ' ' B' ' 122' ' ' LYS . . . -64.45 -28.51 69.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.071 0.462 . . . . 0.0 111.369 -168.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -97.19 -21.33 17.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.578 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.77 -48.22 12.8 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.679 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -92.87 47.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 112.68 -175.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.48 -127.23 1.11 Allowed Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.067 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.699 HG13 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -100.41 136.04 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.426 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -151.84 166.77 30.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.579 HG23 ' HG ' ' B' ' 126' ' ' LEU . 15.2 t -121.98 138.86 50.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.555 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.95 106.99 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.929 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -104.65 139.83 38.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.236 -170.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.791 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 34.5 mt -109.67 96.63 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.911 0.862 . . . . 0.0 109.097 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 72.7 p -96.07 116.26 28.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.884 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.596 ' HB2' HG22 ' A' ' 107' ' ' ILE . 75.0 m -80.59 104.49 11.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.493 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 23.7 m -85.6 102.19 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.175 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.636 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 32.7 t80 -117.98 126.11 51.68 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.929 -0.482 . . . . 0.0 110.26 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 53.8 mtp85 60.39 28.82 18.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.848 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.35 -20.22 51.33 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.752 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.693 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 4.0 pt20 -111.57 142.99 43.15 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.637 0.732 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.9 mt-10 -93.79 119.72 33.12 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.212 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.732 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 43.9 p90 -104.53 -0.52 27.7 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.821 ' O ' ' HA ' ' A' ' 98' ' ' THR . 6.1 tt -157.58 160.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.697 ' HG3' ' HB2' ' A' ' 96' ' ' LEU . 10.5 ttp180 -151.48 119.24 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 123.674 0.609 . . . . 0.0 109.776 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.929 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.6 p -96.01 100.05 10.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.515 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.62 73.42 2.49 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 119.252 -1.452 . . . . 0.0 110.961 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.872 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.8 m-85 -67.67 115.62 7.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.996 -1.102 . . . . 0.0 109.087 175.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.532 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.8 m-85 -67.68 113.26 5.32 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.836 HG11 ' CE2' ' A' ' 44' ' ' TYR . 5.3 p -93.8 110.56 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.699 HD21 HG13 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -95.25 108.61 20.77 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.611 -178.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.677 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 37.8 m-80 -101.79 107.49 18.71 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -129.14 124.01 33.59 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.276 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 29.0 m-85 -42.13 153.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.631 HG23 ' HB2' ' A' ' 136' ' ' GLN . 17.9 p -96.49 -27.75 14.73 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.607 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.537 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -79.48 120.86 24.46 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.505 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 5.8 m -55.49 -30.8 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.986 -170.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.25 -39.73 93.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.878 0.847 . . . . 0.0 109.866 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 66.1 mt -76.68 -24.98 53.2 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.268 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 39.4 mtt180 -72.49 -32.8 66.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.1 mm-40 -71.9 -41.13 68.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.922 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.9 p30 -148.98 102.84 3.37 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 122.051 0.929 . . . . 0.0 111.452 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 33.6 Cg_endo -66.47 113.94 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.425 2.75 . . . . 0.0 110.98 172.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 33.0 Cg_exo -59.8 157.79 31.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.592 2.195 . . . . 0.0 111.094 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.07 -21.9 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.683 -169.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.554 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 1.9 mmpt? -128.36 103.86 20.02 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 122.012 0.91 . . . . 0.0 112.133 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.845 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 12.6 Cg_exo -44.28 140.27 5.83 Favored 'Trans proline' 0 N--CA 1.455 -0.737 1 C-N-CA 125.553 4.169 . . . . 0.0 113.82 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.0 t70 -111.6 114.67 27.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.368 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.627 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.6 m-85 -78.63 -7.13 57.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.21 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.6 p -96.69 -34.56 11.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.537 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 72.2 mmtt -81.78 -17.22 48.38 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.644 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 32.6 tp -66.67 139.65 57.86 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.744 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.631 ' HB2' HG23 ' A' ' 118' ' ' THR . 3.9 tt0 -129.02 121.95 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.769 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.78 108.98 20.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.743 0.782 . . . . 0.0 112.236 -175.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.456 ' CB ' ' HG3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -91.33 101.54 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.603 170.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.617 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 6.3 mm -68.96 106.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 112' ' ' TYR . 66.4 mt -66.72 87.38 0.13 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.922 0.868 . . . . 0.0 111.2 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.872 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.51 -4.85 57.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.162 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.2 p -83.23 -11.65 57.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.576 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 63.3 t30 -143.9 59.86 7.58 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.408 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 13.9 Cg_exo -71.8 105.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.698 1.599 . . . . 0.0 110.658 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.7 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -79.91 81.35 6.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.156 0.503 . . . . 0.0 110.143 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.9 m -80.38 141.67 14.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.205 0.526 . . . . 0.0 111.084 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.488 HG21 HH21 ' A' ' 108' ' ' ARG . 54.2 m -148.83 105.87 3.6 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.753 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -115.46 140.28 49.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 110.381 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -119.43 169.94 9.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.788 -175.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -103.98 111.57 24.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.693 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 22.3 pt -115.06 -173.91 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 121.377 0.608 . . . . 0.0 110.596 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 152' ' ' ASN . 0.0 OUTLIER -88.57 114.45 25.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.793 1.282 . . . . 0.0 109.733 175.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 59.8 m95 -96.06 -8.46 33.43 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.529 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 . . . . . 0 N--CA 1.437 -1.092 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.218 -174.742 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.507 ' NZ ' ' HB1' ' A' ' 87' ' ' ALA . 13.6 mptt . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -37.04 -59.22 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 12.8 tt -68.92 -32.68 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' B' ' 125' ' ' GLN . 8.7 mm100 -62.93 -56.04 20.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.584 HD11 HG11 ' A' ' 45' ' ' VAL . 2.1 mm? -69.48 -29.59 67.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.869 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.3 77.42 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 90.7 mtt180 -53.34 -46.5 69.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.306 0.574 . . . . 0.0 110.312 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.697 ' HG3' HD21 ' A' ' 96' ' ' LEU . 21.4 tpt180 -65.93 -35.66 81.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.518 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 145' ' ' ARG . 18.1 mt -94.72 -22.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 . . . . . 0 C--N 1.324 -0.527 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.432 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.821 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.88 -8.81 51.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.623 -175.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.635 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 38.8 t -148.15 138.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.048 ' HG2' HD11 ' A' ' 31' ' ' ILE . 14.4 mm-40 -124.03 101.29 7.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.73 167.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 81.6 t -72.67 102.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -88.5 -60.7 1.89 Allowed 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.722 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.742 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -107.51 150.59 26.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.217 -1.81 . . . . 0.0 110.386 -171.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 26' ' ' ILE . 2.6 p -145.81 99.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.791 169.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -92.21 107.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.653 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -77.55 119.82 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.677 -178.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 23' ' ' GLN . 2.4 mt -89.31 -47.79 7.8 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.093 -171.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 9.5 t70 -78.58 73.65 5.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.046 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.612 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -81.72 176.7 3.57 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 111.726 -2.488 . . . . 0.0 106.614 169.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.99 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 3.0 Cg_endo -46.74 104.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.68 1.636 . . . . 0.0 113.374 -147.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.775 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 75.1 m -126.5 168.82 13.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.493 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -40.69 132.56 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.298 1.998 . . . . 0.0 111.031 173.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.718 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 7.9 t80 -58.11 -25.36 61.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.753 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 133' ' ' SER . 5.2 m-85 -89.83 3.95 51.34 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.86 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.775 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -97.25 142.72 24.96 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.618 170.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.627 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 6.3 Cg_endo -42.29 151.17 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.16 1 C-N-CA 126.551 4.834 . . . . 0.0 115.877 -178.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.859 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 45.8 m-85 -84.5 120.22 26.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.655 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.92 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.5 mp0 -110.4 121.7 45.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.684 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 82.6 m-85 -125.59 104.34 8.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.219 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.689 ' CB ' HD21 ' A' ' 12' ' ' LEU . 35.5 tt0 -88.14 86.27 7.07 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.656 HG13 HG23 ' A' ' 9' ' ' VAL . 4.6 mt -83.51 134.01 27.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.192 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.5 m -109.1 109.01 19.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.553 172.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.636 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 13.7 p90 -123.37 148.56 45.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.892 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.883 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.3 tt0 -108.39 112.49 24.94 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 110.44 7.4 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.048 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.2 mt -72.04 -35.94 55.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.695 -171.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.821 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 23.9 mt-10 -143.35 172.02 13.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.419 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 p-10 -71.62 144.24 49.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.36 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.047 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 62.5 mt -95.88 161.08 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -112.47 -25.02 9.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.122 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.51 -168.14 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.122 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.12 140.84 29.08 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.77 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -81.73 119.18 23.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.935 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.736 ' HG2' HD22 ' A' ' 61' ' ' LEU . 24.3 mt-10 -101.96 89.29 3.59 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.442 -173.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.577 ' CH2' HG21 ' A' ' 26' ' ' ILE . 19.1 m95 -77.65 151.59 34.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.699 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 0.6 OUTLIER -153.23 134.05 13.88 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.554 -0.459 . . . . 0.0 109.85 -179.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 33.0 mt -103.18 120.54 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.656 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -119.04 106.24 19.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.839 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.771 ' CE2' HG11 ' A' ' 113' ' ' VAL . 56.0 t80 -89.15 126.0 35.28 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.856 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.941 HG22 ' HE2' ' A' ' 53' ' ' TYR . 31.4 t -73.52 117.94 18.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.195 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -92.98 -59.24 1.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 119.846 -1.169 . . . . 0.0 112.092 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.708 ' H ' ' CB ' ' A' ' 53' ' ' TYR . 7.4 m -105.26 72.39 0.98 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -48.19 -21.27 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.552 0.532 . . . . 0.0 111.62 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG3' ' HE2' ' B' ' 122' ' ' LYS . 5.2 tt0 -85.71 -31.99 22.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.388 0.675 . . . . 0.0 112.23 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.7 m -95.62 -27.59 15.24 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.996 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER 64.25 11.63 6.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.865 1.266 . . . . 0.0 112.489 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -99.11 -13.06 19.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.452 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.996 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 29.3 p90 -73.17 -46.51 50.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.563 -1.653 . . . . 0.0 114.416 -161.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.616 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 7.6 p-10 -30.8 113.76 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 125.011 1.445 . . . . 0.0 114.388 -154.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.605 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 14.1 mt-30 -95.84 170.78 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.607 -169.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.612 HG13 ' HE2' ' A' ' 41' ' ' LYS . 2.3 t -130.49 116.03 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.863 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.3 mm? -92.56 -56.66 2.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.289 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 15.2 t70 -162.5 156.63 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.998 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.699 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 36.6 p -132.96 121.82 23.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG11 ' CE1' ' A' ' 72' ' ' PHE . 3.6 p -111.2 137.32 44.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.736 HD22 ' HG2' ' A' ' 39' ' ' GLU . 7.8 mt -108.99 105.06 14.42 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.458 -176.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.01 114.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -68.59 -176.08 11.23 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.011 -167.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.047 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 43.6 Cg_endo -65.15 114.71 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.146 1.231 . . . . 0.0 110.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 63' ' ' GLY . 34.6 m -123.84 140.35 34.31 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.034 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 60.5 Cg_endo -80.55 79.5 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.292 1.994 . . . . 0.0 113.589 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 53.25 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.633 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.03 128.06 3.89 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.703 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.883 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 51.0 ttt180 -87.23 115.92 24.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.698 0.761 . . . . 0.0 109.345 175.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.531 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.1 p80 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.484 -172.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -94.16 136.51 34.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.795 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -121.29 153.03 38.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.33 121.0 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.622 1.201 . . . . 0.0 111.989 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.684 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -95.23 141.01 29.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.329 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.92 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 26.6 mt-30 -152.08 152.54 32.5 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 167.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -169.39 126.98 0.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.747 ' O ' HD12 ' A' ' 57' ' ' LEU . 29.4 t70 -64.53 147.99 51.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.685 0.279 . . . . 0.0 111.445 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -37.17 152.37 0.12 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.859 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 32.9 Cg_endo -64.04 -179.78 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 125.087 3.858 . . . . 0.0 113.344 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -92.84 119.19 67.99 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.206 0.527 . . . . 0.0 110.99 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -66.97 -23.24 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.273 2.649 . . . . 0.0 112.501 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.58 -2.85 90.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.953 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 53.2 mt -108.05 1.99 22.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.573 0.225 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.569 HD11 ' HE1' ' A' ' 44' ' ' TYR . 10.1 mt -109.5 123.52 36.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 91.5 Cg_endo -80.02 163.85 22.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.687 2.925 . . . . 0.0 112.22 168.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 10.3 t70 -44.46 -55.03 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.112 0.965 . . . . 0.0 113.195 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.49 70.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.164 0.507 . . . . 0.0 111.607 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 35.5 m-20 -94.45 -8.6 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.638 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.545 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -88.35 -47.77 8.14 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 121.123 0.487 . . . . 0.0 111.955 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -101.94 44.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.523 0.678 . . . . 0.0 111.906 -174.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.88 -124.13 0.71 Allowed Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.597 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.88 130.12 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-O 122.236 1.017 . . . . 0.0 111.91 -169.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.471 HG22 HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -146.77 170.67 16.52 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.416 -1.72 . . . . 0.0 107.719 179.11 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.52 ' CG2' ' HB3' ' B' ' 126' ' ' LEU . 3.0 t -128.58 151.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.56 0.219 . . . . 0.0 111.481 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 95' ' ' VAL . 7.8 p -131.29 107.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.941 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.9 pp -102.52 140.56 36.64 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.433 -170.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 24' ' ' PHE . 58.7 mt -112.44 106.47 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.47 0.652 . . . . 0.0 109.393 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 62.9 p -93.86 119.47 32.84 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.46 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.642 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.1 m -85.39 128.78 34.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 169.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.7 m -122.65 119.9 32.11 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.386 -171.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.656 ' HB3' HD11 ' A' ' 151' ' ' ILE . 75.2 t80 -124.89 122.85 38.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.537 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.638 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 48.4 mtp180 69.53 28.09 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.062 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.13 -0.7 82.0 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.265 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -121.69 128.64 52.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.203 0.525 . . . . 0.0 110.519 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.3 mp0 -79.84 139.75 37.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.946 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.77 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 42.6 p90 -124.1 -0.63 8.34 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.795 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.4 tt -159.12 158.86 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.617 -0.677 . . . . 0.0 109.185 174.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.562 ' HG3' HG22 ' A' ' 98' ' ' THR . 16.3 ttm180 -151.37 102.56 2.92 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -176.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.941 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.62 99.17 7.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.292 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.646 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -83.72 78.04 2.05 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.889 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.9 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -73.56 113.27 10.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.434 ' CB ' HD12 ' A' ' 140' ' ' LEU . 18.3 m-85 -67.3 127.57 33.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.222 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.771 HG11 ' CE2' ' A' ' 44' ' ' TYR . 7.7 p -109.53 111.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.37 1.081 . . . . 0.0 108.088 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.47 111.06 21.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.271 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.525 ' HB3' HD11 ' A' ' 135' ' ' LEU . 51.8 m-80 -99.29 107.71 20.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -173.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.54 131.63 34.12 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.836 -175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 55.7 m-85 -39.7 151.74 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.3 p -88.97 -33.88 17.06 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.328 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.647 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 6.5 mm-40 -82.46 122.42 28.0 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.875 177.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -55.75 -33.38 64.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.673 -171.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.92 -37.92 87.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.705 0.764 . . . . 0.0 109.549 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.0 mt -74.11 -23.35 59.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.557 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -76.29 -31.24 58.11 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 120' ' ' THR . 30.9 mm-40 -77.97 -33.95 51.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.46 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 1.9 p30 -144.67 87.57 7.44 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.106 0.479 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 11.6 Cg_endo -53.62 117.93 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.764 2.309 . . . . 0.0 110.727 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 77.3 Cg_exo -53.39 160.12 5.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.624 2.216 . . . . 0.0 110.798 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.49 -38.87 9.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 O-C-N 123.658 0.599 . . . . 0.0 111.494 -168.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.719 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 4.6 mmtt -124.44 127.6 25.21 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.719 ' HD2' ' HD3' ' A' ' 129' ' ' LYS . 7.5 Cg_exo -41.31 134.22 3.07 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.613 3.542 . . . . 0.0 113.257 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 25.0 t70 -114.52 114.46 25.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.718 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.2 m-85 -78.57 -16.93 56.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.08 -168.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.436 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -83.32 -28.65 28.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.241 177.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.647 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 66.0 mmtt -98.56 11.46 38.28 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 115' ' ' ASN . 26.2 tp -91.05 147.11 23.3 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.894 -177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.609 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 20.8 tt0 -124.88 123.06 39.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.85 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.0 mtp-105 -82.73 103.6 12.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.99 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 2.1 t30 -99.47 105.0 16.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.944 0.878 . . . . 0.0 108.808 171.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.704 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -78.41 111.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.731 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.434 HD12 ' CB ' ' A' ' 112' ' ' TYR . 69.3 mt -68.16 86.91 0.27 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.9 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.62 -11.41 59.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 p -78.96 -10.66 59.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.069 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.497 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 17.1 m120 -133.06 58.4 34.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.065 -174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 6.0 Cg_exo -80.43 105.28 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.814 1.676 . . . . 0.0 111.053 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.714 ' HB3' HD13 ' B' ' 130' ' ' ILE . 12.6 tpp180 -82.45 81.16 8.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.512 HG12 HG23 ' A' ' 109' ' ' VAL . 6.1 m -83.26 104.77 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.609 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.427 HG22 ' CE1' ' A' ' 149' ' ' PHE . 21.4 m -111.48 106.8 15.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.687 0.756 . . . . 0.0 109.595 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.795 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.0 ptt180 -113.82 146.04 40.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.386 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.1 169.37 15.4 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.241 -173.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -105.0 130.31 53.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.687 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.4 pt -129.08 -177.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.535 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -103.38 87.54 2.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.673 0.749 . . . . 0.0 111.37 -174.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.635 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 37.3 m95 -73.15 -1.18 16.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.401 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -173.163 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.682 ' HE2' ' HG3' ' A' ' 49' ' ' GLU . 23.2 mmtp . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 110.856 -0.053 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -37.26 -53.06 1.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.489 0.493 . . . . 0.0 111.804 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.76 -30.22 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.573 0.225 . . . . 0.0 111.408 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.638 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 9.1 mm100 -60.95 -52.33 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.291 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.681 ' CD1' HG11 ' A' ' 45' ' ' VAL . 2.4 mm? -67.07 -39.99 86.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.05 88.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.29 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 9.3 ptm180 -66.42 -35.89 81.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.78 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -64.7 -38.92 92.62 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.714 HD13 ' HB3' ' A' ' 145' ' ' ARG . 14.8 mt -76.05 -50.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.95 -174.321 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.029 0.442 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 1.144 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.82 -20.42 23.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.98 -175.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.855 HG21 HD21 ' A' ' 38' ' ' LEU . 4.0 t -141.72 130.07 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.694 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -121.66 100.2 6.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.064 173.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -79.61 146.4 7.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.366 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -129.14 -65.57 0.86 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.202 -165.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.684 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.61 150.45 23.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.779 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.632 HG23 HG13 ' A' ' 26' ' ' ILE . 3.5 p -146.18 100.05 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 169.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.987 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -87.6 103.73 13.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.687 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -77.86 109.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.713 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.974 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.7 mt -89.72 -44.64 9.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.989 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.932 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.6 OUTLIER -69.32 75.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.622 1.677 . . . . 0.0 109.597 167.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -85.37 177.9 2.65 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.138 163.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.8 Cg_endo -48.83 103.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 121.916 1.72 . . . . 0.0 113.603 -154.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.69 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.4 m -129.78 171.24 9.2 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.425 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.69 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 83.7 Cg_exo -42.84 138.82 3.64 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.685 2.257 . . . . 0.0 112.106 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.727 ' CE1' ' HG2' ' A' ' 79' ' ' PRO . 43.9 t80 -58.11 -29.62 65.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.659 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -89.12 1.3 55.82 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -78.66 144.52 65.12 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 12.1 Cg_exo -79.54 137.48 13.03 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 123.221 2.614 . . . . 0.0 112.831 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 25.3 m-85 -55.24 146.24 19.52 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.931 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.974 ' HG2' HD12 ' A' ' 12' ' ' LEU . 6.6 tt0 -136.46 92.44 2.77 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.206 -167.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' HD12 ' A' ' 42' ' ' ILE . 52.9 m-85 -113.27 108.38 17.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.329 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.987 ' HB3' HG23 ' A' ' 10' ' ' VAL . 38.4 tt0 -96.27 88.1 4.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 9' ' ' VAL . 3.2 mt -81.43 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.185 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.7 m -108.4 106.48 16.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.935 170.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 39.1 p90 -121.22 146.14 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.829 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.4 tt0 -102.36 110.52 22.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.519 ' HB2' ' C ' ' A' ' 67' ' ' ALA . 20.7 m -72.8 115.36 12.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -80.68 -31.38 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.856 -171.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.144 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 34.8 mt-10 -145.28 168.24 20.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.759 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.4 p-10 -73.45 131.57 41.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 111.798 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.773 HD11 HD22 ' A' ' 38' ' ' LEU . 75.6 mt -83.15 159.21 22.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.497 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 p -112.25 -19.65 12.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.643 0.735 . . . . 0.0 109.215 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -136.97 -172.45 3.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.516 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.94 151.48 33.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.481 0.658 . . . . 0.0 110.761 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.855 HD21 HG21 ' A' ' 4' ' ' VAL . 4.6 tp -107.46 123.16 47.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 23.3 tt0 -106.03 135.58 47.23 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.868 -174.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.596 ' CE3' ' SG ' ' A' ' 99' ' ' CYS . 19.1 m95 -132.14 124.52 29.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.837 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.0 ttmp? -125.49 146.62 49.56 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.812 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.599 HD13 HG12 ' A' ' 97' ' ' ILE . 18.9 mm -102.75 106.87 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 87.6 mt -103.02 106.94 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.801 0.81 . . . . 0.0 109.886 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 79' ' ' PRO . 18.8 t80 -87.46 115.61 25.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.756 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG11 HD12 ' B' ' 126' ' ' LEU . 10.0 t -66.38 99.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 121.378 0.608 . . . . 0.0 109.712 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -57.91 -43.45 94.86 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.231 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.687 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 46.7 t -123.69 109.38 13.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' B' ' 126' ' ' LEU . . . -70.97 -5.66 32.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.419 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' HZ2' ' B' ' 122' ' ' LYS . 3.2 mt-10 -100.89 -22.09 14.92 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.163 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.52 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.9 m -116.07 -150.32 0.46 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.989 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' B' ' 129' ' ' ARG . 8.9 pt-20 -150.69 -33.28 0.17 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.767 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.78 2.57 5.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.389 0.614 . . . . 0.0 111.401 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.687 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 95.8 m-85 -94.58 4.28 54.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.53 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.53 110.17 0.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.012 0.91 . . . . 0.0 109.938 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 4.4 mt-30 -96.02 166.69 11.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.306 -176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.666 HG22 ' HD3' ' A' ' 41' ' ' LYS . 42.3 t -127.31 106.26 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.971 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.61 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 4.0 mt -75.16 -48.23 24.6 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.741 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -170.48 165.3 8.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.843 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 p -141.9 128.92 20.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.4 p -99.5 133.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.946 -173.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.36 105.13 14.67 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.733 0.777 . . . . 0.0 110.099 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 98.3 t -83.56 155.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.47 -163.19 37.08 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.826 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.666 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 61.1 Cg_endo -89.83 118.21 0.75 Allowed 'Trans proline' 0 N--CA 1.424 -2.565 0 C-N-CA 122.057 1.838 . . . . 0.0 110.284 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' H ' HD12 ' A' ' 34' ' ' LEU . 33.8 m -119.51 134.0 23.81 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.489 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.8 Cg_endo -79.13 83.51 2.25 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 113.453 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.519 ' C ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.04 -171.35 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.653 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.61 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 105.01 132.32 7.36 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 14.8 ttp180 -75.08 113.69 12.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.458 0.647 . . . . 0.0 110.286 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.61 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 21.8 m-70 -111.39 129.1 56.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 ttp -106.66 111.84 24.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 168.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 4.8 p90 -126.13 141.09 52.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.739 0.781 . . . . 0.0 109.326 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 2.2 p -101.41 116.71 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.536 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -119.28 132.28 55.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.281 -168.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 44.6 mt-30 -125.15 160.45 29.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.699 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 57' ' ' LEU . . . -153.48 137.63 16.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.035 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 20.6 t70 -57.4 162.1 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -62.61 158.42 50.65 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 121.509 0.671 . . . . 0.0 111.526 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.727 ' HG2' ' CE1' ' A' ' 18' ' ' PHE . 28.9 Cg_endo -62.28 171.41 5.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.813 2.342 . . . . 0.0 111.702 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.87 115.28 62.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.603 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.56 -16.2 53.23 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.631 2.888 . . . . 0.0 112.816 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.84 -18.3 56.54 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.127 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 46.5 mt -91.9 -15.22 28.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.683 0.278 . . . . 0.0 111.385 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 17.1 mt -91.42 127.61 50.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.447 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.4 ' O ' HG22 ' A' ' 84' ' ' ILE . 98.5 Cg_endo -80.68 160.01 21.86 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.726 2.284 . . . . 0.0 111.81 171.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.728 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 6.5 m-20 -46.45 -50.02 17.45 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.419 0.687 . . . . 0.0 112.615 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.17 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.538 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.02 -19.63 21.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.929 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.9 -46.36 30.51 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.147 0.499 . . . . 0.0 111.635 -175.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.667 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -98.17 48.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.289 1.042 . . . . 0.0 110.492 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.58 -137.75 2.27 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.391 -161.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' B' ' 122' ' ' LYS . 9.8 p -130.46 145.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.714 0.769 . . . . 0.0 110.835 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.625 HG23 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -157.33 174.59 15.19 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.742 HG12 HD23 ' A' ' 96' ' ' LEU . 2.2 t -124.17 145.01 31.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.511 -0.475 . . . . 0.0 112.152 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.523 HG11 ' CZ ' ' A' ' 22' ' ' PHE . 27.7 m -116.78 105.17 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.792 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.57 136.27 41.7 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.922 -173.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.872 ' HB ' HG12 ' A' ' 109' ' ' VAL . 25.7 mt -95.79 103.14 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 108' ' ' ARG . 58.1 p -97.04 110.8 23.27 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.75 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.733 ' SG ' HG23 ' A' ' 107' ' ' ILE . 4.7 m -85.6 143.88 28.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.891 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -135.16 129.35 33.67 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -172.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 153' ' ' TRP . 84.3 t80 -135.84 118.1 15.59 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.78 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 29.2 mtp180 67.66 27.12 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.779 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.08 70.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.363 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.16 120.66 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.012 0.434 . . . . 0.0 110.354 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 41.2 mp0 -76.85 124.89 28.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CD2' HG22 ' A' ' 107' ' ' ILE . 34.3 p90 -110.37 -8.66 14.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -168.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.747 ' O ' ' HA ' ' A' ' 98' ' ' THR . 1.7 tt -158.89 162.4 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 119.443 1.02 . . . . 0.0 110.332 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.869 ' HG3' HG22 ' A' ' 98' ' ' THR . 14.1 ttm180 -146.53 105.59 3.88 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.872 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.2 p -95.22 100.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.235 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.76 80.99 1.78 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.878 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.888 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 9.6 m-85 -77.34 116.63 18.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.625 ' HE2' ' HA ' ' B' ' 123' ' ' ASP . 20.5 m-85 -68.0 133.11 48.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.446 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.625 HG13 HG23 ' A' ' 93' ' ' THR . 7.2 p -113.95 110.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.14 130.0 40.51 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.603 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 40.3 m-80 -111.14 113.45 25.98 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -171.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -123.96 124.87 43.54 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.519 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 17.0 m-85 -44.73 151.88 0.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.851 0.834 . . . . 0.0 112.658 173.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -92.43 -34.08 14.28 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.602 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.672 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 2.0 tm-20 -78.76 122.95 26.67 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.977 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 6.1 m -52.57 -34.94 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.465 -171.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.11 -35.65 66.6 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 43.2 mt -71.72 -27.76 63.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.483 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 17.9 mtt180 -73.07 -32.46 65.04 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.3 mm-40 -67.58 -38.68 84.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.917 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -157.47 96.07 2.05 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 121.306 0.574 . . . . 0.0 110.57 178.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.5 Cg_endo -56.14 117.61 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.954 2.436 . . . . 0.0 111.368 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.79 153.51 43.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.128 1.885 . . . . 0.0 110.353 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.1 p -42.14 -41.01 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.851 0.72 . . . . 0.0 112.104 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -110.4 109.75 58.25 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 122.293 1.044 . . . . 0.0 113.334 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.728 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.6 Cg_exo -45.54 140.33 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.778 1 C-N-CA 125.54 4.16 . . . . 0.0 113.892 175.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.62 112.84 22.73 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.696 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 3.6 m-85 -77.98 -18.38 56.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.812 0.815 . . . . 0.0 110.847 -168.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -13.25 50.3 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.3 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.9 mmtt -104.09 12.67 33.73 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.7 tp -99.83 133.38 44.27 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.392 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.94 122.09 41.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.971 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.864 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.69 110.93 23.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.484 0.659 . . . . 0.0 111.501 -175.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.835 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 3.4 t30 -95.03 109.32 21.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.64 176.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -81.54 114.67 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.227 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.432 HD12 ' CB ' ' A' ' 112' ' ' TYR . 80.8 mt -69.78 85.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 110.772 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.888 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -72.13 -20.11 61.67 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.528 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.7 p -78.83 -8.55 58.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.767 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -135.07 69.34 70.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.016 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 77.2 Cg_endo -89.84 114.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.36 2.04 . . . . 0.0 111.608 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.543 ' CB ' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -82.21 81.76 7.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.202 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 109' ' ' VAL . 26.8 m -78.24 130.04 36.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.6 m -148.82 106.88 3.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.254 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -112.73 147.13 37.47 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.983 0.897 . . . . 0.0 110.705 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 170.41 11.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.45 -173.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -94.91 119.94 34.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.994 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 18.0 pt -120.26 -173.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.0 109.766 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -108.2 91.6 3.71 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.437 -176.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.624 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 17.9 m95 -78.78 -13.51 59.77 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.303 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 N--CA 1.441 -0.901 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.772 -173.248 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.604 ' C ' HD22 ' B' ' 126' ' ' LEU . 4.0 mptp? . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.625 ' HA ' ' HE2' ' A' ' 112' ' ' TYR . 1.2 p30 -37.73 -49.93 1.18 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 7.1 tp -65.2 -40.73 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 111.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.653 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 0.7 OUTLIER -65.2 -35.78 82.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 110.648 177.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.604 HD22 ' C ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -64.03 -42.58 97.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.48 -33.03 73.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.96 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 10.4 mmm180 -54.59 -49.33 70.66 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.22 0.533 . . . . 0.0 110.006 173.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.527 ' HD2' ' HB2' ' A' ' 51' ' ' GLU . 6.2 mmp_? -69.18 -30.63 68.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.135 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.649 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 56.7 mt -75.08 -15.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.049 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.582 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.761 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 2.7 mmtt -100.15 -7.1 25.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.532 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.3 t -139.57 123.24 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.329 0.585 . . . . 0.0 110.553 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp60 -117.0 100.5 7.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.834 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.3 m -79.64 135.73 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -117.16 -63.61 1.42 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.003 -164.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.593 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.0 t-20 -103.96 152.7 21.68 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.644 -174.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -146.89 100.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.037 HG23 ' HB2' ' A' ' 25' ' ' GLU . 1.0 OUTLIER -94.18 97.58 7.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.012 -177.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.563 HG13 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -73.62 132.91 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.158 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.113 HD12 ' HG2' ' A' ' 23' ' ' GLN . 7.0 mt -103.85 -65.04 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.384 -169.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.66 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -88.15 55.04 3.28 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.382 1.087 . . . . 0.0 111.748 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 1.091 ' HA ' HD13 ' A' ' 139' ' ' ILE . 27.0 p-10 -81.42 -176.21 0.74 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 161.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.853 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.3 Cg_endo -41.67 104.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 122.428 2.085 . . . . 0.0 114.95 -125.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.671 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.2 m -139.61 172.72 5.98 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 110.305 -3.134 . . . . 0.0 107.054 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 85.3 Cg_exo -41.26 136.56 2.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.139 1.893 . . . . 0.0 111.964 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.711 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 28.6 t80 -60.18 -27.27 66.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.158 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -78.71 -14.32 59.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.706 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -72.95 134.21 81.3 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 22.9 Cg_exo -71.81 146.18 47.51 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.738 2.959 . . . . 0.0 113.599 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.749 ' N ' HH12 ' A' ' 137' ' ' ARG . 62.4 m-85 -55.71 124.86 18.86 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.587 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 1.113 ' HG2' HD12 ' A' ' 12' ' ' LEU . 8.7 tt0 -125.56 100.28 6.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.455 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.661 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.9 m-85 -111.39 155.53 22.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.442 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.037 ' HB2' HG23 ' A' ' 10' ' ' VAL . 59.2 mt-10 -126.27 91.28 3.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 163.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.571 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 6.7 mt -83.72 127.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 122.065 0.936 . . . . 0.0 112.432 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.3 m -101.21 106.42 17.64 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.526 173.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.834 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 25.1 p90 -110.86 141.62 44.0 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.526 0.679 . . . . 0.0 109.913 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.6 tt0 -102.83 113.46 26.9 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.7 m -71.87 122.32 20.55 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -87.41 -23.94 6.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.639 -169.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.23 178.13 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.74 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.919 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 21.9 t70 -78.49 123.47 27.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.414 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.008 HD11 HD23 ' A' ' 38' ' ' LEU . 1.9 mt -81.34 154.96 26.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.033 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -111.81 -35.07 5.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.297 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.709 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 30.5 tt0 -116.47 -169.06 1.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.085 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.709 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -88.38 151.76 22.37 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.669 0.747 . . . . 0.0 109.666 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.008 HD23 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.74 123.32 42.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.651 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 18.5 tt0 -97.05 132.75 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.336 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.775 ' HB2' HG12 ' A' ' 60' ' ' VAL . 69.3 m95 -130.48 109.42 10.68 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.305 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.915 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 4.6 ptpp? -126.0 154.81 42.4 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.217 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 76' ' ' ALA . 37.0 mt -103.37 118.71 50.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.266 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 2.5 mp -102.46 105.97 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' HD1' ' CG1' ' A' ' 95' ' ' VAL . 76.7 t80 -83.6 114.33 21.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG11 HD12 ' B' ' 126' ' ' LEU . 4.1 t -62.11 98.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -35.37 40.58 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.746 ' HB2' ' C ' ' A' ' 50' ' ' SER . 6.7 p -99.21 88.49 3.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.708 -0.746 . . . . 0.0 112.321 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -90.5 -16.89 28.06 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 163.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -89.43 -42.69 11.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.238 -1.347 . . . . 0.0 109.566 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.746 ' C ' ' HB2' ' A' ' 47' ' ' SER . 57.7 m -106.64 -146.76 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -150.62 -4.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -95.62 3.05 54.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.745 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 6.7 m-30 -90.12 -15.46 31.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 119.169 -0.443 . . . . 0.0 111.419 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.6 p-10 -41.64 111.59 0.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.295 1.045 . . . . 0.0 111.564 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 53' ' ' TYR . 14.4 mt-30 -93.45 166.56 12.21 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.173 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG22 HG13 ' A' ' 43' ' ' ILE . 54.6 t -130.94 103.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.6 mm? -70.57 -37.22 73.94 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -171.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 24.8 t0 -177.5 154.11 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.01 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.915 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 97.6 p -130.07 110.32 11.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.775 HG12 ' HB2' ' A' ' 40' ' ' TRP . 11.7 p -99.2 139.84 20.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.895 -166.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 mt -108.22 103.68 12.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.547 0.689 . . . . 0.0 111.353 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 30.6 t -85.34 155.05 3.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.76 -164.57 40.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.654 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.706 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.6 Cg_endo -69.97 114.57 3.78 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.238 1.292 . . . . 0.0 109.967 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.64 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.3 m -108.85 119.33 49.33 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.036 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.919 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 70.7 Cg_endo -84.26 77.48 3.18 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.725 2.283 . . . . 0.0 113.654 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 51.39 169.15 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.796 -2.002 . . . . 0.0 112.554 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.32 123.0 3.22 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.072 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.903 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 11.2 ttt180 -74.76 122.33 23.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.499 0.666 . . . . 0.0 110.852 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.512 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.0 p80 -154.35 146.13 23.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.163 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.687 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 5.5 ttp -97.78 130.2 44.74 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.213 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.3 p90 -112.26 153.44 27.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.65 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.7 p -111.16 132.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.845 0.831 . . . . 0.0 110.224 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.661 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -117.13 130.94 56.95 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.933 -165.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.731 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 25.7 mt-30 -141.6 153.78 45.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -164.51 157.85 17.61 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.526 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.71 -177.22 0.22 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.683 0.754 . . . . 0.0 112.56 -172.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -89.7 147.77 38.46 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.868 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.8 Cg_exo -55.43 154.99 22.08 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 123.521 2.814 . . . . 0.0 113.106 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -77.91 118.42 72.04 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.403 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.43 -13.73 41.31 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.523 2.816 . . . . 0.0 112.778 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.62 -4.93 57.94 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.898 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.79 -25.5 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.55 0.214 . . . . 0.0 110.769 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 85' ' ' PRO . 41.1 mt -84.66 130.3 53.73 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.919 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 84' ' ' ILE . 62.6 Cg_endo -80.11 164.62 22.11 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.36 2.706 . . . . 0.0 112.359 170.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.69 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 7.5 t70 -43.94 -58.04 3.0 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.669 1.187 . . . . 0.0 113.768 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -8.11 59.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.133 -165.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 56.5 m-20 -94.44 -22.37 18.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.681 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HB2' ' CG2' ' A' ' 84' ' ' ILE . . . -85.64 -47.16 10.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.629 -176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -101.34 46.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.814 0.816 . . . . 0.0 111.049 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.89 -157.68 8.57 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.48 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' B' ' 122' ' ' LYS . 10.0 p -97.36 144.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.67 0.748 . . . . 0.0 109.533 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.62 171.6 19.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -171.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -133.68 146.68 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.787 0.722 . . . . 0.0 111.944 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 22' ' ' PHE . 27.2 m -121.8 106.31 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.926 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -102.17 125.01 48.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.127 -173.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 50.4 mt -96.0 101.94 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 45.2 p -98.67 117.0 32.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.38 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 62.4 m -80.66 152.46 28.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.612 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 11.7 m -145.56 119.02 9.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.706 ' HB3' HD11 ' A' ' 151' ' ' ILE . 35.1 t80 -135.43 128.75 32.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 4.5 mmp_? 67.0 12.84 9.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.416 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.48 1.14 57.88 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.825 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -116.6 150.3 38.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 17.2 mp0 -99.72 134.41 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.847 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.793 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 52.4 p90 -120.01 -2.94 10.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -170.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.814 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.5 tt -156.75 159.92 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.834 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 17.7 ttp180 -151.6 99.94 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.845 0.716 . . . . 0.0 109.306 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.926 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.4 p -85.44 101.49 9.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.258 175.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.79 78.08 2.04 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.722 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.973 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -73.7 114.2 11.7 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.455 -0.872 . . . . 0.0 109.015 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.525 ' HA ' HG22 ' A' ' 94' ' ' VAL . 23.5 m-85 -67.72 126.39 29.24 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.532 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.442 HG11 ' HE1' ' A' ' 44' ' ' TYR . 7.5 p -111.49 111.23 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 26.3 t-20 -92.87 117.74 30.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.472 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.487 ' HB3' HD11 ' A' ' 135' ' ' LEU . 48.2 m-80 -109.5 108.65 19.21 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.81 0.814 . . . . 0.0 109.883 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -137.48 139.24 40.45 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.33 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.689 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 62.0 m-85 -46.76 152.42 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -174.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.403 HG22 ' HG3' ' A' ' 136' ' ' GLN . 30.3 p -91.27 -38.29 12.76 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.063 -1.426 . . . . 0.0 108.846 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.918 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -78.25 125.49 29.43 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.062 -174.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.591 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 4.9 m -47.76 -43.11 27.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.824 0.702 . . . . 0.0 111.697 -168.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.19 -35.88 82.46 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.627 0.727 . . . . 0.0 110.266 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 56.3 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.44 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 7.2 mtt180 -74.54 -37.33 63.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.8 mm-40 -63.6 -43.43 96.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.705 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.3 p30 -144.35 82.03 10.91 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.11 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.2 Cg_endo -50.19 116.87 2.71 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.491 2.794 . . . . 0.0 112.326 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.689 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 69.0 Cg_exo -54.54 137.64 73.33 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.713 2.276 . . . . 0.0 111.088 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.618 HG12 ' HE2' ' A' ' 129' ' ' LYS . 36.7 t -50.04 -40.36 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.987 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.618 ' HE2' HG12 ' A' ' 128' ' ' VAL . 2.0 mmpt? -103.35 136.51 19.21 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 111.121 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.69 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -64.39 131.27 29.39 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.749 2.966 . . . . 0.0 113.022 -175.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 23.7 t70 -114.21 114.34 25.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 171.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.711 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 20.6 m-85 -79.22 -15.45 58.01 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.847 -169.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 -28.18 26.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.521 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.918 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 69.7 mmtt -101.68 10.93 39.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 115' ' ' ASN . 27.0 tp -89.23 138.54 31.34 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.516 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.403 ' HG3' HG22 ' A' ' 118' ' ' THR . 3.4 tt0 -113.45 123.03 49.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.853 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -93.02 106.74 18.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.249 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.5 t30 -92.23 105.88 18.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.946 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.091 HD13 ' HA ' ' A' ' 14' ' ' ASN . 1.1 mp -80.66 107.18 12.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.433 HD12 ' CB ' ' A' ' 112' ' ' TYR . 85.9 mt -67.81 84.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.968 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.973 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -73.05 -12.81 61.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.673 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 -9.51 59.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.906 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.49 70.47 76.5 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.783 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 72.1 Cg_endo -89.28 105.02 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.543 1.496 . . . . 0.0 110.404 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' HB3' HG21 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -83.67 81.06 8.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 146' ' ' VAL . 6.7 m -77.06 104.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 0.0 111.261 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.468 HG21 HH21 ' A' ' 108' ' ' ARG . 26.5 m -109.4 105.05 14.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.742 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -116.78 133.3 56.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.531 0.681 . . . . 0.0 110.533 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HD1' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.34 167.79 11.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.913 -175.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -104.58 123.14 47.01 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 101' ' ' TYR . 45.1 pt -119.26 -174.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.505 0.669 . . . . 0.0 109.873 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 1.0 OUTLIER -90.73 105.71 18.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.032 176.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.761 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 11.8 m95 -86.47 2.41 47.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.435 -1.203 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.78 176.751 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.7 ' O ' HD22 ' B' ' 126' ' ' LEU . 27.4 mmtp . . . . . 0 CA--C 1.518 -0.262 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -36.66 -51.76 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.7 0.625 . . . . 0.0 112.292 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.7 -40.62 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.618 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 5.5 mm100 -54.6 -51.08 66.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 174.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.7 HD22 ' O ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -65.28 -43.99 89.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.989 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.64 -37.47 81.61 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.304 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -61.39 -39.12 89.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.5 mmt180 -73.09 -28.39 62.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.084 0.468 . . . . 0.0 110.003 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.834 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 31.1 mt -82.76 -8.5 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.723 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.458 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.775 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.62 -20.92 21.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.621 HG23 HD21 ' A' ' 34' ' ' LEU . 4.3 t -140.71 130.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 111.396 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 13.7 tp60 -123.72 99.71 6.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.656 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -75.87 142.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.073 177.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -127.21 -71.84 0.66 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.263 -163.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.42 100.75 10.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.519 -171.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.472 HG13 ' OH ' ' A' ' 111' ' ' TYR . 2.4 p -100.45 105.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.826 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.5 m -99.33 98.27 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.917 0.865 . . . . 0.0 109.435 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 132.58 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.111 -176.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.01 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -101.65 -40.07 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.048 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 37.1 t0 -67.05 64.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.73 165.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.904 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m120 -83.06 172.95 8.29 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.121 -1.854 . . . . 0.0 108.148 160.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.904 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.4 Cg_endo -50.88 102.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.374 1.383 . . . . 0.0 113.181 -153.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.593 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 17.9 m -132.02 170.96 9.98 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.815 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 68.7 Cg_exo -42.44 140.86 2.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.416 2.077 . . . . 0.0 111.768 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.722 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 6.3 t80 -59.6 -32.12 70.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.043 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -81.68 -9.75 59.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.0 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -63.0 126.23 88.5 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 26.0 Cg_exo -68.25 146.1 68.44 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 123.347 2.698 . . . . 0.0 112.845 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.792 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 87.1 m-85 -52.04 135.72 30.56 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.178 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 1.01 ' HG2' HD12 ' A' ' 12' ' ' LEU . 6.6 tt0 -140.42 84.93 1.98 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.451 -171.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.734 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 96.6 m-85 -100.08 149.76 23.16 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.68 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.826 ' HB3' HG23 ' A' ' 10' ' ' VAL . 32.9 tt0 -124.62 87.43 2.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.619 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 26.8 mt -88.75 125.49 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.697 0.76 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 21.5 m -103.39 110.68 22.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.467 172.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.733 ' HE2' HG21 ' A' ' 65' ' ' VAL . 31.8 p90 -112.75 145.29 40.8 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.895 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.5 tt0 -101.68 114.05 27.75 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 53.2 t -72.35 114.85 10.92 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -81.32 -25.14 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.411 -173.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.775 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.3 mt-10 -153.84 143.56 21.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -55.98 129.97 41.94 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.592 0.558 . . . . 0.0 110.866 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.896 ' HG ' HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -85.1 163.75 18.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.586 0.708 . . . . 0.0 112.365 -169.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 t -113.17 -40.71 3.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.206 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.46 -167.74 1.66 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.311 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 6.4 m-20 -89.84 135.57 33.56 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.236 1.017 . . . . 0.0 109.295 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.896 HD21 ' HG ' ' A' ' 34' ' ' LEU . 3.9 mm? -79.07 143.56 35.46 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.892 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 33.3 tt0 -116.12 135.61 53.77 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.673 173.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.646 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.7 m95 -123.39 125.76 45.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.759 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.6 ttmt -123.35 143.05 50.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.374 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.489 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.7 mt -103.49 108.34 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.358 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.759 HD11 ' HD2' ' A' ' 41' ' ' LYS . 3.8 mp -107.06 109.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.5 0.667 . . . . 0.0 109.427 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.78 ' CD2' ' HG3' ' A' ' 79' ' ' PRO . 22.9 t80 -89.9 109.59 20.6 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.214 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 93' ' ' THR . 25.3 t -69.71 96.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -72.63 -32.54 61.57 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.202 -1.475 . . . . 0.0 109.965 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.789 ' HB2' ' C ' ' A' ' 50' ' ' SER . 4.1 p -88.55 75.93 8.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.4 59.0 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 161.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -100.27 -45.69 5.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.331 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.789 ' C ' ' HB2' ' A' ' 47' ' ' SER . 49.4 m -103.42 -147.32 0.38 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.79 9.07 0.45 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.111 0.481 . . . . 0.0 110.476 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.19 -8.8 26.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.528 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.637 ' HB2' ' N ' ' A' ' 47' ' ' SER . 29.8 m-85 -95.8 1.9 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -168.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.32 104.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.026 0.917 . . . . 0.0 110.875 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.526 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 46.7 mt-30 -95.6 164.12 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.485 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 43' ' ' ILE . 49.5 t -131.07 112.21 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.639 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 mm? -82.29 -55.32 4.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.052 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.65 153.42 30.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.72 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 26.2 p -133.44 109.86 9.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -97.99 135.4 32.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.922 -169.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.8 mt -105.25 103.23 12.73 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.201 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.71 131.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.45 -159.51 11.26 Favored Glycine 0 CA--C 1.494 -1.248 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.998 -164.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.692 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 37.1 Cg_endo -63.71 114.78 2.71 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.733 HG21 ' HE2' ' A' ' 28' ' ' PHE . 35.1 m -110.71 145.36 32.17 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.85 -174.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 136.86 26.69 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.701 2.267 . . . . 0.0 111.448 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -46.76 139.28 5.46 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 111.28 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 128.84 135.1 3.91 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.895 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.2 ptt180 -76.65 130.4 37.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.432 1.111 . . . . 0.0 111.062 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 12.5 p80 -149.98 143.61 25.31 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.038 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.648 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.2 OUTLIER -93.02 146.44 23.62 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.566 0.698 . . . . 0.0 112.537 -174.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.56 ' N ' ' HG2' ' A' ' 71' ' ' MET . 3.0 p90 -133.6 160.74 36.6 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 1.7 p -118.75 139.32 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 121.734 0.778 . . . . 0.0 111.091 -172.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.734 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -121.96 125.87 47.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.95 -166.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.792 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.2 mt-30 -144.19 148.23 34.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.989 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.02 128.62 0.73 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.569 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.608 ' O ' HD12 ' A' ' 57' ' ' LEU . 6.0 p-10 -62.12 165.11 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.646 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.532 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -59.01 160.73 10.51 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -170.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.78 ' HG3' ' CD2' ' A' ' 44' ' ' TYR . 60.5 Cg_endo -67.67 178.67 3.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.75 2.967 . . . . 0.0 111.673 175.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 91.6 m-20 -72.13 119.45 74.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.249 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -64.07 -19.58 66.45 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.347 2.698 . . . . 0.0 111.756 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.19 -9.1 77.24 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.361 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.526 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 5.7 mt -94.1 -25.36 17.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.993 0.396 . . . . 0.0 110.91 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 21.2 mt -78.7 127.84 79.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.797 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 96.3 Cg_endo -78.21 163.23 27.93 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.396 2.73 . . . . 0.0 112.231 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.676 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 15.2 t70 -44.53 -57.06 3.83 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.32 1.048 . . . . 0.0 113.614 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' B' ' 122' ' ' LYS . . . -74.22 -20.88 60.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.776 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.87 -33.82 22.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.356 0.598 . . . . 0.0 109.658 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -77.2 -42.51 37.24 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.752 -171.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.4 m -103.08 47.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.634 0.73 . . . . 0.0 112.075 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -119.98 0.55 Allowed Glycine 0 CA--C 1.504 -0.601 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.15 -169.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.463 HG13 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -112.88 141.15 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 1.01 ' HB ' HG13 ' A' ' 113' ' ' VAL . 24.2 m -143.08 167.96 20.86 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 112' ' ' TYR . 3.2 t -134.42 139.08 48.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 170.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 111' ' ' TYR . 1.8 p -119.82 104.97 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.2 pp -101.27 131.51 47.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.385 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.737 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.2 mt -99.42 92.68 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.79 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 73.1 p -91.09 112.99 25.13 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 89.7 m -76.69 156.29 32.66 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.008 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.0 m -150.96 108.66 3.67 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -170.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.685 ' CZ ' HD12 ' A' ' 34' ' ' LEU . 79.5 t80 -126.76 132.77 50.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.3 mmm180 67.22 12.56 9.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.493 0.496 . . . . 0.0 111.998 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.6 56.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.118 174.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.803 ' CG ' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.2 149.17 43.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 23.8 mp0 -95.66 134.59 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.069 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 99' ' ' CYS . 53.4 p90 -120.52 -3.76 9.86 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -170.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.828 ' O ' ' HA ' ' A' ' 98' ' ' THR . 10.6 tt -155.48 161.21 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 O-C-N 121.209 -0.932 . . . . 0.0 109.058 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.834 HH21 HG21 ' A' ' 147' ' ' THR . 0.4 OUTLIER -153.91 99.47 2.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.927 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.3 p -87.16 101.79 11.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.088 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -86.8 86.52 1.55 Allowed Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 118.943 -1.598 . . . . 0.0 111.129 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.884 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.6 m-85 -73.91 115.2 13.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.276 -0.962 . . . . 0.0 109.538 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 140' ' ' LEU . 3.3 m-85 -67.06 112.94 4.66 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.479 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.01 HG13 ' HB ' ' A' ' 93' ' ' THR . 2.4 p -104.31 111.31 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.463 HD21 HG13 ' A' ' 92' ' ' VAL . 1.6 t-20 -96.5 113.65 25.24 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.852 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.8 m-20 -94.65 109.15 21.11 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.48 0.657 . . . . 0.0 109.415 -170.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.47 124.41 40.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.828 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.607 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 42.9 m-85 -39.39 149.43 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 136' ' ' GLN . 29.8 p -87.58 -32.82 19.14 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.544 -174.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.2 mt-10 -87.78 126.39 34.98 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.262 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.596 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 22.0 m -56.27 -31.22 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.164 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.64 -37.89 76.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.595 0.712 . . . . 0.0 110.008 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 45.2 mt -71.29 -25.41 62.43 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.329 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -73.81 -36.94 65.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.598 0.713 . . . . 0.0 109.136 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.6 mm-40 -66.82 -36.78 83.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.982 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -143.42 87.99 8.19 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.679 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 115.04 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.664 2.243 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.607 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 89.2 Cg_exo -51.06 163.77 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.847 2.364 . . . . 0.0 111.783 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 129' ' ' LYS . 40.5 t -51.87 -52.17 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.166 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.559 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 1.7 mmtt -116.96 121.24 32.89 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 121.435 0.636 . . . . 0.0 110.928 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.676 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 16.3 Cg_exo -35.32 131.73 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 1 C-N-CA 125.778 4.319 . . . . 0.0 114.34 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 117' ' ' TYR . 17.0 t70 -105.42 109.27 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.71 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 40.2 m-85 -75.32 -17.26 60.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.94 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -84.2 -25.43 29.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.262 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 72.8 mmtt -95.51 6.16 49.69 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 115' ' ' ASN . 31.1 tp -92.36 127.84 37.99 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.578 -173.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 1.3 tt0 -111.6 114.46 27.53 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.782 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.9 ptt180 -90.46 111.44 22.71 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.413 0.625 . . . . 0.0 111.05 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 19.7 t30 -87.89 98.06 11.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.105 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.539 HG21 HG11 ' A' ' 11' ' ' VAL . 2.2 mp -73.43 101.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 112' ' ' TYR . 76.7 mt -63.0 89.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.325 0.583 . . . . 0.0 110.792 -176.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.884 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -77.83 -9.71 59.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.96 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 5.7 p -79.55 -15.6 57.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 172.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.422 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 47.3 t-20 -128.29 66.69 73.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.94 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 142' ' ' SER . 4.5 Cg_exo -83.05 105.01 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.03 1.82 . . . . 0.0 110.616 170.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -83.7 81.32 8.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.46 ' CG1' HG23 ' A' ' 109' ' ' VAL . 7.2 m -79.28 106.68 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.543 . . . . 0.0 111.722 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.834 HG21 HH21 ' A' ' 108' ' ' ARG . 42.0 m -110.45 105.34 14.29 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -113.13 123.82 51.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.597 0.713 . . . . 0.0 110.396 -175.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.02 168.24 9.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.728 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -104.11 111.92 24.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.803 ' HB ' ' CG ' ' A' ' 104' ' ' GLN . 18.3 pt -118.13 172.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.893 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 154' ' ' GLU . 3.4 p30 -101.98 97.67 7.98 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.595 1.188 . . . . 0.0 109.903 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.488 ' HA ' ' CD2' ' A' ' 101' ' ' TYR . 13.1 m95 -67.98 0.82 3.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.732 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 152' ' ' ASN . 34.6 mt-10 . . . . . 0 N--CA 1.437 -1.102 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.584 -173.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.6 ' HE2' ' HB1' ' A' ' 87' ' ' ALA . 12.9 mptt . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -37.11 -53.07 1.02 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 tp -70.9 -29.08 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' B' ' 129' ' ' ARG . 10.8 mm100 -65.69 -50.99 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.469 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.593 ' O ' HG13 ' B' ' 130' ' ' ILE . 2.5 mm? -63.82 -40.59 96.97 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.3 ptm180 -67.94 -25.87 65.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 15.7 mmm180 -80.08 -28.04 39.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.638 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 65.2 mt -76.77 1.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.088 0.947 . . . . 0.0 109.263 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 6.6 tpt180 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.212 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.783 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.869 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.5 mptp? -101.17 -21.34 14.97 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -168.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 38' ' ' LEU . 6.5 t -148.81 145.54 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.095 ' HG2' HD11 ' A' ' 31' ' ' ILE . 20.2 mm-40 -143.58 121.16 11.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.18 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.958 HG22 HD13 ' A' ' 107' ' ' ILE . 35.7 m -79.62 117.34 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 117.583 -1.647 . . . . 0.0 109.274 171.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.448 ' N ' HD22 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -86.54 -73.38 0.46 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.522 -172.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.21 109.94 21.87 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.942 -178.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.61 ' N ' HD22 ' A' ' 8' ' ' ASN . 3.1 p -96.13 99.92 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.415 0.626 . . . . 0.0 109.352 169.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.985 HG23 ' HB3' ' A' ' 25' ' ' GLU . 4.1 m -91.19 98.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.829 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -76.43 129.67 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.471 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -99.59 -36.89 9.37 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.979 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.992 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 11.3 t70 -63.33 39.88 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.656 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.807 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -79.73 171.54 12.17 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.847 171.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.831 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.8 Cg_endo -52.65 103.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.5 1.466 . . . . 0.0 114.003 -146.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.567 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 14.9 m -133.37 169.77 13.09 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 112.863 -1.972 . . . . 0.0 109.183 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.1 Cg_exo -39.54 131.61 1.71 Allowed 'Trans proline' 0 C--O 1.21 -0.875 0 C-N-CA 122.943 2.429 . . . . 0.0 111.744 171.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.91 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 17.2 t80 -58.38 -17.86 23.46 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 133' ' ' SER . 7.1 m-30 -83.43 -3.99 58.08 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.781 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 33.0 p-10 -61.13 143.96 91.69 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 165.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.679 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 11.9 Cg_exo -83.37 135.99 7.44 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.643 2.229 . . . . 0.0 111.443 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.778 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 40.8 m-85 -50.49 113.38 0.87 Allowed 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 122.965 0.506 . . . . 0.0 111.351 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.992 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 24.4 mt-30 -112.65 103.82 11.87 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.315 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.603 ' CD1' HD11 ' A' ' 97' ' ' ILE . 91.2 m-85 -108.51 149.79 28.34 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.985 ' HB3' HG23 ' A' ' 10' ' ' VAL . 40.7 tt0 -123.54 87.35 2.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 168.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.449 HG21 HG11 ' A' ' 6' ' ' VAL . 15.9 mt -79.97 137.06 22.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.499 -173.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 58.6 m -115.52 104.7 11.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.619 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.921 ' HB3' HG12 ' A' ' 6' ' ' VAL . 28.2 p90 -106.47 146.78 30.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.659 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.5 tt0 -100.2 114.57 28.09 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.721 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 10.0 m -71.85 101.48 2.64 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.095 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.3 mt -64.71 -34.09 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.263 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 35.1 mt-10 -142.92 179.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.338 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.79 128.58 35.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.959 0.409 . . . . 0.0 110.204 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.836 HD12 ' CE2' ' A' ' 101' ' ' TYR . 4.0 mm? -88.54 149.03 23.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.985 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.1 p -114.92 -37.22 4.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.978 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.3 tt0 -105.97 -171.34 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.743 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 30.7 m-20 -100.52 142.61 31.76 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.507 0.67 . . . . 0.0 110.62 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -81.47 119.61 23.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.059 173.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.754 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.2 tt0 -102.57 88.04 3.14 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.802 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.825 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 61.7 m95 -80.76 119.75 23.75 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.774 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 11.6 ttmt -126.47 139.58 53.13 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.303 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.671 HG22 HG22 ' A' ' 95' ' ' VAL . 13.2 mt -103.22 109.21 26.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.759 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.2 mp -107.43 106.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.953 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.768 ' CE1' HG11 ' A' ' 113' ' ' VAL . 61.8 t80 -86.36 119.25 26.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.438 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.61 101.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.298 0.571 . . . . 0.0 109.625 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.23 88.79 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.523 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 41.2 t -128.79 128.16 43.41 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.766 0.793 . . . . 0.0 110.129 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -85.13 -2.59 58.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.232 170.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.76 -38.32 11.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.847 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.575 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 49.6 m -134.85 121.1 20.15 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.476 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.67 ' HB3' ' OE1' ' B' ' 125' ' ' GLN . 10.3 pt-20 -64.7 -14.11 57.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.269 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.69 1.77 11.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.61 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 89.9 m-85 -105.16 -0.81 26.19 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 31.6 p-10 -53.08 110.61 0.55 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.244 1.021 . . . . 0.0 111.488 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 4.4 mt-30 -92.58 170.01 10.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.426 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 43' ' ' ILE . 54.8 t -130.84 107.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.888 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.7 mm? -76.08 -41.2 51.2 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.362 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -176.46 170.93 2.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 45.5 p -145.63 118.05 8.49 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -100.03 134.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.715 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.6 mt -108.91 104.04 13.2 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 9.0 t -119.7 107.44 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.714 ' CA ' ' HA ' ' A' ' 37' ' ' ASP . . . -102.3 -104.08 2.78 Favored Glycine 0 CA--C 1.475 -2.469 0 C-N-CA 118.831 -1.652 . . . . 0.0 112.926 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.48 113.45 0.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.127 1.884 . . . . 0.0 111.625 176.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 63' ' ' GLY . 30.3 m -141.9 122.68 8.55 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.871 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.07 130.48 22.95 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.184 1.923 . . . . 0.0 110.495 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.721 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.94 133.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.936 0.773 . . . . 0.0 112.117 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 151.64 117.12 0.74 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -173.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.932 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 24.2 ttt180 -66.21 111.87 3.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.772 0.796 . . . . 0.0 110.816 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.7 p80 -145.67 160.81 41.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.87 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.667 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.97 141.64 46.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.515 0.674 . . . . 0.0 112.615 -174.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.627 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.2 p90 -131.69 160.21 36.11 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.8 p -119.24 138.22 50.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.695 0.76 . . . . 0.0 110.278 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.627 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -139.93 121.15 14.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.365 -160.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.778 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -137.81 157.55 46.2 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.97 159.28 26.34 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.82 179.14 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.887 0.851 . . . . 0.0 112.824 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -82.05 151.45 66.85 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.448 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.65 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 65.8 Cg_exo -53.79 153.6 19.06 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 123.995 3.13 . . . . 0.0 113.515 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.438 ' HB2' HD12 ' A' ' 83' ' ' LEU . 17.3 m120 -71.63 113.58 20.99 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.24 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -65.71 -21.28 58.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.891 2.394 . . . . 0.0 111.623 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 5.0 83.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.219 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.474 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 35.1 mt -113.38 -20.34 11.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.561 0.22 . . . . 0.0 111.213 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.572 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 30.2 mt -84.62 129.51 56.9 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 1.2 Cg_endo -80.06 159.36 23.83 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.914 2.409 . . . . 0.0 112.128 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.762 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 4.7 m-20 -47.31 -50.19 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.444 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.27 69.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -169.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.555 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 44.0 m-20 -93.94 -17.99 22.39 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -172.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.29 -47.49 23.53 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-O 121.173 0.511 . . . . 0.0 111.824 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -92.39 47.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.67 -122.58 0.68 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.789 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.428 HG13 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -110.51 141.23 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 121.746 0.784 . . . . 0.0 112.456 -173.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.93 168.38 24.7 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.132 173.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.491 HG11 HD11 ' B' ' 130' ' ' ILE . 3.4 t -124.81 147.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.832 174.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.671 HG22 HG22 ' A' ' 42' ' ' ILE . 9.6 p -129.7 107.3 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -103.01 135.43 44.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.272 -169.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.774 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 59.9 mt -102.18 93.07 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.803 0.811 . . . . 0.0 109.149 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 108' ' ' ARG . 51.9 p -93.96 114.93 27.23 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.592 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.954 ' SG ' HG22 ' A' ' 107' ' ' ILE . 7.0 p -84.82 137.32 33.24 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.947 175.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 51.9 m -118.8 114.94 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.255 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.836 ' CE2' HD12 ' A' ' 34' ' ' LEU . 45.3 t80 -127.32 126.3 42.34 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 102' ' ' ARG . 1.8 mmp_? 69.14 14.53 8.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.464 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.15 4.1 69.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -125.73 132.25 52.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.559 -0.82 . . . . 0.0 109.543 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.2 mp0 -76.26 142.06 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.009 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.737 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 2.8 p90 -115.68 -18.59 10.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.958 HD13 HG22 ' A' ' 6' ' ' VAL . 10.3 tt -159.7 156.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.682 HH21 HG21 ' A' ' 147' ' ' THR . 10.6 ttp180 -145.38 124.85 13.13 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -101.4 102.2 13.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 122.158 0.98 . . . . 0.0 109.758 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.55 79.98 1.84 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.239 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.854 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 7.3 m-85 -79.72 123.13 27.39 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.566 ' CE2' HD23 ' B' ' 126' ' ' LEU . 5.8 m-85 -67.38 129.98 41.6 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.768 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.2 p -108.93 110.9 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.428 HD21 HG13 ' A' ' 92' ' ' VAL . 1.4 t-20 -96.72 121.17 38.28 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.21 -177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.691 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.4 m-80 -110.57 110.81 21.67 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.993 0.901 . . . . 0.0 109.017 -171.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -125.81 125.08 42.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.617 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.632 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 18.9 m-85 -39.97 146.61 0.11 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -85.49 -33.77 21.76 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.202 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -88.76 125.93 35.1 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.487 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -59.78 -28.21 67.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.789 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.14 -39.78 94.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.8 0.81 . . . . 0.0 109.614 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 77.6 mt -72.72 -27.87 62.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.713 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 43.3 mtp180 -76.4 -29.34 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.404 0.621 . . . . 0.0 109.412 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.31 -41.68 84.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.136 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -145.62 80.39 10.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.66 113.07 1.07 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.313 2.676 . . . . 0.0 112.455 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.632 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 52.7 Cg_exo -57.19 134.94 67.43 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.758 2.305 . . . . 0.0 110.702 174.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.527 HG13 ' HE2' ' A' ' 129' ' ' LYS . 3.4 p -56.02 -38.27 52.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.184 -171.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.527 ' HE2' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -91.09 107.72 23.15 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-O 121.088 0.471 . . . . 0.0 110.444 169.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.762 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 35.6 Cg_exo -45.93 140.18 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.593 3.529 . . . . 0.0 113.366 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.5 t0 -110.44 107.27 16.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.648 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 38.2 m-85 -77.48 -20.0 55.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.996 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 64.7 p -85.88 -21.55 27.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.483 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.3 mmtt -102.79 17.12 24.66 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.0 tp -99.62 132.32 45.03 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.015 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.36 118.11 31.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.91 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -93.37 105.38 17.45 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.28 0.562 . . . . 0.0 111.257 -177.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 12.6 t30 -85.55 98.18 10.48 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.461 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.754 HG21 HG11 ' A' ' 11' ' ' VAL . 1.5 mp -70.66 107.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.08 86.29 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.578 0.704 . . . . 0.0 110.446 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -76.49 -11.29 59.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.729 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.7 t -88.24 6.18 38.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.928 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.437 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 33.6 t-20 -139.16 64.92 34.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 1.8 Cg_endo -84.37 105.61 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.33 2.02 . . . . 0.0 111.264 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.517 ' HB3' HD13 ' B' ' 130' ' ' ILE . 5.5 tpt180 -84.24 85.4 7.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 3.3 p -87.63 110.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.894 -174.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.682 HG21 HH21 ' A' ' 108' ' ' ARG . 90.2 m -112.05 107.69 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.814 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.0 ptt180 -105.39 135.82 46.07 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.422 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -110.26 170.59 7.98 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.843 -174.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -104.96 120.17 40.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.683 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.63 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 40.5 pt -132.38 155.84 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.056 0.455 . . . . 0.0 110.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.513 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -82.17 94.51 7.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.136 0.97 . . . . 0.0 110.686 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.869 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 9.8 m95 -69.34 -4.33 17.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.956 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.431 -1.402 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.465 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.503 ' C ' HD22 ' B' ' 126' ' ' LEU . 3.3 mptp? . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -50.56 -32.95 20.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.139 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.43 HG23 ' N ' ' B' ' 125' ' ' GLN . 7.9 tp -69.37 -40.77 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 122.062 0.934 . . . . 0.0 109.576 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.68 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 6.6 tp-100 -71.69 -47.0 57.04 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.791 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.566 HD23 ' CE2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -59.94 -44.96 94.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.186 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.15 -44.93 94.59 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.054 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -53.98 -45.7 71.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.489 ' HB3' HD21 ' A' ' 96' ' ' LEU . 2.0 mmp_? -69.01 -45.84 69.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.374 -176.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 14.9 mt -75.11 -30.08 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.441 . . . . 0.0 111.546 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 . . . . . 0 C--N 1.315 -0.909 0 CA-C-O 121.611 0.72 . . . . 0.0 109.388 176.674 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.546 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.67 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 11.9 mmtt -100.64 -11.64 19.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.282 -175.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.71 122.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 0.0 110.772 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.531 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -121.3 100.18 6.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 171.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.742 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.1 m -79.45 140.17 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.306 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -120.13 -61.5 1.59 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.592 -164.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.681 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.2 t-20 -104.61 152.3 22.61 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.735 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 2.6 p -147.08 99.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.843 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.0 m -93.18 97.71 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.332 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 128.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.049 -178.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.934 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -98.59 -41.1 7.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.766 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.603 ' HB2' ' CB ' ' A' ' 23' ' ' GLN . 23.9 t0 -63.82 76.78 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.981 167.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.445 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -96.6 174.28 3.47 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.825 169.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.8 Cg_endo -51.71 104.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.797 1.665 . . . . 0.0 113.834 -157.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 37.3 m -135.01 171.03 9.69 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.46 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 89.8 Cg_exo -42.16 138.56 2.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.559 2.172 . . . . 0.0 112.148 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.834 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 28.2 t80 -55.83 -29.32 59.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.156 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.23 -19.69 53.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -62.02 132.47 93.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.2 Cg_exo -72.65 154.16 54.53 Favored 'Trans proline' 0 C--N 1.329 -0.467 0 C-N-CA 123.71 2.94 . . . . 0.0 113.577 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 78.2 m-85 -62.97 133.94 55.4 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.934 ' HG2' HD12 ' A' ' 12' ' ' LEU . 7.3 tt0 -136.68 83.05 1.98 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.633 -170.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.738 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 97.3 m-85 -97.05 153.98 17.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.125 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.843 ' HB3' HG23 ' A' ' 10' ' ' VAL . 36.7 tt0 -132.34 87.66 2.45 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 14.6 mt -88.11 122.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.706 0.765 . . . . 0.0 112.738 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.802 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 13.2 m -91.73 107.34 19.14 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.467 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.742 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 23.2 p90 -119.19 148.11 43.47 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.93 0.871 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.83 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 48.6 tt0 -103.45 114.93 29.59 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.39 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 5.0 t -73.36 107.08 5.46 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 171.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -74.98 -22.46 17.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.773 -173.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.67 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 1.5 mt-10 -154.87 167.1 31.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.985 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.32 143.68 55.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.79 0.329 . . . . 0.0 110.549 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.783 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 15.1 mt -95.21 152.67 18.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.091 0.472 . . . . 0.0 111.504 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.3 t -113.13 -35.56 5.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.666 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.795 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.0 tt0 -110.36 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.795 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 39.6 m-20 -98.29 141.6 30.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.573 0.701 . . . . 0.0 110.02 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.39 118.35 23.13 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.28 176.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.5 tt0 -105.72 90.13 3.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.86 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.604 ' CH2' HG11 ' A' ' 6' ' ' VAL . 16.5 m95 -78.58 153.28 31.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.838 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.9 ttmp? -153.31 140.59 19.55 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.213 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.13 115.32 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.842 HG12 HG12 ' A' ' 56' ' ' VAL . 88.0 mt -112.29 108.19 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.768 0.794 . . . . 0.0 109.855 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.649 ' CZ ' HG21 ' A' ' 93' ' ' THR . 76.7 t80 -88.18 130.91 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.084 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 53' ' ' TYR . 7.1 t -77.52 97.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 122.071 0.939 . . . . 0.0 110.01 173.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.786 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -81.85 -2.94 90.7 Favored Glycine 0 C--O 1.214 -1.133 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.086 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.544 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 22.8 m -162.57 80.17 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.453 0.627 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.83 -0.73 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.141 0.576 . . . . 0.0 112.491 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 47' ' ' SER . 1.7 mm-40 -95.49 -25.61 16.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.341 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.609 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 15.7 m -118.96 -153.36 0.53 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.769 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.2 pt-20 -149.27 20.89 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.807 0.813 . . . . 0.0 110.835 171.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.48 -34.58 10.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.988 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.769 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p90 -57.7 -49.17 77.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.738 -167.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.7 p-10 -34.95 105.3 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.235 1.585 . . . . 0.0 113.284 -158.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.551 ' CG ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -93.04 167.44 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.975 -175.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.842 HG12 HG12 ' A' ' 43' ' ' ILE . 19.9 m -128.0 124.97 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.546 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 4.1 mm? -89.54 -31.0 17.82 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.167 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -175.39 159.27 2.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.064 170.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 35.2 p -136.71 112.42 9.45 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.49 132.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.823 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.1 mt -108.7 103.65 12.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.627 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.0 t -96.08 121.13 46.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -86.17 -152.61 20.66 Favored Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.569 -164.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.7 Cg_endo -47.2 117.91 2.52 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.778 1.652 . . . . 0.0 109.468 168.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 34' ' ' LEU . 2.4 p -140.12 129.13 13.36 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.654 -171.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.02 128.33 26.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.117 1.878 . . . . 0.0 111.092 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -40.52 145.83 0.16 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.077 0.86 . . . . 0.0 111.977 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 150.05 122.46 1.12 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.83 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.5 ttt180 -68.87 113.99 6.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.776 0.798 . . . . 0.0 109.789 175.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.487 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.1 p80 -150.89 150.95 31.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.164 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.802 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -91.73 134.31 34.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.92 -178.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.404 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -121.54 150.41 41.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.94 139.81 36.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.662 0.744 . . . . 0.0 110.666 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.738 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -127.47 119.19 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 -164.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 16.4 mt-30 -134.14 153.75 51.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -166.69 158.84 13.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.7 -175.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.686 0.755 . . . . 0.0 112.448 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -88.51 151.89 48.81 Favored Pre-proline 0 N--CA 1.438 -1.055 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.784 175.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.711 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.3 Cg_exo -61.25 173.37 2.57 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.653 2.902 . . . . 0.0 113.071 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.9 m-20 -87.14 115.73 63.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.185 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.48 -23.16 74.38 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.407 2.738 . . . . 0.0 112.294 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.46 -13.97 77.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.61 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.551 HD12 ' CG ' ' A' ' 55' ' ' GLN . 3.1 mt -90.06 -28.79 18.8 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.734 -0.274 . . . . 0.0 110.789 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.786 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 31.9 mt -75.33 125.96 88.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.483 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.8 Cg_endo -80.94 165.31 19.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.03 3.153 . . . . 0.0 113.462 171.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 8.7 t0 -42.74 -48.18 5.55 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.989 171.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.99 -20.93 51.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -168.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.446 ' HB3' HG23 ' A' ' 84' ' ' ILE . 12.8 t70 -89.96 -38.36 13.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.142 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -72.27 -41.27 66.91 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -163.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.77 47.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.59 -126.92 1.0 Allowed Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.222 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.555 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -104.66 132.65 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 122.162 0.982 . . . . 0.0 113.03 -172.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 113' ' ' VAL . 15.8 m -133.07 167.44 20.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 113.0 -1.909 . . . . 0.0 106.976 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 96' ' ' LEU . 37.0 t -133.6 141.47 44.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 120.877 0.37 . . . . 0.0 111.175 177.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 22' ' ' PHE . 27.1 m -124.13 106.6 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.722 HD23 HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.27 137.11 34.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.353 -174.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.838 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 9.1 mt -109.45 91.31 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.463 1.125 . . . . 0.0 108.89 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -90.51 125.69 35.68 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.624 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.659 ' HB2' HG22 ' A' ' 107' ' ' ILE . 72.0 m -90.03 153.53 20.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.248 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 18.5 m -150.1 113.5 4.94 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -168.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.661 ' HB3' HD11 ' A' ' 151' ' ' ILE . 55.4 t80 -128.05 124.04 36.1 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 31.4 mtp180 64.28 35.77 9.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.461 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.82 -1.96 87.28 Favored Glycine 0 C--N 1.317 -0.482 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.554 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.418 ' NE2' HD21 ' A' ' 152' ' ' ASN . 19.0 mt-30 -118.62 131.25 56.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.085 0.469 . . . . 0.0 109.932 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 24.0 mt-10 -89.3 136.1 33.21 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.292 -173.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 51.7 p90 -122.91 0.99 9.27 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.828 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.0 tt -156.62 159.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 O-C-N 121.37 -0.831 . . . . 0.0 109.255 171.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' CZ ' ' HZ ' ' A' ' 149' ' ' PHE . 9.9 ttm180 -153.21 89.13 1.34 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.588 0.555 . . . . 0.0 109.683 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.738 HG12 ' HB ' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -86.93 100.86 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.352 1.073 . . . . 0.0 108.332 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 96' ' ' LEU . . . -91.02 87.48 1.36 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.437 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.996 ' HE2' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -74.57 116.67 15.52 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.488 ' CB ' HD12 ' A' ' 140' ' ' LEU . 7.1 m-85 -67.26 117.98 10.01 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.627 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.748 HG13 ' HB ' ' A' ' 93' ' ' THR . 9.0 p -99.7 110.24 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.555 ' ND2' HG13 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -91.61 114.27 26.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.867 -176.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 86.3 m-20 -99.48 106.38 18.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 124.72 39.38 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.35 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 28.1 m-85 -40.21 149.55 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.0 p -87.31 -33.64 19.15 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.783 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 17.1 mt-10 -86.63 134.16 33.64 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.716 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.585 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 90.6 m -57.17 -38.83 74.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -51.81 -39.51 58.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.053 0.93 . . . . 0.0 109.642 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -84.13 -30.01 26.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.927 -173.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 23.4 mtp180 -77.63 -41.7 37.52 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.361 0.6 . . . . 0.0 110.025 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.778 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 2.8 pt-20 -79.09 -20.74 48.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.017 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.778 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.3 OUTLIER -150.11 82.45 6.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-O 121.719 0.771 . . . . 0.0 109.987 169.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 15.7 Cg_endo -56.18 121.46 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.788 2.992 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.565 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 17.5 Cg_exo -68.68 147.24 69.29 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.843 2.362 . . . . 0.0 110.583 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -28.99 45.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.616 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.503 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 2.1 mmtt -103.84 131.78 21.66 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.232 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.59 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_exo -70.06 140.94 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.527 2.818 . . . . 0.0 113.133 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 8.7 t0 -119.6 111.41 18.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.605 ' CE1' ' HB ' ' A' ' 84' ' ' ILE . 18.5 m-85 -78.51 -22.81 46.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.005 0.907 . . . . 0.0 110.293 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -80.25 -17.7 51.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.212 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.8 mmtt -106.94 16.38 24.34 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.2 tp -102.4 126.5 49.45 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.191 -170.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.442 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -112.13 118.0 34.15 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.834 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -95.57 107.06 19.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.5 0.667 . . . . 0.0 111.081 -172.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 6.3 t30 -91.03 104.91 17.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.94 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.546 HD13 ' O ' ' A' ' 13' ' ' ASP . 3.6 mp -81.15 108.98 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.427 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.488 HD12 ' CB ' ' A' ' 112' ' ' TYR . 91.4 mt -64.58 89.95 0.07 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.155 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.996 ' HA ' ' HE2' ' A' ' 111' ' ' TYR . . . -79.6 -7.13 58.33 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.259 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 p -93.24 -1.88 55.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.741 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -141.67 75.64 21.55 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.402 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 57.2 Cg_endo -88.15 106.41 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.37 2.047 . . . . 0.0 111.533 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -80.69 80.1 7.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.983 0.421 . . . . 0.0 110.586 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.541 ' HB ' HG23 ' A' ' 109' ' ' VAL . 4.9 p -94.6 111.18 24.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 111.927 -173.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -108.65 106.36 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.467 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 3.6 ptt180 -113.45 131.42 56.03 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.527 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -118.44 168.63 10.47 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.673 -174.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.51 152.81 21.24 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.057 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 101' ' ' TYR . 23.4 pt -143.07 174.71 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.418 HD21 ' NE2' ' A' ' 104' ' ' GLN . 0.2 OUTLIER -92.12 96.32 10.26 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.388 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.604 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 18.4 m95 -74.2 -6.52 48.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.514 0.673 . . . . 0.0 109.949 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 . . . . . 0 N--CA 1.441 -0.899 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.158 175.631 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 2.5 mppt? . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -44.38 -52.91 7.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 tt -61.92 -36.05 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 111.623 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.857 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 9.2 mm100 -74.96 -39.04 61.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.591 0.71 . . . . 0.0 110.936 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.568 HD23 HG11 ' A' ' 45' ' ' VAL . 29.0 mt -63.22 -36.77 84.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.936 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -68.76 -33.74 74.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.998 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.857 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 8.5 mmm180 -48.74 -47.38 41.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.344 0.592 . . . . 0.0 109.437 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.41 ' HG3' HG22 ' A' ' 45' ' ' VAL . 4.4 mmp_? -73.91 -48.79 28.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.689 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.936 HG13 ' HA ' ' B' ' 127' ' ' ALA . 2.6 pp -66.87 -17.68 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . 0.471 ' HG2' HD12 ' B' ' 130' ' ' ILE . 34.7 mmt180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.607 0.241 . . . . 0.0 110.951 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.844 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.85 -21.16 20.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -177.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 3.4 t -141.99 134.21 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.667 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.655 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -137.09 105.39 5.73 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.316 176.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.754 HG12 ' CD1' ' A' ' 28' ' ' PHE . 27.5 m -70.29 149.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.301 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 29' ' ' GLU . 53.5 m-80 -127.93 -59.34 1.19 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.073 -168.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.8 t-20 -104.01 150.84 23.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.139 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.3 p -145.64 98.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.88 97.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 122.403 1.096 . . . . 0.0 108.858 -177.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.54 133.45 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.193 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.01 HD12 ' HG2' ' A' ' 23' ' ' GLN . 8.7 mt -110.53 -42.62 4.04 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.626 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 2.9 p-10 -68.17 44.94 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.662 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.675 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.34 175.74 4.21 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.706 177.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.6 Cg_endo -49.78 103.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.562 1.593 . . . . 0.0 113.187 -150.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.675 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -148.89 172.0 5.67 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 111.648 -2.524 . . . . 0.0 107.627 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 59.6 Cg_exo -37.16 130.21 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.774 2.316 . . . . 0.0 112.969 174.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.758 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 8.9 t80 -55.43 -27.9 50.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.422 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -78.5 -14.22 59.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -69.93 138.43 87.69 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -73.34 133.07 18.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 112.76 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.708 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 88.8 m-85 -56.62 121.17 9.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.149 -176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 1.01 ' HG2' HD12 ' A' ' 12' ' ' LEU . 9.6 tt0 -128.92 92.35 3.38 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.949 -157.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' A' ' 97' ' ' ILE . 83.9 m-85 -106.1 115.05 29.56 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.666 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' A' ' 12' ' ' LEU . 22.1 tt0 -90.35 83.71 5.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.523 HG21 HG11 ' A' ' 6' ' ' VAL . 36.6 mt -82.12 141.4 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.671 0.748 . . . . 0.0 111.931 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 20.9 m -125.24 107.31 10.6 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.266 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.754 ' CD1' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.6 166.79 10.15 Favored 'General case' 0 CA--C 1.472 -2.027 0 C-N-CA 118.713 -1.195 . . . . 0.0 110.916 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 29.9 tt0 -117.65 107.54 14.34 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.816 -1.993 . . . . 0.0 106.023 168.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.3 m -72.46 108.04 5.33 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.597 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -72.48 -33.62 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.307 -169.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.844 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 6.0 mt-10 -143.74 171.68 13.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 p-10 -76.53 131.72 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.099 0.476 . . . . 0.0 110.964 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD12 HG22 ' A' ' 65' ' ' VAL . 7.9 mt -87.1 153.47 21.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.26 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -112.6 -31.3 6.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.695 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 20.2 tt0 -122.33 -168.99 1.82 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.695 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.2 p-10 -92.94 147.59 22.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 110.36 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.592 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -95.59 122.87 38.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.219 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.657 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 22.9 tt0 -103.92 89.93 3.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.065 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.822 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 50.0 m95 -82.66 115.46 21.61 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.8 ttmt -118.02 138.98 51.84 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.052 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.613 HG22 HG22 ' A' ' 95' ' ' VAL . 4.8 mt -104.78 123.29 58.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -114.15 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.796 -175.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.616 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.4 t80 -89.0 117.22 27.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.321 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.855 HG13 ' CE2' ' A' ' 53' ' ' TYR . 3.8 t -66.6 111.54 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.803 173.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.739 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -81.32 -63.1 1.89 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.437 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.613 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 15.1 m -102.15 70.77 1.22 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -47.98 -28.4 2.73 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.61 0.569 . . . . 0.0 111.733 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' B' ' 122' ' ' LYS . 4.8 tt0 -67.64 -18.46 64.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.068 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.691 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 24.2 m -115.25 -152.45 0.5 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.683 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.1 pt-20 -154.89 22.48 0.44 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.742 0.782 . . . . 0.0 111.05 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -100.18 -31.61 11.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.368 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.855 ' CE2' HG13 ' A' ' 45' ' ' VAL . 12.1 p90 -63.38 -42.53 98.85 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 125.752 1.621 . . . . 0.0 113.242 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.6 p-10 -23.55 113.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.033 1.458 . . . . 0.0 114.256 -161.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' HG2' HD12 ' A' ' 83' ' ' LEU . 1.4 mp0 -96.64 166.76 11.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.256 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.91 118.53 50.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.65 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.9 mm? -87.72 -48.84 7.55 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.934 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -166.0 161.82 17.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.1 p -139.1 113.23 8.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -98.86 130.64 47.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.7 mt -101.16 104.05 15.12 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.961 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.12 116.84 36.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -67.74 -168.34 4.12 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.304 -168.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -67.56 112.26 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 N-CA-C 109.573 -0.972 . . . . 0.0 109.573 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.735 HG22 HD12 ' A' ' 34' ' ' LEU . 27.4 m -110.68 117.37 50.84 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.525 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 59.6 Cg_endo -76.01 79.92 2.78 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 122.513 2.142 . . . . 0.0 113.09 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 52.43 174.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.629 -2.078 . . . . 0.0 112.494 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.74 117.53 3.35 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.107 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 ttt-85 -64.66 128.5 36.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.069 0.461 . . . . 0.0 110.312 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -164.84 158.23 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.103 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.486 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -113.37 144.46 42.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.411 0.624 . . . . 0.0 111.885 -175.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD1' ' HE1' ' A' ' 28' ' ' PHE . 2.1 p90 -132.37 160.33 36.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.1 127.44 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.46 1.124 . . . . 0.0 111.065 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -108.33 145.4 34.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.148 -168.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 22.2 mt-30 -150.08 152.04 34.16 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -159.68 118.64 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.599 0.237 . . . . 0.0 111.633 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.62 123.36 19.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.246 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -23.96 147.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 127.273 2.229 . . . . 0.0 116.962 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 38.7 Cg_endo -65.93 179.2 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.653 3.569 . . . . 0.0 112.722 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.41 122.12 85.47 Favored Pre-proline 0 CA--C 1.508 -0.654 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.393 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.45 -5.93 17.77 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.933 2.422 . . . . 0.0 111.471 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.17 -8.22 50.84 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.739 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 55' ' ' GLN . 27.0 mt -97.46 -8.73 28.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.046 0.45 . . . . 0.0 110.404 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.607 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 21.8 mt -95.33 125.39 50.14 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.158 171.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.613 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.4 Cg_endo -79.84 162.92 23.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.696 2.931 . . . . 0.0 111.472 171.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.774 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 4.0 m-20 -46.5 -53.67 10.78 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.77 82.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.666 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.495 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 61.1 m-20 -87.79 -16.89 32.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.682 -173.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.24 -46.13 29.57 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.643 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.98 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.502 0.668 . . . . 0.0 112.053 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.94 -132.47 1.55 Allowed Glycine 0 CA--C 1.498 -1.026 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.571 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.624 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.99 136.08 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.674 0.75 . . . . 0.0 112.785 -168.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.18 167.77 28.18 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.533 HG23 ' HG ' ' B' ' 126' ' ' LEU . 20.9 t -123.46 135.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.112 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.613 HG22 HG22 ' A' ' 42' ' ' ILE . 14.3 p -115.86 105.55 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 171.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.818 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.3 pp -103.41 147.68 26.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.728 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 109' ' ' VAL . 41.4 mt -112.26 102.87 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.667 0.746 . . . . 0.0 109.67 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 108' ' ' ARG . 78.0 p -101.32 110.05 22.0 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.668 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.005 ' SG ' HG22 ' A' ' 107' ' ' ILE . 11.9 p -75.62 152.2 37.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.81 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 31.3 m -142.01 103.26 4.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.616 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 89.9 t80 -113.18 122.11 46.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 37.5 mtp180 68.58 23.17 7.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.107 0.479 . . . . 0.0 111.628 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.56 76.03 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.253 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -128.96 123.68 33.12 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 16.2 mp0 -82.25 136.19 35.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 -173.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 52.3 p90 -128.62 -0.32 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.005 HG22 ' SG ' ' A' ' 99' ' ' CYS . 5.2 tt -157.63 160.34 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 O-C-N 121.178 -0.951 . . . . 0.0 108.799 169.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.849 ' HB2' HG22 ' A' ' 98' ' ' THR . 15.9 ttp180 -150.16 104.39 3.26 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.818 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.7 p -88.9 99.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.624 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -88.23 82.01 1.56 Allowed Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.251 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.999 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.7 m-85 -72.8 120.81 18.94 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.408 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB3' HD23 ' A' ' 140' ' ' LEU . 2.9 m-85 -66.84 123.7 20.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.5 p -107.96 111.26 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.723 ' HB2' HD21 ' A' ' 140' ' ' LEU . 0.5 OUTLIER -98.43 113.54 25.57 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.767 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 38.7 m-80 -97.31 132.14 43.33 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.353 0.597 . . . . 0.0 110.032 -174.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.32 134.46 22.76 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.786 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 31.7 m-85 -49.56 151.32 1.67 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.1 p -90.32 -34.42 15.72 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.013 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 9.1 mm-40 -75.32 121.98 23.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.791 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.9 m -50.3 -36.77 33.19 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.762 -172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -64.91 -40.16 94.65 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.615 0.722 . . . . 0.0 110.321 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.8 mt -73.36 -22.24 60.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.654 -176.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 10.4 mtt180 -78.73 -36.75 42.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.791 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.7 mm-40 -61.32 -44.13 97.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.012 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -145.73 85.95 7.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.059 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.16 115.67 2.73 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.047 2.498 . . . . 0.0 112.092 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.43 164.12 33.93 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.142 2.561 . . . . 0.0 111.498 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.01 -62.46 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.076 0.235 . . . . 0.0 110.708 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -67.77 125.79 91.77 Favored Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-O 121.731 0.777 . . . . 0.0 111.785 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.774 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 22.0 Cg_exo -70.27 139.2 37.92 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 124.215 3.277 . . . . 0.0 111.827 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.588 ' CG ' ' HG2' ' A' ' 134' ' ' LYS . 30.1 t0 -117.07 104.04 10.84 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.758 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 37.0 m-85 -74.01 -16.11 61.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.039 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.7 t -85.43 -21.51 28.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.283 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.588 ' HG2' ' CG ' ' A' ' 131' ' ' ASP . 47.0 mmtm -101.12 -0.5 36.04 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.6 tp -85.95 123.51 31.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.308 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.493 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 2.2 tt0 -108.39 116.93 32.89 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.837 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.56 119.63 38.37 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.74 -174.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.613 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.3 t30 -96.03 120.04 35.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.653 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.568 HG21 HG11 ' A' ' 11' ' ' VAL . 3.5 mm -88.34 102.13 12.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' A' ' 114' ' ' ASN . 3.1 mm? -60.21 84.6 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.999 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -63.47 -15.49 57.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.347 168.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.47 -18.14 55.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.107 171.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.99 60.21 33.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.176 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 84.6 Cg_endo -91.36 105.97 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.815 1.677 . . . . 0.0 110.741 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -82.13 81.54 8.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.554 HG12 HG23 ' A' ' 109' ' ' VAL . 17.0 m -78.55 114.54 19.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 111.56 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.657 HG21 HH21 ' A' ' 108' ' ' ARG . 53.7 m -120.4 105.31 10.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.398 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.771 ' HB3' HG13 ' A' ' 107' ' ' ILE . 1.7 ptt180 -106.01 133.87 50.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.51 0.671 . . . . 0.0 110.65 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HD2' ' CA ' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -109.18 168.56 9.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.781 -176.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.518 ' HD2' ' O ' ' A' ' 150' ' ' HIS . 0.9 OUTLIER -103.51 139.7 38.51 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 173.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.1 pt -139.68 -177.9 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.533 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -102.41 82.64 2.2 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.428 0.633 . . . . 0.0 111.34 -172.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.723 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.1 m95 -69.05 -11.98 61.27 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.932 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.413 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' B' ' 126' ' ' LEU . 12.0 mptt . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -35.23 -61.33 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.292 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 7.2 tt -69.39 -33.47 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.515 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 9.2 mm100 -63.23 -52.33 62.6 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.385 0.612 . . . . 0.0 110.822 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 94' ' ' VAL . 1.9 mm? -64.69 -36.37 84.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.129 177.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.97 -37.32 73.97 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 99.7 mtt180 -59.23 -47.83 83.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 111.156 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' B' ' 129' ' ' ARG . 18.1 mmm180 -74.44 -21.67 59.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.286 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.523 HD11 HG21 ' A' ' 94' ' ' VAL . 23.3 mt -93.19 -7.76 10.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.613 0.721 . . . . 0.0 109.885 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.469 174.334 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.872 0.367 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.757 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -91.42 -17.16 26.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.215 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.4 t -137.71 130.05 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.594 0.711 . . . . 0.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.503 HE22 ' HD3' ' A' ' 148' ' ' ARG . 26.1 tp60 -122.88 101.71 7.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.679 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -78.08 132.23 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -116.5 -69.58 0.84 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.207 -163.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.662 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.9 t-20 -93.04 152.68 19.15 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.8 -177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.4 p -146.4 107.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-O 122.244 1.021 . . . . 0.0 109.766 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.1 t -92.59 92.62 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.023 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.536 HG12 ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -76.45 120.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.309 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.005 HD12 ' HB3' ' A' ' 23' ' ' GLN . 4.6 mt -105.45 -40.11 5.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.647 -168.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 1.001 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 17.4 p-10 -67.01 38.25 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.454 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.601 ' HA ' ' HB ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -78.46 174.53 5.88 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.601 178.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.855 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 4.3 Cg_endo -50.05 103.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.802 1.668 . . . . 0.0 113.639 -153.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.5 m -146.34 171.43 6.44 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 111.236 -2.711 . . . . 0.0 106.715 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.646 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 45.5 Cg_exo -38.13 143.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.804 2.336 . . . . 0.0 112.407 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.908 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.3 t80 -60.42 -31.25 70.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.705 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -75.23 -11.27 60.03 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.608 0.242 . . . . 0.0 110.571 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.646 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -67.86 117.32 47.17 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 121.882 0.849 . . . . 0.0 109.271 168.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 46.4 Cg_exo -60.04 169.08 5.15 Favored 'Trans proline' 0 C--N 1.327 -0.571 1 C-N-CA 125.434 4.09 . . . . 0.0 114.291 -173.055 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.798 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 99.1 m-85 -78.27 103.25 8.09 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.552 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 1.005 ' HB3' HD12 ' A' ' 12' ' ' LEU . 2.6 mp0 -104.81 109.8 21.9 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.508 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.716 ' CD2' HD11 ' A' ' 97' ' ' ILE . 83.2 m-85 -123.48 101.4 7.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 1.102 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.9 tt0 -86.16 82.65 7.98 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.344 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.1 mt -87.88 129.27 39.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.081 -176.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.3 m -103.01 104.73 14.94 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 20.7 p90 -112.6 141.87 45.85 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.64 0.733 . . . . 0.0 110.025 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.864 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.6 tt0 -101.7 117.87 35.76 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t -73.85 104.88 4.89 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.473 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -71.48 -30.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.573 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.596 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 40.3 mt-10 -149.63 146.4 27.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.069 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.4 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 p-10 -60.24 138.88 57.85 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.739 0.649 . . . . 0.0 111.288 -170.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 38' ' ' LEU . 6.8 mt -95.35 151.08 19.58 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.876 -171.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.3 t -114.1 -25.75 8.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.307 0.575 . . . . 0.0 110.152 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.725 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 19.9 tt0 -121.39 -168.33 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.725 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.8 p-10 -94.41 135.4 35.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.506 0.669 . . . . 0.0 110.482 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -83.05 119.29 24.29 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.584 176.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 1.2 tm-20 -104.98 89.74 3.24 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.211 -171.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' O ' ' HA ' ' A' ' 59' ' ' SER . 9.6 m95 -82.25 139.93 33.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.0 ttmp? -138.92 145.69 40.16 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.831 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.26 116.48 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.682 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 4.0 mp -113.92 107.25 22.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.818 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.0 t80 -92.78 115.45 28.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.667 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 t -59.29 107.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.65 12.77 61.24 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -134.13 62.1 1.66 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.754 -0.723 . . . . 0.0 112.443 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB1' ' HG3' ' B' ' 122' ' ' LYS . . . -79.64 -10.91 59.87 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.672 0.749 . . . . 0.0 108.982 165.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -100.12 -46.83 5.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.239 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.488 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 49.3 m -105.61 -134.38 0.33 Allowed 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 9.0 pt-20 -154.45 -19.72 0.13 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -90.46 2.86 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 23.3 m-85 -93.61 0.36 56.52 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -54.07 95.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.89 0.852 . . . . 0.0 110.57 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -94.83 169.35 10.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.064 -173.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.0 t -126.11 117.65 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.996 -167.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.723 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 mm? -85.88 -58.22 2.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.183 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -153.35 152.6 31.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.134 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.2 p -134.75 110.87 9.51 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 72' ' ' PHE . 3.1 p -99.59 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.837 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 10.6 mt -105.89 104.65 14.41 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.303 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.25 113.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -164.9 4.21 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.497 -167.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 64.5 Cg_endo -68.29 113.88 3.24 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 120.812 1.008 . . . . 0.0 109.685 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.713 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 27.4 m -120.94 134.34 24.32 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.812 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 59.7 Cg_endo -81.57 78.68 3.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.106 1.871 . . . . 0.0 113.168 -176.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 51.0 -171.83 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.63 -2.077 . . . . 0.0 111.943 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.47 135.73 8.11 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.864 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.4 ttp180 -73.1 115.21 12.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.043 0.925 . . . . 0.0 111.195 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -114.38 118.03 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.231 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.695 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 20.5 ttp -87.82 103.3 15.51 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 173.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.497 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -110.02 128.39 55.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.04 -178.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.102 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -102.05 111.83 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 122.682 1.23 . . . . 0.0 111.376 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -72.61 143.42 48.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.652 -2.067 . . . . 0.0 109.614 179.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.917 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 25.3 mt-30 -152.55 145.2 24.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.23 134.5 2.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.4 p-10 -55.84 159.62 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.731 0.3 . . . . 0.0 110.756 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -76.03 164.65 58.89 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 123.061 0.544 . . . . 0.0 111.642 -167.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 36.0 Cg_endo -59.57 163.38 13.11 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.116 2.544 . . . . 0.0 112.127 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.5 m-20 -69.52 117.17 50.25 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.989 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.4 Cg_endo -61.23 -22.18 73.89 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.678 2.919 . . . . 0.0 112.33 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.37 -10.97 69.95 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.086 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.47 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 24.0 mt -91.14 -31.28 16.28 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 122.685 -0.303 . . . . 0.0 110.491 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 17.0 mt -74.76 124.73 89.82 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.42 ' O ' HG22 ' A' ' 84' ' ' ILE . 94.1 Cg_endo -79.15 163.51 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.776 2.984 . . . . 0.0 112.075 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.555 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 12.7 t70 -44.92 -55.42 5.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.02 62.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.25 0.548 . . . . 0.0 111.108 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 84' ' ' ILE . 10.9 t70 -97.25 -24.43 15.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.634 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -88.84 -46.26 9.09 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -101.34 49.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -170.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.79 -128.98 1.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.352 -168.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.744 HG22 ' ND2' ' A' ' 114' ' ' ASN . 21.5 t -109.89 133.61 54.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.598 -172.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.649 ' HB ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -144.16 170.42 16.0 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.616 HG23 HD13 ' B' ' 126' ' ' LEU . 3.3 t -129.89 145.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 118.719 0.69 . . . . 0.0 111.737 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.515 HG21 ' CE1' ' A' ' 22' ' ' PHE . 7.7 p -132.08 108.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.877 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.6 pp -107.37 147.3 30.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.255 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.716 HD11 ' CD2' ' A' ' 24' ' ' PHE . 36.8 mt -114.91 105.6 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 109.303 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.768 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 56.6 p -100.49 116.57 32.74 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.977 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.675 ' HB2' HG22 ' A' ' 107' ' ' ILE . 76.4 m -81.83 123.22 28.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.11 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 28.3 m -113.32 120.29 40.62 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.676 ' HB3' HD11 ' A' ' 151' ' ' ILE . 61.3 t80 -123.22 117.35 25.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.255 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.586 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.1 mtp180 66.08 23.81 11.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.445 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.05 54.94 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.892 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -111.26 132.52 54.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.931 175.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 33.4 mt-10 -83.38 130.06 35.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.595 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.0 p90 -118.29 1.5 11.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.846 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.4 tt -157.97 155.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.739 HH22 ' HG3' ' A' ' 145' ' ' ARG . 2.8 tmm_? -151.14 113.38 4.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -104.6 100.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.308 1.052 . . . . 0.0 109.689 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.504 ' HA3' HH11 ' A' ' 108' ' ' ARG . . . -93.03 87.14 1.2 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.98 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 88.7 m-85 -76.13 146.58 39.15 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 140' ' ' LEU . 6.6 m-85 -83.2 132.47 35.06 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.818 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.5 p -108.84 109.31 27.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.744 ' ND2' HG22 ' A' ' 92' ' ' VAL . 4.0 t-20 -97.51 108.47 21.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.187 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.673 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 42.7 m-80 -97.03 110.58 23.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.04 133.74 49.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 39.3 m-85 -42.69 157.49 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -95.74 -30.84 13.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.438 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.67 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 4.3 mm-40 -86.33 128.73 34.97 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.571 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.707 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.3 m -48.48 -46.45 38.2 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.08 0.4 . . . . 0.0 111.841 -172.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -53.59 -37.33 62.87 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.234 1.016 . . . . 0.0 110.115 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.59 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 48.2 mt -84.53 -24.74 29.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.919 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 60.9 mtp180 -78.48 -40.43 35.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.936 0.874 . . . . 0.0 108.689 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.74 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 12.6 pt-20 -73.38 -29.78 62.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.977 -177.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.74 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 1.8 p30 -153.73 90.79 3.31 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.006 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.81 117.99 4.69 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 122.889 2.393 . . . . 0.0 111.45 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.466 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 32.5 Cg_exo -59.5 151.38 69.45 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.375 2.05 . . . . 0.0 110.224 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.9 p -48.74 -29.02 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.286 -170.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -118.28 110.96 38.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-O 122.264 1.03 . . . . 0.0 113.451 173.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.629 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 7.0 Cg_exo -44.29 139.93 6.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 125.386 4.057 . . . . 0.0 113.659 174.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.9 t70 -120.23 116.61 25.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.896 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.633 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.7 m-85 -79.18 -16.33 56.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.878 0.846 . . . . 0.0 111.026 -170.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.1 m -83.09 -24.78 32.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.344 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.67 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.3 mmtt -101.23 13.98 33.42 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 115' ' ' ASN . 24.4 tp -98.08 144.7 27.29 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.855 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -125.22 125.76 44.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.908 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 16.7 mtm105 -91.17 104.38 16.95 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.163 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.583 ' C ' HD22 ' A' ' 138' ' ' ASN . 0.1 OUTLIER -89.7 90.99 8.47 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 170.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.853 HD11 HH12 ' A' ' 137' ' ' ARG . 1.3 mm -71.57 115.41 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.898 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 112' ' ' TYR . 35.8 mt -78.73 75.22 5.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.851 0.834 . . . . 0.0 110.797 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -71.7 -19.99 61.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.472 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 p -73.65 -11.96 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.741 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.02 66.96 33.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.627 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.613 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 66.1 Cg_endo -87.64 105.92 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.822 1.682 . . . . 0.0 111.787 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.739 ' HG3' HH22 ' A' ' 108' ' ' ARG . 8.7 tpt180 -76.01 88.57 2.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.501 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.3 p -95.24 137.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.431 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.7 m -145.76 107.9 4.38 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.761 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.846 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 1.0 OUTLIER -96.86 149.98 21.25 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.423 0.63 . . . . 0.0 110.244 175.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -122.16 169.51 10.81 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.404 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -104.83 125.31 50.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.26 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 101' ' ' TYR . 13.7 pt -135.96 173.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 154' ' ' GLU . 4.8 p30 -95.38 109.5 21.65 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.171 0.986 . . . . 0.0 109.675 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.757 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.3 m95 -82.41 15.58 2.43 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.067 171.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 152' ' ' ASN . 63.2 mm-40 . . . . . 0 N--CA 1.442 -0.831 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.559 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.693 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 3.2 mppt? . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 121.185 0.516 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.72 -55.01 15.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.012 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.457 ' HA ' ' HB3' ' B' ' 127' ' ' ALA . 14.4 tt -73.9 -26.02 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.14 -45.34 85.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 122.068 0.937 . . . . 0.0 110.161 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 24.6 mt -65.17 -43.52 91.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.648 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' B' ' 124' ' ' ILE . . . -59.28 -39.1 81.86 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.568 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -66.92 -47.02 73.01 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -39.98 95.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.642 HG12 ' NH1' ' A' ' 108' ' ' ARG . 5.1 mt -56.31 -60.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 113.099 -1.864 . . . . 0.0 112.533 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . 0.454 ' N ' HG22 ' B' ' 130' ' ' ILE . 12.4 mmm180 . . . . . 0 CA--C 1.515 -0.377 0 O-C-N 123.424 0.453 . . . . 0.0 110.991 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' C ' ' HE3' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 121.481 0.658 . . . . 0.0 112.273 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.711 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -95.14 -18.17 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.505 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.6 t -136.49 126.38 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.515 0.674 . . . . 0.0 110.241 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.588 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 18.7 tp60 -116.27 100.08 7.66 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.89 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -76.73 134.79 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.364 176.518 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.05 -62.72 1.56 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 -165.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.683 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.51 151.06 23.3 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.865 -176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.6 p -144.63 99.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.5 170.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.15 95.39 4.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.165 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -67.31 125.3 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.699 177.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.99 HD12 ' HG2' ' A' ' 23' ' ' GLN . 7.3 mt -97.31 -52.31 3.86 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.184 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.71 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 7.7 t70 -74.49 78.64 1.93 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.733 1.254 . . . . 0.0 110.456 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.715 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -82.38 178.09 2.63 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.437 165.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.895 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.9 Cg_endo -48.0 104.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.839 1.693 . . . . 0.0 114.619 -149.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.564 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.2 m -131.76 170.45 11.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 112.767 -2.015 . . . . 0.0 108.495 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 51.6 Cg_exo -46.85 144.58 7.91 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 111.636 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.712 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 11.3 t80 -61.36 -37.14 82.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.85 -0.85 32.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.897 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.597 HD21 ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -89.2 131.35 41.03 Favored Pre-proline 0 N--CA 1.431 -1.388 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 171.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -63.72 150.12 89.2 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 123.792 2.995 . . . . 0.0 114.364 -168.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 95.0 m-85 -66.12 139.15 58.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.103 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.99 ' HG2' HD12 ' A' ' 12' ' ' LEU . 7.8 tt0 -133.83 99.43 4.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.139 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.721 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.5 m-85 -103.37 155.72 18.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.294 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' ' 12' ' ' LEU . 39.5 tt0 -134.71 88.13 2.41 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.569 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 14.0 mt -86.85 131.52 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.941 0.877 . . . . 0.0 112.366 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 24.6 m -108.53 108.1 18.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.345 173.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 32.5 p90 -120.0 148.05 44.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.778 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.875 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 72.0 tt0 -106.76 115.01 29.45 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.64 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -72.68 111.64 8.02 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -77.67 -29.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.44 -174.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.619 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 42.2 mm-40 -151.81 154.77 36.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.437 0.46 . . . . 0.0 110.054 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.72 128.31 20.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.87 0.731 . . . . 0.0 111.256 -175.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.032 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -83.46 146.63 28.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.563 -170.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -113.2 -23.17 10.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.384 -172.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.834 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 29.3 tt0 -129.51 -164.85 1.45 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.834 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.3 m-20 -95.27 137.17 34.7 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.597 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.6 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 47.8 tt0 -105.66 89.7 3.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.571 -171.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.67 ' O ' ' HA ' ' A' ' 59' ' ' SER . 23.4 m95 -80.34 124.67 29.06 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.7 ttmt -130.93 142.5 50.36 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.72 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.716 HG22 HG22 ' A' ' 95' ' ' VAL . 12.5 mt -103.62 112.97 39.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.3 mp -104.43 105.74 19.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.647 ' CE2' HG11 ' A' ' 113' ' ' VAL . 33.5 t80 -90.42 111.87 23.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.795 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -53.43 109.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.253 0.549 . . . . 0.0 109.846 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.61 -45.56 52.5 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.452 -0.88 . . . . 0.0 110.97 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.834 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 91.4 p -128.1 125.02 38.41 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.358 0.599 . . . . 0.0 111.515 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -89.21 -0.1 57.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 161.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.584 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 4.8 mt-10 -88.5 -29.58 20.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.655 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 64.1 m -121.92 -107.88 0.35 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.593 173.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 7.0 pt-20 -179.98 -47.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.173 0.189 . . . . 0.0 111.327 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 38.0 mt-10 -72.83 1.15 9.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.088 0.47 . . . . 0.0 111.777 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 2.0 m-30 -80.73 -7.93 59.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -44.01 108.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.207 1.003 . . . . 0.0 111.057 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.644 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 40.8 mt-30 -92.71 169.44 10.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.512 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' CG1' ' HD3' ' A' ' 41' ' ' LYS . 46.1 t -130.67 110.35 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -172.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.6 mm? -75.54 -54.61 6.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.614 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 19.3 p-10 -160.38 170.43 21.05 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 67.5 p -146.92 115.39 6.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.1 p -99.63 134.65 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.382 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.7 OUTLIER -105.94 103.92 13.51 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.048 -175.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.59 118.74 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -79.72 -162.33 24.69 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.219 -165.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.032 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 31.4 Cg_endo -63.5 117.36 4.32 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.784 1.656 . . . . 0.0 110.806 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.499 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 23.1 m -128.0 137.56 31.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.857 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -82.02 77.23 3.91 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.23 1.953 . . . . 0.0 114.082 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . 51.85 177.37 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.116 -1.856 . . . . 0.0 112.618 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 110.68 129.62 5.61 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 172.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.875 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.3 ptt180 -79.87 128.06 33.0 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.321 1.058 . . . . 0.0 109.787 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -154.12 143.77 21.66 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.395 -177.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.53 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -92.85 136.23 33.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.533 -176.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 6.4 p90 -121.36 160.09 24.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 168.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.46 134.13 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-O 121.882 0.849 . . . . 0.0 110.808 -171.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -115.95 129.75 56.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.345 -164.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 19.3 mt-30 -151.67 143.7 23.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.941 0.4 . . . . 0.0 110.542 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -169.11 138.43 2.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.835 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.639 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.2 p-10 -72.96 156.19 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -174.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -44.1 156.93 0.3 Allowed Pre-proline 0 N--CA 1.443 -0.789 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.532 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 57.3 Cg_endo -66.97 170.57 12.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.841 3.027 . . . . 0.0 111.418 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.8 m-20 -66.55 117.83 48.07 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.0 Cg_endo -61.36 -25.74 80.6 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.544 2.829 . . . . 0.0 111.948 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.0 -11.29 82.77 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.311 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.644 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 25.2 mt -91.85 -21.91 20.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.644 0.259 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.515 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 10.1 mt -84.49 130.07 55.05 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.38 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 1.5 Cg_endo -79.96 161.19 23.95 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.123 2.549 . . . . 0.0 112.076 170.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.729 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -46.54 -53.32 11.56 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.07 69.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.178 0.513 . . . . 0.0 111.114 -167.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 9.8 m-20 -95.74 -19.88 19.32 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.754 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.04 -47.28 15.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.52 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.748 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -96.5 48.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.702 0.763 . . . . 0.0 111.542 -176.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.83 -129.73 1.15 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.089 -166.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.775 HG13 HD22 ' A' ' 114' ' ' ASN . 0.6 OUTLIER -119.91 125.3 74.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.344 0.593 . . . . 0.0 111.524 -173.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.14 169.65 15.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.611 HG23 HD13 ' B' ' 126' ' ' LEU . 2.4 t -126.45 142.53 42.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.266 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 42' ' ' ILE . 9.8 p -127.35 107.47 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 122.14 0.972 . . . . 0.0 108.613 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -104.02 138.93 39.84 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.345 -171.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 mt -102.81 95.57 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.819 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.6 p -96.7 116.04 28.45 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.599 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 40' ' ' TRP . 76.3 m -82.32 118.16 22.94 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.553 176.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 56.6 m -99.31 113.48 25.81 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.771 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.71 ' HB3' HD11 ' A' ' 151' ' ' ILE . 38.2 t80 -123.63 121.72 36.28 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.629 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 34.8 mtp180 63.02 27.37 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.063 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.35 66.51 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.653 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.12 135.44 55.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.165 0.507 . . . . 0.0 110.477 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 2.4 mp0 -82.18 128.96 34.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.597 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 51.4 p90 -111.65 2.41 17.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 98' ' ' THR . 9.3 tt -156.93 158.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.845 HH21 HG21 ' A' ' 147' ' ' THR . 31.3 ttp180 -151.1 107.51 3.48 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -96.86 99.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 118.699 -1.201 . . . . 0.0 108.339 171.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.737 ' HA3' HG21 ' B' ' 130' ' ' ILE . . . -87.42 79.51 1.77 Allowed Glycine 0 CA--C 1.483 -1.962 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.123 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.871 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.9 m-85 -71.58 116.05 11.48 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.122 -1.039 . . . . 0.0 109.082 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.722 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.96 114.58 5.88 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.689 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.647 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.4 p -101.97 110.45 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.775 HD22 HG13 ' A' ' 92' ' ' VAL . 2.0 t-20 -96.87 120.91 38.08 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 47.9 m-80 -108.12 108.95 20.24 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -169.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -127.45 125.01 39.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.18 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 29.6 m-85 -41.24 153.14 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -91.07 -32.81 15.74 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.749 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.562 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.39 130.04 35.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.788 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.631 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.7 m -56.31 -36.4 68.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.474 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.04 -37.82 78.78 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.564 0.697 . . . . 0.0 110.301 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 81.8 mt -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.647 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 mtp85 -75.63 -37.88 59.37 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.2 mm-40 -57.65 -37.43 73.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.821 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.541 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -160.23 98.53 1.44 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.973 177.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 13.2 Cg_endo -56.5 114.6 1.99 Allowed 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.061 2.508 . . . . 0.0 111.341 173.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.4 152.26 33.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.494 2.129 . . . . 0.0 110.794 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -51.12 -24.49 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.979 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 26.0 mttt -123.95 108.21 30.45 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 121.703 0.763 . . . . 0.0 111.676 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.748 ' HB3' HG13 ' A' ' 90' ' ' VAL . 8.9 Cg_exo -45.02 141.83 5.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 125.091 3.861 . . . . 0.0 113.456 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -114.41 114.79 26.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.655 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 14.5 m-85 -78.11 -16.89 57.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.67 0.748 . . . . 0.0 111.303 -168.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -85.47 -20.45 29.71 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.355 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.7 mmtt -101.96 5.38 40.74 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 115' ' ' ASN . 26.3 tp -86.82 143.68 27.37 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.362 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.465 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 2.3 tt0 -126.43 125.1 41.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.895 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.3 mtp-105 -83.68 104.34 13.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.889 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -98.32 103.5 15.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.695 HG21 HG11 ' A' ' 11' ' ' VAL . 1.5 mp -82.03 104.96 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.576 -173.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.722 HD12 ' HB3' ' A' ' 112' ' ' TYR . 83.5 mt -65.84 91.4 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.852 0.834 . . . . 0.0 111.029 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.871 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.88 -15.26 59.74 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.562 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -77.87 -16.01 58.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.411 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -134.35 67.27 72.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.19 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.578 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 90.5 Cg_endo -91.92 108.29 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.551 2.168 . . . . 0.0 110.951 175.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.614 ' HA ' ' NE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -75.53 80.29 2.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.504 -176.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 109' ' ' VAL . 5.2 m -79.18 111.16 15.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.845 HG21 HH21 ' A' ' 108' ' ' ARG . 31.3 m -132.15 106.61 8.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.142 0.496 . . . . 0.0 110.333 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -108.36 133.23 52.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.243 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.66 169.99 8.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.993 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -102.47 116.97 33.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.162 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.7 pt -119.55 179.59 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.194 0.521 . . . . 0.0 109.844 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.548 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -96.45 84.24 3.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 122.191 0.996 . . . . 0.0 112.242 -172.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.711 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 21.8 m95 -69.49 -9.27 53.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.321 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.51 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 4.5 mp0 . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.6 mmtt . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.013 0.435 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.16 -49.53 77.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.645 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . 0.495 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.7 tp -75.78 -27.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.052 0.453 . . . . 0.0 110.571 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.6 tm0? -56.48 -63.72 1.1 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.792 0.806 . . . . 0.0 109.905 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.611 HD13 HG23 ' A' ' 94' ' ' VAL . 62.0 mt -58.99 -44.08 91.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.486 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.892 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -57.25 -32.55 66.68 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 123.566 0.541 . . . . 0.0 111.74 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 96.1 mtt180 -53.11 -53.48 49.71 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -62.94 -38.57 91.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.641 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.892 HG13 ' HA ' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -92.88 6.93 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 120.981 0.419 . . . . 0.0 110.253 171.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.721 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 64.0 mmtt -100.3 -14.7 18.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.498 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 38' ' ' LEU . 2.1 t -150.98 137.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.353 0.597 . . . . 0.0 112.503 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.776 ' HG2' HD11 ' A' ' 31' ' ' ILE . 23.8 mm-40 -128.53 115.4 18.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.951 172.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.912 HG12 ' HB3' ' A' ' 28' ' ' PHE . 5.0 m -78.13 134.71 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.234 -1.786 . . . . 0.0 108.107 167.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.72 -62.09 1.49 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.434 -166.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.473 HD22 ' C ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -103.64 99.87 9.69 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.168 177.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.643 HG11 HG21 ' A' ' 109' ' ' VAL . 3.0 p -95.84 97.86 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -93.54 97.06 6.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 122.236 1.017 . . . . 0.0 108.687 -174.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.15 135.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.659 -176.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.934 HD12 ' HG2' ' A' ' 23' ' ' GLN . 5.7 mt -106.48 -48.21 3.6 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -172.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.69 78.52 0.83 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.653 1.692 . . . . 0.0 109.659 167.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.673 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -85.91 178.32 2.38 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 112.22 -2.264 . . . . 0.0 107.023 162.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.848 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.2 Cg_endo -49.43 103.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 121.73 1.653 . . . . 0.0 113.242 -157.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.692 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.6 m -132.49 171.11 9.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.668 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.1 Cg_exo -43.18 135.79 5.66 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.313 2.009 . . . . 0.0 111.253 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 12.6 t80 -60.46 -26.66 66.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.325 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.17 -7.68 59.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.999 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.22 142.94 76.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 170.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.4 Cg_exo -77.55 136.7 15.77 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 123.407 2.738 . . . . 0.0 113.139 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 32.5 m-85 -57.43 116.43 3.33 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.532 0.682 . . . . 0.0 110.729 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.934 ' HG2' HD12 ' A' ' 12' ' ' LEU . 9.6 tt0 -116.39 106.47 13.66 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.941 -165.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.674 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 92.7 m-85 -110.32 154.01 24.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.564 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 24.5 tt0 -121.69 87.06 2.68 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 167.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.503 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 74.8 mt -82.99 125.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.624 0.726 . . . . 0.0 112.281 -174.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 37.8 m -107.71 106.38 16.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.037 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.912 ' HB3' HG12 ' A' ' 6' ' ' VAL . 29.1 p90 -113.94 146.25 40.35 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.677 1.227 . . . . 0.0 110.924 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.982 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.1 tt0 -101.28 113.42 26.46 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.579 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.665 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -72.14 109.79 6.16 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.776 HD11 ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -70.53 -32.07 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.8 -2.0 . . . . 0.0 108.56 178.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 8.7 mm-40 -144.79 154.05 42.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.182 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.28 132.26 48.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.031 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 44.9 mt -83.06 158.63 22.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.682 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -113.1 -21.08 11.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.454 0.645 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.7 tt0 -126.44 -168.96 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.759 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.5 m-20 -90.63 149.91 21.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 34' ' ' LEU . 4.7 tp -96.38 123.65 40.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.435 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 82.4 tt0 -107.9 92.11 3.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.699 -169.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.687 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 46.2 m95 -88.64 127.78 35.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 22.7 ttmt -124.11 140.59 52.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.032 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.2 mt -104.13 107.26 21.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.111 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.6 mp -103.01 112.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.443 -174.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' A' ' 57' ' ' LEU . 13.4 t80 -96.9 114.2 25.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.492 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.11 103.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.58 -44.91 96.41 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.607 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 43.9 t -134.36 135.32 42.61 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.532 0.682 . . . . 0.0 109.634 176.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -83.61 -11.21 57.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -32.2 25.24 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.938 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.682 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 74.9 m -144.5 117.02 8.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.021 0.915 . . . . 0.0 111.342 166.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' OE2' ' HD3' ' B' ' 128' ' ' ARG . 9.0 pt-20 -66.89 -14.82 63.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.276 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.2 -9.46 32.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.439 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.682 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 95.4 m-85 -90.89 6.43 44.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.463 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -53.63 103.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.909 0.862 . . . . 0.0 111.13 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -101.24 167.48 10.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.21 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.36 122.5 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.334 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.71 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 10.8 mp -81.67 -62.69 1.57 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.2 m-20 -147.23 163.35 36.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.211 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 51.4 p -138.49 116.78 11.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -99.4 131.9 45.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.734 -172.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 12.5 mt -102.92 104.19 14.39 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.184 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.38 125.1 47.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -73.11 -166.21 10.2 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.319 -163.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.031 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 28.4 Cg_endo -60.57 114.7 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.233 1.289 . . . . 0.0 109.285 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 63' ' ' GLY . 28.2 m -116.9 120.99 33.31 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.661 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.83 131.0 37.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.517 2.145 . . . . 0.0 110.429 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.18 132.15 0.39 Allowed 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 124.26 0.975 . . . . 0.0 112.775 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 156.94 118.96 0.58 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -172.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.982 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.2 ttt180 -65.21 114.63 4.83 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.719 0.771 . . . . 0.0 111.214 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.42 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 5.9 p80 -149.07 156.2 41.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.128 -171.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.9 OUTLIER -106.05 151.18 25.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.516 ' N ' ' HG2' ' A' ' 71' ' ' MET . 1.3 p90 -140.75 160.75 39.36 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 171.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.461 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 2.6 p -117.35 136.98 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 122.168 0.985 . . . . 0.0 111.567 -172.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.674 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -118.07 138.14 52.44 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.49 -169.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.714 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 21.5 mt-30 -148.08 151.46 35.7 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.71 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -159.21 121.87 3.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.68 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.83 156.3 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.809 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.05 151.36 16.8 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.516 -169.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 64.3 Cg_endo -67.36 162.54 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.029 2.486 . . . . 0.0 110.16 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 24.0 m-80 -60.9 119.04 41.22 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 21.0 Cg_endo -66.76 -7.78 19.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.067 2.511 . . . . 0.0 110.796 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.46 1.3 55.8 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.978 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.27 -27.81 10.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.996 0.398 . . . . 0.0 110.638 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 89' ' ' ALA . 15.9 mt -80.82 128.64 70.94 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.991 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 84' ' ' ILE . 72.0 Cg_endo -81.88 161.29 18.61 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.066 1.844 . . . . 0.0 111.394 172.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.687 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.5 t70 -46.0 -48.7 16.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.88 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.994 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 7.5 m-20 -106.8 -8.38 16.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.409 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -74.48 -43.8 54.39 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 111.178 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -100.6 46.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.593 -174.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.31 -138.63 2.75 Favored Glycine 0 CA--C 1.508 -0.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.452 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.791 HG23 HD22 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -100.57 139.08 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -168.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.847 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -157.61 169.9 23.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.001 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.689 HG12 HD23 ' A' ' 96' ' ' LEU . 94.9 t -120.95 133.1 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 121.05 0.452 . . . . 0.0 111.63 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 42' ' ' ILE . 3.0 p -117.15 107.13 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.711 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -106.27 151.02 25.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.702 -177.038 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.736 ' HB ' HG12 ' A' ' 109' ' ' VAL . 61.6 mt -110.51 100.86 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-O 121.709 0.766 . . . . 0.0 109.037 175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.831 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 76.1 p -97.66 116.26 29.53 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.744 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.687 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 4.3 t -78.9 158.96 27.97 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.322 174.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.1 m -148.05 111.73 5.05 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.707 ' HB3' HD11 ' A' ' 151' ' ' ILE . 71.3 t80 -123.4 119.82 31.17 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 62.08 33.61 16.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.863 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.84 62.92 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.199 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.72 133.32 43.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 0.0 110.98 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 3.1 mp0 -81.37 132.84 35.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.307 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.0 p90 -125.73 2.06 7.47 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.831 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.3 tt -156.84 159.49 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' HA ' ' B' ' 130' ' ' ILE . 5.0 tmm_? -152.79 105.46 2.96 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.708 0.63 . . . . 0.0 109.559 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.736 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.3 p -95.0 102.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -89.99 102.65 2.93 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.82 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.967 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 10.3 m-85 -98.96 121.98 41.62 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.573 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.572 ' CB ' HD12 ' A' ' 140' ' ' LEU . 57.2 m-85 -68.97 115.86 8.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.295 176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.847 HG13 HG23 ' A' ' 93' ' ' THR . 1.8 p -101.27 109.71 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 122.32 1.057 . . . . 0.0 108.28 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.791 HD22 HG23 ' A' ' 92' ' ' VAL . 14.4 t-20 -97.14 104.4 16.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.727 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.616 ' HB3' HD11 ' A' ' 135' ' ' LEU . 31.8 m-80 -89.55 110.16 21.04 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.02 130.16 49.45 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.69 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 25.9 m-85 -38.55 150.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -84.44 -34.32 23.49 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.223 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.519 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 10.6 tt0 -86.51 119.43 26.76 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.249 -1.796 . . . . 0.0 108.504 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.859 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 99.2 m -54.89 -31.3 59.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.084 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.18 -32.29 70.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 92.0 mt -73.42 -27.05 61.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.253 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.859 ' HE ' ' HA ' ' A' ' 120' ' ' THR . 19.3 mtm180 -74.46 -38.18 63.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.616 0.722 . . . . 0.0 109.257 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.722 ' HG3' ' O ' ' A' ' 120' ' ' THR . 45.9 mt-10 -58.66 -39.64 81.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.339 -1.301 . . . . 0.0 111.126 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.4 p30 -146.8 86.13 6.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 18.7 Cg_endo -57.43 114.36 1.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.789 2.326 . . . . 0.0 111.318 176.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.532 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 54.0 Cg_exo -55.17 141.74 79.56 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.265 1.977 . . . . 0.0 109.899 175.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.75 -13.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.972 0.795 . . . . 0.0 112.454 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -124.63 100.22 34.89 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.162 0.982 . . . . 0.0 111.824 167.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.69 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 7.7 Cg_exo -44.77 144.83 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.827 1 C-N-CA 125.453 4.102 . . . . 0.0 113.378 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.2 t70 -113.65 111.67 22.22 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.684 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 9.9 m-85 -75.93 -11.39 59.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.546 1.165 . . . . 0.0 110.596 -170.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -90.3 -34.5 15.71 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.056 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 61.2 mmtt -92.79 17.67 10.09 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 33.1 tp -100.6 128.67 46.57 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.334 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -120.72 110.93 16.97 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.848 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.94 113.85 25.56 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.096 0.474 . . . . 0.0 111.681 -174.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 11.5 t30 -89.89 112.55 23.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 172.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.514 HG21 HG11 ' A' ' 11' ' ' VAL . 1.7 mp -83.71 103.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.313 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.572 HD12 ' CB ' ' A' ' 112' ' ' TYR . 86.3 mt -63.57 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.296 0.569 . . . . 0.0 110.938 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.967 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.08 -11.82 60.01 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.738 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -79.23 -3.33 45.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.574 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -143.79 71.08 17.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.94 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.3 Cg_endo -89.72 106.54 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.292 1.995 . . . . 0.0 111.234 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 81.22 8.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.038 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 109' ' ' VAL . 32.4 m -77.36 131.52 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 86.2 m -151.09 110.71 4.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.516 0.674 . . . . 0.0 110.566 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 5.6 ptt-85 -108.46 138.51 44.64 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.798 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 169.37 9.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.312 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.466 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.3 pt -129.91 -177.2 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.631 0.729 . . . . 0.0 111.469 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.618 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -98.15 84.22 3.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.972 -171.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TRP . . . . . 0.721 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 63.7 m95 -69.45 -7.44 37.93 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.483 -0.76 . . . . 0.0 111.345 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.822 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' LYS . . . . . 0.663 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 39.5 mmtt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.075 0.464 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.488 ' HA ' HD12 ' B' ' 126' ' ' LEU . 16.0 t70 -31.11 -46.06 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 177.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.3 tt -73.82 -38.3 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.4 0.619 . . . . 0.0 110.489 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 1.6 tp-100 -66.36 -37.39 85.21 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.449 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.801 ' O ' ' HB ' ' B' ' 130' ' ' ILE . 20.0 mt -59.52 -50.32 74.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.299 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' B' ' 131' ' ' ARG . . . -62.65 -42.51 99.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.818 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.554 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 81.3 mtt180 -56.74 -65.1 0.67 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.349 0.595 . . . . 0.0 111.973 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ARG . . . . . 0.459 ' HD3' ' HB2' ' A' ' 51' ' ' GLU . 20.0 mmm180 -60.37 -30.5 69.61 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.118 -175.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -87.82 -7.48 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.215 -175.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' B' ' 127' ' ' ALA . 30.3 mmt180 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 121.513 0.673 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.598 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -102.31 155.93 17.91 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 168.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.669 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.2 mptp? -96.6 -18.53 19.68 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.26 -176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.83 125.36 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.752 0.787 . . . . 0.0 110.71 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.546 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.36 100.05 7.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.786 176.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -77.96 131.84 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.403 177.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -111.73 -66.77 1.05 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.071 -166.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.54 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.4 t-20 -102.76 154.05 19.56 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.82 -176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 9' ' ' VAL . 6.1 p -144.83 99.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 CA-C-O 122.104 0.955 . . . . 0.0 109.214 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -92.26 95.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.322 1.058 . . . . 0.0 108.572 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.85 127.72 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.763 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.913 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.2 mt -97.48 -39.05 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.318 -177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.641 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 9.8 t0 -70.91 65.13 0.34 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.316 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.637 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -84.84 173.44 7.15 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 162.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.0 Cg_endo -50.32 101.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 121.508 1.574 . . . . 0.0 113.101 -158.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.637 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 13.9 m -136.21 169.44 13.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.861 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 70.5 Cg_exo -38.31 137.47 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.18 2.587 . . . . 0.0 113.496 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.729 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 19.2 t80 -63.09 -20.76 65.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.882 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 21.4 m-85 -94.38 5.62 51.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 111.235 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.77 140.92 47.44 Favored Pre-proline 0 C--O 1.213 -0.831 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.593 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 14.3 Cg_exo -74.56 141.92 28.67 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.691 2.261 . . . . 0.0 112.185 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.783 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 94.8 m-85 -60.24 117.07 4.73 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 122.964 0.506 . . . . 0.0 110.015 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.913 ' HB3' HD12 ' A' ' 12' ' ' LEU . 39.3 mt-30 -115.5 111.27 20.49 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.32 -174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' A' ' 97' ' ' ILE . 70.0 m-85 -121.58 107.51 12.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.497 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.624 ' HB2' HD21 ' A' ' 12' ' ' LEU . 22.0 tt0 -90.14 85.05 6.17 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.485 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 14.4 mt -86.83 132.4 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.694 0.759 . . . . 0.0 112.114 -175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.7 m -108.47 106.85 17.14 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.294 174.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 37.3 p90 -118.79 150.92 38.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 121.529 0.681 . . . . 0.0 109.717 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.837 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 47.2 tt0 -107.46 111.04 23.14 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.49 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 29.1 t -72.96 108.1 5.69 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -74.55 -27.21 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.031 -173.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.598 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 8.2 mt-10 -143.8 179.62 7.05 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.88 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -73.57 146.63 44.59 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.021 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -106.73 157.03 18.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -174.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -113.97 -41.85 3.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.889 0.852 . . . . 0.0 110.545 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.803 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 33.2 tt0 -113.33 -165.84 1.03 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.042 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.803 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -98.51 143.59 28.76 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.819 0.819 . . . . 0.0 110.599 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.821 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.68 124.13 29.92 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.38 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.595 ' HB3' ' O ' ' A' ' 100' ' ' THR . 42.3 tt0 -107.55 90.15 3.21 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.929 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 59' ' ' SER . 24.5 m95 -81.67 122.74 28.01 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.6 ttmt -126.4 141.59 51.84 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.574 HG22 HG22 ' A' ' 95' ' ' VAL . 13.8 mt -102.9 120.13 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.673 ' HB ' HD12 ' A' ' 96' ' ' LEU . 3.9 mp -114.38 106.33 20.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.287 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.686 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.5 t80 -88.87 116.69 27.34 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 t -54.73 105.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.151 0.5 . . . . 0.0 109.899 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.44 -35.77 92.49 Favored Glycine 0 CA--C 1.501 -0.808 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.172 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.577 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.6 t -139.14 116.56 11.25 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.587 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -70.35 -1.2 9.83 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 167.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -96.3 -27.02 15.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 47' ' ' SER . 14.5 m -144.67 109.45 4.99 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.828 0.823 . . . . 0.0 111.091 171.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.838 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -70.08 -23.76 63.12 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.364 -1.289 . . . . 0.0 112.399 -166.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -67.4 -2.33 6.11 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 4.2 m-30 -85.71 -4.02 59.05 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.041 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.595 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.2 p-10 -42.53 112.32 0.34 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.316 1.055 . . . . 0.0 112.206 -175.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 3.1 mt-30 -91.36 168.49 11.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.923 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -129.42 114.25 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -173.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.1 mm? -82.73 -49.29 9.92 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.059 -174.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -163.92 164.04 23.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 27.8 p -141.43 117.46 10.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.2 p -100.29 132.76 45.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.624 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.36 105.93 15.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.638 -174.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.8 t -93.23 113.81 28.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.65 -166.38 12.39 Favored Glycine 0 CA--C 1.503 -0.714 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.098 -168.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.021 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.8 Cg_endo -65.23 115.27 3.22 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.407 1.404 . . . . 0.0 110.365 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 31.1 m -131.99 141.36 41.19 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.614 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.55 79.11 3.31 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.082 1.854 . . . . 0.0 113.482 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.29 -171.77 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.015 -1.902 . . . . 0.0 112.343 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.94 122.79 2.62 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.947 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.837 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.9 ttt180 -87.69 118.24 27.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -161.06 166.0 28.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.41 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -108.64 139.46 43.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.174 -177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.485 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 9.8 p90 -126.69 160.91 29.39 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.2 p -124.14 106.42 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-O 123.06 1.41 . . . . 0.0 111.898 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 140.97 37.44 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.443 -2.162 . . . . 0.0 110.572 -176.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.783 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.0 mt-30 -150.68 149.84 30.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 165.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.593 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -158.65 132.14 7.48 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.457 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.719 ' O ' HD12 ' A' ' 57' ' ' LEU . 12.9 m-20 -67.18 143.19 56.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.163 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -52.2 157.22 2.36 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 124.704 1.201 . . . . 0.0 114.028 -173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.686 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.03 -179.92 3.38 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.97 3.113 . . . . 0.0 113.267 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 96.1 m-20 -82.18 119.17 74.4 Favored Pre-proline 0 CA--C 1.515 -0.388 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.263 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 16.1 Cg_endo -60.32 -25.18 79.64 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.538 2.826 . . . . 0.0 112.576 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.0 -15.86 81.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.417 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.422 ' CB ' HE21 ' A' ' 55' ' ' GLN . 31.3 mt -79.57 -25.94 41.47 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.787 0.327 . . . . 0.0 110.242 -178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mt -88.69 129.29 49.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.564 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 85.5 Cg_endo -80.06 164.02 22.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.746 2.964 . . . . 0.0 112.794 173.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.578 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 m-20 -45.12 -55.0 6.11 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.823 0.849 . . . . 0.0 113.071 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.0 -18.56 61.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.218 0.533 . . . . 0.0 110.596 -168.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.666 ' HA ' ' HZ1' ' B' ' 122' ' ' LYS . 40.2 t0 -92.36 -35.82 13.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -70.17 -45.38 66.84 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.381 0.61 . . . . 0.0 111.332 -171.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.19 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.77 0.795 . . . . 0.0 111.559 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.45 -160.14 10.09 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.433 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.686 HG12 ' ND2' ' A' ' 114' ' ' ASN . 4.7 m -94.87 144.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.907 ' HB ' HG13 ' A' ' 113' ' ' VAL . 2.8 m -151.15 170.24 19.92 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.597 HG23 HD13 ' B' ' 126' ' ' LEU . 3.9 t -132.7 144.6 36.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 118.939 0.79 . . . . 0.0 110.954 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 42' ' ' ILE . 10.5 p -129.04 105.48 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.916 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.9 OUTLIER -104.13 135.51 45.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.792 -169.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 45.1 mt -103.29 99.82 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-O 121.919 0.866 . . . . 0.0 109.08 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.781 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 58.0 p -93.61 112.33 24.19 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.717 ' SG ' HD12 ' A' ' 38' ' ' LEU . 1.4 t -79.52 122.3 26.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 18.8 m -121.83 103.71 9.05 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.021 -167.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.677 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 61.4 t80 -109.14 120.28 42.05 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.413 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.677 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 15.5 mtp180 69.67 22.42 6.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.778 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.81 85.0 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -110.05 117.79 34.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.847 -0.676 . . . . 0.0 109.386 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 60.0 mt-10 -82.54 132.47 35.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.821 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.9 p90 -123.19 1.77 9.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.864 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.6 tt -159.24 157.86 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 172.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.73 HH12 ' HA2' ' B' ' 132' ' ' GLY . 22.3 ttm180 -150.99 101.37 2.88 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.463 0.477 . . . . 0.0 109.846 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.916 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -84.52 98.66 6.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.228 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.17 77.25 2.12 Favored Glycine 0 CA--C 1.488 -1.606 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.586 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.993 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -74.06 115.9 14.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 114.137 -1.032 . . . . 0.0 109.121 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.565 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.7 m-85 -66.31 120.58 13.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.907 HG13 ' HB ' ' A' ' 93' ' ' THR . 2.6 p -103.18 110.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.686 ' ND2' HG12 ' A' ' 92' ' ' VAL . 6.0 t-20 -92.43 110.76 22.17 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.184 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 39.1 m-80 -97.78 107.84 20.42 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.96 141.22 36.44 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.184 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.741 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 46.4 m-85 -47.97 151.93 0.86 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -174.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -86.81 -37.72 17.52 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.534 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.3 mt-10 -82.94 132.0 35.17 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.766 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 m -55.73 -36.17 66.95 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.55 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -58.85 -40.42 84.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.897 0.856 . . . . 0.0 109.991 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 46.0 mt -77.73 -23.09 49.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.799 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -80.15 -37.04 34.28 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 120' ' ' THR . 32.2 mm-40 -56.19 -43.1 78.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.769 175.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.478 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -152.72 89.11 3.82 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.447 0.641 . . . . 0.0 109.854 177.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.5 Cg_endo -50.46 116.01 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 123.769 2.979 . . . . 0.0 112.865 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.741 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 77.7 Cg_exo -52.75 136.79 59.44 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.007 2.471 . . . . 0.0 111.249 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' HE2' ' A' ' 129' ' ' LYS . 22.5 t -51.68 -40.68 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.555 -173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 1.8 mmpt? -94.83 137.96 22.25 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-O 121.153 0.501 . . . . 0.0 110.798 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.578 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 11.8 Cg_exo -69.89 123.77 10.38 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.7 2.933 . . . . 0.0 112.332 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' HB2' ' HE1' ' A' ' 117' ' ' TYR . 1.6 m-20 -104.57 97.09 7.05 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.681 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.684 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 33.4 m-85 -68.0 -16.33 64.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.994 0.902 . . . . 0.0 110.549 -175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 2.9 p -83.3 -21.72 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 69.1 mmtt -104.58 5.12 33.57 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 132' ' ' PHE . 17.6 tp -87.82 137.83 31.99 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.556 -168.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.56 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 4.5 tt0 -120.41 127.5 52.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.842 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 21.2 mtm-85 -90.46 104.93 17.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 15.3 t30 -89.75 98.75 11.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -78.73 100.77 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 112' ' ' TYR . 95.8 mt -62.2 92.57 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.706 0.765 . . . . 0.0 111.14 -174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.993 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -78.93 -8.82 59.21 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.419 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.0 p -80.66 -10.55 59.73 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.03 172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.469 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.4 t-20 -142.27 62.97 14.41 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.513 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 4.7 Cg_exo -81.0 109.11 2.14 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.3 2.0 . . . . 0.0 111.098 172.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.651 ' HB3' HD13 ' B' ' 130' ' ' ILE . 15.0 tpt180 -82.23 82.61 7.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -83.98 106.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.2 m -116.46 105.65 12.72 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.601 0.715 . . . . 0.0 109.308 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.864 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 26.5 ptt180 -112.53 148.32 34.74 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.805 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.454 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -129.42 167.45 17.79 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.145 -173.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -106.1 123.14 47.54 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.931 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 101' ' ' TYR . 38.9 pt -121.45 158.73 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -87.25 103.22 15.23 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.495 1.14 . . . . 0.0 110.365 172.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.669 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 7.9 m95 -75.54 -3.56 34.85 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.64 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.4 ' HB2' HD22 ' A' ' 156' ' ' ASN . 6.7 mp0 -114.41 -173.55 2.31 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.212 -176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -114.32 71.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.4 HD22 ' HB2' ' A' ' 154' ' ' GLU . 9.8 p30 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.327 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.47 80.23 7.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.259 0.552 . . . . 0.0 110.101 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 45.6 ttp -87.76 -32.93 18.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.128 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 85.07 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.304 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.666 ' HZ1' ' HA ' ' A' ' 88' ' ' ASP . 9.5 mmmm -69.24 -50.67 45.02 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 109.993 -175.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -40.59 -54.89 2.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.044 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.489 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.9 tp -69.06 -32.07 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.851 0.357 . . . . 0.0 111.247 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 8.4 mm100 -58.07 -46.91 84.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 173.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.597 HD13 HG23 ' A' ' 94' ' ' VAL . 30.8 mt -68.35 -43.62 77.06 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.319 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.29 68.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.712 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 95.9 mtt180 -54.14 -57.65 10.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 1.088 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 6.1 tpt180 -61.4 -35.45 77.56 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.269 -171.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 145' ' ' ARG . 23.8 mt -76.83 -49.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.65 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' B' ' 131' ' ' ARG . 7.3 mmm180 -53.22 -44.92 68.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 111.534 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.73 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 171.9 59.88 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.182 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 1.088 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 6.3 tp10 -128.59 -31.45 2.24 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.909 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.593 ' HG2' HG21 ' A' ' 98' ' ' THR . 17.6 tpt180 -57.84 -48.69 79.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.478 172.285 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.578 0.228 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -82.84 131.2 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.927 0.394 . . . . 0.0 110.706 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.934 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.58 -21.57 18.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 34' ' ' LEU . 3.4 t -137.53 129.22 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.772 0.796 . . . . 0.0 111.08 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp-100 -115.04 100.55 8.26 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.233 -1.349 . . . . 0.0 107.421 169.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 29.9 t -74.28 124.73 32.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -107.39 -65.65 1.09 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.09 0.947 . . . . 0.0 109.146 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.666 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.9 t-20 -106.41 151.8 24.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.066 -1.425 . . . . 0.0 110.849 -172.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.684 HG23 HG13 ' A' ' 26' ' ' ILE . 3.2 p -146.77 99.53 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.663 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.367 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.99 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.4 m -93.67 107.11 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 109.979 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.889 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -78.72 136.6 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.568 -176.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 23' ' ' GLN . 7.6 mt -111.05 -42.14 4.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.32 -172.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 23' ' ' GLN . 4.2 p-10 -69.69 43.66 0.05 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.41 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -79.0 169.91 18.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 2.7 Cg_endo -53.02 100.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.048 1.165 . . . . 0.0 114.206 -138.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.666 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.6 m -136.76 171.22 9.02 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 112.008 -2.36 . . . . 0.0 107.482 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 62.4 Cg_exo -39.83 141.46 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.695 2.263 . . . . 0.0 112.912 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.017 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.0 t80 -60.31 -30.6 69.59 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.378 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -79.38 -6.17 56.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.089 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -77.59 119.94 79.46 Favored Pre-proline 0 CA--C 1.507 -0.682 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.545 ' C ' HH22 ' A' ' 137' ' ' ARG . 47.2 Cg_exo -60.57 154.43 54.28 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 C-N-CA 123.844 3.03 . . . . 0.0 113.391 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.77 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 80.2 m-85 -62.93 133.36 54.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.686 ' HB3' HD12 ' A' ' 12' ' ' LEU . 39.9 mt-30 -132.27 89.86 2.72 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.307 0.575 . . . . 0.0 109.552 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' HD11 ' A' ' 97' ' ' ILE . 79.9 m-85 -100.44 109.14 21.27 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.56 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.99 ' HB3' HG23 ' A' ' 10' ' ' VAL . 31.8 tt0 -91.66 85.87 5.81 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.684 HG13 HG23 ' A' ' 9' ' ' VAL . 2.6 mp -81.85 140.06 17.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.764 . . . . 0.0 112.85 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 11.3 m -115.25 107.16 14.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.327 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 17.6 p90 -121.27 153.41 37.7 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.935 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.897 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 21.9 tt0 -109.4 118.3 36.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 24.4 m -74.07 109.25 7.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.469 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -72.81 -31.4 36.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.962 -174.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.934 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 47.8 mt-10 -142.89 166.74 23.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.772 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.2 m-20 -61.71 131.2 49.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.767 HD12 ' CE1' ' A' ' 101' ' ' TYR . 2.1 mm? -85.51 152.29 23.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -176.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -113.54 -36.82 4.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.68 0.752 . . . . 0.0 110.126 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 13.7 tt0 -117.13 -167.37 1.29 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.449 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 5.3 m-20 -96.19 138.43 33.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.516 0.674 . . . . 0.0 111.316 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.714 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.47 120.02 29.45 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.922 178.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 35.8 tt0 -106.92 89.32 2.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.638 -175.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.706 ' O ' ' HA ' ' A' ' 59' ' ' SER . 27.6 m95 -76.35 129.08 36.08 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 30.0 ttmt -133.38 142.48 48.4 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.903 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 95' ' ' VAL . 10.7 mt -103.22 121.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -114.29 105.71 19.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.119 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.823 ' CE2' HG11 ' A' ' 113' ' ' VAL . 28.3 t80 -89.72 124.55 34.72 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.898 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.01 111.54 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.376 0.608 . . . . 0.0 110.343 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 53' ' ' TYR . . . -70.76 -35.71 66.45 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -172.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 39.6 t -134.53 118.85 17.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.772 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -66.05 0.23 2.04 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.999 0.428 . . . . 0.0 110.01 167.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -102.12 -17.12 16.16 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.286 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 50.4 m -124.64 -171.69 2.4 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.775 0.798 . . . . 0.0 111.086 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.65 -3.31 1.15 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.516 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -94.25 -13.16 26.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.675 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.698 ' CD2' ' HB2' ' A' ' 47' ' ' SER . 3.5 m-30 -84.92 -15.82 43.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.335 -172.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 8.7 p-10 -42.44 115.48 0.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.134 0.968 . . . . 0.0 111.979 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.444 ' HG2' HD12 ' A' ' 83' ' ' LEU . 11.2 mp0 -91.17 166.85 12.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.943 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.81 107.1 15.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.0 mm? -74.92 -40.06 61.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.671 -171.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -173.34 176.26 2.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.887 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 58.1 p -151.49 115.28 4.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.84 132.42 45.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.918 -175.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.684 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 6.4 mt -102.73 106.26 16.85 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.2 t -92.98 120.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -84.16 -156.68 24.44 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.925 -165.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 38.6 Cg_endo -64.6 118.79 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 121.952 1.768 . . . . 0.0 110.53 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.626 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 28.5 m -134.8 141.87 40.22 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.514 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -86.17 75.33 2.98 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 C-N-CA 122.421 2.08 . . . . 0.0 114.599 -173.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.634 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 48.19 -179.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.954 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 114.45 129.22 4.73 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.138 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.897 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 12.1 ptt-85 -75.87 126.21 30.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.421 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 4.9 p80 -153.68 141.6 20.2 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.936 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -95.55 137.75 34.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.465 -177.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.7 p90 -135.68 146.37 47.71 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 13.8 p -104.26 125.65 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-O 122.318 1.056 . . . . 0.0 110.438 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.489 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 12.0 t80 -119.53 113.04 20.12 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.764 -163.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 38.3 mt-30 -138.46 149.99 46.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.764 0.316 . . . . 0.0 110.476 -167.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' C ' ' HB3' ' A' ' 21' ' ' PRO . . . -169.34 146.07 3.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.351 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.656 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.1 p-10 -61.24 170.85 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.05 0.452 . . . . 0.0 111.413 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.63 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -71.12 164.22 58.82 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.688 -170.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.77 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 34.7 Cg_endo -60.92 168.21 7.59 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.355 2.703 . . . . 0.0 111.69 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 11.5 m120 -69.75 115.54 34.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.0 -175.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 13.2 Cg_endo -61.89 -26.68 79.31 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.225 2.617 . . . . 0.0 112.045 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.61 14.55 55.26 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.292 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 83' ' ' LEU . 15.6 mt -116.74 -33.75 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.391 0.139 . . . . 0.0 110.816 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 36.5 mt -73.71 129.89 84.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.127 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HG3' ' OG ' ' A' ' 47' ' ' SER . 95.0 Cg_endo -79.92 162.26 23.72 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.221 2.614 . . . . 0.0 112.699 174.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.734 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 12.1 m-20 -45.85 -52.54 11.19 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.673 0.789 . . . . 0.0 112.202 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.71 -28.61 65.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.835 ' HA ' ' NZ ' ' B' ' 122' ' ' LYS . 49.1 t0 -80.87 -38.97 27.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -65.45 -38.7 90.62 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -165.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -102.39 46.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -172.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 -138.85 3.0 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.118 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.563 HG23 ' ND2' ' A' ' 114' ' ' ASN . 1.1 t -97.13 135.87 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-O 122.059 0.933 . . . . 0.0 113.256 -172.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.699 ' HB ' HG13 ' A' ' 113' ' ' VAL . 1.7 m -140.51 168.82 18.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.769 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -125.54 143.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 118.318 0.508 . . . . 0.0 111.127 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 42' ' ' ILE . 7.3 p -131.06 108.23 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.827 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -101.65 154.91 18.46 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.983 -171.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.647 ' HB ' HG12 ' A' ' 109' ' ' VAL . 2.4 mt -117.39 105.07 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.825 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.0 p -100.62 114.8 28.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.227 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.566 ' HB2' HG22 ' A' ' 107' ' ' ILE . 62.6 m -79.68 115.76 19.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.452 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -108.54 101.91 11.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.991 -175.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.767 ' CE1' HD12 ' A' ' 34' ' ' LEU . 87.1 t80 -104.31 127.83 52.02 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.599 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 37.0 mtp180 67.02 14.19 9.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.49 5.3 65.24 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.731 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.752 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -119.74 129.37 54.47 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.8 mp0 -83.6 133.68 34.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.418 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.714 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.5 p90 -121.47 -5.1 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.825 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.9 tt -156.17 158.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 O-C-N 121.397 -0.815 . . . . 0.0 109.146 174.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.98 HH22 ' HG3' ' A' ' 145' ' ' ARG . 4.3 tmm_? -150.87 107.68 3.54 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -174.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.827 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.2 p -102.64 101.47 12.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.188 0.994 . . . . 0.0 109.321 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.23 86.66 1.38 Allowed Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 119.762 -1.209 . . . . 0.0 111.499 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.771 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 17.1 m-85 -82.17 122.29 27.69 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.192 -1.004 . . . . 0.0 108.805 172.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 140' ' ' LEU . 31.6 m-85 -68.48 131.91 46.08 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.332 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.823 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.6 p -104.89 111.44 34.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.563 ' ND2' HG23 ' A' ' 92' ' ' VAL . 3.0 t-20 -90.58 110.51 21.65 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.349 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 28.5 m-80 -102.68 107.34 18.21 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -131.91 130.03 41.06 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.612 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 12.7 m-85 -40.86 148.78 0.1 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.8 p -89.65 -29.27 18.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.771 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 30.2 mm-40 -91.31 140.0 30.2 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.556 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 52.0 m -52.05 -47.95 64.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 117.928 0.331 . . . . 0.0 111.206 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.27 -39.76 67.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.988 0.899 . . . . 0.0 110.045 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.5 mt -77.6 -30.34 52.39 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.376 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 52.1 mtp180 -76.83 -39.06 52.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.501 0.667 . . . . 0.0 109.516 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.746 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 1.5 pt-20 -80.85 -20.6 41.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.597 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.746 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.7 OUTLIER -149.82 77.38 8.58 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.841 170.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 18.1 Cg_endo -57.03 118.42 5.28 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.634 2.889 . . . . 0.0 112.94 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 14.9 Cg_exo -71.63 147.81 51.98 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.065 2.51 . . . . 0.0 110.197 172.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.1 -27.75 43.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.866 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 0.4 OUTLIER -89.12 122.21 68.93 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 0.0 111.271 175.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.734 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 36.5 Cg_exo -63.54 131.78 33.0 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 124.253 3.302 . . . . 0.0 112.588 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.0 t0 -114.05 105.28 13.03 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.727 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 42.6 m-85 -77.87 -19.86 54.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.846 0.832 . . . . 0.0 110.344 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.3 t -79.94 -29.91 39.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.804 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 71.6 mmtt -98.82 14.41 28.97 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 28.8 tp -99.68 143.91 29.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.213 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.91 129.95 51.41 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 1.017 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 10.0 mtm180 -95.5 106.01 18.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.432 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.769 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 4.4 t30 -96.35 99.71 11.37 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.889 HG21 HG11 ' A' ' 11' ' ' VAL . 10.0 mm -68.05 117.86 10.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.633 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . 62.4 mt -74.35 75.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.719 0.771 . . . . 0.0 110.334 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.771 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -68.85 -13.14 62.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.974 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.4 p -75.46 -12.77 60.31 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.457 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.412 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 2.5 t-20 -133.9 60.46 45.69 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 24.1 Cg_exo -68.84 105.24 1.3 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.549 1.499 . . . . 0.0 111.497 172.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.98 ' HG3' HH22 ' A' ' 108' ' ' ARG . 18.2 tpt85 -87.69 88.67 7.73 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.758 HG12 HG23 ' A' ' 109' ' ' VAL . 22.6 m -92.54 124.58 45.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 -176.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.461 HG22 ' CE2' ' A' ' 149' ' ' PHE . 98.8 m -132.8 107.78 8.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.379 0.609 . . . . 0.0 109.708 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.731 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -106.64 140.33 39.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.418 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -126.18 118.7 25.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.458 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.85 143.49 56.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.089 0.471 . . . . 0.0 110.812 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.752 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 46.6 pt -131.9 177.29 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 154' ' ' GLU . 3.1 p30 -97.97 94.2 6.73 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.313 1.054 . . . . 0.0 109.425 176.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.0 m95 -71.73 4.55 3.13 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.178 -1.373 . . . . 0.0 108.897 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 152' ' ' ASN . 16.9 mt-10 -133.29 151.93 51.91 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.251 -1.341 . . . . 0.0 108.622 -173.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.06 70.12 9.98 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.0 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.842 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.673 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.715 -0.154 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -161.43 -174.07 4.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 73.5 mtm -72.54 -65.35 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -129.6 -64.74 0.11 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.835 ' NZ ' ' HA ' ' A' ' 88' ' ' ASP . 75.7 mmtt -148.44 -61.85 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 p30 13.18 -93.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 164.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' B' ' 127' ' ' ALA . 13.7 tt -62.03 -27.36 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.772 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.5 tm0? -63.84 -58.56 6.42 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 121.745 0.783 . . . . 0.0 110.196 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' B' ' 122' ' ' LYS . 1.2 mm? -64.23 -28.89 70.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.611 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' B' ' 130' ' ' ILE . . . -62.33 -40.53 96.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.813 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -51.35 -53.88 31.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.562 ' O ' ' HB3' ' B' ' 133' ' ' GLU . 16.6 mmm180 -70.47 -25.85 63.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.87 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.547 HG12 HH12 ' A' ' 108' ' ' ARG . 5.6 mt -65.47 -39.48 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.395 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.62 31.6 5.49 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.426 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 178.67 37.31 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.173 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' B' ' 129' ' ' ARG . 0.0 OUTLIER -59.5 -62.55 1.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.903 175.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.07 -31.2 1.01 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.175 -174.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.305 179.338 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' HE2' ' A' ' 3' ' ' LYS . 24.0 ptm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.789 0.328 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -93.22 141.58 28.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.739 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 22.0 mmtt -101.02 -9.02 21.82 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.055 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.502 ' N ' HG13 ' A' ' 31' ' ' ILE . 2.7 t -142.95 126.96 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.417 0.627 . . . . 0.0 110.687 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.578 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 6.0 tp-100 -124.09 100.8 6.9 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.099 174.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.611 HG11 ' CH2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -82.48 131.43 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.127 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -115.81 -63.53 1.44 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.531 -162.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.691 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -100.07 148.88 24.07 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.852 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' VAL . 4.3 p -146.08 102.23 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-O 121.797 0.808 . . . . 0.0 109.934 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.975 HG23 ' HB3' ' A' ' 25' ' ' GLU . 3.3 m -98.39 96.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.779 0.799 . . . . 0.0 109.804 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.865 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -74.96 129.43 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 122.017 0.913 . . . . 0.0 110.427 -177.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.888 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.1 mt -98.82 -36.36 9.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.455 -175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.739 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 16.9 t70 -68.88 39.55 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.683 170.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.632 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -79.22 172.47 9.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.757 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 1.3 Cg_endo -50.38 101.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 CA-C-N 120.841 1.336 . . . . 0.0 113.006 -152.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.661 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 21.2 m -141.95 171.62 7.07 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 112.193 -2.276 . . . . 0.0 107.676 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 67.2 Cg_exo -38.22 132.65 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.484 2.123 . . . . 0.0 112.301 175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.735 ' HA ' ' HG2' ' A' ' 137' ' ' ARG . 33.3 t80 -54.22 -28.13 39.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.868 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -86.84 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.74 0.305 . . . . 0.0 111.039 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.549 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -72.62 120.22 79.48 Favored Pre-proline 0 CA--C 1.513 -0.456 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.721 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.4 Cg_exo -63.85 146.04 91.2 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 123.821 3.014 . . . . 0.0 113.161 -173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.761 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 37.8 m-85 -60.35 115.11 3.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.904 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.888 ' HB3' HD12 ' A' ' 12' ' ' LEU . 37.0 mt-30 -118.99 102.03 8.46 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.95 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.64 ' CD1' HD11 ' A' ' 97' ' ' ILE . 87.5 m-85 -109.65 111.4 22.86 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.462 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.975 ' HB3' HG23 ' A' ' 10' ' ' VAL . 30.6 tt0 -93.38 85.23 4.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.3 mt -88.95 132.95 32.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 122.049 0.928 . . . . 0.0 112.609 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 25.5 m -104.15 107.17 17.95 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.173 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.588 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 27.5 p90 -117.53 148.2 42.09 Favored 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.925 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.861 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 6.9 tm-20 -101.94 111.33 23.55 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.4 t -72.4 108.63 5.6 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -75.03 -23.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.027 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.086 -171.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.739 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 50.3 mt-10 -155.37 148.31 24.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.768 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.62 131.47 50.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.949 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 4.7 tp -86.67 154.24 21.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.768 -168.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -113.18 -30.49 6.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.584 0.707 . . . . 0.0 110.372 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.811 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.8 tt0 -117.01 -167.51 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.811 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 4.6 p-10 -100.67 137.68 38.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.843 0.83 . . . . 0.0 111.523 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.26 122.25 27.69 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.112 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.633 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.9 tt0 -106.84 89.82 3.13 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.28 -176.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 59' ' ' SER . 15.1 m95 -78.0 135.8 37.85 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.7 ttmt -137.37 137.5 38.93 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.288 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.964 HG22 HG22 ' A' ' 95' ' ' VAL . 8.9 mt -102.46 110.16 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.6 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 49.9 mt -108.43 106.11 20.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.74 -172.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.845 ' CE2' HG11 ' A' ' 113' ' ' VAL . 25.3 t80 -89.49 108.53 19.7 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.867 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 t -53.44 104.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.748 174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.08 99.84 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.152 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 53' ' ' TYR . 29.4 t -131.78 128.81 39.6 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 171.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' B' ' 126' ' ' LEU . . . -75.93 -5.94 48.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.978 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -100.03 -35.52 9.67 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.537 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 8.9 m -122.35 97.41 5.45 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.056 0.931 . . . . 0.0 110.059 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' B' ' 128' ' ' ARG . 0.0 OUTLIER -67.65 -11.08 57.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.03 -172.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -72.73 -12.08 60.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.651 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 16.9 m-30 -87.65 10.25 18.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.273 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.486 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 4.9 p-10 -54.93 110.3 0.64 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.092 0.949 . . . . 0.0 111.162 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HG2' HD12 ' A' ' 83' ' ' LEU . 4.8 mt-30 -92.7 169.95 10.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.507 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.64 112.64 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -169.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 44' ' ' TYR . 3.7 mm? -76.34 -42.66 44.19 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.484 -174.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 5.4 p-10 -170.6 173.95 5.25 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.489 171.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 50.8 p -145.36 117.56 8.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.63 128.72 49.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.459 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.617 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.9 mt -103.18 104.02 14.12 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.049 -176.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.49 119.43 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -82.27 -151.67 9.74 Favored Glycine 0 CA--C 1.482 -1.979 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.158 -165.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.949 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 2.1 Cg_endo -46.35 117.14 1.83 Allowed 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.454 1.436 . . . . 0.0 109.144 167.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.413 HG13 ' SG ' ' A' ' 30' ' ' CYS . 2.6 p -133.66 120.98 15.86 Favored Pre-proline 0 C--N 1.288 -2.106 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.7 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.71 130.75 41.58 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.154 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -44.61 147.21 0.63 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.832 0.708 . . . . 0.0 111.255 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 144.84 130.29 2.25 Favored Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.039 -1.077 . . . . 0.0 111.09 -174.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.861 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.9 ttt180 -74.43 116.97 15.71 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.789 0.804 . . . . 0.0 110.889 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 8.2 p80 -150.72 152.13 33.44 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.36 -176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.718 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.6 ttp -98.92 126.94 44.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.324 0.583 . . . . 0.0 111.116 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -117.95 133.18 56.17 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.3 p -101.95 127.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.433 1.111 . . . . 0.0 110.392 -174.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.545 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 1.2 t80 -117.34 133.89 55.46 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.655 -1.612 . . . . 0.0 109.465 -164.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.739 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 66.8 mt-30 -151.69 150.36 30.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.047 0.451 . . . . 0.0 110.398 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -160.37 168.48 25.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.38 173.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.07 -175.32 0.07 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.844 0.831 . . . . 0.0 112.162 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -89.52 158.28 45.9 Favored Pre-proline 0 N--CA 1.438 -1.046 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.726 174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.761 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 46.6 Cg_endo -65.41 168.57 14.21 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.042 2.495 . . . . 0.0 111.602 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 5.1 m-20 -79.56 115.3 52.42 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 -175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.3 Cg_endo -62.85 -19.91 69.93 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.634 2.889 . . . . 0.0 112.707 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.56 -5.06 79.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.349 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.491 HD12 ' HG2' ' A' ' 55' ' ' GLN . 9.3 mt -95.5 -27.82 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.965 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 44' ' ' TYR . 11.4 mt -82.66 130.86 56.79 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 0.0 112.339 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 84' ' ' ILE . 5.4 Cg_endo -81.13 156.6 19.94 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 123.22 2.614 . . . . 0.0 111.903 170.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.77 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.9 m-20 -47.25 -49.12 24.07 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.67 76.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.521 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.5 -17.27 23.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.085 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.583 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -71.59 -45.87 60.96 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.3 0.572 . . . . 0.0 111.258 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.74 45.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.95 -173.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.74 -135.5 2.03 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.838 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.885 HG23 HD22 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -98.94 135.27 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-O 122.164 0.983 . . . . 0.0 112.552 -170.8 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.16 167.62 24.57 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG11 HD11 ' B' ' 130' ' ' ILE . 4.6 t -112.83 141.96 26.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.586 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.964 HG22 HG22 ' A' ' 42' ' ' ILE . 3.8 p -125.61 101.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 158.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.6 ' CD1' ' HB ' ' A' ' 43' ' ' ILE . 1.1 pp -94.62 149.34 21.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.448 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.874 ' HB ' HG12 ' A' ' 109' ' ' VAL . 3.2 mt -114.74 101.81 12.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.352 0.596 . . . . 0.0 109.829 177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.766 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 70.7 p -98.37 116.48 30.69 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.047 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.629 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.4 m -82.31 118.23 23.0 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 20.8 m -106.85 128.22 54.09 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.405 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.784 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 65.3 t80 -132.7 121.18 22.71 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.826 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 22.5 mtp180 67.65 26.17 8.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.292 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.02 6.01 82.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.414 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -116.44 115.28 25.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.083 -0.558 . . . . 0.0 109.836 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 44.0 mp0 -77.27 124.89 28.47 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.784 ' HE2' ' HB2' ' A' ' 101' ' ' TYR . 29.0 p90 -113.88 -4.2 13.33 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 98' ' ' THR . 7.7 tt -158.08 158.83 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.557 HH22 ' HA2' ' B' ' 132' ' ' GLY . 24.4 ttp180 -150.71 106.81 3.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.336 0.397 . . . . 0.0 110.043 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.874 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.2 p -91.27 99.65 10.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 122.544 1.164 . . . . 0.0 108.455 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.507 ' HA3' HG12 ' B' ' 130' ' ' ILE . . . -80.49 95.8 1.6 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.231 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.975 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 4.4 m-85 -93.6 109.57 21.19 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.957 0.884 . . . . 0.0 109.245 174.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' N ' ' HD1' ' A' ' 112' ' ' TYR . 2.3 m-85 -76.15 114.88 15.31 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.286 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.845 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.1 p -88.09 108.67 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.885 HD22 HG23 ' A' ' 92' ' ' VAL . 16.4 t-20 -95.56 103.61 15.48 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.477 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -91.97 121.41 33.52 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.288 0.566 . . . . 0.0 110.064 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.84 138.91 30.64 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.628 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 47.5 m-85 -48.8 156.65 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -92.12 -30.18 16.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.982 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.494 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 4.6 mm-40 -82.22 129.57 34.87 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.097 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.708 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.4 m -53.86 -40.83 66.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.991 0.182 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.01 -35.58 66.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.11 0.957 . . . . 0.0 110.179 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 82.4 mt -85.07 -22.0 29.13 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.785 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 47.3 mtp180 -83.17 -39.67 20.71 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.76 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 11.5 pt-20 -70.35 -31.7 69.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.725 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.76 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 1.2 p30 -147.61 82.08 8.23 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.14 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 29.5 Cg_endo -61.75 117.86 4.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.551 2.834 . . . . 0.0 112.248 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 18.6 Cg_exo -69.04 161.05 47.44 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.915 2.41 . . . . 0.0 110.943 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.69 -25.36 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.508 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HD3' ' HD3' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -89.7 128.38 50.73 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 121.397 0.618 . . . . 0.0 110.788 172.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.77 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 1.1 Cg_endo -82.66 141.64 11.09 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.054 3.169 . . . . 0.0 112.15 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 12.1 t70 -124.85 112.18 16.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.231 0.538 . . . . 0.0 109.592 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.693 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.1 m-85 -79.4 -19.77 49.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.488 -170.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.1 p -83.31 -24.06 32.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.494 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 73.3 mmtt -98.87 11.76 37.82 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 175.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.9 tp -95.91 133.45 40.08 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.806 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.16 120.47 39.12 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.757 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.35 109.05 21.23 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.644 -172.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.687 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -86.2 98.5 10.95 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.094 173.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.865 HG21 HG11 ' A' ' 11' ' ' VAL . 1.4 mp -72.65 108.36 3.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.165 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 112' ' ' TYR . 36.4 mt -64.51 91.81 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.222 0.534 . . . . 0.0 111.834 -171.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.975 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -80.66 -12.19 59.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.4 t -80.14 -11.92 59.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.997 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -138.51 70.12 45.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.818 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.636 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 63.9 Cg_endo -81.83 104.97 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.207 1.272 . . . . 0.0 109.666 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.546 ' HG3' HG21 ' B' ' 130' ' ' ILE . 0.2 OUTLIER -83.66 81.76 8.6 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.255 0.55 . . . . 0.0 110.532 -175.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.779 HG22 HG23 ' A' ' 109' ' ' VAL . 3.9 t -86.4 104.43 13.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.961 -174.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.524 HG21 HH21 ' A' ' 108' ' ' ARG . 48.8 m -112.77 106.93 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.739 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -108.37 138.24 44.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.8 0.81 . . . . 0.0 110.891 -179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -122.3 136.1 54.84 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.88 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.474 ' O ' ' HD2' ' A' ' 150' ' ' HIS . 0.8 OUTLIER -73.79 141.61 46.22 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.707 175.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.03 172.13 14.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.61 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -90.94 106.33 18.45 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 122.17 0.986 . . . . 0.0 110.451 171.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.729 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 8.0 m95 -81.28 5.77 16.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.956 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -130.25 -172.52 2.81 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.237 -1.347 . . . . 0.0 107.805 -173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.49 70.33 3.09 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.44 0.638 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 C--O 1.245 0.859 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 -178.034 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.44 48.86 1.01 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.224 0.535 . . . . 0.0 110.745 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 43.4 mtp -105.09 -64.14 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.149 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.63 136.61 15.16 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.284 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' B' ' 122' ' ' LYS . 11.5 mptt -91.95 -31.84 15.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.246 0.07 . . . . 0.0 110.906 -177.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -44.41 -45.16 8.85 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.321 0.388 . . . . 0.0 111.845 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 -43.07 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.257 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.43 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.5 mm100 -53.41 -54.16 40.77 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.618 0.723 . . . . 0.0 111.278 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.401 HD21 ' HB1' ' A' ' 48' ' ' ALA . 2.4 mm? -62.38 -37.4 85.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.481 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.96 75.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.429 HH21 ' CD ' ' A' ' 51' ' ' GLU . 10.4 mtm180 -59.02 -47.07 86.53 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.75 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 10.8 mmm180 -60.17 -41.6 93.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 145' ' ' ARG . 3.8 mp -90.45 -5.79 10.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -68.48 -44.83 73.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.557 ' HA2' HH22 ' A' ' 108' ' ' ARG . . . -175.46 25.65 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.36 -0.924 . . . . 0.0 113.638 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.75 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 0.4 OUTLIER -113.84 75.49 0.93 Allowed 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.766 0.793 . . . . 0.0 108.873 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.462 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 19.1 mtm180 -53.46 -75.74 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.208 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.383 -177.253 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' HD12 ' A' ' 31' ' ' ILE . 39.2 ttp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.393 0.145 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . -91.04 -62.12 1.52 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.851 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 10.2 mptt -100.11 -22.05 15.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -169.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.438 HG23 HD21 ' A' ' 34' ' ' LEU . 3.6 t -139.28 131.94 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.871 0.843 . . . . 0.0 110.964 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.772 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -125.67 100.14 6.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.851 173.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG22 ' CH2' ' A' ' 40' ' ' TRP . 11.6 t -70.79 146.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.42 HD21 ' CB ' ' A' ' 29' ' ' GLU . 59.8 m-80 -131.16 -65.88 0.76 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.65 0.738 . . . . 0.0 109.594 -172.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.666 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.8 t-20 -104.82 148.21 26.88 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.105 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.2 p -146.73 105.23 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.107 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.049 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -98.02 97.81 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.554 179.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 11' ' ' VAL . 0.8 OUTLIER -70.91 116.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.892 178.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.73 HD22 ' H ' ' A' ' 12' ' ' LEU . 1.4 mm? -80.71 -31.49 36.1 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.62 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' HB3' ' CG ' ' A' ' 23' ' ' GLN . 7.3 p-10 -82.62 44.47 0.9 Allowed 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.681 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' HB3' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -73.59 168.61 23.91 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 159.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 31.6 Cg_exo -51.47 101.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.569 0 CA-C-O 122.729 1.054 . . . . 0.0 113.3 -135.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.846 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 70.1 m -129.99 166.87 23.24 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.731 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 50.1 Cg_exo -46.38 133.48 15.92 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.33 2.02 . . . . 0.0 111.685 174.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.103 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 20.2 t80 -55.4 -23.98 27.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.056 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -92.91 5.56 50.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.846 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -96.3 120.15 63.01 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 169.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 70.3 Cg_exo -55.29 144.43 71.52 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.747 2.298 . . . . 0.0 112.91 -167.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.846 ' HE1' ' HD3' ' A' ' 79' ' ' PRO . 84.3 m-85 -52.58 143.02 16.69 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.745 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.678 ' CG ' ' HB3' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -143.25 110.64 5.78 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.747 0.784 . . . . 0.0 109.599 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 97' ' ' ILE . 81.7 m-85 -114.0 103.52 11.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.461 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.049 ' HB3' HG23 ' A' ' 10' ' ' VAL . 33.6 tt0 -84.23 85.13 7.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 173.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.729 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 4.5 mt -82.47 141.94 14.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 122.001 0.905 . . . . 0.0 113.042 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 9.5 m -119.51 108.8 14.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.294 171.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 17.3 p90 -117.96 146.38 44.04 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.245 0.545 . . . . 0.0 109.655 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.856 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.6 tt0 -101.89 109.36 21.09 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.9 m -72.79 119.76 17.48 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -90.2 -28.01 5.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.253 -169.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 48.3 mt-10 -146.69 169.06 19.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.979 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.06 127.9 34.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.993 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -81.7 155.21 25.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.158 0.504 . . . . 0.0 109.658 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.6 p -113.42 -14.36 12.76 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.208 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 102' ' ' ARG . 7.7 tt0 -138.64 -167.52 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.65 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.813 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 22.2 m-20 -97.74 136.38 38.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.425 0.631 . . . . 0.0 110.872 -175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 99' ' ' CYS . 0.2 OUTLIER -81.67 120.09 24.66 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.202 175.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 100' ' ' THR . 44.1 tt0 -105.65 90.12 3.3 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.093 -175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.729 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 31.0 m95 -74.12 109.41 7.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 173.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.731 ' HE2' HG13 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -116.31 129.61 56.36 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -173.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.711 HG22 HG22 ' A' ' 95' ' ' VAL . 7.7 mt -102.1 115.96 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 43' ' ' ILE . 2.9 mp -110.84 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.611 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.727 ' CE2' HG11 ' A' ' 113' ' ' VAL . 26.4 t80 -84.02 119.78 25.35 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.513 HG11 HD12 ' B' ' 126' ' ' LEU . 17.6 t -70.57 97.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -85.75 -4.54 85.02 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.643 ' HB2' ' C ' ' A' ' 50' ' ' SER . 3.7 p -115.19 68.04 0.7 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.056 0.455 . . . . 0.0 111.439 177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' B' ' 122' ' ' LYS . . . -76.15 -8.82 57.87 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.81 0.814 . . . . 0.0 108.834 166.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -99.17 -49.62 4.43 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.48 -1.237 . . . . 0.0 109.863 172.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.643 ' C ' ' HB2' ' A' ' 47' ' ' SER . 3.5 m -103.01 -138.88 0.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.877 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.61 3.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.502 172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -97.7 -7.26 31.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.814 0.34 . . . . 0.0 111.814 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 37.4 m-85 -94.81 -0.98 53.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -170.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 18.5 p-10 -51.51 110.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.989 0.899 . . . . 0.0 110.592 172.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' HG2' ' H ' ' A' ' 80' ' ' ASN . 18.5 mp0 -91.71 168.26 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.247 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.731 HG13 ' HE2' ' A' ' 41' ' ' LYS . 2.5 t -126.09 110.86 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.193 -173.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 44' ' ' TYR . 2.4 mm? -82.11 -57.58 3.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -172.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 7.7 t70 -170.35 162.35 8.42 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 173.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.71 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 12.1 p -130.19 119.4 22.9 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.0 p -101.59 129.69 52.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.3 mt -104.85 103.32 12.89 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.455 0.645 . . . . 0.0 110.967 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.02 119.04 54.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -87.96 -136.87 5.38 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.754 -1.212 . . . . 0.0 111.922 -162.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.993 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 5.7 Cg_endo -50.32 117.02 2.84 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.231 1.954 . . . . 0.0 111.324 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.473 HG21 ' HE2' ' A' ' 28' ' ' PHE . 13.0 m -121.41 111.67 33.25 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.187 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -74.8 61.49 5.51 Favored 'Trans proline' 0 CA--C 1.511 -0.626 0 C-N-CA 123.353 2.702 . . . . 0.0 114.284 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.751 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.52 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 112.797 -2.001 . . . . 0.0 112.605 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 111.14 122.96 4.34 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 175.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.856 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 5.6 ptp85 -66.65 130.93 44.81 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.858 0.837 . . . . 0.0 110.005 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.461 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -151.58 158.2 43.21 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.099 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.2 138.11 51.91 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.296 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 11.2 p90 -137.49 148.82 46.33 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.3 p -106.67 119.27 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 122.316 1.055 . . . . 0.0 110.555 -174.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.517 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -111.11 154.27 24.53 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 113.468 -1.696 . . . . 0.0 109.217 -168.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.665 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.0 mt-30 -151.89 160.67 43.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -168.98 145.34 3.48 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' O ' HD12 ' A' ' 57' ' ' LEU . 6.5 m-20 -59.26 -177.8 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.114 0.483 . . . . 0.0 112.24 -174.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -84.4 155.12 63.02 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.846 ' HD3' ' HE1' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -66.83 157.52 60.9 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.684 2.256 . . . . 0.0 110.856 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.5 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 94.9 m-20 -63.12 117.84 37.16 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 -170.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.87 -13.42 38.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.41 2.74 . . . . 0.0 112.004 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.37 -1.1 69.44 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.569 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 83' ' ' LEU . 20.7 mt -103.87 -34.09 8.64 Favored 'General case' 0 CA--C 1.514 -0.421 0 O-C-N 122.928 -0.16 . . . . 0.0 111.286 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 36.4 mt -72.35 125.43 91.38 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.801 -175.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 95.8 Cg_endo -79.26 163.14 25.19 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.788 2.992 . . . . 0.0 111.932 170.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.716 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 2.8 m-20 -45.43 -54.08 7.84 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.176 0.99 . . . . 0.0 113.498 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.46 -8.64 58.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.512 0.196 . . . . 0.0 111.442 -167.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.41 -38.77 11.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.997 0.427 . . . . 0.0 110.37 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.25 -46.16 35.51 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.915 -169.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.23 46.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -176.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.34 -134.53 2.03 Favored Glycine 0 CA--C 1.497 -1.057 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.876 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.799 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -104.49 130.77 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.675 0 CA-C-O 122.261 1.029 . . . . 0.0 113.574 -170.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.613 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -143.71 173.17 11.9 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.051 -1.886 . . . . 0.0 105.921 173.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.79 HG12 HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.0 143.52 39.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.704 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.711 HG22 HG22 ' A' ' 42' ' ' ILE . 9.9 p -121.78 104.43 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.921 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.75 126.81 48.68 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.711 -169.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 39.1 mt -95.18 102.0 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.18 0 CA-C-O 121.771 0.796 . . . . 0.0 109.099 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.775 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 67.8 p -91.14 109.81 21.07 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.844 176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.609 ' HB2' HG22 ' A' ' 107' ' ' ILE . 61.5 m -73.44 109.1 6.7 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.894 176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.584 ' O ' ' HB3' ' A' ' 39' ' ' GLU . 16.1 m -103.68 101.87 11.72 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.529 -174.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.53 ' CE1' HD12 ' A' ' 34' ' ' LEU . 71.4 t80 -107.6 118.51 36.93 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 41.0 mtp180 72.97 19.63 3.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.96 0.504 . . . . 0.0 111.667 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.81 5.29 74.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.198 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.676 HE22 ' ND2' ' A' ' 152' ' ' ASN . 2.5 pt20 -120.65 127.96 52.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.554 ' OE2' ' HB3' ' B' ' 135' ' ' ALA . 4.0 mp0 -84.18 135.55 34.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.46 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.468 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 54.5 p90 -122.04 -1.5 9.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.775 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.1 tt -157.69 162.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.752 ' HG3' HG22 ' A' ' 98' ' ' THR . 9.0 ttm180 -149.2 99.39 2.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.921 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.25 100.55 8.56 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.823 175.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.61 79.58 1.74 Allowed Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 119.413 -1.375 . . . . 0.0 111.116 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.906 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.7 m-85 -71.22 114.43 9.27 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.607 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.7 m-85 -66.59 110.84 3.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.727 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.8 p -92.53 109.99 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.799 ' ND2' HG13 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -95.82 108.13 20.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.499 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.687 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.3 m-80 -97.77 121.44 39.68 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.347 0.594 . . . . 0.0 110.086 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.86 140.36 32.88 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.855 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.546 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 46.5 m-85 -46.52 151.91 0.51 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.9 p -93.29 -29.92 15.41 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.345 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 70.5 mm-40 -76.37 125.56 29.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.625 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 16.7 m -55.72 -32.08 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.401 -172.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.45 -39.15 77.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.506 0.67 . . . . 0.0 110.013 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 81.8 mt -73.32 -23.69 60.28 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.626 -177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 22.0 mtt180 -74.45 -36.67 63.38 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 120' ' ' THR . 11.4 mm-40 -67.85 -44.23 77.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.776 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.405 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.6 p30 -138.13 82.05 25.33 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.729 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.4 Cg_endo -57.56 113.64 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.09 2.527 . . . . 0.0 111.579 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 24.2 Cg_exo -64.79 154.15 74.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.666 2.244 . . . . 0.0 111.593 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.1 p -46.76 -50.23 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 123.725 0.641 . . . . 0.0 112.428 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.7 mmtt -84.39 129.13 59.0 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-O 121.37 0.605 . . . . 0.0 111.055 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.716 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -72.06 125.18 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.653 2.902 . . . . 0.0 111.786 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 10.0 t70 -104.3 108.82 20.4 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.611 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 27.2 m-85 -77.91 -17.4 57.31 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.154 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 72.6 p -88.31 -15.07 36.7 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.911 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.1 mmtt -107.05 13.0 27.97 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 115' ' ' ASN . 18.3 tp -95.93 143.41 27.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.0 -172.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -124.29 124.05 41.57 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 1.103 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 25.7 mtm-85 -87.92 104.15 16.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.784 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.608 ' CG ' ' HG3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -90.34 89.38 7.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.461 HD12 HG23 ' A' ' 113' ' ' VAL . 1.3 mp -66.44 109.08 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 112' ' ' TYR . 89.6 mt -69.2 88.2 0.43 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.721 0.772 . . . . 0.0 110.433 -175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.906 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.63 -12.99 60.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.579 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.1 p -78.84 -12.01 60.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.72 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.47 64.21 57.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.661 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 98.6 Cg_endo -85.76 103.96 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.357 1.371 . . . . 0.0 109.902 172.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.632 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -84.47 80.35 9.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.306 -173.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.659 HG12 HG23 ' A' ' 109' ' ' VAL . 26.7 m -76.88 131.76 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.739 178.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.445 HG22 ' CE1' ' A' ' 149' ' ' PHE . 97.7 m -138.82 107.56 5.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.467 0.651 . . . . 0.0 109.286 173.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.75 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 4.2 ptt180 -108.95 142.82 39.04 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.958 0.885 . . . . 0.0 111.321 -175.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -125.04 169.32 12.25 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.199 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.465 ' HD2' ' O ' ' A' ' 150' ' ' HIS . 1.1 p-80 -93.59 149.69 21.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.291 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.565 ' HB ' ' OE1' ' A' ' 104' ' ' GLN . 45.3 pt -142.29 168.33 14.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.676 ' ND2' HE22 ' A' ' 104' ' ' GLN . 3.2 p30 -96.55 89.84 5.14 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.313 1.054 . . . . 0.0 109.979 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.851 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 8.1 m95 -64.43 -1.57 1.81 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.681 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 152' ' ' ASN . 41.9 mt-10 -135.02 161.58 34.88 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.26 -167.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.427 ' C ' HD22 ' A' ' 156' ' ' ASN . 13.9 m-20 -83.68 70.18 10.28 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.711 -1.132 . . . . 0.0 109.152 176.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 155' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.638 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.23 91.4 1.67 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 111.934 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 68.6 mtm -133.93 -66.34 0.63 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -116.78 136.79 13.02 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.876 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.657 ' HG3' HG23 ' A' ' 92' ' ' VAL . 9.8 mmtp -66.31 -34.48 78.09 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.06 -58.13 2.58 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.928 0.768 . . . . 0.0 112.05 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 8.1 tp -65.98 -37.75 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -60.46 -52.7 64.1 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.262 0.554 . . . . 0.0 110.509 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.624 HD22 ' O ' ' B' ' 122' ' ' LYS . 0.0 OUTLIER -65.42 -44.12 88.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.032 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -40.49 82.72 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.29 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -59.31 -46.19 89.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 110.833 177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.845 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 11.6 tpt180 -63.5 -39.15 93.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.505 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 145' ' ' ARG . 31.0 mt -76.44 -43.61 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.544 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -61.29 -30.13 70.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.144 0.497 . . . . 0.0 110.571 -176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.52 72.86 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.795 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.845 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 36.1 tt0 -131.24 -28.48 1.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.191 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.42 ' HD3' ' C ' ' B' ' 134' ' ' ARG . 3.3 tmt_? -56.53 -52.97 62.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.554 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . . . . . . . . 0 C--O 1.248 0.986 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.733 0.301 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -83.87 137.95 33.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.687 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.45 -18.01 27.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.022 -177.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 34' ' ' LEU . 2.7 t -139.97 139.4 37.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.482 0.658 . . . . 0.0 111.101 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.658 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -140.39 102.82 4.43 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.894 177.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 28' ' ' PHE . 2.9 m -72.66 149.66 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.977 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.789 175.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.14 -63.02 1.02 Allowed 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.447 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.641 HD22 ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -105.31 112.41 25.51 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.244 177.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.641 ' N ' HD22 ' A' ' 8' ' ' ASN . 8.2 p -96.83 109.49 23.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -106.48 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 122.368 1.08 . . . . 0.0 108.965 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.586 HG12 ' CD2' ' A' ' 24' ' ' PHE . 18.4 m -77.29 123.15 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.333 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 25' ' ' GLU . 1.5 mt -89.63 -47.35 8.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.672 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.696 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 8.2 t0 -66.2 83.0 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.062 -1.426 . . . . 0.0 110.367 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.742 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -100.7 174.4 2.99 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 113.31 -1.768 . . . . 0.0 107.021 164.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.887 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 3.2 Cg_endo -49.44 102.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 CA-C-N 121.274 1.491 . . . . 0.0 113.123 -151.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.662 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 20.1 m -129.9 170.54 10.73 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 112.587 -2.097 . . . . 0.0 108.886 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.662 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 77.0 Cg_exo -40.77 139.49 1.29 Allowed 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.888 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.728 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 44.7 t80 -68.36 -10.29 53.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.23 175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -96.32 8.26 44.4 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 121.174 -0.954 . . . . 0.0 110.561 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -95.88 126.11 46.15 Favored Pre-proline 0 CA--C 1.508 -0.672 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 169.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.5 Cg_exo -64.97 154.09 75.03 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.254 2.636 . . . . 0.0 112.519 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' HE2' HH21 ' A' ' 137' ' ' ARG . 25.4 m-85 -65.28 128.41 35.74 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.256 174.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.707 ' HA ' ' HG2' ' A' ' 75' ' ' GLN . 33.1 mt-30 -125.76 102.74 7.45 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.798 -173.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.586 ' CD2' HG12 ' A' ' 11' ' ' VAL . 50.6 m-85 -105.77 144.92 31.83 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.022 178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.597 ' HB2' HD21 ' A' ' 12' ' ' LEU . 26.7 tt0 -118.78 88.29 2.9 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 168.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.612 HD11 HD13 ' A' ' 97' ' ' ILE . 43.2 mt -84.51 119.52 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-O 121.939 0.876 . . . . 0.0 111.67 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 20.0 m -100.16 105.15 16.72 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.415 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.039 ' HB3' HG12 ' A' ' 6' ' ' VAL . 32.8 p90 -118.32 150.75 38.97 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.853 0.835 . . . . 0.0 110.343 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 39.8 tt0 -108.65 116.22 31.57 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.636 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 47.7 t -73.16 117.02 14.39 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -83.16 -28.85 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.174 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.832 -171.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.687 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 4.6 mt-10 -150.07 147.63 28.03 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.55 134.54 46.53 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.665 0.269 . . . . 0.0 111.238 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.804 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -94.31 157.79 15.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.288 -170.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.6 m -112.59 -39.58 4.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.037 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.833 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.6 tt0 -119.44 -168.28 1.55 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.297 -175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.833 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 3.2 m-20 -93.69 136.88 33.53 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.391 0.615 . . . . 0.0 110.205 -174.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mm? -83.73 127.09 33.53 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.787 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 57.8 tt0 -116.68 90.23 3.29 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.628 -173.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.677 ' HZ3' HG21 ' A' ' 107' ' ' ILE . 35.7 m95 -84.21 133.65 34.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.5 ttmt -129.84 144.76 51.47 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.935 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.666 HD13 HG12 ' A' ' 97' ' ' ILE . 44.2 mm -102.02 107.45 21.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.8 mp -102.13 113.6 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.831 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' HA ' HG12 ' A' ' 95' ' ' VAL . 34.4 t80 -95.16 122.24 37.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.111 -178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.79 HG13 ' CE2' ' A' ' 53' ' ' TYR . 4.8 t -72.51 98.45 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.698 0.761 . . . . 0.0 109.489 171.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.689 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -72.38 -55.13 7.07 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.383 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.585 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 44.4 m -119.8 73.17 0.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.7 0.4 . . . . 0.0 110.55 -176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -49.69 -19.06 0.55 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.337 0.589 . . . . 0.0 111.927 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' OE2' ' HE2' ' B' ' 122' ' ' LYS . 1.5 tp10 -71.46 -19.29 62.24 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.043 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.617 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 39.9 m -117.04 -151.2 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.768 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 8.5 pt-20 -154.25 19.01 0.49 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.669 0.747 . . . . 0.0 111.267 171.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 50' ' ' SER . 2.0 mp0 -98.18 -36.97 9.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.827 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.79 ' CE2' HG13 ' A' ' 45' ' ' VAL . 10.7 p90 -54.65 -41.79 70.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.915 -1.948 . . . . 0.0 113.593 -169.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 9.8 p-10 -30.71 105.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.212 0 O-C-N 125.134 1.521 . . . . 0.0 112.546 -165.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.723 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 24.0 mt-30 -95.12 165.86 12.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.905 -168.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -120.15 108.96 24.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.148 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.494 HD22 ' CG2' ' A' ' 42' ' ' ILE . 6.6 mp -73.31 -40.7 64.3 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.602 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -176.53 165.83 2.66 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.073 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.9 p -144.63 123.85 12.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.9 p -100.42 136.26 32.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.788 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.5 mt -110.71 105.72 14.69 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.023 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 89.3 t -96.4 118.15 42.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -76.35 -160.39 10.11 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.56 -165.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.804 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.7 Cg_endo -67.9 115.28 3.7 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 121.397 1.398 . . . . 0.0 110.231 177.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.571 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 34.1 m -124.99 141.18 37.69 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.185 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -83.26 77.31 3.58 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 C-N-CA 122.48 2.12 . . . . 0.0 113.575 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.696 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 44.98 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.012 -1.903 . . . . 0.0 112.357 -175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.39 139.43 9.77 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.496 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.887 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 32.8 ttt180 -77.69 116.88 18.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.797 0.808 . . . . 0.0 110.091 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -128.68 122.07 29.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.18 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.753 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -83.59 121.27 27.01 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.651 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.7 p90 -120.66 160.08 24.01 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -120.1 133.83 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.656 0 CA-C-O 121.911 0.863 . . . . 0.0 110.093 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.651 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 2.7 t80 -135.44 107.57 7.19 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.951 -161.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.707 ' HG2' ' HA ' ' A' ' 23' ' ' GLN . 77.3 mt-30 -124.19 155.13 39.05 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -156.94 134.58 10.79 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.183 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 21' ' ' PRO . 2.6 t0 -65.48 171.84 3.73 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -69.87 159.77 82.79 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.658 . . . . 0.0 111.304 -171.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 56.6 Cg_endo -66.75 172.87 8.86 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.343 2.696 . . . . 0.0 111.449 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 10.0 m-80 -70.97 121.37 83.87 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.014 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.5 Cg_endo -63.57 -12.84 33.06 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.154 2.569 . . . . 0.0 110.944 175.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.48 -19.18 46.04 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.714 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.723 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 12.4 mt -94.61 -1.56 53.02 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.594 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 24.8 mt -100.7 125.92 37.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.913 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 86.0 Cg_endo -79.28 158.76 26.29 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.017 2.478 . . . . 0.0 111.145 170.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.659 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 9.1 m-20 -47.53 -47.02 28.08 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -172.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.99 -37.21 47.73 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.798 175.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -68.68 -47.43 66.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.064 -167.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.3 m -101.93 46.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-O 122.208 1.004 . . . . 0.0 110.396 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.88 -139.44 2.66 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.912 -1.494 . . . . 0.0 112.654 -163.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.761 HG13 ' HB2' ' B' ' 122' ' ' LYS . 12.4 p -122.44 145.73 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-O 121.875 0.845 . . . . 0.0 110.366 -173.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.749 HG23 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -160.66 174.36 14.08 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.626 HG21 HD11 ' B' ' 130' ' ' ILE . 1.9 t -132.16 144.38 37.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.882 0.372 . . . . 0.0 111.686 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 29.3 m -124.74 105.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.838 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.4 pp -103.5 145.06 30.57 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.163 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 46.1 mt -102.83 100.77 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.615 0.722 . . . . 0.0 109.235 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 80.8 p -99.8 114.37 27.48 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.702 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 4.6 t -80.83 158.79 25.27 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.867 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 17.7 m -148.44 109.17 4.22 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -165.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 151' ' ' ILE . 56.1 t80 -124.0 120.83 33.58 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.517 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 43.1 mtp180 66.76 25.85 9.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.275 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.62 11.74 73.83 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.455 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.37 131.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.137 0.494 . . . . 0.0 110.078 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' B' ' 134' ' ' ARG . 37.2 mp0 -86.7 125.5 33.92 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.501 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.522 ' HZ ' ' CD1' ' A' ' 38' ' ' LEU . 54.8 p90 -119.82 2.58 11.08 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -168.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.844 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.0 tt -156.35 154.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.799 HH21 HG21 ' A' ' 147' ' ' THR . 0.3 OUTLIER -153.6 108.17 3.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -177.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 4.2 p -97.39 100.64 11.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 122.16 0.981 . . . . 0.0 109.26 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -83.43 84.11 1.58 Allowed Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.616 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.909 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 6.3 m-85 -80.52 116.17 20.42 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.126 . . . . 0.0 109.109 173.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.59 ' HA ' HG22 ' A' ' 94' ' ' VAL . 22.7 m-85 -68.4 135.99 52.61 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.749 HG13 HG23 ' A' ' 93' ' ' THR . 4.1 p -121.25 111.4 31.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 108.826 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -96.34 120.45 36.66 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.968 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.593 ' HB3' HD11 ' A' ' 135' ' ' LEU . 49.2 m-80 -100.42 118.82 37.44 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.535 0.683 . . . . 0.0 109.413 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.62 131.04 42.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.694 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.684 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 20.2 m-85 -43.88 151.48 0.21 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -92.56 -29.47 16.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.003 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 14.3 mm-40 -84.18 128.57 34.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.952 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 72.2 m -48.41 -45.96 36.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.048 0.218 . . . . 0.0 111.344 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.61 -31.38 68.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.766 0.793 . . . . 0.0 110.423 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.684 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 83.4 mt -84.6 -25.52 28.56 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.326 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 63.4 mtp180 -81.1 -36.63 30.14 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' THR . 9.6 pt-20 -74.01 -36.49 64.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.117 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.657 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.6 OUTLIER -142.88 80.58 13.73 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.096 176.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 19.0 Cg_endo -57.36 119.49 6.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.408 2.739 . . . . 0.0 112.045 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 16.8 Cg_exo -69.57 163.12 39.3 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.966 2.444 . . . . 0.0 111.737 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.29 -45.6 89.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 0.0 110.817 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 2.1 mmtt -89.5 129.87 45.61 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 121.385 0.612 . . . . 0.0 110.989 176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.682 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 3.0 Cg_endo -79.21 147.72 20.85 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.966 3.111 . . . . 0.0 112.248 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 7.8 t0 -116.64 111.63 20.12 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.728 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 13.0 m-85 -77.92 -13.46 59.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.049 0.928 . . . . 0.0 109.659 -173.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -87.35 -24.05 24.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.186 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . 74.8 mmtt -98.92 9.6 43.15 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.7 tp -94.36 144.86 25.18 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.535 -172.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 1.1 tt0 -128.82 126.13 39.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.584 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.887 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -90.49 105.79 18.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.74 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.643 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.2 t30 -95.15 108.39 20.5 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.639 0.733 . . . . 0.0 109.434 171.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 139' ' ' ILE . 1.3 mp -85.19 109.71 18.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.058 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.58 85.35 0.19 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.673 . . . . 0.0 110.178 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.909 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.454 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.4 p -72.77 -16.36 61.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.217 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.11 68.67 76.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 46.1 Cg_endo -92.03 104.95 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.954 1.769 . . . . 0.0 110.327 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 145' ' ' ARG . 18.4 tpt180 -85.98 92.5 8.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.16 0.505 . . . . 0.0 110.482 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.622 HG12 HG23 ' A' ' 109' ' ' VAL . 29.7 m -86.33 129.79 37.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.516 0.674 . . . . 0.0 111.446 -175.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.799 HG21 HH21 ' A' ' 108' ' ' ARG . 21.1 m -140.86 107.46 5.33 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.7 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -110.78 130.05 55.68 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.607 0.717 . . . . 0.0 110.701 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.05 142.55 46.83 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.922 -176.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.17 137.18 42.98 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 110.892 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 101' ' ' TYR . 46.4 pt -131.74 -174.01 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.21 92.56 7.8 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.038 0.923 . . . . 0.0 111.479 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.672 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 19.2 m95 -77.3 0.92 20.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.445 175.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.498 ' CG ' HD22 ' A' ' 156' ' ' ASN . 6.7 pt-20 -104.0 168.71 8.94 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 114.421 -1.263 . . . . 0.0 107.778 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -96.76 67.95 2.37 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.094 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.498 HD22 ' CG ' ' A' ' 154' ' ' GLU . 5.3 p30 . . . . . 0 C--O 1.25 1.097 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.51 163.48 16.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 58.9 ttp -61.04 -75.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.925 0.393 . . . . 0.0 110.325 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.68 ' O ' HG11 ' A' ' 92' ' ' VAL . . . -128.39 37.41 2.27 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.761 ' HB2' HG13 ' A' ' 92' ' ' VAL . 22.1 mmtp 65.12 -25.84 0.09 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.729 1.212 . . . . 0.0 112.518 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' B' ' 121' ' ' GLY . 0.9 OUTLIER -11.85 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 166.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.33 -36.2 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' B' ' 122' ' ' LYS . 17.4 mm100 -58.21 -52.37 65.86 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.92 0.867 . . . . 0.0 110.663 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.529 ' O ' HG13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -62.74 -40.88 98.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.042 177.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' B' ' 131' ' ' ARG . . . -63.24 -26.05 68.61 Favored 'General case' 0 C--O 1.219 -0.529 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.339 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 63.9 mtp85 -64.01 -52.05 61.36 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 120.819 0.343 . . . . 0.0 110.196 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.679 ' HD2' HD21 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -62.35 -36.86 83.53 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.77 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 49.4 mt -85.12 -3.01 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.863 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' B' ' 131' ' ' ARG . 1.4 tpm_? -90.97 -40.63 11.57 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 121.18 -0.95 . . . . 0.0 109.995 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 170.0 54.43 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.291 -1.433 . . . . 0.0 113.18 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.661 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 2.8 tp10 -88.5 -52.07 5.37 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.471 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.682 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 38.5 ptt180 44.18 115.83 0.0 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-O 123.382 1.563 . . . . 0.0 115.162 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.283 0 CA-C-N 111.926 -2.397 . . . . 0.0 109.567 -176.378 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' HB3' ' A' ' 150' ' ' HIS . 13.7 ptp . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.29 126.79 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.857 0.361 . . . . 0.0 110.74 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.702 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -94.07 -8.48 39.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.809 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.768 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 1.5 t -147.28 140.78 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.389 0.614 . . . . 0.0 110.999 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.658 ' HB2' HD11 ' A' ' 31' ' ' ILE . 22.9 tp60 -136.85 99.95 4.17 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.653 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.934 HG12 ' HB3' ' A' ' 28' ' ' PHE . 5.1 m -72.05 145.25 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.262 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -125.93 -62.05 1.2 Allowed 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.675 -1.602 . . . . 0.0 108.931 -165.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.6 t-20 -102.9 152.51 21.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.832 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.8 p -145.45 99.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.093 HG23 ' HB2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -88.71 99.5 9.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.825 -174.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.761 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.43 118.42 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.897 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.665 HD21 ' HG3' ' A' ' 25' ' ' GLU . 2.8 mt -88.79 -45.28 9.89 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.154 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.71 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 2.9 t70 -74.31 72.3 1.78 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.092 -1.867 . . . . 0.0 110.12 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.923 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 4.7 m120 -84.07 174.84 5.32 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.719 -2.037 . . . . 0.0 107.801 162.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.923 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.0 Cg_endo -49.12 102.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 CA-C-N 120.912 1.362 . . . . 0.0 113.176 -149.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.832 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 67.7 m -129.93 168.43 16.65 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 112.152 -2.295 . . . . 0.0 109.535 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.8 Cg_exo -43.17 132.69 6.36 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.417 2.078 . . . . 0.0 112.622 174.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.687 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 65.2 t80 -61.51 -9.14 5.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.068 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -95.76 -1.66 49.34 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.725 -0.61 . . . . 0.0 112.226 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.832 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.2 OUTLIER -97.04 134.85 22.38 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.542 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 31.2 Cg_exo -65.11 151.74 84.61 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.271 2.647 . . . . 0.0 113.007 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 27.5 m-85 -62.97 118.8 8.31 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.204 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.71 ' H ' ' HB3' ' A' ' 13' ' ' ASP . 7.8 mt-30 -115.79 111.89 21.19 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.459 -173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CD1' HD11 ' A' ' 97' ' ' ILE . 93.9 m-85 -116.0 155.34 28.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.142 176.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.093 ' HB2' HG23 ' A' ' 10' ' ' VAL . 43.4 mt-10 -126.78 91.07 3.27 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 162.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 97' ' ' ILE . 10.6 mt -77.2 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.816 0.817 . . . . 0.0 112.09 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.8 m -111.19 107.18 16.43 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.303 176.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.934 ' HB3' HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -113.54 150.35 33.1 Favored 'General case' 0 CA--C 1.47 -2.122 0 CA-C-O 122.153 0.977 . . . . 0.0 111.131 176.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 42.9 tt0 -103.51 105.63 15.93 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 172.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.6 m -70.57 126.44 29.63 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.658 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -87.04 -25.71 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -165.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.702 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 44.6 mt-10 -147.47 167.9 23.26 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.908 174.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -74.72 142.42 44.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.919 0.39 . . . . 0.0 110.142 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.054 HD11 ' HE1' ' A' ' 101' ' ' TYR . 0.4 OUTLIER -107.21 156.38 18.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.879 -168.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.607 ' N ' HD13 ' A' ' 34' ' ' LEU . 15.2 m -115.38 -35.99 4.45 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.711 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 23.1 tt0 -104.3 -166.32 1.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -172.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.711 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.3 p-10 -101.19 138.67 37.91 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 121.641 -0.662 . . . . 0.0 111.416 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -87.45 128.99 35.22 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.19 179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 32.7 tt0 -104.03 90.4 3.59 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.299 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.603 ' O ' ' HA ' ' A' ' 59' ' ' SER . 14.8 m95 -86.84 109.5 19.33 Favored 'General case' 0 CA--C 1.502 -0.865 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 1.104 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 0.4 OUTLIER -118.51 160.26 22.06 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.992 173.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.882 HD12 ' HB3' ' A' ' 76' ' ' ALA . 48.8 mt -101.68 108.71 24.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.713 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 2.2 mp -98.2 105.62 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.757 ' CE1' HG11 ' A' ' 113' ' ' VAL . 40.4 t80 -90.67 109.07 20.25 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.86 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.642 HG11 HD23 ' B' ' 126' ' ' LEU . 40.5 t -65.19 98.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.497 173.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.34 42.75 Favored Glycine 0 N--CA 1.436 -1.309 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 171.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.78 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 16.8 p -85.63 87.5 7.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.704 -0.748 . . . . 0.0 111.982 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' B' ' 126' ' ' LEU . . . -84.1 -13.89 51.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 166.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -100.49 -36.6 9.14 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.439 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.667 ' C ' ' HB2' ' A' ' 47' ' ' SER . 50.6 m -103.64 -154.45 0.5 Allowed 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.39 5.07 0.45 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -94.92 -8.25 37.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.78 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 19.5 m-85 -98.18 11.07 39.0 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -170.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -64.32 99.08 0.26 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 122.082 0.944 . . . . 0.0 110.314 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -95.76 169.64 9.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.511 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.488 HG11 ' HE2' ' A' ' 41' ' ' LYS . 23.5 t -127.94 112.42 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -172.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 44' ' ' TYR . 3.3 mm? -77.51 -52.04 9.74 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.863 -175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 35.0 t70 -168.46 153.8 6.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.061 173.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 1.104 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 21.3 p -124.79 120.46 31.8 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG13 ' HD1' ' A' ' 40' ' ' TRP . 4.4 p -101.87 139.06 23.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.736 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.75 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 14.3 mt -108.61 105.35 14.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.293 0.568 . . . . 0.0 111.601 -173.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 21.9 t -116.24 110.84 32.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -97.48 -112.63 3.03 Favored Glycine 0 CA--C 1.487 -1.711 0 C-N-CA 118.665 -1.731 . . . . 0.0 113.417 -159.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.895 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 17.5 Cg_endo -58.71 115.9 2.87 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 121.071 1.181 . . . . 0.0 109.961 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 63' ' ' GLY . 27.5 m -130.31 122.38 19.99 Favored Pre-proline 0 C--N 1.3 -1.544 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.987 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.88 126.84 18.15 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.999 1.799 . . . . 0.0 111.021 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -41.02 134.14 2.05 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.05 0.844 . . . . 0.0 112.004 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 136.41 135.16 3.38 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.884 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 16.3 ptt180 -66.28 139.1 58.04 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.604 0.716 . . . . 0.0 110.46 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 11.0 p80 -166.39 151.23 7.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.392 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.655 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 2.1 ttp -107.9 137.81 45.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.341 0.591 . . . . 0.0 111.627 -174.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.671 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.3 p90 -125.69 150.67 47.46 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.719 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.5 p -105.37 135.12 44.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.8 0.81 . . . . 0.0 110.754 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.671 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.7 t80 -135.47 118.95 16.87 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.449 -166.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -130.35 154.29 47.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.51 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.882 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -155.33 153.33 30.34 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.0 p-10 -64.35 -171.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.933 0.873 . . . . 0.0 113.137 -170.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -86.09 142.96 36.55 Favored Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.299 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.687 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.7 Cg_exo -57.76 149.36 69.25 Favored 'Trans proline' 0 CA--C 1.502 -1.123 0 C-N-CA 124.116 3.21 . . . . 0.0 112.824 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 9.8 t-20 -59.56 119.01 36.24 Favored Pre-proline 0 N--CA 1.428 -1.538 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.367 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.19 -10.99 22.97 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.996 2.464 . . . . 0.0 111.498 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.09 -8.81 58.7 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.553 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 33.7 mt -96.82 -17.38 20.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.549 0.214 . . . . 0.0 111.555 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 25.3 mt -88.48 129.29 49.78 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.293 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 2.5 Cg_endo -77.5 146.68 24.62 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.652 2.902 . . . . 0.0 111.625 170.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.638 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 3.1 m-20 -47.75 -40.3 20.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 125.278 1.431 . . . . 0.0 113.621 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.85 -29.95 58.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.327 0.584 . . . . 0.0 110.605 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 29.8 m-20 -89.16 -21.58 23.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.807 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.34 -49.36 19.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 121.086 0.47 . . . . 0.0 111.86 -174.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.41 47.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.598 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.73 -128.89 1.13 Allowed Glycine 0 CA--C 1.497 -1.035 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.194 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.641 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.04 138.28 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.516 ' OG1' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -147.64 166.26 27.94 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.853 HG12 HD23 ' A' ' 96' ' ' LEU . 5.5 t -126.77 131.85 70.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.049 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 42' ' ' ILE . 2.1 p -106.23 106.05 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.272 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.853 HD23 HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -104.2 132.74 50.14 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 -174.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.715 ' HB ' HG12 ' A' ' 109' ' ' VAL . 50.8 mt -94.48 102.75 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.767 HG22 ' HG3' ' A' ' 108' ' ' ARG . 17.8 p -95.73 109.47 21.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.946 ' SG ' HG23 ' A' ' 107' ' ' ILE . 3.2 m -81.02 111.98 17.99 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.65 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 19.3 m -108.7 111.88 23.89 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.421 -170.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 1.054 ' HE1' HD11 ' A' ' 34' ' ' LEU . 60.8 t80 -117.49 120.67 38.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.702 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 54.7 mtp180 67.87 25.12 7.9 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.204 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.46 8.45 87.04 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.417 ' HB2' HD12 ' A' ' 151' ' ' ILE . 2.3 mt-30 -113.06 115.05 27.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.844 -0.678 . . . . 0.0 109.373 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 28.2 mp0 -78.99 118.64 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.693 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 36.3 p90 -105.63 -5.85 19.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.946 HG23 ' SG ' ' A' ' 99' ' ' CYS . 0.6 OUTLIER -160.57 161.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 O-C-N 121.433 -0.792 . . . . 0.0 109.584 173.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.767 ' HG3' HG22 ' A' ' 98' ' ' THR . 12.2 ttm180 -149.48 97.6 2.66 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.831 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -86.48 100.09 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.696 175.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.41 83.83 1.59 Allowed Glycine 0 CA--C 1.488 -1.633 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.227 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.891 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -76.13 118.13 18.56 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.78 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.546 ' HB3' HD12 ' A' ' 140' ' ' LEU . 4.2 m-85 -68.28 115.54 7.84 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.53 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.757 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.0 p -101.99 112.28 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.641 ' ND2' HG13 ' A' ' 92' ' ' VAL . 1.7 t-20 -95.39 126.13 40.48 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.274 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 55.5 m-80 -113.33 108.47 17.28 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.929 0.871 . . . . 0.0 109.107 -169.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -125.18 137.94 54.14 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.042 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.534 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 39.7 m-85 -51.59 149.38 4.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 42.7 p -100.4 -24.24 14.55 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.495 -176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.841 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 18.7 mm-40 -81.28 120.49 24.98 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.743 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 29.1 m -45.94 -40.65 10.56 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.83 0.706 . . . . 0.0 112.058 -169.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.32 -37.49 77.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.351 0.596 . . . . 0.0 110.372 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -71.2 -28.68 64.39 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.094 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 51.5 mtt180 -70.02 -42.04 73.48 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 120' ' ' THR . 6.2 mm-40 -58.02 -42.84 86.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.039 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.431 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 4.1 p30 -152.17 87.66 4.23 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.68 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.6 Cg_endo -56.24 115.71 2.66 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.435 2.757 . . . . 0.0 112.509 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -63.19 151.25 85.76 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.76 2.307 . . . . 0.0 111.282 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.9 -27.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.679 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -91.63 127.58 49.79 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.626 172.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.638 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.0 Cg_exo -77.29 127.79 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.764 2.976 . . . . 0.0 111.556 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 134' ' ' LYS . 10.2 t70 -111.8 108.68 18.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.67 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 22.5 m-85 -77.19 -16.42 59.1 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.086 -171.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.5 t -82.62 -19.93 37.35 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.334 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.841 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.0 mmtt -107.33 15.08 25.36 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.494 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 16.3 tp -98.1 149.99 21.91 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.115 -171.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 1.6 tt0 -127.88 121.5 30.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.877 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 2.2 ptp85 -84.02 104.0 13.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.573 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 14.6 t30 -92.91 103.48 15.81 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.761 HG21 HG11 ' A' ' 11' ' ' VAL . 1.4 mp -81.79 104.15 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 112' ' ' TYR . 85.1 mt -64.74 86.7 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.686 -177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.891 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -71.83 -11.56 60.86 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.06 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -22.83 60.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.988 173.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -129.69 71.15 82.17 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.312 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.68 104.78 1.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.473 1.449 . . . . 0.0 109.933 167.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.628 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -81.15 81.68 7.28 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.656 HG12 HG23 ' A' ' 109' ' ' VAL . 16.1 m -81.94 117.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.299 0.571 . . . . 0.0 110.864 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.408 HG22 ' CE2' ' A' ' 149' ' ' PHE . 21.7 m -126.02 106.32 9.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.58 0.705 . . . . 0.0 109.89 173.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.738 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 2.0 ptt180 -114.74 146.16 41.26 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.258 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.41 170.4 14.23 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.885 -173.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.475 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 13.7 m170 -103.74 115.04 29.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.246 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 106' ' ' PHE . 20.9 pt -119.39 166.66 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.638 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -95.51 100.26 12.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.548 1.166 . . . . 0.0 111.013 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.768 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 19.4 m95 -73.01 -6.65 46.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.905 -1.498 . . . . 0.0 109.896 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.47 160.33 35.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.068 -174.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -94.17 65.87 3.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.408 178.2 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -142.52 -98.64 0.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.706 0.253 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 7.8 tpt 63.6 153.52 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.51 0.671 . . . . 0.0 111.954 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.31 168.94 45.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.541 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.471 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.5 mmtt -127.79 -61.1 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.989 0.394 . . . . 0.0 110.363 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.11 -52.28 21.11 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.63 0.581 . . . . 0.0 111.806 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 9.7 tt -63.95 -37.35 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 120.699 0.285 . . . . 0.0 111.186 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.425 HE21 ' HB3' ' B' ' 125' ' ' GLN . 9.0 mm100 -63.88 -47.86 78.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.263 0.554 . . . . 0.0 111.029 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.642 HD23 HG11 ' A' ' 45' ' ' VAL . 43.3 mt -65.24 -46.17 81.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.825 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.18 -40.72 77.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.971 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 57.1 mtp180 -52.41 -52.59 53.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.828 0.347 . . . . 0.0 111.457 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.671 ' HA ' ' CB ' ' B' ' 133' ' ' GLU . 12.9 tpt180 -62.68 -37.48 86.6 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.596 -173.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 145' ' ' ARG . 13.0 mt -74.11 -51.6 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.073 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -50.27 -37.35 35.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.505 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.555 ' HA2' ' NH1' ' A' ' 108' ' ' ARG . . . 154.09 64.16 0.01 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.673 176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.671 ' CB ' ' HA ' ' B' ' 129' ' ' ARG . 4.9 tp10 -100.72 -43.01 6.27 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.319 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -59.4 2.85 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.567 ' C ' HH22 ' A' ' 108' ' ' ARG . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 117.459 -1.257 . . . . 0.0 108.614 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.741 0.305 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -84.45 135.56 34.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.896 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.86 -17.33 28.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.28 -178.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.602 HG23 HD21 ' A' ' 34' ' ' LEU . 3.2 t -140.62 129.75 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.733 . . . . 0.0 111.289 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 23.0 tp60 -121.99 99.05 6.23 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 171.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -77.4 143.05 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.007 -1.077 . . . . 0.0 108.518 178.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.427 HD21 ' CB ' ' A' ' 29' ' ' GLU . 28.0 m-80 -123.77 -65.98 1.03 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.173 -164.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.674 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -104.4 152.3 22.46 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.471 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 9' ' ' VAL . 2.8 p -145.77 99.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.101 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.3 101.38 12.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.826 -177.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -76.96 115.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.042 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.553 HD11 HG23 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -88.51 -38.72 14.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 113.933 -1.485 . . . . 0.0 107.524 -175.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.69 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.97 79.44 0.91 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 112.577 -2.101 . . . . 0.0 108.559 168.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -106.14 176.02 1.85 Allowed Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 111.371 -2.649 . . . . 0.0 106.38 170.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.86 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 2.1 Cg_endo -48.65 102.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.892 1.711 . . . . 0.0 113.291 -154.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.655 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.9 m -137.04 171.87 7.88 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 111.926 -2.397 . . . . 0.0 108.593 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 56.1 Cg_exo -39.94 139.09 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.828 2.352 . . . . 0.0 112.25 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.832 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 35.7 t80 -60.16 -27.57 67.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.705 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -83.58 -13.7 53.8 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.286 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -62.28 128.05 90.58 Favored Pre-proline 0 C--O 1.22 -0.464 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.676 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 27.3 Cg_exo -68.0 153.82 74.22 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 123.772 2.981 . . . . 0.0 113.266 -172.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 19.6 m-85 -65.26 122.68 17.68 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 121.061 0.458 . . . . 0.0 109.961 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.763 ' HA ' ' HG3' ' A' ' 75' ' ' GLN . 19.7 mt-30 -127.07 92.91 3.62 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.48 -172.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.558 ' CD1' HD11 ' A' ' 97' ' ' ILE . 92.2 m-85 -103.39 126.07 50.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.101 ' HB3' HG23 ' A' ' 10' ' ' VAL . 32.7 tt0 -105.44 87.25 2.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.759 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 3.3 mt -80.04 133.02 30.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.85 0.833 . . . . 0.0 112.192 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 7.1 m -109.73 104.74 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.193 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.749 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 17.8 p90 -118.3 146.44 44.32 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.958 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.6 tt0 -105.56 116.81 32.57 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -73.26 110.83 7.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -76.78 -29.49 17.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 113.639 -1.619 . . . . 0.0 110.05 -175.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.896 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 5.8 mt-10 -149.54 147.51 28.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -52.82 133.31 37.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 -175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.762 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -87.66 157.23 19.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.578 -172.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 m -112.89 -34.41 5.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.946 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.714 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.1 tt0 -124.07 -167.88 1.71 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.82 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.714 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -92.93 145.01 24.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.499 0.666 . . . . 0.0 110.758 -177.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.7 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -92.7 121.96 34.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.312 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 25.6 tt0 -102.58 93.51 5.16 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.626 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.759 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 23.0 m95 -84.33 111.44 19.42 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.753 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 31.2 ttmt -115.81 143.06 45.94 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.958 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.546 HG21 HD22 ' A' ' 57' ' ' LEU . 10.9 mt -102.95 106.8 20.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.469 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.541 HD12 ' HG2' ' A' ' 41' ' ' LYS . 3.0 mp -105.73 106.64 20.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.29 -176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.755 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.2 t80 -91.69 120.02 32.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.561 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' B' ' 126' ' ' LEU . 24.0 t -58.37 101.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.143 0.497 . . . . 0.0 110.095 174.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.18 -37.24 94.27 Favored Glycine 0 CA--C 1.506 -0.512 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.109 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.75 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 66.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 172.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.03 54.28 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.198 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -90.09 -23.97 21.25 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 51.9 m -117.2 -154.91 0.57 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.85 164.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -134.0 -33.89 1.02 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.659 0.266 . . . . 0.0 110.913 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.571 ' HG3' ' OE1' ' A' ' 51' ' ' GLU . 29.3 mt-10 -71.43 -3.93 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.75 ' CD1' ' HB2' ' A' ' 47' ' ' SER . 96.8 m-85 -85.98 -1.86 57.73 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.446 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -49.22 111.85 0.54 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.133 0.968 . . . . 0.0 110.481 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 1.5 mt-30 -93.4 168.6 10.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.716 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.03 113.28 36.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.459 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 42' ' ' ILE . 10.9 mp -74.54 -50.32 18.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.499 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -170.83 -177.93 2.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.663 -177.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.589 ' HB3' ' HE3' ' A' ' 41' ' ' LYS . 36.1 p -152.69 124.32 7.8 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -100.54 135.63 35.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.0 mt -110.69 105.41 14.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.01 0.433 . . . . 0.0 110.573 -176.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.7 t -93.42 119.11 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -74.67 -164.21 11.41 Favored Glycine 0 CA--C 1.499 -0.911 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.385 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.762 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 53.4 Cg_endo -66.14 115.42 3.46 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.298 1.332 . . . . 0.0 110.194 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.592 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.4 m -123.04 138.4 29.71 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.849 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -85.41 78.18 2.55 Favored 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 122.363 2.042 . . . . 0.0 113.83 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.581 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 52.26 -178.69 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.641 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 106.07 137.96 8.99 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.658 173.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.958 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 6.2 ptt180 -76.14 127.1 32.24 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.997 0.903 . . . . 0.0 109.474 174.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.552 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 22.5 m-70 -123.65 135.25 53.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.683 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.1 ttp -109.22 99.56 8.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 5.8 p90 -108.67 142.31 39.35 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.694 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 3.4 p -104.96 130.55 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.688 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.492 -174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.643 ' HE1' ' OD2' ' A' ' 58' ' ' ASP . 5.1 t80 -132.86 132.04 41.65 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.817 -159.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.763 ' HG3' ' HA ' ' A' ' 23' ' ' GLN . 22.1 mp0 -145.28 156.05 43.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.106 0.479 . . . . 0.0 110.57 -172.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -160.72 161.46 32.23 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.047 -0.978 . . . . 0.0 108.375 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.7 178.4 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.652 0.739 . . . . 0.0 112.28 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -68.76 159.94 79.77 Favored Pre-proline 0 N--CA 1.432 -1.359 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.199 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 57.4 Cg_endo -74.62 166.54 29.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.778 2.319 . . . . 0.0 110.503 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.564 ' HB2' HD12 ' A' ' 83' ' ' LEU . 3.7 m-20 -75.88 114.19 34.57 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.207 0.527 . . . . 0.0 111.161 -171.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 18.5 Cg_endo -64.33 -21.64 66.73 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.578 2.852 . . . . 0.0 112.131 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.38 -0.54 84.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.251 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 80' ' ' ASN . 35.0 mt -103.68 -20.57 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.571 0.224 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 27.9 mt -89.8 129.39 46.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.232 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 88' ' ' ASP . 88.1 Cg_endo -79.99 163.58 22.97 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.527 2.818 . . . . 0.0 111.732 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.669 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -45.64 -56.68 4.91 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.068 0.947 . . . . 0.0 113.268 -174.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -24.39 61.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.121 0.486 . . . . 0.0 111.197 -167.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.548 ' CG ' ' HG2' ' A' ' 85' ' ' PRO . 1.4 m-20 -86.65 -24.97 25.09 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.476 -175.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.654 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -82.91 -46.87 12.44 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.016 -173.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -94.23 46.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-O 122.043 0.925 . . . . 0.0 111.275 -174.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.87 -124.71 0.8 Allowed Glycine 0 CA--C 1.499 -0.914 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.103 -170.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.495 HG23 ' ND2' ' A' ' 114' ' ' ASN . 1.1 t -114.57 134.68 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 -168.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 169.93 17.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.461 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.67 HG23 HD13 ' B' ' 126' ' ' LEU . 3.5 t -127.17 152.31 35.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 118.37 0.532 . . . . 0.0 111.603 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG11 ' CE1' ' A' ' 22' ' ' PHE . 7.6 p -130.83 108.68 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.926 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.21 133.25 47.38 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.025 -172.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 33.9 mt -102.23 97.65 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.038 0.923 . . . . 0.0 108.797 174.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.805 HG22 ' HG3' ' A' ' 108' ' ' ARG . 49.4 p -91.72 114.11 26.56 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.258 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 61.4 m -81.99 105.69 13.31 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.919 0.866 . . . . 0.0 110.706 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.5 m -93.3 106.51 18.47 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.668 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.612 ' CD2' ' HG3' ' A' ' 102' ' ' ARG . 65.7 t80 -116.64 119.63 36.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.038 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.612 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.3 mtp180 64.88 23.71 12.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.2 -0.58 64.07 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.62 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.402 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -118.31 121.11 39.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 175.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' B' ' 134' ' ' ARG . 46.8 mt-10 -72.63 131.36 42.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.783 176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.7 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.6 p90 -115.66 -1.85 12.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.1 tt -157.77 161.54 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.696 -0.627 . . . . 0.0 109.602 173.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.805 ' HG3' HG22 ' A' ' 98' ' ' THR . 17.7 ttm180 -150.71 95.78 2.27 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.926 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -83.15 100.36 6.68 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.705 0 C-N-CA 118.776 -1.169 . . . . 0.0 108.558 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.503 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -87.78 78.65 1.79 Allowed Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.869 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.913 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -72.88 117.99 15.27 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.958 174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.608 ' HB3' HD12 ' A' ' 140' ' ' LEU . 22.6 m-85 -67.55 130.34 42.74 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.9 p -112.02 111.67 37.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.652 ' HB3' ' ND2' ' A' ' 138' ' ' ASN . 3.9 t-20 -94.46 116.78 29.19 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.386 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.654 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 43.9 m-80 -108.39 108.53 19.53 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -171.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -131.5 129.07 40.63 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.392 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.58 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.8 m-85 -39.55 150.09 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 136' ' ' GLN . 68.7 p -92.46 -28.66 16.7 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.167 -177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.963 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.4 mm-40 -84.4 117.31 23.54 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.216 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.738 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 11.7 m -53.07 -34.36 56.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.039 -172.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.16 -32.03 72.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.687 0.756 . . . . 0.0 110.283 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.4 mt -76.96 -24.38 52.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.123 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 123' ' ' ARG . 24.2 mtp-105 -78.57 -31.79 47.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 120' ' ' THR . 10.2 mm-40 -61.57 -39.02 89.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.328 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 6.0 p30 -157.96 95.28 1.99 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.113 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 10.8 Cg_endo -53.8 118.37 4.86 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.528 2.152 . . . . 0.0 110.965 175.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.511 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 73.7 Cg_exo -53.02 144.39 46.07 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.101 1.867 . . . . 0.0 109.424 172.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.52 -27.34 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.101 -166.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 129' ' ' LYS . 10.0 tppt? -116.35 107.1 47.78 Favored Pre-proline 0 N--CA 1.428 -1.535 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.655 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.669 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 75.9 Cg_exo -40.27 139.84 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 125.242 3.962 . . . . 0.0 113.881 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -110.59 106.15 15.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.774 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.5 m-85 -74.47 -12.58 60.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.581 -171.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.7 t -89.36 -21.1 23.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.271 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.963 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 70.9 mmtt -100.01 10.84 40.64 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 115' ' ' ASN . 21.3 tp -95.38 133.12 39.68 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.522 -171.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.488 ' HB2' HG22 ' A' ' 118' ' ' THR . 0.4 OUTLIER -115.31 123.56 49.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.832 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -103.26 108.32 19.49 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.874 -174.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.86 ' HB3' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p-10 -92.77 104.66 16.9 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.862 0.839 . . . . 0.0 109.475 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.687 HG21 HG11 ' A' ' 11' ' ' VAL . 1.3 mp -70.96 108.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 112' ' ' TYR . 88.8 mt -67.04 86.57 0.14 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.685 0.755 . . . . 0.0 110.7 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.913 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -74.9 -15.31 60.71 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.318 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.4 p -81.97 -1.45 48.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.975 173.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -141.56 64.64 19.28 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.7 Cg_endo -93.18 106.18 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.059 1.839 . . . . 0.0 111.362 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.576 ' HB3' HD13 ' B' ' 130' ' ' ILE . 16.4 tpt180 -77.61 81.93 4.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.451 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.435 HG12 HG23 ' A' ' 109' ' ' VAL . 3.0 m -76.92 103.46 4.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.3 0.571 . . . . 0.0 110.501 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' CE2' ' A' ' 149' ' ' PHE . 35.2 m -116.49 106.09 13.21 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.615 0.722 . . . . 0.0 109.362 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.744 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.2 ptt-85 -118.96 154.44 33.02 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.782 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CE2' HG22 ' A' ' 147' ' ' THR . 0.0 OUTLIER -138.07 168.49 19.61 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.931 -172.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.17 144.65 28.94 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.94 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.607 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 22.1 pt -133.99 -172.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.47 0.653 . . . . 0.0 109.936 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -98.31 92.7 5.83 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.38 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.622 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 15.2 m95 -78.46 -16.57 57.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.398 176.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.503 ' OE2' ' HB2' ' A' ' 153' ' ' TRP . 3.0 mp0 -112.9 153.64 27.63 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.233 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.81 72.49 9.88 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.916 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.112 174.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.2 -25.57 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 51.7 ttp 73.4 -58.08 0.61 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.624 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.43 120.46 21.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.144 -0.55 . . . . 0.0 111.791 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.512 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 46.8 mmtm -73.39 -32.7 64.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.711 0.291 . . . . 0.0 110.876 -173.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.88 -57.62 4.2 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.259 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.0 tp -68.69 -35.62 70.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.292 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.8 mm100 -54.82 -51.74 64.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.826 0.822 . . . . 0.0 110.497 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.67 HD13 HG23 ' A' ' 94' ' ' VAL . 44.5 mt -66.22 -43.65 86.09 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.611 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.88 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.68 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 128' ' ' ARG . 18.6 mtp180 -60.09 -49.02 79.29 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.894 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.704 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 4.8 mmt180 -60.62 -41.78 95.53 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 120.935 0.398 . . . . 0.0 111.133 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.576 HD13 ' HB3' ' A' ' 145' ' ' ARG . 7.0 mt -75.25 -43.88 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.213 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -52.14 -53.68 39.86 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.607 0.567 . . . . 0.0 111.05 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.579 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . -176.03 57.19 0.11 Allowed Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.587 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.704 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 3.2 mm-40 -102.27 -48.18 4.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.643 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.633 ' HG2' ' H ' ' B' ' 135' ' ' ALA . 41.5 ttp180 57.43 -178.92 0.06 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 122.088 0.947 . . . . 0.0 112.749 172.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.633 ' H ' ' HG2' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--N 1.309 -1.169 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.092 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -87.35 138.66 31.29 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.026 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.809 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.55 -19.89 24.45 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 4.0 t -140.96 130.49 25.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.755 0.788 . . . . 0.0 111.526 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 20.8 tp60 -125.06 100.55 6.62 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.179 -1.373 . . . . 0.0 107.57 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -74.4 144.59 12.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.76 177.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -123.29 -66.52 1.0 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.469 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.5 t-20 -103.28 151.65 22.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.536 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.761 HG23 HG13 ' A' ' 26' ' ' ILE . 2.6 p -147.43 99.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.578 174.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.03 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -92.87 109.67 21.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.564 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.32 132.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -110.91 -68.8 0.91 Allowed 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.733 0.777 . . . . 0.0 112.328 -162.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' HE21 ' A' ' 23' ' ' GLN . 1.9 m-20 -96.0 34.7 1.51 Allowed 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.161 -162.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.715 ' HB3' ' NH2' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -138.78 99.64 8.35 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 118.089 2.625 . . . . 0.0 118.089 171.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 60.7 Cg_endo -124.99 92.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.27 1 C-N-CA 125.696 4.264 . . . . 0.0 106.139 108.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.663 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 7.5 m -153.83 168.98 10.65 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.188 -167.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 87.9 Cg_exo -38.3 132.26 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.814 2.343 . . . . 0.0 111.679 176.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.913 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 10.1 t80 -60.85 -22.19 63.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.401 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -84.87 -10.56 57.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 110.988 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.671 HD22 ' NH1' ' A' ' 137' ' ' ARG . 0.2 OUTLIER -77.35 128.57 80.07 Favored Pre-proline 0 N--CA 1.441 -0.905 0 CA-C-O 122.49 1.138 . . . . 0.0 108.728 167.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.65 152.83 32.44 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 124.76 3.64 . . . . 0.0 112.995 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HA ' HH21 ' A' ' 137' ' ' ARG . 27.1 m-85 -81.21 124.4 29.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.486 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.056 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.2 mp0 -113.32 114.07 26.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.682 -173.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CG ' HD11 ' A' ' 97' ' ' ILE . 73.4 m-85 -120.97 114.41 21.48 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.03 ' HB3' HG23 ' A' ' 10' ' ' VAL . 33.1 tt0 -97.88 87.12 3.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.761 HG13 HG23 ' A' ' 9' ' ' VAL . 4.5 mp -82.63 140.51 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.929 0.871 . . . . 0.0 112.363 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 14.9 m -113.33 107.13 15.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.286 171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.4 p90 -116.39 150.01 38.46 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.377 0.608 . . . . 0.0 109.565 -177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.891 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.0 tt0 -105.42 112.21 25.22 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.481 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.682 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 4.2 t -72.97 108.16 5.72 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -73.76 -25.15 20.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.384 -174.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.809 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 40.5 mt-10 -152.8 158.0 41.61 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.409 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.6 129.16 40.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.508 . . . . 0.0 110.339 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.022 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -84.5 148.64 26.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.671 -170.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.527 ' N ' HD13 ' A' ' 34' ' ' LEU . 17.7 m -115.37 -25.99 7.75 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.893 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 35.8 tt0 -118.44 -163.41 0.95 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.893 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 8.8 m-20 -93.84 131.32 39.35 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 121.707 -0.621 . . . . 0.0 109.337 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.694 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -82.62 118.58 23.41 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 175.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 40.8 tt0 -102.31 127.61 49.22 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.585 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.9 m95 -115.72 127.52 55.2 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.734 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.7 ttmp? -123.71 146.54 48.19 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.053 -173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.62 HG21 HD22 ' A' ' 57' ' ' LEU . 44.1 mm -102.83 105.8 18.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.685 174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.731 HD11 ' HD2' ' A' ' 41' ' ' LYS . 2.9 mp -103.1 110.8 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.584 ' CE2' HG11 ' A' ' 113' ' ' VAL . 32.2 t80 -95.86 110.78 22.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.256 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG11 HD23 ' B' ' 126' ' ' LEU . 22.9 t -61.53 101.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.425 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -74.34 -42.94 33.07 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 173.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.757 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 27.8 p -95.44 99.65 11.52 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' B' ' 122' ' ' LYS . . . -90.98 -5.07 55.91 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 161.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -99.83 -48.75 4.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.96 -1.473 . . . . 0.0 108.607 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.591 ' C ' ' HB2' ' A' ' 47' ' ' SER . 38.7 m -98.56 -157.43 0.6 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 170.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HB3' HE22 ' B' ' 125' ' ' GLN . 12.9 pt-20 -143.42 -25.91 0.58 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.319 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -79.42 2.81 20.44 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.757 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 9.6 m-30 -88.51 -1.63 58.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.554 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -47.6 109.59 0.23 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.617 0.722 . . . . 0.0 110.536 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.695 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 55.2 mt-30 -91.58 166.04 13.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.812 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.51 112.1 28.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.286 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 42' ' ' ILE . 8.3 mp -82.18 -56.87 3.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.901 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.12 161.37 42.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.355 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.0 p -146.46 114.98 6.76 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -98.27 138.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 10.7 mt -110.88 103.2 11.68 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.107 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.8 t -97.2 122.79 49.1 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.3 -158.56 9.7 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.331 -162.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.022 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 42.6 Cg_endo -65.35 116.75 4.06 Favored 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 121.444 1.429 . . . . 0.0 110.097 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 63' ' ' GLY . 24.5 m -126.22 150.49 70.0 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.35 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.04 138.78 44.89 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.746 2.297 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -43.86 144.58 0.84 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.324 0.583 . . . . 0.0 112.138 173.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 134.03 126.97 2.7 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -174.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.891 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.4 ptt180 -70.93 130.79 42.53 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.375 1.083 . . . . 0.0 110.794 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.518 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 9.0 p80 -150.82 151.1 31.8 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.151 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -107.36 138.45 43.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.455 -172.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 6.2 p90 -139.51 152.27 46.81 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.2 p -111.51 107.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 122.647 1.213 . . . . 0.0 111.339 -169.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.2 t80 -108.91 121.45 45.14 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.308 -1.769 . . . . 0.0 110.637 -170.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 1.056 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 33.4 mt-30 -119.81 166.43 13.27 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.245 -172.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.73 132.6 6.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.848 0.295 . . . . 0.0 111.644 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -66.92 156.69 35.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.592 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.55 152.13 36.2 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.601 ' HD3' HD21 ' A' ' 57' ' ' LEU . 55.5 Cg_endo -72.38 177.4 7.39 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.853 3.035 . . . . 0.0 112.236 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -73.69 116.88 56.08 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.436 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.24 1.08 3.79 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 123.67 2.913 . . . . 0.0 112.654 177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.51 -15.18 28.01 Favored Glycine 0 CA--C 1.495 -1.175 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.695 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 61.4 mt -97.86 -8.87 27.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.525 -0.837 . . . . 0.0 110.926 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.49 ' HB ' ' HE2' ' A' ' 132' ' ' PHE . 22.6 mt -96.07 129.6 33.5 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 119.744 -0.782 . . . . 0.0 112.051 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 3.4 Cg_exo -77.43 155.35 32.18 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.357 2.705 . . . . 0.0 111.673 169.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.764 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.1 p30 -47.52 -47.25 27.86 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.06 -28.13 68.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.423 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 10.7 m-20 -98.58 -21.78 16.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.429 -173.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -81.33 -46.5 14.61 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.242 -173.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.753 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -95.25 46.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.468 0.652 . . . . 0.0 112.247 -174.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.7 -129.62 1.38 Allowed Glycine 0 CA--C 1.501 -0.8 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.075 -172.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.666 HG13 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -98.27 135.31 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -168.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.48 167.86 28.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.368 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.656 HG12 HD23 ' A' ' 96' ' ' LEU . 69.4 t -118.66 128.7 75.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.354 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.19 106.51 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.769 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -105.75 148.43 27.48 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.056 -172.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.795 ' HB ' HG12 ' A' ' 109' ' ' VAL . 45.6 mt -106.98 108.29 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.345 0 CA-C-O 121.313 0.577 . . . . 0.0 109.528 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.857 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 41.8 p -101.92 114.25 28.18 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.189 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 64.1 m -79.32 158.0 27.58 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.282 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -151.14 119.68 6.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -167.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.772 ' HB3' ' CD1' ' A' ' 151' ' ' ILE . 34.6 t80 -138.29 124.14 19.97 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.615 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 61.1 mtp180 65.31 32.87 9.52 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.386 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.97 83.44 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.744 -1.117 . . . . 0.0 112.574 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -114.28 132.23 56.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.15 0.5 . . . . 0.0 110.068 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 31.7 mt-10 -93.89 130.12 40.07 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.146 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.694 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.7 p90 -118.44 -1.17 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -164.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.857 ' O ' ' HA ' ' A' ' 98' ' ' THR . 5.4 tt -156.47 160.29 2.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 120.883 -1.136 . . . . 0.0 109.388 171.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.661 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 13.5 ttp180 -148.08 102.22 3.36 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 123.93 0.769 . . . . 0.0 109.433 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.795 HG12 ' HB ' ' A' ' 97' ' ' ILE . 3.6 p -89.95 101.26 12.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.723 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.18 92.05 1.78 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 119.613 -1.279 . . . . 0.0 112.136 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.77 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 8.7 m-85 -83.95 126.09 32.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.895 -0.652 . . . . 0.0 109.943 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.5 m-85 -68.24 112.12 4.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.962 176.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 44' ' ' TYR . 3.9 p -93.89 111.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.666 HD21 HG13 ' A' ' 92' ' ' VAL . 0.3 OUTLIER -101.63 104.42 15.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.013 -176.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.6 m-80 -94.3 110.27 22.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.255 -172.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.14 128.03 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.645 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 31.6 m-85 -39.29 154.12 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.5 p -98.19 -26.15 14.65 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.253 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.411 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 26.6 mm-40 -78.64 120.99 24.11 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.8 m -54.33 -32.02 55.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.543 -169.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -70.61 -36.17 73.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.682 0.753 . . . . 0.0 109.572 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 65.9 mt -74.88 -25.85 59.24 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.213 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 32.7 mtt180 -70.96 -36.7 72.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.995 0.903 . . . . 0.0 108.787 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 120' ' ' THR . 44.0 mm-40 -69.39 -40.92 77.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.972 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.416 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.0 p30 -146.51 91.06 5.44 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 0.0 111.218 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 14.6 Cg_endo -56.41 114.97 2.15 Favored 'Trans proline' 0 CA--C 1.515 -0.461 0 C-N-CA 122.831 2.354 . . . . 0.0 111.244 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.534 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 50.9 Cg_exo -56.32 160.08 11.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.432 2.088 . . . . 0.0 111.072 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.508 ' O ' ' HD3' ' A' ' 129' ' ' LYS . 11.7 p -51.25 -36.58 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -166.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.518 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 4.8 mmtt -116.19 116.0 40.09 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-O 121.896 0.855 . . . . 0.0 111.745 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.764 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_exo -47.4 141.74 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 125.018 3.812 . . . . 0.0 113.952 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -111.64 109.94 20.08 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 170.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.745 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 18.4 m-85 -70.93 -15.49 62.6 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.649 -172.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -87.39 -17.81 31.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.641 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 47.7 mmtm -101.91 1.56 37.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.502 ' CG ' ' HB3' ' A' ' 115' ' ' ASN . 20.7 tp -86.63 139.79 30.46 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.125 -171.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 115' ' ' ASN . 2.8 tt0 -121.34 116.61 25.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.913 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 4.2 mtp-105 -80.39 101.33 8.94 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -97.48 106.83 19.21 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 171.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.637 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 12.3 mt -95.6 114.11 31.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.945 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 112' ' ' TYR . 28.0 mt -73.54 90.05 1.73 Allowed 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.329 -172.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.77 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -75.45 -9.72 58.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.494 -177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 p -85.06 -3.37 58.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.679 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -137.12 70.44 55.94 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.584 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 73.4 Cg_endo -91.28 109.66 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.883 2.389 . . . . 0.0 112.07 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.403 ' CB ' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.36 81.38 7.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 -179.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 109' ' ' VAL . 16.1 m -71.71 129.29 35.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.152 0.501 . . . . 0.0 111.301 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.547 HG21 HH21 ' A' ' 108' ' ' ARG . 63.5 m -141.09 105.4 4.83 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.736 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -118.52 143.95 46.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.883 0.849 . . . . 0.0 110.836 -173.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' HD1' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -125.36 168.42 13.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.715 -178.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.89 151.03 22.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.005 0.431 . . . . 0.0 111.107 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.772 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 27.9 pt -135.75 172.34 15.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.532 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -94.69 86.56 4.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.545 1.164 . . . . 0.0 111.059 -178.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.659 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 35.2 m95 -64.52 -16.61 62.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.556 -173.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -132.49 167.99 18.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.6 70.6 6.11 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.614 -166.128 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.48 69.53 4.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.161 0.505 . . . . 0.0 110.5 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 10.6 tpt -75.71 117.38 17.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.387 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 143.05 3.26 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.775 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.592 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 0.0 OUTLIER -74.27 -23.39 59.11 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -48.33 -48.47 36.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.073 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.0 tt -67.69 -39.83 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.196 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.519 HE22 ' HB3' ' A' ' 51' ' ' GLU . 3.5 mm100 -63.41 -37.4 87.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.485 0.66 . . . . 0.0 110.485 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 89.4 mt -67.23 -43.57 81.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.276 175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.51 -32.72 72.77 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.959 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -59.36 -47.05 86.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.14 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.64 ' O ' ' HG3' ' B' ' 133' ' ' GLU . 4.4 mmp_? -66.9 -43.44 83.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.382 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.661 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 69.7 mt -68.04 -16.91 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.397 0.618 . . . . 0.0 110.645 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' B' ' 131' ' ' ARG . 20.8 tpt85 -81.39 -26.26 35.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.875 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.654 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 156.41 84.74 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.788 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.649 ' OE1' ' HG2' ' B' ' 134' ' ' ARG . 0.0 OUTLIER -93.68 -56.51 2.87 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 165.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.649 ' HG2' ' OE1' ' B' ' 133' ' ' GLU . 19.5 mmm180 -72.2 -68.49 0.46 Allowed 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 173.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.823 174.904 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' CE ' ' HB3' ' A' ' 150' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.527 ' HB3' HD12 ' A' ' 31' ' ' ILE . . . -80.04 150.69 30.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.63 ' HG2' ' CD2' ' A' ' 153' ' ' TRP . 33.3 mmtt -99.9 -7.56 25.12 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.436 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 2.7 t -146.1 128.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.113 0.482 . . . . 0.0 110.575 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.604 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 24.0 tp60 -125.09 103.98 8.29 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.532 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.738 HG23 ' CH2' ' A' ' 40' ' ' TRP . 2.3 t -65.78 128.85 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 121.884 0.849 . . . . 0.0 109.092 171.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.4 HD21 ' CB ' ' A' ' 29' ' ' GLU . 81.8 m-20 -118.33 -54.33 2.29 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.852 -170.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.821 HD21 HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -104.96 128.9 53.43 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.116 -174.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.758 ' N ' HD22 ' A' ' 8' ' ' ASN . 2.2 t -129.11 99.53 4.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.403 169.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.946 HG23 ' HB3' ' A' ' 25' ' ' GLU . 1.5 m -95.4 101.37 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.444 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.982 HG11 HG21 ' A' ' 139' ' ' ILE . 2.5 t -83.99 117.88 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.325 1.06 . . . . 0.0 108.851 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.0 OUTLIER -86.33 -36.09 19.47 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.341 -175.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' CB ' ' H ' ' A' ' 23' ' ' GLN . 36.7 t0 -74.14 58.28 0.69 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.815 -1.993 . . . . 0.0 109.982 168.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.571 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -82.44 174.48 6.01 Favored Pre-proline 0 C--N 1.305 -1.361 0 CA-C-N 113.139 -1.846 . . . . 0.0 106.376 160.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.747 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.0 Cg_endo -49.91 103.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.82 1.686 . . . . 0.0 113.065 -153.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.646 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 15.7 m -139.33 171.16 8.47 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.428 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 75.2 Cg_exo -40.64 132.49 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.458 2.105 . . . . 0.0 111.941 174.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.771 ' CE1' ' HD2' ' A' ' 79' ' ' PRO . 36.6 t80 -57.96 -27.1 63.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.266 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 133' ' ' SER . 18.9 m-85 -87.06 -3.3 59.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.139 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -76.24 125.56 87.64 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 164.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.587 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 38.5 Cg_exo -62.89 150.58 87.98 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 123.264 2.643 . . . . 0.0 112.855 -172.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 34.6 m-85 -62.65 103.55 0.43 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.804 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.635 ' H ' ' CB ' ' A' ' 13' ' ' ASP . 33.6 mt-30 -106.91 103.02 12.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.237 -173.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CD1' HD11 ' A' ' 97' ' ' ILE . 82.9 m-85 -104.57 155.6 18.69 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.946 ' HB3' HG23 ' A' ' 10' ' ' VAL . 12.7 tt0 -130.51 87.34 2.49 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.523 ' CG2' HG22 ' A' ' 6' ' ' VAL . 23.3 mt -78.06 138.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.782 -173.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.743 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 5.5 m -119.29 109.78 16.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.254 171.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.679 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 19.2 p90 -112.27 140.74 46.73 Favored 'General case' 0 CA--C 1.48 -1.718 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.561 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.944 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.0 tt0 -101.75 114.82 29.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 3.5 m -72.2 113.4 9.19 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -73.83 -24.51 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.109 0 CA-C-N 113.234 -1.803 . . . . 0.0 109.516 -173.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 3' ' ' LYS . 40.0 mt-10 -150.78 164.87 35.17 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.81 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.46 133.72 50.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.2 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.063 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -95.5 152.57 18.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.112 -172.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.503 ' N ' HD13 ' A' ' 34' ' ' LEU . 11.8 p -115.58 -33.11 5.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.707 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 28.9 tt0 -108.17 -163.13 0.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -173.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.707 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 12.4 m-20 -89.73 163.12 15.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.604 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -114.58 119.78 37.94 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 1.1 mp0 -91.19 126.73 36.36 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.017 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.738 ' CH2' HG23 ' A' ' 6' ' ' VAL . 53.5 m95 -120.36 125.81 48.94 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 168.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.844 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.1 ttmt -128.72 143.67 50.98 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.649 -173.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.723 HG22 HG22 ' A' ' 95' ' ' VAL . 12.8 mt -103.69 106.98 21.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.844 HD11 ' HD2' ' A' ' 41' ' ' LYS . 74.0 mt -107.12 106.8 21.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.739 0.781 . . . . 0.0 109.987 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' HG11 ' A' ' 113' ' ' VAL . 58.3 t80 -90.62 131.67 36.19 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.743 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.94 101.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-O 121.578 0.704 . . . . 0.0 110.639 173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.08 -40.22 97.93 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.548 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.891 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 89.8 p -132.57 118.66 19.49 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.663 0.268 . . . . 0.0 110.854 172.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HB3' ' NZ ' ' B' ' 122' ' ' LYS . . . -78.21 -3.62 43.6 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 163.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' OE2' ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -99.44 -17.09 18.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.769 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 53.2 m -131.41 -148.33 0.35 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 168.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.87 -32.7 0.27 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 118.854 0.752 . . . . 0.0 112.507 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.84 1.35 20.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.891 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 3.2 m-30 -82.35 -17.7 44.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.311 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 46' ' ' GLY . 3.3 p-10 -42.38 115.62 0.72 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.115 0.959 . . . . 0.0 111.895 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' CG ' HD12 ' A' ' 83' ' ' LEU . 12.4 mp0 -92.7 165.62 12.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.04 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.639 HG22 HG12 ' A' ' 43' ' ' ILE . 37.5 t -130.24 110.35 18.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.4 mm? -79.52 -40.33 29.89 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.618 -170.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 21.1 t70 -174.43 157.8 2.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 21.0 p -140.12 117.44 11.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.3 p -98.65 141.2 16.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.764 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.487 ' CD1' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -110.63 104.96 13.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.882 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 94.5 t -83.37 154.16 3.79 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -96.48 -162.41 32.73 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 118.633 -1.746 . . . . 0.0 112.456 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.063 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 45.0 Cg_endo -66.3 118.92 5.91 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 121.928 1.752 . . . . 0.0 109.91 173.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' H ' ' CB ' ' A' ' 34' ' ' LEU . 35.8 m -121.15 131.94 24.34 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.398 -173.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.07 138.26 51.46 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.486 2.124 . . . . 0.0 110.789 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -40.58 141.5 0.54 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.063 0.852 . . . . 0.0 112.433 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.05 149.24 7.51 Favored Glycine 0 N--CA 1.434 -1.46 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.944 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 9.4 ptt180 -75.72 143.63 41.97 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 122.028 0.918 . . . . 0.0 111.157 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.581 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 91.6 m-70 -137.85 136.09 36.82 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.607 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.31 123.8 48.6 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.608 0.718 . . . . 0.0 110.763 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.67 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 1.6 p90 -127.97 144.12 51.1 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.365 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 p -105.42 125.9 60.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.109 0.956 . . . . 0.0 110.213 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.67 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 7.3 t80 -126.6 113.1 16.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.025 -162.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 50.2 mt-30 -130.55 154.25 48.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 42' ' ' ILE . . . -158.13 154.32 27.26 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.31 -174.93 0.09 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.839 0.828 . . . . 0.0 113.056 -171.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -81.94 150.49 65.44 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.476 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.771 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 46.7 Cg_exo -62.77 173.75 3.48 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 C-N-CA 123.389 2.726 . . . . 0.0 112.495 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.3 m-20 -81.8 115.6 58.14 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.525 -174.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.08 -9.69 26.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.267 2.645 . . . . 0.0 112.236 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.67 6.46 64.98 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.698 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.491 HD12 ' CG ' ' A' ' 55' ' ' GLN . 10.3 mt -108.9 -37.68 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.548 0.213 . . . . 0.0 111.078 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 49.3 mt -69.57 130.08 90.87 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 88' ' ' ASP . 73.2 Cg_endo -79.69 161.62 24.61 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 0.0 112.468 171.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.609 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 1.0 OUTLIER -46.31 -52.74 12.12 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.787 0.835 . . . . 0.0 112.974 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.439 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . . . -75.0 -23.03 58.19 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.983 -170.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.765 ' HA ' ' HZ1' ' B' ' 122' ' ' LYS . 12.9 t0 -82.68 -27.3 31.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.011 0.434 . . . . 0.0 110.591 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 130' ' ' PRO . . . -73.94 -40.4 63.1 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.759 -174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.38 44.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 114' ' ' ASN . . . -174.77 -129.56 1.2 Allowed Glycine 0 CA--C 1.496 -1.113 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.992 -173.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.756 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -103.04 120.78 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.187 0.994 . . . . 0.0 113.433 -165.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.863 ' HB ' HG13 ' A' ' 113' ' ' VAL . 5.2 m -135.35 169.12 17.97 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.488 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.556 HG12 HD23 ' A' ' 96' ' ' LEU . 8.3 t -130.89 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 118.049 0.386 . . . . 0.0 110.638 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.723 HG22 HG22 ' A' ' 42' ' ' ILE . 7.6 p -131.78 107.22 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.876 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -97.26 130.21 44.49 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.664 -168.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.759 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 49.1 mt -95.36 93.75 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.299 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.794 HG22 ' HG3' ' A' ' 108' ' ' ARG . 32.4 p -92.35 112.94 25.07 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.229 -1.805 . . . . 0.0 108.677 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 1.05 ' SG ' HG22 ' A' ' 107' ' ' ILE . 23.5 p -75.52 159.14 31.61 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 170.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 28.2 m -150.95 103.65 3.08 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -171.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.996 ' HE2' HD11 ' A' ' 34' ' ' LEU . 51.0 t80 -118.9 125.52 49.68 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 16.4 mmt180 67.18 14.46 9.77 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.898 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.26 4.55 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.595 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.46 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.73 138.22 54.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 6.8 mt-10 -87.45 127.62 35.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.539 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.604 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.9 p90 -116.95 1.73 12.66 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -172.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.05 HG22 ' SG ' ' A' ' 99' ' ' CYS . 4.8 tt -154.44 153.98 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.381 -0.825 . . . . 0.0 109.2 167.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.94 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 4.1 ttm-85 -143.63 91.2 2.22 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.582 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.907 HG23 HG12 ' A' ' 146' ' ' VAL . 0.5 OUTLIER -83.39 100.95 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.266 1.031 . . . . 0.0 108.294 175.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA3' HD11 ' B' ' 130' ' ' ILE . . . -89.72 81.73 1.43 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.791 -1.195 . . . . 0.0 111.158 176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.533 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 27.4 m-85 -69.73 115.1 8.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.663 ' HB3' HD12 ' A' ' 140' ' ' LEU . 2.4 m-85 -66.93 111.37 3.75 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.863 HG13 ' HB ' ' A' ' 93' ' ' THR . 1.5 p -91.47 109.33 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.756 ' ND2' HG13 ' A' ' 92' ' ' VAL . 1.7 t-20 -96.7 113.66 25.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.431 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.529 ' HB3' HD11 ' A' ' 135' ' ' LEU . 57.6 m-80 -101.82 108.84 20.46 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.861 0.839 . . . . 0.0 109.151 -166.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.16 132.46 39.85 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.814 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.663 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 50.6 m-85 -49.01 155.5 0.61 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -172.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.556 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 18.3 p -92.27 -28.89 16.7 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.257 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.577 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 21.7 mm-40 -80.81 122.96 27.84 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.298 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.589 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 21.2 m -51.75 -34.09 37.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.336 -170.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.23 -37.33 80.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.652 0.739 . . . . 0.0 109.438 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 55.8 mt -78.77 -19.28 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.551 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 45.9 mtt180 -77.58 -35.11 53.31 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 120' ' ' THR . 5.7 mm-40 -74.45 -38.08 63.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.438 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.2 p30 -142.3 83.23 12.38 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 110.441 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 16.3 Cg_endo -57.39 114.97 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.141 2.561 . . . . 0.0 111.918 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.658 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 34.7 Cg_exo -62.72 142.77 90.54 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.0 110.347 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 128' ' ' VAL . 7.5 t -55.94 -32.84 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.511 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 1.3 mmtt -79.4 133.09 60.56 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-O 121.132 0.491 . . . . 0.0 110.875 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.609 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 6.4 Cg_endo -77.45 129.32 10.13 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.588 2.859 . . . . 0.0 112.433 -175.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.2 t70 -125.63 108.03 11.16 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.885 173.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.715 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 16.5 m-85 -78.5 -16.83 57.07 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.273 1.035 . . . . 0.0 110.579 -172.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.413 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 31.0 t -83.11 -27.95 29.81 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.301 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.577 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 71.9 mmtt -100.8 11.62 39.19 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.3 tp -94.55 129.08 41.5 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.885 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.556 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 3.2 tt0 -112.72 120.06 40.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.747 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.06 107.12 19.44 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.639 -174.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 16.5 t30 -78.74 102.88 8.32 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.828 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.982 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -76.89 105.83 6.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.911 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.663 HD12 ' HB3' ' A' ' 112' ' ' TYR . 83.9 mt -67.11 90.99 0.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.757 0.789 . . . . 0.0 111.336 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.533 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.21 -19.51 43.09 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.454 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 p -80.14 -17.32 52.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.949 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 16.9 m120 -131.31 61.5 59.54 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.709 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -83.72 116.5 2.23 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.81 1.673 . . . . 0.0 111.058 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.682 ' HG3' HG12 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -81.84 81.11 7.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.387 0.613 . . . . 0.0 109.942 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.907 HG12 HG23 ' A' ' 109' ' ' VAL . 19.4 m -89.36 137.39 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.771 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.5 m -149.18 108.76 4.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.487 0.661 . . . . 0.0 110.008 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -101.64 140.75 35.5 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.0 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -118.11 168.51 10.49 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.798 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.425 ' HB3' ' CE ' ' A' ' 1' ' ' MET . 7.5 m170 -104.83 114.54 28.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.413 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.736 HD11 ' HB3' ' A' ' 101' ' ' TYR . 42.3 pt -118.69 -173.47 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.518 0.675 . . . . 0.0 110.971 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.488 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -96.07 92.74 6.59 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.726 -177.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.63 ' CD2' ' HG2' ' A' ' 3' ' ' LYS . 37.8 m95 -77.28 -12.5 59.96 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.344 0.593 . . . . 0.0 109.838 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -129.7 150.49 50.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.832 0.825 . . . . 0.0 110.595 -172.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.49 71.21 9.56 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.286 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 156' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.451 -174.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 CA-C-O 120.285 -0.175 . . . . 0.0 112.744 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.633 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . . . -79.94 84.71 5.66 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.065 0.46 . . . . 0.0 111.137 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 5.8 ttp -161.33 126.59 3.63 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.967 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.55 -153.78 19.29 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.436 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.765 ' HZ1' ' HA ' ' A' ' 88' ' ' ASP . 75.5 mmtt -129.6 -72.52 0.58 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -24.79 -66.72 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.778 1.299 . . . . 0.0 114.001 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.74 -35.61 75.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.633 ' OE1' ' HA ' ' B' ' 119' ' ' ALA . 7.4 mm100 -66.5 -50.11 64.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.954 0.407 . . . . 0.0 111.899 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.468 ' HG ' HG23 ' A' ' 94' ' ' VAL . 1.5 mm? -68.3 -33.96 75.28 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.18 90.1 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.549 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' B' ' 125' ' ' GLN . 49.9 mtp180 -51.77 -56.41 14.0 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.28 176.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.845 ' HD3' ' HB3' ' B' ' 133' ' ' GLU . 0.1 OUTLIER -56.93 -42.69 80.45 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 -176.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.94 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 1.7 mp -70.13 -50.2 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 123.747 0.654 . . . . 0.0 112.543 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -59.41 -46.57 88.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 175.68 55.29 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.709 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.845 ' HB3' ' HD3' ' B' ' 129' ' ' ARG . 9.1 tp10 -96.97 -2.66 43.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.518 ' HB2' ' OE2' ' A' ' 105' ' ' GLU . 18.6 ptt180 -36.22 147.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 112.592 -2.095 . . . . 0.0 114.024 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-N 114.044 -1.434 . . . . 0.0 112.245 176.661 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.925 0.393 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -77.43 138.19 39.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.906 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -90.68 -20.58 22.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 -176.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.492 ' HB ' ' CZ3' ' A' ' 153' ' ' TRP . 3.0 t -136.64 129.51 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.482 0.658 . . . . 0.0 110.275 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.781 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -115.54 99.59 7.46 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 170.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 28' ' ' PHE . 21.9 t -73.12 134.03 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -120.24 -64.88 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.89 0.852 . . . . 0.0 109.465 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.696 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.2 t-20 -105.09 150.0 25.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.587 -173.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 9' ' ' VAL . 5.9 p -145.57 102.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 CA-C-O 121.957 0.885 . . . . 0.0 109.322 173.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -95.75 100.22 10.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.513 1.149 . . . . 0.0 109.667 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 139' ' ' ILE . 2.1 m -79.18 126.87 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.184 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.859 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -102.76 -34.75 8.9 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.745 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.721 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 26.0 t70 -59.34 28.79 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.874 -1.966 . . . . 0.0 112.566 171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.626 ' OD1' ' HD3' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -82.22 172.48 9.47 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.871 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 24.2 Cg_exo -54.37 101.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.323 1.349 . . . . 0.0 113.658 -136.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.563 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 24.8 m -138.44 168.51 15.64 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 112.922 -1.944 . . . . 0.0 109.252 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 82.6 Cg_exo -36.49 132.86 0.36 Allowed 'Trans proline' 0 CA--C 1.504 -1.011 0 C-N-CA 123.31 2.673 . . . . 0.0 112.07 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.734 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 16.5 t80 -51.27 -24.25 4.3 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.786 0.679 . . . . 0.0 112.535 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -86.32 0.85 53.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.934 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.498 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 31.2 p-10 -63.56 138.73 97.45 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 165.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.718 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 16.6 Cg_exo -78.89 145.71 20.06 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 122.843 2.362 . . . . 0.0 111.715 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.81 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 53.5 m-85 -60.65 126.22 26.61 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.859 ' HB3' HD12 ' A' ' 12' ' ' LEU . 34.5 mt-30 -125.72 99.36 5.94 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.759 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 67.9 m-85 -107.92 102.37 11.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.88 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 10' ' ' VAL . 29.5 tt0 -85.94 83.7 7.73 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.685 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 7.3 mt -84.91 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.57 0.7 . . . . 0.0 112.441 -176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.4 m -111.68 107.45 16.56 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.323 171.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.479 ' HB3' HG13 ' A' ' 6' ' ' VAL . 27.7 p90 -121.21 148.14 44.66 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 37.0 tt0 -106.01 112.66 25.8 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.739 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 41.5 t -73.49 109.41 6.99 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.524 ' C ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -78.63 -29.0 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.641 -173.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.906 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 1.8 mt-10 -149.66 148.15 28.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.582 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.4 p-10 -56.27 135.04 53.7 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.934 0.397 . . . . 0.0 111.691 -177.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.06 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 93.3 mt -82.74 160.47 22.31 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.356 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.6 t -113.17 -21.62 10.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.803 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.886 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.5 tt0 -137.89 -168.52 2.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.886 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 17.6 m-20 -95.12 137.4 34.23 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.418 0.628 . . . . 0.0 109.69 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.732 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.31 118.95 23.53 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.602 176.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 33.8 tt0 -108.63 89.76 3.09 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.878 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.685 ' CZ3' HG21 ' A' ' 26' ' ' ILE . 15.0 m95 -78.22 126.54 30.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.791 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.9 ttmp? -126.15 141.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.048 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mt -102.88 107.9 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.745 ' HB ' HD12 ' A' ' 96' ' ' LEU . 40.1 mt -111.74 104.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.839 0.828 . . . . 0.0 109.034 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.836 ' CE2' HG11 ' A' ' 113' ' ' VAL . 17.0 t80 -86.81 115.42 24.22 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.195 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HD11 ' B' ' 126' ' ' LEU . 6.8 t -62.27 101.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.237 174.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.49 56.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.832 ' HB3' ' CG ' ' A' ' 53' ' ' TYR . 14.8 p -96.94 88.36 4.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.857 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HB1' ' HG3' ' B' ' 122' ' ' LYS . . . -80.41 -17.72 50.97 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -100.3 -23.47 14.78 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.028 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.742 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 48.7 m -110.32 -147.69 0.42 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 170.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -155.96 -5.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.76 1.44 53.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.065 0.46 . . . . 0.0 111.939 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.832 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 4.2 m-30 -91.33 -14.42 30.81 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.369 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -40.81 113.99 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.449 1.119 . . . . 0.0 112.605 -174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 14.8 mt-30 -92.71 163.09 13.88 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.219 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 43' ' ' ILE . 39.4 t -132.6 115.67 25.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.3 mm? -84.2 -45.26 13.1 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.655 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -170.5 165.75 8.46 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 61.9 p -141.8 117.53 10.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -100.0 136.6 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.639 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.2 mt -107.9 104.84 14.4 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.379 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.99 110.76 23.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -71.7 -170.19 12.28 Favored Glycine 0 CA--C 1.499 -0.957 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.889 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.06 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 35.2 Cg_endo -62.12 115.11 2.63 Favored 'Trans proline' 0 N--CA 1.447 -1.265 0 C-N-CA 121.259 1.306 . . . . 0.0 109.994 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASP . 34.0 m -123.94 140.25 34.22 Favored Pre-proline 0 C--N 1.307 -1.272 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.342 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.55 76.81 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.987 1.791 . . . . 0.0 113.463 -176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.54 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 50.64 -172.93 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.039 -176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.21 124.89 3.56 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.992 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.854 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 31.9 ttt180 -79.53 118.19 21.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.446 0.641 . . . . 0.0 109.501 173.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -150.74 143.92 24.81 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.394 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -96.86 134.23 40.44 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.361 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -127.0 150.02 49.62 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.15 101.67 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-O 123.189 1.471 . . . . 0.0 111.448 -170.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.759 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -76.13 137.26 39.99 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 112.494 -2.139 . . . . 0.0 109.841 -176.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.81 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 24.1 mt-30 -151.84 152.28 32.42 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.034 0.445 . . . . 0.0 109.941 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -169.44 155.89 6.46 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.419 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.0 p-10 -62.34 179.35 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.53 0.605 . . . . 0.0 111.983 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -77.06 158.65 79.75 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.363 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.68 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 38.8 Cg_endo -63.73 164.73 20.39 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.5 2.134 . . . . 0.0 110.817 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -69.21 115.97 37.48 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.599 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -66.74 -12.76 37.24 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.098 2.532 . . . . 0.0 112.519 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.86 -5.54 61.08 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.105 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.454 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 20.7 mt -96.45 -37.11 10.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 122.613 -0.345 . . . . 0.0 110.592 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 19.2 mt -72.35 127.7 89.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.05 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.62 162.55 24.46 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.902 2.401 . . . . 0.0 112.423 172.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.845 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.7 t70 -43.72 -54.53 5.04 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.055 0.942 . . . . 0.0 113.487 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB1' ' NZ ' ' B' ' 122' ' ' LYS . . . -64.45 -28.51 69.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.071 0.462 . . . . 0.0 111.369 -168.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -97.19 -21.33 17.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.578 -172.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.77 -48.22 12.8 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.679 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -92.87 47.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.654 0.74 . . . . 0.0 112.68 -175.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.48 -127.23 1.11 Allowed Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.067 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.699 HG13 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -100.41 136.04 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.426 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -151.84 166.77 30.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.579 HG23 ' HG ' ' B' ' 126' ' ' LEU . 15.2 t -121.98 138.86 50.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.555 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.95 106.99 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.929 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.3 OUTLIER -104.65 139.83 38.92 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.236 -170.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.791 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 34.5 mt -109.67 96.63 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.21 0 CA-C-O 121.911 0.862 . . . . 0.0 109.097 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 72.7 p -96.07 116.26 28.69 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.884 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.596 ' HB2' HG22 ' A' ' 107' ' ' ILE . 75.0 m -80.59 104.49 11.15 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.493 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 23.7 m -85.6 102.19 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.175 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.636 ' HB2' ' HE2' ' A' ' 106' ' ' PHE . 32.7 t80 -117.98 126.11 51.68 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.929 -0.482 . . . . 0.0 110.26 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 53.8 mtp85 60.39 28.82 18.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.848 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.35 -20.22 51.33 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.752 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.693 ' HG3' ' HB ' ' A' ' 151' ' ' ILE . 4.0 pt20 -111.57 142.99 43.15 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.637 0.732 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 25.9 mt-10 -93.79 119.72 33.12 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.212 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.732 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 43.9 p90 -104.53 -0.52 27.7 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.821 ' O ' ' HA ' ' A' ' 98' ' ' THR . 6.1 tt -157.58 160.73 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.697 ' HG3' ' HB2' ' A' ' 96' ' ' LEU . 10.5 ttp180 -151.48 119.24 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 123.674 0.609 . . . . 0.0 109.776 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.929 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.6 p -96.01 100.05 10.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.515 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.62 73.42 2.49 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 119.252 -1.452 . . . . 0.0 110.961 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.872 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.8 m-85 -67.67 115.62 7.45 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.996 -1.102 . . . . 0.0 109.087 175.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.532 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.8 m-85 -67.68 113.26 5.32 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.836 HG11 ' CE2' ' A' ' 44' ' ' TYR . 5.3 p -93.8 110.56 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.699 HD21 HG13 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -95.25 108.61 20.77 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.611 -178.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.677 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 37.8 m-80 -101.79 107.49 18.71 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -173.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -129.14 124.01 33.59 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.276 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 122' ' ' LEU . 29.0 m-85 -42.13 153.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.631 HG23 ' HB2' ' A' ' 136' ' ' GLN . 17.9 p -96.49 -27.75 14.73 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.607 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.537 ' CG ' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -79.48 120.86 24.46 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.505 ' HA ' ' HG3' ' A' ' 123' ' ' ARG . 5.8 m -55.49 -30.8 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.986 -170.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.25 -39.73 93.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.878 0.847 . . . . 0.0 109.866 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB3' ' CD2' ' A' ' 117' ' ' TYR . 66.1 mt -76.68 -24.98 53.2 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.268 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 39.4 mtt180 -72.49 -32.8 66.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.1 mm-40 -71.9 -41.13 68.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.922 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 5.9 p30 -148.98 102.84 3.37 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 122.051 0.929 . . . . 0.0 111.452 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 33.6 Cg_endo -66.47 113.94 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.425 2.75 . . . . 0.0 110.98 172.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 126' ' ' PRO . 33.0 Cg_exo -59.8 157.79 31.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.592 2.195 . . . . 0.0 111.094 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.07 -21.9 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.683 -169.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.554 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 1.9 mmpt? -128.36 103.86 20.02 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-O 122.012 0.91 . . . . 0.0 112.133 174.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.845 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 12.6 Cg_exo -44.28 140.27 5.83 Favored 'Trans proline' 0 N--CA 1.455 -0.737 1 C-N-CA 125.553 4.169 . . . . 0.0 113.82 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.644 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 7.0 t70 -111.6 114.67 27.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.368 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.627 ' O ' ' HB3' ' A' ' 18' ' ' PHE . 2.6 m-85 -78.63 -7.13 57.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.21 -168.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 96.6 p -96.69 -34.56 11.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.537 ' HD2' ' CG ' ' A' ' 119' ' ' GLU . 72.2 mmtt -81.78 -17.22 48.38 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.644 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 32.6 tp -66.67 139.65 57.86 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.339 -1.755 . . . . 0.0 109.744 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.631 ' HB2' HG23 ' A' ' 118' ' ' THR . 3.9 tt0 -129.02 121.95 29.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.769 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -94.78 108.98 20.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.743 0.782 . . . . 0.0 112.236 -175.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.456 ' CB ' ' HG3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -91.33 101.54 14.24 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.603 170.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.617 ' HB ' ' ND2' ' A' ' 14' ' ' ASN . 6.3 mm -68.96 106.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 112' ' ' TYR . 66.4 mt -66.72 87.38 0.13 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.922 0.868 . . . . 0.0 111.2 -175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.872 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -81.51 -4.85 57.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.162 175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 10.2 p -83.23 -11.65 57.6 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.576 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 63.3 t30 -143.9 59.86 7.58 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.408 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 13.9 Cg_exo -71.8 105.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.698 1.599 . . . . 0.0 110.658 172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.7 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -79.91 81.35 6.18 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.156 0.503 . . . . 0.0 110.143 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.9 m -80.38 141.67 14.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.205 0.526 . . . . 0.0 111.084 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.488 HG21 HH21 ' A' ' 108' ' ' ARG . 54.2 m -148.83 105.87 3.6 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.753 ' HB3' HG13 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -115.46 140.28 49.28 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.709 0.766 . . . . 0.0 110.381 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -119.43 169.94 9.58 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.788 -175.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -103.98 111.57 24.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.693 ' HB ' ' HG3' ' A' ' 104' ' ' GLN . 22.3 pt -115.06 -173.91 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-O 121.377 0.608 . . . . 0.0 110.596 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 152' ' ' ASN . 0.0 OUTLIER -88.57 114.45 25.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 122.793 1.282 . . . . 0.0 109.733 175.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 59.8 m95 -96.06 -8.46 33.43 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.529 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -131.3 177.76 7.23 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.218 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.95 71.55 4.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.52 0.676 . . . . 0.0 109.181 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.5 m120 . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.954 -178.068 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.17 -173.66 2.33 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.801 -0.235 . . . . 0.0 110.475 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 83.3 mtp 70.94 176.33 0.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 123.697 0.623 . . . . 0.0 111.489 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 122' ' ' LYS . . . 79.43 -20.82 4.76 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.983 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.507 ' NZ ' ' HB1' ' A' ' 87' ' ' ALA . 13.6 mptt 73.43 -47.52 0.66 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.816 0.846 . . . . 0.0 111.679 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -37.04 -59.22 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 12.8 tt -68.92 -32.68 55.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' B' ' 125' ' ' GLN . 8.7 mm100 -62.93 -56.04 20.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.584 HD11 HG11 ' A' ' 45' ' ' VAL . 2.1 mm? -69.48 -29.59 67.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.869 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.3 77.42 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 173.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 90.7 mtt180 -53.34 -46.5 69.51 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.306 0.574 . . . . 0.0 110.312 175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.767 ' HD2' ' HB3' ' B' ' 133' ' ' GLU . 21.4 tpt180 -65.93 -35.66 81.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.518 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 145' ' ' ARG . 18.1 mt -94.72 -22.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -67.64 -33.16 74.4 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.477 ' HA2' ' OXT' ' B' ' 135' ' ' ALA . . . 153.04 71.57 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.829 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.767 ' HB3' ' HD2' ' B' ' 129' ' ' ARG . 16.1 tp10 -110.08 -49.31 3.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.421 ' HG3' ' OE2' ' A' ' 105' ' ' GLU . 19.1 tpt180 -65.83 -51.34 59.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.477 ' OXT' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.245 0.835 0 CA-C-N 114.123 -1.398 . . . . 0.0 107.798 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.651 0.263 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.82 126.17 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.821 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.88 -8.81 51.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.623 -175.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.635 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 38.8 t -148.15 138.71 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.048 ' HG2' HD11 ' A' ' 31' ' ' ILE . 14.4 mm-40 -124.03 101.29 7.16 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.73 167.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 28' ' ' PHE . 81.6 t -72.67 102.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -88.5 -60.7 1.89 Allowed 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.722 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.742 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.1 t-20 -107.51 150.59 26.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.217 -1.81 . . . . 0.0 110.386 -171.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.656 HG23 HG13 ' A' ' 26' ' ' ILE . 2.6 p -145.81 99.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.791 169.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -92.21 107.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.653 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -77.55 119.82 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.677 -178.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 23' ' ' GLN . 2.4 mt -89.31 -47.79 7.8 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.093 -171.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 9.5 t70 -78.58 73.65 5.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.046 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.612 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -81.72 176.7 3.57 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 111.726 -2.488 . . . . 0.0 106.614 169.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.99 ' HB3' ' HB2' ' A' ' 138' ' ' ASN . 3.0 Cg_endo -46.74 104.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.68 1.636 . . . . 0.0 113.374 -147.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.775 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . 75.1 m -126.5 168.82 13.26 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 112.362 -2.199 . . . . 0.0 109.493 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.9 Cg_exo -40.69 132.56 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.298 1.998 . . . . 0.0 111.031 173.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.718 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 7.9 t80 -58.11 -25.36 61.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.753 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 133' ' ' SER . 5.2 m-85 -89.83 3.95 51.34 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.86 -178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.775 ' OD1' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -97.25 142.72 24.96 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.618 170.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.627 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 6.3 Cg_endo -42.29 151.17 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.16 1 C-N-CA 126.551 4.834 . . . . 0.0 115.877 -178.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.859 ' HE2' ' HD3' ' A' ' 79' ' ' PRO . 45.8 m-85 -84.5 120.22 26.07 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.655 170.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.92 ' HG3' ' HG2' ' A' ' 75' ' ' GLN . 2.5 mp0 -110.4 121.7 45.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.684 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 82.6 m-85 -125.59 104.34 8.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.219 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.689 ' CB ' HD21 ' A' ' 12' ' ' LEU . 35.5 tt0 -88.14 86.27 7.07 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG13 HG23 ' A' ' 9' ' ' VAL . 4.6 mt -83.51 134.01 27.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.192 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 8.5 m -109.1 109.01 19.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.553 172.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.636 ' CB ' ' HA ' ' A' ' 6' ' ' VAL . 13.7 p90 -123.37 148.56 45.94 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.892 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.883 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.3 tt0 -108.39 112.49 24.94 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.9 m -73.11 110.44 7.4 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.048 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.2 mt -72.04 -35.94 55.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.695 -171.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.821 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 23.9 mt-10 -143.35 172.02 13.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.419 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.4 p-10 -71.62 144.24 49.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.36 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.047 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 62.5 mt -95.88 161.08 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.302 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -112.47 -25.02 9.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.122 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -126.51 -168.14 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.122 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.12 140.84 29.08 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.77 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -81.73 119.18 23.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.935 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.736 ' HG2' HD22 ' A' ' 61' ' ' LEU . 24.3 mt-10 -101.96 89.29 3.59 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.442 -173.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.577 ' CH2' HG21 ' A' ' 26' ' ' ILE . 19.1 m95 -77.65 151.59 34.22 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 174.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.699 ' HG2' ' HB3' ' A' ' 59' ' ' SER . 0.6 OUTLIER -153.23 134.05 13.88 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.554 -0.459 . . . . 0.0 109.85 -179.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 57' ' ' LEU . 33.0 mt -103.18 120.54 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.656 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -119.04 106.24 19.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.839 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.771 ' CE2' HG11 ' A' ' 113' ' ' VAL . 56.0 t80 -89.15 126.0 35.28 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.856 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.941 HG22 ' HE2' ' A' ' 53' ' ' TYR . 31.4 t -73.52 117.94 18.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.195 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA2' HG12 ' A' ' 84' ' ' ILE . . . -92.98 -59.24 1.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 119.846 -1.169 . . . . 0.0 112.092 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.708 ' H ' ' CB ' ' A' ' 53' ' ' TYR . 7.4 m -105.26 72.39 0.98 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -48.19 -21.27 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.552 0.532 . . . . 0.0 111.62 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG3' ' HE2' ' B' ' 122' ' ' LYS . 5.2 tt0 -85.71 -31.99 22.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.388 0.675 . . . . 0.0 112.23 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 47' ' ' SER . 68.7 m -95.62 -27.59 15.24 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -168.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.996 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER 64.25 11.63 6.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.865 1.266 . . . . 0.0 112.489 175.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -99.11 -13.06 19.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.452 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.996 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 29.3 p90 -73.17 -46.51 50.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.563 -1.653 . . . . 0.0 114.416 -161.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.616 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 7.6 p-10 -30.8 113.76 0.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 125.011 1.445 . . . . 0.0 114.388 -154.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.605 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 14.1 mt-30 -95.84 170.78 9.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.066 -1.879 . . . . 0.0 111.607 -169.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.612 HG13 ' HE2' ' A' ' 41' ' ' LYS . 2.3 t -130.49 116.03 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.863 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.3 mm? -92.56 -56.66 2.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.289 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 15.2 t70 -162.5 156.63 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.998 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.699 ' HB3' ' HG2' ' A' ' 41' ' ' LYS . 36.6 p -132.96 121.82 23.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG11 ' CE1' ' A' ' 72' ' ' PHE . 3.6 p -111.2 137.32 44.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -172.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.736 HD22 ' HG2' ' A' ' 39' ' ' GLU . 7.8 mt -108.99 105.06 14.42 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.458 -176.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.01 114.72 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -68.59 -176.08 11.23 Favored Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.011 -167.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.047 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 43.6 Cg_endo -65.15 114.71 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.146 1.231 . . . . 0.0 110.382 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 63' ' ' GLY . 34.6 m -123.84 140.35 34.31 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.034 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 60.5 Cg_endo -80.55 79.5 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.292 1.994 . . . . 0.0 113.589 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 53.25 -173.58 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.633 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.03 128.06 3.89 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.703 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.883 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 51.0 ttt180 -87.23 115.92 24.95 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.698 0.761 . . . . 0.0 109.345 175.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.531 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.1 p80 -151.63 146.12 25.59 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.484 -172.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -94.16 136.51 34.37 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.795 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.549 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -121.29 153.03 38.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.33 121.0 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.622 1.201 . . . . 0.0 111.989 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.684 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -95.23 141.01 29.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.329 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.92 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 26.6 mt-30 -152.08 152.54 32.5 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 167.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -169.39 126.98 0.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.747 ' O ' HD12 ' A' ' 57' ' ' LEU . 29.4 t70 -64.53 147.99 51.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.685 0.279 . . . . 0.0 111.445 -174.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -37.17 152.37 0.12 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.859 ' HD3' ' HE2' ' A' ' 22' ' ' PHE . 32.9 Cg_endo -64.04 -179.78 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 125.087 3.858 . . . . 0.0 113.344 176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -92.84 119.19 67.99 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 121.206 0.527 . . . . 0.0 110.99 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -66.97 -23.24 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.273 2.649 . . . . 0.0 112.501 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.58 -2.85 90.68 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.953 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 53.2 mt -108.05 1.99 22.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.573 0.225 . . . . 0.0 110.965 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.569 HD11 ' HE1' ' A' ' 44' ' ' TYR . 10.1 mt -109.5 123.52 36.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 91.5 Cg_endo -80.02 163.85 22.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.687 2.925 . . . . 0.0 112.22 168.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 10.3 t70 -44.46 -55.03 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.112 0.965 . . . . 0.0 113.195 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.17 -30.49 70.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.164 0.507 . . . . 0.0 111.607 -169.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 35.5 m-20 -94.45 -8.6 38.1 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.638 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.545 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -88.35 -47.77 8.14 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-O 121.123 0.487 . . . . 0.0 111.955 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -101.94 44.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 121.523 0.678 . . . . 0.0 111.906 -174.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.88 -124.13 0.71 Allowed Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.597 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.88 130.12 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-O 122.236 1.017 . . . . 0.0 111.91 -169.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.471 HG22 HG12 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -146.77 170.67 16.52 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.416 -1.72 . . . . 0.0 107.719 179.11 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.52 ' CG2' ' HB3' ' B' ' 126' ' ' LEU . 3.0 t -128.58 151.62 35.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.56 0.219 . . . . 0.0 111.481 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 95' ' ' VAL . 7.8 p -131.29 107.46 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.941 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 2.9 pp -102.52 140.56 36.64 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.433 -170.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 24' ' ' PHE . 58.7 mt -112.44 106.47 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 CA-C-O 121.47 0.652 . . . . 0.0 109.393 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 62.9 p -93.86 119.47 32.84 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.46 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.642 ' HB2' HG22 ' A' ' 107' ' ' ILE . 58.1 m -85.39 128.78 34.83 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 169.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 3.7 m -122.65 119.9 32.11 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.386 -171.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.656 ' HB3' HD11 ' A' ' 151' ' ' ILE . 75.2 t80 -124.89 122.85 38.54 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.537 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.638 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 48.4 mtp180 69.53 28.09 4.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.062 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.13 -0.7 82.0 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.265 175.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -121.69 128.64 52.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.203 0.525 . . . . 0.0 110.519 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 1.3 mp0 -79.84 139.75 37.07 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.946 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.77 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 42.6 p90 -124.1 -0.63 8.34 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.795 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 11.4 tt -159.12 158.86 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.617 -0.677 . . . . 0.0 109.185 174.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.562 ' HG3' HG22 ' A' ' 98' ' ' THR . 16.3 ttm180 -151.37 102.56 2.92 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -176.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.941 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -85.62 99.17 7.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 C-N-CA 118.741 -1.184 . . . . 0.0 109.292 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.646 ' HA3' HD13 ' B' ' 130' ' ' ILE . . . -83.72 78.04 2.05 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.889 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.9 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 2.6 m-85 -73.56 113.27 10.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.434 ' CB ' HD12 ' A' ' 140' ' ' LEU . 18.3 m-85 -67.3 127.57 33.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.222 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.771 HG11 ' CE2' ' A' ' 44' ' ' TYR . 7.7 p -109.53 111.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.37 1.081 . . . . 0.0 108.088 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -89.47 111.06 21.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.271 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.525 ' HB3' HD11 ' A' ' 135' ' ' LEU . 51.8 m-80 -99.29 107.71 20.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -173.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -136.54 131.63 34.12 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.836 -175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 55.7 m-85 -39.7 151.74 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.3 p -88.97 -33.88 17.06 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.328 -176.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.647 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 6.5 mm-40 -82.46 122.42 28.0 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.875 177.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -55.75 -33.38 64.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.673 -171.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.92 -37.92 87.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.705 0.764 . . . . 0.0 109.549 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 76.0 mt -74.11 -23.35 59.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.557 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.3 mtp85 -76.29 -31.24 58.11 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 120' ' ' THR . 30.9 mm-40 -77.97 -33.95 51.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.46 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 1.9 p30 -144.67 87.57 7.44 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.106 0.479 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 11.6 Cg_endo -53.62 117.93 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.764 2.309 . . . . 0.0 110.727 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD2' ' CZ ' ' A' ' 117' ' ' TYR . 77.3 Cg_exo -53.39 160.12 5.31 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.624 2.216 . . . . 0.0 110.798 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.49 -38.87 9.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 O-C-N 123.658 0.599 . . . . 0.0 111.494 -168.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.719 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 4.6 mmtt -124.44 127.6 25.21 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-O 121.388 0.614 . . . . 0.0 111.389 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.719 ' HD2' ' HD3' ' A' ' 129' ' ' LYS . 7.5 Cg_exo -41.31 134.22 3.07 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.613 3.542 . . . . 0.0 113.257 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 25.0 t70 -114.52 114.46 25.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.718 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.2 m-85 -78.57 -16.93 56.86 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.08 -168.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.436 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -83.32 -28.65 28.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.241 177.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.647 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 66.0 mmtt -98.56 11.46 38.28 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 115' ' ' ASN . 26.2 tp -91.05 147.11 23.3 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.894 -177.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.609 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 20.8 tt0 -124.88 123.06 39.11 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.85 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.0 mtp-105 -82.73 103.6 12.35 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.99 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 2.1 t30 -99.47 105.0 16.87 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.944 0.878 . . . . 0.0 108.808 171.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.704 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -78.41 111.05 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.731 -175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.434 HD12 ' CB ' ' A' ' 112' ' ' TYR . 69.3 mt -68.16 86.91 0.27 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.169 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.9 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.62 -11.41 59.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 p -78.96 -10.66 59.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.069 171.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.497 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 17.1 m120 -133.06 58.4 34.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.065 -174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 6.0 Cg_exo -80.43 105.28 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.814 1.676 . . . . 0.0 111.053 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.714 ' HB3' HD13 ' B' ' 130' ' ' ILE . 12.6 tpp180 -82.45 81.16 8.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.512 HG12 HG23 ' A' ' 109' ' ' VAL . 6.1 m -83.26 104.77 12.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.609 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.427 HG22 ' CE1' ' A' ' 149' ' ' PHE . 21.4 m -111.48 106.8 15.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.687 0.756 . . . . 0.0 109.595 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.795 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 18.0 ptt180 -113.82 146.04 40.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.386 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 147' ' ' THR . 0.1 OUTLIER -130.1 169.37 15.4 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.241 -173.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -105.0 130.31 53.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.687 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.4 pt -129.08 -177.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.535 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.2 OUTLIER -103.38 87.54 2.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.673 0.749 . . . . 0.0 111.37 -174.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.635 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 37.3 m95 -73.15 -1.18 16.52 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.401 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -129.79 162.75 27.74 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.79 70.88 3.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.623 -176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 . . . . . 0 C--O 1.247 0.953 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.156 174.306 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.64 151.92 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.259 0.552 . . . . 0.0 111.496 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.513 ' O ' ' HE3' ' B' ' 122' ' ' LYS . 49.3 ttp -74.24 -32.88 63.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.792 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.63 105.13 1.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.592 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.682 ' HE2' ' HG3' ' A' ' 49' ' ' GLU . 23.2 mmtp -73.91 -33.7 64.08 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 122.93 -0.159 . . . . 0.0 110.856 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -37.26 -53.06 1.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.489 0.493 . . . . 0.0 111.804 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.76 -30.22 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.573 0.225 . . . . 0.0 111.408 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.638 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 9.1 mm100 -60.95 -52.33 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.008 0.432 . . . . 0.0 111.291 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.681 ' CD1' HG11 ' A' ' 45' ' ' VAL . 2.4 mm? -67.07 -39.99 86.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.05 88.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.29 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.638 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 9.3 ptm180 -66.42 -35.89 81.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.78 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.786 ' HA ' ' HB2' ' B' ' 133' ' ' GLU . 23.0 tpt180 -64.7 -38.92 92.62 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.41 0.624 . . . . 0.0 109.992 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.714 HD13 ' HB3' ' A' ' 145' ' ' ARG . 14.8 mt -76.05 -50.79 21.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.5 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -51.26 -43.2 61.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.95 -174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.37 57.66 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.065 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.786 ' HB2' ' HA ' ' B' ' 129' ' ' ARG . 26.2 mm-40 -103.83 -50.55 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' B' ' 133' ' ' GLU . 9.7 ptm180 47.31 -179.99 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.294 175.373 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.669 0.271 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.21 127.48 32.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.029 0.442 . . . . 0.0 110.193 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 1.144 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -89.82 -20.42 23.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.98 -175.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.855 HG21 HD21 ' A' ' 38' ' ' LEU . 4.0 t -141.72 130.07 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 0.0 111.718 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.694 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -121.66 100.2 6.88 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.064 173.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -79.61 146.4 7.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.366 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -129.14 -65.57 0.86 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.202 -165.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.684 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.61 150.45 23.96 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.779 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.632 HG23 HG13 ' A' ' 26' ' ' ILE . 3.5 p -146.18 100.05 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 169.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.987 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.6 m -87.6 103.73 13.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.687 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -77.86 109.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.592 -1.186 . . . . 0.0 108.713 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.974 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.7 mt -89.72 -44.64 9.87 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.989 -172.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.932 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.6 OUTLIER -69.32 75.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.622 1.677 . . . . 0.0 109.597 167.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.619 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -85.37 177.9 2.65 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 112.136 -2.302 . . . . 0.0 107.138 163.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.864 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.8 Cg_endo -48.83 103.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 121.916 1.72 . . . . 0.0 113.603 -154.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.69 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 31.4 m -129.78 171.24 9.2 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 112.456 -2.156 . . . . 0.0 109.425 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.69 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 83.7 Cg_exo -42.84 138.82 3.64 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.685 2.257 . . . . 0.0 112.106 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.727 ' CE1' ' HG2' ' A' ' 79' ' ' PRO . 43.9 t80 -58.11 -29.62 65.63 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.659 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -89.12 1.3 55.82 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -78.66 144.52 65.12 Favored Pre-proline 0 N--CA 1.445 -0.716 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 12.1 Cg_exo -79.54 137.48 13.03 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 123.221 2.614 . . . . 0.0 112.831 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 25.3 m-85 -55.24 146.24 19.52 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.931 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.974 ' HG2' HD12 ' A' ' 12' ' ' LEU . 6.6 tt0 -136.46 92.44 2.77 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.206 -167.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE1' HD12 ' A' ' 42' ' ' ILE . 52.9 m-85 -113.27 108.38 17.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.329 -174.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.987 ' HB3' HG23 ' A' ' 10' ' ' VAL . 38.4 tt0 -96.27 88.1 4.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 9' ' ' VAL . 3.2 mt -81.43 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.185 -176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 6.7 m -108.4 106.48 16.62 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.935 170.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 39.1 p90 -121.22 146.14 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.829 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 36.4 tt0 -102.36 110.52 22.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.519 ' HB2' ' C ' ' A' ' 67' ' ' ALA . 20.7 m -72.8 115.36 12.0 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -80.68 -31.38 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.856 -171.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.144 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 34.8 mt-10 -145.28 168.24 20.92 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.759 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 4.4 p-10 -73.45 131.57 41.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.0 111.798 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.773 HD11 HD22 ' A' ' 38' ' ' LEU . 75.6 mt -83.15 159.21 22.1 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.497 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 p -112.25 -19.65 12.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.643 0.735 . . . . 0.0 109.215 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -136.97 -172.45 3.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.516 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -77.94 151.48 33.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.481 0.658 . . . . 0.0 110.761 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.855 HD21 HG21 ' A' ' 4' ' ' VAL . 4.6 tp -107.46 123.16 47.99 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 23.3 tt0 -106.03 135.58 47.23 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.868 -174.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.596 ' CE3' ' SG ' ' A' ' 99' ' ' CYS . 19.1 m95 -132.14 124.52 29.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.837 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.0 ttmp? -125.49 146.62 49.56 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.812 -175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.599 HD13 HG12 ' A' ' 97' ' ' ILE . 18.9 mm -102.75 106.87 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 174.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 87.6 mt -103.02 106.94 20.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.801 0.81 . . . . 0.0 109.886 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.662 ' CE2' ' HG3' ' A' ' 79' ' ' PRO . 18.8 t80 -87.46 115.61 25.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.756 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG11 HD12 ' B' ' 126' ' ' LEU . 10.0 t -66.38 99.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-O 121.378 0.608 . . . . 0.0 109.712 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -57.91 -43.45 94.86 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.231 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.687 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 46.7 t -123.69 109.38 13.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 174.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' B' ' 126' ' ' LEU . . . -70.97 -5.66 32.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.419 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' HZ2' ' B' ' 122' ' ' LYS . 3.2 mt-10 -100.89 -22.09 14.92 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.163 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.52 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 46.9 m -116.07 -150.32 0.46 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.989 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' B' ' 129' ' ' ARG . 8.9 pt-20 -150.69 -33.28 0.17 Allowed 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.767 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -71.78 2.57 5.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.389 0.614 . . . . 0.0 111.401 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.687 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 95.8 m-85 -94.58 4.28 54.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.53 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.53 110.17 0.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.012 0.91 . . . . 0.0 109.938 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 4.4 mt-30 -96.02 166.69 11.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.306 -176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.666 HG22 ' HD3' ' A' ' 41' ' ' LYS . 42.3 t -127.31 106.26 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.51 -1.223 . . . . 0.0 107.971 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.61 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 4.0 mt -75.16 -48.23 24.6 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.741 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -170.48 165.3 8.56 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.843 173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.7 p -141.9 128.92 20.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.4 p -99.5 133.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.946 -173.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.36 105.13 14.67 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.733 0.777 . . . . 0.0 110.099 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 98.3 t -83.56 155.7 3.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.47 -163.19 37.08 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.826 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.666 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 61.1 Cg_endo -89.83 118.21 0.75 Allowed 'Trans proline' 0 N--CA 1.424 -2.565 0 C-N-CA 122.057 1.838 . . . . 0.0 110.284 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' H ' HD12 ' A' ' 34' ' ' LEU . 33.8 m -119.51 134.0 23.81 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.489 -173.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.759 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 60.8 Cg_endo -79.13 83.51 2.25 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.162 1.908 . . . . 0.0 113.453 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.519 ' C ' ' HB2' ' A' ' 30' ' ' CYS . . . 53.04 -171.35 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 112.874 -1.966 . . . . 0.0 111.653 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.61 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 105.01 132.32 7.36 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 14.8 ttp180 -75.08 113.69 12.7 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.458 0.647 . . . . 0.0 110.286 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.61 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 21.8 m-70 -111.39 129.1 56.12 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.077 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.506 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 ttp -106.66 111.84 24.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 168.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 4.8 p90 -126.13 141.09 52.08 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.739 0.781 . . . . 0.0 109.326 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 2.2 p -101.41 116.71 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.536 -174.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -119.28 132.28 55.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.902 -1.499 . . . . 0.0 110.281 -168.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 44.6 mt-30 -125.15 160.45 29.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.699 -173.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 57' ' ' LEU . . . -153.48 137.63 16.47 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.035 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.61 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 20.6 t70 -57.4 162.1 3.03 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -62.61 158.42 50.65 Favored Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 121.509 0.671 . . . . 0.0 111.526 -176.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.727 ' HG2' ' CE1' ' A' ' 18' ' ' PHE . 28.9 Cg_endo -62.28 171.41 5.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.813 2.342 . . . . 0.0 111.702 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -87.87 115.28 62.55 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.603 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.56 -16.2 53.23 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.631 2.888 . . . . 0.0 112.816 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.84 -18.3 56.54 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.127 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.577 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 46.5 mt -91.9 -15.22 28.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.683 0.278 . . . . 0.0 111.385 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 17.1 mt -91.42 127.61 50.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.447 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.4 ' O ' HG22 ' A' ' 84' ' ' ILE . 98.5 Cg_endo -80.68 160.01 21.86 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.726 2.284 . . . . 0.0 111.81 171.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.728 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 6.5 m-20 -46.45 -50.02 17.45 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.419 0.687 . . . . 0.0 112.615 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.17 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.538 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -93.02 -19.63 21.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.929 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -75.9 -46.36 30.51 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.147 0.499 . . . . 0.0 111.635 -175.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.667 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -98.17 48.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.289 1.042 . . . . 0.0 110.492 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.58 -137.75 2.27 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.391 -161.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' B' ' 122' ' ' LYS . 9.8 p -130.46 145.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.714 0.769 . . . . 0.0 110.835 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.625 HG23 HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -157.33 174.59 15.19 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.742 HG12 HD23 ' A' ' 96' ' ' LEU . 2.2 t -124.17 145.01 31.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.511 -0.475 . . . . 0.0 112.152 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.523 HG11 ' CZ ' ' A' ' 22' ' ' PHE . 27.7 m -116.78 105.17 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.792 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -101.57 136.27 41.7 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.922 -173.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.872 ' HB ' HG12 ' A' ' 109' ' ' VAL . 25.7 mt -95.79 103.14 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 108' ' ' ARG . 58.1 p -97.04 110.8 23.27 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.75 175.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.733 ' SG ' HG23 ' A' ' 107' ' ' ILE . 4.7 m -85.6 143.88 28.19 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.891 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 24.3 m -135.16 129.35 33.67 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -172.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 153' ' ' TRP . 84.3 t80 -135.84 118.1 15.59 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.78 176.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 29.2 mtp180 67.66 27.12 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.779 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.08 70.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.363 174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.16 120.66 38.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.012 0.434 . . . . 0.0 110.354 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.679 ' OE1' ' HD2' ' B' ' 134' ' ' ARG . 41.2 mp0 -76.85 124.89 28.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CD2' HG22 ' A' ' 107' ' ' ILE . 34.3 p90 -110.37 -8.66 14.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -168.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.747 ' O ' ' HA ' ' A' ' 98' ' ' THR . 1.7 tt -158.89 162.4 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 119.443 1.02 . . . . 0.0 110.332 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.869 ' HG3' HG22 ' A' ' 98' ' ' THR . 14.1 ttm180 -146.53 105.59 3.88 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.872 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.2 p -95.22 100.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.235 174.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.76 80.99 1.78 Allowed Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.878 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.888 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 9.6 m-85 -77.34 116.63 18.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.625 ' HE2' ' HA ' ' B' ' 123' ' ' ASP . 20.5 m-85 -68.0 133.11 48.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.446 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.625 HG13 HG23 ' A' ' 93' ' ' THR . 7.2 p -113.95 110.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.14 130.0 40.51 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.603 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 40.3 m-80 -111.14 113.45 25.98 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -171.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -123.96 124.87 43.54 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 113.734 -1.576 . . . . 0.0 108.519 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 17.0 m-85 -44.73 151.88 0.26 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.851 0.834 . . . . 0.0 112.658 173.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -92.43 -34.08 14.28 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.602 -175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.672 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 2.0 tm-20 -78.76 122.95 26.67 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.977 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 6.1 m -52.57 -34.94 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.465 -171.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.11 -35.65 66.6 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 43.2 mt -71.72 -27.76 63.23 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.483 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 17.9 mtt180 -73.07 -32.46 65.04 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.3 mm-40 -67.58 -38.68 84.41 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.865 -1.062 . . . . 0.0 110.917 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -157.47 96.07 2.05 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 121.306 0.574 . . . . 0.0 110.57 178.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 12.5 Cg_endo -56.14 117.61 4.28 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.954 2.436 . . . . 0.0 111.368 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.79 153.51 43.08 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.128 1.885 . . . . 0.0 110.353 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.1 p -42.14 -41.01 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.851 0.72 . . . . 0.0 112.104 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.541 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -110.4 109.75 58.25 Favored Pre-proline 0 N--CA 1.44 -0.975 0 CA-C-O 122.293 1.044 . . . . 0.0 113.334 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.728 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 6.6 Cg_exo -45.54 140.33 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.778 1 C-N-CA 125.54 4.16 . . . . 0.0 113.892 175.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.62 112.84 22.73 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.696 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 3.6 m-85 -77.98 -18.38 56.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.812 0.815 . . . . 0.0 110.847 -168.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.28 -13.25 50.3 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.3 175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 73.9 mmtt -104.09 12.67 33.73 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.528 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.7 tp -99.83 133.38 44.27 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.392 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.94 122.09 41.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.971 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.864 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -97.69 110.93 23.4 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.484 0.659 . . . . 0.0 111.501 -175.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.835 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 3.4 t30 -95.03 109.32 21.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.64 176.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 11' ' ' VAL . 1.6 mp -81.54 114.67 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.227 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.432 HD12 ' CB ' ' A' ' 112' ' ' TYR . 80.8 mt -69.78 85.23 0.48 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 110.772 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.888 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -72.13 -20.11 61.67 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.528 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.7 p -78.83 -8.55 58.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.767 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -135.07 69.34 70.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.016 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 77.2 Cg_endo -89.84 114.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.36 2.04 . . . . 0.0 111.608 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.543 ' CB ' HD13 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -82.21 81.76 7.99 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.202 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 109' ' ' VAL . 26.8 m -78.24 130.04 36.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 51.6 m -148.82 106.88 3.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.254 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.684 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -112.73 147.13 37.47 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.983 0.897 . . . . 0.0 110.705 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 170.41 11.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.45 -173.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -94.91 119.94 34.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.994 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 18.0 pt -120.26 -173.51 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 121.322 0.582 . . . . 0.0 109.766 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.489 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.8 OUTLIER -108.2 91.6 3.71 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.437 -176.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.624 ' CH2' ' HB ' ' A' ' 4' ' ' VAL . 17.9 m95 -78.78 -13.51 59.77 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.303 177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -128.2 173.89 9.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.772 -173.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -102.08 71.87 1.29 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.043 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.182 175.782 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -134.85 27.11 3.62 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.72 -0.283 . . . . 0.0 111.075 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 71.0 mtp 69.5 -79.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.688 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -123.86 162.15 17.98 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.604 ' C ' HD22 ' B' ' 126' ' ' LEU . 4.0 mptp? -81.67 -50.0 9.82 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.625 ' HA ' ' HE2' ' A' ' 112' ' ' TYR . 1.2 p30 -37.73 -49.93 1.18 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' B' ' 128' ' ' ARG . 7.1 tp -65.2 -40.73 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.772 0.32 . . . . 0.0 111.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.653 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 0.7 OUTLIER -65.2 -35.78 82.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 110.648 177.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.604 HD22 ' C ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -64.03 -42.58 97.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.48 -33.03 73.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.96 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 10.4 mmm180 -54.59 -49.33 70.66 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.22 0.533 . . . . 0.0 110.006 173.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.71 ' HD3' ' HB2' ' B' ' 133' ' ' GLU . 6.2 mmp_? -69.18 -30.63 68.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.135 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.649 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 56.7 mt -75.08 -15.59 15.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.337 0.589 . . . . 0.0 110.072 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -94.32 -20.05 20.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -168.65 39.6 0.22 Allowed Glycine 0 C--O 1.226 -0.381 0 C-N-CA 119.6 -1.286 . . . . 0.0 114.373 -174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.71 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 5.3 tp10 -138.06 72.34 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.478 0.656 . . . . 0.0 109.552 172.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.679 ' HD2' ' OE1' ' A' ' 105' ' ' GLU . 10.8 ptt180 -69.0 -58.28 4.31 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.605 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.542 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.244 0.799 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.288 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 ttm . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.389 0.138 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.582 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -64.15 119.82 10.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.219 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.761 ' HE3' ' HB2' ' A' ' 153' ' ' TRP . 2.7 mmtt -100.15 -7.1 25.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.532 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.3 t -139.57 123.24 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.329 0.585 . . . . 0.0 110.553 173.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 7.3 tp60 -117.0 100.5 7.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.834 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.3 m -79.64 135.73 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -117.16 -63.61 1.42 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.003 -164.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.593 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 4.0 t-20 -103.96 152.7 21.68 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.644 -174.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 3.1 p -146.89 100.11 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.037 HG23 ' HB2' ' A' ' 25' ' ' GLU . 1.0 OUTLIER -94.18 97.58 7.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.012 -177.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.563 HG13 ' CD2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -73.62 132.91 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.158 179.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.113 HD12 ' HG2' ' A' ' 23' ' ' GLN . 7.0 mt -103.85 -65.04 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.384 -169.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.66 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 0.2 OUTLIER -88.15 55.04 3.28 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.382 1.087 . . . . 0.0 111.748 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 1.091 ' HA ' HD13 ' A' ' 139' ' ' ILE . 27.0 p-10 -81.42 -176.21 0.74 Allowed Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 161.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.853 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.3 Cg_endo -41.67 104.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 122.428 2.085 . . . . 0.0 114.95 -125.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.671 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 30.2 m -139.61 172.72 5.98 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 110.305 -3.134 . . . . 0.0 107.054 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 85.3 Cg_exo -41.26 136.56 2.46 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.139 1.893 . . . . 0.0 111.964 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.711 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 28.6 t80 -60.18 -27.27 66.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.158 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -78.71 -14.32 59.35 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.706 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -72.95 134.21 81.3 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 22.9 Cg_exo -71.81 146.18 47.51 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.738 2.959 . . . . 0.0 113.599 -172.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.749 ' N ' HH12 ' A' ' 137' ' ' ARG . 62.4 m-85 -55.71 124.86 18.86 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.587 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.113 ' HG2' HD12 ' A' ' 12' ' ' LEU . 8.7 tt0 -125.56 100.28 6.39 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.455 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.661 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.9 m-85 -111.39 155.53 22.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.442 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.037 ' HB2' HG23 ' A' ' 10' ' ' VAL . 59.2 mt-10 -126.27 91.28 3.34 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 163.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.571 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 6.7 mt -83.72 127.05 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 122.065 0.936 . . . . 0.0 112.432 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.3 m -101.21 106.42 17.64 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.288 -1.324 . . . . 0.0 109.526 173.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.834 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 25.1 p90 -110.86 141.62 44.0 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.526 0.679 . . . . 0.0 109.913 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 33.6 tt0 -102.83 113.46 26.9 Favored 'General case' 0 CA--C 1.476 -1.869 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 2.7 m -71.87 122.32 20.55 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -87.41 -23.94 6.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.639 -169.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.23 178.13 9.28 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.74 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.919 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 21.9 t70 -78.49 123.47 27.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.968 0.414 . . . . 0.0 110.136 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.008 HD11 HD23 ' A' ' 38' ' ' LEU . 1.9 mt -81.34 154.96 26.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.033 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -111.81 -35.07 5.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.297 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.709 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 30.5 tt0 -116.47 -169.06 1.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.085 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.709 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -88.38 151.76 22.37 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.669 0.747 . . . . 0.0 109.666 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.008 HD23 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -98.74 123.32 42.89 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.651 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 18.5 tt0 -97.05 132.75 42.54 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.336 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.775 ' HB2' HG12 ' A' ' 60' ' ' VAL . 69.3 m95 -130.48 109.42 10.68 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.305 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.915 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 4.6 ptpp? -126.0 154.81 42.4 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.761 -1.175 . . . . 0.0 112.217 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 76' ' ' ALA . 37.0 mt -103.37 118.71 50.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.266 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 2.5 mp -102.46 105.97 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' HD1' ' CG1' ' A' ' 95' ' ' VAL . 76.7 t80 -83.6 114.33 21.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG11 HD12 ' B' ' 126' ' ' LEU . 4.1 t -62.11 98.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -35.37 40.58 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.746 ' HB2' ' C ' ' A' ' 50' ' ' SER . 6.7 p -99.21 88.49 3.94 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.708 -0.746 . . . . 0.0 112.321 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -90.5 -16.89 28.06 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 163.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -89.43 -42.69 11.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.238 -1.347 . . . . 0.0 109.566 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.746 ' C ' ' HB2' ' A' ' 47' ' ' SER . 57.7 m -106.64 -146.76 0.4 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -150.62 -4.64 0.32 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 171.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -95.62 3.05 54.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.745 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 6.7 m-30 -90.12 -15.46 31.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 119.169 -0.443 . . . . 0.0 111.419 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.41 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 7.6 p-10 -41.64 111.59 0.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.295 1.045 . . . . 0.0 111.564 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 53' ' ' TYR . 14.4 mt-30 -93.45 166.56 12.21 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.173 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG22 HG13 ' A' ' 43' ' ' ILE . 54.6 t -130.94 103.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.6 mm? -70.57 -37.22 73.94 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.982 -171.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 41' ' ' LYS . 24.8 t0 -177.5 154.11 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.01 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.915 ' HB3' ' HB3' ' A' ' 41' ' ' LYS . 97.6 p -130.07 110.32 11.53 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.775 HG12 ' HB2' ' A' ' 40' ' ' TRP . 11.7 p -99.2 139.84 20.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.895 -166.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.5 mt -108.22 103.68 12.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.547 0.689 . . . . 0.0 111.353 -171.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 30.6 t -85.34 155.05 3.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.76 -164.57 40.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.654 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.706 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 56.6 Cg_endo -69.97 114.57 3.78 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.238 1.292 . . . . 0.0 109.967 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.64 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 35.3 m -108.85 119.33 49.33 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.036 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.919 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 70.7 Cg_endo -84.26 77.48 3.18 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.725 2.283 . . . . 0.0 113.654 -175.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 51.39 169.15 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 112.796 -2.002 . . . . 0.0 112.554 -174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 118.32 123.0 3.22 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.072 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.903 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 11.2 ttt180 -74.76 122.33 23.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.499 0.666 . . . . 0.0 110.852 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.512 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.0 p80 -154.35 146.13 23.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.163 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.687 ' SD ' ' HB3' ' A' ' 25' ' ' GLU . 5.5 ttp -97.78 130.2 44.74 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.213 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 3.3 p90 -112.26 153.44 27.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 169.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.65 HG23 ' HG2' ' A' ' 25' ' ' GLU . 7.7 p -111.16 132.44 59.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.845 0.831 . . . . 0.0 110.224 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.661 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -117.13 130.94 56.95 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.933 -165.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.731 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 25.7 mt-30 -141.6 153.78 45.0 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -164.51 157.85 17.61 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.526 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.71 -177.22 0.22 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.683 0.754 . . . . 0.0 112.56 -172.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -89.7 147.77 38.46 Favored Pre-proline 0 N--CA 1.438 -1.028 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.868 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.648 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 81.8 Cg_exo -55.43 154.99 22.08 Favored 'Trans proline' 0 CA--C 1.514 -0.502 0 C-N-CA 123.521 2.814 . . . . 0.0 113.106 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -77.91 118.42 72.04 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.403 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.43 -13.73 41.31 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.523 2.816 . . . . 0.0 112.778 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.62 -4.93 57.94 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.898 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -102.79 -25.5 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.55 0.214 . . . . 0.0 110.769 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 85' ' ' PRO . 41.1 mt -84.66 130.3 53.73 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 121.222 0.534 . . . . 0.0 111.919 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 84' ' ' ILE . 62.6 Cg_endo -80.11 164.62 22.11 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.36 2.706 . . . . 0.0 112.359 170.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.69 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 7.5 t70 -43.94 -58.04 3.0 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.669 1.187 . . . . 0.0 113.768 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -8.11 59.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.133 -165.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 56.5 m-20 -94.44 -22.37 18.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.681 175.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HB2' ' CG2' ' A' ' 84' ' ' ILE . . . -85.64 -47.16 10.08 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.629 -176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 m -101.34 46.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.814 0.816 . . . . 0.0 111.049 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.89 -157.68 8.57 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.48 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.646 HG13 ' HB2' ' B' ' 122' ' ' LYS . 10.0 p -97.36 144.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.67 0.748 . . . . 0.0 109.533 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.62 171.6 19.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -171.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 96' ' ' LEU . 3.0 t -133.68 146.68 31.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 118.787 0.722 . . . . 0.0 111.944 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.563 HG11 ' CZ ' ' A' ' 22' ' ' PHE . 27.2 m -121.8 106.31 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.926 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -102.17 125.01 48.75 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.127 -173.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 50.4 mt -96.0 101.94 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 45.2 p -98.67 117.0 32.14 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.38 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 62.4 m -80.66 152.46 28.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.612 172.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 11.7 m -145.56 119.02 9.03 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -169.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.706 ' HB3' HD11 ' A' ' 151' ' ' ILE . 35.1 t80 -135.43 128.75 32.1 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 152' ' ' ASN . 4.5 mmp_? 67.0 12.84 9.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.416 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.48 1.14 57.88 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.825 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -116.6 150.3 38.27 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 174.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 17.2 mp0 -99.72 134.41 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.847 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.793 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 52.4 p90 -120.01 -2.94 10.18 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -170.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.814 ' O ' ' HA ' ' A' ' 98' ' ' THR . 8.5 tt -156.75 159.92 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.834 ' HD2' ' HA ' ' B' ' 130' ' ' ILE . 17.7 ttp180 -151.6 99.94 2.65 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.845 0.716 . . . . 0.0 109.306 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.926 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.4 p -85.44 101.49 9.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.258 175.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.79 78.08 2.04 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.722 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.973 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 3.9 m-85 -73.7 114.2 11.7 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.455 -0.872 . . . . 0.0 109.015 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.525 ' HA ' HG22 ' A' ' 94' ' ' VAL . 23.5 m-85 -67.72 126.39 29.24 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.532 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.442 HG11 ' HE1' ' A' ' 44' ' ' TYR . 7.5 p -111.49 111.23 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' A' ' 138' ' ' ASN . 26.3 t-20 -92.87 117.74 30.36 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.861 -1.518 . . . . 0.0 109.472 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.487 ' HB3' HD11 ' A' ' 135' ' ' LEU . 48.2 m-80 -109.5 108.65 19.21 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.81 0.814 . . . . 0.0 109.883 -171.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -137.48 139.24 40.45 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.33 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.689 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 62.0 m-85 -46.76 152.42 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -174.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.403 HG22 ' HG3' ' A' ' 136' ' ' GLN . 30.3 p -91.27 -38.29 12.76 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.063 -1.426 . . . . 0.0 108.846 -175.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.918 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 5.2 mm-40 -78.25 125.49 29.43 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.062 -174.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.591 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 4.9 m -47.76 -43.11 27.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.824 0.702 . . . . 0.0 111.697 -168.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -65.19 -35.88 82.46 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.627 0.727 . . . . 0.0 110.266 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 56.3 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.44 -176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 7.2 mtt180 -74.54 -37.33 63.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 120' ' ' THR . 7.8 mm-40 -63.6 -43.43 96.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.705 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.3 p30 -144.35 82.03 10.91 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.11 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 9.2 Cg_endo -50.19 116.87 2.71 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.491 2.794 . . . . 0.0 112.326 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.689 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 69.0 Cg_exo -54.54 137.64 73.33 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.713 2.276 . . . . 0.0 111.088 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.618 HG12 ' HE2' ' A' ' 129' ' ' LYS . 36.7 t -50.04 -40.36 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.987 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.618 ' HE2' HG12 ' A' ' 128' ' ' VAL . 2.0 mmpt? -103.35 136.51 19.21 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 121.435 0.636 . . . . 0.0 111.121 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.69 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -64.39 131.27 29.39 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.749 2.966 . . . . 0.0 113.022 -175.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 23.7 t70 -114.21 114.34 25.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 171.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.711 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 20.6 m-85 -79.22 -15.45 58.01 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.847 -169.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 -28.18 26.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.521 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.918 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 69.7 mmtt -101.68 10.93 39.65 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 115' ' ' ASN . 27.0 tp -89.23 138.54 31.34 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.516 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.403 ' HG3' HG22 ' A' ' 118' ' ' THR . 3.4 tt0 -113.45 123.03 49.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.853 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -93.02 106.74 18.66 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.249 -178.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 18.5 t30 -92.23 105.88 18.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.946 176.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.091 HD13 ' HA ' ' A' ' 14' ' ' ASN . 1.1 mp -80.66 107.18 12.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.433 HD12 ' CB ' ' A' ' 112' ' ' TYR . 85.9 mt -67.81 84.08 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.968 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.973 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -73.05 -12.81 61.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.673 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 -9.51 59.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.906 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.49 70.47 76.5 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.783 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 72.1 Cg_endo -89.28 105.02 0.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.543 1.496 . . . . 0.0 110.404 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' HB3' HG21 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -83.67 81.06 8.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -176.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 146' ' ' VAL . 6.7 m -77.06 104.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 0.0 111.261 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.468 HG21 HH21 ' A' ' 108' ' ' ARG . 26.5 m -109.4 105.05 14.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.742 ' HB3' HG13 ' A' ' 107' ' ' ILE . 2.1 ptt180 -116.78 133.3 56.19 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.531 0.681 . . . . 0.0 110.533 -174.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HD1' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.34 167.79 11.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.913 -175.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -104.58 123.14 47.01 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.922 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 101' ' ' TYR . 45.1 pt -119.26 -174.07 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.505 0.669 . . . . 0.0 109.873 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 1.0 OUTLIER -90.73 105.71 18.01 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.032 176.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.761 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 11.8 m95 -86.47 2.41 47.95 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.558 ' HB2' HD22 ' A' ' 156' ' ' ASN . 1.5 mp0 -115.03 -179.45 3.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.096 -1.411 . . . . 0.0 107.78 176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -108.93 71.9 0.79 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.529 0.68 . . . . 0.0 109.915 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.558 HD22 ' HB2' ' A' ' 154' ' ' GLU . 35.4 m-80 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.21 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 60.16 68.64 0.76 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.797 0.439 . . . . 0.0 111.494 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 66.9 mtp -54.93 -73.09 0.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.487 0.661 . . . . 0.0 109.592 175.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.6 154.35 19.68 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 168.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.7 ' O ' HD22 ' B' ' 126' ' ' LEU . 27.4 mmtp -64.79 -20.88 66.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.191 0.496 . . . . 0.0 111.395 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -36.66 -51.76 0.87 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.7 0.625 . . . . 0.0 112.292 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.7 -40.62 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.589 0.233 . . . . 0.0 111.372 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.618 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 5.5 mm100 -54.6 -51.08 66.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 174.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.7 HD22 ' O ' ' B' ' 122' ' ' LYS . 0.1 OUTLIER -65.28 -43.99 89.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.989 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.64 -37.47 81.61 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.304 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -61.39 -39.12 89.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.5 mmt180 -73.09 -28.39 62.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.084 0.468 . . . . 0.0 110.003 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.834 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 31.1 mt -82.76 -8.5 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.474 0.654 . . . . 0.0 109.873 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.22 -24.35 18.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.723 177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' B' ' 135' ' ' ALA . . . 164.02 59.02 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.709 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.547 ' OE2' ' HD3' ' B' ' 134' ' ' ARG . 0.2 OUTLIER -76.52 -42.61 42.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 171.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.547 ' HD3' ' OE2' ' B' ' 133' ' ' GLU . 3.5 mpt_? -103.28 -75.97 0.6 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.622 169.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.564 ' O ' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.748 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.616 0.246 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -88.75 130.16 35.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.775 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.62 -20.92 21.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.621 HG23 HD21 ' A' ' 34' ' ' LEU . 4.3 t -140.71 130.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.627 0.727 . . . . 0.0 111.396 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.631 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 13.7 tp60 -123.72 99.71 6.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.656 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -75.87 142.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.073 177.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -127.21 -71.84 0.66 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.263 -163.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.42 100.75 10.31 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.519 -171.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG13 ' OH ' ' A' ' 111' ' ' TYR . 2.4 p -100.45 105.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.826 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.5 m -99.33 98.27 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-O 121.917 0.865 . . . . 0.0 109.435 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 132.58 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.111 -176.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.01 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -101.65 -40.07 7.17 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.37 -1.286 . . . . 0.0 108.048 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' H ' ' HB3' ' A' ' 23' ' ' GLN . 37.1 t0 -67.05 64.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.466 -1.697 . . . . 0.0 109.73 165.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.904 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 2.3 m120 -83.06 172.95 8.29 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.121 -1.854 . . . . 0.0 108.148 160.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.904 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 2.4 Cg_endo -50.88 102.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 121.374 1.383 . . . . 0.0 113.181 -153.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.593 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 17.9 m -132.02 170.96 9.98 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.815 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.596 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 68.7 Cg_exo -42.44 140.86 2.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.416 2.077 . . . . 0.0 111.768 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.722 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 6.3 t80 -59.6 -32.12 70.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.043 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -81.68 -9.75 59.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.0 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -63.0 126.23 88.5 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 166.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 26.0 Cg_exo -68.25 146.1 68.44 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 123.347 2.698 . . . . 0.0 112.845 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.792 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 87.1 m-85 -52.04 135.72 30.56 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.178 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.01 ' HG2' HD12 ' A' ' 12' ' ' LEU . 6.6 tt0 -140.42 84.93 1.98 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.451 -171.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.734 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 96.6 m-85 -100.08 149.76 23.16 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.68 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.826 ' HB3' HG23 ' A' ' 10' ' ' VAL . 32.9 tt0 -124.62 87.43 2.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 169.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.619 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 26.8 mt -88.75 125.49 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.697 0.76 . . . . 0.0 112.555 -174.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 21.5 m -103.39 110.68 22.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.467 172.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.733 ' HE2' HG21 ' A' ' 65' ' ' VAL . 31.8 p90 -112.75 145.29 40.8 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.895 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 41.5 tt0 -101.68 114.05 27.75 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 53.2 t -72.35 114.85 10.92 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -81.32 -25.14 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.411 -173.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.775 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 43.3 mt-10 -153.84 143.56 21.79 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -55.98 129.97 41.94 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 123.592 0.558 . . . . 0.0 110.866 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.896 ' HG ' HD21 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -85.1 163.75 18.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.586 0.708 . . . . 0.0 112.365 -169.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 t -113.17 -40.71 3.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.206 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -123.46 -167.74 1.66 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.311 -174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 6.4 m-20 -89.84 135.57 33.56 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.236 1.017 . . . . 0.0 109.295 -175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.896 HD21 ' HG ' ' A' ' 34' ' ' LEU . 3.9 mm? -79.07 143.56 35.46 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.892 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 33.3 tt0 -116.12 135.61 53.77 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.673 173.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.646 ' O ' ' HA ' ' A' ' 59' ' ' SER . 19.7 m95 -123.39 125.76 45.57 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.759 ' HD2' HD11 ' A' ' 43' ' ' ILE . 23.6 ttmt -123.35 143.05 50.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.374 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.489 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.7 mt -103.49 108.34 24.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.358 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.759 HD11 ' HD2' ' A' ' 41' ' ' LYS . 3.8 mp -107.06 109.31 27.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.5 0.667 . . . . 0.0 109.427 178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.78 ' CD2' ' HG3' ' A' ' 79' ' ' PRO . 22.9 t80 -89.9 109.59 20.6 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.214 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 93' ' ' THR . 25.3 t -69.71 96.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 85' ' ' PRO . . . -72.63 -32.54 61.57 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.202 -1.475 . . . . 0.0 109.965 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.789 ' HB2' ' C ' ' A' ' 50' ' ' SER . 4.1 p -88.55 75.93 8.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.37 -12.4 59.0 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 161.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -100.27 -45.69 5.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.331 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.789 ' C ' ' HB2' ' A' ' 47' ' ' SER . 49.4 m -103.42 -147.32 0.38 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -152.79 9.07 0.45 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.111 0.481 . . . . 0.0 110.476 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -98.19 -8.8 26.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.528 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.637 ' HB2' ' N ' ' A' ' 47' ' ' SER . 29.8 m-85 -95.8 1.9 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -168.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.32 104.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.026 0.917 . . . . 0.0 110.875 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.526 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 46.7 mt-30 -95.6 164.12 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.485 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 43' ' ' ILE . 49.5 t -131.07 112.21 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.639 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.5 mm? -82.29 -55.32 4.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.052 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.65 153.42 30.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.72 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 26.2 p -133.44 109.86 9.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -97.99 135.4 32.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.922 -169.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.8 mt -105.25 103.23 12.73 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.201 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.71 131.69 38.14 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -77.45 -159.51 11.26 Favored Glycine 0 CA--C 1.494 -1.248 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.998 -164.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.692 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 37.1 Cg_endo -63.71 114.78 2.71 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.693 -1.31 . . . . 0.0 108.693 173.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.733 HG21 ' HE2' ' A' ' 28' ' ' PHE . 35.1 m -110.71 145.36 32.17 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.85 -174.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 136.86 26.69 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.701 2.267 . . . . 0.0 111.448 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -46.76 139.28 5.46 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 111.28 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 128.84 135.1 3.91 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -174.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.895 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.2 ptt180 -76.65 130.4 37.75 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 122.432 1.111 . . . . 0.0 111.062 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 12.5 p80 -149.98 143.61 25.31 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.038 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.648 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.2 OUTLIER -93.02 146.44 23.62 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.566 0.698 . . . . 0.0 112.537 -174.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.56 ' N ' ' HG2' ' A' ' 71' ' ' MET . 3.0 p90 -133.6 160.74 36.6 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 1.7 p -118.75 139.32 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 121.734 0.778 . . . . 0.0 111.091 -172.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.734 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -121.96 125.87 47.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.95 -166.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.792 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 42.2 mt-30 -144.19 148.23 34.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.989 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -171.02 128.62 0.73 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.569 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.608 ' O ' HD12 ' A' ' 57' ' ' LEU . 6.0 p-10 -62.12 165.11 6.0 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.646 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.532 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -59.01 160.73 10.51 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -170.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.78 ' HG3' ' CD2' ' A' ' 44' ' ' TYR . 60.5 Cg_endo -67.67 178.67 3.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.75 2.967 . . . . 0.0 111.673 175.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 91.6 m-20 -72.13 119.45 74.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.249 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -64.07 -19.58 66.45 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.347 2.698 . . . . 0.0 111.756 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.19 -9.1 77.24 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.361 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.526 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 5.7 mt -94.1 -25.36 17.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.993 0.396 . . . . 0.0 110.91 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.56 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 21.2 mt -78.7 127.84 79.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.797 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 96.3 Cg_endo -78.21 163.23 27.93 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 123.396 2.73 . . . . 0.0 112.231 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.676 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 15.2 t70 -44.53 -57.06 3.83 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.32 1.048 . . . . 0.0 113.614 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' B' ' 122' ' ' LYS . . . -74.22 -20.88 60.03 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.776 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.87 -33.82 22.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.356 0.598 . . . . 0.0 109.658 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -77.2 -42.51 37.24 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.752 -171.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 130' ' ' PRO . 2.4 m -103.08 47.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.634 0.73 . . . . 0.0 112.075 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -119.98 0.55 Allowed Glycine 0 CA--C 1.504 -0.601 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.15 -169.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.463 HG13 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -112.88 141.15 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.01 ' HB ' HG13 ' A' ' 113' ' ' VAL . 24.2 m -143.08 167.96 20.86 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 112' ' ' TYR . 3.2 t -134.42 139.08 48.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 170.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 111' ' ' TYR . 1.8 p -119.82 104.97 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.2 pp -101.27 131.51 47.25 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.385 -172.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.737 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.2 mt -99.42 92.68 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.79 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 73.1 p -91.09 112.99 25.13 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 106' ' ' PHE . 89.7 m -76.69 156.29 32.66 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.008 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 6.0 m -150.96 108.66 3.67 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -170.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.685 ' CZ ' HD12 ' A' ' 34' ' ' LEU . 79.5 t80 -126.76 132.77 50.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HG2' ' CD2' ' A' ' 101' ' ' TYR . 19.3 mmm180 67.22 12.56 9.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.493 0.496 . . . . 0.0 111.998 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.6 56.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.118 174.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.803 ' CG ' ' HB ' ' A' ' 151' ' ' ILE . 0.0 OUTLIER -121.2 149.17 43.24 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 177.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 23.8 mp0 -95.66 134.59 38.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.069 -169.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 99' ' ' CYS . 53.4 p90 -120.52 -3.76 9.86 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -170.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.828 ' O ' ' HA ' ' A' ' 98' ' ' THR . 10.6 tt -155.48 161.21 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 O-C-N 121.209 -0.932 . . . . 0.0 109.058 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.834 HH21 HG21 ' A' ' 147' ' ' THR . 0.4 OUTLIER -153.91 99.47 2.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.927 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 3.3 p -87.16 101.79 11.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.088 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 145' ' ' ARG . . . -86.8 86.52 1.55 Allowed Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 118.943 -1.598 . . . . 0.0 111.129 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.884 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.6 m-85 -73.91 115.2 13.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 114.276 -0.962 . . . . 0.0 109.538 175.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 140' ' ' LEU . 3.3 m-85 -67.06 112.94 4.66 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.022 -1.071 . . . . 0.0 108.479 174.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.01 HG13 ' HB ' ' A' ' 93' ' ' THR . 2.4 p -104.31 111.31 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.463 HD21 HG13 ' A' ' 92' ' ' VAL . 1.6 t-20 -96.5 113.65 25.24 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.852 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 25.8 m-20 -94.65 109.15 21.11 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 121.48 0.657 . . . . 0.0 109.415 -170.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -126.47 124.41 40.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.828 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.607 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 42.9 m-85 -39.39 149.43 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 136' ' ' GLN . 29.8 p -87.58 -32.82 19.14 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.544 -174.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HB2' ' HG ' ' A' ' 122' ' ' LEU . 16.2 mt-10 -87.78 126.39 34.98 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.262 178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.596 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 22.0 m -56.27 -31.22 63.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.164 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.64 -37.89 76.94 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.595 0.712 . . . . 0.0 110.008 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 45.2 mt -71.29 -25.41 62.43 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.329 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -73.81 -36.94 65.04 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.598 0.713 . . . . 0.0 109.136 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 120' ' ' THR . 8.6 mm-40 -66.82 -36.78 83.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.982 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -143.42 87.99 8.19 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.679 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 115.04 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.664 2.243 . . . . 0.0 110.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.607 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 89.2 Cg_exo -51.06 163.77 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.847 2.364 . . . . 0.0 111.783 177.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 129' ' ' LYS . 40.5 t -51.87 -52.17 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.166 -167.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.559 ' HD3' ' HD2' ' A' ' 130' ' ' PRO . 1.7 mmtt -116.96 121.24 32.89 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 121.435 0.636 . . . . 0.0 110.928 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.676 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 16.3 Cg_exo -35.32 131.73 0.24 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 1 C-N-CA 125.778 4.319 . . . . 0.0 114.34 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' HB3' ' HE1' ' A' ' 117' ' ' TYR . 17.0 t70 -105.42 109.27 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.71 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 40.2 m-85 -75.32 -17.26 60.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.94 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -84.2 -25.43 29.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.262 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 72.8 mmtt -95.51 6.16 49.69 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 115' ' ' ASN . 31.1 tp -92.36 127.84 37.99 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.578 -173.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 1.3 tt0 -111.6 114.46 27.53 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.782 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.9 ptt180 -90.46 111.44 22.71 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.413 0.625 . . . . 0.0 111.05 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 19.7 t30 -87.89 98.06 11.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.105 174.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.539 HG21 HG11 ' A' ' 11' ' ' VAL . 2.2 mp -73.43 101.66 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 112' ' ' TYR . 76.7 mt -63.0 89.13 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.325 0.583 . . . . 0.0 110.792 -176.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.884 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -77.83 -9.71 59.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.96 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 144' ' ' PRO . 5.7 p -79.55 -15.6 57.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 172.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.422 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 47.3 t-20 -128.29 66.69 73.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.94 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 142' ' ' SER . 4.5 Cg_exo -83.05 105.01 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.03 1.82 . . . . 0.0 110.616 170.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -83.7 81.32 8.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.46 ' CG1' HG23 ' A' ' 109' ' ' VAL . 7.2 m -79.28 106.68 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.543 . . . . 0.0 111.722 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.834 HG21 HH21 ' A' ' 108' ' ' ARG . 42.0 m -110.45 105.34 14.29 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -113.13 123.82 51.14 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.597 0.713 . . . . 0.0 110.396 -175.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.02 168.24 9.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.728 -172.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -104.11 111.92 24.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.803 ' HB ' ' CG ' ' A' ' 104' ' ' GLN . 18.3 pt -118.13 172.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.893 -174.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 154' ' ' GLU . 3.4 p30 -101.98 97.67 7.98 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.595 1.188 . . . . 0.0 109.903 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.488 ' HA ' ' CD2' ' A' ' 101' ' ' TYR . 13.1 m95 -67.98 0.82 3.15 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.732 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 152' ' ' ASN . 34.6 mt-10 -135.27 -166.97 1.92 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.584 -173.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -97.49 71.84 2.33 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 C--O 1.252 1.199 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.162 -178.157 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -166.84 131.11 2.0 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.045 0.423 . . . . 0.0 111.602 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 75.4 mtp -84.21 146.19 27.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.576 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.82 94.83 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.139 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.6 ' HE2' ' HB1' ' A' ' 87' ' ' ALA . 12.9 mptt -73.99 -37.07 64.54 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.529 -0.395 . . . . 0.0 110.483 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -37.11 -53.07 1.02 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 10.0 tp -70.9 -29.08 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.782 0.325 . . . . 0.0 111.2 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' B' ' 129' ' ' ARG . 10.8 mm100 -65.69 -50.99 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.469 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.593 ' O ' HG13 ' B' ' 130' ' ' ILE . 2.5 mm? -63.82 -40.59 96.97 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' B' ' 125' ' ' GLN . 5.3 ptm180 -67.94 -25.87 65.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.66 ' HB3' ' HB2' ' B' ' 133' ' ' GLU . 15.7 mmm180 -80.08 -28.04 39.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.638 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 65.2 mt -76.77 1.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 122.088 0.947 . . . . 0.0 109.263 169.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' B' ' 131' ' ' ARG . 6.6 tpt180 -99.64 -36.32 9.54 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.212 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.57 24.42 0.31 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 119.415 -1.374 . . . . 0.0 115.079 -172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' B' ' 129' ' ' ARG . 7.8 tp10 -76.55 -6.85 53.66 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.619 0.709 . . . . 0.0 111.395 176.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.785 ' HA ' HG21 ' A' ' 98' ' ' THR . 2.1 ptm180 -24.86 -52.89 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.254 1.021 . . . . 0.0 113.4 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.565 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.103 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' SD ' ' HA ' ' A' ' 150' ' ' HIS . 9.8 ttt . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.494 0.187 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.783 ' HB3' ' CD1' ' A' ' 153' ' ' TRP . . . -100.4 -65.46 0.97 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -171.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.869 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 2.5 mptp? -101.17 -21.34 14.97 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -168.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 38' ' ' LEU . 6.5 t -148.81 145.54 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.095 ' HG2' HD11 ' A' ' 31' ' ' ILE . 20.2 mm-40 -143.58 121.16 11.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.18 169.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.958 HG22 HD13 ' A' ' 107' ' ' ILE . 35.7 m -79.62 117.34 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 C-N-CA 117.583 -1.647 . . . . 0.0 109.274 171.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.448 ' N ' HD22 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -86.54 -73.38 0.46 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.522 -172.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -107.21 109.94 21.87 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.942 -178.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.61 ' N ' HD22 ' A' ' 8' ' ' ASN . 3.1 p -96.13 99.92 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.415 0.626 . . . . 0.0 109.352 169.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.985 HG23 ' HB3' ' A' ' 25' ' ' GLU . 4.1 m -91.19 98.23 8.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.829 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.754 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -76.43 129.67 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.471 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 23' ' ' GLN . 1.4 mt -99.59 -36.89 9.37 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.979 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.992 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 11.3 t70 -63.33 39.88 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.325 -2.216 . . . . 0.0 112.656 175.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.807 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -79.73 171.54 12.17 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.847 171.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.831 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.8 Cg_endo -52.65 103.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.5 1.466 . . . . 0.0 114.003 -146.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.567 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 14.9 m -133.37 169.77 13.09 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 112.863 -1.972 . . . . 0.0 109.183 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 76.1 Cg_exo -39.54 131.61 1.71 Allowed 'Trans proline' 0 C--O 1.21 -0.875 0 C-N-CA 122.943 2.429 . . . . 0.0 111.744 171.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.91 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 17.2 t80 -58.38 -17.86 23.46 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 133' ' ' SER . 7.1 m-30 -83.43 -3.99 58.08 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.781 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 33.0 p-10 -61.13 143.96 91.69 Favored Pre-proline 0 N--CA 1.447 -0.594 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 165.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.679 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 11.9 Cg_exo -83.37 135.99 7.44 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.643 2.229 . . . . 0.0 111.443 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.778 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 40.8 m-85 -50.49 113.38 0.87 Allowed 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 122.965 0.506 . . . . 0.0 111.351 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.992 ' H ' ' HB2' ' A' ' 13' ' ' ASP . 24.4 mt-30 -112.65 103.82 11.87 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.315 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.603 ' CD1' HD11 ' A' ' 97' ' ' ILE . 91.2 m-85 -108.51 149.79 28.34 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.985 ' HB3' HG23 ' A' ' 10' ' ' VAL . 40.7 tt0 -123.54 87.35 2.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 168.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG21 HG11 ' A' ' 6' ' ' VAL . 15.9 mt -79.97 137.06 22.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.499 -173.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 58.6 m -115.52 104.7 11.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.619 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.921 ' HB3' HG12 ' A' ' 6' ' ' VAL . 28.2 p90 -106.47 146.78 30.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.659 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 44.5 tt0 -100.2 114.57 28.09 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.721 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 10.0 m -71.85 101.48 2.64 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.095 HD11 ' HG2' ' A' ' 5' ' ' GLN . 1.3 mt -64.71 -34.09 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.263 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.527 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 35.1 mt-10 -142.92 179.87 6.76 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.338 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.79 128.58 35.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.959 0.409 . . . . 0.0 110.204 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.836 HD12 ' CE2' ' A' ' 101' ' ' TYR . 4.0 mm? -88.54 149.03 23.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.985 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.1 p -114.92 -37.22 4.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.978 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.743 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 27.3 tt0 -105.97 -171.34 1.88 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.743 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 30.7 m-20 -100.52 142.61 31.76 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.507 0.67 . . . . 0.0 110.62 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -81.47 119.61 23.95 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.059 173.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.754 ' O ' ' HA ' ' A' ' 99' ' ' CYS . 37.2 tt0 -102.57 88.04 3.14 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.802 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.825 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 61.7 m95 -80.76 119.75 23.75 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.774 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 11.6 ttmt -126.47 139.58 53.13 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.303 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.671 HG22 HG22 ' A' ' 95' ' ' VAL . 13.2 mt -103.22 109.21 26.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.759 HD11 ' HD2' ' A' ' 41' ' ' LYS . 4.2 mp -107.43 106.74 21.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.953 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.768 ' CE1' HG11 ' A' ' 113' ' ' VAL . 61.8 t80 -86.36 119.25 26.43 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.438 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.61 101.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.298 0.571 . . . . 0.0 109.625 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -47.23 88.79 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.523 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 41.2 t -128.79 128.16 43.41 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 121.766 0.793 . . . . 0.0 110.129 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -85.13 -2.59 58.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.232 170.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.76 -38.32 11.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.309 -1.314 . . . . 0.0 107.847 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.575 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 49.6 m -134.85 121.1 20.15 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.476 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.67 ' HB3' ' OE1' ' B' ' 125' ' ' GLN . 10.3 pt-20 -64.7 -14.11 57.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.269 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.69 1.77 11.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.61 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 89.9 m-85 -105.16 -0.81 26.19 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.498 ' OD2' ' HD2' ' B' ' 134' ' ' ARG . 31.6 p-10 -53.08 110.61 0.55 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.244 1.021 . . . . 0.0 111.488 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 4.4 mt-30 -92.58 170.01 10.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.426 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 43' ' ' ILE . 54.8 t -130.84 107.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.888 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.7 mm? -76.08 -41.2 51.2 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.362 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -176.46 170.93 2.45 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 45.5 p -145.63 118.05 8.49 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.8 p -100.03 134.73 38.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.715 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.6 mt -108.91 104.04 13.2 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.455 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 9.0 t -119.7 107.44 21.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.714 ' CA ' ' HA ' ' A' ' 37' ' ' ASP . . . -102.3 -104.08 2.78 Favored Glycine 0 CA--C 1.475 -2.469 0 C-N-CA 118.831 -1.652 . . . . 0.0 112.926 -164.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -44.48 113.45 0.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.127 1.884 . . . . 0.0 111.625 176.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 63' ' ' GLY . 30.3 m -141.9 122.68 8.55 Favored Pre-proline 0 N--CA 1.42 -1.96 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.871 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.07 130.48 22.95 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.184 1.923 . . . . 0.0 110.495 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.721 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.94 133.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.936 0.773 . . . . 0.0 112.117 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 151.64 117.12 0.74 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -173.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.932 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 24.2 ttt180 -66.21 111.87 3.66 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.772 0.796 . . . . 0.0 110.816 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 6.7 p80 -145.67 160.81 41.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.87 -173.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.667 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -112.97 141.64 46.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.515 0.674 . . . . 0.0 112.615 -174.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.627 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 3.2 p90 -131.69 160.21 36.11 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 172.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 9.8 p -119.24 138.22 50.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.695 0.76 . . . . 0.0 110.278 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.627 ' HB2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 t80 -139.93 121.15 14.84 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.365 -160.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.778 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 72.8 mt-30 -137.81 157.55 46.2 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.97 159.28 26.34 Favored 'General case' 0 C--O 1.209 -1.038 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.82 179.14 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.887 0.851 . . . . 0.0 112.824 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HA ' HH12 ' A' ' 137' ' ' ARG . . . -82.05 151.45 66.85 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.448 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.65 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 65.8 Cg_exo -53.79 153.6 19.06 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 123.995 3.13 . . . . 0.0 113.515 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.438 ' HB2' HD12 ' A' ' 83' ' ' LEU . 17.3 m120 -71.63 113.58 20.99 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.24 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -65.71 -21.28 58.85 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.891 2.394 . . . . 0.0 111.623 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 5.0 83.85 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.219 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.474 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 35.1 mt -113.38 -20.34 11.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.561 0.22 . . . . 0.0 111.213 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.572 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 30.2 mt -84.62 129.51 56.9 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.634 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HG2' ' OD2' ' A' ' 88' ' ' ASP . 1.2 Cg_endo -80.06 159.36 23.83 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.914 2.409 . . . . 0.0 112.128 172.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.762 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 4.7 m-20 -47.31 -50.19 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.444 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.38 -30.27 69.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -169.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.555 ' OD2' ' HG2' ' A' ' 85' ' ' PRO . 44.0 m-20 -93.94 -17.99 22.39 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -172.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.691 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.29 -47.49 23.53 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-O 121.173 0.511 . . . . 0.0 111.824 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -92.39 47.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.67 -122.58 0.68 Allowed Glycine 0 CA--C 1.5 -0.895 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.789 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.428 HG13 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -110.51 141.23 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-O 121.746 0.784 . . . . 0.0 112.456 -173.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.93 168.38 24.7 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.132 173.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.491 HG11 HD11 ' B' ' 130' ' ' ILE . 3.4 t -124.81 147.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.832 174.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.671 HG22 HG22 ' A' ' 42' ' ' ILE . 9.6 p -129.7 107.3 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.064 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.891 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.4 OUTLIER -103.01 135.43 44.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.272 -169.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.774 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 59.9 mt -102.18 93.07 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.803 0.811 . . . . 0.0 109.149 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 108' ' ' ARG . 51.9 p -93.96 114.93 27.23 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.592 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.954 ' SG ' HG22 ' A' ' 107' ' ' ILE . 7.0 p -84.82 137.32 33.24 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.947 175.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.656 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 51.9 m -118.8 114.94 23.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.255 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.836 ' CE2' HD12 ' A' ' 34' ' ' LEU . 45.3 t80 -127.32 126.3 42.34 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 102' ' ' ARG . 1.8 mmp_? 69.14 14.53 8.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.464 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.15 4.1 69.16 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -125.73 132.25 52.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.559 -0.82 . . . . 0.0 109.543 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 1.2 mp0 -76.26 142.06 41.5 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.009 -175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.737 ' CE1' ' HB2' ' A' ' 101' ' ' TYR . 2.8 p90 -115.68 -18.59 10.82 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.958 HD13 HG22 ' A' ' 6' ' ' VAL . 10.3 tt -159.7 156.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 172.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.682 HH21 HG21 ' A' ' 147' ' ' THR . 10.6 ttp180 -145.38 124.85 13.13 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -101.4 102.2 13.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 122.158 0.98 . . . . 0.0 109.758 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.55 79.98 1.84 Allowed Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 119.867 -1.158 . . . . 0.0 111.239 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.854 ' CE1' ' HA ' ' A' ' 141' ' ' ALA . 7.3 m-85 -79.72 123.13 27.39 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.566 ' CE2' HD23 ' B' ' 126' ' ' LEU . 5.8 m-85 -67.38 129.98 41.6 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.768 HG11 ' CE1' ' A' ' 44' ' ' TYR . 2.2 p -108.93 110.9 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.428 HD21 HG13 ' A' ' 92' ' ' VAL . 1.4 t-20 -96.72 121.17 38.28 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.21 -177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.691 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 52.4 m-80 -110.57 110.81 21.67 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.993 0.901 . . . . 0.0 109.017 -171.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -125.81 125.08 42.32 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.617 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.632 ' CE2' ' HD2' ' A' ' 127' ' ' PRO . 18.9 m-85 -39.97 146.61 0.11 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -85.49 -33.77 21.76 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.202 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -88.76 125.93 35.1 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 113.056 -1.884 . . . . 0.0 108.487 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -59.78 -28.21 67.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.789 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.14 -39.78 94.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.8 0.81 . . . . 0.0 109.614 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 77.6 mt -72.72 -27.87 62.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.713 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 43.3 mtp180 -76.4 -29.34 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.404 0.621 . . . . 0.0 109.412 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -67.31 -41.68 84.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.136 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -145.62 80.39 10.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.283 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.66 113.07 1.07 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.313 2.676 . . . . 0.0 112.455 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.632 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 52.7 Cg_exo -57.19 134.94 67.43 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.758 2.305 . . . . 0.0 110.702 174.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.527 HG13 ' HE2' ' A' ' 129' ' ' LYS . 3.4 p -56.02 -38.27 52.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.184 -171.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.527 ' HE2' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -91.09 107.72 23.15 Favored Pre-proline 0 N--CA 1.445 -0.701 0 CA-C-O 121.088 0.471 . . . . 0.0 110.444 169.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.762 ' CG ' ' HA ' ' A' ' 86' ' ' ASP . 35.6 Cg_exo -45.93 140.18 10.37 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 124.593 3.529 . . . . 0.0 113.366 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.553 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 15.5 t0 -110.44 107.27 16.89 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.648 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 38.2 m-85 -77.48 -20.0 55.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.996 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 64.7 p -85.88 -21.55 27.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.483 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.3 mmtt -102.79 17.12 24.66 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.567 HD11 ' HB3' ' A' ' 115' ' ' ASN . 19.0 tp -99.62 132.32 45.03 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.015 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.36 118.11 31.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.91 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -93.37 105.38 17.45 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.28 0.562 . . . . 0.0 111.257 -177.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 12.6 t30 -85.55 98.18 10.48 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.461 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.754 HG21 HG11 ' A' ' 11' ' ' VAL . 1.5 mp -70.66 107.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.08 86.29 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.578 0.704 . . . . 0.0 110.446 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -76.49 -11.29 59.86 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.729 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.7 t -88.24 6.18 38.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.928 174.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.437 ' N ' ' HD3' ' A' ' 144' ' ' PRO . 33.6 t-20 -139.16 64.92 34.59 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 143' ' ' ASN . 1.8 Cg_endo -84.37 105.61 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.33 2.02 . . . . 0.0 111.264 174.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.517 ' HB3' HD13 ' B' ' 130' ' ' ILE . 5.5 tpt180 -84.24 85.4 7.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 3.3 p -87.63 110.94 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.894 -174.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.682 HG21 HH21 ' A' ' 108' ' ' ARG . 90.2 m -112.05 107.69 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.814 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 7.0 ptt180 -105.39 135.82 46.07 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.485 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.422 ' HD1' ' C ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -110.26 170.59 7.98 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.843 -174.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.4 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 9.6 m170 -104.96 120.17 40.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.683 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.63 ' CD1' ' HB3' ' A' ' 101' ' ' TYR . 40.5 pt -132.38 155.84 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.056 0.455 . . . . 0.0 110.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.513 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -82.17 94.51 7.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.136 0.97 . . . . 0.0 110.686 175.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.869 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 9.8 m95 -69.34 -4.33 17.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.956 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.64 152.67 44.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -77.42 70.93 3.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.004 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.681 179.248 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.868 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 69.81 103.81 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.393 0.677 . . . . 0.0 111.157 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -79.19 123.55 27.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.779 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.06 167.72 43.66 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.106 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.503 ' C ' HD22 ' B' ' 126' ' ' LEU . 3.3 mptp? -97.7 -35.78 10.46 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -50.56 -32.95 20.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.139 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.43 HG23 ' N ' ' B' ' 125' ' ' GLN . 7.9 tp -69.37 -40.77 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 122.062 0.934 . . . . 0.0 109.576 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.68 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 6.6 tp-100 -71.69 -47.0 57.04 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.791 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.566 HD23 ' CE2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -59.94 -44.96 94.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.186 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.15 -44.93 94.59 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.054 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -53.98 -45.7 71.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.489 ' HB3' HD21 ' A' ' 96' ' ' LEU . 2.0 mmp_? -69.01 -45.84 69.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.374 -176.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' A' ' 108' ' ' ARG . 14.9 mt -75.11 -30.08 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.441 . . . . 0.0 111.546 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -90.78 -4.56 56.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.611 0.72 . . . . 0.0 109.388 176.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.8 -94.88 1.66 Allowed Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.299 -174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -157.18 -72.49 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.632 0.729 . . . . 0.0 111.962 -156.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.577 ' HD3' HG21 ' A' ' 43' ' ' ILE . 6.7 tpm_? 51.96 -72.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.853 -164.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.586 ' HA ' ' HG2' ' A' ' 105' ' ' GLU . . . . . . . . 0 C--O 1.25 1.116 0 O-C-N 123.816 0.698 . . . . 0.0 110.636 -168.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.546 ' HA ' ' NE1' ' A' ' 153' ' ' TRP . . . -69.3 133.68 48.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.67 ' HD3' ' HB2' ' A' ' 32' ' ' GLU . 11.9 mmtt -100.64 -11.64 19.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.282 -175.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.71 122.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.864 0.84 . . . . 0.0 110.772 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.531 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -121.3 100.18 6.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 171.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.742 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 1.1 m -79.45 140.17 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.306 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -120.13 -61.5 1.59 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.592 -164.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.681 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.2 t-20 -104.61 152.3 22.61 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.735 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' ILE . 2.6 p -147.08 99.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.843 HG23 ' HB3' ' A' ' 25' ' ' GLU . 2.0 m -93.18 97.71 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.332 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -72.58 128.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.049 -178.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.934 HD12 ' HG2' ' A' ' 23' ' ' GLN . 1.4 mt -98.59 -41.1 7.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.766 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.603 ' HB2' ' CB ' ' A' ' 23' ' ' GLN . 23.9 t0 -63.82 76.78 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.981 167.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -96.6 174.28 3.47 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 113.463 -1.699 . . . . 0.0 107.825 169.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.8 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.8 Cg_endo -51.71 104.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.797 1.665 . . . . 0.0 113.834 -157.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.649 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 37.3 m -135.01 171.03 9.69 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 112.579 -2.1 . . . . 0.0 109.46 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 89.8 Cg_exo -42.16 138.56 2.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.559 2.172 . . . . 0.0 112.148 174.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.834 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 28.2 t80 -55.83 -29.32 59.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.156 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.23 -19.69 53.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -62.02 132.47 93.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 172.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 21.2 Cg_exo -72.65 154.16 54.53 Favored 'Trans proline' 0 C--N 1.329 -0.467 0 C-N-CA 123.71 2.94 . . . . 0.0 113.577 -174.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 78.2 m-85 -62.97 133.94 55.4 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.934 ' HG2' HD12 ' A' ' 12' ' ' LEU . 7.3 tt0 -136.68 83.05 1.98 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.633 -170.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.738 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 97.3 m-85 -97.05 153.98 17.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.125 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.843 ' HB3' HG23 ' A' ' 10' ' ' VAL . 36.7 tt0 -132.34 87.66 2.45 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 169.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 14.6 mt -88.11 122.25 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.706 0.765 . . . . 0.0 112.738 -173.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.802 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 13.2 m -91.73 107.34 19.14 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.467 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.742 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 23.2 p90 -119.19 148.11 43.47 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.93 0.871 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.83 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 48.6 tt0 -103.45 114.93 29.59 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.39 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 5.0 t -73.36 107.08 5.46 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 171.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -74.98 -22.46 17.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 CA-C-N 113.78 -1.555 . . . . 0.0 109.773 -173.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.67 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 1.5 mt-10 -154.87 167.1 31.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.985 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.32 143.68 55.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.79 0.329 . . . . 0.0 110.549 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.783 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 15.1 mt -95.21 152.67 18.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.091 0.472 . . . . 0.0 111.504 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.3 t -113.13 -35.56 5.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.666 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.795 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 22.0 tt0 -110.36 -167.71 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.795 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 39.6 m-20 -98.29 141.6 30.99 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.573 0.701 . . . . 0.0 110.02 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.39 118.35 23.13 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.28 176.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 29.5 tt0 -105.72 90.13 3.3 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.86 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.604 ' CH2' HG11 ' A' ' 6' ' ' VAL . 16.5 m95 -78.58 153.28 31.31 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.838 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 2.9 ttmp? -153.31 140.59 19.55 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.213 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.13 115.32 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.842 HG12 HG12 ' A' ' 56' ' ' VAL . 88.0 mt -112.29 108.19 24.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 121.768 0.794 . . . . 0.0 109.855 -177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.649 ' CZ ' HG21 ' A' ' 93' ' ' THR . 76.7 t80 -88.18 130.91 34.93 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.084 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 53' ' ' TYR . 7.1 t -77.52 97.43 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 122.071 0.939 . . . . 0.0 110.01 173.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.786 ' O ' ' HA ' ' A' ' 84' ' ' ILE . . . -81.85 -2.94 90.7 Favored Glycine 0 C--O 1.214 -1.133 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.086 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.544 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 22.8 m -162.57 80.17 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.453 0.627 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.83 -0.73 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.141 0.576 . . . . 0.0 112.491 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 47' ' ' SER . 1.7 mm-40 -95.49 -25.61 16.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.341 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.609 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 15.7 m -118.96 -153.36 0.53 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.769 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.2 pt-20 -149.27 20.89 0.96 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.807 0.813 . . . . 0.0 110.835 171.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.48 -34.58 10.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.988 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.769 ' CE1' ' HA ' ' A' ' 51' ' ' GLU . 4.1 p90 -57.7 -49.17 77.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 112.993 -1.912 . . . . 0.0 112.738 -167.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.7 p-10 -34.95 105.3 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 125.235 1.585 . . . . 0.0 113.284 -158.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.551 ' CG ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -93.04 167.44 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.975 -175.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.842 HG12 HG12 ' A' ' 43' ' ' ILE . 19.9 m -128.0 124.97 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -176.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.546 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 4.1 mm? -89.54 -31.0 17.82 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.167 -172.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -175.39 159.27 2.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.064 170.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 35.2 p -136.71 112.42 9.45 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 176.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.458 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.7 p -99.49 132.25 45.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.823 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 11.1 mt -108.7 103.65 12.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.627 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.0 t -96.08 121.13 46.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 37' ' ' ASP . . . -86.17 -152.61 20.66 Favored Glycine 0 CA--C 1.482 -1.986 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.569 -164.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.7 Cg_endo -47.2 117.91 2.52 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 121.778 1.652 . . . . 0.0 109.468 168.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 34' ' ' LEU . 2.4 p -140.12 129.13 13.36 Favored Pre-proline 0 C--N 1.291 -1.963 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.654 -171.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.02 128.33 26.23 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.117 1.878 . . . . 0.0 111.092 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . -40.52 145.83 0.16 Allowed 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.077 0.86 . . . . 0.0 111.977 173.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 150.05 122.46 1.12 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.83 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.5 ttt180 -68.87 113.99 6.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.776 0.798 . . . . 0.0 109.789 175.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.487 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 7.1 p80 -150.89 150.95 31.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.164 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.802 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -91.73 134.31 34.84 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.92 -178.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.404 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -121.54 150.41 41.68 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 p -112.94 139.81 36.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.662 0.744 . . . . 0.0 110.666 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.738 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -127.47 119.19 25.54 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 -164.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 16.4 mt-30 -134.14 153.75 51.63 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -166.69 158.84 13.44 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.7 -175.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.686 0.755 . . . . 0.0 112.448 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . . . -88.51 151.89 48.81 Favored Pre-proline 0 N--CA 1.438 -1.055 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.784 175.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.711 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 52.3 Cg_exo -61.25 173.37 2.57 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.653 2.902 . . . . 0.0 113.071 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HB2' ' HG ' ' A' ' 83' ' ' LEU . 76.9 m-20 -87.14 115.73 63.67 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.185 -176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -60.48 -23.16 74.38 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.407 2.738 . . . . 0.0 112.294 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.46 -13.97 77.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.61 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.551 HD12 ' CG ' ' A' ' 55' ' ' GLN . 3.1 mt -90.06 -28.79 18.8 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 122.734 -0.274 . . . . 0.0 110.789 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.786 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 31.9 mt -75.33 125.96 88.31 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.483 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.8 Cg_endo -80.94 165.31 19.7 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.03 3.153 . . . . 0.0 113.462 171.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 8.7 t0 -42.74 -48.18 5.55 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.834 -1.53 . . . . 0.0 111.989 171.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.99 -20.93 51.67 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -168.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.446 ' HB3' HG23 ' A' ' 84' ' ' ILE . 12.8 t70 -89.96 -38.36 13.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.142 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -72.27 -41.27 66.91 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -163.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.77 47.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.59 -126.92 1.0 Allowed Glycine 0 CA--C 1.495 -1.172 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.222 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.555 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -104.66 132.65 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-O 122.162 0.982 . . . . 0.0 113.03 -172.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.748 ' HB ' HG13 ' A' ' 113' ' ' VAL . 15.8 m -133.07 167.44 20.31 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 113.0 -1.909 . . . . 0.0 106.976 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.722 HG12 HD23 ' A' ' 96' ' ' LEU . 37.0 t -133.6 141.47 44.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 120.877 0.37 . . . . 0.0 111.175 177.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 22' ' ' PHE . 27.1 m -124.13 106.6 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.722 HD23 HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -95.27 137.11 34.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.353 -174.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.838 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 9.1 mt -109.45 91.31 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.463 1.125 . . . . 0.0 108.89 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.1 OUTLIER -90.51 125.69 35.68 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.624 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.659 ' HB2' HG22 ' A' ' 107' ' ' ILE . 72.0 m -90.03 153.53 20.5 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.248 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 18.5 m -150.1 113.5 4.94 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -168.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.661 ' HB3' HD11 ' A' ' 151' ' ' ILE . 55.4 t80 -128.05 124.04 36.1 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 31.4 mtp180 64.28 35.77 9.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.461 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.82 -1.96 87.28 Favored Glycine 0 C--N 1.317 -0.482 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.554 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.418 ' NE2' HD21 ' A' ' 152' ' ' ASN . 19.0 mt-30 -118.62 131.25 56.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.085 0.469 . . . . 0.0 109.932 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 24.0 mt-10 -89.3 136.1 33.21 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.292 -173.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 51.7 p90 -122.91 0.99 9.27 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -169.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.828 ' O ' ' HA ' ' A' ' 98' ' ' THR . 15.0 tt -156.62 159.17 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 O-C-N 121.37 -0.831 . . . . 0.0 109.255 171.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.567 HH12 ' HA2' ' B' ' 132' ' ' GLY . 9.9 ttm180 -153.21 89.13 1.34 Allowed 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.588 0.555 . . . . 0.0 109.683 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.738 HG12 ' HB ' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -86.93 100.86 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.352 1.073 . . . . 0.0 108.332 177.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 96' ' ' LEU . . . -91.02 87.48 1.36 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.437 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.996 ' HE2' ' HA ' ' A' ' 141' ' ' ALA . 5.9 m-85 -74.57 116.67 15.52 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.488 ' CB ' HD12 ' A' ' 140' ' ' LEU . 7.1 m-85 -67.26 117.98 10.01 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.627 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.748 HG13 ' HB ' ' A' ' 93' ' ' THR . 9.0 p -99.7 110.24 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.555 ' ND2' HG13 ' A' ' 92' ' ' VAL . 0.8 OUTLIER -91.61 114.27 26.76 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.867 -176.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 86.3 m-20 -99.48 106.38 18.4 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 124.72 39.38 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.35 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 134' ' ' LYS . 28.1 m-85 -40.21 149.55 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.0 p -87.31 -33.64 19.15 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.783 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 17.1 mt-10 -86.63 134.16 33.64 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.716 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.585 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 90.6 m -57.17 -38.83 74.17 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.801 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -51.81 -39.51 58.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.053 0.93 . . . . 0.0 109.642 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 67.4 mt -84.13 -30.01 26.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.927 -173.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 23.4 mtp180 -77.63 -41.7 37.52 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.361 0.6 . . . . 0.0 110.025 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.778 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 2.8 pt-20 -79.09 -20.74 48.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.017 -173.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.778 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 0.3 OUTLIER -150.11 82.45 6.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-O 121.719 0.771 . . . . 0.0 109.987 169.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 15.7 Cg_endo -56.18 121.46 10.03 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.788 2.992 . . . . 0.0 113.103 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.565 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 17.5 Cg_exo -68.68 147.24 69.29 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.843 2.362 . . . . 0.0 110.583 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.5 p -61.7 -28.99 45.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.616 -174.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.503 ' HA ' ' HD3' ' A' ' 129' ' ' LYS . 2.1 mmtt -103.84 131.78 21.66 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.232 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.59 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 Cg_exo -70.06 140.94 42.73 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.527 2.818 . . . . 0.0 113.133 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 134' ' ' LYS . 8.7 t0 -119.6 111.41 18.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.605 ' CE1' ' HB ' ' A' ' 84' ' ' ILE . 18.5 m-85 -78.51 -22.81 46.81 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.005 0.907 . . . . 0.0 110.293 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 35.4 t -80.25 -17.7 51.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.212 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 75.8 mmtt -106.94 16.38 24.34 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.2 tp -102.4 126.5 49.45 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.191 -170.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.442 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -112.13 118.0 34.15 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.834 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -95.57 107.06 19.21 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.5 0.667 . . . . 0.0 111.081 -172.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 6.3 t30 -91.03 104.91 17.44 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.94 175.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.546 HD13 ' O ' ' A' ' 13' ' ' ASP . 3.6 mp -81.15 108.98 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.427 -177.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.488 HD12 ' CB ' ' A' ' 112' ' ' TYR . 91.4 mt -64.58 89.95 0.07 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.155 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.996 ' HA ' ' HE2' ' A' ' 111' ' ' TYR . . . -79.6 -7.13 58.33 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.259 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.8 p -93.24 -1.88 55.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.741 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -141.67 75.64 21.55 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 110.402 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 57.2 Cg_endo -88.15 106.41 0.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.37 2.047 . . . . 0.0 111.533 176.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -80.69 80.1 7.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.983 0.421 . . . . 0.0 110.586 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.541 ' HB ' HG23 ' A' ' 109' ' ' VAL . 4.9 p -94.6 111.18 24.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.428 0.632 . . . . 0.0 111.927 -173.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -108.65 106.36 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.467 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 3.6 ptt180 -113.45 131.42 56.03 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.527 ' HZ ' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -118.44 168.63 10.47 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.673 -174.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.51 152.81 21.24 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.057 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 101' ' ' TYR . 23.4 pt -143.07 174.71 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.418 HD21 ' NE2' ' A' ' 104' ' ' GLN . 0.2 OUTLIER -92.12 96.32 10.26 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.388 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.604 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 18.4 m95 -74.2 -6.52 48.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.514 0.673 . . . . 0.0 109.949 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -121.52 179.02 4.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.158 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -114.93 68.17 0.7 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.315 -176.733 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.07 -58.98 1.95 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 4.9 tpt 63.94 149.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.876 0.846 . . . . 0.0 112.223 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.6 -33.73 5.64 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 2.5 mppt? 71.96 -59.54 0.55 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.796 0.839 . . . . 0.0 112.875 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -44.38 -52.91 7.32 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 tt -61.92 -36.05 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 111.623 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.857 ' HA ' ' HG2' ' B' ' 128' ' ' ARG . 9.2 mm100 -74.96 -39.04 61.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.591 0.71 . . . . 0.0 110.936 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.568 HD23 HG11 ' A' ' 45' ' ' VAL . 29.0 mt -63.22 -36.77 84.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.936 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -68.76 -33.74 74.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.998 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.857 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 8.5 mmm180 -48.74 -47.38 41.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.344 0.592 . . . . 0.0 109.437 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.858 ' HD3' ' HB2' ' B' ' 133' ' ' GLU . 4.4 mmp_? -73.91 -48.79 28.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.689 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.936 HG13 ' HA ' ' B' ' 127' ' ' ALA . 2.6 pp -66.87 -17.68 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . 0.471 ' HG2' HD12 ' B' ' 130' ' ' ILE . 34.7 mmt180 -95.98 -23.9 16.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.607 0.241 . . . . 0.0 110.951 175.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.567 ' HA2' HH12 ' A' ' 108' ' ' ARG . . . 176.14 75.48 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.458 -176.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.858 ' HB2' ' HD3' ' B' ' 129' ' ' ARG . 1.2 pm0 -82.54 -56.2 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.88 0.848 . . . . 0.0 109.879 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.547 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 35.0 ttt180 -107.03 -47.41 3.7 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.377 -176.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.715 178.653 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.133 0.492 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 32' ' ' GLU . . . -90.5 149.17 22.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.844 ' HE2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -91.85 -21.16 20.78 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -177.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 30' ' ' CYS . 3.4 t -141.99 134.21 27.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.667 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.655 HE21 ' HA ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -137.09 105.39 5.73 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.316 176.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.754 HG12 ' CD1' ' A' ' 28' ' ' PHE . 27.5 m -70.29 149.79 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.301 174.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 29' ' ' GLU . 53.5 m-80 -127.93 -59.34 1.19 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.493 -1.685 . . . . 0.0 108.073 -168.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 2.8 t-20 -104.01 150.84 23.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.139 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.3 p -145.64 98.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -91.88 97.89 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 122.403 1.096 . . . . 0.0 108.858 -177.044 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -75.54 133.45 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.193 -177.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.01 HD12 ' HG2' ' A' ' 23' ' ' GLN . 8.7 mt -110.53 -42.62 4.04 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.626 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 2.9 p-10 -68.17 44.94 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.662 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.675 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.34 175.74 4.21 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.706 177.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 7.6 Cg_endo -49.78 103.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 0 CA-C-N 121.562 1.593 . . . . 0.0 113.187 -150.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.675 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 16.6 m -148.89 172.0 5.67 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 111.648 -2.524 . . . . 0.0 107.627 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 59.6 Cg_exo -37.16 130.21 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.774 2.316 . . . . 0.0 112.969 174.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.758 ' CE2' ' HB3' ' A' ' 132' ' ' PHE . 8.9 t80 -55.43 -27.9 50.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.422 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -78.5 -14.22 59.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -69.93 138.43 87.69 Favored Pre-proline 0 N--CA 1.447 -0.585 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.6 Cg_exo -73.34 133.07 18.66 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 112.76 -172.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.708 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 88.8 m-85 -56.62 121.17 9.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.149 -176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.01 ' HG2' HD12 ' A' ' 12' ' ' LEU . 9.6 tt0 -128.92 92.35 3.38 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.949 -157.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' A' ' 97' ' ' ILE . 83.9 m-85 -106.1 115.05 29.56 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.666 -174.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' A' ' 12' ' ' LEU . 22.1 tt0 -90.35 83.71 5.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.523 HG21 HG11 ' A' ' 6' ' ' VAL . 36.6 mt -82.12 141.4 15.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.671 0.748 . . . . 0.0 111.931 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.677 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 20.9 m -125.24 107.31 10.6 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.266 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.754 ' CD1' HG12 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -104.6 166.79 10.15 Favored 'General case' 0 CA--C 1.472 -2.027 0 C-N-CA 118.713 -1.195 . . . . 0.0 110.916 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 29.9 tt0 -117.65 107.54 14.34 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 112.816 -1.993 . . . . 0.0 106.023 168.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 4.3 m -72.46 108.04 5.33 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.597 HD11 ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -72.48 -33.62 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.307 -169.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.844 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 6.0 mt-10 -143.74 171.68 13.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 5.2 p-10 -76.53 131.72 39.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.099 0.476 . . . . 0.0 110.964 -173.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD12 HG22 ' A' ' 65' ' ' VAL . 7.9 mt -87.1 153.47 21.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.26 -174.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.2 t -112.6 -31.3 6.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.919 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.695 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 20.2 tt0 -122.33 -168.99 1.82 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.945 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.695 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 1.2 p-10 -92.94 147.59 22.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 110.36 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.592 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -95.59 122.87 38.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.219 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.657 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 22.9 tt0 -103.92 89.93 3.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.065 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.822 ' CE3' ' HB3' ' A' ' 99' ' ' CYS . 50.0 m95 -82.66 115.46 21.61 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 172.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 26.8 ttmt -118.02 138.98 51.84 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.052 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.613 HG22 HG22 ' A' ' 95' ' ' VAL . 4.8 mt -104.78 123.29 58.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 3.6 mp -114.15 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.796 -175.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.616 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.4 t80 -89.0 117.22 27.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.321 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.855 HG13 ' CE2' ' A' ' 53' ' ' TYR . 3.8 t -66.6 111.54 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.803 173.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.739 ' H ' ' HD2' ' A' ' 53' ' ' TYR . . . -81.32 -63.1 1.89 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.437 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.613 ' HA ' ' CD ' ' A' ' 85' ' ' PRO . 15.1 m -102.15 70.77 1.22 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' HB3' ' OD1' ' A' ' 88' ' ' ASP . . . -47.98 -28.4 2.73 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.61 0.569 . . . . 0.0 111.733 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' B' ' 122' ' ' LYS . 4.8 tt0 -67.64 -18.46 64.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.068 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.691 ' C ' ' HE1' ' A' ' 53' ' ' TYR . 24.2 m -115.25 -152.45 0.5 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.683 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.1 pt-20 -154.89 22.48 0.44 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.742 0.782 . . . . 0.0 111.05 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -100.18 -31.61 11.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.368 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.855 ' CE2' HG13 ' A' ' 45' ' ' VAL . 12.1 p90 -63.38 -42.53 98.85 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 125.752 1.621 . . . . 0.0 113.242 -168.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' N ' ' CD2' ' A' ' 53' ' ' TYR . 5.6 p-10 -23.55 113.64 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 O-C-N 125.033 1.458 . . . . 0.0 114.256 -161.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' HG2' HD12 ' A' ' 83' ' ' LEU . 1.4 mp0 -96.64 166.76 11.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.256 -175.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.91 118.53 50.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.65 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 3.9 mm? -87.72 -48.84 7.55 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.934 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -166.0 161.82 17.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.1 p -139.1 113.23 8.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.3 p -98.86 130.64 47.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 13.7 mt -101.16 104.05 15.12 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.961 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.12 116.84 36.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -67.74 -168.34 4.12 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.304 -168.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -67.56 112.26 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 N-CA-C 109.573 -0.972 . . . . 0.0 109.573 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.735 HG22 HD12 ' A' ' 34' ' ' LEU . 27.4 m -110.68 117.37 50.84 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.525 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 33' ' ' ASP . 59.6 Cg_endo -76.01 79.92 2.78 Favored 'Trans proline' 0 CA--C 1.51 -0.713 0 C-N-CA 122.513 2.142 . . . . 0.0 113.09 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . 52.43 174.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 112.629 -2.078 . . . . 0.0 112.494 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.74 117.53 3.35 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.107 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 ttt-85 -64.66 128.5 36.06 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.069 0.461 . . . . 0.0 110.312 172.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -164.84 158.23 17.17 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.103 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.486 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -113.37 144.46 42.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.411 0.624 . . . . 0.0 111.885 -175.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.501 ' CD1' ' HE1' ' A' ' 28' ' ' PHE . 2.1 p90 -132.37 160.33 36.65 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.1 127.44 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-O 122.46 1.124 . . . . 0.0 111.065 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.685 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -108.33 145.4 34.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.148 -168.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 22.2 mt-30 -150.08 152.04 34.16 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -159.68 118.64 2.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.599 0.237 . . . . 0.0 111.633 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.62 123.36 19.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.379 0.609 . . . . 0.0 112.246 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 18' ' ' PHE . . . -23.96 147.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 127.273 2.229 . . . . 0.0 116.962 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 38.7 Cg_endo -65.93 179.2 1.93 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.653 3.569 . . . . 0.0 112.722 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.41 122.12 85.47 Favored Pre-proline 0 CA--C 1.508 -0.654 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.393 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.45 -5.93 17.77 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.933 2.422 . . . . 0.0 111.471 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.17 -8.22 50.84 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.739 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 55' ' ' GLN . 27.0 mt -97.46 -8.73 28.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.046 0.45 . . . . 0.0 110.404 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.607 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 21.8 mt -95.33 125.39 50.14 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.158 171.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.613 ' CD ' ' HA ' ' A' ' 47' ' ' SER . 89.4 Cg_endo -79.84 162.92 23.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.696 2.931 . . . . 0.0 111.472 171.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.774 ' HA ' ' HG3' ' A' ' 130' ' ' PRO . 4.0 m-20 -46.5 -53.67 10.78 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.77 82.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.666 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.495 ' OD1' ' HB3' ' A' ' 48' ' ' ALA . 61.1 m-20 -87.79 -16.89 32.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.682 -173.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -76.24 -46.13 29.57 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.643 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.98 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.502 0.668 . . . . 0.0 112.053 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.94 -132.47 1.55 Allowed Glycine 0 CA--C 1.498 -1.026 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.571 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.624 HG13 ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -99.99 136.08 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.674 0.75 . . . . 0.0 112.785 -168.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.18 167.77 28.18 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.533 HG23 ' HG ' ' B' ' 126' ' ' LEU . 20.9 t -123.46 135.02 64.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.112 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.613 HG22 HG22 ' A' ' 42' ' ' ILE . 14.3 p -115.86 105.55 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 171.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.818 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.3 pp -103.41 147.68 26.82 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.728 -172.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.682 ' HB ' HG12 ' A' ' 109' ' ' VAL . 41.4 mt -112.26 102.87 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 121.667 0.746 . . . . 0.0 109.67 175.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 108' ' ' ARG . 78.0 p -101.32 110.05 22.0 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.668 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 1.005 ' SG ' HG22 ' A' ' 107' ' ' ILE . 11.9 p -75.62 152.2 37.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.81 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 31.3 m -142.01 103.26 4.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.616 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 89.9 t80 -113.18 122.11 46.52 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 152' ' ' ASN . 37.5 mtp180 68.58 23.17 7.36 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.107 0.479 . . . . 0.0 111.628 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.56 76.03 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.253 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 101' ' ' TYR . 0.0 OUTLIER -128.96 123.68 33.12 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.665 ' HG2' ' HG3' ' B' ' 134' ' ' ARG . 16.2 mp0 -82.25 136.19 35.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 -173.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 52.3 p90 -128.62 -0.32 5.51 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.005 HG22 ' SG ' ' A' ' 99' ' ' CYS . 5.2 tt -157.63 160.34 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 O-C-N 121.178 -0.951 . . . . 0.0 108.799 169.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.849 ' HB2' HG22 ' A' ' 98' ' ' THR . 15.9 ttp180 -150.16 104.39 3.26 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.818 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.7 p -88.9 99.51 9.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.624 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -88.23 82.01 1.56 Allowed Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.251 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.999 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.7 m-85 -72.8 120.81 18.94 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.408 177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.603 ' HB3' HD23 ' A' ' 140' ' ' LEU . 2.9 m-85 -66.84 123.7 20.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 44' ' ' TYR . 2.5 p -107.96 111.26 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.723 ' HB2' HD21 ' A' ' 140' ' ' LEU . 0.5 OUTLIER -98.43 113.54 25.57 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.767 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 38.7 m-80 -97.31 132.14 43.33 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.353 0.597 . . . . 0.0 110.032 -174.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.32 134.46 22.76 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.786 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.552 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 31.7 m-85 -49.56 151.32 1.67 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 136' ' ' GLN . 19.1 p -90.32 -34.42 15.72 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.013 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 9.1 mm-40 -75.32 121.98 23.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.791 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 30.9 m -50.3 -36.77 33.19 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.762 -172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -64.91 -40.16 94.65 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.615 0.722 . . . . 0.0 110.321 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . 70.8 mt -73.36 -22.24 60.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.654 -176.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 10.4 mtt180 -78.73 -36.75 42.8 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.791 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.7 mm-40 -61.32 -44.13 97.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.012 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -145.73 85.95 7.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.059 -176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.16 115.67 2.73 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.047 2.498 . . . . 0.0 112.092 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.43 164.12 33.93 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.142 2.561 . . . . 0.0 111.498 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.01 -62.46 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 123.076 0.235 . . . . 0.0 110.708 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -67.77 125.79 91.77 Favored Pre-proline 0 CA--C 1.514 -0.442 0 CA-C-O 121.731 0.777 . . . . 0.0 111.785 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.774 ' HG3' ' HA ' ' A' ' 86' ' ' ASP . 22.0 Cg_exo -70.27 139.2 37.92 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 124.215 3.277 . . . . 0.0 111.827 177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.588 ' CG ' ' HG2' ' A' ' 134' ' ' LYS . 30.1 t0 -117.07 104.04 10.84 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.758 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 37.0 m-85 -74.01 -16.11 61.07 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.039 -172.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.7 t -85.43 -21.51 28.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.283 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.588 ' HG2' ' CG ' ' A' ' 131' ' ' ASP . 47.0 mmtm -101.12 -0.5 36.04 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 115' ' ' ASN . 15.6 tp -85.95 123.51 31.37 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.308 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.493 ' HB2' ' CG2' ' A' ' 118' ' ' THR . 2.2 tt0 -108.39 116.93 32.89 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.837 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -99.56 119.63 38.37 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.74 -174.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.613 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 13.3 t30 -96.03 120.04 35.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.653 173.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.568 HG21 HG11 ' A' ' 11' ' ' VAL . 3.5 mm -88.34 102.13 12.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' A' ' 114' ' ' ASN . 3.1 mm? -60.21 84.6 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.999 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -63.47 -15.49 57.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.347 168.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.47 -18.14 55.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.107 171.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.99 60.21 33.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.176 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 84.6 Cg_endo -91.36 105.97 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.815 1.677 . . . . 0.0 110.741 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HB3' HD13 ' B' ' 130' ' ' ILE . 0.1 OUTLIER -82.13 81.54 8.02 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.305 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.554 HG12 HG23 ' A' ' 109' ' ' VAL . 17.0 m -78.55 114.54 19.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.378 0.609 . . . . 0.0 111.56 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.657 HG21 HH21 ' A' ' 108' ' ' ARG . 53.7 m -120.4 105.31 10.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.398 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.771 ' HB3' HG13 ' A' ' 107' ' ' ILE . 1.7 ptt180 -106.01 133.87 50.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.51 0.671 . . . . 0.0 110.65 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HD2' ' CA ' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -109.18 168.56 9.29 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.781 -176.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.518 ' HD2' ' O ' ' A' ' 150' ' ' HIS . 0.9 OUTLIER -103.51 139.7 38.51 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 173.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.1 pt -139.68 -177.9 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.533 ' O ' ' HD3' ' A' ' 102' ' ' ARG . 0.9 OUTLIER -102.41 82.64 2.2 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.428 0.633 . . . . 0.0 111.34 -172.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.723 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 11.1 m95 -69.05 -11.98 61.27 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.932 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.07 157.07 25.28 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -81.95 69.29 8.61 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.329 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.607 ' N ' HD22 ' A' ' 156' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.604 166.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.129 -0.389 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . 66.47 -175.52 0.19 Allowed 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.169 0.587 . . . . 0.0 111.144 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 54.6 mtm -112.35 -74.74 0.62 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.53 -178.97 19.33 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 171.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.528 ' HB3' ' CD2' ' B' ' 126' ' ' LEU . 12.0 mptt -81.23 -21.77 39.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.911 0.356 . . . . 0.0 110.214 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -35.23 -61.33 0.44 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.292 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 7.2 tt -69.39 -33.47 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.515 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 9.2 mm100 -63.23 -52.33 62.6 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.385 0.612 . . . . 0.0 110.822 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 94' ' ' VAL . 1.9 mm? -64.69 -36.37 84.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.129 177.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.97 -37.32 73.97 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.761 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 99.7 mtt180 -59.23 -47.83 83.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 111.156 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.679 ' CZ ' ' HG2' ' B' ' 133' ' ' GLU . 18.1 mmm180 -74.44 -21.67 59.5 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.286 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.523 HD11 HG21 ' A' ' 94' ' ' VAL . 23.3 mt -93.19 -7.76 10.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.613 0.721 . . . . 0.0 109.885 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -80.93 -29.28 35.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.469 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.692 ' HA2' ' OXT' ' B' ' 135' ' ' ALA . . . 165.91 53.19 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.4 -176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.679 ' HG2' ' CZ ' ' B' ' 129' ' ' ARG . 2.0 tm-20 -70.03 -70.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 168.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.665 ' HG3' ' HG2' ' A' ' 105' ' ' GLU . 1.8 tpm_? -74.04 -51.53 15.54 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.893 -176.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.692 ' OXT' ' HA2' ' B' ' 132' ' ' GLY . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.9 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.78 142.5 28.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.872 0.367 . . . . 0.0 110.096 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.757 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -91.42 -17.16 26.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.215 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.4 t -137.71 130.05 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.594 0.711 . . . . 0.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.503 HE22 ' HD3' ' A' ' 148' ' ' ARG . 26.1 tp60 -122.88 101.71 7.6 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.679 171.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -78.08 132.23 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 176.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -116.5 -69.58 0.84 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.207 -163.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.662 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.9 t-20 -93.04 152.68 19.15 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.8 -177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.4 p -146.4 107.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-O 122.244 1.021 . . . . 0.0 109.766 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.848 ' HB ' ' HB3' ' A' ' 25' ' ' GLU . 48.1 t -92.59 92.62 3.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.023 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.536 HG12 ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -76.45 120.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.309 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.005 HD12 ' HB3' ' A' ' 23' ' ' GLN . 4.6 mt -105.45 -40.11 5.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.647 -168.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 1.001 ' HB3' ' H ' ' A' ' 23' ' ' GLN . 17.4 p-10 -67.01 38.25 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.454 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' HA ' ' HB ' ' A' ' 139' ' ' ILE . 0.2 OUTLIER -78.46 174.53 5.88 Favored Pre-proline 0 C--N 1.306 -1.323 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.601 178.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.855 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 4.3 Cg_endo -50.05 103.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 121.802 1.668 . . . . 0.0 113.639 -153.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.644 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 19.5 m -146.34 171.43 6.44 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 111.236 -2.711 . . . . 0.0 106.715 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.646 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 45.5 Cg_exo -38.13 143.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.804 2.336 . . . . 0.0 112.407 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.908 ' HA ' ' HG3' ' A' ' 137' ' ' ARG . 11.3 t80 -60.42 -31.25 70.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.705 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -75.23 -11.27 60.03 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.608 0.242 . . . . 0.0 110.571 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.646 ' HB3' ' O ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -67.86 117.32 47.17 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 121.882 0.849 . . . . 0.0 109.271 168.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HB2' ' OE1' ' A' ' 23' ' ' GLN . 46.4 Cg_exo -60.04 169.08 5.15 Favored 'Trans proline' 0 C--N 1.327 -0.571 1 C-N-CA 125.434 4.09 . . . . 0.0 114.291 -173.055 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.798 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 99.1 m-85 -78.27 103.25 8.09 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.552 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 1.005 ' HB3' HD12 ' A' ' 12' ' ' LEU . 2.6 mp0 -104.81 109.8 21.9 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.508 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.716 ' CD2' HD11 ' A' ' 97' ' ' ILE . 83.2 m-85 -123.48 101.4 7.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 1.102 ' HG3' ' HB ' ' A' ' 73' ' ' VAL . 20.9 tt0 -86.16 82.65 7.98 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.344 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 7.1 mt -87.88 129.27 39.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.081 -176.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 12.3 m -103.01 104.73 14.94 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 20.7 p90 -112.6 141.87 45.85 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.64 0.733 . . . . 0.0 110.025 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.864 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.6 tt0 -101.7 117.87 35.76 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 67' ' ' ALA . 48.8 t -73.85 104.88 4.89 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.473 HG13 ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -71.48 -30.23 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.573 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.596 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 40.3 mt-10 -149.63 146.4 27.27 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.069 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' CB ' ' HA ' ' A' ' 66' ' ' PRO . 7.3 p-10 -60.24 138.88 57.85 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.739 0.649 . . . . 0.0 111.288 -170.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 38' ' ' LEU . 6.8 mt -95.35 151.08 19.58 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.876 -171.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.3 t -114.1 -25.75 8.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.307 0.575 . . . . 0.0 110.152 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.725 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 19.9 tt0 -121.39 -168.33 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.725 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.8 p-10 -94.41 135.4 35.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.506 0.669 . . . . 0.0 110.482 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -83.05 119.29 24.29 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.584 176.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 1.2 tm-20 -104.98 89.74 3.24 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.211 -171.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' O ' ' HA ' ' A' ' 59' ' ' SER . 9.6 m95 -82.25 139.93 33.94 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 3.0 ttmp? -138.92 145.69 40.16 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.326 -0.949 . . . . 0.0 111.831 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.3 mt -103.26 116.48 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.682 ' HB ' ' CD1' ' A' ' 96' ' ' LEU . 4.0 mp -113.92 107.25 22.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.818 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.0 t80 -92.78 115.45 28.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.667 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 t -59.29 107.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.65 12.77 61.24 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -134.13 62.1 1.66 Allowed 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.754 -0.723 . . . . 0.0 112.443 -175.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB1' ' HG3' ' B' ' 122' ' ' LYS . . . -79.64 -10.91 59.87 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.672 0.749 . . . . 0.0 108.982 165.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -100.12 -46.83 5.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.239 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.488 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 49.3 m -105.61 -134.38 0.33 Allowed 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.983 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 9.0 pt-20 -154.45 -19.72 0.13 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -90.46 2.86 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.031 0.443 . . . . 0.0 111.358 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 23.3 m-85 -93.61 0.36 56.52 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -176.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -54.07 95.92 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.89 0.852 . . . . 0.0 110.57 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -94.83 169.35 10.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.064 -173.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.0 t -126.11 117.65 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.996 -167.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.723 ' HG ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 mm? -85.88 -58.22 2.73 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.183 -172.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -153.35 152.6 31.28 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.134 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.2 p -134.75 110.87 9.51 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 72' ' ' PHE . 3.1 p -99.59 134.32 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.837 -171.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 10.6 mt -105.89 104.65 14.41 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.303 -176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -90.25 113.88 27.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -164.9 4.21 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.497 -167.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 64.5 Cg_endo -68.29 113.88 3.24 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 120.812 1.008 . . . . 0.0 109.685 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.713 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 27.4 m -120.94 134.34 24.32 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.812 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 33' ' ' ASP . 59.7 Cg_endo -81.57 78.68 3.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.106 1.871 . . . . 0.0 113.168 -176.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . . . 51.0 -171.83 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 112.63 -2.077 . . . . 0.0 111.943 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.47 135.73 8.11 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.864 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.4 ttp180 -73.1 115.21 12.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.043 0.925 . . . . 0.0 111.195 174.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -114.38 118.03 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.231 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.695 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 20.5 ttp -87.82 103.3 15.51 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 173.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.497 ' HE2' ' CE3' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -110.02 128.39 55.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.04 -178.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.102 ' HB ' ' HG3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -102.05 111.83 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 122.682 1.23 . . . . 0.0 111.376 -176.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -72.61 143.42 48.21 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.652 -2.067 . . . . 0.0 109.614 179.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.917 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 25.3 mt-30 -152.55 145.2 24.23 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 166.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -167.23 134.5 2.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.657 ' O ' HD12 ' A' ' 57' ' ' LEU . 10.4 p-10 -55.84 159.62 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.731 0.3 . . . . 0.0 110.756 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 79' ' ' PRO . . . -76.03 164.65 58.89 Favored Pre-proline 0 N--CA 1.443 -0.819 0 C-N-CA 123.061 0.544 . . . . 0.0 111.642 -167.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 78' ' ' ALA . 36.0 Cg_endo -59.57 163.38 13.11 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.116 2.544 . . . . 0.0 112.127 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.5 m-20 -69.52 117.17 50.25 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.989 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 19.4 Cg_endo -61.23 -22.18 73.89 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 123.678 2.919 . . . . 0.0 112.33 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.37 -10.97 69.95 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.086 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.47 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 24.0 mt -91.14 -31.28 16.28 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 122.685 -0.303 . . . . 0.0 110.491 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 89' ' ' ALA . 17.0 mt -74.76 124.73 89.82 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' O ' HG22 ' A' ' 84' ' ' ILE . 94.1 Cg_endo -79.15 163.51 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.776 2.984 . . . . 0.0 112.075 170.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.555 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 12.7 t70 -44.92 -55.42 5.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.02 62.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.25 0.548 . . . . 0.0 111.108 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 84' ' ' ILE . 10.9 t70 -97.25 -24.43 15.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.634 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -88.84 -46.26 9.09 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -101.34 49.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -170.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.79 -128.98 1.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.352 -168.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.744 HG22 ' ND2' ' A' ' 114' ' ' ASN . 21.5 t -109.89 133.61 54.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.598 -172.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.649 ' HB ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -144.16 170.42 16.0 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.616 HG23 HD13 ' B' ' 126' ' ' LEU . 3.3 t -129.89 145.42 35.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 118.719 0.69 . . . . 0.0 111.737 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.515 HG21 ' CE1' ' A' ' 22' ' ' PHE . 7.7 p -132.08 108.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.877 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 1.6 pp -107.37 147.3 30.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.255 -173.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.716 HD11 ' CD2' ' A' ' 24' ' ' PHE . 36.8 mt -114.91 105.6 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 109.303 175.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.768 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 56.6 p -100.49 116.57 32.74 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.977 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.675 ' HB2' HG22 ' A' ' 107' ' ' ILE . 76.4 m -81.83 123.22 28.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.11 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 28.3 m -113.32 120.29 40.62 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.676 ' HB3' HD11 ' A' ' 151' ' ' ILE . 61.3 t80 -123.22 117.35 25.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.255 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.586 ' HG3' ' CD2' ' A' ' 101' ' ' TYR . 10.1 mtp180 66.08 23.81 11.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.445 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.58 -6.05 54.94 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.892 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 151' ' ' ILE . 0.3 OUTLIER -111.26 132.52 54.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.931 175.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 33.4 mt-10 -83.38 130.06 35.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.595 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 50.0 p90 -118.29 1.5 11.86 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -173.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.846 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 8.4 tt -157.97 155.19 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.739 HH22 ' HG3' ' A' ' 145' ' ' ARG . 2.8 tmm_? -151.14 113.38 4.57 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 1.4 p -104.6 100.07 9.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 122.308 1.052 . . . . 0.0 109.689 176.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.504 ' HA3' HH11 ' A' ' 108' ' ' ARG . . . -93.03 87.14 1.2 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.98 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 144' ' ' PRO . 88.7 m-85 -76.13 146.58 39.15 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 140' ' ' LEU . 6.6 m-85 -83.2 132.47 35.06 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.818 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.5 p -108.84 109.31 27.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 171.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.744 ' ND2' HG22 ' A' ' 92' ' ' VAL . 4.0 t-20 -97.51 108.47 21.2 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.187 -177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.673 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 42.7 m-80 -97.03 110.58 23.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.04 133.74 49.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 39.3 m-85 -42.69 157.49 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -95.74 -30.84 13.5 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.438 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.67 ' HG3' ' HD2' ' A' ' 134' ' ' LYS . 4.3 mm-40 -86.33 128.73 34.97 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.571 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.707 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 93.3 m -48.48 -46.45 38.2 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.08 0.4 . . . . 0.0 111.841 -172.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -53.59 -37.33 62.87 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 122.234 1.016 . . . . 0.0 110.115 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.59 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 48.2 mt -84.53 -24.74 29.19 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.919 -174.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 117' ' ' TYR . 60.9 mtp180 -78.48 -40.43 35.48 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.936 0.874 . . . . 0.0 108.689 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.74 ' HG3' ' ND2' ' A' ' 125' ' ' ASN . 12.6 pt-20 -73.38 -29.78 62.85 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.977 -177.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.74 ' ND2' ' HG3' ' A' ' 124' ' ' GLU . 1.8 p30 -153.73 90.79 3.31 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.006 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.81 117.99 4.69 Favored 'Trans proline' 0 CA--C 1.513 -0.526 0 C-N-CA 122.889 2.393 . . . . 0.0 111.45 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.466 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 32.5 Cg_exo -59.5 151.38 69.45 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.375 2.05 . . . . 0.0 110.224 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.9 p -48.74 -29.02 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.286 -170.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.489 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -118.28 110.96 38.8 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-O 122.264 1.03 . . . . 0.0 113.451 173.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.629 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 7.0 Cg_exo -44.29 139.93 6.09 Favored 'Trans proline' 0 N--CA 1.455 -0.777 1 C-N-CA 125.386 4.057 . . . . 0.0 113.659 174.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 11.9 t70 -120.23 116.61 25.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.896 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.633 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 39.7 m-85 -79.18 -16.33 56.74 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.878 0.846 . . . . 0.0 111.026 -170.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.1 m -83.09 -24.78 32.53 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.344 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.67 ' HD2' ' HG3' ' A' ' 119' ' ' GLU . 73.3 mmtt -101.23 13.98 33.42 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 115' ' ' ASN . 24.4 tp -98.08 144.7 27.29 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.855 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -125.22 125.76 44.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.908 ' HG3' ' HA ' ' A' ' 18' ' ' PHE . 16.7 mtm105 -91.17 104.38 16.95 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.163 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.583 HD22 ' C ' ' A' ' 138' ' ' ASN . 0.1 OUTLIER -89.7 90.99 8.47 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 170.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.853 HD11 HH12 ' A' ' 137' ' ' ARG . 1.3 mm -71.57 115.41 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.898 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 112' ' ' TYR . 35.8 mt -78.73 75.22 5.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.851 0.834 . . . . 0.0 110.797 -173.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HA ' ' CE1' ' A' ' 111' ' ' TYR . . . -71.7 -19.99 61.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.472 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 p -73.65 -11.96 60.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.741 174.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -140.02 66.96 33.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.627 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.613 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 66.1 Cg_endo -87.64 105.92 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.822 1.682 . . . . 0.0 111.787 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.739 ' HG3' HH22 ' A' ' 108' ' ' ARG . 8.7 tpt180 -76.01 88.57 2.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.501 175.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.3 p -95.24 137.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.431 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 94.7 m -145.76 107.9 4.38 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.761 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.846 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 1.0 OUTLIER -96.86 149.98 21.25 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.423 0.63 . . . . 0.0 110.244 175.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -122.16 169.51 10.81 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.404 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -104.83 125.31 50.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.26 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 101' ' ' TYR . 13.7 pt -135.96 173.5 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 154' ' ' GLU . 4.8 p30 -95.38 109.5 21.65 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 122.171 0.986 . . . . 0.0 109.675 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.757 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 12.3 m95 -82.41 15.58 2.43 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.067 171.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 152' ' ' ASN . 63.2 mm-40 -122.04 -164.18 1.14 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.559 -176.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -127.67 71.15 1.34 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 171.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.769 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.46 79.14 6.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.837 -0.214 . . . . 0.0 110.72 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 90.4 mtp 58.29 -92.41 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.682 0.614 . . . . 0.0 111.89 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.58 -148.86 5.31 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.1 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.693 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 3.2 mppt? -71.59 -43.99 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.185 0.516 . . . . 0.0 110.643 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.72 -55.01 15.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.012 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.457 ' HA ' ' HB3' ' B' ' 127' ' ' ALA . 14.4 tt -73.9 -26.02 20.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.652 0.263 . . . . 0.0 111.209 -175.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.14 -45.34 85.43 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 122.068 0.937 . . . . 0.0 110.161 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' B' ' 122' ' ' LYS . 24.6 mt -65.17 -43.52 91.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.648 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' B' ' 124' ' ' ILE . . . -59.28 -39.1 81.86 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.568 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -66.92 -47.02 73.01 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.773 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.483 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 0.9 OUTLIER -62.81 -39.98 95.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.642 HG12 ' NH1' ' A' ' 108' ' ' ARG . 5.1 mt -56.31 -60.83 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 113.099 -1.864 . . . . 0.0 112.533 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . 0.454 ' N ' HG22 ' B' ' 130' ' ' ILE . 12.4 mmm180 -53.49 -42.73 67.61 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 123.424 0.453 . . . . 0.0 110.991 -173.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.762 ' HA2' ' NH2' ' B' ' 134' ' ' ARG . . . 155.8 70.36 0.01 OUTLIER Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.767 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 21.0 tt0 -108.25 -24.56 11.45 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.238 -175.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.762 ' NH2' ' HA2' ' B' ' 132' ' ' GLY . 0.0 OUTLIER -69.7 -75.46 0.11 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.785 0.802 . . . . 0.0 108.867 173.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.407 ' H ' ' HB2' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.423 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 150' ' ' HIS . 21.9 ttt . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.859 0.361 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' C ' ' HE3' ' A' ' 3' ' ' LYS . . . -67.26 155.73 38.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.481 0.658 . . . . 0.0 112.273 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.711 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 0.0 OUTLIER -95.14 -18.17 21.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.505 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.477 ' HB ' ' CH2' ' A' ' 153' ' ' TRP . 2.6 t -136.49 126.38 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 121.515 0.674 . . . . 0.0 110.241 173.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.588 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 18.7 tp60 -116.27 100.08 7.66 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.89 172.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -76.73 134.79 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.364 176.518 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -115.05 -62.72 1.56 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 -165.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.683 ' HB3' ' HB ' ' A' ' 27' ' ' THR . 3.7 t-20 -103.51 151.06 23.3 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.865 -176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.6 p -144.63 99.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.5 170.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.15 95.39 4.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.165 -179.252 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -67.31 125.3 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.699 177.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.99 HD12 ' HG2' ' A' ' 23' ' ' GLN . 7.3 mt -97.31 -52.31 3.86 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.184 -170.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.71 ' HB2' ' HB3' ' A' ' 23' ' ' GLN . 7.7 t70 -74.49 78.64 1.93 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.733 1.254 . . . . 0.0 110.456 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.715 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -82.38 178.09 2.63 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.437 165.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.895 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 5.9 Cg_endo -48.0 104.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.839 1.693 . . . . 0.0 114.619 -149.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.564 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 8.2 m -131.76 170.45 11.27 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 112.767 -2.015 . . . . 0.0 108.495 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 51.6 Cg_exo -46.85 144.58 7.91 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 111.636 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.712 ' HA ' ' HD3' ' A' ' 137' ' ' ARG . 11.3 t80 -61.36 -37.14 82.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.127 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -78.85 -0.85 32.3 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.897 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.597 HD21 ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -89.2 131.35 41.03 Favored Pre-proline 0 N--CA 1.431 -1.388 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 171.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 31.8 Cg_exo -63.72 150.12 89.2 Favored 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 123.792 2.995 . . . . 0.0 114.364 -168.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 95.0 m-85 -66.12 139.15 58.13 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.103 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.99 ' HG2' HD12 ' A' ' 12' ' ' LEU . 7.8 tt0 -133.83 99.43 4.45 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.139 -174.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.721 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 94.5 m-85 -103.37 155.72 18.27 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.294 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' ' 12' ' ' LEU . 39.5 tt0 -134.71 88.13 2.41 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.569 HG21 ' CZ3' ' A' ' 40' ' ' TRP . 14.0 mt -86.85 131.52 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.941 0.877 . . . . 0.0 112.366 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.683 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 24.6 m -108.53 108.1 18.88 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.345 173.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 32.5 p90 -120.0 148.05 44.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.778 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.875 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 72.0 tt0 -106.76 115.01 29.45 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.64 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 67' ' ' ALA . 49.0 t -72.68 111.64 8.02 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -77.67 -29.66 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.44 -174.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.619 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . 42.2 mm-40 -151.81 154.77 36.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 123.437 0.46 . . . . 0.0 110.054 -177.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.72 128.31 20.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.87 0.731 . . . . 0.0 111.256 -175.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.032 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -83.46 146.63 28.29 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.563 -170.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -113.2 -23.17 10.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.52 . . . . 0.0 111.384 -172.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.834 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 29.3 tt0 -129.51 -164.85 1.45 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.834 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.3 m-20 -95.27 137.17 34.7 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.597 HD11 ' HZ ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.6 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 47.8 tt0 -105.66 89.7 3.18 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.571 -171.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.67 ' O ' ' HA ' ' A' ' 59' ' ' SER . 23.4 m95 -80.34 124.67 29.06 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.7 ttmt -130.93 142.5 50.36 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.72 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.716 HG22 HG22 ' A' ' 95' ' ' VAL . 12.5 mt -103.62 112.97 39.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 3.3 mp -104.43 105.74 19.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.647 ' CE2' HG11 ' A' ' 113' ' ' VAL . 33.5 t80 -90.42 111.87 23.28 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.795 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -53.43 109.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.253 0.549 . . . . 0.0 109.846 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.61 -45.56 52.5 Favored Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.452 -0.88 . . . . 0.0 110.97 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.834 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 91.4 p -128.1 125.02 38.41 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.358 0.599 . . . . 0.0 111.515 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' O ' ' HG3' ' B' ' 125' ' ' GLN . . . -89.21 -0.1 57.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 161.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.584 ' HB2' ' HG2' ' A' ' 85' ' ' PRO . 4.8 mt-10 -88.5 -29.58 20.0 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.655 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 64.1 m -121.92 -107.88 0.35 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.593 173.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 52' ' ' GLU . 7.0 pt-20 -179.98 -47.92 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.173 0.189 . . . . 0.0 111.327 176.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 38.0 mt-10 -72.83 1.15 9.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.088 0.47 . . . . 0.0 111.777 -172.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.834 ' CD2' ' HB3' ' A' ' 47' ' ' SER . 2.0 m-30 -80.73 -7.93 59.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.91 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -44.01 108.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.207 1.003 . . . . 0.0 111.057 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.644 ' NE2' ' HB2' ' A' ' 83' ' ' LEU . 40.8 mt-30 -92.71 169.44 10.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.512 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' CG1' ' HD3' ' A' ' 41' ' ' LYS . 46.1 t -130.67 110.35 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -172.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 77' ' ' ASP . 3.6 mm? -75.54 -54.61 6.72 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.614 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' OD2' ' HE1' ' A' ' 74' ' ' PHE . 19.3 p-10 -160.38 170.43 21.05 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.822 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 67.5 p -146.92 115.39 6.7 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 3.1 p -99.63 134.65 38.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.382 -175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . 0.7 OUTLIER -105.94 103.92 13.51 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.048 -175.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.59 118.74 42.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -79.72 -162.33 24.69 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.219 -165.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.032 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 31.4 Cg_endo -63.5 117.36 4.32 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 121.784 1.656 . . . . 0.0 110.806 175.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.499 ' H ' ' HB2' ' A' ' 34' ' ' LEU . 23.1 m -128.0 137.56 31.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.857 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -82.02 77.23 3.91 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.23 1.953 . . . . 0.0 114.082 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . . . 51.85 177.37 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.116 -1.856 . . . . 0.0 112.618 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 110.68 129.62 5.61 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 172.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.875 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 21.3 ptt180 -79.87 128.06 33.0 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.321 1.058 . . . . 0.0 109.787 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.403 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 13.3 p80 -154.12 143.77 21.66 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.395 -177.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.53 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -92.85 136.23 33.43 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.533 -176.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 26' ' ' ILE . 6.4 p90 -121.36 160.09 24.76 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 168.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.46 134.13 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-O 121.882 0.849 . . . . 0.0 110.808 -171.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -115.95 129.75 56.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.345 -164.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 19.3 mt-30 -151.67 143.7 23.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.941 0.4 . . . . 0.0 110.542 177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 58' ' ' ASP . . . -169.11 138.43 2.11 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.835 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.639 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.2 p-10 -72.96 156.19 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.182 -174.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -44.1 156.93 0.3 Allowed Pre-proline 0 N--CA 1.443 -0.789 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -172.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.532 ' HG3' ' CD1' ' A' ' 44' ' ' TYR . 57.3 Cg_endo -66.97 170.57 12.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.841 3.027 . . . . 0.0 111.418 176.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 4.8 m-20 -66.55 117.83 48.07 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 17.0 Cg_endo -61.36 -25.74 80.6 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.544 2.829 . . . . 0.0 111.948 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.0 -11.29 82.77 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.311 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.644 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 25.2 mt -91.85 -21.91 20.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.644 0.259 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.515 ' HB ' ' CE2' ' A' ' 132' ' ' PHE . 10.1 mt -84.49 130.07 55.05 Favored Pre-proline 0 N--CA 1.451 -0.401 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.38 175.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.584 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 1.5 Cg_endo -79.96 161.19 23.95 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.123 2.549 . . . . 0.0 112.076 170.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.729 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -46.54 -53.32 11.56 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.07 69.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.178 0.513 . . . . 0.0 111.114 -167.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 9.8 m-20 -95.74 -19.88 19.32 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.754 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 115' ' ' ASN . . . -80.04 -47.28 15.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.52 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.748 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -96.5 48.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 121.702 0.763 . . . . 0.0 111.542 -176.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -170.83 -129.73 1.15 Allowed Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.089 -166.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.775 HG13 HD22 ' A' ' 114' ' ' ASN . 0.6 OUTLIER -119.91 125.3 74.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.344 0.593 . . . . 0.0 111.524 -173.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.14 169.65 15.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 173.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.611 HG23 HD13 ' B' ' 126' ' ' LEU . 2.4 t -126.45 142.53 42.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.266 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 42' ' ' ILE . 9.8 p -127.35 107.47 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 CA-C-O 122.14 0.972 . . . . 0.0 108.613 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -104.02 138.93 39.84 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.345 -171.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 2.3 mt -102.81 95.57 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.819 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 81.6 p -96.7 116.04 28.45 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.599 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.561 ' SG ' ' CE3' ' A' ' 40' ' ' TRP . 76.3 m -82.32 118.16 22.94 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.553 176.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 56.6 m -99.31 113.48 25.81 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.771 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.71 ' HB3' HD11 ' A' ' 151' ' ' ILE . 38.2 t80 -123.63 121.72 36.28 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.629 ' HG3' ' CD1' ' A' ' 101' ' ' TYR . 34.8 mtp180 63.02 27.37 15.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.063 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.35 66.51 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.653 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.12 135.44 55.17 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.165 0.507 . . . . 0.0 110.477 176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 2.4 mp0 -82.18 128.96 34.68 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.597 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 51.4 p90 -111.65 2.41 17.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.819 ' O ' ' HA ' ' A' ' 98' ' ' THR . 9.3 tt -156.93 158.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.845 HH21 HG21 ' A' ' 147' ' ' THR . 31.3 ttp180 -151.1 107.51 3.48 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 2.8 p -96.86 99.29 8.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 118.699 -1.201 . . . . 0.0 108.339 171.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.737 ' HA3' HG21 ' B' ' 130' ' ' ILE . . . -87.42 79.51 1.77 Allowed Glycine 0 CA--C 1.483 -1.962 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.123 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.871 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 7.9 m-85 -71.58 116.05 11.48 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.122 -1.039 . . . . 0.0 109.082 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.722 ' HB3' HD12 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.96 114.58 5.88 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.689 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.647 HG11 ' CE2' ' A' ' 44' ' ' TYR . 4.4 p -101.97 110.45 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.775 HD22 HG13 ' A' ' 92' ' ' VAL . 2.0 t-20 -96.87 120.91 38.08 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.471 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 89' ' ' ALA . 47.9 m-80 -108.12 108.95 20.24 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -169.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -127.45 125.01 39.78 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.18 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 29.6 m-85 -41.24 153.14 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -91.07 -32.81 15.74 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.077 -1.42 . . . . 0.0 108.749 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.562 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -82.39 130.04 35.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.788 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.631 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 8.7 m -56.31 -36.4 68.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.474 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -69.04 -37.82 78.78 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.564 0.697 . . . . 0.0 110.301 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.569 ' HB3' ' CG ' ' A' ' 117' ' ' TYR . 81.8 mt -71.58 -25.28 62.13 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.647 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 23.7 mtp85 -75.63 -37.88 59.37 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 120' ' ' THR . 14.2 mm-40 -57.65 -37.43 73.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.821 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.541 ' N ' HD22 ' A' ' 125' ' ' ASN . 0.0 OUTLIER -160.23 98.53 1.44 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.973 177.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 13.2 Cg_endo -56.5 114.6 1.99 Allowed 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 123.061 2.508 . . . . 0.0 111.341 173.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.4 152.26 33.37 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.494 2.129 . . . . 0.0 110.794 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.4 p -51.12 -24.49 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.979 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 26.0 mttt -123.95 108.21 30.45 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 121.703 0.763 . . . . 0.0 111.676 172.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.748 ' HB3' HG13 ' A' ' 90' ' ' VAL . 8.9 Cg_exo -45.02 141.83 5.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 125.091 3.861 . . . . 0.0 113.456 177.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -114.41 114.79 26.32 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.655 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 14.5 m-85 -78.11 -16.89 57.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.67 0.748 . . . . 0.0 111.303 -168.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -85.47 -20.45 29.71 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.355 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 74.7 mmtt -101.96 5.38 40.74 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' A' ' 115' ' ' ASN . 26.3 tp -86.82 143.68 27.37 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.362 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.465 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 2.3 tt0 -126.43 125.1 41.59 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.895 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 8.3 mtp-105 -83.68 104.34 13.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.889 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 5.5 t30 -98.32 103.5 15.46 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.695 HG21 HG11 ' A' ' 11' ' ' VAL . 1.5 mp -82.03 104.96 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.576 -173.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.722 HD12 ' HB3' ' A' ' 112' ' ' TYR . 83.5 mt -65.84 91.4 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.852 0.834 . . . . 0.0 111.029 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.871 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.88 -15.26 59.74 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.562 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 m -77.87 -16.01 58.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.411 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -134.35 67.27 72.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.19 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.578 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 90.5 Cg_endo -91.92 108.29 0.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.551 2.168 . . . . 0.0 110.951 175.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.614 ' HA ' ' NE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -75.53 80.29 2.55 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.504 -176.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 109' ' ' VAL . 5.2 m -79.18 111.16 15.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.845 HG21 HH21 ' A' ' 108' ' ' ARG . 31.3 m -132.15 106.61 8.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.142 0.496 . . . . 0.0 110.333 176.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.708 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -108.36 133.23 52.84 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.243 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.66 169.99 8.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.993 -174.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.403 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 9.2 m170 -102.47 116.97 33.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.162 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 101' ' ' TYR . 43.7 pt -119.55 179.59 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.194 0.521 . . . . 0.0 109.844 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.548 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -96.45 84.24 3.67 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 122.191 0.996 . . . . 0.0 112.242 -172.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.711 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 21.8 m95 -69.49 -9.27 53.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.321 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.569 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 4.5 mp0 -119.32 159.23 24.53 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.583 ' HA ' HH12 ' A' ' 102' ' ' ARG . 36.3 t70 -83.43 70.16 10.16 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.631 0.729 . . . . 0.0 110.245 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 154' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.956 177.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.34 65.33 0.69 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.027 0.441 . . . . 0.0 110.718 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 57.8 mtp -91.12 138.49 31.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.32 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.61 92.77 0.75 Allowed Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.553 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.555 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 73.6 mmtt -60.89 -27.21 67.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.013 0.435 . . . . 0.0 110.42 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.16 -49.53 77.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.645 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . 0.495 ' O ' ' HG3' ' B' ' 128' ' ' ARG . 10.7 tp -75.78 -27.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.052 0.453 . . . . 0.0 110.571 -178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 48' ' ' ALA . 1.6 tm0? -56.48 -63.72 1.1 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.792 0.806 . . . . 0.0 109.905 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.611 HD13 HG23 ' A' ' 94' ' ' VAL . 62.0 mt -58.99 -44.08 91.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.486 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.892 ' HA ' HG13 ' B' ' 130' ' ' ILE . . . -57.25 -32.55 66.68 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 123.566 0.541 . . . . 0.0 111.74 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' B' ' 124' ' ' ILE . 96.1 mtt180 -53.11 -53.48 49.71 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 1.074 ' HA ' ' HB3' ' B' ' 133' ' ' GLU . 5.1 tpp180 -62.94 -38.57 91.58 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.641 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.892 HG13 ' HA ' ' B' ' 127' ' ' ALA . 0.3 OUTLIER -92.88 6.93 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -98.32 -39.08 8.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.981 0.419 . . . . 0.0 110.253 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.402 ' CA ' HH12 ' A' ' 108' ' ' ARG . . . 172.92 54.83 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.156 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 1.074 ' HB3' ' HA ' ' B' ' 129' ' ' ARG . 33.8 tt0 -133.0 6.43 3.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.402 0.62 . . . . 0.0 109.733 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.659 ' HG3' ' H ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -26.4 -75.33 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.817 -1.538 . . . . 0.0 113.301 178.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.659 ' H ' ' HG3' ' B' ' 134' ' ' ARG . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.872 176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ttt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.997 0.427 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.79 152.93 42.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.567 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.721 ' HB2' ' CE3' ' A' ' 153' ' ' TRP . 64.0 mmtt -100.3 -14.7 18.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.498 -174.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 38' ' ' LEU . 2.1 t -150.98 137.88 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.353 0.597 . . . . 0.0 112.503 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.776 ' HG2' HD11 ' A' ' 31' ' ' ILE . 23.8 mm-40 -128.53 115.4 18.06 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.951 172.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.912 HG12 ' HB3' ' A' ' 28' ' ' PHE . 5.0 m -78.13 134.71 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 C-N-CA 117.234 -1.786 . . . . 0.0 108.107 167.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.72 -62.09 1.49 Allowed 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.434 -166.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.473 HD22 ' C ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -103.64 99.87 9.69 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.168 177.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.643 HG11 HG21 ' A' ' 109' ' ' VAL . 3.0 p -95.84 97.86 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -93.54 97.06 6.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 122.236 1.017 . . . . 0.0 108.687 -174.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -73.15 135.26 28.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.659 -176.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.934 HD12 ' HG2' ' A' ' 23' ' ' GLN . 5.7 mt -106.48 -48.21 3.6 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -172.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -71.69 78.52 0.83 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.653 1.692 . . . . 0.0 109.659 167.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.673 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -85.91 178.32 2.38 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 112.22 -2.264 . . . . 0.0 107.023 162.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.848 ' HA ' ' O ' ' A' ' 137' ' ' ARG . 6.2 Cg_endo -49.43 103.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 CA-C-N 121.73 1.653 . . . . 0.0 113.242 -157.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.692 ' HB3' ' HD2' ' A' ' 17' ' ' PRO . 27.6 m -132.49 171.11 9.71 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 112.897 -1.956 . . . . 0.0 109.668 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' HD2' ' HB3' ' A' ' 16' ' ' SER . 53.1 Cg_exo -43.18 135.79 5.66 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.313 2.009 . . . . 0.0 111.253 172.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 132' ' ' PHE . 12.6 t80 -60.46 -26.66 66.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.325 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -80.17 -7.68 59.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.999 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -75.22 142.94 76.05 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 170.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 20' ' ' ASN . 16.4 Cg_exo -77.55 136.7 15.77 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 123.407 2.738 . . . . 0.0 113.139 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 75' ' ' GLN . 32.5 m-85 -57.43 116.43 3.33 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.532 0.682 . . . . 0.0 110.729 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.934 ' HG2' HD12 ' A' ' 12' ' ' LEU . 9.6 tt0 -116.39 106.47 13.66 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.941 -165.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.674 ' HB2' ' HB3' ' A' ' 74' ' ' PHE . 92.7 m-85 -110.32 154.01 24.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.564 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 24.5 tt0 -121.69 87.06 2.68 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 167.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.503 ' HB ' ' CE1' ' A' ' 72' ' ' PHE . 74.8 mt -82.99 125.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.624 0.726 . . . . 0.0 112.281 -174.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 37.8 m -107.71 106.38 16.68 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.037 174.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.912 ' HB3' HG12 ' A' ' 6' ' ' VAL . 29.1 p90 -113.94 146.25 40.35 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.677 1.227 . . . . 0.0 110.924 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.982 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 35.1 tt0 -101.28 113.42 26.46 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.579 178.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.665 ' HB2' ' HA ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -72.14 109.79 6.16 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 174.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.776 HD11 ' HG2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -70.53 -32.07 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.8 -2.0 . . . . 0.0 108.56 178.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . 8.7 mm-40 -144.79 154.05 42.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.182 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.28 132.26 48.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.031 ' HB2' ' HA ' ' A' ' 64' ' ' PRO . 44.9 mt -83.06 158.63 22.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.682 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -113.1 -21.08 11.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.454 0.645 . . . . 0.0 110.532 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.759 ' HG2' ' H ' ' A' ' 37' ' ' ASP . 26.7 tt0 -126.44 -168.96 1.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.759 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 6.5 m-20 -90.63 149.91 21.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 34' ' ' LEU . 4.7 tp -96.38 123.65 40.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.435 -177.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HB3' ' HB ' ' A' ' 100' ' ' THR . 82.4 tt0 -107.9 92.11 3.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.699 -169.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.687 ' CZ3' ' HB2' ' A' ' 99' ' ' CYS . 46.2 m95 -88.64 127.78 35.58 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 22.7 ttmt -124.11 140.59 52.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.032 -175.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 HG23 ' CG2' ' A' ' 95' ' ' VAL . 56.2 mt -104.13 107.26 21.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.111 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.831 HG12 ' HB3' ' B' ' 135' ' ' ALA . 3.6 mp -103.01 112.88 38.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.443 -174.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' A' ' 57' ' ' LEU . 13.4 t80 -96.9 114.2 25.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.492 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.11 103.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.58 -44.91 96.41 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.607 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB3' ' CD2' ' A' ' 53' ' ' TYR . 43.9 t -134.36 135.32 42.61 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.532 0.682 . . . . 0.0 109.634 176.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . . . -83.61 -11.21 57.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -32.2 25.24 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.938 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.682 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 74.9 m -144.5 117.02 8.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.021 0.915 . . . . 0.0 111.342 166.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' OE2' ' HD3' ' B' ' 128' ' ' ARG . 9.0 pt-20 -66.89 -14.82 63.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.276 -176.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.2 -9.46 32.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.439 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.682 ' CE2' ' HB2' ' A' ' 50' ' ' SER . 95.4 m-85 -90.89 6.43 44.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.463 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -53.63 103.06 0.07 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.909 0.862 . . . . 0.0 111.13 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -101.24 167.48 10.17 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.21 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.36 122.5 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.334 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.71 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 10.8 mp -81.67 -62.69 1.57 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.56 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 76' ' ' ALA . 1.2 m-20 -147.23 163.35 36.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.211 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 51.4 p -138.49 116.78 11.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 2.6 p -99.4 131.9 45.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.734 -172.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 12.5 mt -102.92 104.19 14.39 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.184 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.38 125.1 47.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -73.11 -166.21 10.2 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.319 -163.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.031 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 28.4 Cg_endo -60.57 114.7 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.233 1.289 . . . . 0.0 109.285 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 63' ' ' GLY . 28.2 m -116.9 120.99 33.31 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.661 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.83 131.0 37.36 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.517 2.145 . . . . 0.0 110.429 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . . . -35.18 132.15 0.39 Allowed 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 124.26 0.975 . . . . 0.0 112.775 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 70' ' ' HIS . . . 156.94 118.96 0.58 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -172.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.982 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 36.2 ttt180 -65.21 114.63 4.83 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.719 0.771 . . . . 0.0 111.214 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.42 ' HD2' ' O ' ' A' ' 68' ' ' GLY . 5.9 p80 -149.07 156.2 41.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.128 -171.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 0.9 OUTLIER -106.05 151.18 25.0 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.516 ' N ' ' HG2' ' A' ' 71' ' ' MET . 1.3 p90 -140.75 160.75 39.36 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 171.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.461 ' HB ' ' CE ' ' A' ' 71' ' ' MET . 2.6 p -117.35 136.98 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 122.168 0.985 . . . . 0.0 111.567 -172.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.674 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 0.5 OUTLIER -118.07 138.14 52.44 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.49 -169.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.714 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 21.5 mt-30 -148.08 151.46 35.7 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 172.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.71 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -159.21 121.87 3.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.68 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.83 156.3 14.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 110.809 -174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 18' ' ' PHE . . . -55.05 151.36 16.8 Favored Pre-proline 0 N--CA 1.439 -1.008 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.516 -169.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HD2' ' CE1' ' A' ' 18' ' ' PHE . 64.3 Cg_endo -67.36 162.54 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.029 2.486 . . . . 0.0 110.16 177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 24.0 m-80 -60.9 119.04 41.22 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 80' ' ' ASN . 21.0 Cg_endo -66.76 -7.78 19.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.067 2.511 . . . . 0.0 110.796 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.46 1.3 55.8 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.978 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt -106.27 -27.81 10.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.996 0.398 . . . . 0.0 110.638 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 89' ' ' ALA . 15.9 mt -80.82 128.64 70.94 Favored Pre-proline 0 N--CA 1.45 -0.451 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.991 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 84' ' ' ILE . 72.0 Cg_endo -81.88 161.29 18.61 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 122.066 1.844 . . . . 0.0 111.394 172.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.687 ' HA ' ' CG ' ' A' ' 130' ' ' PRO . 1.5 t70 -46.0 -48.7 16.61 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.05 -36.88 68.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.994 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 48' ' ' ALA . 7.5 m-20 -106.8 -8.38 16.79 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.409 -172.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 84' ' ' ILE . . . -74.48 -43.8 54.39 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 111.178 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -100.6 46.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.593 -174.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.31 -138.63 2.75 Favored Glycine 0 CA--C 1.508 -0.367 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.452 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.791 HG23 HD22 ' A' ' 114' ' ' ASN . 0.9 OUTLIER -100.57 139.08 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -168.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.847 HG23 HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -157.61 169.9 23.62 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.001 171.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.689 HG12 HD23 ' A' ' 96' ' ' LEU . 94.9 t -120.95 133.1 68.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 121.05 0.452 . . . . 0.0 111.63 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 42' ' ' ILE . 3.0 p -117.15 107.13 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.711 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 0.0 OUTLIER -106.27 151.02 25.35 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.702 -177.038 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.736 ' HB ' HG12 ' A' ' 109' ' ' VAL . 61.6 mt -110.51 100.86 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-O 121.709 0.766 . . . . 0.0 109.037 175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.831 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 76.1 p -97.66 116.26 29.53 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.744 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.687 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 4.3 t -78.9 158.96 27.97 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.322 174.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' A' ' 39' ' ' GLU . 32.1 m -148.05 111.73 5.05 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.707 ' HB3' HD11 ' A' ' 151' ' ' ILE . 71.3 t80 -123.4 119.82 31.17 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.7 mtp-105 62.08 33.61 16.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.863 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.84 62.92 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.199 170.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.72 133.32 43.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 0.0 110.98 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 99' ' ' CYS . 3.1 mp0 -81.37 132.84 35.35 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.307 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' HZ ' HD11 ' A' ' 38' ' ' LEU . 55.0 p90 -125.73 2.06 7.47 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.831 ' O ' ' HA ' ' A' ' 98' ' ' THR . 11.3 tt -156.84 159.49 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' HA ' ' B' ' 130' ' ' ILE . 5.0 tmm_? -152.79 105.46 2.96 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.708 0.63 . . . . 0.0 109.559 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.736 HG12 ' HB ' ' A' ' 97' ' ' ILE . 2.3 p -95.0 102.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 96' ' ' LEU . . . -89.99 102.65 2.93 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 119.373 -1.394 . . . . 0.0 111.82 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.967 ' HE1' ' HA ' ' A' ' 141' ' ' ALA . 10.3 m-85 -98.96 121.98 41.62 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.573 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.572 ' CB ' HD12 ' A' ' 140' ' ' LEU . 57.2 m-85 -68.97 115.86 8.76 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.295 176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.847 HG13 HG23 ' A' ' 93' ' ' THR . 1.8 p -101.27 109.71 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 122.32 1.057 . . . . 0.0 108.28 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.791 HD22 HG23 ' A' ' 92' ' ' VAL . 14.4 t-20 -97.14 104.4 16.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.727 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.616 ' HB3' HD11 ' A' ' 135' ' ' LEU . 31.8 m-80 -89.55 110.16 21.04 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -127.02 130.16 49.45 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.69 ' OH ' ' HA ' ' A' ' 130' ' ' PRO . 25.9 m-85 -38.55 150.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -84.44 -34.32 23.49 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.223 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.519 ' HB3' ' HG ' ' A' ' 122' ' ' LEU . 10.6 tt0 -86.51 119.43 26.76 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 113.249 -1.796 . . . . 0.0 108.504 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.859 ' HA ' ' HE ' ' A' ' 123' ' ' ARG . 99.2 m -54.89 -31.3 59.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.084 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.18 -32.29 70.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 119' ' ' GLU . 92.0 mt -73.42 -27.05 61.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.253 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.859 ' HE ' ' HA ' ' A' ' 120' ' ' THR . 19.3 mtm180 -74.46 -38.18 63.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.616 0.722 . . . . 0.0 109.257 177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.722 ' HG3' ' O ' ' A' ' 120' ' ' THR . 45.9 mt-10 -58.66 -39.64 81.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.339 -1.301 . . . . 0.0 111.126 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 126' ' ' PRO . 2.4 p30 -146.8 86.13 6.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 125' ' ' ASN . 18.7 Cg_endo -57.43 114.36 1.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.789 2.326 . . . . 0.0 111.318 176.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.532 ' HD2' ' CE2' ' A' ' 117' ' ' TYR . 54.0 Cg_exo -55.17 141.74 79.56 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.265 1.977 . . . . 0.0 109.899 175.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.75 -13.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 O-C-N 123.972 0.795 . . . . 0.0 112.454 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -124.63 100.22 34.89 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.162 0.982 . . . . 0.0 111.824 167.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.69 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 7.7 Cg_exo -44.77 144.83 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.827 1 C-N-CA 125.453 4.102 . . . . 0.0 113.378 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.626 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 13.2 t70 -113.65 111.67 22.22 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.684 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 9.9 m-85 -75.93 -11.39 59.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.546 1.165 . . . . 0.0 110.596 -170.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -90.3 -34.5 15.71 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.056 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 117' ' ' TYR . 61.2 mmtt -92.79 17.67 10.09 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 172.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 33.1 tp -100.6 128.67 46.57 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.334 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.513 ' NE2' ' HB2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -120.72 110.93 16.97 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -176.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.848 ' O ' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.94 113.85 25.56 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.096 0.474 . . . . 0.0 111.681 -174.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.7 ' HB2' ' HB3' ' A' ' 15' ' ' PRO . 11.5 t30 -89.89 112.55 23.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 172.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.514 HG21 HG11 ' A' ' 11' ' ' VAL . 1.7 mp -83.71 103.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.313 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.572 HD12 ' CB ' ' A' ' 112' ' ' TYR . 86.3 mt -63.57 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.296 0.569 . . . . 0.0 110.938 -176.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.967 ' HA ' ' HE1' ' A' ' 111' ' ' TYR . . . -76.08 -11.82 60.01 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.738 178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.7 m -79.23 -3.33 45.3 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.574 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -143.79 71.08 17.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.94 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 111' ' ' TYR . 92.3 Cg_endo -89.72 106.54 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.292 1.995 . . . . 0.0 111.234 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.23 81.22 8.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.038 -177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.73 HG12 HG23 ' A' ' 109' ' ' VAL . 32.4 m -77.36 131.52 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 86.2 m -151.09 110.71 4.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.516 0.674 . . . . 0.0 110.566 177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 107' ' ' ILE . 5.6 ptt-85 -108.46 138.51 44.64 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.798 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 169.37 9.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.312 -176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -102.98 123.33 46.39 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.466 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 101' ' ' TYR . 37.3 pt -129.91 -177.2 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.631 0.729 . . . . 0.0 111.469 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.618 ' H ' HD22 ' A' ' 152' ' ' ASN . 0.1 OUTLIER -98.15 84.22 3.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.972 -171.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TRP . . . . . 0.721 ' CE3' ' HB2' ' A' ' 3' ' ' LYS . 63.7 m95 -69.45 -7.44 37.93 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 121.483 -0.76 . . . . 0.0 111.345 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -131.68 153.99 49.44 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.37 71.0 1.74 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.072 0.939 . . . . 0.0 111.534 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 . . . . . 0 C--O 1.247 0.927 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.837 173.116 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.35 -38.43 2.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.437 0.161 . . . . 0.0 110.872 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 72.0 mtm 65.87 -75.51 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.995 0.809 . . . . 0.0 111.11 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.91 152.76 47.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' LYS . . . . . 0.663 ' O ' ' HG ' ' B' ' 126' ' ' LEU . 39.5 mmtt -84.85 -36.27 21.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.075 0.464 . . . . 0.0 110.042 -171.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.488 ' HA ' HD12 ' B' ' 126' ' ' LEU . 16.0 t70 -31.11 -46.06 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 177.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 6.3 tt -73.82 -38.3 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.4 0.619 . . . . 0.0 110.489 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 1.6 tp-100 -66.36 -37.39 85.21 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.449 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.801 ' O ' ' HB ' ' B' ' 130' ' ' ILE . 20.0 mt -59.52 -50.32 74.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.299 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' B' ' 131' ' ' ARG . . . -62.65 -42.51 99.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.818 -177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.554 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 81.3 mtt180 -56.74 -65.1 0.67 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.349 0.595 . . . . 0.0 111.973 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.614 ' HD2' ' HG3' ' B' ' 133' ' ' GLU . 20.0 mmm180 -60.37 -30.5 69.61 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.118 -175.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.801 ' HB ' ' O ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -87.82 -7.48 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.215 -175.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' B' ' 127' ' ' ALA . 30.3 mmt180 -77.84 -36.32 50.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 141.13 65.12 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.42 176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.614 ' HG3' ' HD2' ' B' ' 129' ' ' ARG . 6.7 mm-40 -80.13 -42.38 23.61 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' B' ' 133' ' ' GLU . 9.8 ptt180 60.7 128.32 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 123.068 1.413 . . . . 0.0 112.45 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.831 ' HB3' HG12 ' A' ' 43' ' ' ILE . . . . . . . . 0 C--N 1.304 -1.372 0 CA-C-N 112.838 -1.983 . . . . 0.0 111.42 -176.325 . . . . . . . . 1 1 . 1 stop_ save_